<SEC-DOCUMENT>0001628280-25-038087.txt : 20250806
<SEC-HEADER>0001628280-25-038087.hdr.sgml : 20250806
<ACCEPTANCE-DATETIME>20250806072348
ACCESSION NUMBER:		0001628280-25-038087
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20250630
FILED AS OF DATE:		20250806
DATE AS OF CHANGE:		20250806

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVO NORDISK A S
		CENTRAL INDEX KEY:			0000353278
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-82318
		FILM NUMBER:		251187451

	BUSINESS ADDRESS:	
		STREET 1:		NOVO ALLE DK 2880
		CITY:			BAGSVAERD DENMARK
		STATE:			G7
		ZIP:			00000
		BUSINESS PHONE:		4544448888

	MAIL ADDRESS:	
		STREET 1:		NOVO ALLE DK 2880
		CITY:			BAGSVAERD DENMARK
		STATE:			G7
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NOVO NORDISK A/S
		DATE OF NAME CHANGE:	19900807

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NOVO INDUSTRI A S /DENMARK/
		DATE OF NAME CHANGE:	19890811
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>caq22025.htm
<DESCRIPTION>6-K
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i5f24413bd450420f8ea4b0735ad53ee5_1"></div><div style="min-height:49.61pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">UNITED STATES </font></div><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Washington, D.C. 20549</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">_________________________</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">FORM 6-K</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">_________________________</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">REPORT OF FOREIGN PRIVATE ISSUER</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Pursuant to rule 13a-16 or 15d-16</font></div><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">of the Securities Exchange Act of 1934</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">August 6, 2025</font><font style="color:#ff198d;font-family:'Frutiger LT 45 Light',sans-serif;font-size:10pt;font-weight:400;line-height:150%"> </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">_________________________</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">NOVO NORDISK A&#47;S</font></div><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(Exact name of Registrant as specified in its charter)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">_________________________</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Novo All&#233;</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">DK-2880 Bagsv&#230;rd</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Denmark</font></div><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">(Address of principal executive offices)</font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Form 20-F</font><font style="color:#000000;font-family:'Frutiger LT 45 Light',sans-serif;font-size:8pt;font-weight:400;line-height:150%"> </font><font style="color:#001965;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:150%">x  </font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:150%"> </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Form 40-F</font><font style="color:#000000;font-family:'Frutiger LT 45 Light',sans-serif;font-size:8pt;font-weight:400;line-height:150%"> </font><font style="color:#001965;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:150%">o</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Yes</font><font style="color:#000000;font-family:'Frutiger LT 45 Light',sans-serif;font-size:8pt;font-weight:400;line-height:150%"> </font><font style="color:#001965;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:150%">o </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> No</font><font style="color:#000000;font-family:'Frutiger LT 45 Light',sans-serif;font-size:8pt;font-weight:400;line-height:150%"> </font><font style="color:#001965;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:150%">x</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">If &#8220;Yes&#8221; is marked, indicate below the file number assigned to the registrant in connection with Rule 12g-32(b)&#58;82-________</font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_7"></div><hr style="page-break-after:always"><div style="min-height:86.74pt;width:100%"><div style="text-align:right"><font><br></font></div><div><img alt="newheadera.jpg" src="newheadera.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:281px"><font style="color:#ff198d;font-family:'Frutiger LT 45 Light',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;            &#160;&#160;&#160;&#160;</font><img alt="nn_logoxcmykxbluexsmalla.jpg" src="nn_logoxcmykxbluexsmalla.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:83px"><font style="color:#ff198d;font-family:'Frutiger LT 45 Light',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;                                                                                      </font></div><div><font><br></font></div></div><div><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">6 August 2025&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:5pt;font-weight:700;line-height:150%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">Novo Nordisk's sales increased by 16% in Danish kroner and by 18% at constant exchange rates to DKK 154.9 billion in the first six months of 2025</font></div><div><font><br></font></div><div style="margin-bottom:11pt;padding-left:11.25pt;text-indent:-9pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:5.62pt">Operating profit increased by 25% in Danish kroner a</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:125%">nd 29% at co</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:125%">nstant exchange rates (CER) to DKK 72.2 billion.  </font></div><div style="padding-left:11.25pt;text-indent:-9pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8.9pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8.8pt;font-weight:400;line-height:125%;padding-left:5.66pt">Sales in US Operations increased by 16% in Danish kroner (17% at CER). Sales in the US were positively impacted by gross-to-net sales adjustments related to prior years, including an adjustment related to the 340B provision of around DKK 3 billion in the second quarter of 2025. Sales in International Operations increased by 16% in Danish kroner (19% at CER)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8.9pt;font-weight:400;line-height:125%">. </font></div><div style="text-indent:9pt"><font><br></font></div><div style="padding-left:11.25pt;text-indent:-9pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:8.9pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8.9pt;font-weight:400;line-height:125%;padding-left:5.66pt">Sales within Diabetes and Obesity care increased by 16% in Danish kroner to DKK 145.4 billion (18% at CER), mainly driven by Obesity care growth of 56% in Danish kroner to DKK 38.8 billion (58% at CER) and GLP-1 diabetes sales growing 8% in Danish kroner (10% at CER). Rare disease sales increased by 14% measured in Danish kroner (15% at CER).</font></div><div><font><br></font></div><div style="padding-left:11.25pt;text-indent:-9pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:5.62pt">Within R&#38;D, Novo Nordisk will advance subcutaneous and oral amycretin into phase 3 development in weight management based on completed clinical studies during the first quarter of 2025. Further, within obesity, REDEFINE 11 has been initiated to investigate further the potential efficacy and safety of CagriSema, and semaglutide 7.2 mg (a higher dose of Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:125%">) has been submitted to the EU regulatory authorities.</font></div><div style="text-indent:9pt"><font><br></font></div><div style="padding-left:11.25pt;text-indent:-9pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.24pt">For the 2025 outlook, sales growth is now expected to be 8-14% at CER, and operating profit growth is now expected to be 10-16% at CER. Sales and operating profit growth reported in Danish kroner is now expected to be 3 and 5 percentage points lower than at CER, respectively. The lowered sales outlook for 2025 is driven by lower growth expectations for the second half of 2025, reflecting the persistent use of compounded GLP-1s, slower-than-expected market expansion and competition. The outlook is related to lower growth expectations for Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in the US obesity market, for Ozempic</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in the US GLP-1 diabetes market as well as for Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in select IO markets</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Novo Nordisk continues the global rollout of Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to more markets and invests in commercial activities towards driving market penetration for both Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174; </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and Ozempic</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</font></div><div style="text-indent:9pt"><font><br></font></div><div style="padding-left:11.25pt;text-indent:-9pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:10.5pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:5.06pt">In July, Novo Nordisk announced that Maziar Mike Doustdar will succeed Lars Fruergaard J&#248;rgensen as president and chief executive officer. Further, Novo Nordisk announced that it has decided to consolidate its research and development areas under the leadership of Martin Holst Lange. Lastly, Emil Kongsh&#248;j Larsen will succeed Mike Doustdar as executive vice president, International Operations. All changes are effective 7 August. </font></div><div style="text-indent:9pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8.9pt;font-weight:400;line-height:125%"> </font></div><div style="padding-right:-12.37pt;text-align:center;text-indent:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.481%"><tr><td style="width:1.0%"></td><td style="width:40.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.447%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">PROFIT AND LOSS</font></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">H1 2025</font></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">H1 2024</font></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Growth<br>as reported</font></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Growth<br>at CER*</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">DKK million</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net sales</font></td><td colspan="2" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">154,944&#160;</font></td><td style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">133,409&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Operating profit</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">72,240&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">57,780&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">29</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net profit</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">55,537&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">45,457&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">22</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N&#47;A</font></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Diluted earnings per share (in DKK)</font></td><td colspan="2" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12.49&#160;</font></td><td style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10.17&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">23</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N&#47;A</font></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">* CER&#58; Constant exchange rates (average 2024).</font></div></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr></table></div><div style="padding-left:7.09pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:130%">Lars Fruergaard J&#248;rgensen, president and CEO&#58; &#34;While delivering 18% sales growth in the first half of 2025, we have lowered our full-year outlook due to lower growth expectations for our GLP-1 treatments in the second half of 2025. As a result, we are taking measures to sharpen our commercial execution further, and ensure efficiencies in our cost base while continuing to invest in future growth. With more than one billion people living with obesity globally, including more than 100 million living in the US, and only a few million on treatment, I am confident that under Mike Doustdar's leadership, Novo Nordisk will maximise the significant growth opportunities, supported by a strong product portfolio and future pipeline&#34;.<br></font><font style="background-color:#ffff00;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:130%"><br></font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:130%">On 6 August 2025 at 13.00 CET, corresponding to 07.00 am EST, an earnings call will be held. Investors will be able to listen in via a link on novonordisk.com, which can be found under 'Investors' (the contents of the company's website do not form a part of this Form 6-K).</font></div><div style="height:74.27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.837%"><tr><td style="width:1.0%"></td><td style="width:22.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.065%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Novo Nordisk A&#47;S</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Investor Relations</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Novo Alle 1<br>2880 Bagsv&#230;rd<br>Denmark</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Telephone&#58;<br>+45 4444 8888<br>www.novonordisk.com</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">CVR Number&#58;<br>24 25 67 90</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div><div style="text-align:center"><font><br></font></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_10"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.895%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 2 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div style="margin-bottom:14pt;margin-top:14pt"><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">STRATEGIC ASPIRATIONS</font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">STRATEGIC ASPIRATIONS 2025 </font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">The strategic aspirations are objectives that Novo Nordisk intends to work towards and are not a projection of Novo Nordisk's financial outlook or expected growth. Novo Nordisk intends to describe how its activities develop in relation to each of the four dimensions on an ongoing basis. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Performance highlights for </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">the first six months of 2025 </font><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">(blue indicates second-quarter development)</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.738%"><tr><td style="width:1.0%"></td><td style="width:48.299%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.001%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.300%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">PERFORMANCE HIGHLIGHTS</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f7f6f5;border-top:0.5pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Purpose and sustainability (ESG)</font></td><td colspan="3" style="background-color:#f7f6f5;border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#f7f6f5;border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f7f6f5;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:150%">Progress towards zero environmental impact&#58;</font></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:21.25pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Overall CO</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:150%;position:relative;top:0.98pt;vertical-align:baseline">2</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">e emissions (scope 1, 2 and full scope 3) increased by 31% compared to the first half of 2024</font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:150%">Adding value to society&#58;</font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Medical treatment provided to 42.8 million people living with diabetes and 2.9 million people living with obesity</font></div><div style="text-indent:10.91pt"><font><br></font></div></td><td colspan="3" style="background-color:#f7f6f5;padding:0 1pt"></td><td colspan="3" style="background-color:#f7f6f5;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:150%">Being recognised as a sustainable employer&#58;</font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Share of women in senior leadership positions has increased to 43% from 41% end of June 2024</font></div><div style="margin-bottom:3pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f7f6f5;border-top:0.5pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Innovation and therapeutic focus</font></td><td colspan="3" style="background-color:#f7f6f5;border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#f7f6f5;border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f7f6f5;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:135%">Further raise innovation bar for Diabetes treatment&#58;</font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Ozempic</font><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:150%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</font><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%"> received positive opinion by CHMP for the treatment of peripheral arterial disease in the EU</font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:150%">to</font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:135%">Develop superior treatment solutions for Obesity&#58;</font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#000000;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#000000;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">CagriSema demonstrated superior weight loss in REDEFINE 2</font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#000000;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Oral semaglutide 25 mg for weight management submitted to the US regulatory authorities </font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">In-license agreements of a GLP-1&#47;GIP&#47;Glucagon triple agonist and two oral molecules,</font><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%"> incl Septerna for GPCR targets</font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Novo Nordisk to advance subcutaneous and oral amycretin for weight management into phase 3 clinical development </font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Initiation of phase 3b REDEFINE 11 trial with CagriSema</font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Semaglutide 7.2 mg submitted for regulatory approval in the EU</font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Once-weekly GLP-1&#47;GIP development terminated in weight management</font></div></td><td colspan="3" style="background-color:#f7f6f5;padding:0 1pt"></td><td colspan="3" style="background-color:#f7f6f5;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:150%">Strengthen and progress Rare disease pipeline&#58;</font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Sogroya</font><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:150%;position:relative;top:-2.44pt;vertical-align:baseline">&#174;</font><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%"> non-replacement indications submitted in US and Japan</font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Alhemo</font><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:150%;position:relative;top:-2.44pt;vertical-align:baseline">&#174; </font><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">(concizumab) for the treatment of haemophilia A and B without inhibitors, received positive CHMP opinion in the EU and is approved in the US</font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:150%">Establish presence in Cardiovascular &#38; Emerging Therapy Areas&#58;</font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Semaglutide 2.4 mg in MASH submitted for regulatory approval in Japan, </font><font style="color:#494949;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">the EU and in the US, in which it has been granted priority review</font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Phase 2 trial with zalfermin in MASH completed, and development terminated</font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#0094ff;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Phase 2 trial with CDR132L completed and initiation of two further phase 2 trials in patients with chronic heart failure and preserved or reduced ejection fraction</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f7f6f5;border-top:0.5pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Commercial execution</font></td><td colspan="3" style="background-color:#f7f6f5;border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#f7f6f5;border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f7f6f5;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:135%">Strengthen diabetes leadership to more than one-third&#58;</font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Diabetes value market share declined by 1.4 percentage points to 32.6% (MAT)</font></div></td><td colspan="3" style="background-color:#f7f6f5;padding:0 1pt"></td><td colspan="3" style="background-color:#f7f6f5;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:150%">More than DKK 25 billion* in Obesity care sales by 2025&#58;</font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Obesity care sales increased by 58% (CER) to DKK 38.8 billion</font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:150%">Secure a sustained growth outlook for Rare Disease&#58;</font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Rare disease sales increased by 15% (CER) to DKK 9.5 billion</font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:135%">e-t</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f7f6f5;border-top:0.5pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Financials</font></td><td colspan="3" style="background-color:#f7f6f5;border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#f7f6f5;border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f7f6f5;border-bottom:0.5pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:150%">Deliver solid sales and operating profit growth&#58; </font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Sales growth of 18% (CER)</font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Operating profit growth of 29% (CER), impacted by the impairment loss related to ocedurenone in 2024 and partially countered by impact related to the acquisition of the three former Catalent manufacturing sites</font></div></td><td colspan="3" style="background-color:#f7f6f5;border-bottom:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#f7f6f5;border-bottom:0.5pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:150%">Drive operational efficiencies&#58; </font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Operational leverage reflecting sales growth</font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:150%">Enable attractive capital allocation to shareholders&#58;</font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">Free cash flow of DKK 33.6 billion </font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">&#8211;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%;padding-left:14.5pt">DKK 36.5&#160;billion returned to shareholders</font></div><div style="padding-left:21.25pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interim dividend for 2025 of DKK 3.75 for each Novo Nordisk A and B share of DKK 0.10 will be paid in August 2025.</font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:150%">e</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font style="color:#0a2299;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">* on a full-year basis.</font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_13"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.895%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 3 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">PERFORMANCE HIGHLIGHTS</font></div><div><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">FINANCIAL HIGHLIGHTS FOR THE FIRST SIX MONTHS OF 2025 </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.738%"><tr><td style="width:1.0%"></td><td style="width:55.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.960%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.961%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">PROFIT AND LOSS</font></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">H1 2025</font></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">H1 2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;% change<br>&#160;H1 2025 to<br>&#160;H1 2024</font></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;% change<br>&#160;H1 2025 to<br>&#160;H1 2024 at CER&#185;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(Amounts are in DKK million, except for earnings per share</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net sales</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">154,944</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">133,409</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Gross profit</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">129,208</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">113,219</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Gross margin</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">83.4%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">84.9%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Sales and distribution costs</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(32,425)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(28,190)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Percentage of sales</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">20.9%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">21.1%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Research and development costs</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(21,998)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(24,772)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(11</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(11</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Percentage of sales</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">14.2%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">18.6%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Administrative costs</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2,536)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2,314)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Percentage of sales</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">1.6%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">1.7%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other operating income and expenses</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(9)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(163)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N&#47;A</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N&#47;A</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Operating profit (EBIT)</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">72,240</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">57,780</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">29</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Operating margin</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">46.6%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">43.3%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Financial items (net)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,402)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(530)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N&#47;A</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;N&#47;A</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Profit before income taxes</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">70,838</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">57,250</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">24</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;N&#47;A</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Income taxes</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(15,301)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(11,793)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">30</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;N&#47;A</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Effective tax rate</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">21.6%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">20.6%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net profit</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">55,537</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">45,457</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">22</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;N&#47;A</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Net profit margin</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">35.8%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">34.1%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">OTHER KEY NUMBERS</font></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Depreciation, amortisation and impairment losses </font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8,663</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11,759</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(26</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;N&#47;A</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Capital expenditure (PP&#38;E)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">28,083</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18,944</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">48</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;N&#47;A</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net cash generated from operating activities</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">65,376</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">64,817</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;N&#47;A</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Free cash flow</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33,571</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">41,309</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(19</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;N&#47;A</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">EBITDA</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">80,903</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">69,539</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">19</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Adjusted net profit</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">58,569</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">52,244</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;N&#47;A</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total assets</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">482,153</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">369,383</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">31</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;N&#47;A</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Equity</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">168,066</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">112,522</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">49</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;N&#47;A</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Equity ratio</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">34.9%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">30.5%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Diluted earnings per share &#47; ADR (in DKK)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12.49</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10.17</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">23</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;N&#47;A</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Full-time equivalent employees end of period</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">78,387</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">69,260</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;N&#47;A</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> See appendix 7&#58; Non-IFRS financial measures (additional information).</font></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:11pt"><td colspan="24" style="padding:0 1pt"><div style="margin-bottom:2pt"><font><br></font></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">These unaudited consolidated financial statements for the first six months of 2025 have been prepared in accordance</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">with IAS 34 &#8216;Interim Financial Reporting&#8217; and additional Danish disclosure requirements for listed companies. </font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">The accounting policies adopted in the preparation are consistent with those applied in the Annual Report 2024 of Novo</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Nordisk.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_22"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.895%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 4 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">COMMERCIAL EXECUTION</font></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_16"></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">SALES DEVELOPMENT ACROSS THERAPEUTIC AREAS</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales grew by 16% measured in Danish kroner and by 18% at CER in the first six months of 2025, driven by Obesity care sales growth of 58% (CER) and Diabetes care sales growth of 8% (CER). Rare disease sales increased by 15% (CER). </font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.139%"><tr><td style="width:0.1%"></td><td style="width:1.159%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.298%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.948%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.951%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Sales split per therapy</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;Sales H1 2025<br>DKK million</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;Sales H1 2024<br>DKK million</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Growth<br>as reported</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Growth<br>at CER</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Share of growth<br>at CER</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Diabetes and Obesity care segment</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Injectable GLP-1</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">66,592&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">61,086&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">27</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">&#160;-   Ozempic</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">64,520&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">56,685&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">14</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">15</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">37</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">&#160;-   Victoza</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">2,072&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">4,401&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(53</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(52</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(10</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">%)</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Rybelsus</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11,348&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10,931&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total GLP-1</font></td><td colspan="2" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">77,940&#160;</font></td><td style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">72,017&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">30</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Long-acting insulin</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</font></div></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9,855&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9,902&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Premix insulin</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2</font></div></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5,449&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5,404&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Fast-acting insulin</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3</font></div></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9,594&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8,355&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Human insulin</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,845&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,316&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(14</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(11</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total insulin</font></td><td colspan="2" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">27,743&#160;</font></td><td style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">26,977&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other Diabetes care</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">4</font></div></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">927&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,116&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(17</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(16</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total Diabetes care</font></td><td colspan="2" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">106,610&#160;</font></td><td style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">100,110&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">36,888&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">21,036&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">75</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">78</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">70</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Saxenda</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,908&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,903&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(51</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(50</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total Obesity care</font></td><td colspan="2" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">38,796&#160;</font></td><td style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">24,939&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">56</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">58</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">62</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Diabetes and Obesity care total</font></td><td colspan="2" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">145,406&#160;</font></td><td style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">125,049&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">95</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Rare disease segment</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Rare blood disorders</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">5</font></div></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6,017&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5,752&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Rare endocrine disorders</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">6</font></div></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,732&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,843&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">48</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">49</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other Rare disease</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">7</font></div></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">789&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">765&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Rare disease total</font></td><td colspan="2" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9,538&#160;</font></td><td style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8,360&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total sales</font></td><td colspan="2" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">154,944&#160;</font></td><td style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">133,409&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">100</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Comprises Tresiba</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, Xultophy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, Levemir</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174; </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">and</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">  </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Awiqli</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;.</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">2)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Comprises Ryzodeg</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174; </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">and NovoMix</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">3)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Comprises Fiasp</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174; </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">and NovoRapid</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">4)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Primarily NovoNorm</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, needles and GlucaGen</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> HypoKit</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">5)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Comprises NovoSeven</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, NovoEight</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, Esperoct</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">,</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"> </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Refixia</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, NovoThirteen</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174; </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">and Alhemo</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.  </font></div></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">6)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Primarily Norditropin</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> and Sogroya</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">7)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Primarily Vagifem</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> and Activelle</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">. </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"> </font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-indent:7.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.895%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 5 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">DIABETES AND OBESITY CARE</font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Diabetes care, sales and market share development</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales in Diabetes care increased by 6% measured in Danish kroner and by 8% at CER to DKK 106,610 million, mainly driven by growth of GLP</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">-1-based products. Novo Nordisk's global diabetes value market share decreased by 1.4 percentage points over the last 12 months to</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> 32.6%. The market share development was driven by market share losses in US Operations and International Operations. In IO countries, tirzepatide is categorised under GLP-1 diabetes only in IQVIA data, despite having indications for Diabetes and Obesity in most launched countries. Novo Nordisk has a strategic aspiration of strengthening the Diabetes care leadership, aiming at reaching a global value market share of more than one-third in 2025. Novo Nordisk has a total GLP-1 volume market share, across Diabetes and Obesity care, of 62.1% globally. Within the US and IO, Novo Nordisk has a total GLP-1 volume market share of 51.1% and 71.0%, respectively. </font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In the following sections, unless otherwise noted, market data are based on moving annual total (MAT) from May 2024 and May 2025 provided by the independent data provider IQVIA. EUCAN covers Europe and Canada, Emerging Markets covers mainly Latin America, the Middle East and Africa. APAC covers Japan, Korea, Oceania, and Southeast Asia. Region China covers Mainland China, Hong Kong and Taiwan.</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.438%"><tr><td style="width:0.1%"></td><td style="width:1.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.907%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Diabetes care, development per geographical  area</font></td><td colspan="6" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Novo Nordisk&#8217;s share of the total diabetes market (value, MAT)</font></td><td colspan="6" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Diabetes care, sales development</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">May</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">May</font></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;Sales H1 2025<br>DKK million</font></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Growth<br>at CER</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2025</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2024</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Global</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">32.6</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">34.0</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">106,610&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">US Operations</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33.8</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">35.0</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">58,106&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">International Operations</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">29.1</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">31.0</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">48,504&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">- EUCAN *</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33.3</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">35.9</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">21,619&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">- Emerging Markets **</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">27.3</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">29.0</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11,705&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">- APAC ***</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">17.9</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18.9</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6,467&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">- Region China ****</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">31.7</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33.3</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8,713&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr></table></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Source&#58; IQVIA, May 2025 data. *Data for EUCAN available for 26 European markets and Canada representing approximately 98% of Novo Nordisk&#8217;s Diabetes care in the area. **Data for Emerging Markets available for 13 markets representing approximately 80% of Novo Nordisk&#8217;s Diabetes care in the area. ***Data for APAC available for five markets representing approximately 78% of Novo Nordisk&#8217;s Diabetes care in the area ****Data for mainland China, excluding Hong Kong and Taiwan. In IO countries, tirzepatide is categorised under GLP-1 diabetes only, despite having indications for diabetes and obesity in most launched countries. </font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">GLP-1-based therapies for type 2 diabetes</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales of GLP-1-based products for type 2 diabetes (Rybelsus</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">,</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline"> </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Ozempic</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> and Victoza</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">) increased by 8% measured in Danish kroner and by 10% at CER to DKK 77,940 million. The estimated global GLP-1 share of total diabetes prescriptions </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">increased</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> to 7.1% compared with 6.3% 12 months ago. It is possible for a patient to have a prescription for more than one diabetes treatment. Novo Nordisk is the </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">global market leader in the diabetes GLP-1 segment with </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">a 51.9% v</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">alue ma</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">rket shar</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">e. </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.289%"><tr><td style="width:0.1%"></td><td style="width:1.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.774%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.930%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">GLP-1 diabetes, development per geographical area</font></td><td colspan="6" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Novo Nordisk's share of the diabetes GLP-1 market (value, MAT)</font></td><td colspan="6" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">GLP-1 diabetes, sales development</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">May</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">May</font></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;Sales H1 2025<br>DKK million</font></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Growth<br>at CER</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2025</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2024</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Global</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">51.9</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">56.1</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">77,940&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">US Operations</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">50.4</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">53.4</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">49,944&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">International Operations</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">61.8</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">73.6</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">27,996&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">- EUCAN *</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">63.0</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">74.3</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14,995&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">- Emerging Markets **</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">55.9</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">68.1</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6,204&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">- APAC ***</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">54.2</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">75.7</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,575&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">- Region China ****</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">81.5</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">79.2</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,222&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(11</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr></table></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:112%">Source&#58; IQVIA, May 2025 data. Data for EUCAN available for 26 European markets and Canada representing approximately 98% of Novo Nordisk&#8217;s Diabetes care in the area. **Data for Emerging Markets available for 13 markets representing approximately 80% of Novo Nordisk&#8217;s Diabetes care in the area. ***Data for APAC available for five markets representing approximately 78% of Novo Nordisk&#8217;s Diabetes care in the area ****Data for mainland China, excluding Hong Kong and Taiwan. Note&#58; the estimated GLP-1 share of prescriptions is based on volume packs from IQVIA. Volume packs are converted into full-year patients&#47;prescriptions based on WHO assumptions for average daily doses, or if not available, Novo Nordisk assumptions. In IO countries, tirzepatide is categorised under GLP-1 diabetes only, despite having indications for diabetes and obesity in most launched countries. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-indent:7.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.895%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 6 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Ozempic</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> sales increased by 14% measured in Danish kroner and by 15% at CER to DKK 64,520 million. Sales growth was driven by both US Operations and International Operations.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Rybelsus</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> sales increased by 4% measured in Danish kroner and by 5% at CER to DKK 11,348 million. Sales growth was driven by International Operations, mainly within EUCAN and APAC, offset by decreasing sales in US Operations. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Victoza</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> sales decreased by 53% measured in Danish kroner and by 52% at CER to DKK 2,072 million. The decline was driven by the GLP-1 diabetes market moving towards once-weekly treatments in both US Operations and International Operations. </font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%;text-decoration:underline">US Operations</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales of GLP-1 Diabetes care products in US Operations increased by 8% measured in Danish kroner and by 9% at CER. The sales increase was driven by continued uptake of Ozempic</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">, partially countered by Victoza</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174; </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">and Rybelsus</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">. Ozempic</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> sales in the US were positively impacted by gross-to-net sales adjustments related to prior years. Novo Nordisk is the market leader with a 50.4%</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">v</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">alue market share. The estimated GLP-1 share of total diabetes prescriptions has increas</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">ed to 19.1% compared with 16.7% 1</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">2 months ago.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales grow</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">th in US Operations was mainly driven </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">by </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">a prescription volume growth of the GLP-1 class around 15% in the second quarter of 2025 compared with the second quarter of 2024, countered by a decline in market share. Novo Nordisk's share of total monthly prescriptions was 46.5%, while the share of new-to-brand prescriptions amounts to 40.1%. </font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%;text-decoration:underline">International Operations</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">S</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">ales of GLP-1 Diabetes care products in International Operations increased by 8% measured in Danish kroner and by 10% at CER.</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> The estimated GLP-1 share of total diabetes prescriptions has increased to </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">5.0% compared with 4.4% </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">12 months ago. Novo Nordisk is the market leader with a value market shar</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">e of 61.8% compared with 73.6% 12 </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">months ago. </font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">EUCAN</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales of GLP-1 Diabetes care products in EUCAN increased by 14% measured in Danish kroner and by 15% at CER. The sales growth mainly reflects the uptake of Ozempic</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> and Rybelsus</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">. The estimated GLP-1 share of total diabetes prescriptions has increased to 9.4% compared with 8.4% 12 months ago. Novo Nordisk is the market leader in EUCAN with a value market share of 63.0%.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Emerging Markets</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">of GLP-1 Diabetes care products in Emerging Markets </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">increased by 6% measured in Danish kroner and by 13% at CER. The sales growth reflects increased </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">sales of Ozempic</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174; </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">as well as </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">higher sales of Victoza</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">. </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">T</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">he estimated GLP-1 share of total diabetes prescriptions has increased to 2.9% compared with 2.3% 12 months ago. Novo Nordisk is the market leader in Emerging markets with a value market share of 55.9%.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">APAC</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">of GLP-1 Diabetes care products</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> in APAC increased by 11% in both Danish kroner and at CER. The sales growth reflects increased sa</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">les of</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline"> </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Rybelsus</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> and Ozempic</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">, partially offset by lower sales of Victoza</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">. The estimated GLP-1 share of total diabetes prescriptions has increased to 2.9% compared with 2.3% </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">12 months ago. Novo Nordisk is the market leader with a value market share</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> of 54.2%. </font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Region China</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales of GLP-1 Diabetes care products in Region China decreased by 13% measured in Danish kroner and by 11% at CER. The sales decline is driven by lower sales of Ozempic</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> as well as Victoza</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">. Ozempic</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> is negatively impacted by wholesaler inventory movements. T</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">he GLP-1 sh</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">are of total diabetes prescriptions has decreased to 3.1% compared with 3.6% 12 months ago. Novo Nordisk is the market leader in Region China with a value market share of 81.5%. </font></div><div><font><br></font></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-indent:7.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.895%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 7 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Insulin </font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales of insulin increased by 3% measured in Danish kroner and by 4% at CER to DKK 27,743 million. </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.438%"><tr><td style="width:0.1%"></td><td style="width:1.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.907%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Insulin, development per geographical area</font></td><td colspan="6" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Novo Nordisk&#8217;s share of the total insulin market (volume, MAT)</font></td><td colspan="6" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Insulin, sales development</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">May</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">May</font></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;Sales H1 2025<br>DKK million</font></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Growth<br>at CER</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2025</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2024</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Global</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">43.3</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">44.9</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">27,743&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">US Operations</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">30.1</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">34.9</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8,081&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">17</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">International Operations</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">46.9</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">47.8</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">19,662&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">- EUCAN *</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">45.1</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">45.4</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6,361&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">- Emerging Markets **</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">51.8</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">51.8</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5,357&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">- APAC ***</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">53.7</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">56.3</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,754&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">- Region China ****</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">40.2</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">41.1</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5,190&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr></table></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Source&#58; IQVIA, May 2025 data. Data for EUCAN available for 26 European markets and Canada representing approximately 98% of Novo Nordisk&#8217;s Diabetes care in the area. **Data for Emerging Markets available for 13 markets representing approximately 80% of Novo Nordisk&#8217;s Diabetes care in the area. ***Data for APAC available for five markets representing approximately 78% of Novo Nordisk&#8217;s Diabetes care in the area ****Data for mainland China, excluding Hong Kong and Taiwan.</font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%;text-decoration:underline">US Operations</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales of insulin in US Operations </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">increased by 16% measured in Danish kroner and by 17% at CER</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">. The sales increase in US Operations was impacted by gross to net adjustments related to prior years as well as channel and payer mix, partially countered by a decline in volume. Novo Nordisk has a volume market shar</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">e of 30.1% of t</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">he total US insulin market. </font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%;text-decoration:underline">International Operations</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales of insulin in International Operations decreased by 2% measured in Danish kroner and by 1% at CER</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">. </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">The sales decrease at CER was mainly driven by EUCAN. </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Novo Nordisk has a volume market share </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">of 46.9% of</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> the total insulin market in International Operations.</font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">EUCAN</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales of insulin in EUCAN decreased by 6% measured in Danish kroner and by 5% at CER. The sales decrease at CER was driven by long-acting insulin, fast-acting insulin and human insulin. Novo Nordisk has a volume market share of 45.1%</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> of the total insulin market. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Emerging Markets</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales of insulin in Emerging Markets increased by 2% in both Danish kroner and at CER. The sales increase at CER was mainly driven by premix insulin and long-acting insulin, partially countered by human insulin. Novo Nordisk has a volume market share o</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">f 51.8% of </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">the total insulin market.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">APAC</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales of insulin in APAC decreased by 5% measured in Danish kroner and by 3% at CER. The sales decrease at CER was m</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">ainly driven by human insulin, premix insulin and fast-acting insulin. Novo Nordisk has a volume market share of 53.7% of the</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> total insulin market.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Region China</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales of insulin in Region China increased by 2% measured in Danish kroner and by 3% at CER. The sales increase at CER was mainly driven by long-acting insulin, partially countered by fast-acting insulin. Novo Nordisk has a volume market sha</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">re of 40.2% of the t</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">otal insulin market. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-indent:7.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.895%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 8 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Obesity care</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales of Obesity care products, Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174; </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">and Saxenda</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">, increased by 56% measured in Danish kroner and by 58% at CER to DKK 38,796 million. Sales growth was driven by bot</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">h US Operations and International Operations. The volume growth of the global branded obesity market was </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">141%</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">. Novo Nordisk is the global market leader with a branded volume market share of</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> 64.6%. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.888%"><tr><td style="width:1.0%"></td><td style="width:25.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Obesity care, development per geographical area</font></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Global branded obesity market growth (Volume, MAT)</font></td><td colspan="6" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Obesity care, sales development</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">May</font></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;Sales H1 2025<br>DKK million</font></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Growth<br>at CER</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2025</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Global</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">38,796&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">58</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">US Operations</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">160</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">24,899&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">36</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">International Operations</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">113</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13,897&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">125</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">- EUCAN *</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">78</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7,060&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">64</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">- Emerging Markets **</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">150</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,260&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">157</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">- APAC ***</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">372</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,715&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">361</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">- Region China ****</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N&#47;A</font></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">862&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td></tr></table></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:112%">Source&#58; IQVIA, May 2025 data. *Data for EUCAN available for 26 European markets and Canada representing approximately 93% of Novo Nordisk&#8217;s Obesity care sales in the area. **Data for Emerging Markets available for 10 markets representing approximately 76% of Novo Nordisk&#8217;s Obesity care sales in the area. ***Data for APAC available for four markets representing approximately 54% of Novo Nordisk&#8217;s Obesity care sales in the area.  **** Branded obesity market data for mainland China, excluding Hong Kong and Taiwan, is not fully covered by global IQVIA data. In IO countries, tirzepatide is categorised under GLP-1 diabetes only, despite having indications for diabetes and obesity in most launched countries. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Wegovy</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> sales increased by 75% measured in Danish kroner and by 78% at CER to DKK 36,888 million. Sales of Saxenda</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174; </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">decreased by 51% measured in Danish kroner and by 50% at CER to DKK 1,908 million as the obesity care market is moving towards once-weekly treatments.</font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%;text-decoration:underline">US Operations</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:140%">Sales of Obesity care products in US Operations increased by 34% measured in Danish kroner and by 36% at CER to DKK 24,899 million. Sales of Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:140%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:140%"> increased by 36% measured in Danish kroner and by 37% at CER to DKK 24,716 million, driven by increased volumes, partially countered by lower realised prices. In the US, Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:140%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:140%"> has around 280,000 weekly prescriptions, and the volume growth of the branded obesity market in the US was 160%. Prescriptions via NovoCare</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:140%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:140%"> Pharmacy (incl TeleHealth partnerships) are now captured by independent data provider IQVIA. The volume of compounded GLP-1s in the US is estimated to have impacted the uptake of Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:140%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:140%"> prescriptions as well as the growth of the branded obesity market during the first half of 2025. </font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Despite the expiry of the FDA grace period for mass compounding on 22 May 2025, Novo Nordisk market research shows that unsafe and unlawful mass compounding has continued, and that multiple entities continue to market and sell compounded GLP-1s under the false guise of &#8216;personalisation&#8217;. Novo Nordisk is pursuing multiple strategies, including litigation, to protect patients from knockoff &#8216;semaglutide&#8217; drugs. Novo Nordisk is deeply concerned that, without intervention by federal and state regulators and law enforcement, patients will continue to be exposed to the significant risks posed by knockoff &#8216;semaglutide&#8217; drugs made with illicit foreign active pharmaceutical ingredients. </font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">While unsafe and unlawful compounding has continued, the Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> penetration within the cash channel has been lower than expected. Within this channel, NovoCare</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> Pharmacy was launched in March 2025. Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> prescriptions via NovoCare</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> Pharmacy (including TeleHealth collaborations) amount to around 10,000 total weekly prescriptions, in addition to around 17,000 weekly prescriptions in the retail cash channel. Novo Nordisk will continue to invest in expanding direct-to-patient initiatives such as NovoCare</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> Pharmacy and further collaborations with telehealth organisations.  </font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Within the insured channel,  Novo Nordisk continues to engage in additional commercial initiatives and expects a regulatory decision around the Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> MASH indication during the third quarter of 2025. Effective 1 July 2025, Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> is now the only GLP-1 medicine covered for obesity care in CVS national template formulary.  </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8.9pt;font-weight:400;line-height:150%">Novo Nordisk continues to work on expanding channels and access to Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8.9pt;font-weight:400;line-height:150%"> in the US.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-indent:7.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.895%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 9 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%;text-decoration:underline">International Operations</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales of Obesity care p</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">roducts in International Operations increased by 117% measured in Danish kroner and by 125% at CER to DKK 13,897 million. Sales of Wegovy</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">increased by 320% measured in Danish kroner and by 335% at CER to </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">DKK 12,172 million. </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> has now been launched in around 35 countries in International Operations</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">. This was partially countered by s</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">ales of Saxenda</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> in In</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">ternational Operations decreasing by 51% measured in Danish kroner and by 49% at CER to DKK 1,725 million. The volume growth of the branded obesity market in International Operations w</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">as 113%. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">EUCAN</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales of Obesity care products in EUCAN increased by 62% measured in Danish kroner and by 64% at CER to DKK 7,060 million, driven by Wegovy</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">, partially countered by declining Saxenda</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174; </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">sales. The volume growth of the branded obesity market in EUCAN w</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">as 78%.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Emerging Markets</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales of Obesity care products in Emerging Markets increased by 135% measured in Danish kroner and by 157% at CER to DKK 3,260 million, driven by Wegovy</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">, partially countered by declining Saxenda</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174; </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">sales. The volume growth of the branded obesity market in Emerging Markets w</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">as 150%.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">APAC</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales of Obesity care products in APAC increased by 339% measured in Danish kroner and by 361% at CER to DKK 2,715 million, driven by uptake of Wegovy</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">, partially countered by declining Saxenda</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174; </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">sales. The volume growth of the branded obesity market in APAC was</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> 372%.</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">  </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Region China</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales of Obesity care products in Region China amounted to DKK 862 million, driven by the launch of Wegovy</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">. </font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-indent:7.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.895%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 10 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Rare disease, sales development</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Rare disease sales increased by 14% measured in Danish kroner and by 15% at CER to DKK 9,538 million. Sal</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">es of rare endocrine disorder products increased by 48% measured in Danish kroner and by 49% at CER to DKK 2,732 million. Sales of rare blood disorder products increased by 5% measured in Danish kroner and by 6% at CER to DKK 6,017 million.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.438%"><tr><td style="width:0.1%"></td><td style="width:1.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.907%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="6" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Rare disease, development per geographical area</font></td><td colspan="6" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Rare disease, sales development</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;Sales H1 2025<br>DKK million</font></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Growth<br>at CER</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Global</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9,538&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">US Operations</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4,274&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">23</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">International Operations</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5,264&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;- EUCAN</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,533&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;- Emerging Markets</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,369&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;- APAC</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,027&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">22</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;- Region China</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">335&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">93</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%;text-decoration:underline">US Operations</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Rare disease sales in US Operations increased by 22% measured in Danish kroner and by 23% at CER. The sales increase was mainly driven by Rare endocrine disorder products, increasing by 66% measured in Danish kroner and by 67% at CER. The sales increase was driven primarily by Norditropin</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">, positively impacted by channel and payer mix and Sogroya</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> launch uptake. Further, sales of Norditropin</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> in 2024 were negatively impacted by a reduction of manufacturing output. Rare blood disorder products increased by 5% measured in Danish kroner and by 6% at CER, mainly driven by increased NovoSeven</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174; </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">and Alhemo</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174; </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">sales, partially countered by sales of haemophilia A products. </font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%;text-decoration:underline">International Operations</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Rare disease sales in International Operations increased by 9% measured in Danish kroner and by 10% at CER. Rare endocrine disorder products increased by 31% measured in Danish kroner and by 30% at CER, driven by Norditropin</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> due to improvements in manufacturing output as well as Sogroya</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174; </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">launch uptake. Sales of rare blood disorder products increased by 4% measured in Danish kroner and by 6% at CER, driven by higher haemophilia B and Alhemo</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> sales. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">EUCAN</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Rare disease sales increased by 1% in both Danish kroner and at CER. Sales of rare endocrine disorder products increased by 18% in both Danish kroner and at CER. Sales of rare blood disorder products decreased by 2% in both Danish kroner and CER, mainly driven by lower sales of haemophilia A products. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Emerging Markets</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Rare disease sales increased by 4% measured in Danish kroner and by 6% at CER. Sales of rare endocrine disorder products</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> increased by 47% measured in Danish kroner and by 44% at CER, driv</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">en by sales of both Norditropin</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> and Sogroya</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">. Sales of rare blood disorder products decreased by 6% measured in Danish kroner and by 3% at CER, mainly driven by lower NovoSeven</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174; </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">sales.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">APAC</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Rare disease sales increased by 22% in both Danish kroner and at CER. Sales of rare endocrine disorder products increased by 32% measured in Danish kroner and by 31% at CER, driven by sales of both Norditropin</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> and Sogroya</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">. Sales of rare blood disorder products increased by 19% measured in Danish kroner and by 21% at CER, driven by higher sales of Alhemo</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Region China</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Rare disease sales increased by 88% measured in Danish kroner and by 93% at CER. This is driven by rare blood disorders, which increased by 93% measured in Danish kroner and by 97% at CER, mainly due to increased haemophilia A sales and positively impacted by timing of shipments, mainly for NovoSeven</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-indent:7.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_1467"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.895%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 11 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">GEOGRAPHIC SALES DEVELOPMENT</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales increased by 16% measured in Danish kroner and by 18% at CER to DKK 154,944 million in the first six months of 2025. In US Operations, sales increased by 16% measured in Danish kroner and by 17% at CER. Sales growth in the first six months of 2025 was positively impacted by gross-to-net sales adjustments related to prior years, including an adjustment related to the 340B provision of around DKK 3 billion in the second quarter. As of 30 June 2025, the provision for 340B statutory discounts amounts to USD 4.2 billion. Sales in International Operations increased by 16% measured in Danish kroner and by 19% at CER. </font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">As of January 2025, North America Operations and International Operations were reorganised and financial reporting was divided into US Operations and International Operations. Please see appendix 8 for a breakdown of sales per area in 2024.</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.438%"><tr><td style="width:0.1%"></td><td style="width:1.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.907%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Sales split per geographical area</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;Sales H1 2025<br>DKK million</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Growth<br>as reported</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Growth<br>at CER</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Share of growth<br>at CER</font></td></tr><tr style="height:3pt"><td colspan="6" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="6" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">US Operations</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">87,279&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">17</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">54</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">International Operations</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">67,665&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">19</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">46</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;- EUCAN</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">31,212&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">19</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;- Emerging Markets</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16,334&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">17</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">22</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;- APAC</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10,209&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">32</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">35</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;- Region China</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9,910&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total sales</font></td><td colspan="2" style="background-color:#e2f0fa;border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">154,944&#160;</font></td><td style="background-color:#e2f0fa;border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</font></td><td style="border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</font></td><td style="border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">100</font></td><td style="border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr></table></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%;text-decoration:underline">US Operations</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales in US Operations increased by 16% measured in Danish kroner and by 17% at CER. The sales increase reflects Obesity care sales growing by 36% at CER, estimated to be negatively impacted by compounded GLP-1s, an</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">d</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> GLP-1 diabetes sales growing by 9% at CER, </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">including an adjustment related to the 340B provision of around DKK 3 billion in the second quarter of 2025</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">. Insulin sales are increasing by 17% at CER, and Rare disease products are growing by 23% at CER.  </font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%;text-decoration:underline">International Operations</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales in International Operations increased by 16% measured in Danish kroner and by 19% at CER. Sales growth was driven by </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Obesity care sales growing by 125% at CER and </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">GLP-1 diab</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">etes sales growing by 10% at CER. GLP-1 diabetes sales growth was negatively impacted by periodic supply constraints. Insulin sales decreased by 1% at CER, </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">also </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">negatively impacted by periodic supply constraints, while Rare disease sales increased by 10% at </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">CER. </font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:150%">EUCAN</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales in EUCAN increased by 15% measured in Danish kroner and by 16% at CER. Sales growth was driven by Obesity care, which grew by 64% at CER. Diabetes care sales increased by 8% at CER, driven by</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> GLP-1 diabetes sales growing by 15% at CER, while insulin sales decreased by 5% at CER. </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Rare disease sales increased by 1% at CER.</font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:140%">Emerging Markets</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:145%">Sales in Emerging Markets increased by 17% measured in Danish kroner and by 22% at CER. Sales growth was driven by Obesity care, which grew by 157% at CER. Diabetes care sales increased by 7% at CER, driven by GLP-1 diabetes sales growing by 13% at CER, and insulin sales increasing by 2% at CER. Rare disease sales increased by 6% at CER.</font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:145%">APAC</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:145%">Sales in APAC increased by 32% measured in Danish kroner and by 35% at CER. Sales growth was driven by Obesity care sales increasing by 361% at CER and Diabetes care growing by 4% at CER, reflecting GLP-1 diabetes sales growing 11% at CER. Rare disease sales increased by 22% at CER.</font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:150%">Region China</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:140%">Sales in Region China increased by 5% measured in Danish kroner and by 6% at CER. The sales increase at CER was driven by Obesity care sales amounting to DKK 862 million. GLP-1 diabetes sales decreased by 11% at CER negatively impacting wholesaler inventory movements. Insulin sales increased by 3% at CER, and Rare disease sales by 93% at CER. </font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-indent:7.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_25"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.895%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 12 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">FINANCIALS</font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">DEVELOPMENT IN COSTS AND OPERATING PROFIT</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">The </font><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">cost of goods sold</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> increased by 27% in both Danish kroner and at CER to DKK 25,736 million, resulting in a gross margin of 83.4%, measured in Danish kroner, compared with 84.9% in the first six months of 2024. The decline in gross margin mainly reflects amortisations and depreciations related to Catalent as well as costs related to ongoing capacity expansions. This is partially countered by a</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">positive product mix driven by increased sales of GLP-1-based treatments.</font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Sales and distribution costs</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> increased by 15% in both Danish kroner and at CER to DKK 32,425 million. The increase in costs is driven by both US Operations and International Operations. In US Operations, t</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">he cost increase is mainly driven by promotional activities related to Wegovy</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174; </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">and Ozempic</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">. In International Operations, the increase is primarily related to the Wegovy</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174; </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">launch and promotional activities. Sales and distribution costs amounted to 20.9% as a percentage of sales.</font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Research and development costs</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> decreased by 11% in both Danish kroner and CER to DKK 21,998 million, driven by the impairment loss related to ocedurenone of DKK 5.7 billion and other impairments of intangible assets in 2024. This is partially countered by increasing investments within Obesity care and reflecting increased late-stage clinical trial activity as well as increased early research activities. </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Research and development costs amounted to 14.2% as a percentage of sales. </font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Administration costs</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> increased by 10% measured in Danish kroner and by 11% at CER to DKK 2,536 million, or</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> 1.6% of sales.</font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Other operating income and expenses (net)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> showed a loss of DKK 9 million compared to a loss of DKK 163 million in 2024. This is driven by transaction costs related to the Catalent acquisition during the first half of 2024. </font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Operating profit </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">increased by 25% measured in Danish kroner and by 29% at CER to DKK 72,240 million, </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">mainly impacted by the impairment loss related to ocedurenone in 2024, partially countered by impacts related to the acquisition of the three former Catalent manufacturing sites. EBITDA increased by 16% measured in Danish kroner and by 19% at CER.</font></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_28"></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Financial items (net)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> showed a net loss of DKK 1,402 million, compared with a net loss of DKK 530 million in the first six months of 2024. This primarily reflects financing costs related to the funding of the Catalent transaction.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In line with Novo Nordisk&#8217;s treasury policy, the most significant foreign exchange risks for Novo Nordisk have been hedged, primarily through foreign exchange forward contracts. The foreign exchange result was a net gain of DKK 20 million compared with a net loss of DKK 461 million in the first six months of 2024. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">At the end of June 2025, a positive market value of financial contracts of approximately DKK 10.9 billion had been deferred for recognition in 2025 and 2026. </font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">The effective tax rate</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> was 21.6% in the first six months of 2025, compared with an effective tax rate of 20.6% in the first six months of  2024.</font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Net profit</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> increased</font><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%"> </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">by 22% to DKK 55,537 million, and diluted earnings per share increased by 23% to DKK 12.49. </font></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_31"></div><div style="margin-bottom:3pt"><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:28.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.679%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.895%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 13 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">KEY DEVELOPMENTS IN THE SECOND QUARTER OF 2025</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales in the second quarter of 2025</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> increased by 13% measured in Danish kroner and by 18% at CER co</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">mpared to the second quarter of 2024.  Sales growth in US Operations 2025 was positively impacted by gross-to-net sales adjustments related to prior years, including an adjustment related to the 340B provision of around DKK 3 billion in the second quarter of 2025. Operating profit increased by 29% measured in Danish kroner and by 40% at CER, impacted by the impairment loss related to ocedurenone in the second quarter of 2024, partially countered by impacts related to the acquisition of the three former Catalent manufacturing sites. Please refer to appendix 1 for an overview of the quarterly numbers in DKK and to appendix 6 for additional details on sales in the second quarter of 2025. </font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.438%"><tr><td style="width:0.1%"></td><td style="width:1.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.907%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Sales split per geographical area</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;Sales Q2 2025<br>DKK million</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Growth<br>as reported</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Growth<br>at CER</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Share of growth<br>at CER</font></td></tr><tr style="height:3pt"><td colspan="6" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="6" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">US Operations</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">42,963&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">55</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">International Operations</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33,894&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">45</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;- EUCAN</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16,447&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">20</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">23</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;- Emerging Markets</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7,544&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">20</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;- APAC</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5,615&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">40</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">45</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;- Region China</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4,288&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(14</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total sales</font></td><td colspan="2" style="background-color:#e2f0fa;border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">76,857&#160;</font></td><td style="background-color:#e2f0fa;border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13</font></td><td style="border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</font></td><td style="border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">100</font></td><td style="border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">The increase in global sales of 18% at CER was driven by increased sales across the portfolio. GLP-1 diabetes sales increased by 8% at CER, and Obesity care sales increased by 53% at CER. Insulin sales increased by 5% at CER, and Rare disease sales increased by 28% at CER.  </font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%;text-decoration:underline">US </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%;text-decoration:underline">Operations</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales in US Operations increased by 12% measured in Danish kroner and by 18% at CER. Sales growth in the second quarter of 2025 was positively impacted by gross-to-net sales adjustments related to prior years, including an adjustment related to the 340B provision of around DKK 3 billion in the second quarter of 2025. Sales growth was driven by GLP-1 diabetes sales growing by 9% at CER. Ozempic</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> sales growth was positively impacted by gross-to-net sales adjustments related to prior years. Obesity care sales increased by 32% at CER. Insulin sales increased by 23% at CER, positively impacted by gross-to-net adjustments related to prior years and channel and payer mix, partially countered by lower realised volumes. Rare disease sales increased by 52% at CER, mainly driven by volume growth for rare endocrine disorder products, also positively impacted by gross-to-net adjustments related to prior years, as well as negative channel and payer mix </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">and a reduction of manufacturing output of Norditropin</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174; </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">in the second quarter of 2024.  </font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%;text-decoration:underline">International Operations</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales in International Operations increased by 14% measured in Danish kroner and by 18% at CER. Sales growth was driven by EUCAN, APAC and Emerging Markets. Sales in Region China declined, negatively impacted by wholesaler inventory movements within Diabetes GLP-1 and Obesity Care sales. </font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:150%"> </font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sales growth was driven by Diabetes and Obesity </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">care growing by 19% at CER,</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> driven by Obesity care increasing by 115% at CER following the</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> uptake of Wegovy</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">. </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">GLP-1 diabetes sales grew by 8% at CER, and insulin</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> sales decreased by 1% at CER. Rare disease sales increased by 14% at CER. </font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:28.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.679%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.895%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 14 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.888%"><tr><td style="width:1.0%"></td><td style="width:43.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.943%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.096%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">PROFIT AND LOSS</font></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Q2 2025</font></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Q2 2024</font></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;% change<br>&#160;Q2 2025 to<br>&#160;Q2 2024</font></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;% change<br>&#160;Q2 2025 to<br>&#160;Q2 2024 at CER</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net sales</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">76,857</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">68,060</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Gross profit</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">64,011</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">57,786</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Gross margin</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">83.3%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">84.9%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Sales and distribution costs</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(17,533)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(14,934)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">17</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">19</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Percentage of sales</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">22.8%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">21.9%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Research and development costs</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(11,690)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(16,166)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(28</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(26</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Percentage of sales</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15.2%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">23.8%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Administrative costs</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,316)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,157)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Percentage of sales</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.7%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.7%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other operating income and expenses</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(23)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">405</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N&#47;A</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N&#47;A</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Operating profit (EBIT)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33,449</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25,934</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:700;line-height:100%">29</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:700;line-height:100%">40</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Operating margin</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">43.5%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">38.1%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Financial items (net)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">356</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(602)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N&#47;A</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N&#47;A</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Profit before income taxes</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33,805</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25,332</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:700;line-height:100%">33</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N&#47;A</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Income taxes</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7,302)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5,282)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">38</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N&#47;A</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Effective tax rate</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">21.6%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">20.9%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net profit</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">26,503</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">20,050</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N&#47;A</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Net profit margin</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">34.5%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">29.5%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%;text-decoration:underline">Costs and operating profit</font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">The gross margin</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> was realised at 83.3% in the second quarter of 2025, compared with 84.9% in 2024. The gross margin decrease mainly reflects </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">amortisations and depreciations related to Catalent, partially countered by</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> a positive product mix driven by increased sales of GLP-1-based treatments and a positive price impact due to gross-to-net sales adjustments in the US related to prior years.</font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Sales and distribution costs</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> increased by 17% measured in Danish kroner and by 19% at CER compared with 2024. T</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">he increase in costs is driven by both US Operations and International Operations. In the US, t</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">he cost increase is mainly driven by promotional activities related to Wegovy</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">. In International Operations, the increase is mainly related to Wegovy</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174; </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">launch activities and promotion spend directed towards Ozempic</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">. Sales and distribution costs amounted to 22.8% as a percentage of sales.</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> </font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Research and development costs</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> decreased by 28% measured in Danish kroner and by 26% at CER compared with 2024.  This is mainly driven by th</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">e impairment loss related to ocedurenone of DKK 5.7 billion and other impairments of intangible assets during the second quarter of 2024, partially countered by</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> increased late-stage clinical trial and research activities mainly related to Obesity care. Research and development costs amounted to 15.2% as a percentage of sales.  </font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> </font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Administrative costs</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> increased by 14% measured in Danish kroner and by 16% at CER, compared with the same period in 2024. The cost increase is partly driven by severance costs related to previously announced changes in Executive Management. Administration costs amounted to 1.7% as a percentage of sales.</font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Other operating income and expenses </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">showed a loss of DKK 23 million in the second quarter of 2025. </font></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:28.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.679%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.895%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 15 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Operating profit</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> increased by 29% measured in Danish kroner and by 40% at CER compared with the second quarter of 2024. This is mainly impacted by the impairment loss related to ocedurenone in 2024, partially countered by impacts related to the acquisition of the three former Catalent manufacturing sites. EBITDA increased by 10%, measured in Danish kroner and by 18% at CER.  </font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Financial items (net)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> showed a net gain of DKK 356 million compared with a net loss of DKK 602 million in the second quarter of 2024, mainly reflecting gains on hedged currencies, primarily the US dollar. This is partly countered by financing costs related to the funding of the Catalent transaction.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">The effective tax rate</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> was 21.6% in the second quarter of 2025, compared with an effective tax rate of 20.9% in the second quarter of 2024.</font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Net profit increased</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> by 32% to DKK 26,503 million and diluted earnings per share increased by 33% to DKK 5.96. </font></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:28.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.679%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_34"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.895%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 16 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div style="margin-bottom:1pt"><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">CASH FLOW AND CAPITAL ALLOCATION </font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:140%">FREE CASH FLOW IN THE FIRST SIX MONTHS OF 2025 AND CAPITAL EXPENDITURE</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Free cash flow in the first six months of 2025 was DKK 33.6 billion compared to DKK 41.3 billion in the first six months of 2024. The reduction in free cash flow is driven by increased capital expenditures, partially countered by higher net cash generated from operating activities. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Capital expenditure for property, plant and equipment was DKK 28.1 billion compared with DKK 18.9 billion in 2024, primarily reflecting investments in additional capacity for active pharmaceutical ingredient (API) production and fill-finish capacity for both current and future injectable and oral products. Capital expenditure related to intangible assets was DKK 2.8 billion in the first six months of 2025 compared with DKK 3.3 billion in 2024, reflecting business development activities. </font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">EQUITY</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Total equity was DKK 168,066 million at the end of June 2025, equivalent to 34.9% of total assets, compared with 30.5% at the end of June 2024. Please refer to appendix 5 for further elaboration of changes in equity. </font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Interim dividend</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">The Board of Directors has decided to pay out an interim dividend for 2025 of DKK 3.75 for each Novo Nordisk A and B</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">share of DKK 0.10, an increase of around 7% compared to DKK 3.50 in August 2024. The interim dividend for 2025 will be paid in August 2025.The ex-dividend date for the interim dividend will be 15 August 2025 for A and B shares, while the ex-dividend date will be 18 August for the ADRs. The record date will be 18 August 2025 for the A and B shares as well as the ADRs. The payment date for the A and B shares will be 19 August 2025, while the payment date for the ADRs will be 26 August 2025. No dividend will be paid on the company&#8217;s own holding of B shares.</font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Treasury shares</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">As disclosed in the Financial report for the first three months of 2025, Novo Nordisk owned as of 6 May 2025 a total of 21,623,682 B shares of DKK 0.10 as treasury shares. Transactions related to Novo Nordisk's employee share programmes, including incentive programmes, have resulted in a net transfer from Novo Nordisk of 53,722 B shares of DKK 0.10 from 6 May 2025 to 5 August 2025. With the transactions stated above, Novo Nordisk now owns a total of 21,569,960 B shares of DKK 0.10 as treasury shares, corresponding to 0.5% of the share capital. The total amount of A and B shares of DKK 0.10 in the company is 4,465,000,000, including treasury shares.</font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Novo Nordisk&#8217;s capital allocation principles focus on attractive internal growth investments, including the significant supply chain expansion, and a dividend payout ratio of around 50% of net profit. Following the step-up in CAPEX investments in 2025, Novo Nordisk is not conducting a share buyback programme. An authorisation to the Board of Directors to buy back shares was, however, in line with previous years, adopted by the Annual General Meeting on 27 March 2025, should initiating a share buyback programme later be deemed relevant. </font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Issuance of Eurobonds</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">On 20 May 2025, Novo Nordisk announced the successful Eurobond issuance of EUR 6 billion, across five tranches, under its EUR 20 billion Euro Medium Term Note Programme. For further information, please see the press release here&#58; https&#58;&#47;&#47;www.novonordisk.com&#47;investors&#47;bond-investors.html (the contents of the company's website do not form a part of this Form 6-K). The net proceeds of the issuance are used for general corporate purposes, including the refinancing of existing indebtedness related to the acquisition of three fill-finish sites from Novo Holdings A&#47;S in connection with Novo Holdings A&#47;S&#8217; acquisition of Catalent, Inc. With the latest issuance, Novo Nordisk has EUR 12.3 billion outstanding in bonds. The current rating from Moody's and S&#38;P is Aa3 and AA, respectively. </font></div><div><font><br></font></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.452%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_37"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.895%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 17 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">OUTLOOK</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">The current expectations for 2025 are summarised in the table below&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.042%"><tr><td style="width:1.0%"></td><td style="width:49.517%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:23.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Frutiger LT 45 Light',sans-serif;font-size:10pt;font-weight:400;line-height:100%">r</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Expectations are as reported, if not otherwise stated</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Expectations <br>6 August 2025</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Expectations <br>7 May 2025</font></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Sales growth</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">at CER</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7pt;font-weight:400;line-height:120%">8% to 14%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">13% to 21%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">as reported</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Around 3 percentage points lower than at CER</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Around 3 percentage points lower than at CER</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Operating profit growth</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">at CER</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7pt;font-weight:400;line-height:120%">10% to 16%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">16% to 24%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">as reported</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Around 5 percentage points lower than at CER</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Around 5 percentage points lower than at CER</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Financial items (net)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Gain of around 1.6 bDKK</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Gain of around 0.9 bDKK</font></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Effective tax rate</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:700;line-height:120%">21% to 23%</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">21% to 23%</font></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Capital expenditure (PP&#38;E)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Around 65 bDKK</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Around 65 bDKK</font></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Depreciation, amortisation and impairment losses</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Around DKK 17 billion</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Around DKK 17 billion</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Free cash flow (excluding impact from business development)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Between 35 and 45 bDKK</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Between 56 and 66 bDKK</font></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr></table></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8.9pt;font-weight:400;line-height:150%">Sales</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> growth is now expected to be 8-14% at CER, and operating profit growth is now expected to be 10-16% at CER. Sales and operating profit growth reported in Danish kroner is now expected to be 3 and 5 percentage points lower than at CER, respectively. The lowered sales outlook for 2025 is driven by lower growth expectations for the second half of 2025. This is related to lower growth expectations for Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> in the US obesity market, for Ozempic</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> in the US GLP-1 diabetes market and for Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> in select IO markets</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:150%">. </font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8.9pt;font-weight:400;line-height:150%">The updated outlook reflects expectations for sales growth in both US Operations and International Operations, mainly driven by volume growth of GLP-1-based treatments for obesity and diabetes. In the US, Novo Nordisk is focused on preventing unlawful and unsafe compounding and on further expanding access to Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.78pt;font-weight:400;line-height:150%;position:relative;top:-3.11pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8.9pt;font-weight:400;line-height:150%">, such as through NovoCare</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.78pt;font-weight:400;line-height:150%;position:relative;top:-3.11pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8.9pt;font-weight:400;line-height:150%"> Pharmacy and collaborations with telehealth organisations. Moreover, Novo Nordisk continues to expect a volume contribution from changes to the CVS national template formulary effective 1 July 2025, where Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.78pt;font-weight:400;line-height:150%;position:relative;top:-3.11pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8.9pt;font-weight:400;line-height:150%"> is now the only GLP-1 medicine covered for obesity. The company continues to engage in additional commercial initiatives and expects a regulatory decision around the Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.78pt;font-weight:400;line-height:150%;position:relative;top:-3.11pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8.9pt;font-weight:400;line-height:150%"> MASH indication during the third quarter of 2025. With around 1 billion people living with obesity globally and only a few million on treatment, the outlook reflects a continued global rollout of Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.78pt;font-weight:400;line-height:150%;position:relative;top:-3.11pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8.9pt;font-weight:400;line-height:150%"> to more markets. </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Operating profit growth is now expected to be 10% to 16% at CER. Given the current exchange rates versus the Danish krone, growth reported in DKK is expected to be 5 percentage points lower than at CER, primarily due to depreciation of the USD&#47;DKK exchange rate. The updated expectation for operating profit growth mainly reflects the lower sales growth outlook, partially countered by reduced spending. A negative mid-single-digit operating profit growth impact related to the acquisition of the three former Catalent manufacturing sites remains included in the guidance. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Novo Nordisk now expects</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:700;line-height:150%"> </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">financial items (net)</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> for 2025 to amount to a gain of around DKK 1.6 billion. This is mainly driven by gains on hedged currencies, primarily the US dollar, partially offset by interest expenses related to funding of the debt-financed Catalent transaction. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">The effective tax rate for 2025 is still expected to be in the range of 21-23%. </font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Capital expenditure</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> is still expected to be around DKK 65 billion in 2025, reflecting the expansion of the global supply chain. The investments will create additional capacity across the supply chain, including the manufacturing of active pharmaceutical ingredients (API), additional aseptic production and finished production processes as well as packaging capacity. In the coming years, the capital expenditure-to-sales ratio is still expected to be in the low double-digit range. </font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Depreciation, amortisation and impairment losses</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> are still expected to be </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">around</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> DKK</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> 17 bil</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">li</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">on and in</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">clude depreciations and amortisations related to the Catalent transaction.</font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.895%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 18 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">The </font><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">free cash flow </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">is now expected to be DKK 35-45 billion, reflecting the lower-than-planned expected sales growth, mainly driven by lower volume growth of GLP-1-based treatments in the US and related cash flow implications amplified by the US gross-to-net system.</font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">All of the above expectations are based on assumptions that the global or regional macroeconomic and political environment will not significantly change business conditions for Novo Nordisk during 2025, including energy and supply chain disruptions, the potential implications from major healthcare reforms and legislative changes, taxation changes, including changes in tariffs and duties, as well as outcome of legal cases including litigations related to the 340B Drug Pricing Program in the US, and that the currency exchange rates, especially the US dollar, will remain at the current level versus the Danish krone. The guidance is also based on assumptions in relation to the estimation of gross-to-net developments in the US gross sales. Finally, the guidance does not include the financial implications of any new significant business development transactions and significant impairments of intangible assets during 2025. </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8.9pt;font-weight:400;line-height:150%">The outlook further reflects periodic supply constraints and related drug shortage notifications for certain products and geographies.</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">  </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.738%"><tr><td style="width:1.0%"></td><td style="width:56.407%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.260%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.260%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.260%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.313%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FX (average rates)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">H1 2025</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">H1 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">% change</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Spot rate<br>31 July 2025</font></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">USD</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">685&#160;</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">690&#160;</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="2" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">652&#160;</font></td><td style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CNY</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">94&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">96&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">91&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">JPY</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.60&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.54&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.35&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CAD</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">485&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">508&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">471&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">BRL</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">119&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">136&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(13</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">117&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr></table></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Novo Nordisk has hedged expected net cash flows in a number of invoicing currencies, and, all other things being equal, movements in key invoicing currencies will impact Novo Nordisk&#8217;s operating profit as outlined in the table below.</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.588%"><tr><td style="width:1.0%"></td><td style="width:21.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.826%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Key invoicing currencies</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Impact on Novo Nordisk's operating profit in the next 12 months of a 5% movement in currency</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Hedging period (months)</font><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">USD</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">DKK 5,600 million</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CNY</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">DKK 540 million</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CAD</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">DKK 490 million</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">0</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">BRL</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">DKK 210 million</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">0</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">JPY</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">DKK 200 million</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td></tr></table></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1)</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> As of 31 July 2025. </font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">2)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Chinese yuan traded offshore (CNH) used as proxy when hedging Novo Nordisk&#8217;s CNY currency exposure. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">The financial impact of foreign exchange hedging is included in Financial items (net). </font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_40"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.895%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 19 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">INNOVATION AND THERAPEUTIC FOCUS</font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:135%">Diabetes care</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Ozempic</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%"> received a positive opinion from the European Medicines Agency for the treatment of peripheral arterial disease in people living with type 2 diabetes </font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In June 2025, the European Medicines Agency&#8217;s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for an update of the Ozempic</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> label based on STRIDE data. The trial achieved its primary objective by demonstrating a statistically significant and superior improvement in maximum walking distance of 13% for people treated with semaglutide 1.0 mg compared to placebo. Further, a 54% reduction in disease progression (composite endpoint of rescue treatment, all-cause death or major adverse limb events) was demonstrated. In the trial, semaglutide 1.0 mg appeared to have a safe and well-tolerated profile in line with previous semaglutide 1.0 mg trials</font><font style="color:#001965;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:150%">.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Exploratory phase 1 study with zalfermin in combination with either semaglutide or placebo in type 1 diabetes initiated</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In July 2025, Novo Nordisk initiated an exploratory study with once-weekly, subcutaneous zalfermin, a long-acting FGF-21 analogue, in a population with type 1 diabetes. The 32-week trial is investigating the efficacy and safety of zalfermin either in a fixed-dose combination with semaglutide or placebo on glycaemic control. The purpose of the trial is to generate data to inform potential future first human dose candidates rather than progress into next stage development phases. </font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:135%">Obesity care</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Semaglutide 7.2 mg submitted to the EU regulatory authorities</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In July 2025, Novo Nordisk announced the submission of a label extension application for semaglutide 7.2 mg (a higher dose of Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">) to the EMA for the existing marketing authorisation for Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">. The submission is based on the results of the STEP UP and STEP UP T2D programme for semaglutide 7.2 mg. Novo Nordisk is expecting a regulatory decision around the turn of the year. Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> is currently approved in the EU at doses up to 2.4 mg for the treatment of overweight and obesity. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Initiation of CagriSema phase 3b trial, REDEFINE 11, in people living with obesity </font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In June 2025, Novo Nordisk initiated a phase 3b trial, REDEFINE 11, for CagriSema in people living with obesity. The main phase of the REDEFINE 11 trial lasts 80 weeks and investigates further potential efficacy and safety of subcutaneous CagriSema (a fixed dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg) compared to placebo. Following the first treatment period, an additional extension phase of 80 weeks is planned, with the purpose of exploring weight maintenance with three standardised doses of CagriSema concerning the long-term efficacy and safety outcomes. The trial is expected to enrol approximately 600 people living with obesity.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Novo Nordisk to advance subcutaneous and oral amycretin for weight management into phase 3 clinical development</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In June 2025, Novo Nordisk announced that it will advance subcutaneous and oral amycretin into phase 3 development in weight management based on completed clinical studies. The decision to advance subcutaneous and oral amycretin into phase 3 is based on feedback received from regulatory authorities following end-of-phase 2 interactions for subcutaneous and oral amycretin in weight management. Novo Nordisk is now planning to initiate a phase 3 development programme with amycretin for adults with overweight or obesity during the first quarter of 2026. For further information, please see the company announcement here&#58; https&#58;&#47;&#47;www.novonordisk.com&#47;news-and-media&#47;news-and-ir-materials&#47;news-details.html&#63;id&#61;916348 (the contents of the company's website do not form a part of this Form 6-K).</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Phase 2 trial completed with a once-weekly GLP-1&#47;GIP co-agonist and development terminated in weight managemen</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">t </font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In June 2025, Novo Nordisk completed a phase 2 study with a once-weekly GIP&#47;GLP-1 co-agonist analogue (NNC0519-0130) in people with overweight or obesity. The study investigated the safety and efficacy of different doses of NNC0519-0130. The primary objective was met, demonstrating statistically significantly greater body weight reductions compared with placebo across all doses investigated after 36 weeks of treatment. The safety profile of NNC0519-0130 was consistent with incretin-based therapies. Due to portfolio considerations, Novo Nordisk will not pursue further development of the GIP&#47;GLP-1 co-agonist in weight management.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Phase 1 trial with INV-347 completed and development terminated </font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In May 2025, Novo Nordisk completed a phase 1 trial with INV-347, a next-generation oral small molecule CB1 receptor blocker. The trial investigated the safety, tolerability and pharmacokinetics of INV-347 administered once daily to participants with normal weight or overweight&#47;obesity at both single and multiple ascending doses for up to 28 days. In </font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.895%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 20 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">the trial, INV-347 appeared to have a safe and well-tolerated profile. Following completion of the trial, Novo Nordisk has terminated further development of INV-347 due to the pharmacokinetic profile and portfolio considerations. The trial was conducted by Inversago Pharma, which was acquired by Novo Nordisk in 2023. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Phase 1 pharmacokinetics study with CagriSema single-chamber product presentations successfully completed</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> </font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In June 2025, Novo Nordisk successfully completed a phase 1 pharmacokinetics study of CagriSema. The study demonstrated comparable exposure of a single dose of CagriSema (a fixed dose combination of cagrilintide 0.25 mg and semaglutide 0.25 mg) in a single-chamber drug product presentation compared to the dual-chamber presentation investigated in the REDEFINE programme. In the trial, CagriSema appeared to have a safe and well-tolerated profile. Novo Nordisk is planning for the next phase of clinical development for the single-chamber product presentation in 2026.</font></div><div><font><br></font></div><div style="margin-bottom:5pt;text-align:justify"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Cardiovascular &#38; Emerging Therapy </font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Once-weekly semaglutide 2.4 mg in MASH submitted for regulatory approval in Japan</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In May 2025, Novo Nordisk submitted once-weekly semaglutide 2.4 mg for regulatory approval in Japan for the treatment of MASH (F2-F3). In February 2025, Novo Nordisk submitted once-weekly semaglutide 2.4 mg for regulatory approval in the US. The submission has been granted priority review by the FDA, and approval is still expected in the third quarter of 2025.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Phase 2 trial with zalfermin in MASH completed and development terminated.</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Earlier this year, Novo Nordisk completed a phase 2 trial in around 700 patients with MASH F2-F4, evaluating the safety and efficacy of zalfermin, a long-acting FGF-21 analogue, co-administered with semaglutide 2.4 mg compared to placebo. The fixed dose combination of zalfermin and semaglutide 2.4 mg did not meet the primary endpoint of superior improvement in liver fibrosis and no worsening of MASH, compared to placebo. In the trial, the fixed-dose combination of zalfermin and semaglutide 2.4 mg appeared safe and well tolerated. Following the completion of the trial, the development of zalfermin in MASH has been terminated due to portfolio considerations. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Phase 1 trial with ANGPTL3i completed and development terminated</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In May 2025, Novo Nordisk completed a phase 1 trial with ANGPTL3i, a monoclonal antibody in development for dyslipidaemia. The objective of the phase 1 trial was to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of a novel  ANGPTL3i mAb. In the trial, ANGPLT3i appeared to have a safe and well-tolerated profile. Following the completion of the trial, Novo Nordisk has terminated the development of ANGPTL3i due to portfolio considerations.</font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:150%">Phase 2 trial with coramitug (PRX004) successfully completed in people living with ATTR cardiomyopathy</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In July 2025, Novo Nordisk successfully completed a phase 2 trial with coramitug (PRX004, NNC6019-0001), an antibody designed to deplete amyloid deposits. The trial investigated efficacy and safety of once-monthly IV doses of coramitug compared to placebo in 105 participants living with the rare heart disease, ATTR-cardiomyopathy. The primary endpoints of the trial included the functional endpoints of a 6-minute walking test (6MWT) as well as a change in NT-proBNP at 52 weeks. Coramitug was acquired from Prothena Biosciences by Novo Nordisk in July 2021. Detailed data are expected to be shared at a medical conference later this year. Following the successful completion of this phase 2 trial, coramitug in ATTR-cardiomyopathy is expected to initiate a Phase 3 programme during 2025. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:8.8pt;font-style:italic;font-weight:400;line-height:150%">Phase 2 trial with CDR132L in patients with acute myocardial infarction and reduced left ventricular ejection fraction completed and initiation of two phase 2 trials with CDR132L in patients with chronic heart failure with preserved or reduced ejection fraction</font></div><div style="margin-top:3pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In July 2025, Novo Nordisk completed the phase 2 trial HF-REVERT with CDR132L. CDR132L was part of the acquisition of Cardior Pharmaceuticals GmbH in 2024, and the HF-REVERT trial was conducted by Cardior. The trial investigated the efficacy and safety of 5 and 10 mg&#47;kg of CDR132L, an antisense oligonucleotide targeting miR-132, in 294 patients with reduced left ventricular ejection fraction after an acute myocardial infarction. The trial did not meet the primary endpoint of percent change in left ventricular end-systolic volume index from baseline to month 6 with CDR132L versus placebo. In the trial, CDR132L appeared to have a safe and well-tolerated profile. Novo Nordisk is not planning further development of CDR132L within reduced left ventricular ejection fraction following myocardial infarction.</font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">As planned, in June 2025, Novo Nordisk initiated two phase 2 trials with CDR132L in patients with chronic heart failure. The first trial will investigate the safety and efficacy of 3 dose levels of CDR132L over 48 weeks in 200 patients with heart failure with preserved injection fraction and left ventricular hypertrophy. The second trial will investigate the safety and efficacy of </font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.895%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 21 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">a single dose level of CDR132L over 48 weeks in 200 patients with heart failure with reduced injection fraction and left ventricular hypertrophy.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Phase 1 trial with NLRP3 inhibitor initiated</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In July 2025, Novo Nordisk initiated a phase 1 trial with an oral NRLP3 inhibitor </font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:8.8pt;font-style:italic;font-weight:400;line-height:150%">(NN6705</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">), aiming for oral treatment in a broad range of liver, kidney and cardiometabolic diseases. The trial is investigating safety, tolerability, pharmacokinetics and biomarkers of the NLRP3 inhibitor.</font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:135%">Rare disease</font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Submission of Sogroya</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%"> non-replacement indications in the US and Japan successfully completed</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In May 2025, based on data from REAL 8 and REAL 9, Novo Nordisk has submitted for regulatory approval in the US for Sogroya</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">, including the three indications Small for Gestational Age (SGA), Noonan Syndrome (NS) and Idiopathic short stature (ISS). Likewise, Novo Nordisk has submitted in Japan for regulatory approval for the SGA and NS indications. Regulatory decisions are expected during the first half of 2026. Finally, in REAL 8, the fourth sub-study in children with Turner Syndrome (TS) has read-out and met the primary endpoint of demonstrating non-inferiority in height velocity at week 52 for Sogroya</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> vs daily Norditropin</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">. In the trial, Sogroya</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> appeared to have a safe and well-tolerated profile, consistent with the known safety profile of daily Norditropin</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">.</font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Alhemo</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174; </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">(concizumab</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">) </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">regulatory milestones within haemophilia </font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In July 2025, concizumab was approved in the US for the treatment of haemophilia A and B without inhibitors. Concizumab was approved under the brand name Alhemo</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">. Further, in July 2025, the European Medicines Agency&#8217;s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion of Alhemo</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> for the treatment of haemophilia A and B without inhibitors in the EU. </font></div><div><font><br></font></div><div style="margin-bottom:3pt;text-align:justify"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Business development  </font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Novo Nordisk entered exclusive collaboration and licence agreement with Septerna Inc. for oral small molecules </font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In May 2025, Novo Nordisk and Septerna Inc. announced an exclusive global collaboration and licence agreement to discover, develop and commercialise oral small molecule medicines for key GPCR targets including GLP-1, GIP and glucagon receptors for the treatment of obesity, type 2 diabetes and other cardiometabolic diseases. Under the terms of the agreement, Septerna is eligible to receive approximately USD 2.2 billion from Novo Nordisk, including more than USD 200 million in upfront and near-term milestone payments. Septerna is also eligible to receive tiered royalties on global net sales of marketed products and has the right to opt in to a worldwide profit share for one programme in the collaboration in lieu of future milestones and royalties for that product candidate. For further information, please see the press release here&#58; https&#58;&#47;&#47;www.novonordisk.com&#47;news-and-media&#47;news-and-ir-materials&#47;news-details.html&#63;id&#61;916006 (the contents of the company's website do not form a part of this Form 6-K). </font></div><div><font><br></font></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_43"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 22 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">PURPOSE AND SUSTAINABILITY</font></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_46"></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">ENVIRONMENT</font></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.390%"><tr><td style="width:1.0%"></td><td style="width:48.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.056%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.032%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.100%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">ENVIRONMENTAL PERFORMANCE</font></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unit</font></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">H1 2025</font></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">H1 2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;% change<br>&#160;H1 2025 to<br>&#160;H1 2024</font></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total CO</font><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:1.12pt;vertical-align:baseline">2</font><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">e emissions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">1,000 tonnes CO</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:1.12pt;vertical-align:baseline">2</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">e</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,311</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,001</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">31</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">&#160;- Scope 1 CO</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:1.12pt;vertical-align:baseline">2</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">e emissions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">1,000 tonnes CO</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:1.12pt;vertical-align:baseline">2</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">e</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">61</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">38</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">61</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">&#160;- Scope 2 CO</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:1.12pt;vertical-align:baseline">2</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">e emissions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">1,000 tonnes CO</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:1.12pt;vertical-align:baseline">2</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">e</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">32</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">220</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">&#160;- Scope 3 CO</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:1.12pt;vertical-align:baseline">2</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">e emissions</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">1,000 tonnes CO</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:1.12pt;vertical-align:baseline">2</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">e</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,218</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">953</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">28</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plastic footprint (absolute)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">tonnes </font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15,670</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14,916</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plastic footprint per patient</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">kg&#47;patient</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">0.34</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">0.35</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">%)</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1) Figure has been restated from 2,155 in H1 2024 Company announcement due to updated calculation methodology.</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2) Plastic footprint over a 12-month period, calculated as a moving annual total.  </font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Emissions</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Novo Nordisk is committed to reaching net zero emissions across scope 1, scope 2 and scope 3 greenhouse gas emissions by 2045. Overall CO</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:1.26pt;vertical-align:baseline">2</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">e emissions (scope 1, 2 and full scope 3) increased by 31% compared to the first half of 2024. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Compared to the first six months of 2024, scope 1 CO</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:1.26pt;vertical-align:baseline">2</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">e emissions increased by 61% primarily due to the acquisition of new production sites and increased consumption of natural gas related hereto. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Scope 2 CO</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:1.26pt;vertical-align:baseline">2</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">e emissions increased by 220% compared to the first six months of 2024 primarily due to use of non-renewable electricity at the newly acquired production sites, mainly related to Catalent. Since 2020, Novo Nordisk has sourced 100% renewable electricity for its production sites. As of June 2025, the overall share of renewable electricity for production sites is 86% driven by recent acquisition of new sites without renewable electricity setup.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Scope 3 CO</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:1.26pt;vertical-align:baseline">2</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">e emissions increased by 28% compared to the first six months of 2024 due to an increase in raw material supply and increased investments in capital expenditure for property, plant and equipments. Novo Nordisk is actively working on reducing scope 3 CO</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:1.26pt;vertical-align:baseline">2</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">e emissions and has set a target for 2033, approved by the Science-Based Target initiative.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Plastic target</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Novo Nordisk has set a global target to reduce the plastic footprint per patient from Diabetes and Obesity care products by 30% by 2033, compared to a baseline of 0.35 kg per patient in 2024. Due to increased production volumes, the absolute plastic footprint rose by 5%, while the relative footprint per patient decreased by 3%. This reduction was mainly driven by an increase in once-weekly treatments compared to once-daily treatments.</font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.738%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 23 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">SOCIAL</font></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.438%"><tr><td style="width:1.0%"></td><td style="width:47.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.990%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">SOCIAL PERFORMANCE</font></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unit</font></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">H1 2025</font></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">H1 2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;% change<br>&#160;H1 2025 to<br>&#160;H1 2024</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Patients</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total numbers of patients reached</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Estimate in millions</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">45.7</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">42.1</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:14.17pt;text-indent:-7.09pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;padding-left:3.25pt">Patients reached with Novo Nordisk's Diabetes care products </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Estimate in millions</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">42.8</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">40.7</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:14.17pt;text-indent:-7.09pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;padding-left:3.25pt">Patients reached with Novo Nordisk's Obesity care products </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Estimate in millions</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.9</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.4</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">107</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Vulnerable patients reached with Diabetes care products</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Estimate in millions</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7.5</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8.6</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(13</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:150%">Children reached through the Changing Diabetes</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:150%"> in Children programme</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Number of children</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">72,760</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">56,821</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">28</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Sustainable employer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total number of employees (FTEs)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Number</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">78,387</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">69,260</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Gender in senior leadership positions</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">4</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Men&#58;women</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">57&#58;43 </font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">59&#58;41</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N&#47;A</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1) Calculated as a moving annual total. The estimated total number of full-year patients reached over a 12-month period.</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2) Patients reached either through products sold under local affordability thresholds, or public tenders in low-, lower middle- or upper middle-income countries (LMICs), or through specific diabetes access and affordability programmes or humanitarian donations. </font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3) Total cumulative number of children. The number of children reached with Diabetes care treatment through the Changing Diabetes</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174; </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">in Children programme since the initiation of the partnership in 2009.</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4) Defined as chief executive officer (CEO), executive vice presidents (EVP), senior vice presidents (SVP), corporate vice presidents (CVP) and vice presidents (VP). The number has been updated to reflect the entire Novo Nordisk group, and this restatement did not result in any change to the comparison number.</font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Patients</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:140%">The number of people reached with Novo Nordisk products, across Diabetes and Obesity care, was 45.7 million at the end of June 2025. This is an increase of 3.6 million patients compared to end of June 2024. </font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">By the end of June 2025, the number of vulnerable patients treated with Diabetes care products reached 7.5 million. This is a 13% decline compared to the same period last year, driven by fewer tender sales and portfolio consolidation of human insulin.</font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">The Changing Diabetes</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:5.85pt;font-weight:400;line-height:150%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> in Children programme aims to reach 100,000 children by 2030. By the end of June 2025, a total of 72,760 children were reached with Diabetes care treatment, an increase of 28% compared to the end of June 2024.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">Sustainable employer</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Novo Nordisk aspires to be a sustainable employer. At the end of June</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> 2025, 43% of leaders in senior positions were women and 57% were men. At the end of June 2024, 41% of leaders in senior positions were women and 59% were men.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">The number of full-time employees at the end of June 2025 was 78,387. This is an increase of 13% compared to end of June 2024. The increase is mainly driven by Product Supply. The</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> acquisition of Catalent accounts for around 3,000 full-time employees. </font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:150%">International crises, geopolitical tensions and natural disasters</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Novo Nordisk is committed to supporting the safety of our employees and ensuring uninterrupted access to essential </font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">medicines during humanitarian crises. Our priorities include safeguarding our workforce and collaborating with </font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">humanitarian organisations to provide critical medications to affected regions. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In recent crises, including the Israel-Hamas and Israel-Iran conflicts and Russia's invasion of Ukraine, we have maintained essential supplies to ensure patients can continue their treatments, underscoring our dedication to supporting communities in need.</font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.738%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_49"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 24 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">CORPORATE GOVERNANCE</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Changes in Executive Management</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In May, Novo Nordisk announced changes in Executive Management. After an accomplished career of 34 years with the company, including eight years as CEO, Lars Fruergaard J&#248;rgensen will step down from his role, by mutual agreement with the Novo Nordisk Board.</font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In July, it was announced that Mike Doustdar, executive vice president, International Operations, has been appointed as president and chief executive officer as of 7 August 2025. Mike Doustdar joined Novo Nordisk in 1993 and held leadership roles in finance and IT prior to leading commercial areas in the Middle East and Malaysia. Mike Doustdar became senior vice president of International Operations in 2013 and executive vice president in 2015.</font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">At the same time, additional changes to Executive Management were announced. Novo Nordisk has decided to merge the company&#8217;s Research &#38; Early Development with its Development area into a new, consolidated R&#38;D unit, under the leadership of Martin Holst Lange, MD, PhD. Martin Holst Lange, currently executive vice president, Development, will be appointed chief scientific officer (CSO), effective 7 August.</font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Marcus Schindler, executive vice president, Research &#38; Early Development and CSO, has decided to retire from the company. Marcus Schindler joined Novo Nordisk in January 2018 as senior vice president of External Innovation and Strategy and has been CSO since 2021. Marcus Schindler has played an integral role in leading the discovery of early scientific innovation.</font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Lastly, Emil Kongsh&#248;j Larsen, currently senior vice president of the Europe and Canada region (EUCAN), will join Executive Management and succeed Mike Doustdar in the role of executive vice president, International Operations. Emil Kongsh&#248;j Larsen has previously led other business areas throughout Europe, Africa and the Middle East, as well as Commercial Affairs and Strategy in International Operations.</font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">With these changes, Executive Management will have the following members, effective 7 August&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;padding-left:14.62pt">Mike Doustdar, president and CEO*</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;padding-left:14.62pt">Thilde Hummel B&#248;gebjerg, EVP, Quality, IT &#38; Environmental Affairs</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;padding-left:14.62pt">Emil Kongsh&#248;j Larsen, EVP, International Operations</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;padding-left:14.62pt">Ludovic Helfgott, EVP, Product &#38; Portfolio Strategy</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;padding-left:14.62pt">Karsten Munk Knudsen, EVP, chief financial officer*</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;padding-left:14.62pt">Martin Holst Lange, EVP, chief scientific officer, Research &#38; Development</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;padding-left:14.62pt">David Moore, EVP, US Operations</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;padding-left:14.62pt">Tania Sabroe, EVP, People, Organisation and Corporate Affairs</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;padding-left:14.62pt">Henrik Wulff, EVP, CMC &#38; Product Supply</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">* Registered as an executive with the Danish Business Authority.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Changes in the Board of Directors</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Dr. Mikael Dolsten has joined the Novo Nordisk Board of Directors as an observer effective 5 August 2025, with the intention of being nominated for election as a Board member at the Annual General Meeting in 2026.</font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Dr. Mikael Dolsten brings more than 30 years of leadership experience from the pharmaceutical industry across Europe and the US, most notably from his 16-year tenure at Pfizer Inc., where he served as chief scientific officer and president of Research &#38; Development. He has also held leadership roles at Boehringer Ingelheim, AstraZeneca and Wyeth. Dr. Mikael Dolsten is a Swedish and American citizen and holds a Ph.D. in Tumor Immunology and an M.D. from the University of Lund, Sweden. Dr. Mikael Dolsten will add deep scientific and strategic R&#38;D expertise to the Novo Nordisk Board as the company continues to advance its leading R&#38;D pipeline in Diabetes and Obesity.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_55"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 25 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">STATEMENT BY THE BOARD OF DIRECTORS AND EXECUTIVE MANAGEMENT</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">The Board of Dir</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">ectors and Executive Management have today considered and approved this financial report of Novo Nordisk A&#47;S containing condensed financial information and condensed sustainability information for the first six months of 2025. This financial report has not been audited or reviewed by the company's independent auditors.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">The condensed financial information in this financial report has been prepared in accordance with the recognition and measurement requirements in the IFRS Accounting Standards</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> as adopted by the EU and</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> the accounting policies are consistent with those applied in the Annual Report 2024. </font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">The condensed sustainability information in this financial report has been prepared in accordance with the ESRS and</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> the accounting policies are consistent with those applied in the Annual Report 2024.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">In our opinion, the accounting policies used are appropriate, and the overall presentation of this financial report is </font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">adequate. Furthermore, in our opinion, this financial report includes a true and fair view of the financial position at 30 June 2025 as well as of the results of the operations, the cash flows and the sustainability performance for the period 1 January - 30 June 2025. Furthermore, in our opinion, Management's Review contains a fair review of the development of the Group's business and financial matters, the results for the period and of the financial position, together with a description of the principal risks and uncertainties that the Group faces in accordance with Danish disclosure requirements for listed companies.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%"> Bagsv</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">&#230;rd, 6 August 2025</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.839%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Executive Management&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Lars Fruergaard J&#248;rgensen</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">President and CEO</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Karsten Munk Knudsen</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">CFO</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Board of Directors&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Helge Lund</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Chair</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Henrik Poulsen</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Vice chair</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Elisabeth Dahl Christensen</font></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Laurence Debroux</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Andreas Fibig</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Sylvie Gr&#233;goire</font></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Liselotte Hyveled</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Mette B&#248;jer Jensen</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Kasim Kutay</font></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Christina Law</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Martin Mackay</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Thomas Rantzau</font></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_58"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 26 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:115%">A</font><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:700;line-height:115%">bout Novo Nordisk</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. Novo Nordisk employs abou</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:115%">t 78,400 </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:115%">people in 80 countries and markets its products in around 170 countries. Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com, Facebook, X, LinkedIn and YouTube. </font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.888%"><tr><td style="width:1.0%"></td><td style="width:24.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.150%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">Financial Calendar</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5 November 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial results for the first nine months of 2025</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4 February 2026</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial statement for 2025</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.738%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">Contacts for further information</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Media&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Ambre James-Brown</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">+45 3079 9289</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">abmo&#64;novonordisk.com</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Liz Skrbkova (US)</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">+1 609 917 0632</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">lzsk&#64;novonordisk.com</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Investors&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Jacob Martin Wiborg Rode</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">+45 3075 5956</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">jrde&#64;novonordisk.com</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Sina Meyer</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">+45 3079 6656</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">azey&#64;novonordisk.com</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Max Ung</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">+45 3077 6414</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">mxun&#64;novonordisk.com</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Alex Bruce</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">+45 3444 2613</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">axeu&#64;novonordisk.com</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Christoffer Sho Togo Tullin</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">+45 3079 1471</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">cftu&#64;novonordisk.com</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Frederik Taylor Pitter (US)</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">+1 609 613 0568</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">fptr&#64;novonordisk.com</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.588%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #939aa7;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Forward-looking statements</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:115%">Novo Nordisk&#8217;s statutory Annual Report 2024, Form 20-F, any quarterly financial reports, and written information released, shown, or oral statements made, to the public in the future by or on behalf of Novo Nordisk, may contain certain forward-looking statements relating to the operating, financial and sustainability performance and results of Novo Nordisk and&#47;or the industry in which it operates. Forward-looking statements can be identified by the fact that they do not relate to historical or current facts and include guidance. Words such as &#8216;believe&#8217;, &#8216;expect&#8217;, &#8216;may&#8217;, &#8216;will&#8217;, &#8216;plan&#8217;, &#8216;strategy&#8217;, &#8216;transition plan&#8217;, &#8216;prospect&#8217;, &#8216;foresee&#8217;, &#8216;estimate&#8217;, &#8216;project&#8217;, &#8216;anticipate&#8217;, &#8216;can&#8217;, &#8216;intend&#8217;, &#8216;target&#8217; and other words and terms of similar meaning in connection with any discussion of future operating, financial or sustainability performance identify forward-looking statements. Examples of such forward-looking statements include, but are not limited to&#58; </font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Statements of targets, future guidance, (transition) plans, objectives or goals for future operations, including those related to operating, financial and sustainability matters, Novo Nordisk&#8217;s products, product research, product development, product introductions and product approvals as well as cooperation in relation thereto&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:15.75pt">Statements containing projections of or targets for revenues, costs, income (or loss), earnings per share, capital expenditures, dividends, capital structure, net financials and other financial measures&#59;  </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:15.75pt">Statements regarding future economic performance, future actions and outcome of contingencies such as legal proceedings&#59; and  </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:15.75pt">Statements regarding the assumptions underlying or relating to such statements. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%;padding-left:15.75pt">These statements are based on current plans, estimates, opinions, views and projections. Although Novo Nordisk believes that the expectation reflected in such forward-looking statements are reasonable, there can be no assurance that such expectation will prove to be correct. By their very nature, forward-looking statements involve risks, uncertainties and assumptions, both general and specific, and actual results may  differ materially from those contemplated, expressed or implied by any forward-looking statement. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Factors that may affect future results include, but are not limited to, global as well as local political, economic and environmental conditions, such as interest rate and currency exchange rate fluctuations or climate change, delay or failure of projects related to research and&#47;or development, unplanned loss of patents, interruptions of supplies and production, including as a result of interruptions or delays affecting supply chains on which Novo Nordisk relies, shortages of supplies, including energy supplies, product recalls, unexpected contract breaches or terminations, government- mandated or market-driven price decreases for Novo Nordisk&#8217;s products, introduction of competing products, reliance on information technology including the risk of cybersecurity breaches, Novo Nordisk&#8217;s ability to successfully market current and new products, exposure to product liability and legal proceedings and investigations, changes in governmental laws and related interpretation thereof, including on reimbursement, intellectual property protection and regulatory controls on testing, approval, manufacturing and marketing, and taxation changes, including changes in tariffs and duties, perceived or actual failure to adhere to ethical marketing practices, investments in and divestitures of domestic and foreign companies, unexpected growth in costs and expenses, strikes and other labour market disputes, failure to recruit and retain the right employees, failure to maintain a culture of compliance, epidemics, pandemics or other public health crises, the effects of domestic or international crises, civil unrest, war or other conflict and factors related to the foregoing matters and other factors not specifically identified herein.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">For an overview of some, but not all, of the risks that could adversely affect Novo Nordisk&#8217;s results or the accuracy of forward-looking statements in the Annual Report 2024, reference is made to the overview of risk factors in &#8216;Risks&#8217; of the Annual Report 2024.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">None of Novo Nordisk or its subsidiaries or any such person's officers, or employees accept any responsibility for the future accuracy of the opinions expressed in the Annual Report 2024, Form 20-F, any quarterly financial reports, and written information released, shown, or oral statements made, to the public in the future by or on behalf of Novo Nordisk or the actual occurrence of the forecasted developments.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Unless required by law, Novo Nordisk has no duty and undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.</font></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_61"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 27 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">APPENDIX 1&#58; QUARTERLY NUMBERS IN DKK</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.888%"><tr><td style="width:1.0%"></td><td style="width:27.835%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.795%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.795%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.795%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.795%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.795%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.795%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.797%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(Amounts in DKK million, except number of full-time equivalent employees, earnings per share and number of shares outstanding).</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2025</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Q2 2025 vs.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Q2</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Q1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Q4</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Q3</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Q2</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Q1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Q2 2024</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Net sales</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">76,857</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">78,087</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">85,683</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">71,311</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">68,060</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">65,349</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Gross profit</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">64,011</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">65,197</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">72,659</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">60,003</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">57,786</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">55,433</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">11</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Gross margin</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">83.3%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">83.5%</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">84.8%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">84.1%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">84.9%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">84.8%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Sales and distribution costs</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(17,533)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(14,892)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(18,701)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(15,210)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(14,934)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(13,256)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">17</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Percentage of sales</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">22.8%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">19.1%</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">21.8%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">21.3%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">21.9%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">20.3%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Research and development costs</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(11,690)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(10,308)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(13,802)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(9,488)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(16,166)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(8,606)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(28</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Percentage of sales</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">15.2%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">13.2%</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">16.1%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">13.3%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">23.8%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">13.2%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Administrative costs</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1,316)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1,220)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1,580)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1,382)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1,157)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1,157)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">14</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Percentage of sales</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1.7%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1.6%</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1.8%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1.9%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1.7%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1.8%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Other operating income and expenses</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(23)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">14</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1,839)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(101)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">405</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(568)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">N&#47;A</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Operating profit (EBIT)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">33,449</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">38,791</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">36,737</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">33,822</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">25,934</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">31,846</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">29</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Operating margin</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">43.5%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">49.7%</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">42.9%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">47.4%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">38.1%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">48.7%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Financial income</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,314</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,425</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,913</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(821)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">960</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,146</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">454</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Financial expenses</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(4,958)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(5,183)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(5,093)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,383</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1,562)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(2,074)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">217</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Financial items (net)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">356</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1,758)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1,180)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">562</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(602)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">72</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(159</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%)</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Profit before income taxes</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">33,805</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">37,033</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">35,557</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">34,384</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">25,332</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">31,918</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">33</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Income taxes</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(7,302)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(7,999)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(7,327)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(7,083)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(5,282)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(6,511)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">38</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Net profit</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">26,503</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">29,034</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">28,230</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">27,301</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">20,050</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">25,407</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">32</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Depreciation, amortisation and impairment losses</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,833</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,830</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,198</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,150</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8,845</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,914</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(45</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Capital expenditure (PP&#38;E)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">14,661</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13,422</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">16,101</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12,119</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10,470</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8,474</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">40</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Net cash flows from operating activities</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">40,785</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">24,591</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12,301</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">43,850</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">50,503</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">14,314</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(19</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Free cash flow</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">24,079</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9,492</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(86,467)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">30,451</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">36,289</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(34</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">EBITDA</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">38,282</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">42,621</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">41,935</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">35,972</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">34,779</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">34,760</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Adjusted net profit</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">28,265</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">30,304</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">30,516</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">27,797</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">25,795</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">26,449</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total assets</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">482,153</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">489,162</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">465,795</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">397,441</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">369,383</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">298,921</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">31</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total equity</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">168,066</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">138,540</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">143,486</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">120,522</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">112,522</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">98,911</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">49</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Equity ratio</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">34.9%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">28.3%</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">30.8%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">30.3%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">30.5%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">33.1%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Full-time equivalent employees end of period</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">78,387</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">77,406</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">76,302</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">71,880</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">69,260</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">66,015</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Basic earnings per share&#47;ADR (in DKK)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5.96</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6.54</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6.34</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6.13</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4.50</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5.70</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">32</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Diluted earnings per share&#47;ADR (in DKK)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5.96</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6.53</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6.34</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6.12</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4.49</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5.68</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">33</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Average number of shares outstanding (million)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,443.4</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,439.5</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,446.2</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,452.3</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,457.7</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,459.6</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">0</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Average number of diluted shares outstanding (million)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,446.7</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,446.4</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,455.5</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,460.5</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,465.4</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,470.5</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">0</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Sales by business segment&#58;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Total GLP-1</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">38,366</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">39,574</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">42,173</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">34,935</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">37,035</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">34,982</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Long-acting insulin</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,467</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,388</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,158</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,035</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,737</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,165</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(6</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Premix insulin</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,636</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,813</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,867</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,518</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,436</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,968</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Fast-acting insulin</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,542</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,052</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,017</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,150</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,868</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,487</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">17</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Human insulin</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,101</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,744</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,845</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,806</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,571</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,745</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(30</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Total insulin</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12,746</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">14,997</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">15,887</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12,509</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12,612</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">14,365</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Other Diabetes care</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">454</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">473</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">512</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">492</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">533</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">583</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(15</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Total Diabetes care</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">51,566</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">55,044</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">58,572</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">47,936</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">50,180</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">49,930</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">19,528</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">17,360</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">19,866</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">17,304</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">11,659</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9,377</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">67</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Saxenda</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">844</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,064</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,540</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,497</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,245</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,658</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(62</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Total Obesity care </font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">20,372</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">18,424</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">21,406</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">18,801</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13,904</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">11,035</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">47</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Diabetes and Obesity care total</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">71,938</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">73,468</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">79,978</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">66,737</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">64,084</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">60,965</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Rare blood disorders</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,096</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,921</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,398</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,988</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,864</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,888</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Rare endocrine disorders</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,420</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,312</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,923</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,227</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">730</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,113</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">95</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Other Rare disease</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">403</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">386</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">384</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">359</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">382</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">383</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Rare disease total</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,919</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,619</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,705</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,574</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,976</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,384</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">24</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Sales by geographic segment&#58;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">US Operations</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">42,963</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">44,316</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">52,371</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">39,847</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">38,404</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">36,782</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">International Operations</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">33,894</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">33,771</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">33,312</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">31,464</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">29,656</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">28,567</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">14</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;- EUCAN</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">16,447</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">14,765</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">16,418</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">14,098</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13,910</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13,119</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">18</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;- Emerging Markets</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">7,544</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8,790</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">7,194</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8,323</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,758</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">7,240</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;- APAC</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,615</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,594</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,376</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,335</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,025</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,702</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">40</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;- Region China</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,288</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,622</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,324</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,708</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,963</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,506</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(14</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%)</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Segment operating profit&#58;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Diabetes and Obesity care</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">32,931</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">38,247</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">36,044</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">33,473</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">26,984</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">31,218</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">22</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Rare disease</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">518</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">544</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">693</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">349</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1,050)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">628</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(149</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">%)</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Research and development costs include an impairment loss of DKK 5.7 billion in the second quarter of 2024 related to ocedurenone. The impairment loss is recognised in the segment Diabetes and Obesity. </font></div></td></tr></table></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_64"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 28 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">APPENDIX 2&#58; INCOME STATEMENT AND STATEMENT OF COMPREHENSIVE INCOME</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.888%"><tr><td style="width:1.0%"></td><td style="width:43.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.093%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.093%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.093%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.097%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">DKK million</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">H1 2025</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 13pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">H1 2024</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Q2 2025</font></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Q2 2024</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt 0 13.75pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">Income statement</font></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 13.75pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Net sales</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">154,944</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">133,409</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">76,857</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">68,060</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Cost of goods sold</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(25,736)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(20,190)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(12,846)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(10,274)</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Gross profit</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">129,208</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">113,219</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">64,011</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">57,786</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Frutiger LT 45 Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Sales and distribution costs</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(32,425)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(28,190)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(17,533)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(14,934)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Research and development costs</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(21,998)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(24,772)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(11,690)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(16,166)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Administrative costs</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2,536)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2,314)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,316)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,157)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Other operating income and expenses</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(9)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(163)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(23)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">405</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 13pt 0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 13pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 13pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 13pt 0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Operating profit</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">72,240</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">57,780</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">57780000000</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">33,449</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">25,934</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Financial income</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,739</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,106</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,314</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">960</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Financial expenses</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(10,141)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,636)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(4,958)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,562)</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 13pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 13pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 13pt 0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Profit before income taxes</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">70,838</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">57,250</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">33,805</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">25,332</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 13pt 0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Income taxes</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(15,301)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(11,793)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(7,302)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(5,282)</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 13pt 0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 13pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 13pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 13pt 0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NET PROFIT</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">55,537</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,457</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45457000000</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">26,503</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">20,050</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 13pt 0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt 0 13pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 13pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 13pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Basic earnings per share (DKK)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12.50</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10.20</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5.96</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4.50</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Diluted earnings per share (DKK)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12.49</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10.17</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5.96</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4.49</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">Segment Information</font></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt 0 13pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 13pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 13pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Segment sales&#58;</font></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Diabetes and Obesity care</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">145,406</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">125,049</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">71,938</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">64,084</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Rare disease</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,538</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,360</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,919</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,976</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Segment operating profit&#58;</font></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Diabetes and Obesity care</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">71,178</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">58,202</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">32,931</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">26,984</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Operating margin</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">49.0%</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">46.5%</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">45.8%</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">42.1%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Rare disease</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,062</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(422)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">518</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,050)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Operating margin</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">11.1%</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">(5.0)%</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">10.5%</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">(26.4)%</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Total segment operating profit</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">72,240</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">57,780</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">33,449</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">25,934</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 13pt 0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 13pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 13pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 13pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">Statement of comprehensive income</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Net profit</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">55,537</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,457</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">26,503</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">20,050</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Other comprehensive income</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Items that will not subsequently be reclassified to the Income <br>&#160;&#160;&#160;&#160;statement</font></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Remeasurements of defined benefit obligations</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">87</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(34)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">39</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Items that will not be reclassified subsequently to the income statement</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #b6b6b6;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">87</font></td><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(34)</font></td><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #b6b6b6;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5</font></td><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">39</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Items that will be reclassified subsequently to the Income <br>&#160;&#160;&#160;&#160;statement</font></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Exchange rate adjustments of investments in subsidiaries </font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(7,959)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,194</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(5,440)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">769</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Cash flow hedges&#58;</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Realisation of previously deferred (gains)&#47;losses </font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,243</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(679)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,472</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">933</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Deferred gains&#47;(losses) on hedges, incurred during the period</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">13,404</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2,490)</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,968</font></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,243)</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Tax and other items</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(4,113)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">626</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2,608)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">53</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Items that will be reclassified subsequently to the income statement</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #b6b6b6;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,575</font></td><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,349)</font></td><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #b6b6b6;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,392</font></td><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">512</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;Other comprehensive income</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,662</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,383)</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,397</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">551</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">TOTAL COMPREHENSIVE INCOME</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #b6b6b6;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">60,199</font></td><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">44,074</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #b6b6b6;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">28,900</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">20,601</font></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr></table></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_67"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 29 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">APPENDIX 3&#58; CASH FLOW STATEMENT</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.888%"><tr><td style="width:1.0%"></td><td style="width:69.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.292%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.295%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">DKK million</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">H1 2025</font></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">H1 2024</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Net profit </font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">55,537&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,457&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7.75pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Adjustment for non-cash items&#58;</font></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7.75pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Income taxes in the income statement</font></div></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">15,301&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,793&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Depreciation, amortisation and impairment losses</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,663&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,759&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other non-cash items</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,076&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,297&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Change in working capital</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(11,673)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">249&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Interest received</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">824&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">547&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Interest paid</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,952)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(217)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Income taxes paid</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(8,400)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(16,068)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Net cash flows from operating activities</font></div></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">65,376&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">64,817&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Frutiger LT 45 Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7.75pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Purchase of intangible assets</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2,778)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,303)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Purchase of property, plant and equipment</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(28,083)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(18,944)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Cash used for acquisition of businesses</font></div></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(668)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Purchase of other financial assets </font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(199)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(32)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Purchase of marketable securities</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(498)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(10,993)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Sale of marketable securities</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10,637&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">17,165&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Net cash flows from investing activities</font></div></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(20,921)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(16,775)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7.75pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Purchase of treasury shares</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,388)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(10,285)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Dividends paid</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(35,100)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(28,557)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Proceeds from borrowings</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">72,598&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">34,513&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Repayment of borrowings</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(76,889)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(5,370)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Net cash flows from financing activities</font></div></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(40,779)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(9,699)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7.75pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Net cash generated from activities</font></div></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,676&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">38,343&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7.75pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Cash and cash equivalents at the beginning of the year</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">15,655&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">14,392&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Exchange gain&#47;(loss) on cash and cash equivalents</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(896)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">86&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Cash and cash equivalents at the end of the period</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">18,435&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">52,821&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:27pt"><td colspan="6" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_70"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 30 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">APPENDIX 4&#58; BALANCE SHEET</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.888%"><tr><td style="width:1.0%"></td><td style="width:69.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.292%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.295%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">DKK million</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">30 Jun 2025</font></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31 Dec 2024</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:150%">ASSETS</font></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Intangible assets</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">107,866&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">111,090&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Property, plant and equipment</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">180,758&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">162,488&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Investments in associated companies</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">390&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">400&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Deferred income tax assets</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">23,747&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">24,627&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Other receivables and prepayments</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,439&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,016&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Other financial assets</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,248&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,277&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">TOTAL NON-CURRENT ASSETS</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">319,448&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">304,898&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 13.75pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13.75pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Inventories</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,652&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">40,849&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Trade receivables</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">69,575&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">71,949&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Tax receivables</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,995&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,853&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Other receivables and prepayments</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">13,273&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12,612&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Marketable securities</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">499&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10,653&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Derivative financial instruments</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12,276&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,326&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Cash at bank</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">18,435&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">15,655&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">TOTAL CURRENT ASSETS</font></td><td colspan="2" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">162,705&#160;</font></td><td style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">160,897&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">TOTAL ASSETS</font></td><td colspan="2" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">482,153&#160;</font></td><td style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">465,795&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 13.75pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 13.75pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:150%">EQUITY AND LIABILITIES</font></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 13.75pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13.75pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 13.75pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13.75pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Share capital</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">446&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">446&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Treasury shares</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Retained earnings</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">164,453&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">144,448&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Other reserves</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,169&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,406)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">TOTAL EQUITY</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">168,066&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">143,486&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 13.75pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13.75pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Borrowings</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">87,305&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">89,674&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Deferred income tax liabilities</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,796&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,426&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Retirement benefit obligations</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">810&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">903&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Other liabilities</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">17&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">23&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Provisions</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,637&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,755&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Total non-current liabilities</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">106,565&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">104,781&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt 0 13.75pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt 0 13.75pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Borrowings</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,963&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">13,113&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Trade payables</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">28,206&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">28,846&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Tax payables</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">16,927&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,716&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Other liabilities</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">32,970&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">37,993&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Derivative financial instruments</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,329&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,531&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Provisions</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:4.87pt;font-weight:400;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">1</font></div></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">112,127&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">120,329&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Total current liabilities</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">207,522&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">217,528&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">TOTAL LIABILITIES</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">314,087&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">322,309&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">TOTAL EQUITY AND LIABILITIES</font></td><td colspan="2" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">482,153&#160;</font></td><td style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">465,795&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="12" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:115%;position:relative;top:-2.1pt;vertical-align:baseline">1)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:115%"> At 30 June 2025, the provision for 340B statutory discounts amounts to USD 4.2 billion. Given the passage of time and the current legal and regulatory landscape relating to enforcement of the 340B program, the Company has reduced the provision for 340B statutory discounts by USD 0.4 billion (around DKK 3 billion) from USD 4.6 billion (as of 31 December 2024) to USD 4.2 billion, reflecting an assessment of current applicable laws, historical legal and administrative rulings as well as attrition and experience from historical claims. During the first six months of 2024, the Company increased the provision for 340B statutory discounts by a total of USD 0.4 billion.</font></div></td></tr></table></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_73"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 31 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">APPENDIX 5&#58; EQUITY STATEMENT</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.888%"><tr><td style="width:1.0%"></td><td style="width:48.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.944%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.800%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">DKK million</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Share<br>capital</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Treasury<br>shares</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Retained<br>earnings</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Other reserves</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Total</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">H1 2025</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Balance at the beginning of the year</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">446&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">144,448&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,406)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">143,486&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Net profit</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">55,537&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">55,537&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Other comprehensive income for the period</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">87&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,575&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,662&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Total comprehensive income for the period</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">55,624&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,575&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">60,199&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">Transactions with owners&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Dividends</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(35,100)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(35,100)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Share-based payments</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">906&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">906&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Purchase of treasury shares</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,388)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,388)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Tax related to transactions with owners</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(37)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(37)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Balance at the end of the period</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">446&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(2)</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">164,453&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,169&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">168,066&#160;</font></td><td style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">DKK million</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Share<br>capital</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Treasury<br>shares</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Retained<br>earnings</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Other reserves</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Total</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">H1 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Balance at the beginning of the year</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">451&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(5)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">104,839&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,276&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">106,561&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Net profit</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,457&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,457&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Other comprehensive income for the period</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(34)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,349)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,383)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Total comprehensive income for the period</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,423&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,349)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">44,074&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">Transactions with owners&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Dividends</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(28,557)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(28,557)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Share-based payments</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">829&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">829&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Purchase of treasury shares</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(10,284)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(10,285)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Reduction of the B share capital</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(5)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Tax related to transactions with owners</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(100)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(100)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Balance at the end of the period</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">446&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1)</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">112,150&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(73)</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">112,522&#160;</font></td><td style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_79"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 32 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">APPENDIX 6&#58; SALES SPLIT PER AREA</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.725%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.304%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.001%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.001%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.001%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.001%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.001%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.001%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.482%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Q2 2025 sales split per area</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="9" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">DKK million</font></td><td colspan="3" style="border-left:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">US Operations</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">International<br>&#160;Operations</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">EUCAN</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Emerging Markets</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">APAC</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Region China</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="9" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Diabetes and Obesity care segment</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Injectable GLP-1</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">32,713</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">22,130</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10,583</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,072</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,219</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">930</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,362</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">25%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(2%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(35%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Ozempic</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">31,799</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">21,972</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">9,827</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">5,877</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,827</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">871</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,252</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">15%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">19%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">8%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">28%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">5%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(34%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Victoza</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">914</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">158</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">756</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">195</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">392</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">59</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">110</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(57%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(87%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(19%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(34%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">29%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(47%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(51%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Rybelsus</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,653</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,262</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,391</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,853</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">539</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">940</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">59</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(18%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">15%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">16%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">21%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total GLP-1</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">38,366</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">24,392</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13,974</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">7,925</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,758</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,870</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,421</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">22%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(34%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Long-acting insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,467</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,086</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,381</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,594</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">722</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">333</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">732</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(2%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(16%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(5%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">23%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Awiqli</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">60</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">60</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">22</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">3</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">35</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Tresiba</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,800</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">975</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,825</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">899</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">486</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">215</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">225</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">27%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">93%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">7%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(2%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">25%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">9%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">9%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Xultophy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,132</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">57</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,075</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">470</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">76</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">95</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">434</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">10%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">13%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">10%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(7%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">10%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">36%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Levemir</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">475</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">54</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">421</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">203</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">160</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">20</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">38</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(65%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(93%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(27%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(23%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(25%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(36%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(44%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Premix insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,636</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">130</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,506</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">238</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">608</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">534</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,126</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">11%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">119%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(9%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">29%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Ryzodeg</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,363</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,363</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">55</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">265</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">345</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">698</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">20%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">20%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">24%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">55%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">18%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">12%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">NovoMix</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,273</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">130</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,143</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">183</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">343</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">189</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">428</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">119%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(4%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(16%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">15%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(13%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(7%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Fast-acting insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,542</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,936</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,606</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,229</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">779</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">264</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">334</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">21%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">71%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(4%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">8%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(11%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Fiasp</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">515</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">70</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">445</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">341</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">52</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">52</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(5%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(40%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">7%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">7%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">8%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">NovoRapid</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4,027</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,866</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,161</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">888</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">727</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">212</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">334</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">26%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">85%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(2%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(8%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">7%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(14%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">3%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Human insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,101</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">236</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">865</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">157</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">337</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">219</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">152</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(26%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(12%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(29%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(28%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(39%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(10%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(24%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12,746</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,388</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9,358</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,218</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,446</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,350</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,344</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">23%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(7%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(2%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Other Diabetes care</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">454</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">40</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">414</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">131</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">73</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">68</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">142</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(12%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(11%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(12%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(4%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(3%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(5%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(24%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total Diabetes care</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">51,566</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">27,820</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">23,746</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">11,274</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,277</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,288</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,907</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">7%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(14%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">19,528</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12,862</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,666</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,500</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,334</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,676</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">156</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">75%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">36%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">298%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">114%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Saxenda</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">844</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">98</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">746</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">385</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">266</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">93</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(61%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(73%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(58%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(50%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(59%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(72%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(90%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total Obesity care </font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">20,372</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12,960</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">7,412</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,885</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,600</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,769</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">158</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">53%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">32%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">115%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">62%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">120%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">451%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">471%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Diabetes and Obesity care total</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">71,938</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">40,780</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">31,158</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">15,159</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,877</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,057</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,065</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">17%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">16%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">19%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">21%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">20%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">46%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(11%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Rare disease segment</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Rare blood disorders</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">2</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,096</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,296</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,800</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">838</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">458</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">287</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">217</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">16%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(2%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">25%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">36%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">73%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Haemophilia A</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">584</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">95</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">489</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">248</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">90</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">65</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">86</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(1%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(2%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(1%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(17%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">94%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">51%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(23%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Haemophilia B</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">338</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">118</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">220</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">157</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">17</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">42</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(4%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(22%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">10%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">5%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">55%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">23%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">NovoSeven</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,991</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">986</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,005</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">411</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">334</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">133</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">127</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">16%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">11%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">21%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">11%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">9%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Rare endocrine disorders</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">3</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,420</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">816</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">604</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">230</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">145</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">223</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">100%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">335%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">14%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">31%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(19%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">33%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">250%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Other Rare disease</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">4</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">403</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">71</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">332</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">220</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">64</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">48</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">44%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(5%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">64%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(2%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(67%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Rare disease total</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,919</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,183</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,736</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,288</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">667</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">558</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">223</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">28%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">52%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">14%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">14%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">31%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">73%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total sales</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">76,857</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">42,963</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">33,894</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">16,447</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">7,544</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,615</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,288</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">18%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">18%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">18%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">20%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">20%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">45%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(9%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change as reported</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">14%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">18%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">40%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(14%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="6" style="border-bottom:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Share of growth</font></td><td colspan="3" style="background-color:#e2f0fa;border-bottom:0.25pt solid #939aa7;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">100%</font></td><td colspan="3" style="background-color:#e2f0fa;border-bottom:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">55%</font></td><td colspan="3" style="background-color:#e2f0fa;border-bottom:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">45%</font></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">23%</font></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">11%</font></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">15%</font></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(4%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"> 1)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Primarily NovoNorm</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, needles and GlucaGen</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> HypoKit</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"> 2)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Comprises NovoSeven</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, NovoEight</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, Esperoct</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">,</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"> </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Refixia</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, NovoThirteen</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174; </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">and Alhemo</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"> 3)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Primarily Norditropin</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;  </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">and Sogroya</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">4)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Primarily Vagifem</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> and Activelle</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_82"></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.997%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 33 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div style="text-indent:36pt"><font style="color:#ff198d;font-family:'Frutiger LT 45 Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.446%"><tr><td style="width:0.1%"></td><td style="width:1.004%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.446%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">H1 2025 sales split per area</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="9" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="border-bottom:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">DKK million</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">US Operations</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">International<br>Operations</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">EUCAN</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt;text-align:right"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Emerging Markets</font></div></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">APAC</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt;text-align:right"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Region China</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="9" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Diabetes and Obesity care segment</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Injectable GLP-1</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">66,592</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">45,273</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">21,319</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">11,261</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,138</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,814</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,106</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">14%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(12%)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Ozempic</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">64,520</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">44,841</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">19,679</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">10,815</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4,401</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,701</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,762</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">15%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">18%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">10%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">15%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">10%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">9%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(5%)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Victoza</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,072</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">432</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,640</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">446</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">737</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">113</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">344</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(52%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(82%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(13%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(19%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">47%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(48%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(46%)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Rybelsus</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">11,348</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,671</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,677</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,734</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,066</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,761</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">116</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(10%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">20%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">23%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">22%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">7%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total GLP-1</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">77,940</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">49,944</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">27,996</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">14,995</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,204</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,575</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,222</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">15%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">11%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(11%)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Long-acting insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9,855</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,875</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,980</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,154</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,587</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">672</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,567</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(5%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(4%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">19%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Awiqli</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">119</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">119</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">35</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">79</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Tresiba</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">6,377</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,675</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">3,702</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,762</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,006</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">433</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">501</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">27%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">83%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(1%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">15%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">3%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Xultophy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,341</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">146</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,195</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">952</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">164</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">184</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">895</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">9%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(1%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">9%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(4%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(3%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(7%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">38%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Levemir</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,018</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">54</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">964</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">405</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">417</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">50</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">92</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(62%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(96%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(21%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(22%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(9%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(18%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(49%)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Premix insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,449</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">267</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,182</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">478</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,151</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,028</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,525</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(9%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(5%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Ryzodeg</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,795</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,795</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">112</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">484</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">644</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,555</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">16%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">16%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">24%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">42%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">3%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">15%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">NovoMix</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,654</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">267</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,387</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">366</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">667</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">384</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">970</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(11%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(13%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(16%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(2%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(16%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(16%)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Fast-acting insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9,594</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,369</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,225</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,382</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,568</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">554</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">721</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">15%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">47%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(3%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(4%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(6%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(10%)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Fiasp</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,349</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">476</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">873</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">653</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">114</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">106</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">20%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">49%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">8%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">5%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">26%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">9%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">NovoRapid</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">8,245</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">3,893</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4,352</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,729</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,454</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">448</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">721</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">14%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">47%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(5%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(7%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">3%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(9%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(10%)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Human insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,845</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">570</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,275</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">347</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,051</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">500</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">377</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(11%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(10%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(11%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(22%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(14%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(9%)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">27,743</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8,081</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">19,662</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,361</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,357</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,754</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,190</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">17%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(5%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(3%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Other Diabetes care</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">927</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">81</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">846</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">263</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">144</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">138</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">301</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(16%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(23%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(15%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(5%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(31%)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total Diabetes care</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">106,610</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">58,106</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">48,504</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">21,619</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">11,705</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,467</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8,713</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">7%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(4%)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">36,888</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">24,716</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12,172</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,179</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,622</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,529</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">842</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">78%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">37%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">335%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">128%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Saxenda</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,908</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">183</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,725</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">881</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">638</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">186</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">20</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(50%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(53%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(49%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(45%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(44%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(69%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(63%)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total Obesity care</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">38,796</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">24,899</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13,897</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">7,060</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,260</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,715</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">862</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">58%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">36%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">125%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">64%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">157%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">361%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">&#8212;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Diabetes and Obesity care total</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">145,406</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">83,005</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">62,401</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">28,679</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">14,965</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9,182</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9,575</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">18%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">17%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">19%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">18%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">24%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">37%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;border-top:0.5pt solid #dbdbdb;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Rare disease segment</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Rare blood disorders</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">2</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,017</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,615</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,402</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,630</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">924</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">528</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">320</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(2%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(3%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">21%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">97%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Haemophilia A</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,138</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">186</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">952</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">501</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">162</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">121</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">168</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(5%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(34%)</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(8%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">13%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">22%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">26%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Haemophilia B</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">680</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">260</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">420</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">292</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">38</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">81</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">9</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">9%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">8%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">10%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">146%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">12%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">NovoSeven</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">3,870</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,979</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,891</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">795</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">700</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">253</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">143</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">5%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">8%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(4%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(9%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">3%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Rare endocrine disorders</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">3</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,732</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,530</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,202</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">444</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">337</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">409</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">49%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">67%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">30%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">18%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">44%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">31%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">160%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Other Rare disease</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">4</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">789</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">129</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">660</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">459</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">108</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">90</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">31%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">0%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(2%)</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(57)%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #929292;padding:0 1pt"></td><td colspan="6" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Rare disease total</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9,538</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,274</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,264</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,533</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,369</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,027</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">335</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">15%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">23%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">22%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">93%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total sales</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">154,944</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">87,279</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">67,665</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">31,212</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">16,334</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10,209</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9,910</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">18%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">17%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">19%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">16%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">22%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">35%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">% change as reported</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">16%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">16%</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">16%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">15%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">17%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">32%</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="6" style="border-bottom:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Share of growth</font></td><td colspan="3" style="background-color:#e2f0fa;border-bottom:0.25pt solid #939aa7;border-left:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">100%</font></td><td colspan="3" style="background-color:#e2f0fa;border-bottom:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">54%</font></td><td colspan="3" style="background-color:#e2f0fa;border-bottom:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">46%</font></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">19%</font></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13%</font></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12%</font></td><td colspan="3" style="border-bottom:0.25pt solid #939aa7;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"> 1)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Primarily NovoNorm</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, needles and GlucaGen</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> HypoKit</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"> 2)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Comprises NovoSeven</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, NovoEight</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, Esperoct</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, Refixia</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, NovoThirteen</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174; </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">and Alhemo</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">3)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Primarily Norditropin</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> and Sogroya</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">4)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Primarily Vagifem</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> and Activelle</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div><div style="height:69.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_88"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 34 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">APPENDIX 7&#58; NON-IFRS FINANCIAL MEASURES (ADDITIONAL INFORMATION)</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:130%">In this Company Announcement, Novo Nordisk discloses certain financial measures of the Group&#8217;s financial performance, financial position and cash flows that reflect adjustments to the directly comparable measures calculated and presented in accordance with IFRS. These non-IFRS financial measures may not be defined and calculated by other companies in the same manner and may thus not be comparable with such measures. The non-IFRS financial measures presented in the Company Announcement are Net sales and operating profit at CER, EBITDA, EBITDA at CER, Adjusted net profit and Free cash flow.</font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:130%">Net sales and operating profit growth at CER</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:130%">'Growth at CER&#8217; means that the effect of changes in exchange rates is excluded. It is defined as Net sales&#47;Operating profit for the period measured at the average exchange rates for the same period prior year compared with Net sales&#47;Operating profit for the same period prior year. Price adjustments within hyperinflation countries, as defined in IAS 29 &#8216;Financial reporting in hyperinflation economies&#8217;, are excluded from the calculation to avoid growth at CER being artificially inflated.</font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:130%">Growth at CER is considered to be relevant information for investors in order to understand the underlying development in net sales and operating profit by adjusting for the impact of currency fluctuations.</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:39.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.737%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Net sales at CER</font></div></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">DKK million</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">H1 2025</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">H1 2024</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;% change<br>H1 2025 to<br>H1 2024</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Q2 2025</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Q2 2024</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;% change<br>Q2 2025 to<br>Q2 2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net sales</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">154,944</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">133,409&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">76,857</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">68,060&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Effect of exchange rates </font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,106</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">782&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,335</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(176)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net sales at CER</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">157,050</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">134,191&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N&#47;A</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">80,192</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">67,884&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N&#47;A</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net sales previous period</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">133,409</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">68,060</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">% increase&#47;(decrease) in constant exchange rates</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating profit at CER</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">DKK million</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">H1 2025</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">H1 2024</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;% change<br>H1 2025 to<br>H1 2024</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Q2 2025</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Q2 2024</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;% change<br>Q2 2025 to<br>Q2 2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Operating profit</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">72,240</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">57,780&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33,449</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25,934&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">29</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Effect of exchange rates</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,110</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">628&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,740</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(120)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Operating profit at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">74,350</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">58,408&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N&#47;A</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">36,189</font></td><td colspan="2" style="border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25,814&#160;</font></td><td style="border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N&#47;A</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Operating profit previous period</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">57,780</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25,934</font></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">% increase&#47;(decrease) in constant exchange rates</font></td><td colspan="2" style="background-color:#e2f0fa;border-bottom:0.25pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">29&#160;</font></td><td style="background-color:#e2f0fa;border-bottom:0.25pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="border-bottom:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;border-bottom:0.25pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">40&#160;</font></td><td style="background-color:#e2f0fa;border-bottom:0.25pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="border-bottom:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">EBIT</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">DA and EBITDA at CER</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:130%">Novo Nordisk has significantly increased its Business Development M&#38;A activities and Capital expenditure for property, plant and equipment during recent years. Novo Nordisk defines EBITDA as &#8217;Net profit&#8217; adjusted for 'income taxes', 'financial items', 'depreciation and amortisation' and 'impairment losses and reversals'. EBITDA is a measure that is widely used by investors and analysts as it helps analyse operating results from core business operations without including the effects of capital structure, tax rates and depreciation and amortisation and impairment losses. These factors can vary substantially between companies. 'EBITDA at CER&#8217; means that the effect of changes in exchange rates is excluded by measuring EBITDA (as defined above) at the average exchange rates for the same period prior year. </font></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 35 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:39.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.737%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">EBITDA and EBITDA at CER</font></div></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">DKK million</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">H1 2025</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">H1 2024</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;% change<br>H1 2025 to<br>H1 2024</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Q2 2025</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Q2 2024</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;% change<br>Q2 2025 to<br>Q2 2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net profit</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">55,537</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">45,457&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">22</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">26,503&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">20,050&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">32</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Income taxes</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15,301</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11,793&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">30</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7,302&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5,282&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">38</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Financial income</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8,739)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3,106)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">181</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5,314)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(960)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">454</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Financial expenses</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10,141</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,636&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">179</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4,958&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,562&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">217</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Operating profit (EBIT)</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #b6b6b6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:700;line-height:120%">72,240</font></td><td colspan="2" style="border-top:0.25pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">57,780&#160;</font></td><td style="border-top:0.25pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25</font></td><td style="border-top:0.25pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;border-top:0.25pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33,449&#160;</font></td><td style="background-color:#e2f0fa;border-top:0.25pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25,934&#160;</font></td><td style="border-top:0.25pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">29</font></td><td style="border-top:0.25pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Depreciation, amortisation,  impairment losses and reversals</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8,663</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11,759&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(26</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4,833&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8,845&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(45</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">EBITDA</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #b6b6b6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:700;line-height:120%">80,903</font></td><td colspan="2" style="border-top:0.5pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">69,539&#160;</font></td><td style="border-top:0.5pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</font></td><td style="border-top:0.5pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;border-top:0.5pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">38,282&#160;</font></td><td style="background-color:#e2f0fa;border-top:0.5pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">34,779&#160;</font></td><td style="border-top:0.25pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</font></td><td style="border-top:0.25pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Effect of exchange rates</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,138</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">633&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,790&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(134)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">EBITDA at CER</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #b6b6b6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">83,041</font></td><td colspan="2" style="border-top:0.5pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">70,172&#160;</font></td><td style="border-top:0.5pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N&#47;A</font></td><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #b6b6b6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">41,072</font></td><td colspan="2" style="border-top:0.5pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">34,645&#160;</font></td><td style="border-top:0.5pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">N&#47;A</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">EBITDA previous period</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">69,539</font></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">34,779</font></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:0.25pt solid #b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">% increase&#47;(decrease) in constant exchange rates</font></td><td colspan="2" style="background-color:#e2f0fa;border-bottom:0.25pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">19</font></td><td style="background-color:#e2f0fa;border-bottom:0.25pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="border-bottom:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;border-bottom:0.25pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</font></td><td style="background-color:#e2f0fa;border-bottom:0.25pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Adjusted net profit</font></div><div><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:130%">Novo Nordisk defines Adjusted net profit as &#8217;Net profit&#8217; excluding 'impairment losses and reversals on intangible assets', 'amortisations on intangible assets' and the related</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:130%"> 'Tax effects of impairment losses and reversals and amortisations of intangible assets'. Adjusted net profit is considered to be relevant information for investors</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:130%"> to enhance the comparability as it helps analyse financial performance from core business operations without including the effects of amortisation and impairment losses. These factors can vary substantially between companies and from year to year.</font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.139%"><tr><td style="width:1.0%"></td><td style="width:39.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.723%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Adjusted net profit</font></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">DKK million</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">H1 2025</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">H1 2024</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;% change<br>H1 2025 to<br>H1 2024</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Q2 2025</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Q2 2024</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;% change<br>Q2 2025 to<br>Q2 2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #b6b6b6;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net profit</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">55,537</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">45,457&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">22</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">26,503&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">20,050&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">32</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Impairment losses and reversals on intangible assets</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">637</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7,565&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(92</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">635&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6,808&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(91</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amortisations on intangible assets</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,244</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,117&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">190</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,621&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">531&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">205</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:130%">Tax effects of impairment losses and reversals and amortisations of intangible assets</font></div></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(849)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,895)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(55</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(494)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,594)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(69</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%)</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Adjusted net profit</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #b6b6b6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:700;line-height:120%">58,569</font></td><td colspan="2" style="border-top:0.25pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">52,244&#160;</font></td><td style="border-top:0.25pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12</font></td><td style="border-top:0.25pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #b6b6b6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:700;line-height:120%">28,265</font></td><td colspan="2" style="border-top:0.25pt solid #b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25,795&#160;</font></td><td style="border-top:0.25pt solid #b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Free cash flow</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:130%">Novo Nordisk defines free cash flow as &#8217;net cash generated from operating activities&#8217;, less &#8216;net cash used in investing activities&#8217;, less repayment on lease liabilities and excluding net change of marketable securities. Free cash flow is a measure of the amount of cash generated in the period which is available for</font><font style="background-color:#ffffff;color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:130%"> the Board of Directors to allocate between Novo Nordisk's capital providers, through e.g. dividends, share repurchas</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:130%">es and repayment of debt (excluding lease liability repayments) or for retaining in the business to fund future growth. </font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:130%">The following table shows a reconciliation of Free cash flow with Net cash generated from operating activities, the most directly comparable IFRS financial measure&#58;</font></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 36 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.545%"><tr><td style="width:1.0%"></td><td style="width:46.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Free cash flow</font></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #939aa7;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">DKK million</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">H1 2025</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">H1 2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Q2 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Q2 2024</font></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.25pt solid #939aa7;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #939aa7;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net cash generated from operating activities</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">65,376&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">64,817&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">40,785&#160;</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">50,503&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net cash used in investing activities</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(20,921)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(16,775)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(14,248)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(20,731)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Add-back of net purchase (net sale) of marketable securities</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(10,139)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6,172)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2,111)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6,808&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Repayment on lease liabilities</font></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(745)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(561)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e2f0fa;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(347)</font></td><td style="background-color:#e2f0fa;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(291)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Free cash flow</font></td><td colspan="2" style="background-color:#e2f0fa;border-bottom:0.5pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33,571&#160;</font></td><td style="background-color:#e2f0fa;border-bottom:0.5pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">41,309&#160;</font></td><td style="border-bottom:0.5pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e2f0fa;border-bottom:0.5pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">24,079&#160;</font></td><td style="background-color:#e2f0fa;border-bottom:0.5pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">36,289&#160;</font></td><td style="border-bottom:0.5pt solid #939aa7;border-top:0.25pt solid #939aa7;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_3298534884819"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 37 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">APPENDIX 8&#58; NEW SALES SPLIT PER AREA (ADDITIONAL INFORMATION)</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">As of January 2025, North America Operations and International Operations were reorganised and the sales split per area was restated to reflect the new organisation consisting of US Operations and International Operations. International Operations cover the following Regions&#58;  EUCAN (covering Europe and Canada), Emerging Markets (covering mainly Latin America, Middle East and Africa), APAC (covering Japan, Korea, Oceania and Southeast Asia) and Region China (covering Mainland China, Hong Kong and Taiwan). </font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.438%"><tr><td style="width:0.1%"></td><td style="width:1.004%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.446%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">Q2 2024 sales split per area</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="9" style="border-bottom:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">DKK million</font></td><td colspan="3" style="border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">US Operations</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">International<br>&#160;Operations</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">EUCAN</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Emerging Markets</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">APAC</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Region China</font></td></tr><tr style="height:3pt"><td colspan="9" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Diabetes and Obesity care segment</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Injectable GLP-1</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">31,117</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">20,709</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10,408</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,963</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,242</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">975</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,228</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Ozempic</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">28,875</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">19,448</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">9,427</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4,664</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,914</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">866</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,983</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Victoza</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,242</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,261</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">981</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">299</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">328</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">109</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">245</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Rybelsus</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,918</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,909</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,009</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,653</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">535</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">768</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">53</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total GLP-1</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">37,035</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">23,618</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13,417</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,616</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,777</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,743</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,281</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Long-acting insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,737</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,384</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,353</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,699</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">701</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">329</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">624</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Awiqli</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Tresiba</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,297</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">547</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,750</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">925</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">405</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">202</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">218</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Xultophy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,067</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">54</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,013</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">507</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">78</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">94</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">334</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Levemir</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,371</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">783</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">588</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">265</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">218</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">33</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">72</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Premix insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,436</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">63</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,373</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">261</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">442</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">531</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,139</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Ryzodeg</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,163</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,163</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">45</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">157</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">306</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">655</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">NovoMix</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,273</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">63</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,210</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">216</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">285</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">225</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">484</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Fast-acting insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,868</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,204</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,664</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,279</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">732</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">312</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">341</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Fiasp</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">565</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">144</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">421</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">318</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">49</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">54</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">NovoRapid</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">3,303</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,060</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,243</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">961</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">683</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">258</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">341</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Human insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:700;line-height:120%">1,571</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">286</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,285</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">220</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">589</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">261</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">215</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12,612</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,937</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9,675</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,459</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,464</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,433</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,319</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Other Diabetes care</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">533</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">47</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">486</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">137</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">79</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">74</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">196</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total Diabetes care</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">50,180</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">26,602</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">23,578</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10,212</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,320</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,250</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,796</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">11,659</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9,907</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,752</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,648</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">104</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Saxenda</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,245</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">392</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,853</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">779</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">701</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">342</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">31</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total Obesity care</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13,904</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10,299</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,605</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,427</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">805</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">342</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">31</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Diabetes and Obesity care total</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">64,084</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">36,901</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">27,183</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12,639</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,125</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,592</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,827</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Rare disease segment</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Rare blood disorders</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">2</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,864</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,255</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,609</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">859</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">402</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">217</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">131</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Haemophilia A</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">613</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">102</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">511</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">298</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">52</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">45</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">116</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Haemophilia B</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">361</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">158</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">203</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">153</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">11</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">35</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">NovoSeven</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,802</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">932</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">870</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">404</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">327</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">128</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">11</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Rare endocrine disorders</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">3</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">730</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">196</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">534</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">174</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">192</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">166</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Other Rare disease</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">4</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">382</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">52</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">330</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">238</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">39</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">50</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Rare disease total</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,976</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,503</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,473</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,271</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">633</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">433</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">136</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td></tr><tr><td colspan="9" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total sales</font></td><td colspan="3" style="background-color:#e2f0fa;border-bottom:0.5pt solid #dbdbdb;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">68,060</font></td><td colspan="3" style="background-color:#e2f0fa;border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">38,404</font></td><td colspan="3" style="background-color:#e2f0fa;border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">29,656</font></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13,910</font></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,758</font></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,025</font></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,963</font></td></tr></table></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"> 1)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Primarily NovoNorm</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, needles and GlucaGen</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> HypoKit</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"> 2)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Comprises NovoSeven</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, NovoEight</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, Esperoct</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">,</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"> </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Refixia</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, NovoThirteen</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174; </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">and Alhemo</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"> 3)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Primarily Norditropin</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;  </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">and Sogroya</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">4)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Primarily Vagifem</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> and Activelle</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_3298534884838"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 38 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">APPENDIX 8&#58; NEW SALES SPLIT PER AREA - CONTINUED (ADDITIONAL INFORMATION)</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.438%"><tr><td style="width:0.1%"></td><td style="width:1.004%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.446%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">H1 2024 sales split per area</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="9" style="border-bottom:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">DKK million</font></td><td colspan="3" style="border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">US Operations</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">International<br>&#160;Operations</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">EUCAN</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Emerging Markets</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">APAC</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Region China</font></td></tr><tr style="height:3pt"><td colspan="9" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Diabetes and Obesity care segment</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Injectable GLP-1</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">61,086</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">40,842</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">20,244</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10,121</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,749</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,798</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,576</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Ozempic</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">56,685</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">38,392</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">18,293</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">9,568</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4,208</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,582</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,935</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Victoza</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4,401</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,450</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,951</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">553</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">541</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">216</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">641</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Rybelsus</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10,931</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,245</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,686</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,030</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,122</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,426</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">108</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total GLP-1</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">72,017</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">46,087</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">25,930</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13,151</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,871</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,224</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,684</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Long-acting insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9,902</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,051</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,851</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,299</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,530</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">693</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,329</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Awiqli</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Tresiba</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">5,060</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,471</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">3,589</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,784</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">885</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">430</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">490</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Xultophy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,190</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">148</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,042</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">997</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">187</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">201</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">657</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Levemir</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,650</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,432</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,218</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">516</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">458</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">62</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">182</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Premix insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,404</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">259</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,145</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">525</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">971</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,104</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,545</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Ryzodeg</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,430</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,430</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">90</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">323</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">641</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,376</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">NovoMix</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,974</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">259</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,715</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">435</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">648</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">463</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,169</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Fast-acting insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8,355</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,004</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,351</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,473</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,464</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">603</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">811</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Fiasp</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,132</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">323</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">809</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">620</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">88</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">101</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">NovoRapid</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">7,223</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,681</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4,542</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,853</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,376</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">502</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">811</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Human insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:700;line-height:120%">3,316</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">642</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,674</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">447</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,306</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">499</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">422</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">26,977</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,956</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">20,021</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,744</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,271</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,899</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,107</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Other Diabetes care</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,116</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">105</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,011</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">279</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">148</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">140</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">444</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total Diabetes care</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">100,110</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">53,148</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">46,962</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">20,174</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">11,290</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,263</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9,235</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">21,036</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">18,139</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,897</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,723</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">173</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Saxenda</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,903</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">390</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,513</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,624</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,215</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">618</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">56</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total Obesity care</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">24,939</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">18,529</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,410</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,347</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,388</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">619</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">56</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Diabetes and Obesity care total</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">125,049</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">71,677</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">53,372</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">24,521</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12,678</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,882</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9,291</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Rare disease segment</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Rare blood disorders</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">2</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,752</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,485</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,267</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,671</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">987</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">443</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">166</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Haemophilia A</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,216</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">287</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">929</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">543</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">151</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">101</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">134</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Haemophilia B</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">623</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">243</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">380</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">285</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">13</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">73</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">9</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">NovoSeven</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">3,754</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,856</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,898</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">825</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">797</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">253</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">23</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Rare endocrine disorders</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">3</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,843</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">924</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">919</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">375</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">230</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">309</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Other Rare disease</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">4</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">765</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">100</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">665</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">462</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">103</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">93</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">7</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Rare disease total</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8,360</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,509</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,851</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,508</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,320</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">845</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">178</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td></tr><tr><td colspan="9" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total sales</font></td><td colspan="3" style="background-color:#e2f0fa;border-bottom:0.5pt solid #dbdbdb;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">133,409</font></td><td colspan="3" style="background-color:#e2f0fa;border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">75,186</font></td><td colspan="3" style="background-color:#e2f0fa;border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">58,223</font></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">27,029</font></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13,998</font></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">7,727</font></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9,469</font></td></tr></table></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"> 1)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Primarily NovoNorm</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, needles and GlucaGen</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> HypoKit</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"> 2)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Comprises NovoSeven</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, NovoEight</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, Esperoct</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">,</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"> </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Refixia</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, NovoThirteen</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174; </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">and Alhemo</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"> 3)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Primarily Norditropin</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;  </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">and Sogroya</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">4)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Primarily Vagifem</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> and Activelle</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_1099511628684"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:58.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Financial report for the period 1 January 2025 to 30 June 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Page 39 of <a href="#i5f24413bd450420f8ea4b0735ad53ee5_91" style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%;text-decoration:none">39</a></font></div></td></tr></table></div></div><div><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">APPENDIX 8&#58; NEW SALES SPLIT PER AREA - CONTINUED (ADDITIONAL INFORMATION)</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.438%"><tr><td style="width:0.1%"></td><td style="width:1.004%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.446%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:9pt;font-weight:700;line-height:150%">2024 sales split per area</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="9" style="border-bottom:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">DKK million</font></td><td colspan="3" style="border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">US Operations</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">International<br>&#160;Operations</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">EUCAN</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Emerging Markets</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">APAC</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Region China</font></td></tr><tr style="height:3pt"><td colspan="9" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Diabetes and Obesity care segment</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Injectable GLP-1</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">125,824</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">85,901</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">39,923</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">20,987</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8,712</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,487</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,737</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Ozempic</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">120,342</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">84,202</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">36,140</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">19,818</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">7,448</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">3,112</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">5,762</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Victoza</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">5,482</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,699</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">3,783</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,169</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,264</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">375</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">975</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Rybelsus</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">23,301</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10,795</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12,506</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,783</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,182</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,030</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">511</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total GLP-1</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">149,125</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">96,696</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">52,429</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">27,770</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10,894</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,517</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">7,248</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Long-acting insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">19,095</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,539</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13,556</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,698</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,803</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,359</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,696</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Awiqli</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">19</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">19</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Tresiba</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">9,905</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,807</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">7,098</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">3,632</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,642</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">846</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">978</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Xultophy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4,503</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">281</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4,222</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,068</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">347</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">393</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,414</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Levemir</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4,668</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,451</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,217</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">985</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">814</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">120</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">298</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Premix insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10,789</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">632</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10,157</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,039</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,067</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,267</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,784</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Ryzodeg</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4,929</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4,929</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">186</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">627</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,334</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,782</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">NovoMix</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">5,860</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">632</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">5,228</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">853</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,440</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">933</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,002</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Fast-acting insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">18,522</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">7,774</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10,748</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,962</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,111</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,201</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,474</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Fiasp</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,869</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">214</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,655</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,269</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">192</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">194</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">NovoRapid</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">16,653</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">7,560</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">9,093</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">3,693</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,919</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,007</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,474</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Human insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:700;line-height:120%">6,967</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,535</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,432</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">868</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,745</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,013</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">806</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total insulin</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">55,373</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">15,480</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">39,893</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13,567</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10,726</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,840</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9,760</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Other Diabetes care</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,120</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">212</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,908</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">553</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">277</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">296</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">782</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total Diabetes care</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">206,618</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">112,388</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">94,230</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">41,890</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">21,897</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12,653</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">17,790</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Wegovy</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">58,206</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">45,770</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12,436</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">7,705</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,677</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,858</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">196</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Saxenda</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,940</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">778</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,162</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,795</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,195</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,070</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">102</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total Obesity care</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">65,146</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">46,548</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">18,598</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10,500</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,872</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,928</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">298</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Diabetes and Obesity care total</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">271,764</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">158,936</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">112,828</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">52,390</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">26,769</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">15,581</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">18,088</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 7pt 0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Rare disease segment</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Rare blood disorders</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">2</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12,138</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,388</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,750</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,391</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,040</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">956</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">363</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Haemophilia A</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">2,454</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">538</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,916</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,112</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">348</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">220</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">236</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">Haemophilia B</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,306</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">486</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">820</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">614</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">38</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">151</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">17</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">NovoSeven</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">7,983</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">4,135</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">3,848</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,613</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">1,604</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">521</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">110</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Rare endocrine disorders</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">3</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4,993</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,921</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,072</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">818</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">511</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">702</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">41</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Other Rare disease</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">4</font></div></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,508</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">159</font></td><td colspan="3" style="background-color:#e2f0fa;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,349</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">946</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">195</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">199</font></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">9</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Rare disease total</font></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">18,639</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8,468</font></td><td colspan="3" style="background-color:#e2f0fa;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10,171</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,155</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,746</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,857</font></td><td colspan="3" style="border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">413</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;border-left:0.5pt solid #dbdbdb;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#e2f0fa;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 7pt 0 1pt"></td></tr><tr><td colspan="9" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total sales</font></td><td colspan="3" style="background-color:#e2f0fa;border-bottom:0.5pt solid #dbdbdb;border-left:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">290,403</font></td><td colspan="3" style="background-color:#e2f0fa;border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">167,404</font></td><td colspan="3" style="background-color:#e2f0fa;border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">122,999</font></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">57,545</font></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">29,515</font></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">17,438</font></td><td colspan="3" style="border-bottom:0.5pt solid #dbdbdb;border-top:0.5pt solid #dbdbdb;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6pt;font-weight:400;line-height:120%">18,501</font></td></tr></table></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"> 1)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Primarily NovoNorm</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, needles and GlucaGen</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> HypoKit</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"> 2)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Comprises NovoSeven</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, NovoEight</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, Esperoct</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">,</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"> </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Refixia</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">, NovoThirteen</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174; </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">and Alhemo</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"> 3)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Primarily Norditropin</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;  </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">and Sogroya</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">4)</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> Primarily Vagifem</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> and Activelle</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">&#174;</font><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_91"></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Strategic aspirations</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Performance highlights</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Commercial execution</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Financials</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Cash flow and capital allocation</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Outlook</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Innovation and therapeutic focus</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Purpose and sustainability</font></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">Corporate Governance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#001965;font-family:'Apis Medium',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">Financial Information</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Company announcement No 20 &#47; 2025</font></td></tr></table></div></div></div><div id="i5f24413bd450420f8ea4b0735ad53ee5_94"></div><hr style="page-break-after:always"><div style="min-height:49.61pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#001965;font-family:'Apis',sans-serif;font-size:12pt;font-weight:400;line-height:150%">SIGNATURES</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf of the undersigned, thereunto duly authorized. </font></div><div><font><br></font></div><div><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Date&#58; August 6, 2025 </font></div><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Novo Nordisk A&#47;S</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Lars Fruergaard J&#248;rgensen</font></div><div style="text-align:right"><font style="color:#001965;font-family:'Apis Light',sans-serif;font-size:9pt;font-weight:400;line-height:150%">Chief Executive Officer</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:49.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>newheadera.jpg
<TEXT>
begin 644 newheadera.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !Z DL# 2(  A$! Q$!_\0
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M"*2?EW9923Z_0'[07[0WA?\ 9S\%MKWB*5IIYB8['3+<CS[R3^ZH/0#(+,>
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MH3Z;=-"9'E.(XVVD?=5"W_;05\<V_P"TG\7KJXB@A^(WBF261@B(NJ399B<
M#YO6J?[0WQ,F^,'QJ\7>*Y9!)#?7[BUQT6V3]W"/^_:IGU.3WKTO]@'X3'XI
M_M':%)<6PGTGP^#K-WN'RYC(\E3ZDRE..X5O0U][1H4<#@DZD5>*N_7_ (<^
M3J5JF*Q34).S=EZ'ZW?!_P ,ZIX-^&'AG1]<U2ZUK6[:QC%]?WDK2R2W!&Z0
M[FYP&) ST  KL***_,Y2<Y.3ZGV\5RI)!1114C"BBB@ HHHH **** "BBB@
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M>VCWM^I^KO\ P2IU22\_9_UNU=B4L_$$R(#V#0PL<?B37QM_P46_Y.Z\9_\
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M_P %&_\ D[?Q;_U[V/\ Z215Y_\ LF_\G,?#+_L/6G_HP5^@4?\ D71_P?\
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M:%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=Q&A^S6((P1"&&2QY'F$ X. !SF:N,PF64?9TFFULEK]XZ>%Q..J\]167?\
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M7?\ OP/\:]7(:U.GAI*<DGS=7Y(X,VI5)UHN,6].WFS]%/\ @F#_ ,FP1_\
M89N_Y1U]:U\U?\$^_A]XC^&?[/L>C>*='NM#U0:K<S?9;M=K[&V;6QZ'!KZ5
MKY3,)*6+J.+NKL^APJ<:$$^R/QJ_X*-_\G;^+?\ KWL?_22*O/\ ]DW_ ).8
M^&7_ &'K3_T8*^B?VZ/V;OB=\1/VEO$NN^&_!6JZSH]Q#9K%>6L0:-RMM&K
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MC5F)_P!DU^.%?T2:GIMKK6FW>GWL"W-E=PO!/#(,K)&RE64^Q!(K\G/VCO\
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M[E7DCS\L\).)(F]59<C\<CD"OWRL+R/4K&WNX3NAGC65&]58 C]#7\[-?O\
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MPQZ=?#X#V3]G)<R\]SXB^"7QBUWX%_$;2_%F@SM'-;.%N;?/R75N2/,A<>C
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M4,_Y/!\?_P#</_\ 3?;5^T5?B[_P4,_Y/!\?_P#</_\ 3?;5Y/#W^]2_PO\
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M'[F-)K>6.1%DC="K*PR"".01Z5CF.93P<U2HQ2UN:X/ QQ$74JRN?SK5^_\
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M]O+BY>2:XN-*@DDD8GEF8IDD^IK@R6M[&K-VOI^IV9G2]M3BKVU/SZ_X)O\
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+U[E99AN=N=^A_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>nn_logoxcmykxbluexsmalla.jpg
<TEXT>
begin 644 nn_logoxcmykxbluexsmalla.jpg
M_]C_XO__24-#7U!23T9)3$4  0D "(!P041"10(0  !P<G1R0TU92TQA8B '
MT  ' !H !0 I #5A8W-P05!03     !!1$)%
M]M8  0    #3+4%$0D4
M                      ID97-C    _    '1C<')T   !<    "MW='!T
M   !G    !1!,D(P   !L   H@9!,D(R   !L   H@9!,D(Q  "CN   H@9"
M,D$P  %%P  ".+1",D$Q  -^=  ".+1",D$R  6W*  ".+1G86UT  ?OW
MD)%D97-C         !I5+E,N(%=E8B!#;V%T960@*%-73U I('8R
M
M                                     '1E>'0     0V]P>7)I9VAT
M(#(P,# @061O8F4@4WES=&5M<RP@26YC+@  6%E:(        +5:  "\9P
MDC!M9G0R      0#"0   0                    $
M   !   !   "   ") 0=!=H':0C9"C8+A0S'#?\/,1!>$8L2MQ/B%0L6,A=7
M&'D9F!JU&](<[QXE'UD@AR&R(MHC_R4C)D0G9BB&*:<JQROH+0@N*"](,&DQ
MB3*F,\(TWC7[-Q@X-3E1.FT[B3RE/<(^WC_X01%"*4-"1%Q%=4:/1ZE(PTG=
M2O=,$DTL3D-/65!O4892G%.R5,E5WU;V6 U9(UHZ6U%<9EUX7HI?FV"M8;YB
MSV/@9/%F F<2:"-I,VI":U)L7FUG;G%O>G"#<8QRE'.<=*-UJG:Q=[=XO7G#
M>LA[S7S.?<U^S'_+@,F!QX+%@\*$OX6[AK>'LXBNB:F*I(N>C)B-D8Z&CWN0
M<)%DDEB33)1 E3.6)I<9F R8_YGRFN2;UIS(G;N>K9^?H(ZA?*)JHU>D1:4S
MIB"G#J?\J.JIUZK%J[.LH:V/KGVO:[!9L4>R-K,DM!*U +7MMMJWR+BUN:.Z
MD+M^O&N]6;Y'OS7 (L$0P?["[,/:Q,?%M<:CQY'(?LELREG+1,PNS1C. <[K
MS]70OM&GTI#3>=1AU4G6,=<8V #8YMG-VK+;F-Q]W6+>1]\LX!#@].'8XKOC
MGN1[Y5?F,^<.Y^CHP>F:ZG'K2.P=[/#MP^Z6[W;P5?$S\@_RZO/#])SU<_9)
M]Q[W\_C&^97Z8?LI^^O\I_U<_@O^M/]:__\   'H Z<%+ :$![\(YPH$"Q8,
M' T>#AP/&1 7$102$!,+% 04_!7S%N87V!C,&=8:WAOA'.$=WQ[;']8@T2'+
M(L0COB2X);,FKB>J**8IHBJ@*YXLG2V:+I4OD3"-,8DRAC.#-($U?S9_-W\X
M@#F".G\[?CQ\/7P^?#]]0']!@D*%0XE$C4621IA'FDB;29U*GTNC3*9-JDZO
M3[10NE' 4L=3SE355==6V5?;6-Y9X%KC6^=<ZEWM7O%?]6#X8?QC &0#90%E
M_V;\9_IH^&GU:O-K\&SN;>MNZ&_E<.%QWG+:<]9TS77#=KEWKWBE>9MZD'N%
M?'I];WYD?UB 38%!@C6#*80<A1"%_H;MA]N(RHFXBJ:+E8R#C7&.8(].D#V1
M+)(;DPJ3^I3IE=F6R9>ZF*>9DYJ FVV<6IU(GC:?): 4H02A]:+FH]BDRJ6]
MIK&GIJB;J9&JAZM_K'>M;ZYGKV"P6K%4LD^S3+1)M4:V1;=$N$6Y1KI(NTJ\
M3KU2OE>_7<!CP6K"<L-[Q(3%BL:0QY;(G<FERJW+MLR_S<C.TL_<T.;1\=+[
MU ;5$M8>URK8-]E$VE';7MQKW7G>AM^4X)SAHN*HXZWDLN6VYKKGO>C Z</J
MU.OE[/7N!.\2\"#Q+/(X\T/T3O59]F/W:OAN^6_Z;/MD_%;]1/XO_Q?__P
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M@H.;:*KD@9F)?J;:@.!V^Z,3@&-CJ)^;@"9/4YQ_@",Y=)H%@$P?H9F6@1<
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MKP.7HJ=]JKB%PJ-RIL-S0)^LHT-@*9PVH$],09D<GCLV]I: G7T=\Y7(E$
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MB=6-FK/>B$E\SZ\:ANYK5:JCA>U9'J9ZA31%X:+&A,PP^I_LA,07@: <A@0
M (_+@ "=:+?SDA",^+,/C^=\&JY2C?MJJJG.C&-8?:6KBRU%6:'VBE<PE9\3
MBBP77)\<BK   (\^@ "<U;=&FFF,8K)AEZ9[>ZVFE31J!JDDDQA7[:3PD5U$
MX:$_D#4P/IY2D"H7/IXVCK@  ([$@ "<.[:_HNZ+V;'1GY)Z^JT/G(]IBZB/
MF?A7>:1:E]9$?:"2EG O^)V>EJ07)YUGCZ@  (Y>@ ";R+8VJZ"+<+%$IZ5Z
MF*R"I!-I+Z@$H057):/4GI=$.: (G4DOQ)SPG"<7%9RHCYL  (X*@ ";2K77
MM(R+(K#4K]MZ5ZP#JZMHZ:=YJ#%6WZ-+I;!#_)^5I)XOG)R&H#$7%9P7CYL
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MD&N Z+TCCE]PZ;>\C)5@:[*&BR9/.JVRBB4] *EJB9,H]J9(B>,/VJ<$B0(
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MN<E_KKHMM)MO[;2;L"U?AZ]1K/I.>ZIPJUP\@*8@I_4HW*+(FZ 0L**XBT@
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MEH5U6,9XE =F'<!PD?!6:KJ7D$E&(;45CR0TQ+!5CM\A6JT@CWL)S*Q"AJ
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M>(,@@*;>A(%*C:O)3H#AB]ZS48"'BB^<9X!1B,.$U( RAXQLAH NAH%3#(!
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MF8J==IF3EP2+<I;BE*=XLY1EDG-E,9(;D()0MI SCNXZRHZGC=PA%XYMCB\
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M=#F3GZ;L=+R"L:-\=4]Q!:!%=?Q><YU*=L5*O)JH=Z(U5YB^>&L;0)EK>.P
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MG]Z/[:*)G/-^_)\6FC5M5IO:E[9:^)C:E89'H)8YD^4RNY0[DXD9A)16D.H
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M? &&'Z_%>[1V-*N>>Y!ECJ>R>Y93^Z01>\A!.*#I?!HLCY[)?&D25*"=?*\
M (C$@ "4U;,9A"R%C*[#@S1UL*J3@F5D_*:I@=A3;Z,'@7] O9_@@5LL+YVT
M@6<2/Y\_@@D  (@A@ "43K(?C%.$[*W/BL)T^ZFDB6!D6:6QB#]2UJ(8AVA
M/9[RAM@KTIRZAL$2*YX&ALH  (>3@ "3N[%3E)*$5*T$DG!T6:C<D(ACLJ3I
MCM]22J% C80_R)X?C*$K@9O;C*@2&YSNBN(  (<9@ "3*K"WG/F#RZQFFDMS
MU*@XE]5C+Z1!E:U1SJ"4D^4_9IU9DL,K0)L+DQ,2$)ORC#8  (:S@ "2OK E
MI86#8*O5HDMS:*>EGTIBQJ.MG*=1;J !FHX_&YR_F7HK$)I&F)02"9L,C#(
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M@NEY8KC]@?1J7K0F@2Y:EJ^/@+5)]JM,@'0X&J>L@&PD$Z6!@)0*WZ:#@28
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MJI5WU;5:IQYHQK!KH_99#ZNSH65(FJ=>G^4W%*.FGPHCJJ#\F!T+P*"TA_(
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MB11M?<)SAYY?%[T1AF=0);?4A85 7K,!A0(O2J\"A-\;K:T=A80%$JJ;@VX
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MKSYM/K[AJY-?";DXJ%M0*K/,IC- A:[7I,XON:JPH$4<LZ@QDV<&R*5&A)8
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MHGT5@R9."WUV@I@RDWWM@B4-3'[2@8/1;GJ&DAB]97J\D!FHH7KWCC"3#7M
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MDH9R<MJ,&X71<^YVMX5'=0M@7(3<=C5(M(2>=U4MQ83T>%((W(9/>6#%1H:
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MBD"5PI3JB1^$QI+'B UR]I#-AP]@&X\3AD%,.8V6A94VP(Q^A1L<_(S=A68
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MN9J22)'@M5N!(X^NL/-O.(VAK+]<JHO8J5))-XI@IT@T4HDPHM<;-XD8DF<
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MD-V(0YU\CT)X1YJAC;UG=)?WC%A5T96!BQI"_)-[BC4N;)(,B=$4RI,;B4
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M;@!^5ZM[;Q=O7:@#<"]?>:3 <4M.C*&[<F@\09\W<W<GS9WW="0-+Z"X<\4
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MEL1[KJ:6E,ULF*,%DNQ<NI^AD3E,"9R%C]$Z,IG=CO0F6Y@_CUL-0IDGB/<
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M=5!QQ[3)=8QCD;">=>E4BJRI=F)$=JD)=O RZZ8F=W4>Q*4P=Y(&(*4A>,4
M (  @ !^^;?Q?/YQ;[.??)UC1:]G?%Y4,ZMH?%1$*J?"?&LRMJ35?)8>N:.U
M?*$&<J,V?:,  (  @ !^JK:_A))Q!;)Q@[!BQJX]@O%3RJHX@F9#R::6@A0R
M<J.D@? >I*)B@A8&MJ%_@>0  (  @ !^3+6_C#API+%RBN%B6ZT^B;!35:DW
MB*U#=*6&A_ R,:*3AYX>D*$TB"L&\9_ZA+$  (  @ !]\+3^E 9P3["MDD!B
M"*QQD)=3 JABCR9#):2JCA(Q_J&=C;4>@: CC> '(9ZCA-(  (  @ !]G[1I
MF^9P"[ 2F;9AQJO)EYE2OJ>OE<1"XJ/VE((QTJ#>E'H>?I\NDJ<'3IUXA/$
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M>[AEJKYR>T58)KFU>OU)UK4D>O<ZB+$#>Q(IGJWR>S@5;JW>>P0 HZ?3?2X
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MH&!E/;G,GAI7L;35F^Y)9+ 6FCHZ.JO2F;8IMZA]F'D6A:=-CSH"C:"S@;H
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M<V6<!XCX=%6*[H@,=3)XN8<_=@AE<8:-=N)1!X8&=[P[$87 >'@@]H9J>,<
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MHS*6R(-%H(B%K8)VG:QSF8'"FLI@Q($WF"9- (#-E?(WQX!VE+H>48!LDE<
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M>TZ.$)!B>WU^(8[&>Z=M (U8>]A:X(P-?!A'CHL!?%\R?HIC?)$8?HM\?&P
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MJ,R)]8O8I>EYW(I$HLUHW(C)G[=7$H>(G0]$0(:+FTDOYH6]FBD6OH7ACV$
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M@CV DIAN@=MQA)8M@7EAD)03@290>Y(W@.H^*I"S@,(IWH_B@*D/TI&2@*H
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MK<1]PY3TJMQND9*:IZA>@I!6I)%-M(Y;HE$[SXS&H/4H'XNOFR$/'(OYBC<
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MB$=S\*$DAWAEM9X\AJU6GYMYA?%&EICZA5PU&Y</A0(A6I9"A10(O)7?@]$
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M9W]I]; X:0A<@*SE:HQ.&*F\; (^AZ;B;5PM/:3K;FL8N:67;FP!B:*J< (
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MC8IH**IUC'):KZ;CBUA,7Z-YBE@]'J!HB9HL7YX8B6@8TIVVB8,#(YBV@A\
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M;C)=S[HY;MA0];9";YQ#1;)W<&XT6Z\N<3$C<ZU*<9P.M:[H<.8  )W >"D
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MD?Y=%+1'D,A0/[ 8CX)"E*P;CFPS\:B;C>$CIZ8RCD40(J99BND  )C?@
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M9!F3H(469HF#EX2<:,)R/X1':M%?N(0+;,I+\8/R;JPV@80@<$@<985A<.8
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MDNZ.)'UED95^"GTZD ]L\GT9CG=:]7T.C/A'UWT9B[$S''TDBMT9QWS[BF8
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M;'J&*XOW;?YW#HKE;VAFRXGT<,!568DE<@M"D8B3<S\MWXA]=!X38HI]<ZP
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MF+6!FH5XEQ=RA82)E3EB9X.IDT91;8+RD8H_58)ED$(K;X'[D!T1Y8(>C!D
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M<]MX[I.(=*5JTI'9=61;>Y!1=AY+#([U=M0Y+HWZ=W0E#HW4=[L+'([(=WT
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MG<YU=HY"G 5G.HR7F>]8!(KVE\Q'ZHF3EAHVCXB,E6LC-(?IE!4*MH<0ASX
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M>AUL,IN[>F%>S9EX>IQ0?)=8>MQ [)6!>QTOTY0\>T\;]Y1G>S$$=)' ?$P
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MHBMJ I>-H'M<BY4GGEQ.')+,G$0^TI#$FQDN)X]+F? ;!X[-DD8$V(M2@T8
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M?VQ@.*2O?U!3@:'9?RM%XY\F?P0W,9S0?O0FG9MP?O(2DIR&?N,  )+H@
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M8(E5]+5\8E))H;*09!@\8:_#9<,MNZV,9R4<DJU$9[@(7*ZD9VL  )-8<M@
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M@_%4QZZ!@Y=(HZLD@RH[FZ?Q@L$M;Z5(@H,=):00@J *)Z/,@CD  (WC@
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M>_>2C7$7?$^"6'(??(QQ&7,>?+E>N'0E?.E+/'4>?1@V-775?38<\W5W?0,
M (  ?J*@;&XFA9R1.&]:A3N!"'!UA+=OU'&#A!]=M'*4@Y!*57.?@Q<U?'1-
M@JT<:G.%@F\  (  @ "?4&ROCU:0(&WOCCY_^&\3C/=NS7 LBYU<O7%%BE5)
MC7),B38TVW+RB&,;[W'+B$L  (  @ ">;6N F1.//&S(ET=_%&WNE3]M\&\+
MDR=;[G ND31(W'$WCX@T67'%CG$;D'!=C5@  (  @ "=Q&J6HM..BFOCH%=^
M6&T%G9%M-6X=FKQ;-F]"F"M(,'!2EADST7#4E1\;.F\UD7H  (  @ "=5&GQ
MK)>."&L]J7)]P6Q4I?)LEVU?HFM:I6Y]GTU'M6^*G0,S5F__FW@:Q&Y'DAD
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M@PZ%KG=_@O-VA'?J@K!F37A2@E)5'WC'@?M"EGE(@;0N5WF2@784Z7E-@5,
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M7?!^$8>M8,=OTX<=8VI@1X:X9=M/=(9Q:"<]*X9F:CLHO(;M:[D.!HC^:T<
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MB4]Y-G[8B--K GZ;B"-;PGY>AU9+C7XWAI<Y_7XLA@DF47XDA=D-#7YZA*,
M (  @ "%L7WSDA%X>7W,D09J1WV-C[=;#7U.CE!*W'TIC0\Y9GT6C"PE]7SC
MC#H,ZGTRB)8  (  @ "%(GT=FM5WYWS[F41IL'RWEU]:>7QOE6)*27Q&D[(X
MTWPTDK$E@GOFDDH,RWPGB*8  (  @ "$N'Q_H[%W='Q@H:QI+WP3GSA9]GN\
MG+%)UGN'FJPX=GMKF> E)GL,ER,,BGM?B'H  (  @ !^0Y'Y769QVI"18!ID
M:8]Q8J95NHZ#90=%OHW#9SDT'XUR:1L?THY6:A<&3HZ9:A0  (  ?,M]>X_H
M9:AQ*HZP9Z!CLHV9:7]5&8RD:T-%-HO<;.4SM8M];D4?CHPG;N &:HOV;O
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MCHQM.H<:C<Y?XX8GC,I1=X4PBZ="&81IBK(Q8(/>BC(>*8.CBHD&BX+SA&P
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M;$)DHI9J;8Y8#I3+;LQ*/Y--;_L[-)(1<0DJ5I&"<<H6%9+<<84 <XYP=#,
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MDPIAL9 7DC55$HYYD0%':8S3C[$XO(MTCM,H<(J>CP05&8K'C* !&H;1@+X
M (  @ !L[Y#XFPYA7X]]F?A4N8W4F%]'$(P@EK$X<HJQE=$H.8G%E2<4_(G)
MCC !)X8#@,@  (  @ !E8J976[!:$J0?7A5-\*(C8&5 JZ!;8HTQ\I\%9&@@
MYY\398H+^Z&[91H  (V4;=(  (  @ !DLZ3,8R=9IJ*.9/%-DZ!M9K! ;)Y[
M:%8QTIS_:;\@\YS5:HH,3Y[Z:?T  (O[<LP  (  @ !D*Z+H:G59#*"X:[A-
M&9Z4;/$_^)R:;AXQ?YL1;QH@T)K!;Y4,?9QL;P8  (I[=Z(  (  @ !CG:$'
M<:M8:Y[B<GI,:)S)<SP_=9K1<_4Q$9E(=(T@D)C>=,,,CIH9=%4  (D4>^4
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MELU6OYFNEB1*Q9=LE.\]O94HDZPOJY-*DV<?L9);D>\,OY'LB)\  (2<@
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M=AQ,BJB"=HI!!*7_=NHTBJ.F=S,FNJ'U=VT6":)==RD$PI\&>.$  (0^@
M (  @ !6_ZFM?2-,4*<J?4I U:2=?4XT7J(W?3\FDJ!T?3,6&Z"7?18$_YSO
M?A8  (->@    (  @ !6NJB@A"U,*:82A!9 N:-U@\<T0:$"@VPF=)\T@T<6
M'9\M@X<%/ILA@GH  (*M@    (  @ !6A:?2BT-,$Z4RBOU JJ*#BF<T,I_^
MB<\F79XAB<H5_YX1B38%39FK@Y8  ((6@    (  @ !68J<TDGY,#*1ZDB)
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ME720,ER\D\R &E\^D?MO!F&;D"1=$6/BCF]*$V7<C/,UOV;EB^$=CV4SBXP
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M;""*/VQ ;<=[$6V];U5JA6\F<,98[G"#<BA&&'')<W0QF7*E='P88W(F=),
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MFXF$LF,[F:%UCF4.EW5E;F;#E3I47FAMDSU"+VG2D;(NDVHND2465FH5C>4
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M<[)]:W&H=,!O*7*A=:U?Z'.-=H=/3W1Z=TL]9W5/=_LICG6]>&D0 W;L=_
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MH+-Y3VI_GK1K"FN>G%%;T&RAF=Y+IVV=E](Z16Y?EJXG%6X)E64.IW"1B>@
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M>DMP^7@+>MQCC'AY>TE5+'C:>YE%M'D_>^$TBWFI?!LA&7G ?" (JGNA?)8
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M5]II@(G[6O!<LHE\7=Y.I(DG8)L_-(C^8QLM\XE*92D9?XKY9?,!]8H49Q@
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M?_)D[W]_@"-84G]5@"=*M7\A@ P\!W[X?_ KLW[I?^48,W[S?^@"C7^]?_@
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M7JA='Y$48/U1"9 A8SA#S(]194XU%X[,9Q\D/H\<:%L/:9%M9_H  (8B;F0
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MA(M94H?FA'=-:(<@A"] =H94@] R6H6P@XHB@(58@XD/,X4A@T<  (  @
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M9$-0]9D;9?Q%GY>]9Z(Y!9:$:28JZI7%:E8:)I:':K4'%Y6<:N0  ("7=Q0
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MB&!.+Y$ZB#M"YX_FA\0VD(Z&AS8HW(U^AP88MXUSAT<'*XJCA-D  (  @
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M:*=$HZ)9:=XYI*"V:P$MH9]);  ?P)Z_;)$.QJ _;"@  )AW;RL  (  ??\
M (  @ !.2Z(+;W%$*Z!K<$XY,Y[%<1$M*YU,<:0?C)RE<?8.P)W9<8X -98
M=0D  (  @    (  @ !-UZ!J=F!#RI[3=O XY)TH=U4LZYN>=Y$?6)K7=YP.
MV)NI=UX <9/:>E0  (  @    (  @ !-<Y\3?55#?YV#?:(XJYO/?; LMYHW
M?9X?)IE=?8P.T9GE?;4 L)()?LX  (  @    (  @ !-))X#A%E#2IQSA'$X
M@9JVA#(LF9D(@]\?"I@2@^0.JIAW@WL M9"9@'L  (  @    (  @ !,\9TI
MBX]#*)N4BX8X9)G0BP@LAI@0BHX?$Y;SBJ\.V9<>B$0 W8]G@)8  (  @
M (  @ "ISEKJ4ZF9K5W'5WR(\V"&6S5W4&,L7LQDJ&6Z8D-0X6@5994[PFG=
M:*,C)6EP:ND#YWEG;,NGPE:C7B"8%%G@8/Z'AUSN8\9V#5_89GAC@&*?:1!/
MUF4B:XTZTV;G;= B9678;VP#R'F<<6>EW%+,:(V61U95:G.%^UFG;$QTE5S&
M;AQB,E^[;]].MF)><9 YY608<Q4AL6*Q=!D#K7G*=F*C^4]3<MV4>E,@<]J$
M/%:A=-1S'UGQ=<A@X5T4=KM-F5_0=Z@Y 6%\>'@A"F $>/D#E7GR>O6B,DQ
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M4X".I&1E5UA^]F:56P9N.FBW7HA<86K%8>9)46RI91<TLVX&9^T;UVV":9L
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MA+6'/%4!A&1X*U@Q@_IH%5LE@X)7#%WC@Q)$U6 D@KDQ&F#T@H$92&&E@J$
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M7+Z"4V? 7[=SMFFA8HED VMO93=3&6TG9\! V&ZN:AHLQV^2; (387#G;%(
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MBT][YUI]BIYMQ5T8B;Q>EE]_B,A.9&&NA^T\^F-+AT(IZ6,GAO\1LV>PAD,
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M9-UUTFP!9Q=H6&V#:3)9C6[N:RE)F'! ;/\X(W%>;IXD@G&\;[(+976";XH
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MD.5PLV#4C_9C9&+0CKM5#&24C6M%GV8>C% TU&<*BZ4B+F78B^D*LVWJASP
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M:]]I<W$Z;7U<NG)/;OY/$'-%<& _XG0N<9HO(73?<I8;IG2Z<N($GWFQ="@
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ME8UEA&@:E(Y8]VEPDR)+96J#D9X\O6M8D( LBFN%D%\9T&JTCH@$;'B'@OT
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M<=-=5'>0<O5177@E<_5$47BB=-$V(WD+=8TER'E@=@,1]7GX=9X  (  >>(
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M49A6!XOM5-Q*=XNI5_T]G(N56N0O&HO7764>"(TI7OH)@(YJ7RD  (  :6D
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M=L11B'\*=X5&/7\?>!PYW7\7>(XL(W\4>.(<)7\H>/$)6G^T>9D  (  @
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M5S])O)-$6> ^Q9*G7%TRB))$7ILD9Y*(8$\2V)3G8)D!U)$*8FD  (  <?@
M (  @ !2RY$,7C](W)!Y8&<^"H_L8FTQV(^'9#DCY(^O98<2FY&D98X"!HW+
M9V<  (  =N0  (  @ !2 (Y"94!(!HW(9O$]*(U+:($Q+XSI:>$C5(T!:M 2
M2HZ3:IT"'XKP;*0  (  >SP  (  @ !1.8O(;%5'1(MI;98\:XKW;K4P=(J/
M;YXBXXJ*<#T1_HN^;^8"+8AX<EH  (  ?P8  (  @ !0@HFK<X!&F8EG=%P[
MTHC]=0TOZHB,=8\B:8AH==<1XHD?=8@"1895>$H  (  @    (  @ !/XH?B
M>JE&#(>X>RT[6(=4>W4O@(;5>Y<B!(:3>Z81J(;E>XL"<(2"?5<  (  @
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M6YT]-)PM7:PRPIMO7XXFVYKY8208PYN]8>H(EYO.8E   (Q#:5$  (  >:D
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M?9 Z;9'V?>TP,I%/??@DPY"(?=H70I!S?<@(4HWP?G@  (-%@    (  @
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MS7SU@3B3@UJ^3>Z%0UUA4B!V6U_]5CEF?6**6B]5@63Y7?M#/6<788\O3VA
M9+$6JFEU9E0  (  ;=*1>5695YF#U5B[6OYU+5NV7DIE?UZ-8794HV$Q9'A"
M@&-J9THNN61=:;<63F9@:MH  (  <K"/FE#D84F" E1M8]=SF5>Y9E!D EK/
M:*]35EVE:O)!8U_Q;1 MT6"=;MH5L6/@;XH  (  =V*-RDR3:NN 1U!S;*=Q
M]50!;E9BM%=2;_)2*5I9<7A :ERO<N<M$UT*=!@5.&&X=',  (  >W:,'$BN
M=(9^Q4S;=7MPDE"M=F-A8%0L=SQ1-%=<> T_E%F[>-0L<5FZ>7L4U5_G>:P
M (  ?O.*L45(?AM]A$FX?DUO>DW$?G)@9E%V?HQ03E2_?JD^]%<=?M0K]5;
M?PD4AUYD?U@  (  @ ")B$);AYY\?D<&APUNETM$AFU?GD\>A<U/E%)^A4,^
M6%34A-\KFU1,A,0455VBA/H  (  @ "(H3_PD/][LD3*CZUMXDDPCDI? 4TF
MC/-/ U"5B] ]RU+<BODK+5)'BL84*EWKB9L  (  @ "'_SX1FAY['$,,F!9M
M5D>*E?5>ADN2D_).H$\*DD4]@E%%D1TJX5"MD1,3WUYIC4   (  @ "('6'L
M3@QZPV0'4AULL68F5A==FV@Y6>Q-5FHN79$[I&O:8.\G\FR88ZD.DW#K9&@
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M>Z=S@%#A?!=F-E1'?&]7WU=6?+5(>UGV?/DWLEN0?4,D]EK,?8D-4FE\?@D
M (  @ !^X4I-A+1RCDX\A'AE6U'*A!E7&%3X@[!'P%>E@UDW&5DF@RDDIEB1
M@T0-/&FA@Q,  (  @ !^$T?UC:5QTDP*C,-DJD^VB[)6=U+XBIQ')U6JB;@V
MA%<*B2LD-U;"B6(-)6G(AS8  (  @ !]@D8@EF=Q2$I3E/)D'TX1DS95\U%;
MD7I&NE0+D!<V,55/CU$CWU50CV0,X6H\B+4  (  @ !\E6ES3A-P!FL-4?QB
MNFRW5=)486Y868-$QF_=7/LSCW$K8!,?U'&L8CD',W>V8Q   (  =89ZLV2R
M5I%NG&:W6=QA@VBI70M36&I]8!5#XFPA8NHRTFUE96@?1&U/9PH''W3J9[\
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M@;EH8%7/@<9;X5BQ@:9.4%LR@7,_H%TF@4\O=5W$@4L=#%Y^@8@&V'1O@6D
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M7?=B4FIX8)%6-FPC8Q%(V&V=96DZ)F[=9X@IFF^?:3<5QW!]::T X'Z&;"H
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MAL!=1%N[AH]1>5X+AA=$H%_CA8DVB6$(A2DFM&!AA284!F54A40!,'W^@,X
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M9#)6&V]19C1*L'"7:!T^-W&L:=\P'G)^:UD?U7*S;#\,,'98;"   (  =-$
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MBNQ2)F*JBJ5&_V1NB?4ZS&65B2TM2V78B,P=J&4FB2H+66T^AJH  (  @
M (  @ !8\X-<3&!.JX.63]U#A(0$4SXW"H2:5F$HO(6 60(75H>)6EP$<8?5
M6Z(  (  :34  (  ?AI7>'].4WQ-A'_55HI">8!@67$V+(#Q7!LH$X&Q7DD6
M\8,S7T,$C80(8&X  (  ;?$  (  @ !62'M:6K-,5'P?74!!>WS)7ZHU/GU?
M8=<G4WX"8Y$6:W[[9"\$BH"V958  (  <R0  (  @ !5*W>B8?5+,7B28_U
M5GE59>0T6'GW9YHFB'I_:.85TWKX:2\$<WW<:F\  (  >"   (  @ !4&G0Y
M:4=**752:LX_578O;#8S8G;0;6PEXG<W;E@51W>$;EX$6GMI;^,  (  ?'(
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M2M=#8(UJ3C8XU8V#46DLO8W_5$0>58]?5E<,@)'=5O8  (F*7#0  (  ;*T
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M;4P^37RP;G S_GTV;V@H<7U]<"(:^WVF<&P+$WZ&<(<  (  =E4  (  @
M (  @ !&^'DQ=%T]E7HM=1TS7'K+=:<GYGL%=@,:<GKG=A,*U'PV=FP  (
M>T<  (  @    (  @ !&3W;0>VP\ZW@#>] RO7B\>_@G77CM?  9^GB$>_L*
M;7IO?*T  (  ?W@  (  @    (  @ !%TW3;@KP\AW9$@N R;W<@@I\G.G<Y
M@DL:)'9R@EL*SGBU@@8  (  @    (  @    (  @ ! F9E%2*LWLIBM2^4M
MHYB43M0AJIE143L2>9PR4E,#4IF^5&   (2R7XH  (  < T  (  @  _-Y6\
M3P0V5)6.4=DL+)695&(@2Y9 5F81;IBA5R\#"94563\  (&N9$   (  =0$
M (  @  ^09(657@U.I(95^$K'I(^6@(?.I+76Z 0H)3#7!\"TI#/7BX  (
M:2,  (  >70  (  @  ];XY]6_TT4(Z?7?8J&([57ZD>9X]D8.@/_Y#782H"
MJHT&8SH  (  ;E8  (  ?5@  (  @  \FHL48IHS=(MI9"8I1(NM970=F8PB
M9DL/IXT09F<"F8G%:(<  (  = 0  (  @    (  @  [RX?R:5TRIHB':H$H
MD(CE:VL=!HE":_$//XFD:]8"IH<#;C   (  >3L  (  @    (  @  [%84I
M<"DQ](7^<.\G^(9W<7D<C8:_<;0.YX:N<88"EH3%=%,  (  ?9@  (  @
M (  @  Z?(*[=PHQ78//=WPG=H1E=ZX<+H27=Z@.HX1)=Y(";H,">BL  (
M@    (  @    (  @  Z#8"J?B<PYX'V?D\G"X*L?C$;XX+,?@$.D8)<?BX"
MB8&(?O\  (  @    (  @    (  @    /__  #__P  __\  &UF=#(
M! ,)   !                     0                    $   $   (
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M>9P4?Z-^98-,?\9^A6J%?_Y^P%&_@&-_/3D @1* #_S%?GR+-.2U?F.);,Q
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MWWRR@Q>=RFBD@G.8H%39@=V3/4%7@7*-?BZ @1:')\J@AL>\#[><A8JV :0
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M.X7J<W6K?G!@=0JCIUL3=KV;=T7W>)R2QC%1>J^)8=<@?Q5R&L.:?QES.:^
M?RAT3IK)?T!U:(6J?V1VEW!B?Y9WY5LS?]AY3D8>@#YZ]3%^@-Y\_=6C?69\
MF<)R?8M\FJYH?;-\HYFX?>)\P82>?AY\^V]I?FU]3UI1?M%]LD5F?UU^-S$
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MC/Y[2TB4BL)\+#A(B(1]0BD'AC5^F:G#ET.!+)I_E-B OHJRDH* 7GHZD$^
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ML8Q"FN*51'V-E\:2SFY^E+>05%]7D;*-W5!(CKB+:$&UB[J(YS/)B+6&2"=
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MZ['T9&"T4I\99I^N5XO8:.BH+7B1:VNB!V5M;BF;T%*G<1657$ _=$".C"[
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M?Q]^II>O=YB"W8I\>"6"NGR2>+&";FX0>4B""5]*>@"!IE!=>N:!3$'F>^6
M\3/N?1> DB<Y?G6 *9:_=DZ+;XF+=NJ*C7NJ=X.)<6TY>"N(,EZ*>/B&[$_2
M>?&%IT&(>Q&$7C/!?&:"_"=#?>2!@)7_=4&3V(C,=>J2-7KQ=HJ016R*=SZ.
M)EWM>!Z+_4]8>2R)S$%">ER'C3.C>]"%*R=,?6R"J95L='&<#X@U=2.9J7I5
M=<66WFOV=GN3UUUC=VB0Q4[>>(^-ID#P>=**=C.%>U6'&R=3?0F#I94&<]JD
M!H?!=)*@WGG4=3"=,6MV=>*9.ESV=M*5.$Z+> 21*D"I>5R-!C-7>O>(O2=9
M?+J$=8^7A^]?J8-WAQ%BKW:(AFEEEFC-A=MH;UJ8A5)K6$Q%A,]N:3Y;A%=Q
MIC#E@_UU/"2E@\MY0H[+A<EH$(*RA2YJ0'6XA*9L7F@6A"QN>UG_@[IPJDO1
M@UAR^CX/@P-U;##0@M%X("36@L-[(8WI@\!P48&L@U9QP'35@NMS(6<\@HUT
M@5E-@CMU\4M+@?UW>3VZ@<]Y&C"V@<1ZY24!@=I\W(SM@>]X<("B@9YY+G/!
M@5!YV&9J@0AZ>5B8@-I[)4K&@,%[WCUI@+A\IC"<@-1]@R4G@0Y^<HOZ@%"
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MC=I\I3 YBM5]:B>]A]Y^12"IA1-_(FK*FM: 2V$]F$R 4E=8E9* .DU DK*
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M36-9A^)]KUEHANE][T\MA>%^'D3LA.%^53KF@_%^HC%<@Q]^_"B7@FY_6B%
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MCG5[N$@%C'=\*S[BBG!\L#7_B')]5"VPAHM^!28HA,A^OQ_]@SA_<F*"D,&
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M83][/$439UM\/S=$;=-]:BKC=&I^O9DJ0NZ =HP92*^ 97YX3D" 5' \4]>
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M>F]_8WI(6 Z!CF_E6_"!D&4#7\*!:%FI8ZB!+4X<9\" ^T*B;!: V#?'<)6
MQ"V =4R M"2A>>2 H'F;5BZ)&6])6D"(;F1Q7C^'?EDI8E&&<$VI9IN%;D(^
M:R>$>3>/;]2#D"U]=+*"H"2Z>7.!K7D>5+202F[66.V._6/^70Z-15B^84"+
M8$U59:N)B4(':EV'P3=@;S>& BUC=$"$/B3.>1B"BG=L<P91!6SQ=%=5*V(<
M=<Q99%;5=U5=L4M">/!B'3^R>K%FO32O?)AKF"I7?L1PX"%D@1-VF778;QA8
MO6O/<-5<3&$N<IY?XE8;='-CA4JV=F)G0S]6>'YK,#2&>L%O3RIL?41SRR&]
M?]IXG72':W%@@FJ4;9)C:F T;ZUF5E5!<=%I2TH.=!-L6#[C=H9OC#1/>2%R
M["IU>_)VEB(*?LAZ>W-,:!YH.6EG:I)J=5\7;/ELM51\;V1N^TEL<?QQ4SY[
M=,)SRS0A=ZYV92I_>LEY.")-?=E\+W(?92EOXVA29^5Q<UX@:I!S %.B;4)T
MBTCV<!YV*3XJ<S)WX30$=F9YL"J0><1[J2*%?0Q]MW$A8IQW=F>"99=X85UP
M:']Y-U+Z:W!Z!$A>;HEZWCW1<=A[TC/5=4M\V"J0>.9]\B*U?&!_#W!38&M^
MTF;%8YQ_&5S'9KE_-5)E:>!_0$??;3%_5SUY<+5_@C.Z=%=_O2J9>"A__2+<
M>]& .&^P7IF%Y68T8?>%C5Q!94&$[U'P:).$,T=X;!&#A#TA;\F"YS.-<Y6"
M62J@=XJ!QR+\>UV!,F\Y722,JF7'8*J+OUO69!:*95&.9XB(VT<N:R6'8#SS
M;P"%^3-G<OB$GRJ.=Q>#1B,5>P"!_VS2>LU1%6-*>X=5+EEM?&)98$\I?45=
MKT2D?BUB)3HP?RUFU3!5@$IKOB<X@9IQ#A^ @P1VLFMH=Q]856)$>#Q;Y5B5
M>5Y?@TZ$>H)C-40O>[-G"3GN?01K#S!*?G)O1R=H@!)SUA_L@;]XHFI <Z=?
MH&$M=1]BEU>[=HMEF$W&=_1HJ$.E>7!KUCF:>Q)O+S P?-!RLB>*?KEV>R!)
M@*%Z:VDH<'IFWV =<CUI.%:[<^UKETT-=9YN!$,1=VAPB3D]>5=S,3 ->V%U
M^B>A?8UX^""9?ZI\"F@D;:1N"U\S;ZEOQE7D<9EQ@DQ&<XQS0T*D=95U&#CS
M=\YW#B_V>AMY&2>Z?(9[2"#>?M=]?&<[:RIU)EY?;6UV1%4M;YEW5$NW<<1X
M84(U= =Y?3C-=G)ZN2_R>/I\!B?4>Z!]9B$7?B5^P69\:0=\$5W#:X=\F%2K
M;>=\^$M&<$%]2T'.<K5]L#B$=51^+B_D> 5^OB?G>MY_3R%&?9)_UV7D9SV"
MN5TY:>Z"K%0O;'R"7$K>;OZ!\D%V<9R!G#@Z=&J!7"_ =T*!+B?U>C^ ^R%L
M?1J P65R9<N)'%S0:*2(@U/+:UB'@$J';?N&4T$X<+>%.S@7<Z6$.R^I=J6#
M3"?Q><B"7R&+?+J!@&*$@MQ0X5GT@O%4]U$4@R!9*D?3@TM=@SY;@VYB#34#
M@YMFUBQ-@]MKV"1BA$-Q-1W5A,1VQV%#?VI7MUD#?]U;3U!'@$I>^T<V@*IB
MQ#WT@0AFMC35@7MJWRQ;@@)O."2J@K%SWAY2@W%XI6!#?!U>D%@,?.%AGD^$
M?9!DN4:/?BYG[#V ?M!K0S28?XQNR2Q:@%QR=B3B@4]V81Z^@DEZ6U]4>0YE
M7E<B>A=GV4ZE>P-J7T7P>^1L^CT'?,YOLC14?=)RD2Q.?NEUCR4-@!QXNQ\<
M@4E[YUYP=D]L'U9.=YAN!DWC>,%O\T5&>=QQZCRE>P9T #07?$YV-BQ"?:-X
M@24P?Q%ZZA]K@&Y]1UVE<^1RRU67=6QT(4U'=LYU;D3">"%VP3Q!>7YX*#/Z
M>O1YKBQ%?(%[1B53?BA\Z1^M?[=^>EST<<EY1%3R<X]Z"$RW=2AZLD1.=JM[
M63OJ>#5\%#/0>=A\YBQ=>X5]RB5Y?5]^KQ_C?Q]_@%QF< )_C%2(<@=_QTQG
M<]%_QD09=7-_LCO'=QQ_NS.F>.Q_W2Q">L& %"6/?+R 0" /?J2 7%O\;I"%
MFE0D<+^%3$P+<K2$GD//='B#T3N7=CR#(S.1>"F"CRP]>B*"#R6;?$*!C" R
M?D*!#UB*BSI085#XBI14@4D:B@!8OD#=B5Y=*SAQB*=ATS RA^YFP2B=AT)K
MY"'8AK9Q51Q@AE%VV5=QA_U6UU 5A[A:@4A,AUI>14 ^AN)B+C@0AEAF2# 2
MA==JGBB_A69O("(UA1MSXASMA/%XIU:8A-5=24\[A-A@=4><A+ACLS^HA'9G
M$S>OA"AJG"_J@^AN6"C5@[ER-B*!@Z]V1AUG@[YZ3%72@=UCKTYV@AUF4T;<
M@C=I!S\C@C1KV#=0@BANSR^_@BQQ["C@@C]U)2*^@G)X@1W0@K9[QU41?REJ
M#4W!?ZML)D8Y?_YN3#Z7@#%P@C<*@&%RX2^;@*1U7RCH@/1W[B+Q@6!ZD1XI
M@=1]%U1??,1P6TT=?8IQZD6Q?A=S>CXM?GQU%3:^?MQVS2^(?TUXIRCS?])Z
MBR,<@'1\=!YS@1=^.U/%>K-V>4R4>[AW@$5"?'MX=#W9?0QY;C9[?9=Z@R]K
M?C)[LBD(?M9\[B-$?ZI^(1ZP@'M_,U-!>.=\64P6>B]\UD35>R9]+3V&>^!]
M@C9 ?(Q]\B\Z?5)^>"D#?@]_#B-O?O]_EA[A?_V  U+@=W&"'DO,>/:"%T2@
M>A^!OSUQ>NV!6#95>Z.!&B]H?'R ^"DG?6. Z".*?GZ SA\(?YB K$[8D_U/
MHTA*DH13TD%QD1%8'3H]CX5<I#+AC=EA=BN[C"-FDR5!BGIKY!^4B/9Q;QL9
MA[1VYTW,D/I5N4=2C^U9?4" CJ]=7SE]C3]A<3)LBZUEP2N6BAUJ3R5LB)]O
M R  AU)SY1NUAD=XITT4C?A;RT:,C2Q?'#_5C"EBA#CJBNAF'#(1B8EIXRMY
MB#%MX"60ANUQ]R!;A=UV+QP[A0EZ/DQXBQ%AT$7JBGQDI#\QB:]GCSA[B*QJ
MGS')AXEMX"MEAF]Q1B6OA6ITP""HA)=X31RO@_A[JDO:B%YGSD53B!!J(3ZN
MAWMLB#@0AJAO"#&BA;]QN2M<A.)TBB7/A!=W8B#L@WUZ01T0@Q!\[$M!A>]M
MQT3&A?%OE3Y A9EQ;C?$A/9S7C%SA#EU<"MC@XEWI"7P@O%YVB$F@HQ\"1UA
M@DY^ TJ\@]!SDT1,A"!TW#WDA )V(C>&@XMW>S%,@O5X\BM:@FUZ@B82@?=\
M%R%;@<!]G!VD@:Y^[TI,@@!Y+T/G@I=Y\CV5@J]ZGS=6@EY[6#$M@>I\,BM%
M@8M]("8:@3)^%B&$@1E^^1W:@2Q_M$G[@'Q^I4.7@5)^VSU5@9U^YC<Q@6Q^
M^3$D@0]_,"M4@,I_?"8H@)9_T2&:@)Z &QX%@,2 5   __\  /__  #__P
M;69T,0     #!"$   $                    !
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M=)=USG>8<\UYFG+->YMQS'V;<,M_G&_+@)UORX"=;\N G6_+@)UORX"=;\N
MG6_+@)UORX"=;\N G6_+@)UORX"=;\N G6_+@)UORX"=;\N G6_+@)UORX"=
MV=(+&,3M#BFP_19!G_\D59'T-66'ZT9P?^54>7OA87]VW6B$<MMNAV_9<8EM
MV'2+:]AWC&K6>8UIUGJ.:-5\CF?5?H]GU7Z/9]5^CV?5?H]GU7Z/9]5^CV?5
M?H]GU7Z/9]5^CV?5?H]GU7Z/9]5^CV?5?H]GU7Z/9]5^CV?5?H]GU7Z/_Z,Y
M*O^?1D#_G5!5^J!09>^C477DI%.&VJ);EM"@9:3(G7"PQ9Q[M<*<@[F_FHF^
MO)6+PKJ0C,6XC(_)MHB2S+.$E\^R@9_2K7^BTZU_HM.M?Z+3K7^BTZU_HM.M
M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3_Z,Y*O^?
M1D#_G5!5^J!09>^C477DI%.&VJ);EM"@9:3(G7"PQ9Q[M<*<@[F_FHF^O)6+
MPKJ0C,6XC(_)MHB2S+.$E\^R@9_2K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3
MK7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3_Z,Y*O^?1D#_
MG5!5^J!09>^C477DI%.&VJ);EM"@9:3(G7"PQ9Q[M<*<@[F_FHF^O)6+PKJ0
MC,6XC(_)MHB2S+.$E\^R@9_2K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^B
MTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3_Z,Y*O^?1D#_G5!5
M^J!09>^C477DI%.&VJ);EM"@9:3(G7"PQ9Q[M<*<@[F_FHF^O)6+PKJ0C,6X
MC(_)MHB2S+.$E\^R@9_2K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_
MHM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3_Z,Y*O^?1D#_G5!5^J!0
M9>^C477DI%.&VJ);EM"@9:3(G7"PQ9Q[M<*<@[F_FHF^O)6+PKJ0C,6XC(_)
MMHB2S+.$E\^R@9_2K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M
M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3_Z,Y*O^?1D#_G5!5^J!09>^C
M477DI%.&VJ);EM"@9:3(G7"PQ9Q[M<*<@[F_FHF^O)6+PKJ0C,6XC(_)MHB2
MS+.$E\^R@9_2K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3
MK7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3_Z,Y*O^?1D#_G5!5^J!09>^C477D
MI%.&VJ);EM"@9:3(G7"PQ9Q[M<*<@[F_FHF^O)6+PKJ0C,6XC(_)MHB2S+.$
ME\^R@9_2K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^B
MTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3_Z,Y*O^?1D#_G5!5^J!09>^C477DI%.&
MVJ);EM"@9:3(G7"PQ9Q[M<*<@[F_FHF^O)6+PKJ0C,6XC(_)MHB2S+.$E\^R
M@9_2K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_
MHM.M?Z+3K7^BTZU_HM.M?Z+3_Z,Y*O^?1D#_G5!5^J!09>^C477DI%.&VJ);
MEM"@9:3(G7"PQ9Q[M<*<@[F_FHF^O)6+PKJ0C,6XC(_)MHB2S+.$E\^R@9_2
MK7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M
M?Z+3K7^BTZU_HM.M?Z+3_Z,Y*O^?1D#_G5!5^J!09>^C477DI%.&VJ);EM"@
M9:3(G7"PQ9Q[M<*<@[F_FHF^O)6+PKJ0C,6XC(_)MHB2S+.$E\^R@9_2K7^B
MTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3
MK7^BTZU_HM.M?Z+3_Z,Y*O^?1D#_G5!5^J!09>^C477DI%.&VJ);EM"@9:3(
MG7"PQ9Q[M<*<@[F_FHF^O)6+PKJ0C,6XC(_)MHB2S+.$E\^R@9_2K7^BTZU_
MHM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^B
MTZU_HM.M?Z+3_Z,Y*O^?1D#_G5!5^J!09>^C477DI%.&VJ);EM"@9:3(G7"P
MQ9Q[M<*<@[F_FHF^O)6+PKJ0C,6XC(_)MHB2S+.$E\^R@9_2K7^BTZU_HM.M
M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_
MHM.M?Z+3_Z,Y*O^?1D#_G5!5^J!09>^C477DI%.&VJ);EM"@9:3(G7"PQ9Q[
MM<*<@[F_FHF^O)6+PKJ0C,6XC(_)MHB2S+.$E\^R@9_2K7^BTZU_HM.M?Z+3
MK7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M
M?Z+3_Z,Y*O^?1D#_GD]4^J%.9.^D3W7EIE&%VJ58E=&B8J/)GVVOQ9]WM<*>
M@+F_G8B^O)F)P[F4B\>VCXW+LXJ0S[&&EM2N@Z#7IX&AU:>!H=6G@:'5IX&A
MU:>!H=6G@:'5IX&AU:>!H=6G@:'5IX&AU:>!H=6G@:'5IX&AU:>!H=6G@:'5
M_Z,Y*O^@1D#_GDY4^J)-9/"E3G3EJ$^$VZ=5E-*E7Z'*HVFMQ:)TM,*A?;F_
MH(6^NYV(P[B8B<BUDXO-L8Z.TZZ)EMBGA9W:H86@UJ&%H-:AA:#6H86@UJ&%
MH-:AA:#6H86@UJ&%H-:AA:#6H86@UJ&%H-:AA:#6H86@UJ&%H-:AA:#6_Z,Y
M*O^@1D#_GTU4^Z-,9/"G3'3FJ4Z#W*I3DM*I6Z#+IF:KQJ5PL\.E>KB_I(*]
MNZ*'P[B=A\FSF(G/L)2.U:N2E]J@BIS<FXF?V)N)G]B;B9_8FXF?V)N)G]B;
MB9_8FXF?V)N)G]B;B9_8FXF?V)N)G]B;B9_8FXF?V)N)G]B;B9_8_Z,X*O^@
M14#_H$Q4^Z1+8_&H2W/FJTR#W:U0D=2L6)[,JF*IQZILL<2J=K; JGZ\O*B$
MPKBDALFSH8C/K)R-U:.6E-J:D9S<EHZ>V):.GMB6CI[8EHZ>V):.GMB6CI[8
MEHZ>V):.GMB6CI[8EHZ>V):.GMB6CI[8EHZ>V):.GMB6CI[8_Z0X*O^@14#_
MH$M3^Z5*8_&I27+GK4J!WK!-D-6P59S.L%ZGR;!HK\:R<[/#LGRXO;" P;:L
M@LFNIX7/I:&*U9R<D=J5F9S<D92>V9&4GMF1E)[9D92>V9&4GMF1E)[9D92>
MV9&4GMF1E)[9D92>V9&4GMF1E)[9D92>V9&4GMF1E)[9_Z0X*O^@14#_H4I3
M^Z9(8O*K2''HKTB W[-*CM:U49K0MEJDS+AEJ\J]<:[!N7NVM[* P*ZLA,BF
MJ(7.G:2'U)2@CMB.GYG;C)N>V8R;GMF,FY[9C)N>V8R;GMF,FY[9C)N>V8R;
MGMF,FY[9C)N>V8R;GMF,FY[9C)N>V8R;GMF,FY[9_Z0X*O^A14#_HDE3_*='
M8?*M1G#ILD9_X+='C-F[3I?3OU>?T,5CI,7 <*VZN'FWL+* P*FMA<>@J(3-
MEZ6%THZAB=>'H)+9AZ&<V(>AG-B'H9S8AZ&<V(>AG-B'H9S8AZ&<V(>AG-B'
MH9S8AZ&<V(>AG-B'H9S8AZ&<V(>AG-B'H9S8_Z0W*O^A1$#_HTA2_*E%8?.N
M1&_JM4-]XKQ$B=S"2I/8RE29RL9BI+R];K"RMGBYJK& P:2MA<>;J83,DZ:$
MT(JCA]2#HH[6@J*6UH*BEM:"HI;6@J*6UH*BEM:"HI;6@J*6UH*BEM:"HI;6
M@J*6UH*BEM:"HI;6@J*6UH*BEM:"HI;6_Z4W*O^A1$'_I$92_:I$8/2Q0F[K
MN$%[Y,%"AM_,1HW3SU*7P<1AI[.[;;.KM7B[I;& P9^NA,:8JX3*D*B$SHBF
MAM&"I(S3@*22TX"DDM. I)+3@*22TX"DDM. I)+3@*22TX"DDM. I)+3@*22
MTX"DDM. I)+3@*22TX"DDM. I)+3_Z4W*O^A1$'_I451_JQ"7_6T/VSMO#YX
MY\= @>#61H?)S5&:N,)@JJRZ;;6EM7B\H+& P9NNA,65K(3(CJJ$RX>HALZ"
MIXO/?Z:/T'^FC]!_IH_0?Z:/T'^FC]!_IH_0?Z:/T'^FC]!_IH_0?Z:/T'^F
MC]!_IH_0?Z:/T'^FC]!_IH_0_Z4V*O^B0T'_IT-0_ZX_7?>W/&GPPCMSYM _
M>=/9/XJ^RU&=K\!AK*6Y;K:@M7F\G+*!P)BOA,.2KH3&C*R%R(>JA\J"J8K,
M?ZF.S7^ICLU_J8[-?ZF.S7^ICLU_J8[-?ZF.S7^ICLU_J8[-?ZF.S7^ICLU_
MJ8[-?ZF.S7^ICLU_J8[-_Z8V*O^B0D'_J4!/_[([6_F].&7LRSAMW-PU>,?6
M/HZSR5*@I\!CK9^Y<+::M7J\F+*!OY2QA<*/KX7$BZZ&Q8:MA\>"K(K(?ZN-
MR7^KC<E_JXW)?ZN-R7^KC<E_JXW)?ZN-R7^KC<E_JXW)?ZN-R7^KC<E_JXW)
M?ZN-R7^KC<E_JXW)_Z<U*O^C0D'_K#Q-_[<V5_+%,U_AUC9CS>,Q?+K3/Y&I
MR%2AG\!EK9FZ<K66MGNZE+."OI*RA<"-L8;!B;"'PX:OB,2"KHK%@*Z,Q8"N
MC,6 KHS%@*Z,Q8"NC,6 KHS%@*Z,Q8"NC,6 KHS%@*Z,Q8"NC,6 KHS%@*Z,
MQ8"NC,6 KHS%_Z@T*O^F/C__L3=*^;XP4N?/+U71XBQHP.$P?ZW20I.@R%>A
MF,%GJY2\<[*2N'RWD+:"NHZTA;R+LX:^B+*'P(6QB<&#L8K!@;",PH&PC,*!
ML(S"@;",PH&PC,*!L(S"@;",PH&PC,*!L(S"@;",PH&PC,*!L(S"@;",PH&P
MC,*!L(S"_ZDR*O^K.#W_N"]%[L@I2-;?)5+#["ELL=\Q@J'219*7REJ?D<-I
MIXZ_=*V-O'RQB[J!M(BY@[:%N(2X@[>&N8&VA[I_M8F[?K6+O'ZUB[Q^M8N\
M?K6+O'ZUB[Q^M8N\?K6+O'ZUB[Q^M8N\?K6+O'ZUB[Q^M8N\?K6+O'ZUB[Q^
MM8N\_ZLP*O^Q+SCVPB8\W-H?.\;K(U>S["IOH]\U@I;42I"/S5V:B\AKH8G$
M=::&PGNJ@\!^K(&_@*Y_OH*P?;V#L7N\A;)ZNX>S>;N(LWF[B+-YNXBS>;N(
MLWF[B+-YNXBS>;N(LWF[B+-YNXBS>;N(LWF[B+-YNXBS>;N(LWF[B+-YNXBS
M_ZTN*OZ[)3#CTAHMR>@;0;;W(UJE["YOEN$\?XS83XN'TE^3A,ULF8'*=)Y^
MR'BA>\=[HWG&?:1XQ7^E=L2!IG7#@Z=TPX2H<\*&J7/"AJESPH:I<\*&J7/"
MAJESPH:I<\*&J7/"AJESPH:I<\*&J7/"AJESPH:I<\*&J7/"AJESPH:I_[0D
M)>S*%B/-Y1,LN?8;1J?Z)EN8[C5LC.5$>H3>4X. V6**?-5LCWC2<9-UT'65
M<\]XEW'.>IAPS7R9;\U^FF[,@)MMS(*<;,N$G&S+A)QLRX2<;,N$G&S+A)QL
MRX2<;,N$G&S+A)QLRX2<;,N$G&S+A)QLRX2<;,N$G&S+A)QLRX2<]<$5&='?
M#!B\\Q,QJO\>1YK\+%F.\CQGA.I+<GWE6'IYX&. =-YJA'#;;X=MVG.):]EV
MBFK8>(MIUWJ,:-9\C6?6?HYFU8".9=6!CV75@8]EU8&/9=6!CV75@8]EU8&/
M9=6!CV75@8]EU8&/9=6!CV75@8]EU8&/9=6!CV75@8]EU8&/TM(*";_H#1VM
M_Q4SG?\C19#_,U2%]T-??O%1:'?L7&]PZ6)T:^=G=VCE;7EFY'![9>-S?6/B
M=GUBX7A^8N%Y?V'A>W]@X'V 7^!_@5_@?X%?X'^!7^!_@5_@?X%?X'^!7^!_
M@5_@?X%?X'^!7^!_@5_@?X%?X'^!7^!_@5_@?X%?X'^!_Z Y(?^<1C;_FE%*
M_YU26?>?5&GMH%=XXY]<A]J<9Y72F7"AS)9[J\:4A+/$DXNVPH^/NL"+DKR^
MAY6_O8.8P;R!F\.[?J#$NGRFQK=ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5Z
MK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&_Z Y(?^<1C;_FE%*_YU2
M6?>?5&GMH%=XXY]<A]J<9Y72F7"AS)9[J\:4A+/$DXNVPH^/NL"+DKR^AY6_
MO8.8P;R!F\.[?J#$NGRFQK=ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U
M>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&_Z Y(?^<1C;_FE%*_YU26?>?
M5&GMH%=XXY]<A]J<9Y72F7"AS)9[J\:4A+/$DXNVPH^/NL"+DKR^AY6_O8.8
MP;R!F\.[?J#$NGRFQK=ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&
MM7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&_Z Y(?^<1C;_FE%*_YU26?>?5&GM
MH%=XXY]<A]J<9Y72F7"AS)9[J\:4A+/$DXNVPH^/NL"+DKR^AY6_O8.8P;R!
MF\.[?J#$NGRFQK=ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JL
MQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&_Z Y(?^<1C;_FE%*_YU26?>?5&GMH%=X
MXY]<A]J<9Y72F7"AS)9[J\:4A+/$DXNVPH^/NL"+DKR^AY6_O8.8P;R!F\.[
M?J#$NGRFQK=ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5Z
MK,:U>JS&M7JLQK5ZK,:U>JS&_Z Y(?^<1C;_FE%*_YU26?>?5&GMH%=XXY]<
MA]J<9Y72F7"AS)9[J\:4A+/$DXNVPH^/NL"+DKR^AY6_O8.8P;R!F\.[?J#$
MNGRFQK=ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U
M>JS&M7JLQK5ZK,:U>JS&_Z Y(?^<1C;_FE%*_YU26?>?5&GMH%=XXY]<A]J<
M9Y72F7"AS)9[J\:4A+/$DXNVPH^/NL"+DKR^AY6_O8.8P;R!F\.[?J#$NGRF
MQK=ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&
MM7JLQK5ZK,:U>JS&_Z Y(?^<1C;_FE%*_YU26?>?5&GMH%=XXY]<A]J<9Y72
MF7"AS)9[J\:4A+/$DXNVPH^/NL"+DKR^AY6_O8.8P;R!F\.[?J#$NGRFQK=Z
MK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JL
MQK5ZK,:U>JS&_Z Y(?^<1C;_FE%*_YU26?>?5&GMH%=XXY]<A]J<9Y72F7"A
MS)9[J\:4A+/$DXNVPH^/NL"+DKR^AY6_O8.8P;R!F\.[?J#$NGRFQK=ZK,:U
M>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5Z
MK,:U>JS&_Z Y(?^<1C;_FE%*_YU26?>?5&GMH%=XXY]<A]J<9Y72F7"AS)9[
MJ\:4A+/$DXNVPH^/NL"+DKR^AY6_O8.8P;R!F\.[?J#$NGRFQK=ZK,:U>JS&
MM7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U
M>JS&_Z Y(?^=1C;_FE!*_YY16?>@4FCMH59XY*%:AMN>9)32FVZ@S)AXJL:5
M@;+$E8FVP9&.NK^,D+V]B)/ O(27P[J!F\6Y?J#'N'RGR+)[JLBP>ZK(L'NJ
MR+![JLBP>ZK(L'NJR+![JLBP>ZK(L'NJR+![JLBP>ZK(L'NJR+![JLBP>ZK(
M_Z X(O^=1C?_FT]*_Y]/6?BB4&CNHU-WY:17A=RB8)/3GFJ?S9MTJ<>8?;'$
MEX:VP92,NK^/CKZ\BI+"NH:5Q;B"FLBW?Z#+M'RGS*Q\J<JJ?:G*JGVIRJI]
MJ<JJ?:G*JGVIRJI]J<JJ?:G*JGVIRJI]J<JJ?:G*JGVIRJI]J<JJ?:G*_Z X
M(O^=13?_G$Y*_Z!.6/BC3V?OI5%VY:95A-VE79'4HF:=S9]PJ,B<>K#$FH*V
MP9B*NKZ2C+^[C8_$N(B3R+:#F<RT@*'/K'VESZ9^I\RD?ZC+I'^HRZ1_J,ND
M?ZC+I'^HRZ1_J,ND?ZC+I'^HRZ1_J,ND?ZC+I'^HRZ1_J,ND?ZC+_Z$X(O^=
M13?_G4U)_Z%,6/FE36;OIT]UYJE3@]ZH6I#5IF*<SZ-LILF@=J[%GG^UP9R'
MNKZ7BL"ZD(W&MHN2R[2(FLZRAJ31IH"DT:"!I\V?@:?,GX&GS)^!I\R?@:?,
MGX&GS)^!I\R?@:?,GX&GS)^!I\R?@:?,GX&GS)^!I\R?@:?,_Z$X(O^>13?_
MGDQ)_Z)+5_FF3&;PJ4YTYZM1@M^K5X[7JE^:T*AII,NE<ZS&HWRSPJ"$N;Z<
MB,"YEHS&M9&2RZ^-F,^JBJ'2H(2CTYN$ILZ:A*?-FH2GS9J$I\V:A*?-FH2G
MS9J$I\V:A*?-FH2GS9J$I\V:A*?-FH2GS9J$I\V:A*?-_Z$X(O^>13?_GDM)
M_Z-*5_JG2V7PJTQSZ*U/@."O5(W9KER8TJUFH<VK<*G(JGFPPZ>!M[ZAA,"U
MFXG&KI6/S*B1E<^BCI[2FHFBTY:'I<^5AZ;.E8>FSI6'ILZ5AZ;.E8>FSI6'
MILZ5AZ;.E8>FSI6'ILZ5AZ;.E8>FSI6'ILZ5AZ;._Z$W(O^>1#?_GTI)_Z1)
M5OJH263QK$MRZ;!-?^&S48O:LUJ5U+-CGL^S;J7+LWBKPZQ\M[BE@;^OGH;&
MJ)F,RZ&5DM";DIO3E8ZBU)&,I="1BZ;.D8NFSI&+ILZ1BZ;.D8NFSI&+ILZ1
MBZ;.D8NFSI&+ILZ1BZ;.D8NFSI&+ILZ1BZ;._Z$W(O^>1#?_H$E(_Z5(5ONJ
M2&3RKDEQZK),?>*V3XG<N%>2UKIAFM.];:#)N'6KOK!ZMK.I?[^JHH3&HIV*
MRYN:D,^5EYG2D)6BU(V0I=",D*;/C)"FSXR0IL^,D*;/C)"FSXR0IL^,D*;/
MC)"FSXR0IL^,D*;/C)"FSXR0IL^,D*;/_Z$W(O^>1#?_H$E(_Z9'5?NK1V/S
ML$APZ[5*?.2Z3H;>OU6/VL-@E=+$;9S%NW.JN;-XMJZM?;^EIX+%G:*(RY:?
MCL^/G);2BYRBTXB5I-")E*7/B92ESXF4I<^)E*7/B92ESXF4I<^)E*7/B92E
MSXF4I<^)E*7/B92ESXF4I<^)E*7/_Z(W(O^?1#?_H4A(_Z=&5?RL16+TLD9N
M[+A(>N:_3(/AQU.*W,UBCL[(;)O OW&JM+=WM:FQ?+Z?K('%EZ>&RI"DC,Z*
MHI71AJ*ATH2;I="%FJ7/A9JESX6:I<^%FJ7/A9JESX6:I<^%FJ7/A9JESX6:
MI<^%FJ7/A9JESX6:I<^%FJ7/_Z(V(O^?0S?_HD9'_ZA$5/VN0V'UM41L[KQ&
M=^G$2W_CSU2$V=1EB,C+:YJZPG"IKKIWM*.T?+V:KX'#DJR%R(NIBLR$IY+/
M@*:<T("CI<^ H:;.@*&FSH"AILZ H:;.@*&FSH"AILZ H:;.@*&FSH"AILZ
MH:;.@*&FSH"AILZ H:;._Z(V(O^?0S?_HT5'_ZI"4_ZQ05_VN$%J\<%$<^K,
M2WG@VE9\S]5>C<#,:9NSPW*HI[MYLYZU?[N7L8/"CJV%QH>KB,J!J8W-?*B6
MSGNHHLU[J:;->ZFFS7NIILU[J:;->ZFFS7NIILU[J:;->ZFFS7NIILU[J:;-
M>ZFFS7NIILU[J:;-_Z,V(O^?0S?_I4-&_ZQ 4O^T/EWYO3]F[LA#;>/636_5
MW4Z!Q--9D;7)9I^IP7&KH+MYLYFV@+J4LH7 C*^&Q(:MB,> JXS)?*J2RGJK
MG,IYJY_*>:N?RGFKG\IYJY_*>:N?RGFKG\IYJY_*>:N?RGFKG\IYJY_*>:N?
MRGFKG\IYJY_*_Z,U(O^@0C?_ID%%_Z\]4/ZX.UGSQ#QAYM%#9-G?0W/(W$J%
MM]!7E:K'9:*@P'"LF;IYM)2V@+J1LX6^B[&&P86PB,.!KHO%?:V0QGJME\9Z
MK9K&>JV:QGJMFL9ZK9K&>JV:QGJMFL9ZK9K&>JV:QGJMFL9ZK9K&>JV:QGJM
MFL9ZK9K&_Z0T(O^A03?_J3U#_[,Y3?F^-U7JS#I9V]T[8LOE/W>[V4B)J\Y7
MF*#&9:28P'&LD[MZLY"X@;B,M82[B+.&OH6RB<"!L8O!?K"/PGNPE,-ZL);#
M>K"6PWJPEL-ZL);#>K"6PWJPEL-ZL);#>K"6PWJPEL-ZL);#>K"6PWJPEL-Z
ML);#_Z0T(O^C/C;_K3E!_[@T2/#&,TW?V390S>4V9[[D.WNMUTB,H,U8F9?&
M9Z22P7*KCKU[L(RZ@;2(N(.WA+>%N8*UB+M_M(J]?+.-OGJSD;]ZLY._>K.3
MOWJSD[]ZLY._>K.3OWJSD[]ZLY._>K.3OWJSD[]ZLY._>K.3OWJSD[]ZLY._
M_Z8R(O^F.C3_LC,]]\ N0N32+T'/Y"Y5O^\S:Z_A.WZ@UDJ-ELY;F9#(::&,
MPW.HB<![K(:^?Z^"O(&R@+N$LWVZAK5[N8BV>;B+MW>WC[AWMY"Y=[>0N7>W
MD+EWMY"Y=[>0N7>WD+EWMY"Y=[>0N7>WD+EWMY"Y=[>0N7>WD+EWMY"Y_Z<Q
M(O^L,S'_N2LVZLPF-M+A)D'![RQ:L.TS;J'A/7^5UTV,C=!>EHG+:YV&QW2B
M@\1ZIG_#?:E\P8"K>L""K'F_A*UWOH:O=;Z)L'.]C+%SO8VQ<[V-L7.]C;%S
MO8VQ<[V-L7.]C;%SO8VQ<[V-L7.]C;%SO8VQ<[V-L7.]C;%SO8VQ_ZDN(?^S
M*BORQ2(LUMX<+</M(T>R^2M=HNPV;Y7B0GV+VE*(A=1@D(+0;)9^S'.;>\IW
MGGC)>Z!VR'ZB=,> HW/&@J1QQ82E<,2'IF[$BJ=NPXNG;L.+IV[#BZ=NPXNG
M;L.+IV[#BZ=NPXNG;L.+IV[#BZ=NPXNG;L.+IV[#BZ=NPXNG_ZPJ(/J]'R+<
MV1(;Q>L:,[3Z(TJC^2Y>E>X\;8KE27F#WU:"?MIDB7K6;(YVTW&1<])UE''0
M>95OSWN7;<Y^F&S.@)EKS8*::LV$FVG,AYQHS(B<:,R(G&C,B)QHS(B<:,R(
MG&C,B)QHS(B<:,R(G&C,B)QHS(B<:,R(G&C,B)QHS(B<_[8>&.30#A/(Z1$@
MM?D;-Z7_)DN7^C1<B_%":(+J3W)\Y5MZ=^%D?W+>:H-NW'"&;-MTB&K9=XEH
MV7F+9]A\BV;7?HQEUH"-9-:"CF/5A8]BU86/8M6%CV+5A8]BU86/8M6%CV+5
MA8]BU86/8M6%CV+5A8]BU86/8M6%CV+5A8]BU86/Z<<-#,K:"P^W]Q(DI_\=
M.9C_*TF,_CI7@_9)87SP56EU[%YO;NEC=&KG:7=GY6YY9>1R>V/C=7QBXG=]
M8>)Y?F#A>W]?X7U_7^!_@%[@@H%=WX.!7=^#@5W?@X%=WX.!7=^#@5W?@X%=
MWX.!7=^#@5W?@X%=WX.!7=^#@5W?@X%=WX.!R] ) [KB"Q.H_Q0FFO\A-XW_
M,46$_T!0?/Q.6'3X5U]M]%UD9_)B9V/P:&IA[FQL7^UP;5WM<F]<['5O6^QW
M<%KK>7%:ZWIQ6>I\<ECJ?W)8ZG]S6.I_<UCJ?W-8ZG]S6.I_<UCJ?W-8ZG]S
M6.I_<UCJ?W-8ZG]S6.I_<UCJ?W-8ZG]S_YPX&O^:1BW_EU%!_YI33_Z<55[U
MG%IL[)M?>N299X?<EG&2U9-[G,^0A*3+CHRKR(J0L,6'E+3#A)BWPH&;N<%_
MGKK!?:*[P'NFO,!YJ[V_>+*]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBS
MO;MXL[V[>+.]NWBSO;MXL[V[>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[UG%IL
M[)M?>N299X?<EG&2U9-[G,^0A*3+CHRKR(J0L,6'E+3#A)BWPH&;N<%_GKK!
M?:*[P'NFO,!YJ[V_>+*]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MX
ML[V[>+.]NWBSO;MXL[V[>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[UG%IL[)M?
M>N299X?<EG&2U9-[G,^0A*3+CHRKR(J0L,6'E+3#A)BWPH&;N<%_GKK!?:*[
MP'NFO,!YJ[V_>+*]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[
M>+.]NWBSO;MXL[V[>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[UG%IL[)M?>N29
M9X?<EG&2U9-[G,^0A*3+CHRKR(J0L,6'E+3#A)BWPH&;N<%_GKK!?:*[P'NF
MO,!YJ[V_>+*]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]
MNWBSO;MXL[V[>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[UG%IL[)M?>N299X?<
MEG&2U9-[G,^0A*3+CHRKR(J0L,6'E+3#A)BWPH&;N<%_GKK!?:*[P'NFO,!Y
MJ[V_>+*]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBS
MO;MXL[V[>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[UG%IL[)M?>N299X?<EG&2
MU9-[G,^0A*3+CHRKR(J0L,6'E+3#A)BWPH&;N<%_GKK!?:*[P'NFO,!YJ[V_
M>+*]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MX
ML[V[>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[UG%IL[)M?>N299X?<EG&2U9-[
MG,^0A*3+CHRKR(J0L,6'E+3#A)BWPH&;N<%_GKK!?:*[P'NFO,!YJ[V_>+*]
MNWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[
M>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[UG%IL[)M?>N299X?<EG&2U9-[G,^0
MA*3+CHRKR(J0L,6'E+3#A)BWPH&;N<%_GKK!?:*[P'NFO,!YJ[V_>+*]NWBS
MO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]
M_YTX&O^:12[_EU!!_YM13_^=5%WUGEAK[)U=>>2;9(;<F&Z2U95XG-"2@:3+
MCXFKQXV/L<6)D[7#A9>XPH*:NL%_GKO ?:*]OWNGOK]YK;Z[>+&^MGFROK9Y
MLKZV>;*^MGFROK9YLKZV>;*^MGFROK9YLKZV>;*^MGFROK9YLKZV>;*^_YTX
M&O^:12[_F$] _YU03O^?4ESVH%5J[:!:>.6?8(7=G&J1UIASF]"5?:3+DH6K
MQX^-L<2,D;;"AY6YP8.9N[]_G;Z^?:*_O7JHP+QYK\&T>;#!L'JPP+!ZL,"P
M>K# L'JPP+!ZL,"P>K# L'JPP+!ZL,"P>K# L'JPP+!ZL,"P>K# _YTW&O^;
M12[_F4Y _YY.3O^A4%OWHE-I[J-7=^:B78/>GV:/UYQOFM&8>:/+E8*KQY*)
ML<2.C[;"B9.ZOX28O;V G<"\?:/"NWNJQ+1ZK<2M>Z[#JGNOP:I[K\&J>Z_!
MJGNOP:I[K\&J>Z_!JGNOP:I[K\&J>Z_!JGNOP:I[K\&J>Z_!_YXW&O^;1"[_
MFDU _Y]-3?^B3EOWI%%H[Z55=>>E6H+?HV*-V*!KF-*<=:',F7ZIR)6&L,22
MC;;!C)&[OH:6O[R!G,.Z?J3%MWRKQZU[J\:G?*W$I'VNPZ1]KL.D?:[#I'VN
MPZ1]KL.D?:[#I'VNPZ1]KL.D?:[#I'VNPZ1]KL.D?:[#_YXW&O^;1"[_FTQ
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MA(;@@(N-W'R1DMIYEY;8=IR9U7.@F]1QI9W3;ZF?TFZNH-)MLZ'1;+FBT6O
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M#O^4/1[_G4 I_Z0^,O^K/SO_L4)"^+A'2>V^3D_EQE=3VL9>7\N^9'&^MFJ
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M=LR:FG?-F9EWS9B9=\V8F7?-F)EWS9B9=\V8F7?-F)EWS9B9=\V8_WXB!O^
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MD7Z%IHR&C*"(C9&:A966EH*>FI* IYV/?[*>C8#!GHR R9Z+@,J=BH#+FXJ
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M6$#\J5A _*E80/RI6$#\J5A _*E80/RI6$#\J5A _*E8QK@$ +;$! "JTP4
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M?<ICX'[#9.!_O6;?@+=GWX"W9]^ MV??@+=GWX"W9]^ MV??@+=GWX"W9]^
M_V\A!/]O, O_?C82_XD\&_^01"3_DTPM_Y-2-O^264#_CF!)^8AF4O2";EKO
M?'EAZW>#:.=RC&[D;95SX&J==]UGIGK:9:Y\UF.X?M-BPX#18M.!RF3?@<%E
MWH*[9]V"M6C=@[!IW8.P:=V#L&G=@[!IW8.P:=V#L&G=@[!IW8.P:=V#_W A
M!/]R+PO_@302_XP[&O^30R+_ETLK_Y=1-/^65SWZDUU&\XYD3^Z(:UCH@G5@
MXWQ_:-YWB6[9<I%TTVZ9>=!KH7W,:*F R6:R@L=EO8/%9<N$P6;<A+EHVX6S
M:=N%KFO;A:ELVX6I;-N%J6S;A:ELVX6I;-N%J6S;A:ELVX6I;-N%_W$A!/]T
M+@K_A#,1_X\Z&?^60R'_FDDI_YI.,OR:5#OUF%M$[I1B3>>/:57AB7->VX)\
M9M-\A6_-=XUUR7*5>L5OG7_!;*6"OFJMA;MIN(>Y:<2(MVG8B+!KV8BK;-F(
MIVW9B*-OVH>C;]J'HV_:AZ-OVH>C;]J'HV_:AZ-OVH>C;]J'_W$@!/]V+ K_
MAC(1_Y(Z&/^90B#_G$<G_YY,+_B>4CCPG5A Z9I?2>*59U+:CW!<T8=X9LJ!
M@6_%?(EVP'>0?+MTF("W<:"$M&^IA[%MLXFN;+^*K&S/BZANUXND;]B*H'#8
MBIUQV8F=<=F)G7'9B9UQV8F=<=F)G7'9B9UQV8F=<=F)_W(@!/]X*PK_B# 0
M_Y0Y%_^;01[_GT4E_:%*+?2B4#3LHE8\Y*!<1=R;94_2DVU<RHQU9L.&?6^]
M@85VMWR-?;-XE(&N=9R&JW.EB:=QKHNE<+J-HW#)C:!QU8V<<]:,FG36BY=T
MV(J7=-B*EW38BI=TV(J7=-B*EW38BI=TV(J7=-B*_W,@!/]Z*@G_BR\/_Y8Y
M%O^=/QS_H4,C^J1(*O&F3C'HIU0XX:=<0-6?8D[+F&M;PY%R9KR+>F^VA8)W
ML(&)?:M]D8*F>9F&HG>ABI]UJXV<=+:.FG3%CYAUU(Z5=M6-DW?5C9)WUHN2
M=]:+DG?6BY)WUHN2=]:+DG?6BY)WUHN2=]:+_W,@!/]\*0G_C2\/_Y@X%?^?
M/1O_I$$A]ZA&)^VK3"WEK5(SW*I9/]"C84W&G&E:OI5P9;:/=V^OBG]VJ86&
M?:2!CH*??I:'FWN>BY=YJ(Z4>+./DGC!D)!YTY"/>M2/CGK5C8Q[UHR,>]:,
MC'O6C(Q[UHR,>]:,C'O6C(Q[UHR,>]:,_W0?!/]^* G_CBX._YLX%/^A/!G_
MIS\?]*M$).JO2BGBLU$NUJY7/LNG7TW!H&=:N9EN9;&3=6ZJCGQVHXJ#?9Z&
MBX*9@Y.'E(";BY!^I8Z-?;"0BGV]D8E^T)&(?M./B'[4CH=^U8V'?M6-AW[5
MC8=^U8V'?M6-AW[5C8=^U8V'?M6-_W0?!/^ )PC_D"X._YTW$_^C.AC\J3T<
M\:]"(.>T2"3?MTXLT;%5/<>J7DR]HV59M)UL9*N7<VZDDWIVGHZ!?)B+B(*2
MAY"'CH69BXF#HHZ&@JV0@X*[D8*"S)&"@M.0@H+4CX*!U8V"@=6-@H'5C8*!
MU8V"@=6-@H'5C8*!U8V"@=6-_W4?!/^")@C_DBT-_Y\V$O^E.!;YK#L:[K,_
M'>6Y1A_:NTLKS;14/,*N7$NXIV-8KZ%J8Z:<<6V?EW=UF)-^?)*0AH*,C8Z'
MAXJ6BX.(H(Y_AZN0?8>XD7N'R9%\A].0?(;4CWV%U8U]A=6-?875C7V%U8U]
MA=6-?875C7V%U8U]A=6-_W4?!/^$)0C_E"T,_Z U$/^H-A3VKS@7Z[<]&.*_
M11G5ODDJR+A3.[VQ6TJSJV)7JJ9H8J&A;VR9G'5TDIA\>XR5@X&&DHN&@9"4
MBWR.GHYYC:B0=HRUD72-QI%UC=.0=HO4CWB)U8UXB=6->(G5C7B)U8UXB=6-
M>(G5C7B)U8UXB=6-_W8> _^&) ?_ERP+_Z(R#_^K,Q'RLS43Z+PZ$][%/Q?0
MP4@IQ+M1.;FU64BNL&!5I:IG89RF;6N4HG1SC9YZ>H:;@8" F(F%>Y:2B7:4
MFXURDZ:/;Y.SD&Z3PY!ND]./<)'4CG*.U8URCM6-<H[5C7*.U8URCM6-<H[5
MC7*.U8URCM6-_W<> _^)(@?_F2P*_Z4P#?RN+P[ON#$.Y,,W#=G*.Q;+Q48G
MO[]0.+.Z6$>IM5]4G[!E7Y:L:VF.J')QAJ5X>("B?WYZGX>#=)V/B&^;F8ML
MFJ2-:9JPCF>;P(YGF]6.:9C5C6R4UHQLE-:,;)36C&R4UHQLE-:,;)36C&R4
MUHQLE-:,_W@> _^,(0;_G2L(_Z@L"OBS*@OJORL)X,PR!M'..17%R44EN<1.
M-JZ_5D6CNUU2F;9C79"R:6>'KW!O@*QV=GFI?7QSIX2!;J6-A6FDEXAEHZ**
M8Z.NC&&COHQ@I-*+8Z#7BV6<V(IEG-B*99S8BF6<V(IEG-B*99S8BF6<V(IE
MG-B*_WH= _^/( 7_H"D'_ZPG!_*X) ;EQR0$V=4G!<O3-Q._SD,CL\I,-*?%
M5$*<P5M/DKUB6HFZ:&2!MVYL>;1T<G.R>WAML(-]:*^+@6.NE81?K:"&7:VM
MAUNMO(=:KM"'7*K:AU^EVH=?I=J'7Z7:AU^EVH=?I=J'7Z7:AU^EVH=?I=J'
M_WX: _^4'P3_I28%_;$@!.S!&@/?TQ<!T-PE!,39-1"XU4$AK-!+,:#,4C^5
MR5E,B\5@5X+#9F!ZP&QG<[YS;6R\>G-GNX)W8KJ*>UZYE'Y:N)^ 6+BL@5:Y
MNX%5NL^!5K;>@EBPW8)8K]V"6*_=@EBOW8)8K]V"6*_=@EBOW8)8K]V"_X07
M O^9' +_JA\#];D5 M[-# #0WQ( Q> F!;O?-@ZPW4 =I-E)+9C543N-T5A(
M@\]>4GO,95ISRVMA;,ER9V;(>6QAQX%P7<:*=%G&E'96Q9]X4\:L>5+&NWI1
MQ\]Y4<3C>E.\XGQ3O.)\4[SB?%.\XGQ3O.)\4[SB?%.\XGQ3O.)\_XH4 ?^?
M& '_L!0!V,,* ,[1"@#$Y10!N>0F"*[D-!.DXC\@F>!'+8_>3SF%W%9$>]I=
M3'/99%1LUVM:9M9R7V'5>61<U()G6-2+:E74E6U2U*!N4-2M;T[5O'!-UM!O
M3=7H<$[,Z7).S.ER3LSI<D[,Z7).S.ER3LSI<D[,Z7).S.ER_Y(1 ?^G$0#8
MN0D R\8( ,+5"@"WZA8#K.HG#*+I-!B8Z#XDC>=',(/F3CIZY51#<>1:2FGD
M85!DXVA57^-P65KC>%Q6XX!?4^.)8E#CDV1-Y)UE2^2I9TKEMF=)Y<9G2.;?
M9TK@[&=*W^QG2M_L9TK?[&=*W^QG2M_L9TK?[&=*W^QG_YP- -NQ!@#*O0<
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ML4<CRZM2,L&E6D"XGV),L)EI5ZB4<&"ACW=GFXM^;I:(AG.1A8YXC(*6?(B
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M=%2PYW56K.=U5JSG=5:LYW56K.=U5JSG=5:LYW56K.=U_X,2 ?^6$0#_J!$
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M<F62ZG%GC^IP9X[J<&>.ZG!GCNIP9X[J<&>.ZG!GCNIP_W,5 O^%$P'_E!0
M_*,5 .JP$@#9O@P S<$; <+ +0>XO3H3KKE&(:2U3RV:L58YDJY>0XJK9$R#
MJ&I3?*5Q67:C>%]QH7]C;)^':&B>D6MDG9QN8)RH<%Z<MG%=G,EQ79SD<%Z:
MZW!@ENMO897L;V&5[&]AE>QO897L;V&5[&]AE>QO_W<2 ?^)$0'_F1$ \Z@.
M ->U"@#/P0H QL48 +S$*@6RPC@1I[]$'IZ[32N4N%4VB[5<0(2R8DE\KVE0
M=JUO5G"K=EMKJGU@9JB&9&*GCV=>IIIJ6Z6F;%BEM6U7IL=M5Z;B;%>D[6Q:
MG^UL6I[M;%J>[6Q:GNUL6I[M;%J>[6Q:GNUL_WP0 ?^.$ #VG@T V*T) ,VX
M"0#'Q @ OLH4 +7*)P2KR#8/H<5!&Y?"2RB-OU,SA;U:/'VZ845VN&=+<+=M
M46JU=%9EM'Q;8+*$7URQCF)8L9EE5;"E9E.PLV=2L<9G4K'A9U&O\6A3JO!H
M5*GP:%2I\&A4J?!H5*GP:%2I\&A4J?!H_X(. /^4# #;I08 SK$' ,6[!P"]
MQP< M= 0 *S0(P.CSS,,F<T_&(_*2"2&R%$N?<98.';$7S]OPF9&:<%L2V3
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M3$;:[4Q$V/E/0]C[3T/8^T]#V/M/0]C[3T/8^T]#V/M/VYH  ,JI @"[LP(
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M)0/_920$_VXJ!O]V- O_>CT1_WI&&/]X3R#[=%@H]F]A+_%K;#;M9W8\Z6.
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M6D^K[EM/JOI;4:;Z6U&F^EM1IOI;4:;Z6U&F^EM1IOI;_X ) .&2 0#1H 0
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M.#WB^S@]XOLX/>+[.#WB^S@]XOLXQJ$  +>K  "JM   GKX  )/) @"(U 8
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M2(@L_T:2+O]%FS#_1*(R_T.I,_]"L#3_0K<U_T&_-O]!R3;_0-<W_T#E-_U
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M65^,[EE?C/M888K]5V&)_5=AB?U788G]5V&)_5=AB?U7_V\, /]_"0#?C0,
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M2DBP_TI(L/]*2+#_2DBP_TI(L/]*XH8  ,Z4  #"H0  MJD  *NQ  "AN@$
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M4&YW[T]N=_Q.;G?_36]W_TQO=_],;W?_3&]W_TQO=_],_V0- /]R"@#P?@8
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M2EB._TE8CO])6([_25B._TE8CO])_W$! ."   #/C   Q)8" +N> @"RI
MJ:H% **L%0";K"8"E*LT!XRJ/P^%J$@7?J90'GBD6"5SHEXK;J%E,&J?;#1E
MGG,Y89U[/%Z;A$!:FHY#5YF:1529IT=2F;9(49G*2%&8YDA1E_5(49?_1U&6
M_T=1EO]'49;_1U&6_T=1EO]']G<  -B%  #)D0  OYL! +2B  "KJ   H;
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M-T"W_S= M_\WSHL  +^8  "RH0  IZD  )RP  "1N   AL " 'O(!P!TRQ(
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MCPXK]9T/*O:K$"GVO! H]LX1)_?F$2?U\1$G]?$1)_7Q$2?U\1$G]?$1HZ@
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M1'QG[T-\9_Q!?&C_0'QH_T!\:/\_?&C_/WQH_S]\:/\__UL, /]G"0#W<0<
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M:W/_0FQS_T%L<_] ;'/_0&QS_T!L<_] _V$% /IN 0#=>0  T((" ,>)! #
MC@0 N9$, +&2&P"IDBL#HI X")N-0P^4BDP7CHA4'8F%6R.$@V(H@(%I+7Q_
M<#%X?G<U=7Q_.'%[B#QN>I(_:WF=06AXJD-F>+A$97C,165XYT1E>/=#9GC_
M0F9X_T%F>/] 9GC_0&9X_T!F>/] _V0# .YQ  #8?   RX4" ,., P"[D0,
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M/$^1_SQ/D?\\Y'0  ,^!  #"C   N)8  *V<  "CH0  F*@  )"J#0"+JQL
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MG!\\PZL@.\.\(3K#U2$[PNXA.<#Y(CB__R0XO_\D.+__)#B__R0XO_\DO9$
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M""3QN @C\<P((O+E""+P\P@B[_4((N_U""+O]0@B[_4(GJ8  )&O  "$N
M=\$  &K)  !=T   4=<  $;=   _Z@4 //8. #GV%P V]R  ,_<H #'X,  N
M^38!*_D] 2GZ1 $G^DH")?M2 B/[6@(@_&,#'OQN QS]>P,;_HD$&?Z8!!C_
MJ 07_[<$%O_(!!;_X 06_^0$%O_D!!;_Y 06_^0$DZX  (6W  !XP   :LD
M %W2  !0V0  1-\  #KD   U]P, ,O\, "[_$@ K_QH */\A ";_)P C_RT
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M-(Y7\#2-5_TSC%C_,XQ8_S*,6/\QC%C_,8Q8_S&,6/\Q_U$, /];"0#_8P@
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M-W)H_S9R:/\U<FC_-7)H_S5R:/\U_UD" /9E  #=;@  SW8! ,=[ P# ?P0
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M-5YX_S5>>/\U]60  -QP  #*>@  P(,  +:)  "NC0  I(\  )V1$ "7DB
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MFRQ(FJDM1YFZ+4::T"U&F.LM1I?Y+D:6_RY&EO\N1I;_+D:6_RY&EO\NT7<
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M&#:]RA@WO.<7-;OV&36Z_QHTN?\;-+G_&S2Y_QLTN?\;N(\  *J8  "?GP
MDZ8  (>L  ![LP  ;[D  &.^  !8Q 0 4,@, $W(%P!,R24 2LHQ $?*.P%%
MRD0"0\I, T'*5 0^REP&/,ID!SK+;@DXRW@*-LN%##3+D@TRRZ(.,<NR#S#,
MQP\PR^4.+\GU#R[(_1$NQ_\2+L?_$B['_Q(NQ_\2KI<  *&>  "5I0  B:T
M 'RT  !PNP  9,$  %G&  !.RP, 1= ( #[5#@ ]U1H /-8F #O7,0 YV#L
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M A#[W0(0^^D"$/OI A#[Z0(0^^D"CZL  (&T  !SO0  9L8  %G-  !+TP
M0-D  #7>   LXP  )O$  "3^"@ A_Q  '_\6 !S_'  9_R( %_\H !7_+@ 3
M_S4 $O\\ !#_0P ._TP #?]6  O_8@ )_V\ "/]_ 0?_D $%_Z !!/^N 03_
MO $#_\<! __' 0/_QP$#_\<!@[0  '6]  !GQ@  6L\  $O5   _W   ,^$
M "GE   A[   'OT  !K_!0 7_PP %?\0 !+_%  0_QD #O\>  W_(P +_R@
M"/\N  ;_-0 #_ST  /]&  #_40  _UT  /]K  #_>P  _XL  /^9  #_I0
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M(*=&\R&E1O\AHT;_(J)&_R&B1O\AHD;_(:)&_R&B1O\A_T4. /]+"@#_4PP
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M*H!8_RJ 6/\I@%C_*8!8_RF 6/\I_T\" /U9  #B8   U6<  ,QJ P#&; 4
MP&P. +=M'0"P;BP!JFPY!*5J1 B@:$X-FV97$9=D7A648F49D6!L'(Y?<QZ+
M7GLAB5V")(9<BR:$6Y0H@5N>*G]:JBQ]6K<M?%K)+GI:XRYZ6_4M>ES_+'E<
M_RMZ7/\J>ES_*GI<_RIZ7/\J_U$  /);  #>9   SVH  ,=N @# < 0 NG ,
M +)Q&@"K<2D!I7 W Y]N0@>:;$L,EFI4$9)H7!6.9F,8BV5I&XAC<!Z%8G@A
M@F%_)(!@B"9]7Y$I>U^<*WA>IRUV7K4N=5[&+W1>X2]T7_,N=%__+'1@_RMT
M8/\K=&#_*W1@_RMT8/\K_U,  .A>  #99P  RVT  ,-Q 0"[<P( M7,) *UU
M%P"G=2<!H70T YMR/P>5<$D+D6Y2$(QL612):F 8A6EG&X)H;AY_9G4A?65]
M)'IDA29W9(\I=6.:*W)BI2UP8K,O;V+$+VYBWB]N8_(N;F/^+6YC_RQN8_\K
M;F/_*VYC_RMN8_\K_U4  .5@  #3:0  R'   +]T  "W=P$ L'<' *AX%0"B
M>20 G'@R I9V/0:1=$<+C')/#XAP5Q.$;UX7@&UD&GUL:QUZ:W,@=VIZ(W1I
M@R9R:(TI;V>7+&UGHRYK9K$O:6;!,&EFVS!I9_ O:6?]+6EG_RQJ9_\K:F?_
M*VIG_RMJ9_\K_E@  .%C  #/;   Q',  +MX  "S>@  JWH$ *1[$@">?"(
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MG"M6>ZDL5'NY+5-[SBU4>NHM5'KY+%1Y_RM5>?\J57G_*E5Y_RI5>?\JX64
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M(T.4R"-#E.4C0Y+U)$.1_R1#D/\D0Y#_)$.0_R1#D/\DRG4  +N!  "PBP
MI)$  )J5  "/F0  @YT  '2B  !NHPL :J07 &:E)0!CI3$!7Z0[ UND1 58
MI$L(5:-3"U*C6@U/HF$03:)H$TJA<15'H'L81*"&&D*?DQQ GZ(=/I^R'CV?
MQAX]G^,=/9WT'CV<_Q\\F_\?/)O_(#R;_R \F_\@PGP  +6(  "ID   GI8
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M""G"^PDHP?\**,'_"RC!_PLHP?\+J)4  )V;  "1H@  A*D  'BO  !KM0
M7[L  %2_  !)PP  /\@$ #;-"0 SSA$ ,L\< #'/)P PT#$ +] Z "[10P M
MT4P *])5 "K27P$HTVD!)]-V 273A (DU)0"(M2F B'5N0(AU=("(-/K B#2
M]@,?T?\$']'_!!_1_P0?T?\$GYL  )2B  "'J0  >;$  &VX  !@O@  5,,
M $G'   ^RP  -= ! "W5!@ EVPL )-X2 "/>'  BWR4 (> N "#@-P ?X4
M'N%* !WB4P <XUX &^-J !KD>  8Y(@!%^6: 1;FK $5YL !%.?= 1/E[P$3
MX_H!$^/Z 1/C^@$3X_H!EJ(  (FI  ![L0  ;KD  &'   !4Q@  2,H  #W/
M   STP  *MD  "+> @ >ZPH '.P0 !OM%P 9[1\ %^XF !7N+0 4[S4 $_ ]
M !'P1@ 0\5  #_);  [R:0 -\W@ #/2*  OUG  *]:X "?;"  GVV0 (]>T
M"/7M  CU[0 (]>T BZD  'VR  !ON@  8L(  %7)  !'S@  .](  #'8   G
MW0  '^$  !GH   6^ 8 %/H- !+[$@ 0_!< #OP=  W](P ,_2D "OXP  C_
M.  &_T$  _],  #_6   _V8  /]W  #_B0  _YL  /^K  #_NP  _\X  /_/
M  #_SP  _\\ ?[(  '&Z  !CPP  5LL  $C1   ZU@  +]T  "7A   <Y0
M%.D  !'W   /_P$ #?\)  O_#0 (_Q  !O\4  /_&   _QX  /\C  #_*@
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M"L8Q]PS#,?\.P3'_#\ Q_P^_,?\/OS'_$+\Q_Q"_,?\0_S83 /\Y#P#_/A
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M&Y1&_QN31O\;DT?_&Y-'_QN31_\;_T(% /]* 0#R4   X50! -E6!0#350D
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M(758_R%U6/\A_TT  .57  #37P  R&0  +]G  "W:   L6<' *EH% "C:20
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MG"-B9JDE8&:Y)E]FS29?9N@F8&;Y)&!F_R-@9O\C86;_(F%F_R)A9O\BZ%@
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M(U!VQB10=N,C4'7U(U%U_R)1=/\A473_(5%T_R%1=/\AV&,  ,5M  "X=@
MKGT  *6"  ":@P  C8,  (2$ P!]A1  >88> '6'*P%QAS8";88_!&F%1P=E
MA$\*8H-6#5^#7 ]<@F,26H%K%5> <QA4?WT:47^('$]^E!]-?J(@2WVQ(4I]
MQ")*?>$A2WST(4M[_R!+>_\@2WO_($M[_R!+>_\@T&<  ,!R  "T>P  JH(
M *"&  "5B   AX@  'R*  !VC X <HT: &Z.)P!JCC(!9HT\ V.-1 5@C$P(
M7(M3"EJ+6@U7BF$05(EH$E&(<15/B'H73(>%&DJ&DAQ(AJ =1H:O'D6%PAY%
MA=\>183R'D6#_AY%@O\>18+_'D6"_QY%@O\>RFT  +IX  "O@0  I8<  )J+
M  "/C0  @8X  '21  !NDPH :905 &:5(@!CE2X!8)4X ER50019E$D&5I10
M"%235PI1DUX,3I)F#TR2;A%)D7@41I"#%D20D!A"CYX90(^M&C^/P!H_C]P:
M/XWQ&C^,_1L_B_\;/XO_&S^+_QL_B_\;PG,  +5^  "JAP  GXP  )20  "(
MDP  >Y4  &R9  !EFP0 8)P0 %V='0!;GBD 6)XT 56>/0)2G44#4)U-!4V=
M5 =+G%L)2)QC"T:<:PU#FW4/09N $3Z:C1,\FIL4.IJK%3F:O14YFMD5.9CO
M%CF7_!8XEO\7.)7_%SB5_Q<XE?\7NWH  *^%  "DC   F)$  (V5  "!F@
M=9T  &B@  !;I   5J4, %.F%P!1IR, 3Z<O $RG. %*IT$!2*=) D:G4 1#
MIU@%0:=?!C^F: @]IG(*.J9]"SBFB@TVI9D.-*6I#S.ENP\SI=0/,Z3N#S*B
M^Q RH?\1,J'_$3*A_Q$RH?\1M((  *B,  "=D@  DI<  (:<  !YH0  ;:4
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M AC*_P(8RO\"FYD  (^?  ""I@  =:T  &BS  !<N0  4+T  $3!   YQ
M,,@  "C, 0 @T 8 &=4+ !;7$  5V!D %=DB !39*P 3VC0 $]H] !+;2  1
MW%, $=U? !#=;0 0WGX #M^1  [@I  -X+@ #.#2  O?[0 ,WO< #-W[  S=
M^P ,W?L DI\  (6G  !WK@  :K4  %V\  !0P0  1,4  #C)   NS0  )=$
M ![5   6V@$ $=X& !#G#0 .YQ( #>@9  SH(0 +Z2D "NHQ  GJ.P 'ZT4
M!>M1  3K7@ #ZVX  >N   #JE   ZJ<  .N\  #KT@  Z^D  .SO  #L[P
M[.\ AZ<  'FO  !KMP  7KX  %'%  !#R0  -\T  "W1   CU@  &]L  !/?
M   .XP  #.X"  KV"@ ']@X !?82  /V&   ]1X  /4E  #U+@  ]3<  /9"
M  #V3@  ]ET  /9N  #V@0  ]I4  />G  #WMP  ^,<  /C0  #XT   ^-
M>Z\  &VX  !@P   4L@  $3-   WT0  *]<  "'<   8X   $>0   SG   '
M[P  !/H   '_ P  _P@  /\-  #^$   _A0  /\:  #_(0  _RD  /\S  #_
M/@  _TL  /];  #_;   _X   /^2  #_H0  _ZT  /^S  #_LP  _[, _QPF
M /\<) #_&B4 _Q4G /\1+@#_$#H _PY' ?\-4P'_"U\!_PIK ?\*=0'_"G\!
M_PJ' ?\*C@'_"I4!_PJ; ?\)H '_":4 _PFK /\)L0#_";@ _PG! /X)S #\
M"=X ^0GK /4)]@#S"?\ \@K_ /$*_P'Q"_\!\0O_ ?$+_P'Q"_\!_Q\C /\?
M(0#_'B$ _QDD /\7+ #_%3< _Q-$ /\14 '_$%P!_PYG ?\.<@'_#GL!_PZ$
M ?\.BP'_#I(!_PZ8 ?\.G0'_#J,!_@ZH ?P.K@'[#K4 ^@Z^ /@.R0#U#ML
M\@[J .X.]0#L#O\!ZP__ >H/_P'J$/\!Z1#_ >D0_P'I$/\!_R(? /\B' #_
M(1P _Q\@ /\?*0#_'#0 _QI  /\73 '_%5@!_Q1C ?\3;@'_$W<!_A.  ?P3
MB 'Z$HX!^1*5 ?@2F@'V$J !]1*F ?02K 'S$K,!\1*\ ? 2QP'M$M@!Z1/H
M >83]0'D%/\!XA3_ N$5_P+A%?\"X!7_ N 5_P+@%?\"_R4; /\F%P#_)!8
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M"ZXP_PNN,/\+K3#_"ZTP_PNM,/\+_S,, /\V!@#_/ D _SX, /T]$ #O/!4
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M%85'_Q6%1_\5_S\  .Q(  #=3P  SU,  ,95  # 4P, NU$, +-2&0"M4RD
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MG!IN5JD;;%:X'&M6RQUJ5N8<:E?W&VI7_QIJ5_\9:U?_&6M7_QEK5_\9ZTP
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M85ZT'6!>QQU@7N,=8%[U'&!>_QM@7O\:85[_&F%>_QIA7O\:Y%(  ,]<  #
M9   MFD  *QL  "C;   F6D  ))J"P",:A8 AVLD ()K, %^:CH">FE#!'9H
M2P9S9U((<&=9"FUF8 UK968/:&1N$69D=A1D8X 68F.+&&!BEQI>8J0<7&*R
M'5MBQ1U;8N$=6V+T'%MB_QM<8O\:7&+_&EQB_QI<8O\:X%4  ,M?  "]9P
MLFP  *EP  "?;P  E&P  (QM" "&;A, @F\A 'UO+0%Y;S@"=6Y! W)M205N
M;% ':VM7"FEK7@QF:F4.9&EL$6%I=!-?:'X676>)&%MGE1I99J(;5V:P'%9F
MPQU69M\=5F;S'%=F_QM79O\:5V;_&E=F_QI79O\:VUD  ,=B  "Z:@  KW
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M&$=V_!A'=O\81W7_%T=U_Q='=?\7R64  +IO  "N=P  I'T  )A_  "+?P
M?G\  '.!  !L@PD :(03 &6%( !BABP 7X8V 5R&/P)9A48#5X5.!52%50=2
MA%P)3X-C"TV#:PU+@G0/2()_$4:!C!-$@9H50H"I%D& NA9 @-(607_M%D%^
M^Q9!??\607W_%D%]_Q9!??\6PFH  +5U  "J?0  GX(  )*#  "%A   >84
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M"BV;_PHMF_\*KX   *.)  "7C@  C9,  '^5  !RF   9IP  %N@  !/I
M1:<  #ZI#  \JA0 .JH? #FJ*0 XJS( -ZL[ #6K0P TK$L ,JQ3 3&L7 $O
MK&8"+:QQ BNL?P,JK(X#**R>!">LL 0FK,4$)JOD R6I]00EJ/\%):?_!26G
M_P4EI_\%IXD  )N/  "1E   A)D  'B>  !KH@  7Z8  %.J  !(K0  /;
M #2S P OM0X +;46 "RU(  KMBD *K8R "FW.@ HMT, )[=, ":X50 DN%\
M([AK "*X> $@N(@!'[B9 1VYJP$<N< !'+C? 1RV\@$;M?P"&[3_ ANT_P(;
MM/\"GX\  )25  "(FP  >Z$  &ZF  !BJP  5K   $JS   _M@  -;D  "R\
M   DOP8 '\(- !W"%  <PAX &\,F !K#+P 9Q#@ &,1! !?$2@ 6Q54 %<5A
M !3&;P 3QG\ $L:1 !''I  0Q[D #\?4 !#&[@ 0Q/H $,/_ !##_P 0P_\
MEY8  (N<  !^H@  <:D  &2O  !8M   2[@  $"[   UO@  *\$  "/%   ;
MR0$ %,P& !#0"P .T1$ #=$9  W1(0 ,T2H #-$T  O2/@ *TDD "=-5  G3
M8@ (TW( !M2$  74F  $U*L  ]7   '5W  !U>T  =7V  '5]@ !U?8 CIT
M ("D  !SJP  9K$  %FX  !,O0  /\   #3#   JQP  (<H  !G.   2T@
M#=8!  G;!0 &W T !-P1  /=&  !WB   -XH  #?,0  X#P  .%'  #B5
MXV,  .-T  #DB   Y)L  .6N  #EP0  Y=4  .;G  #FYP  YN< @Z0  '6L
M  !HLP  6KL  $W!  ! Q   ,\@  "C,   ?T   %]0  !#9   +W0  !>$
M  #D    Y0<  .8-  #G$0  Z!8  .D=  #J)0  ZRX  .TY  #O10  \%,
M /%D  #Q=@  \HH  /.<  #SK0  ]+L  /3(  #TR   ],@ =ZT  &JU  !<
MO0  3\0  $#)   SS0  )]$  !W6   4W   #N    CC   !Y@   .H   #N
M    [@   .\$  #P"@  \0X  /,2  #T&   ]B   /@J  #Z-0  _4,  /Y2
M  #_8P  _W8  /^)  #_F@  _Z8  /^P  #_L   _[  _Q8C /\5(0#_$2$
M_PTD /\)*P#_!C< _P-$ /\ 40#_ %T _P!H /\ <@#_ 'L _P"# /\ B@#_
M )$ _P"6 /\ G #_ *$ _0"F /L K #Y +, ]P"[ /4 Q0#S -$ \@#D /$
M\0#O /H [@#_ .X _P#M /\ [0#_ .T _P#M /\ _QD@ /\8'0#_%1T _Q ?
M /\.*0#_##0 _PI! /\'30#_!5D _P1D /\$;@#_ W< _P.  /\#AP#_ XT
M_0*3 /L"F0#Y IX ]P*D /4"J@#S ;  \0&X .\!P@#M <\ ZP'C .H![P#H
M OL YP3_ .8%_P#F!O\ Y@;_ .8&_P#F!O\ _QP; /\;&0#_%Q@ _Q4= /\3
M)0#_$3  _Q ] /\.20#_#%4 _PM@ /\+:@#]"W, ^PM\ /D*@P#W"HH ]0J0
M /0*E@#S"IL \0JA .\)IP#M":X ZPFV .@)P #F"<T Y GB .(*\ #?"_L
MW@S_ -P-_P#<#?\ VPW_ =L-_P';#?\!_Q\7 /\>$P#_&Q( _QP9 /\;(@#_
M&"P _Q4X /\31 #^$E  ^1%; /409@#S$&\ \!!W .X0?P#L$(8 ZA", .D0
MD@#H$)@ Y@^> .4/I0#C#ZP X0^T . /O@#>#\P VA#A -41\ #2$OL SQ+_
M <X3_P'-$_\!S1/_ <P3_P',$_\!_R(2 /\B#P#_(0\ _R(4 /\B' #_("<
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M")PQ_PB<,?\(_S   /\U  #O.   XCH  -LY! #6-0D SC03 ,8V(@"_.#$
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MGP]^1*L0?$6Y$7M%RQ%Z1>81>4;W$7A&_Q!X1O\0>$;_#WA&_P]X1O\/\#\
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M%&91PQ5E4MX595+R%&52_Q-E4O\295+_$F52_Q)E4O\2Y$H  ,]3  # 6@
MM5X  *Q@  "B7@  FED  )):"P"-6Q8 B%PC (1<+P" 6SH!?5M# GE:2P-V
M65($=%A8!G%87P=O5V8);5=M"VM6=0UI5GX/9U:)$655E1)C5:$48E6O%6%5
MP19@5=L68%;Q%6!6_A1@5O\385;_$F%6_Q)A5O\2X$T  ,M6  "]70  LF$
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M%5)A^Q128?\34V'_$E-A_Q)38?\2T58  ,!?  "S9@  J6L  )QK  "0:@
MA6<  'UI  !W:@T <VL7 &]K) !L;"\ :6PX 69K00)C:TD#86M0!%YJ5P9<
M:ET'6FEE"5AI;0M5:'8-4VB!#U%GC1%/9YH23F>I%$UGN11,9\\43&;K%$UF
M^Q--9O\23F7_$DYE_Q).9?\2S%H  +QC  "P:@  I6\  )AN  ",;0  @&P
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M#CUW_PX]=_\.O&@  *]R  "D>0  EGH  (AZ  !\>@  <'P  &-_  !<@@
M5X0+ %.%% !1AB  3X8J $Z'- !,ASP!2H=$ 4B'2P)&AU,"1(9: T*&8@1
MAFP&/H5V!SN%@P@YA9$*.(2@"S:$L0LVA,8+-H/D"S:"]@LV@?\,-H#_##:
M_PPV@/\,MF\  *IX  "??P  D'X  (-_  !W@   :X(  %Z'  !5B@  3HP&
M $J.$ !(CQH 1X\E $60+P!$D#@ 0I!  $"01P$_D$\!/9!6 CN07P(YD&@#
M-X]S!#6/@ 4SCXX&,8^>!S".KP<OCL,'+X[A!R^,] @OB_\(+XK_""^*_PDO
MBO\)L'8  *5_  "8A   BH0  'V%  !PAP  98H  %J.  !/D@  1I4  $&8
M#  ^F!0 /9D? #N9*  ZFC$ .9HZ #>:0@ VFDH -9I2 3.:6@$QFF0!+YIO
M BV:>P(LFHH#*IJ: RF:K 0HFL $)YG> R>7\@0GEOT%)Y7_!2>5_P4GE?\%
MJ7X  )Z%  "2B0  A(H  ':,  !JCP  7I,  %27  !)FP  0)\  #>B!  R
MHPX ,:,7 #"D(0 NI"H +:0R "RE.@ KI4, *J5+ "FE5  HI5X )J5I "6E
M=@$CI84!(J66 2"FJ $?I;L!'J77 1ZD[P$>HOL"'J'_ AZA_P(>H?\"HH8
M )>,  "+CP  ?9$  &^4  !CF   5YT  $VA  !#I0  .*@  #"K   HK@<
M)*\0 ".O%P AKR$ (+ I !^P,0 >L#H ';%" !RQ3  ;L58 &K%A !FR;P 8
MLGX %K*0 !6RH@ 4LK8 $[+. !.QZP 3K_D $Z[_ 1.N_P$3KO\!FHT  )"2
M  "$EP  =9H  &B?  !;HP  4*@  $6L   [L   ,;(  ">U   @N   &+H'
M !2\#@ 3O!4 $KP> !&])@ 1O2X $+TW !"^00 .ODP #KY7  V^90 ,OW0
M"[^&  J^F0 (OJP ![["  >^WP (OO  "+WZ  B]_  (O?P DY0  (>9  !Z
MGP  ;*4  &"J  !3KP  1[,  #RV   QN   )[L  !^^   7P0  $<0!  S(
M"  (R0X !\D4  ;)'  %R20 !,HL  /*-@ "RD   ,M,  #+60  RV@  ,MY
M  #,C   RY\  ,NS  #+R   S.(  ,SO  #,\0  S/$ BIH  'RA  !OIP
M8JT  %6S  !(N   .[L  #"^   FP0  '<0  !7(   /RP  "LX   32 @
MTPH  -,/  #4%   U1H  -8B  #7*@  V30  -H_  #<2P  W%H  -UJ  #=
M?0  W9$  -VD  #>M@  WL@  -[>  #>X@  WN( ?Z(  '&I  !DL   5K<
M $F\   \P   +\0  "3'   ;RP  $\\   W2   'U@   -L   #>    WP,
M . )  #A#@  XA(  .,7  #E'@  YB<  .@Q  #J/0  [$L  .Q:  #M;
M[H   .Z4  #NI0  [K0  .["  #NQ@  [L8 =*H  &:R  !8N0  2\   #W%
M   OR0  ),T  !G1   1U@  "]L   />    X0   .4   #H    Z0   .H
M  #K!@  [0L  .\/  #P$P  \AH  /0C  #W+@  ^3L  /M*  #\6P  _6T
M /V   #^DP  _J(  /ZM  #^KP  _J\ _Q ? /\.'0#_"AT _P$@ /\ * #_
M #4 _P!! /\ 3@#_ %H _P!E /\ ;@#_ '< _P!_ /X A@#\ (P ^P"2 /D
MEP#X )P ]P"B /8 IP#U *T \P"U /( O0#Q ,D [P#< .X ZP#M /< [ #_
M .L _P#J /\ Z@#_ .H _P#J /\ _Q,< /\1&0#_#1D _P8< /\#)0#_ #$
M_P ^ /\ 2@#_ %8 _P!A /\ :P#] ', ^@![ /< @P#U (D ] "/ /( E #Q
M )D \ "? .X I #M *L [ "R .H N@#H ,8 YP#6 .4 Z #D /4 XP#^ .(
M_P#A /\ X0#_ .$ _P#A /\ _Q48 /\3% #_#Q0 _PT9 /\+(@#_""T _P0Y
M /\!1@#_ %$ _@!< /H 9@#V &\ \@!W .\ ?@#M (4 ZP"+ .H D0#H )8
MYP"< .8 H0#D *@ XP"O .$ N #? ,, W0#1 -L Y@#9 /, UP#] -4"_P#4
M O\ U /_ -0#_P#4 _\ _Q@3 /\5$ #_$@\ _Q(5 /\1'0#_#B@ _PPT /\*
M00#Y"$P ]097 /$&80#M!FH Z05R .8%>@#D!8$ X@6' . &C0#?!I( W0:8
M -L&G@#9!J4 UP:M -0&M0#2!L  T ?/ ,X(Y0#,"?0 R@O_ ,@,_P#'#/\
MQPS_ ,8,_P#&#/\ _QL. /\9# #_& T _Q@1 /\7& #_%"( ^Q$N /,0.@#M
M#D8 Z U2 .4-7 #A#64 W@UM -L-=0#8#7P U0V" -,-B0#1#8\ T V5 ,X-
MG #-#J, RPZK ,D.M #(#L  Q@[/ ,,0Y@# $?4 O1+_ +P2_P"[$O\ NA+_
M ;H2_P&Z$O\!_Q\* /\<! #_'P@ _Q\- /\=$@#X&AL [A8F .84,P#@$S\
MVA-+ -035@#0$U\ SA1H ,L4;P#)%'< QQ5] ,85A #$%8H PQ61 ,$6F #
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MI 26+Z\$E2^]!),OSP21,.@%CS#X!8TQ_P6-,?\%C#'_!8PQ_P6,,?\%_RT
M .HU  #<.@  SCT  ,8\  # -P( NS,- +,T&0"N-B< J3<T *4W0 "B-TH
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M"G5 PPMT0-T+<T'Q"W)!_PIR0?\*<D'_"7)!_PER0?\)Z3P  -5%  #%2P
MNDX  +!.  "G2P  HD8  )M&#@"61QH D4@G (Y(,P"*2#T AT=& 81'3@&"
M1E4"@$9< WY%8@1\16D$>D5P!7A$> 9V1($(=$2+"7)$E@IP1*(+;T2O#&Y$
MP QM1=D-;$7O#&M%_0MK1O\+:T;_"FM&_PIK1O\*Y4   ,])  #!3P  M5(
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M#EM1^@U;4?\,6U'_#%M1_PM;4?\+UDH  ,-3  "V60  JUP  )Y:  "360
MBU0  (16 P!^5A  >E<: '97)@!S6#$ <%<Z &U70@%J5TD":%90 F965P-D
M5EX$8E5E!6!5;0=>578(756!"EM5C0M95)H-6%2G#E95N ]65<P/5E7I#E95
M^0U65?\-5U3_#%=4_PQ75/\,T4T  ,!6  "S7   IUX  )I=  "/7   AE@
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M"TE@_PM)8/\+Q%@  +5@  "J9@  FV8  (UF  ""90  =F0  &YE  !H9@4
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M? 0T?XH$,G^:!3%^J@8P?KT&,'[:!C!]\ 8P>_T&,'O_!C!Z_P8P>O\&L&P
M *1U  "4=0  AG4  'EV  !N=P  8WD  %=]  !/@0  1X0  $*&#  _AQ,
M/8@= #R()P [B3  .HDX #B)0  WB4@ -HE/ #2)6 $SB6$!,8EL 2^)> (M
MB8<"+(F7 RJ(IP,IB+H#*8C4 RF&[@,IA?P$*83_!"F$_P0IA/\$JG0  )Y[
M  ".>@  @'H  '1[  !H?@  78$  %*%  !)B0  08P  #F0!0 UD0\ ,Y(7
M #*2(0 QDBD ,),R "Z3.@ MDT$ +)-* "N44@ JE%P *)1G ">4<P$EE((!
M))23 2*3I $AD[<!()// 2&2[ $@D/H"((__ B"/_P(@C_\"I'P  )>   "'
M?P  >X   &Z"  !BA0  5XD  $V.  !"D@  .I8  #*9   JG D *)T1 ":=
M&0 EG2( ))XJ ".>,@ BGCH (9Y" "">2P ?GU4 'I]@ !R?;0 ;GWP &I^-
M !B?GP 7G[( %I_) !:>Z  6G/< %IO_ 1>;_P$7F_\!G8,  (^&  ""A@
M=(<  &>+  !;CP  4),  $:8   \G   ,Z   "NC   CI@  '*@+ !JI$0 8
MJ1@ %ZDA !:J*0 5JC$ %*HY !.J0P 3JTT $JM8 !&K90 0JW0 #JN&  ZK
MF0 -JZP #*O!  RJWP ,J?( #:C\  VH_P -J/\ EHH  (F,  !ZC0  ;)$
M &"5  !4F@  29\  #^C   UIP  *ZH  ".N   ;L   %+,!  ^U"@ -MA
M#+86  NV'P *MB< ";8O  BV.0 'MT, !K=/  2W6P #MVH  K=[  "WC@
MMZ$  +:T  "VRP  MN4  +7Q  "U]P  M?< CY$  (&4  !REP  99P  %BA
M  !,I@  0:L  #>O   LL@  ([4  !JX   3NP  #KT   G !0 #P0T  ,$1
M  #!%P  PAX  ,(F  #"+P  PSD  ,1$  #$4   Q%X  ,5O  #%@0  Q94
M ,6H  #%O   Q-$  ,3F  #$[@  Q.X AI@  'F>  !KHP  7:D  %"N  !$
MLP  -[8  "RY   BO   &;\  !'"   ,Q0  !L@   #+    S <  ,P-  #-
M$0  S18  ,X=  #/)   T"T  -(X  #41   U%(  -5A  #5<P  UH<  -:;
M  #6K0  U[\  -C.  #8W0  V-T >Z   &ZF  !@K0  4[,  $6X   XO
M*[\  "'"   7Q@  $,D   K,   "T    -0   #7    V    -H%  #;"P
MW X  -X3  #?&0  X2$  .,J  #E-@  YT,  .=3  #H9   Z7<  .F,  #J
MGP  ZJX  .JZ  #JPP  ZL, <*@  &*O  !5M@  1[P  #G    LQ   (,@
M !;,   .T   !]0   #9    W0   .$   #C    Y    .8   #G 0  Z0<
M .L,  #L$   [A4  / =  #S)P  ]C,  /=#  #X5   ^68  /EZ  #ZC@
M^IX  /NI  #[L   ^[  _PL; /\'&0#_ !D _P < /\ )0#_ #( _P _ /\
M2P#_ %< _P!B /\ :P#_ ', _0![ /L @@#Z (@ ^ "- /< D@#V )@ ]0"=
M /0 H@#S *D \0"P .\ N #N ,, [ #1 .L Y@#I /, Z #^ .@ _P#H /\
MZ #_ .@ _P#H /\ _PX8 /\*%0#_ 10 _P 8 /\ (@#_ "X _P [ /\ 1P#_
M %, _0!> /H 9P#W &\ ]0!W /, ?@#R (0 \ ") .\ CP#N )0 [ ": .L
MGP#I *4 Z "L .8 M #D +\ XP#, .$ X@#? /  W@#[ -X _P#= /\ W0#_
M -P _P#< /\ _Q 3 /\-$0#_!A  _P(5 /\ '@#_ "D _P V /\ 0@#Z $X
M] !9 /$ 8@#N &L [ !R .H >0#H '\ YP"% .4 BP#D )  X@"6 .$ G #?
M *( W0"I -H L0#8 +L U0#( -( W0#1 .T T #Y ,\ _P#. /\ S0#_ ,T
M_P#- /\ _Q$/ /\.#0#_# T _PL2 /\'&0#_ B0 _P P /8 / #O $D Z@!3
M .< 70#D &8 X0!M -\ = #= 'L VP"! -D A@#6 (P U "2 -( F #0 )X
MS@"F ,P K@#* +@ R #$ ,8 UP#% .H PP#W ,( _P#! ?\ P +_ , "_P#
M O\ _Q0+ /\0!@#_$ D _Q . /\.% #_"AX ]08I .L$-@#C T( WP-. -L$
M5P#6!&  TP1H - $;P#.!78 S 5\ ,H%@@#)!8@ QP6. ,8%E #$!9L P@6C
M , &JP"^!K4 O0;" +L(U "Z">D MPOX +4,_P"T#/\ M S_ +0,_P"T#/\
M_Q<$ /\4  #_%@, _Q0) /\1#@#R#A4 Z PA -X*+@#6"SL T Q' ,P,40#)
M#%H Q@UB ,0-:@#"#7$ P UW +\-?0"]#H, O Z* +H.D0"Y#I@ MPZ@ +8.
MJ0"T#[0 L@_! +$0U "N$>L JQ+Z *D2_P"H$_\ IQ/_ *<3_P"G$_\ _QH
M /\;  #Y&P  ZQD  .44!@#E$ X V0X7 ,\1)@#($C0 Q!-  +\42P"\%%0
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M HTIQ@*+*=\"B2KR H<J_P*&*O\"ABK_ H8J_P*&*O\"]"@  .,Q  #1-@
MQ3@  +PV  "V,   LBL) *LL% "F+2( HBXO )XN.@";+D0 F"]- )8O50"4
M+EP DBYB ) N:0&/+F\!C2YV 8PN?@&*+H8"B"Z/ H<NF@*%+Z4#@R^R X(O
MP@.!,-H#?S#O WTQ_@-],?\#?#'_ WPQ_P-\,?\#[2\  -LW  #)/0  OCX
M +,\  "L.   IS,$ *(R$0"=-!T F34J )4U-0"2-4  CS5) (TU4 "+-5<
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M!V9 ^09E0/\&94#_!F5 _P5E0/\%W#X  ,=&  "Y2P  K$P  *!*  "71P
MD4,  (M#" "&0Q( @D0> 'Y$*0![130 >44] '9%10!T1$P!<D13 7!$60%N
M1& ";$-G FM#;P-I0W<$9T.!!69#C09D0YD&8D.G!V%$M@A@1,H(8$3F"%]%
M^ =?1?\'8$7_!F!$_P9@1/\&UD$  ,-)  "V3@  IT\  )M-  "22P  C$<
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M!U%/_P913_\&R4L  +E3  "K5P  G%8  (]5  "%5   ?%   '51  !P4@D
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M?01 8HL%/V*:!CYBJ@8]8KP'/&+6!SUA[P8]8?T&/F#_!CY@_P8^8/\&N5D
M *MA  ":80  BV$  ']A  !T80  :6$  %]B  !99   5&8) %%G$0!.9QH
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M BMXHP(J>+4"*GC, BIWZ@(J=OD#*G7_ RIT_P,J=/\#JFH  )IM  ");
M?&T  '!M  !F;@  6W$  %!U  !(>   07L  #I^!0 V?PX -( 6 #.!(  R
M@2@ ,($P "^".  N@D  +8)( "R"4  K@EH *H)D "B"<  F@G\!)8*/ 22"
MH $C@K(!(H+) 2*!YP$B?_<!(G[_ B)]_P(B??\"I7$  )-Q  "#<0  =G$
M &QR  !@=0  5G@  $Q\  !#@   .X,  #.&   MB0H *HH1 "F+&0 GBR(
M)HLJ "6,,0 DC#D (XQ" "*-2@ AC50 ((U> !^-:P =C7D '(V* !N-G  9
MC:X &(S$ !B,XP 9BO4 &8G_ 1F(_P$9B/\!G7<  (QV  !]=@  <G<  &5Y
M  !:?   4(   $:$   \B0  -(P  "V0   EDP( 'Y4, !V6$@ <EAH &Y<B
M !J7*@ 9ES( &)@Z !>80P 6F$T %9A8 !289  3F', $9B$ !"8E@ 0F*D
M#IB_  Z7W0 /EO( $)7\ !"4_P 0E/\ E7T  (5\  !X?   :WX  %^!  !4
MA@  2HH  $"/   VDP  +9<  "::   >G0  %Z # !*B#  0HQ( $*,9  ^C
M(0 .I"D #J0Q  VD.@ ,I$4 "Z10  JD7  )I&H !Z1[  :CC@ $HZ$  J.T
M  .BRP #HN8  Z'S  .A^P #H?L C8,  '^"  !QA   9(<  %B,  !-D0
M0I8  #B:   OG@  )J(  !ZE   7J   $:L   RN!P 'KPT  Z\2  *O&0 !
MKR$  *\I  "P,@  L#P  +!'  "P4P  L&$  +!Q  "P@P  KY<  *^J  "O
MOP  KMD  *[K  "N]   KO0 AXD  'B*  !JC@  79,  %&8  !%G0  .Z(
M #"F   GJ@  'JX  !:Q   0M   "[8   6Y P  N@H  +H.  "Z$P  NQD
M +LA  "\*   O#$  +T\  "^2   OE8  +YE  "^=P  OHP  +Z?  "]LP
MOL<  +[>  "]ZP  O>L ?Y(  '"5  !BF@  59\  $FE   ]JP  ,J\  "BT
M   >M@  %;D   Z\   )OP   L(   #$    Q00  ,8*  #&#@  QQ(  ,@8
M  #)'P  RB<  ,PP  #./   SDD  ,]9  #/:@  SWX  ,^3  #/I@  S[@
M ,_(  #/VP  S]L =YP  &BA  !;IP  3JX  $&T   TMP  *+H  !V]   3
MP   #<0   ;'    R@   ,X   #0    T0   -("  #3"   U0P  -80  #9
M%0  VQP  -TD  #@+P  XCP  .-+  #D7   Y&\  .6#  #EF   Y:D  .6V
M  #EPP  Y<, ;*4  %^L  !1L@  1+D  #6\   HP   ',0  !+(   ,RP
M \\   #3    V    -P   #?    WP   .$   #C    Y ,  .8(  #H#0
MZ1$  .P8  #N(@  \2X  /,\  #T30  ]5\  /9S  #WAP  ]YD  /BE  #X
ML   ^+  _P,7 /\ %0#_ !4 _P 8 /\ (P#_ "\ _P \ /\ 2 #_ %0 _P!>
M /\ 9P#] &\ ^P!V /D ?0#X (, ]@"( /4 C@#T ), \@"8 /$ G@#P *0
M[@"K .T LP#K +T Z@#+ .@ X0#G /$ Y@#] .4 _P#D /\ Y #_ .0 _P#D
M /\ _P<3 /\ $0#_ !$ _P 5 /\ 'P#_ "L _P W /\ 1 #^ $\ ^@!: /<
M8P#T &L \@!R /  >0#O '\ [0"$ .L B@#J (\ Z "4 .< F@#E *  Y "G
M .( KP#@ +D W@#& -P V@#: .P V #Y -8 _P#6 /\ UP#_ -@ _P#8 /\
M_PH0 /\##@#_  T _P 2 /\ &@#_ "8 _  R /< /P#T $H \0!5 .T 7@#J
M &8 Z !N .4 = #C 'H X@"  .  A0#> (L W "0 -L E@#8 )P U0"C -,
MJP#1 +4 S@#! ,P T0#+ .< R0#U ,@ _P#( /\ R #_ ,@ _P#( /\ _PP,
M /\&" #_ @H _P / /\ %0#\ "  \0 L .P .0#I $4 Y0!/ .$ 60#> &$
MVP!H -< ;P#4 '4 T@![ -  @ #. (8 S ", ,L D@#) )@ QP"@ ,4 J ##
M +$ P0"\ +\ RP"] ., O #R +L _0"[ /\ N@#_ +H _P"Z /\ _PX% /\)
M  #_"04 _P8+ /\!$ #P !D Y@ E .$ ,@#< #\ U@!) -$ 4P#. %L RP!C
M ,@ :@#& '  Q0!V ,, >P#! ($ P "' +X C@"\ )0 NP"< +D I "W *X
MM0"Y +, R "Q -\ L 'O *\!^P"N O\ K0/_ *T#_P"M _\ _Q   /\.  #_
M#0  ]@L# /('"@#B 1$ VP(= -(#*P#, S< R 1# ,0$30#!!%8 O@5= +P%
M9 "Z!6L N 5Q +<%=@"U!7P LP:# +(&B0"P!I$ KP>9 *T'H0"K!ZL J0BW
M *@)Q@"F"MT I0OP *,,_0"B#?\ H0W_ *$-_P"@#?\ _Q$  /P2  #L$P
MXA,  -L/ P#6"0L S@@4 ,8*(@# ##  O T\ +@-1@"U#4\ L@Y7 + .7P"N
M#F4 K0YK *L.<0"J#G@ J Y^ *</A0"E#XT I ^6 *(0GP"@$*D GQ"U )T1
MQ0";$=X F1+Q )<3_P"6%/\ E13_ )44_P"4%/\ _Q4  .T;  #@'P  TA\
M ,D;  #$% 4 P1 . +H2&P"T$RD L!0U *P50 "I%4D IA52 *0660"B%F
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M 7<K^0%V*_\!=BO_ 74K_P%U*O\!Y2P  - T  #!.   LS@  *@U  "B,0
MG2T  )DJ#@"4*Q@ D"PD (TM, "*+3H ARU# (4M2@"#+5$ @2Y8 ( N7@!^
M+F0 ?2YK 'LN<P%Y+GL!>"Z% 78NCP%T+YL!<R^H G$OM@)P,,D";S#E FXQ
M]P)M,?\";3'_ FTQ_P)M,?\"WS(  ,DY  "[/@  K#T  *$Z  ":-P  E3,
M ) Q"@",,10 AS(@ (0S*P"!,S4 ?S,^ 'TS1@![,TT >3-4 '<S6@!V,V$
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M UD__P-9/_\#S#\  +Q&  "K2   G$<  )%&  "(1   @D   'P_  !W0 P
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M?0))3HL#2$Z9!$=/J 1&3[H$1D_1!$9/[01&3OP$1D[_ T=._P-'3O\#O4P
M *Y2  "<40  C5$  (%1  !W4   ;DP  &=.  !B3P  75 - %I0% !741X
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M CA=HP,W7;4#-EW+ S9<Z ,W7/D#-UO_ SA;_P,X6O\#LE<  *!:  "/60
M@5D  '59  !K60  8%H  %9;  !170  3%X" $A@#0!%8!0 1&$> $)B)@!
M8BX /V(V #YC/@ ]8T4 /&-- #MC50 Y8UX .&-H 39C= $U8X$!,V.1 C)C
MH0(Q8[,",6/( C%BYP(Q8?@",6'_ C)@_P(R8/\"KEP  )M=  "*70  ?%T
M '!=  !F70  7%X  %)@  !,8@  164  $%F"@ ^9Q$ /&@: #MH(@ Y:2L
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M !I[W@ :>?( &WC^ !MW_P$;=_\!F6D  (AI  !Y:0  ;6D  &-J  !9;
M3V\  $5S   ]=P  -7H  "Y]   G@0, (H,- ""$$@ ?A!H '80B !R%*@ ;
MA3$ &H4Y !F%0@ 8ADP %X96 !:&8P 5AG$ %(:! !*&DP 1AJ8 $86[ !"%
MU@ 1@^\ $8+[ !*"_P 2@?\ D6X  (%M  !T;@  :6X  %UP  !3<P  27<
M $!\   W@   +X,  ">'   AB@  &HT& !6/#0 3D!, $I : !*0(@ 1D"H
M$)$R !"1.P /D40 #I%/  V17  ,D6H "Y%Z  J1C0 (D)\ !Y"S  >/R0 '
MC^8 !X[T  B-_  (C?\ B7,  'MS  !O<P  8W4  %=X  !-?0  0X$  #F&
M   PB@  *(X  "&1   :E0  $Y<   Z:"  +G X "9P3  B<&@ 'G"( !IPJ
M  2<,P #G#T  IU(  "=5   G6(  )QR  "<A   G)<  )NJ  ";OP  FML
M )KL  ":]0  F?@ @GD  '9Y  !H>@  7'X  %&"  !&AP  /(P  #*1   I
ME0  (9D  !F=   2H   #J,   FF!0 #IPP  *<0  "G%0  J!P  *@C  "H
M*P  J30  *D_  "I2P  J5D  *EH  "I>@  J8X  *FA  "HM0  J,L  *?D
M  "G[P  I_, ?8   &^!  !AA   58D  $F.   ^E   -)D  "J>   AH@
M&:8  !*I   -K   !Z\   "R    LP<  +,,  "S$   M!4  +0;  "U(@
MMBL  +<U  "W0   N$X  +A=  "X;@  N((  +B7  "XJ@  M[X  +?2  "W
MY@  M^H =H@  &>+  !:D   3I8  $*<   WH@  +*<  "*K   9KP  $;,
M  NV   $N0   +P   "^    O@   +\&  # "P  P0\  ,(3  ##&0  Q"
M ,4I  #'-   R$(  ,E1  #)8@  R74  ,F*  #)GP  RK$  ,K!  #)T0
MR=D ;I,  &"8  !3G@  1J0  #JK   OL   )+4  !FX   0O   "K\   '!
M    Q    ,@   #*    R@   ,P   #- P  S@@  - -  #1$   TQ8  -8>
M  #:*   W30  -Y#  #?5   WV<  .!\  #@D0  X*0  ."R  #@O@  X,,
M9I\  %FF  !,K0  /[0  #*X   DO   &+\  !##   (QP   ,H   #-
MT0   -4   #8    V0   -L   #=    WP   .$$  #C"@  Y0X  .<3  #J
M'   [2<  / U  #Q1@  \E@  /-K  #S@   ])0  /2C  #TK@  ]+( _P 3
M /\ $0#_ !$ _P 5 /\ 'P#_ "P _P Y /\ 10#_ %  _P!: /X 8P#[ &L
M^0!R /< > #U 'X ] "$ /( B0#Q (X \ "3 .X F0#M )\ [ "F .H K@#H
M +@ Y@#% .4 VP#C .T X@#[ .( _P#A /\ X0#_ .$ _P#A /\ _P 0 /\
M#@#_  T _P 2 /\ &P#_ "@ _P T /X 00#[ $P ]P!6 /0 7P#Q &8 [P!M
M .P = #J 'H Z0!_ .< A0#F (H Y0"/ ., E0#A )L X "B -X J@#; +0
MV0#  -8 T #3 .@ T@#W -$ _P#1 /\ T #_ -  _P#0 /\ _P - /\ "0#_
M  H _P / /\ %@#[ "( ]P O /0 .P#P $< [0!1 .D 6@#E &( X@!I .
M;P#> '4 W !Z -H @ #8 (4 U0"+ -, D0#1 )< SP"> ,T I@#+ *\ R0"Z
M ,< R0#% .( Q #R ,, _@#" /\ P0#_ ,( _P#" /\ _P,& /\  0#_  8
M_P , /D $0#Q !T ZP I .< -@#C $$ WP!+ -L 5 #5 %P T@!C ,\ :@#-
M '  RP!U ,D >P#( (  Q@"& ,4 C ## ), P0": +\ H@"] *L NP"V +D
MQ "W -H M@#M +0 ^@"T /\ M #_ +0 _P"T /\ _P0  /\   #_    _P &
M .P #0#E !8 W@ B -< +P#1 #L S0!% ,H 3@#& %< Q !> ,$ 9 "_ &H
MO0!P +P =0"Z 'L N0"! +< AP"U (X LP"5 +( G@"P *< K@"R *P OP"J
M -$ J #H *@ ]P"G /\ IP#_ *8 _P"F /\ _P8  /\%  #Q P  Z    .$
M!P#5 !  S0 ; ,< )P## #, OP ^ +P 2 "Y %$ M@!8 +0 7P"R &4 L !J
M *\ < "M '8 K !\ *H @@"I (D IP"1 *4 F@"C *0 H0"N *  NP"> <T
MG0+F )P$] ";!/\ F@7_ )H%_P"9!?\ _PH  /$.  #D$   V0\  ,X+  #(
M PL P@ 3 +P"'P"W RP LP0W + %0@"M!DH J@92 *@'60"F!U\ I0=E *,'
M:P"B"'$ H AW )\(?@"="(4 FPF. )H)EP"8"J$ E@JL )4+N@"3"\P D@SE
M ) -]@"/#O\ C@[_ (X._P"-#O\ ]A$  .87  #6&P  QQD  +X5  "Y$
MMPH- +$+%P"L#20 J XP *4..P"B#D0 GP], )T/4P";#UH F@]@ )@09@"7
M$&P E1!R ),0>0"2$($ D!"* (\1E "-$9\ BQ&J (H2N "($LL AA/F (44
M]P"#%?\ @Q7_ ((5_P""%?\ [1H  -PA  #*)0  NR(  +$?  "K&@  J10&
M *42$0"@%!X G!4J )D5-0"6%CX E!9' )(63@"0%E4 CA=; (P780"+%V<
MB1=M (@7= "&&'P A1B& (,9D "!&9L @!JG 'X:M0!]&\< ?!SB 'H=]0!Y
M'?\ >!W_ '@=_P!X'?\ Y2(  - I  "_+   L"H  *<G  "@(P  G1\  )H:
M#@"5'!@ D1TD (X>+P",'CD B1Y! (<?20"%'U  @Q]6 ((?7 " 'V( ?Q]I
M 'T@< !\('@ >B"! 'DAC !W(9< =2*D '0BL@!S(\, <B/? ' D\P!O)/\
M;R3_ &XD_P!N)/\ W2D  ,@P  "W,@  J#   )XN  "7*@  DR<  ) C"@",
M(Q, B"0? (0E*@"")30 @"8] 'TF1 !\)DL >B92 '@F6 !W)EX =29E '0G
M; !R)W0 <2=] &\HB !N*)0 ;"BA &LIKP%J*< !:2K; 6<J\0%G*_\!9BO_
M 68J_P%F*O\!U"\  ,(V  "O-@  H34  )8T  "0,   BBT  (<J!@"#*1
M?RH: 'PK)0!Y*R\ =RPX '4L0 !S+$< <2Q- ' L5 !N+%H ;2QA &LM: !J
M+7  :"UZ &<NA0!E+I$!9"Z> 6(OK %A+[T!83#5 6 P[P%?,/T!7S#_ 5\P
M_P%?,/\!S30  +P[  "I.@  FSH  ) X  ")-0  @S(  '\P 0![+PX =S 6
M '0P(0!Q,2L ;S$T &TQ/ !K,4, :C%* &@R4 !G,E< 93)= &0R90!B,FT
M83-W %\S@@%>,XX!732< 5LTJ@%:-;L!6C72 5DU[0%9-?P!6#7_ 5@U_P%9
M-?\!R#@  +<^  "D/@  ECT  (L\  "#.@  ?3<  '@T  !T- L <#43 &TU
M'0!J-2< :#8P &8V. !D-C\ 8S9& &$V30!@-E, 7C=: %TW8@!<-VH 6CAT
M 5DX?P%7.(P!5CF9 54YJ )4.;D"4SK/ E,ZZP)3.OL!4SK_ 5,Y_P%3.?\!
MQ#P  +)!  "@0   DD   (8_  !^/0  >#H  ',X  !N.0@ :CD1 &<Y&@!D
M.B0 8CHL & Z- !>.CP 73M# %L[2@!:.U  6#M7 %<[7P!6/&< 5#QQ 5,\
M? %2/8D!43V7 4\]I@)./K<"3C[- DX^Z0)-/OH"3C[_ 4X]_P%./?\!P#\
M *Y#  "<0P  CD,  ()"  !Z0   <ST  &T\  !H/04 9#T. &$^%P!>/B$
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M 4%)H@) 2;,"/TK' C]*Y0(_2?<"0$G_ D!(_P) 2/\!MDD  *)*  "12@
M@TH  '=*  !N20  944  %Y'  !92   54D( %%*$ !/2A@ 3$HA $I+*0!)
M2S$ 1TLX $9,/P!%3$8 1$Q. $--5@!"35\ 04UH $!-= $^38$!/4V0 3Q-
MH $[3K$".D[& CI.Y ([3?8".TW_ 3M,_P$\3/\!LTT  )Y,  "-3   ?TP
M '1,  !J3   8$H  %E+  !43   4$T% $Q.#@!)3Q4 1T\> $5/)@!$4"X
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M 2E=W@$J7/(!*EO^ 2M;_P$K6O\!HU4  (]5  !_50  <E4  &=6  !>5@
M5%<  $Q9  !%6P  /UT  #I?!  V8 T -&$3 #)B'  Q8B, ,&(K "]C,@ N
M8SH +6-" "QC2@ J9%, *61= "AD:0 G9'8 )F2& "5DEP D9*D (V2] ")D
MV@ C8_$ (V+] 21A_P$D8?\!G%@  (E8  !Z60  ;ED  &-9  !:6@  4%P
M $A>  !!8   .F,  #1F   O: H +&D0 "II%P I:A\ *&HF "=J+@ F:S4
M)6L] "1K1@ C:T\ (FQ9 "!L90 ?;'( 'FR" !ULE  <;*8 &VNZ !IKU  ;
M:NX '&G\ !QH_P <:/\ E5P  (-<  !U7   :5T  %]=  !67@  3&$  $-D
M   \9P  -6H  "]M   H< 0 (W(- "%R$@ @<QH 'W,A !YS*  ==#  ''0X
M !MT0  :=$H &714 !=U8  6=6X %75^ !1UD  3=*( $G2V !%TSP 2<^P
M$G+Z !-Q_P 3<?\ CF   'U@  !O80  96$  %MB  !19   2&<  #YK   W
M;@  ,'$  "EU   B>   ''L' !=]#@ 6?1, %7T; !1^(@ 3?BH $GXQ !%^
M.@ 1?D0 $'].  ]_6@ .?V@ #7]X  Q_B@ +?IT "GZP  E]Q@ *?>0 "GST
M  M[_0 +>O\ AF4  '=E  !J90  868  %9H  !,:P  0F\  #ES   Q=P
M*GH  "-^   <@0  %80  !"'"  -B0X #(D4  R)&P +B2, "HDK  F),P (
MB3T !HE(  6)5  $B6$  HEQ  &)@P  B98  (BI  "'O@  A]H  (;L  "&
M]0  AOH ?FH  '%J  !G:P  6VP  %!P  !&=   /'@  #-]   J@0  (X4
M !R(   5C   $(\   R2!@ &DPP  I,1  "4%@  E!T  )0D  "5+   E34
M )5   "53   EED  )9I  "5>@  E8X  )2A  "4M0  D\P  )+F  "2\@
MDO< >'   &UP  !@<@  5'4  $EY   _?@  -8,  "R(   CC0  &Y$  !24
M   /EP  "IH   2= P  G@D  )\.  "?$@  H!<  * =  "A)0  HBT  *(W
M  "C0P  HU   *-?  "C<0  HX0  **9  "BK0  H<(  *'<  "AZP  H/(
M<W8  &9W  !9>P  38   $*%   XBP  +I   "25   ;F@  %)X   ZA   )
MI    J<   "J    JP0  *L*  "L#0  K1$  *T6  "N'   KR0  + M  "Q
M.0  L48  +)5  "R9@  LGD  +*.  "QHP  LK<  +'*  "QX   L>D ;'X
M %^"  !2AP  1HT  #N3   PF0  )IX  !RC   3IP  #:L   >N    L@
M +4   "W    N    +D"  "Y"   N@P  +L0  "\%   O1L  +\C  #!+0
MPCH  ,))  ##6@  PVP  ,2"  #$EP  Q*L  ,2\  #$RP  Q-H 98D  %B.
M  !+E0  /YL  #.B   HJ   ':T  !2Q   -M@  !KD   "\    OP   ,,
M  #$    Q0   ,8   #'    R00  ,H)  #+#0  S1$  ,\8  #2(0  U2T
M -8\  #830  V5\  -IS  #:B@  VYX  -NN  #;N@  W,, 7I8  %&<  !$
MHP  .*H  "RQ   @MP  %;L   V^   $P@   ,4   #)    S0   -    #2
M    T@   -4   #6    V0   -L   #>!0  X H  .(/  #E%@  Z"   .PM
M  #M/@  [5$  .YE  #O>@  [X\  /"?  #PJP  \+, _P 0 /\ #@#_  X
M_P 2 /\ '0#_ "D _P U /\ 00#_ $T _@!6 /L 7P#X &8 ]@!M /0 = #R
M 'D \0!_ /  A #N (D [0"/ .L E0#J )L Z "B .8 J@#E +, XP#  .$
MT@#@ .H WP#Y -T _P#= /\ W0#_ -X _P#> /\ _P - /\ "@#_  D _P /
M /\ & #_ "0 _@ Q /L /0#X $@ ] !2 /  6@#M &( ZP!I .D ;P#G '4
MY0!Z ., ?P#B (4 X "* -X D #< )8 V@"= -@ I0#5 *\ T@"Z -  R@#.
M ., S0#T ,L _P#+ /\ RP#_ ,L _P#+ /\ _P ( /\  P#_  4 _P , /P
M% #W !\ \@ K .\ -P#K $( YP!, .0 50#@ %T W0!D -H :@#8 '  U0!U
M -( >@#0 (  SP"% ,T BP#+ )( R0"9 ,< H0#% *H PP"U ,$ PP"_ -H
MO@#N +T _ "\ /\ O #_ +P _P"\ /\ _P   /\   #_    ^0 ' /$ $ #J
M !H Y  E -\ ,0#; #P UP!' -( 4 #. %< RP!> ,D 90#& &H Q0!P ,,
M=0#! 'H P "  +X A@"\ (T N@"4 +D G "W *4 M0"P +, O0"Q ,\ KP#H
M *X ^ "N /\ K0#_ *T _P"M /\ _P   /\   #]    [@ ! ., # #: !0
MT0 ? ,P *P#( #8 Q0!  ,( 2@"_ %( O !9 +H 7P"X &4 M@!J +0 ;P"S
M '4 L0!Z +  @0"N (@ K0"/ *L F "I *$ IP"K *4 N "C ,@ H@#B *$
M\P"@ /X H #_ *  _P"@ /\ _P   /8   #J    X    -, !@#)  \ P@ 8
M +T ) "Y "\ M@ Z +0 0P"Q $P K@!3 *P 60"J %\ J0!D *< :@"F &\
MI !U *, >P"A (( H "* )X DP"< )T F@"G )@ M "6 ,, E0#< )0 [P"3
M /L DP#_ ), _P"2 /\ ^04  .H+  #<#0  RPH  ,(%  "\  H M@ 1 +$
M' "N "@ J@ S *< /0"D $4 H@!- *  4P"> %D G !? )L 9 ": &H F !P
M )< =@"5 'X DP"& )(!CP"0 9D C@*D (P"L0"+ \  B076 (@&[0"(!_H
MAPC_ (8(_P"&"/\ [P\  -X4  #*%0  O!(  +,0  "N#   JP8- *<#%0"B
M!2  GP<L )P(-@"9"#\ EPE' )4)3@"3"50 D0I: ) *7P"."F4 C0IK (L*
M<@"*"WD B N" (<+C "%#)< @PRB ($-L " #<  ?PW8 'T.[P!\#_T >P__
M 'L0_P![$/\ YA<  -$>  "]'0  KQP  *89  "A%0  GA $ )T-#P"8#AD
ME XE )$/+P"/$#D C!!! (H02 "($$\ AQ!5 (406P"$$6$ @A%G ( 1;@!_
M$74 ?1%^ 'P2B !Z$I0 >!*@ '<3K@!U$[X =!35 ',5[@!Q%OT <1;_ '$6
M_P!P%O\ W!\  ,8E  "S)0  I2,  )PA  "6'@  DAD  )$4"P"-%!0 B14?
M (86*0"#%C, @1<\ ( 70P!^%TH ?!=0 'H75@!Y&%P =QAB '88:0!T&'$
M<QEZ '$9A !O&I  ;AJ= &P;JP!K'+L :AS0 &D=[ !H'OL :![_ &<>_P!G
M'O\ T28  +TJ  "K*@  G2H  ),H  "-)0  B"(  (8=!@"#&Q  ?QP: 'P=
M) !Z'2X =QXV '8>/@!T'D4 <A]+ '$?40!O'U@ ;A]> &P?90!K(&T :2!V
M &@A@0!F(8T 92*: &,BJ !B([@ 82/- & DZ0!@)/H 7R3_ %\D_P!?)/\
MRBP  +8O  "D+P  EB\  (PM  "%*@  @"@  'TD  !Z(@T =B,5 ',C( !Q
M)"D ;R0R &TD.@!K)4$ :B5' &@E30!F)50 925: &0F80!B)FD 829R %\G
M?0!>)XH 72B7 %LII0!:*;4 6BK* %DJYP!8*O@ 6"K_ %@J_P!8*O\ Q3$
M *\S  ">,P  D#,  (8R  !_+P  >2T  '4J  !R* H ;R@2 &LI&P!I*24
M9RHM &4J-0!C*CT 8BI# & J2@!?*U  7BM7 %PK7@!;+&8 62QO %@M>@!7
M+8< 5BZ5 %0NHP!3+[, 4R_' %(OY0!2+_< 4B__ %(O_P!2+_\ P38  *HV
M  "9-@  BS8  ($U  !Y,P  <S$  &\O  !K+@8 :"T0 &0N& !B+B$ 8"\J
M %XO,0!<+SD 6R]  %DO1@!8+TT 5S!3 %8P6P!4,6, 4S%L %(R=P!1,H0
M3S.2 $XSH0!-,[$ 333% 4PTXP%,-/8 3#3_ $PT_P!,,_\ NSD  *8Y  "5
M.0  ASD  'PY  !T-P  ;C0  &DS  !E,@( 83(- %XR% !<,QX 6C,F %@S
M+@!6,S4 530\ %,T0P!2-$H 4310 % U6 !.-6  339J $PV=0!+-X( 2C>0
M $DXGP!(.+ !1SC# 4<XX0%'./4!1SC_ 4<X_P%'./\!MSL  *(\  "1/
M@SP  '@\  !P.@  :C<  &0V  !@-@  7#8+ %DW$@!6-QH 5#<C %(W*P!0
M-S( 3S@Y $TX0 !,.$< 2SA. $HY50!).5X 2#IH $<Z<P!&.X  13N. $0\
MG@!#/*X!0CS" 4(]WP%"//,!0CS_ 4(\_P%"._\!LST  )X^  "-/@  ?SX
M '4^  !L/0  9CH  & Y  !;.@  5SH( %,[$ !1.Q@ 3CL@ $P[* !+.R\
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M #-(V0 T2/  -$?] #1'_P U1O\ ID0  ))%  ""1@  =48  &I&  !A10
M640  %%$  !,1@  2$<  $1'"@!!2!  /TD8 #U)(  \22< .DHN #E*-@ X
M2CT -TM$ #9+3  U2U4 -$Q? #-,:@ R3'< ,4R& #!,EP O3:@ +DV[ "Y-
MU0 N3.\ +TS] "]+_P P2_\ H4<  (Y(  !^2   <4@  &9)  !=2   54@
M $Q)  !'2@  0DL  #],!@ [30X .4X5 #=.'0 V3R0 -4\K #-/,P R4#H
M,5!" #!02@ O45( +E%< "U19P L474 *U&$ "I2E0 I4J8 *5*Y "A2T@ I
M4>X *5#\ "I0_P J3_\ G$H  (E*  !Z2P  ;4L  &-,  !:3   44P  $A-
M  !#3P  /5   #E2 @ U4PP ,U02 #%4&0 P52$ +E4H "U5+P L5C< *U8^
M "I61@ I5D\ *%=9 "=79  F5W( )5>! "17D@ C5Z0 (E>W ")7SP B5^P
M(U;Z "-5_P D5?\ EDT  (1.  !U3@  :4X  %]/  !63P  35   $52   _
M4P  .58  #-8   O6@@ *UL/ "I;%0 H7!T )UPD "9<*P E7#, )%TZ "-=
M0P B74P (5U6 "!>80 ?7FX 'EY^ !U>CP <7J$ &UZT !I=S  ;7>D &USY
M !Q;_P <6_\ D%$  'Y1  !P40  9%(  %M2  !24P  2E0  $%7   [60
M-5L  "Y>   H8 , )&(, ")C$0 A8Q@ 'V0@ !YD)P =9"X '&0V !ME/@ :
M94< &651 !AE70 796H %F5Z !5EBP 499X $V6Q !)ER  29.< $V/W !1B
M_P 48O\ B50  'A5  !K50  8%8  %=6  !/5P  1ED  #U<   V7P  ,&(
M "ED   C9P  '6H' !EL#@ 8;!, %FT: !5M(0 4;2D %&TP !-M.0 2;D(
M$6Y, !!N6  /;F4 #FYU  UNAP -;IH #&VM  MMP@ +;.  #&OS  UK_0 -
M:O\ @ED  ')9  !F60  7%H  %1:  !*7   05\  #EC   Q9@  *FD  "1L
M   =;P  %W(  !)U"0 /=P\ #G<4  YW&P -=R, #'<J  MW,P *=SP "7='
M  AW4@ '=U\ !7=O  1W@  #=Y0  7:G  !VNP !==4  73K  )T]@ "=/P
M>UT  &U=  !B7@  65X  $Y@  !%8P  /&<  #-K   K;@  )'(  !YU   7
M>0  $GP   U_!@ )@0P !8$1  .!%@ "@1T  8$D  "!+0  @C8  ()   ""
M3   @ED  ()H  "">0  @HT  (&@  " M   @,L  '_G  !^\@  ?OD =&(
M &AB  !>8@  4V0  $EG   _:P  -G   "UT   E>   'GP  !>    1@P
M#88   B)!  "BPH  (L.  "+$P  C!@  (P?  "-)@  C2\  (XY  ".1
MCE$  (Y@  ".<0  CH4  (Z9  "-K0  C,,  (S?  "+[@  B_8 ;F@  &1G
M  !8:0  36P  $)Q   X=@  +WL  "9_   >A   %H@  !",   ,CP  !I(
M  "5    E@<  )<,  "7#P  F!,  )D8  ":'P  FR8  )LP  "<.P  G$@
M )Q7  "<:   G'L  )R0  ";I0  F[H  )K0  ":YP  FO$ :FT  %YO  !1
M<@  1G<  #M\   Q@@  )X<  !Z,   6D0  $)4   J9   $G    *    "B
M    HP$  *,&  "D"P  I0X  *82  "G%P  J!X  *HF  "K,0  JSX  *Q-
M  "L70  K'   *R%  "LFP  JZ\  *O#  "KV0  JN@ 9'4  %=Y  !+?@
M/X0  #2*   ID   'Y8  !:;   0GP  ":,   &G    J@   *X   "P
ML    +$   "R P  M @  +4-  "V$   MQ4  +D=  "[)@  O#,  +U!  "]
M4@  O60  +YY  "^D   O:0  +VW  "]Q@  O=< 7'\  %"%  !$BP  .)(
M "R9   AGP  %Z0  !"I   )K@   +(   "V    N0   +T   "_    OP
M ,    #!    PP   ,0%  #&"@  QPX  ,D3  #+'   SB8  - U  #110
MTE<  -)K  #3@@  TY<  -.I  #2N   TL0 58P  $F3   ]F@  ,*(  "6H
M   :K@  $;0   FY    O0   ,$   #$    R    ,L   #-    S0   ,\
M  #0    T@   -0   #8    V@8  -T,  #@$0  XQH  .8G  #G.   Z$H
M .E=  #J<@  ZX@  .N;  #LJ   [+( _P - /\ "P#_  L _P 0 /\ &@#_
M "8 _P R /\ /0#_ $@ ^P!2 /@ 6@#V &( \P!I /$ ;P#P '4 [@!Z .P
M?P#K (0 Z0"* .@ D #F )8 Y "= .( I0#A *\ WP"[ -T RP#; .8 V0#W
M -@ _P#8 /\ UP#_ -< _P#4 /\ _P ( /\ ! #_  0 _P - /\ %0#^ "$
M^@ L /< . #T $, \ !- .T 50#J %T YP!D .0 :@#B '  X !U -X >@#=
M '\ VP"% -D BP#5 )$ TP"9 -$ H #/ *H S0"U ,L Q #) -T R #Q ,<
M_P#& /\ Q@#_ ,8 _P#' /\ _P   /\   #_    _P * /@ $0#Q !P [  G
M .D ,@#F #T X@!' -T 4 #9 %@ U0!? -( 90#0 &H S@!P ,P =0#* 'H
MR0!_ ,< A0#% (P PP"4 ,$ G "_ *4 O0"P +L O0"Z -  N #K +< ^P"V
M /\ M@#_ +8 _P"V /\ _P   /\   #]    \P % .D #@#A !8 VP A -4
M+0#1 #< S@!! ,H 2@#' %( Q !9 ,( 7P#  &4 O@!J +P ;P"[ '0 N0!Z
M +< @ "V (< M ". +( EP"P *  K@"J *T MP"K ,@ J0#C *@ ]0"G /\
MIP#_ *< _P"F /\ _P   /X   #Q    Y0   -< "@#- !$ QP < ,( )@"_
M #$ O  [ +H 1 "W $P M !3 +( 60"Q %\ KP!D *T :0"L &\ J@!T *D
M>@"G ($ I@") *0 D0"B )L H "E )X L@"= ,$ FP#: )H [P"9 /T F #_
M )@ _P"8 /\ _0   /    #A    T0   ,8 ! "]  T MP 5 +, ( "P "L
MK0 U *L /@"H $8 I@!- *0 5 "C %D H0!? *  9 "> &D G0!N )L =0":
M 'L F "# )8 C "5 )8 DP"A )$ K0"/ +L C0#/ (P Z0"+ /@ C #_ (P
M_P", /\ \P(  .('  #,!P  OP0  +<   "Q  @ JP 0 *< &0"D "0 H  N
M )X -P"< $  F@!' )@ 3@"6 %0 E0!9 ), 7@"2 &0 D !I (\ ;P"- '8
MBP!^ (H B "( )( A@"= (4 J0"# +@ @0#* (  Y0"  /4 ?P#_ '\ _P!_
M /\ Z T  - 0  "^$   L0X  *@-  "C"   H (, )P $P"8 !T E0 G )(
M,0"0 #D C@%! (P!2 "* DX B0)4 (<"60"& E\ A -D (,#:P"! W( @ 1Z
M 'X$A !]!8X >P6: 'D&IP!X!K4 =@?( '4(XP!U"?0 = K_ ',*_P!S"O\
MW14  ,07  "Q%P  I18  )P3  "6$0  E T$ ),(#0".!Q4 BPD@ (@)*@"%
M"C, @PL[ ($+0@" "TD ?@M/ 'T,5 ![#%H >@Q@ '@,9P!W#&X =0UV '0-
M@ !R#8P < V9 &\.I@!M#K4 ; [) &L/Y@!J$/< :1#_ &D0_P!I$/\ T!T
M +D>  "H'@  FQT  )(;  "+&0  B!4  (<1!P"%#A  @0\: 'X0) ![$"T
M>1 V '<1/0!V$40 =!%* ',14 !Q$58 <!%< &X28@!M$FH :Q)S &D3?0!H
M$XD 9A.6 &44HP!C%;, 8A7& &(6XP!A%O8 8!?_ & 7_P!@%_\ QR(  + C
M  "?)   DB,  (DB  ""(   ?AT  'P9  !Z%0T =Q45 '06'P!Q%B@ ;Q<P
M &X7. !L%S\ :Q=% &D82P!H&%$ 9AA8 &487@!C&68 8AEO & 9>0!?&H4
M71N2 %P;H0!;'+  6AS# %D=X !8'O0 6![_ %@>_P!8'O\ OR<  *DH  "9
M*   BR@  ((G  ![)0  =B,  ',@  !Q' D ;AP1 &L<&@!I'2, 9QTL &4=
M,P!C'CH 8AY! & >1P!?'DT 7AY4 %P?6P!;'V( 62!K %@@=@!6(8( 52&0
M %0BG@!3(JX 4B/  %$CW0!1)/( 423_ %$D_P!1(_\ N2L  *,L  "3+
MABT  'PL  !T*@  ;R@  &LE  !I(@4 9B$. &,B%@!A(A\ 7R,G %TC+P!<
M(S8 6B,] %DD0P!7)$H 5B10 %4D5P!3)5\ 4B5H %$F<P!/)G\ 3B>- $TH
MG !,**P 2RF^ $LIV@!**?$ 2BG_ $LI_P!+*?\ LRX  )XO  ".,   @3
M '<O  !O+@  :BL  &4J  !C)P$ 7R<, %PG$P!:)QL 6"@D %8H*P!5*#(
M4R@Y %(I0 !0*48 3RE- $XI5 !-*EP 3"IE $HK< !)*WP 2"R+ $<MF@!&
M+:H 12Z\ $4NU@!%+N\ 12[^ $4N_P!%+?\ KC$  )HR  "),P  ?#,  '(S
M  !K,0  92\  & M  !=+   62P) %8L$ !4+!@ 4BP@ % L* !.+2\ 32TV
M $PM/ !*+4, 22U* $@N40!'+ED 1B]C $4P;0!#,'H 0C&) $$QF !!,J@
M0#*[ #\RTP _,NX 0#+] $ R_P! ,O\ JC,  )8U  "&-0  >38  &XU  !F
M-0  83(  %PP  !7,   5# & %$P#@!.,!4 3#$= $HQ)0!(,2P 1S$R $8Q
M.0!$,4  0S)' $(R3P!!,U< 0#-@ #\T:P ^-7@ /36' #PVE@ [-J< .S:Y
M #HVT0 Z-NT .S;\ #LV_P [-O\ IC8  )(W  "".   =3@  &LX  !C-P
M738  %<S  !3-   3S0# $LT# !)-!( 1C4: $4U(@!#-2D 034O $ U-@ _
M-CT /C9$ #TW3  \-U4 .SA> #HX:0 Y.78 .#F% #<ZE0 W.J4 -CJX #4Z
MSP V.NP -CK[ #8Y_P W.?\ HC@  (XY  !^.@  <CL  &@[  !?.@  63D
M %,V  !.-P  2C@  $8X"@!$.1  03D7 #\Y'P ^.28 /#DM #LZ-  Z.CL
M.3M" #@[2@ W.U, -CQ< #4\9P T/70 ,SV# #,^DP R/J0 ,3ZV #$^S0 Q
M/NH ,3[Z #(]_P R/?\ GCL  (L\  ![/   ;CT  &0]  !</0  53P  $XZ
M  !).P  13P  $$]!P ^/0X /#T5 #H^'  Y/B, -SXJ #8_,0 U/S@ -#]
M #- 2  R0%  ,4!: #!!90 O07( +D*! "U"D0 M0J( +$*U "M"RP L0ND
M+$+Y "U!_P M0?\ F3T  (<^  !W/P  :S\  &%   !9/P  4C\  $D^  !$
M/P  0$   #Q!!  Y0@T -T(2 #5#&0 S0R$ ,D,H #%$+P P1#8 +T0] "Y%
M10 M14X +$58 "M&8P J1F\ *49^ "A&CP G1Z$ )D>S "9'R0 F1N< )T;X
M "A%_P H1?\ E4   ()!  !S0@  9T(  %Y"  !50@  3D(  $5"   _1
M.T4  #=&   T1PH ,4@0 "](%@ N21X +$DE "M)+  J23, *4HZ "A*0@ G
M2DL )DM5 "5+8  D2VT (TM\ ")+C0 A3)\ (4RQ "!,QP @2^8 (4OW ")*
M_P B2O\ D$,  'Y$  !O1   9$4  %I%  !210  2D8  $%'   \2   -TD
M #)+   N30< *TX. "E.$P G3QH )D\A "5/*  D3S  (U W ")0/P A4$@
M(%!2 !]170 >46H '5%Y !Q1B@ ;49P &E&O !E1Q0 94>0 &E#V !M/_P <
M3_\ BD8  'E'  !K1P  8$@  %9(  !.2   1TD  #Y+   Y3   ,TX  "Y0
M   H4P( )%0+ ")5$  @518 'U8> !Y6)  =5BP '%8S !M7.P :5T0 &5=.
M !A760 76&8 %5AU !18AP 46)H $U>L !)7P@ 25^$ $U;T !15_P 45?\
MA$D  '1*  !F2P  7$L  %-+  !+3   1$T  #Q/   U40  +U0  "E6   D
M60  'EL' !I=#0 871( %UT9 !9>(  57B< %%XN !->-P 27D  $5]* !%?
M50 07V( #U]Q  Y?@P -7Y8 #5^I  Q>O@ ,7MH #5WP  U<_  .7/\ ?DT
M &Y.  !B3@  6$\  $]/  !(4   0%(  #A4   P5P  *EH  "1=   ?7P
M&6(! !-E"0 19@\ $&84  ]F&P .9R( #6<I  UG,@ ,9SL "V=%  IG4  )
M9UT !V=L  9G?0 %9Y  !&:C  )FMP #9<\ !&7I  1D]0 $9/P =U$  &E2
M  !=4@  5%(  $Q3  !#50  .U@  #-;   K7@  )6$  !]D   99P  $VH
M  ]M!@ +< P "' 1  =P%@ %<!T !' D  -P+  "<#4  ' _  !P2@  <%<
M '!E  !P=@  <(H  &^>  !OL@  ;L@  &WE  !M\@  ;?D <%8  &-6  !9
M5@  45<  $?_XO__24-#7U!23T9)3$4 ! E8   ^6P  -E\  "YB   F9@
M'VH  !EM   3<   #G,   MV!  %> L  7@/  !Y$P  >1D  'D?  !Z)@
M>B\  'HY  !Z1   >E   'I?  !Z<   >H,  'J8  !ZK   ><(  'C?  !X
M[P  =_< :EL  %];  !66P  3%P  $)@   Y8P  ,&@  "AL   @<   &70
M !-W   .>P  "7X   2! @  @@@  (,-  "#$   A!0  (49  "&(   AB@
M (<Q  "'/   ATD  (=7  "':   AWL  (>0  "&I0  A;H  (73  "$Z@
MA/0 96   %Q@  !180  1F0  #QI   R;0  *7(  "%W   9>P  $H    V#
M   (AP   HH   "-    C@0  (X)  "/#0  D!   )$4  "2&0  DR   )0I
M  "5,P  E4   )9.  "67P  E7(  )6(  "5G0  E+(  )3(  "3X@  D^X
M864  %9F  !*:@  /VX  #5T   K>0  (7\  !F$   1B0  #(T   :1
ME    )@   ":    FP   )P"  "=!P  G@L  )\.  "A$@  HA@  *,@  "E
M*0  IC8  *9$  "F50  IF@  *9]  "FE   I:D  *2]  "DT0  I.0 6VP
M $]P  !#=0  .'L  "V!   CAP  &8T  !&2   +EP  !)P   "@    HP
M *8   "H    J0   *H   "L    K00  *X)  "P#0  L1$  +,7  "U(
MMBL  +<Z  "W2P  N%P  +AQ  "XB   N)T  +BQ  "WP@  M]  5'8  $A\
M   \@@  ,8D  ":0   ;EP  $IT   RB   #IP   *L   "N    L@   +8
M  "X    N    +H   "[    O0   +X   # !0  P0L  ,,0  #&%@  R2
M ,HN  #+/@  S%   ,QD  #->@  S9$  ,VD  #-M   S<  38,  $&*   U
MD0  *9D  !Z@   3I@  #*P   .Q    M@   +H   "^    P@   ,8   #(
M    R    ,H   #+    S0   ,X   #0    T@$  -4(  #9#@  W14  .$A
M  #B,0  Y$,  .56  #F:P  YH(  .>6  #GI0  YK  _P ) /\ !0#_  8
M_P . /\ %@#_ "$ _P M /\ . #] $, ^0!- /4 50#R %T \ !C .X :0#L
M &\ Z@!T .D >@#G '\ Y@"% .0 BP#C )$ X0"9 -\ H0#< *H V@"V -<
MQ@#5 .$ TP#T -( _P#1 /\ T0#_ ,\ _P#* /\ _P ! /\   #_  $ _P ,
M /\ $@#Z !T ]@ H /, ,P#P #X [ !( .@ 4 #E %@ X@!> -\ 9 #= &H
MVP!O -D = #6 'H U !_ -( A0#0 (P S@"3 ,P G #) *4 QP"P ,8 O@#$
M -0 P@#N ,$ _@#  /\ P #_ +\ _P"^ /\ _P   /\   #_    ^@ ' /$
M#P#K !@ Y@ C .( +@#@ #@ VP!" -4 2P#1 %( S@!9 ,L 7P#) &4 QP!J
M ,8 ;P#$ '0 P@!Z ,$ @ "_ (8 O0". +L E@"Y *  MP"J +8 MP"T ,H
ML@#F +$ ^ "P /\ KP#_ *\ _P"P /\ _P   /\   #W    Z@ " .$ # #7
M !, T  = ,P * #) #( Q@ \ ,( 10"_ $T O !3 +H 60"X %\ MP!D +4
M:0"T &X L@!T +$ >@"O (  K0"( *P D0"J )H J "E *8 L0"D ,$ HP#<
M *$ \@"A /\ H #_ *  _P"A /\ _P   /<   #H    V0   ,L " ## !
MO0 8 +D (@"V "P M  V +( /P"O $< K !- *L 5 "I %D IP!> *8 8P"E
M &@ HP!N *( = "@ 'H G@"" )P BP"; )4 F0"? )@ K "6 +H E #/ ),
MZP"2 /L D@#_ )( _P"1 /\ ]P   .<   #3    Q@   +L  @"S  P K0 2
M *H ' "G "8 I  P *, . "@ $  G@!' )P 3@": %, F0!8 )< 70"6 &,
ME0!H ), ;@"2 '0 D !\ (\ A0"- (\ BP": (H IP"( +4 A@#' (4 Y "$
M /4 A #_ (, _P"# /\ [    -,   #! 0  M    *P   "F  < H  . )T
M%@": "  EP I )4 ,@"3 #H D0!! (\ 2 "- $T C !3 (L 6 ") %T B !C
M (< :0"% &\ @P!W (( @ "  (H ?@"6 'T HP![ +  >@#" 'D W0!X /$
M=P#] '@ _P!X /\ W@H  ,0+  "R#   I@L  )T(  "9!   E0 * )$ $0".
M !D BP C (D + "' #0 A0 [ (, 0@"" $@ @ !. '\ 4P!] %@ ? !> 'L
M9 !Y &H > !R '8 >P!T (8 <P"2 '$ GP!P *T ;@"^ &T!U@!M NT ; /Z
M &P#_P!L _\ SA   +<1  "F$@  FA$  )$0  "+#@  B0L# (<%# "$ 1,
M@0$< 'X")0!\ RX >@,V '@$/ !W!$, =05( '0%3@!S!50 <059 ' &7P!N
M!F8 ;09N &L'> !J!X, : B0 &<)G0!E":P 9 F\ &,*U !C"^P 8@SZ &(,
M_P!B#/\ PQ8  *T7  "=&   D!@  (<6  "!%   ?1$  'P.!@!\"@X > H6
M '4+'P!R"R@ < PP &\,-P!M##X ; Q$ &L-2@!I#4\ : U5 &<-7 !E#6,
M8PYK &(.=0!@#H$ 7PZ. %T/G !<$*L 6Q"] %H0U@!9$?  61'] %D1_P!9
M$?\ N1L  *4=  "4'@  B!X  'X=  !X&P  =!@  '$5  !Q$0D ;Q 1 &P0
M&0!I$"( 9Q$J &81,@!D$3D 8Q$_ &(110!@$DL 7Q)1 %T26 !<$E\ 6A-H
M %D3<@!7%'T 5A2+ %05F0!3%:D 4A:Z %$6T@!1%^T 41?] %$7_P!1%_\
MLB   )XB  ".(@  @2,  '<B  !P(0  ;!X  &D;  !G& 0 9A4. &,6%0!A
M%AX 7Q8F %T6+0!<%S0 6A<[ %D700!8&$< 5AA- %485 !3&%P 4AED %$9
M;@!/&GH 3AN( $T;EP!+'*8 2ARX $H=SP!)'>L 21W[ $D=_P!*'?\ K"0
M )@E  "()@  >R<  '$F  !J)0  9B,  &(A  !@'@  7AP+ %L;$@!9'!H
M5QPB %4<*0!4'#  4QTW %$=/0!0'4, 3QU* $T>40!,'E@ 2Q]A $D?:P!(
M('< 1R"% $8AE !$(J0 1"*V $,BS !#(^D 0R/Z $,C_P!#(O\ IB<  ),I
M  "#*@  =BH  &TJ  !E*0  8"<  %PE  !9(P  5R$' %4A#P!2(18 4"$>
M $XA)0!-(BP 3"(S $HB.0!)(D  2")& $<C30!%(U4 1"1> $,D:0!")74
M0":# #\FD@ ^)Z, /B>T #TGR@ ]*.@ /2CY #TG_P ^)_\ HBH  (XK  !_
M+0  <BT  &@M  !A+   7"L  %@H  !4)@  428$ $XE#0!,)1, 2B8: $@F
M(@!')BD 128O $0F-@!#)SP 02=# $ G2P _*%, /BE< #TI9@ \*G( .RJ!
M #HKD  Y*Z$ ."RR #<LR  W+.8 ."SX #@L_P X+/\ G2P  (HN  ![+P
M;S   &4P  !=+P  6"X  %,K  !0*@  3"H  $DJ"P!&*A$ 1"H7 $(J'P!!
M*B4 /RHL #XK,P ]*SD /"M  #LL2  Z+%  .2U9 #@N9  W+G  -B]_ #4O
MCP T,)\ ,S"Q #(PQP R,.4 ,S#W #,P_P T+_\ F2\  (<Q  !W,@  :S(
M &(R  !:,@  5#$  $\O  !++0  1RX  $0N" !!+@X /RX4 #TN'  [+B(
M.2\I #@O+P W+S8 -C ^ #4P1@ U,4X -#%7 #,R8@ R,FX ,3-] # SC0 O
M-)X +C2P "TTQ0 M-., +C3V "\S_P O,_\ E3$  (,S  !T-   :#4  %XU
M  !7-   430  $LR  !&,0  0C(  #\R!0 \,@T .3,2 #@S&0 V,R  -#,F
M #,S+0 R-#0 ,30[ # U0P P-4P +S95 "XV8  M-VP +#=[ "LWBP J.)P
M*3BN "@XPP H..( *3CU "HW_P J-_\ DC0  '\U  !Q-@  93<  %LW  !4
M-P  338  $<V  !"-0  /38  #HV @ W-PL -#<0 #(W%@ Q.!T +S@D "XX
M*P M.3( +#DY "LY00 J.DD *CI3 "D[7@ H.VH )SMY "8\B0 E/)L )#RM
M ",\P@ C/.  )#ST "4[_P E._\ C38  'PX  !M.0  8CD  %@Z  !1.0
M2CD  $0Y   ].0  .3H  #4[   R.P@ +SP. "T]%  L/1H *CTA "D]*  H
M/B\ )SXV "8^/@ E/T< )#]0 "- 6P B0&@ (4!V "! AP ?09D 'T&K !Y!
MP  >0=X 'T#S !] _@ @/_\ B3D  '@Z  !I.P  7CP  %4\  !-/   1SP
M $ \   X/0  -#X  #!    M004 *D(, "="$0 F0Q@ )$,> "-#)0 B0RP
M(40S "!$.P ?1$0 'D5. !U%60 <164 &T5T !I%A0 91I< &4:I !A&O@ 7
M1=P &$7Q !E$_0 :1/\ A#P  ',]  !F/@  6S\  %(_  !*/P  1#\  #U
M   V00  ,4,  "Q$   G1@$ )$<* "%(#P @210 'DD; !U)(@ <22D &THP
M !I*.  92D$ &$I+ !=+50 62V( %4MQ !1+@@ 32Y0 $DNG !)+O  12]D
M$DKP !-*_  42?\ ?S\  &]   !A00  5T(  $Y"  !'0@  04(  #I#   R
M10  +4<  "A)   C2P  'DT& !M/#0 84!$ %U 7 !90'@ 54"4 %% L !-1
M-  243T $5%' !%14@ 045\ #U)M  Y2?@ -49$ #5&D  Q1N  ,4=$ #5#L
M  U0^@ .3_\ >4,  &I$  !=1   4T4  $M%  !$10  /D8  #9(   O2@
M*4P  "1/   ?40  &E,  !16"0 15PX $%@3 !!8&0 /6"  #E@H  U8,  -
M6#D #%A#  M83@ *6%H "%AH  =8>0 &6(P !5B?  18LP $5\H !5?F  57
M\P &5OP <T8  &1'  !92   4$@  $A(  !!20  .DH  #)-   K4   )5(
M "!5   :6   %5H  !!=!@ ,8 P "F 0  E@%0 (8!P !V C  5@*P $8#0
M V ]  %@20  8%4  &!C  !@<P  8(8  %^:  !?K@  7\0  %[B  !>\
M7O@ ;$H  %]+  !52P  3$P  $5,   ]3@  -5   "Y3   G5@  (%D  !I<
M   57P  $&(   UE!  (9PL  V<.  !H$P  :!@  &@?  !I)@  :2X  &DX
M  !I0P  :4\  &E=  !I;0  :8   &F4  !HJ0  :+\  &?<  !F[@  9O<
M9D\  %I/  !13P  2D\  $%1   X5   ,%<  "A;   A7@  &F(  !1E   0
M:   #&L   =N P !< D  ' -  !Q$   <10  '(:  !S(0  <R@  ',Q  !S
M/   =$@  '-6  !S9@  <WD  '..  !SHP  <KD  ''2  !QZP  </0 85,
M %93  !/4P  154  #M8   R7   *F   ")D   ;:   %&P   ]O   +<@
M!G8   !Y    >@8  'H*  ![#@  ?!$  'T5  !^&P  ?R(  ( J  " -0
M@$$  (!/  " 7P  @'$  ("&  " G0  ?[(  '[*  !^Y0  ??$ 7%@  %18
M  !)6@  /UT  #5A   L90  (VH  !MO   4<P  #G<   E[   #?P   ((
M  "$    A@$  (8&  "("@  B0T  (H0  "+%0  C!L  (XB  "/+   CS@
M (]&  "/5@  CV@  (]^  "/E0  CJL  (W!  "-W   C.L 65T  $Y?  !#
M8@  .&8  "YL   D<0  ''<  !1\   .@0  "(4   ")    C0   )    "2
M    DP   )0   "6 P  EP@  )@,  ":#P  FQ,  )T:  "?(P  H"X  * \
M  "@3   H%X  *!T  "?C   GZ(  )^W  ">RP  GN  4V0  $=H   \;0
M,7,  "=Y   =?P  %(4   V+   &D    )0   "8    G    )\   "A
MH@   *0   "E    IP   *@$  "J"0  K T  *T2  "P&0  LB,  +(Q  "R
M0@  LE0  +)I  "R@   LI@  +&L  "ROP  L<X 3&X  $!S   U>@  *H$
M !^(   5C@  #I4   ::    GP   *0   "H    K    *\   "Q    L0
M +,   "U    M@   +@   "Z    O 8  +X,  # $0  PQD  ,4F  #%-P
MQDD  ,9=  #'<@  QXH  ,B?  #(KP  R+P 1GH  #F!   NB0  (I   !>8
M   /GP  !Z4   "J    KP   +,   "W    O    +\   #!    P@   ,0
M  #%    QP   ,D   #+    S0   ,\#  #2"@  UA   -P:  #=*@  WCP
M -]0  #@90  X7L  .&1  #BH@  XJT _P " /\   #_  , _P , /\ $P#_
M !T _P H /X ,P#[ #X ]P!( /, 4 #P %< [0!> .L 9 #H &D YP!O .4
M= #C 'D X@!_ .  A0#> (P W "3 -D G #6 *8 TP"Q -$ P #/ -H S@#Q
M ,P _P#+ /\ RP#_ ,8 _P#! /\ _P   /\   #_    _P ( /L $ #V !D
M\@ D .\ +@#M #D Z !" ., 2P#@ %( W0!9 -D 7P#6 &0 TP!I -$ ;@#/
M '0 S@!Y ,P ?P#* (8 R ". ,8 E@#$ *  P@"K ,  N0"^ ,T O #J +L
M_ "Z /\ N@#_ +H _P"V /\ _P   /\   #^    ]  $ .L #0#D !0 WP ?
M -L *0#8 #, TP ] ,X 10#* $T QP!3 ,4 60## %\ P0!D +\ :0"] &X
MNP!S +H >0"X (  M@"( +0 D "R )H L0"E *\ L@"M ,0 K #A *L ]@"J
M /\ J@#_ *H _P"J /\ _P   /T   #N    X@   -4 "@#- !$ QP 9 ,0
M(P#! "T OP W +L /P"W $< M0!. +( 4P"P %D KP!> *T 8P"L &@ JP!M
M *D <P"H 'H I@"! *0 B@"C )0 H0"? )\ K "> +L G #2 )L [@": /\
MF@#_ )D _P"9 /\ _@   .X   #>    RP   ,$ !0"Y  T M  4 +$ '@"N
M "< JP P *H .0"G $$ I !( *( 30"A %, GP!8 )X 70"= &( FP!G )H
M;0"8 ', EP![ )4 A "4 (X D@"9 )  I@". +0 C0#( (P Y@"+ /D B@#_
M (H _P"+ /\ \    -L   #'    N@   +    "H  H I  0 *  & "= "$
MFP J )H ,P"8 #L E@!! )0 2 "2 $T D0!2 (\ 5P". %P C !A (L 9P"*
M &X B !U (< ?@"% (@ @P"4 (( H "  *\ ?P#  'X W0!] /( ?0#_ 'T
M_P!] /\ X    ,8   "U    J@   *(   ";  4 E0 - )( $P"0 !P C0 D
M (L +0"* #0 B  [ (8 0@"% $< @P!- (( 4@"! %< ?P!< 'X 8@!] &@
M>P!P 'H >0!X (, =@"/ '4 G !T *H <@"Z '$ T0!P .P < #[ '  _P!P
M /\ S00  +<&  "G!P  FP8  ),$  ".    B@ ( (8 #P"$ !8 @0 > '\
M)P!] "X ?  V 'H / !Y $( =P!' '8 3 !U %( <P!7 '( 70!Q &, ;P!K
M &X = !L 'X :P"* &D F !H *8 9P"V &8 RP!E .< 90#W &4 _P!E /\
MP P  *L-  ";#@  CPX  (8-  "!"P  ?@<! 'P!"P!Y !$ =P 8 '4 (0!S
M "D <0 P &\ -@!N #P ; !" &L 1P!J $T :0!2 &@ 6 !F %\ 90!G &,
M< !B 7H 8 &' %\"E0!> J, 7 .S %P#QP!;!.0 6P7T %L&_@!;!O\ M1
M *$2  "1$P  A1,  'P2  !V$0  <PX  '(,! !Q!PT ;@02 &P$&P!I!2,
M9P4J &8&,0!D!C< 8P8] &('0P!A!TD 7P=. %X(50!="%P 6PEC %H);0!8
M"G@ 5PJ% %8+DP!4"Z( 4PNS %(,QP!2#.0 40WU %$-_P!1#?\ K14  )D7
M  ")&   ?1D  '08  !M%P  :A0  &<1  !G#@< 9@P. &,,%0!A#!T 7PPE
M %T-+ !<#3, 6PTY %H-/P!8#44 5PU+ %8.40!5#ED 4PYA %(.:P!0#W8
M3A"# $T0D@!,$*( 2Q"R $H1R !)$>4 21'W $D2_P!)$?\ I1D  )(<  "#
M'0  =AX  &T=  !F'   8AH  %\7  !>% $ 7A$* %L0$0!9$1@ 5Q$@ %41
M)P!4$2X 4Q$T %$1.P!0$D$ 3Q)' $X23@!,$E4 2Q-> $D39P!(%', 1A2
M $45CP!$%9\ 0Q:P $(6Q0!"%^, 0A?V $(7_P!"%_\ GQT  (P@  !](0
M<2(  &@B  !A(0  7!\  %D<  !7&0  518& %05#@!1%10 3Q8< $X6(P!,
M%BH 2Q8P $H6-P!)%ST 1Q=# $872@!%&%( 0QA: $(99 !!&7  /QI] #X;
MC0 ]&YT /!RN #L<PP ['.$ .QWU #L<_P \'/\ FB$  (<C  !X)   ;"4
M &,E  !<)   5R,  %,@  !1'@  3QP" $T;# !+&A$ 2!L8 $<;( !%&R8
M1!LM $,<,P!"'#D 0!Q  #\=1P ^'4\ /1Y8 #P>8@ Z'VT .1][ #@@BP W
M(9L -B&M #4AP0 U(=\ -2'S #8A_P V(?\ EB,  (,F  !T)P  :"@  %\H
M  !8)P  4R8  $\D  !,(@  22   $<@"0!$'P\ 0A\5 $ @'  _(", /B I
M #P@+P [(38 .B$] #DA1  X(DP -R)5 #8C7P T(VL ,R1Y #(EB0 Q)9H
M,"6K # FOP O)MP ,";R # F_P Q)?\ D28  '\H  !Q*@  92H  %PJ  !5
M*@  3RD  $LH  !()0  1"0  $$D!0 _) T /202 #LD&0 Y)!\ -R0F #8D
M+  U)3, -"4Z #,F00 R)DH ,2=3 # G70 O*&D +BEW "TIAP L*9@ *RJJ
M "HJO0 J*MH *RKQ "LJ_@ L*?\ C2@  'PJ  !M+   8BT  %DM  !1+0
M3"P  $<K  !#*   /R@  #PH @ Y* L -R@0 #4H%@ S*!P ,B@C # H*0 O
M*3  +RHW "XJ/P M*T< +"M1 "LL6P J+&< *2UU "@MA0 G+9< )BZH "4N
MO  E+M@ )B[P "8N_0 G+?\ BBL  '@M  !J+@  7R\  %8O  !.+P  2"X
M $,M   _+   .RP  #<L   T+ D ,BP. # M$P N+1H +2T@ "LM)P J+BT
M*BXU "DO/0 H+T4 )S!. "8P60 E,64 )#%S ",Q@P B,I4 (3*G "$RNP @
M,M0 (3+O "(Q_  B,?\ ABT  '4O  !G,   7#$  %,Q  !+,0  13$  $ P
M   [,   -C   #,P   P,08 +3$- "LQ$0 I,A< *#(> "<R)  E,RL )3,R
M "0S.@ C-$, (C1, "$U5P @-6, 'S5Q !XV@0 =-I, '#:E !LVN0 ;-M(
M'#;M !TV^P =-?\ @C   '$R  !C,P  630  % T  !)-   0C,  #TS   W
M,P  ,30  "XU   K-0( *#8+ "4W$  D-Q4 (C<; "$X(@ @."@ 'S@P !XX
M-P =.4  '#E) !LZ5  :.F  &3IN !@Z?P 7.Y$ %SND !8[MP 5.]  %CKL
M !<Z^@ 8.?\ ?3(  &TT  !@-0  538  $TV  !&-@  0#8  #HV   T-@
M+C@  "HY   F.@  (SL( " \#@ >/1( '3T8 !P]'P ;/B4 &CXM !D^-  7
M/CT %C]' !4_40 4/UX %#]L !- ?  20(\ $4"B !% M@ 00,X $3_K !(_
M^0 2/O\ >34  &DW  !<.   4CD  $HY  !#.0  /3D  #<Y   Q.@  *SP
M "<]   B/P  'D$$ !I""P 80Q  %T,5 !5$&P 41"( $T0I !-$,0 21#H
M$45# !!%3@ 015L #D5I  Y%>0 -18P #46?  Q%L@ +1<D #$7E  U$]@ -
M1/\ =#D  &4Z  !8.P  3SL  $<\  ! /   .CP  #0\   N/@  *$   "-"
M   ?1   &D8  !5("  22@T $4H2 !!*&  /2QX #DLE  U++0 -2S8 #$M
M  M+2@ *2U8 "4MD  A+=  '2X< !4N:  1+K@ $2L0 !4K@  5*\  &2?H
M;CP  & ]  !4/@  2SX  $0^   ]/@  -S\  #%    J0@  )$4  !]'   :
M20  %4P  !%.!0 .40L "U$0  I1%  )41L "%$B  =1*0 %43( !%([  -2
M1@ !4E(  %)?  !2;P  4H$  %&6  !1J0  4;\  %#<  !0[@  4/< :$
M %M!  !000  2$$  $%!   [0@  -$,  "U%   F2   ($L  !M-   64
M$5,   Y5!  *6 H !E@.  )8$@  61<  %D=  !9)0  62T  %DV  !900
M64T  %I:  !::0  67P  %F0  !9I0  6+H  %C5  !7[   5_8 8T0  %9%
M  !-10  144  #]%   W1P  +TD  "A,   B3P  &U(  !95   16   #5H
M  E= P $7PD  & -  !@$   810  &$9  !B(   8B<  &(Q  !B.P  8D<
M &)5  !C9   8G8  &*+  !BH   8;8  &'/  !@Z@  8/4 74@  %))  !*
M2   0T@  #I*   R30  *E   "-3   <5P  %EH  !%=   -8   "&,   -F
M 0  9P8  &@+  !I#@  :A$  &L5  !L&P  ;2(  &TJ  !M-   ;4   &U.
M  !M70  ;6\  &V$  !LF@  ;+   &O(  !KY@  :O, 6$T  $Y-  !(3
M/DX  #51   L5   )%@  !U<   68   $&0   QG   ':P   6X   !P
M<@,  '('  !S"P  =0X  '81  !W%@  >!P  'DC  !Z+0  >CD  'I'  !Z
M5@  >6@  'I\  !YE   >*H  'C!  !WWP  =^\ 5%$  $Q1  !"4@  .%4
M "]9   F7@  'F(  !9G   0:P  "V\   5S    =P   'H   !\    ?@
M '\"  " !@  @0H  (,-  "$$0  AA4  (@<  "))0  BC   (H^  ")30
MB5\  (ES  "(BP  B*(  (>Y  "'T0  AN@ 4E8  $=7   \6@  ,E\  "AD
M   ?:0  %F\  !!T   *>0   GT   "!    A0   (@   "*    C    (T
M  "/    D 0  )((  "3#   E1   )<5  "9'0  FR<  )LT  ";1   FE8
M )IJ  "9@@  FIH  )BP  "8QP  E]X 2UP  $!@   U90  *VH  "%Q   7
M=P  $'T   F#   !B    (P   "1    E0   )@   ":    FP   )T   "?
M    H    *(   "D!0  I@H  *@.  "J%   K1T  *TJ  "M.0  K4L  *U?
M  "M=P  K)   *NG  "KN@  J\L 168  #EK   N<0  (W@  !E_   0A@
M"8T   "3    F    )T   "A    I0   *@   "K    JP   *X   "O
ML0   +,   "U    MP$  +D'  "\#0  OQ,  ,(?  #"+@  PD   ,)4  #!
M:P  P8,  ,";  #!K0  P;P /G(  #)X   G@   '(@  !*0   *EP   )T
M  "C    J    *T   "R    M@   +D   "[    O    +X   #     P@
M ,0   #&    R    ,L   #.!0  T0T  -84  #7(P  V#4  -E)  #:7@
MVW4  -N,  #<GP  W*L _P   /\   #_    _P ) /\ $ #_ !D _@ D /P
M+P#Y #D ] !# /  2P#M %( Z@!9 .< 7P#D &0 X@!I .  ;@#> ', W !Y
M -H ?P#7 (8 U ". -$ E@#/ *$ S "L ,H NP#( -( Q@#N ,8 _P#% /\
MQ0#_ +\ _P"Z /\ _P   /\   #_    _@ % /< #@#R !4 [@ ? .L *@#I
M #0 XP ] -X 10#9 $T U !3 -$ 60#. %X S !C ,H : #) &T QP!S ,4
M>0## (  P0"( +\ D "] )L NP"F +D M "W ,@ M@#F +4 ^P"T /\ M #_
M +, _P"N /\ _P   /\   #X    [0   .4 "P#= !$ UP : -( ) #/ "X
MRP W ,< 0 ## $< P !. +X 4P"\ %D N@!> +@ 8P"V &@ M0!M +, <P"Q
M 'D KP"! *T B@"K )0 J0"@ *@ K0"F +X I0#; *0 ] "D /\ HP#_ *,
M_P"B /\ _P   /8   #F    UP   ,L !@#$  X O@ 5 +L 'P"Y "@ MP Q
M +0 .@"P $$ K0!( *L 3@"I %, IP!8 *8 7 "D &$ HP!G *$ ; "@ ',
MG@!Z )T @P"; (X F0"9 )< I@"6 +8 E0#, )0 ZP"3 /T DP#_ ), _P"3
M /\ ]P   .0   #0    P0   +<  @"O  L JP 1 *< &0"E "( HP K *(
M,P"? #L G !" )L 2 "9 $T EP!2 )8 5P"5 %L DP!A )( 9@"0 &T CP!T
M (T ?0", (< B@"3 (@ H "' *\ A0#" (4 X@"$ /< A #_ (0 _P"$ /\
MY0   ,T   "\    KP   *8   ">  < F@ . )8 % "4 !T D@ E )$ +0"0
M #4 C0 \ (P 0@"* $< B !, (< 40"& %8 A !; (, 8 "! &< @ !N 'X
M=P!] ($ >P"- 'H F@!X *D =P"Z '8 TP!V .\ =@#^ '4 _P!U /\ T
M +L   "K    GP   )<   "0  ( BP + (@ $ "& !< A  @ (( )P"! "\
M?P U 'T / !\ $$ >P!& 'D 2P!X %  =P!5 '8 6P!T &$ <P!I '$ <0!P
M 'L ;@"' &T E0!K *, :@"T &H R0!I .@ :0#Y &D _P!I /\ P    *P
M  "< @  D (  (@   "#    ?P & 'L #0!Y !( =P : '8 (@!T "D <P P
M '$ -@!P #P ;P!! &T 1@!L $L :P!0 &H 5@!H %P 9P!D &4 ; !D '8
M8P"" &$ D !@ )\ 7P"O %X PP!> .$ 7@#T %T _P!= /\ M <  * )  "0
M"P  A L  'P*  !W!P  = 0  '$ "0!O  \ ;0 5 &L ' !I ", :  J &<
M,0!E #8 9  \ &, 00!B $8 8 !, %\ 4@!> %@ 70!? %L : !: '( 6 !^
M %< C !6 )L 50"K %0 O@!4 -H 4P#O %0 ^P!4 /\ J0T  )8.  "'$
M>A   '(0  !L#@  :0P  &<) P!F! L 9  0 &( %P!@ !X 7@ E %T *P!<
M #$ 6@ W %D / !8 $( 5P%' %8!3@!5 E0 4P)< %(#90!1 V\ 3P1[ $X$
MB@!-!9D 3 6I $L%O !*!M0 2@?M $H'^0!*!_\ H1   (X2  !^%   <Q0
M &H4  !D$P  8!$  %X/  !=#04 70D- %H&$@!8!QD 5@<@ %4')P!3!RT
M4@@S %$(. !0"#X 3PE$ $X)2@!,"5$ 2PI9 $H*8@!("VT 1PMZ $8,B !$
M#)@ 0PRI $(-O !"#=4 0@WN $(-^P!"#?\ FA0  (<6  !X&   ;!D  &,9
M  !=&   618  %83  !4$0  5 X( %,-#@!1#10 3PT; $T-(@!,#2@ 2PTN
M $H-- !)#3H 1PY! $8.1P!%#D\ 1 Y7 $(/80!!$&P /Q!Y #X0B  ]$9@
M.Q&I #L1O  Z$=8 .A'P #H2_0 [$?\ DQ@  ($:  !S'   9QT  %X=  !8
M'   4QL  % 8  !.%@  3!,# $P1"P!*$!  2!$7 $81'@!%$20 1!$J $(1
M, !!$3< 0!(] #\21  ]$DP /!-4 #L37@ Y%&D .!1V #<5A0 V%98 -!:G
M #06N@ S%M, ,Q;N #06_  T%O\ CAL  'P=  !N'P  8R   %H@  !3(
M3AX  $H=  !(&@  1A@  $46!P!#%0X 0143 #\5&@ ^%2  /14G #L5+0 Z
M%C, .18Z #@600 W%TD -1=1 #086P S&68 ,AES # :@P O&I0 +ANE "T;
MN  M&]  +1OL "X;^P N&_\ BAX  '@@  !J(@  7R,  %8C  !/(@  2B$
M $8@  !#'@  01L  #\: P ]&@P .QD1 #D9%@ W&AT -AHC #4:*0 T&C
M,QLV #$;/@ P'$8 +QQ/ "X=60 M'60 +!YQ "L?@0 J'Y( *1^D "@@MP G
M(,X )R#K "@@^@ I'_\ AB   '0C  !G)   7"4  %,E  !,)0  1R0  $(C
M   _(0  /1\  #H>   W'@D -1X. #,>$P Q'AH ,!X@ "\>)@ N'RT +1\S
M "P@.P K($, *B%, "DA5@ H(F( )B)O "4C?P D(Y  (R.B "(DM0 B),P
M(B3I ",D^0 D(_\ @B,  '$E  !C)@  62<  % H  !))P  0R<  #\F   [
M)   ."(  #4B   R(@8 ,"(- "XB$0 L(A< *B(= "DB(P H(RH )R,Q "8D
M.  E)4$ )"5* ",F5  B)F  (2=M " G?0 ?)X\ 'BBA !XHM  =*,H '2CH
M !XH^  ?)_\ ?B4  &XG  !@*0  5BD  $TJ  !&*@  02D  #PH   W)P
M-"8  # F   M)@, *R<+ "@G$  G)Q0 )2<: "0G(0 C*"< (B@N "$I-@ @
M*3X 'RI( !XJ4@ =*UX '"MK !LK>P :+(T &2R? !@LL@ 8+,D &"SG !DK
M]P :*_\ >B<  &HJ  !=*P  4RP  $HL  !#+   /BL  #DK   T*@  ,"H
M "LJ   I*P  )BL( ",L#@ B+!( ("P8 !\L'@ >+24 '2TL !PM,P ;+CP
M&BY% !DO4  8+UP %R]I !8P>0 5,(L %#"> !0PL0 3,,< $S#E !0P]@ 5
M+_\ =BH  &<L  !:+0  4"X  $@N  !!+@  .RX  #8M   Q+0  +"T  "<O
M   D+P  (3 % !\Q#  <,1  &S(5 !HR'  9,B( &#(I !<S,0 6,SD %3-#
M !0T30 3-%D $C1G !$U=P 1-8D $#6< ! UL  .-<8 #S3D ! T]0 0-/\
M<BP  &,N  !7,   33   $4P   ^,   .#   #,P   O,   *3$  "0R   A
M,P  '34" !HV"0 7-PX %3<3 !0X&0 3.!\ $C@F !(X+@ 1.38 $#E  ! Y
M2P ..5< #CID  TZ=  ,.H8 ##J9  LYK  *.<$ "CG>  LY\0 ,./P ;B\
M %\Q  !3,@  2C,  $(S   [,P  -C,  #$R   L,P  )S0  "$V   =.
M&3D  !4[!@ 2/0P $#X0 ! ^%0 ./AP #CXC  T^*@ ,/C, ##X\  L_1P *
M/U( "#]@  <_;P &/X$ !3^4  0_J  #/KP !#[7  4^[  %/O< :3,  %LT
M  !0-0  1S4  #\U   Y-0  -#4  "XU   I-P  (S@  !X[   :/   %C\
M !)!!  .0PH #$0.  I$$P )1!D "$0@  =$)P &1"\ !40X  -%0@ "14X
M $5;  !%:@  17P  $60  !$I   1+D  $31  !$Z@  0_4 9#8  %<W  !,
M.   0S@  #PX   W.   ,3@  "LY   E.P  (#T  !I    60@  $D0   Y'
M!  +20D !TH-  1+$0 !2Q8  $L<  !+(P  2RL  $LT  !+/@  3$D  $Q7
M  !,9@  3'<  $N,  !+H0  2[4  $K.  !*Z0  2O4 7SH  %([  !(.P
M0#L  #H[   T.P  +CP  "<^   B00  '$,  !9&   220  #DL   M. P '
M4 @  E$,  !1$   4A,  %,8  !3'P  4R8  %,O  !3.0  4T4  %-2  !3
M80  4W(  %.'  !2G   4K$  %'*  !1YP  4?0 63X  $X^  !%/@  /CX
M #@^   P0   *4(  "-$   =1P  %TH  !)-   .4   "U,   95 @  5P<
M %@+  !9#@  6A$  %H5  !;&@  7"$  %PJ  !<-   7#\  %Q-  !<6P
M7&P  %R!  !;EP  6ZT  %K%  !:Y   6?, 5$(  $I"  !"0@  /$(  #1#
M   L1@  )4D  !Y,   73P  $E,   Y6   *60  !5L   !>    8 0  &$(
M  !B#   8PX  &01  !E%@  9AP  &<C  !G+0  9SD  &=&  !G50  9V8
M &=Z  !FD0  9:@  &7   !DW@  9/  3T8  $=&  ! 10  -T<  "]*   F
M30  'U$  !A5   260  #5P   A@   "8P   &8   !H    :@   &L$  !L
M"   ;0P  &\.  !P$@  <A<  ',=  !T)@  =#(  '0_  !T3@  <U\  '1R
M  !SB@  <J$  '&X  !QU   <.P 3$H  $5*   [2P  ,DX  "E2   @5@
M&%L  !)?   -9   !V@   !K    ;P   '(   !U    =@   '<   !Y @
M>@8  'P*  !^#@  @!$  ((6  "$'@  A"D  (0V  "$10  A%8  (-J  "#
M@0  @ID  (&Q  " R0  @.4 2DX  #]0   U4P  *U<  ")<   98@  $F<
M  QL   %<0   '4   !Y    ?0   ($   "#    A0   (8   "(    B0
M (L$  "-"   CPT  )(0  "4%@  EB   )8L  "6.P  EDP  )5@  "5=@
ME)   ).G  "2O0  DM4 1%4  #E9   O70  )&,  !II   2;P  #'4   1[
M    @    (4   ")    C0   )$   "3    E    )8   "8    F@   )P
M  ">    H 8  *(+  "E$   J!<  *DC  "I,0  J4,  *E6  "H;0  IH<
M *>>  "FLP  I<< /EX  #)C   G:@  '7   !-X   ,?P   X4   "+
MD0   )8   ";    GP   *(   "D    I0   *<   "I    JP   *T   "P
M    L@   +4"  "W"0  NQ   +X8  "^)@  OC@  +Y+  "]80  O'H  +N4
M  "ZJ0  NKD -VH  "MP   @>   %H    V(   %CP   )8   "<    H@
M *<   "L    L    +,   "V    MP   +D   "[    O0   +\   #"
MQ0   ,@   #*    S@@  -(0  #5&P  U2P  -1   #45P  TVX  -2&  #4
MFP  TZL _P   /\   #_    _P % /\ #@#_ !4 _  @ /D *@#V #0 \0 ]
M .T 1@#I $T Y@!3 .0 60#A %X W@!C -P : #9 &X U0!S -, >0#0 (
MS@"( ,L D0#) )P Q@"G ,0 MP#" ,P P #L +\ _P"^ /\ O0#_ +< _P"R
M /\ _P   /\   #_    ^@ ! /, "P#M !( Z  ; .4 )0#D "X WP X -@
M0 #2 $< S@!. ,L 5 #( %D Q@!> ,0 8P#" &< P !M +\ <P"] 'H NP"!
M +D BP"V )4 M "A +( KP"P ,( K@#C *X ^@"L /\ K0#_ *D _P"F /\
M_P   /\   #R    Y@   -T !P#2  X S0 6 ,H ( #( "D Q0 R ,  .@"\
M $( N0!( +< 3@"U %, LP!8 +$ 70"P &( K@!G *P ; "J ', J0![ *<
MA "E (X HP": *$ J "? +D G@#2 )T \@"< /\ G0#_ )P _P"9 /\ _
M .X   #=    S    ,$  @"Z  P M@ 2 +( &@"P ", KP L *T - "I #P
MI@!" *0 2 "B $T H !2 )X 5P"= %L G !@ )H 9@"9 &P EP!T )4 ?0"3
M (< D0"3 )  H0". +$ C0#& (P Z "+ /T C #_ (P _P", /\ [0   -@
M  #%    MP   *P   "F  @ H0 . )\ %0"= !X FP F )H +@"7 #4 E0 \
M ), 0@"1 $< D !, (X 40"- %4 BP!: (H 8 ") &8 AP!M (4 =@"$ (
M@@", (  F@!_ *D ?0"\ 'P W !\ /4 ? #_ 'P _P!\ /\ V0   ,$   "Q
M    I    )P   "4  , D  , (T $0"+ !@ B0 @ (D * "' "\ A0 V (,
M/ "" $$ @ !& '\ 2P!] $\ ? !4 'L 6@!Y &  > !G '8 < !U 'H <P"&
M '$ DP!P *( ;P"T &X S !N .T ;@#^ &X _P!N /\ Q    *\   "@
ME    (P   "&    @0 ( 'X #@!\ !0 >P ; 'D (@!X "D =P P '4 -@!T
M #L <@!  '$ 10!P $H ;P!/ &T 5 !L %L :P!B &D :@!H '0 9@"  &4
MC@!C )T 8@"M &$ P@!A .0 80#X &$ _P!A /\ M    *    "1    A@
M 'X   !Y    =0 # '$ "P!O !  ;0 6 &P '0!K "0 :P J &D , !H #8
M9@ [ &4 0 !D $4 8P!* &$ 3P!@ %8 7P!= %T 90!< &\ 6@!Z %D B !8
M )@ 5P"H %8 NP!6 -@ 5@#Q %8 _P!6 /\ J $  )0%  "%!P  >@<  '(&
M  !L!   :0$  &< !P!D  T 8P 1 &$ & !@ !\ 7P E %X *P!= #  6P V
M %H .P!9 $  6 !% %< 2P!6 %$ 50!8 %, 80!2 &H 4 !V $\ A !. ),
M30"D $P M@!, ,T 3 #K $P ^@!, /\ G0D  (L+  !\#0  < T  &@-  !B
M#   7PH  %T& 0!< 0D 6@ . %@ $P!7 !D 5@ @ %4 )@!3 "L 4@ Q %$
M-@!0 #L 3P!! $X 1P!- $T 2P!5 $H 70!) &< 1P!S $8 @ !% )  1 "A
M $, L@!# ,@ 0P#F $, ]0!# /\ E0T  (,/  !T$   :1$  & 1  !:$
M5@X  %0-  !3"@0 4P8+ %$#$ !/ 14 3@$; $P!(0!+ 2< 2@(L $D",@!(
M C< 1P,] $4#0P!$ TH 0P11 $($6@! !60 /P5P #X&?@ ]!HX / >? #L'
ML0 Z!\8 .@?C #H'\P Z"/P CA   'P2  !N%   8A4  %H5  !4%   4!,
M $T1  !+#@  2PT& $H*# !)"!$ 1P@6 $4('0!$"", 0@@H $$)+@! "3,
M/PDY #X*0  ]"D< / I/ #H+6  Y"V, . QO #8,?@ U#(X - V? #,-L0 R
M#<< ,@WC #(-]  R#?X B!,  '<5  !I%P  7A@  %48  !/&   2A8  $<5
M  !%$P  0Q " $,." !"#0X 0 T2 #\-&  ]#1\ / TD #L-*@ Y#3  . XW
M #<./0 V#D4 -0Y- #,/5P R#V( ,1!N "\0?0 N$(X +1&@ "P1L@ K$<@
M*Q'F "L1]@ L$?\ @Q8  '(9  !D&@  61L  %$;  !+&P  1AH  $(8   _
M%P  /A0  #P2!  [$0H .A 0 #@0%0 W$!L -1$A #01)P S$2T ,A$S # 1
M.@ O$D( +A)+ "T35  K$U\ *A1L "D4>P H%(P )Q6> "85L  E%<8 )17D
M "45]@ F%?\ ?AD  &X;  !@'0  5AX  $T>  !''@  0AT  #X<   Z&@
M.!@  #<6   U%0< -!0- #(4$@ P%!< +Q0= "T4(P L%2H *Q4P "H5-P I
M%C\ *!9( "<74@ F&%T )!AJ ",9>0 B&8H (1F< " 9KP ?&<0 'QGB " 9
M]  @&?\ >AL  &H>  !='P  4R   $H@  !$(   /A\  #H>   W'0  -!P
M #(9   P&00 +A@+ "P8$  J&!0 *1@: "<8(  F&28 )1DM "0:-0 C&CT
M(AM& "$;4  @'%L 'QUH !X==P ='8@ '!Z; !L>K0 :'L, &A[@ !H=\P ;
M'?\ =QT  &<@  !:(0  4"(  $@B  !!(@  .R(  #<A   S(   ,!\  "T=
M   K'0  *!T( "8=#@ E'1( (QT7 "$='0 A'20 (!XJ !\>,@ >'SH '1]#
M !P@30 ;(5D &B%F !DA=0 8(H< %R*9 !8BK  5(L$ %2+? !4A\@ 6(?X
M<R   &0B  !7(P  320  $4E   ^)   .20  #0C   P(@  +"(  "DA   F
M(0  )"$& "(A#  @(1  'B$5 !TB&P ;(B$ &R(H !HC+P 9(S@ &"1! !<D
M2P 6)5< %25D !0F<P 3)H4 $B:8 !$FJP 1)L  $";= !$E\0 2)?T <"(
M &$D  !4)@  2B8  $(G   \)@  -B8  #$E   M)0  *20  "8D   B)0
M'R4# !TF"@ ;)@X &2<2 !@G&  7)Q\ %B<E !4H+0 4*#4 $RD^ !(I20 1
M*54 $2IB ! J<0 /*H, #BJ6  XJJ0 -*KT #2K7  TJ[@ .*?L ;"0  %TF
M  !1*   2"@  $ I   Y*   -"@  "\H   K)P  )R<  "(H   >*0  &RH
M !@K!P 6*PT %"P1 !,L%@ 2+!P $2TC ! M*@ 0+3( #RX\  XN1@ -+E(
M#2Y?  PO;@ ++W\ "B^2  DOI0 )+KD ""[0  DNZ0 *+O< :"<  %HI  !.
M*@  12L  #TK   W*P  ,2H  "TJ   I*@  )"H  " K   ;+0  &"X  !4O
M!  2,0H $#(.  \R$P .,AD #3(@  TR)P ,,B\ "S,X  HS0@ ),TX "#-;
M  8T:@ %-'L !#..  ,SH@ ",[8  C/-  ,SYP $,O, 9"H  %8L  !++0
M0BT  #HM   T+0  +RP  "LL   F+   (BT  !TO   9,0  %3(  !(T P /
M-@D ##@-  HX$0 ).!8 "#@=  <X)  &."P !#@T  ,X/@ ".4H  #E7   Y
M90  .7<  #F+   XGP  .+,  #C*   XY@  -_( 7RT  %(N  !(+P  /S
M #@O   R+P  +2\  "DO   D,   'S$  !HS   5-0  $C<   \Y P ,.P@
M"#T-  4^$  #/A0  #X:   ^(0  /B@  #XQ   _.P  /T8  #]3   _80
M/W,  #^'   ^G   /K   #W'   ]Y   /?( 6C   $XR  !$,@  /#(  #4R
M   P,0  *S$  "8R   @-   &S8  !8X   2.P  #ST   P_ P (00@ !$,,
M  !##@  1!(  $46  !%'0  120  $4M  !&-@  1D(  $9.  !&70  1FX
M $6"  !%F   1*T  $3$  !#XP  0_( 530  $HU  !!-0  .34  #,T   N
M-   *#4  "(W   =.@  %SP  !(_   /00  #$0   A& 0 #2 8  $D*  !*
M#0  2Q   $P4  !-&0  3B   $XH  !.,@  33T  $Y*  !.6   36D  $U]
M  !,E   3*H  $O!  !+X0  2O( 4#@  $8X   ].   -S@  #$W   J.0
M)#L  !X]   80   $T,   ]&   +20  !TL   ).    4 0  %$(  !2"P
M4PX  %01  !5%0  5AL  %<C  !7+   5S@  %=$  !74@  5F,  %9W  !6
MC@  5:4  %2]  !3W0  4_  2SP  $(\   [.P  -3L  "T\   F/P  'T(
M !E%   32   #DL   M/   %40   %0   !7    6 $  %H%  !;"   7 P
M %T.  !?$0  8!8  &(=  !B)@  8C$  &(^  !A3   85T  &%P  !@B
M8*   %^W  !>U   7>X 1T   #\_   Z/P  ,4   "E#   A1@  &DH  !-.
M   .40  "E4   18    6P   %X   !A    8P   &0!  !E!   9P@  &@+
M  !J#@  ;!(  &X7  !O(   ;RH  &\V  !N10  ;E4  &YH  !M?P  ;9@
M &RP  !KR@  :N@ 1$0  #Y#   U1   *T<  "-+   ;3P  $U0   Y8   (
M7    F    !D    9P   &L   !M    ;P   '    !R    = (  '4&  !W
M"@  >0X  'P2  !^&   ?R(  '\N  !_/0  ?DT  'UA  !]=P  ?)   'NH
M  !ZP   >=\ 0T<  #E)   O3   )5   !Q5   46P  #F    =E    :@
M &X   !R    =@   'D   !\    ?@   '\   "!    @P   (4   "' P
MB@@  (P-  "/$0  DAD  )(E  "2,P  DD0  )%7  "0;0  CX8  (Z?  "-
MM0  C,T /4X  #)1   H5@  'EP  !5B   .:   !VX   !T    >0   'X
M  ""    A@   (D   ",    C@   )    "2    E    )8   "8    FP
M )X&  "A#   I!$  *8;  "F*0  ICH  *5-  "E8@  I'L  *.4  "AJP
MH;\ -E<  "Q<   A8@  %VD   ]P   '=P   'X   "$    B@   (\   "4
M    F    )L   ">    GP   *(   "D    I@   *@   "K    K0   +
M  "S!   MPP  +L2  "['P  NS   +M#  "Z6   N7   +>+  "WH0  M[,
M,&(  "5I   :<   $'@   F     B    (\   "6    FP   *$   "F
MJ@   *X   "P    L0   +0   "V    N    +L   "]    P    ,,   #'
M    RP,  ,\,  #3%0  TB4  -(X  #13@  T&4  ,]^  #-E@  S*D _P
M /\   #_    _P # /\ "P#\ !$ ^0 ; /< )0#S "\ [@ X .D 0 #F $@
MX@!. -\ 5 #< %D V0!> -4 8P#3 &@ T !M ,X <P#+ 'H R "" ,8 C ##
M )< P "C +X L@"\ ,@ N@#J +D _P"X /\ L0#_ *H _P"G /\ _P   /\
M  #[    ]@   .T !P#G  \ X@ 6 -\ ( #> "D V0 S -$ .P#, $( R !(
M ,4 3@#" %, P !8 +X 70"\ &( N@!G +D ;0"W '0 M0![ +( A0"P )
MK@"< *P J@"I +T IP#> *8 ^0"E /\ HP#_ )T _P"; /\ _0   /8   #K
M    WP   -$  P#*  P Q0 2 ,, &P#  "0 O@ L +D -0"V #P LP!# +
M2 "N $X K !2 *L 5P"I %P IP!A *8 9P"D &T H@!T *  ?0"> (@ G "5
M )H HP"8 +0 E@#- )4 \0"4 /\ E0#_ )  _P". /\ \P   .8   #1
MP@   +@   "Q  @ K0 / *H %@"H !X J  G *8 +P"B #8 GP \ )T 0@";
M $< F0!, )< 40"6 %4 E !: ), 8 "1 &8 D !N (X =@", ($ B@"- (@
MFP"& *P A0#! (0 Y@"# /T A #_ (, _P"! /\ Y    ,L   "Z    K
M *(   "<  0 F  , )8 $0"4 !D DP A )( * "/ #  C0 V (L / ") $$
MB !& (8 2P"% $\ A !4 (( 6@"! &  ?P!G 'X ;P!\ 'H >@"& '@ E !W
M *0 =0"W '0 U !S /0 = #_ '0 _P!T /\ RP   +8   "F    F@   )(
M  "*    A@ ( (, #@"! !0 @0 ; (  (P!_ "H ?0 P 'L -@!Z #L > !
M '< 10!U $D = !. ', 5 !Q %H < !A &X :0!M ', :P!_ &D C0!H )T
M9P"N &8 QP!E .H 9@#_ &8 _P!G /\ N    *0   "5    B@   ($   !\
M    =@ $ '0 # !R !  <0 6 '  '0!P "0 ;@ J &T , !K #4 :@ Z &D
M/P!H $0 9P!) &4 3@!D %0 8P!; &$ 8P!@ &T 7@!Y %T AP!; )8 6@"H
M %D O0!9 -\ 60#X %H _P!: /\ J    )4   "'    >P   ',   !N
M:@ ! &< " !E  X 9  2 &, & !C !\ 8@ E &$ *@!? #  7@ U %T .@!<
M #X 6P!$ %D 20!8 $\ 5P!6 %8 7@!4 &@ 4P!S %$ @0!0 )$ 3P"B $X
MM0!. -  3@#P $X _P!/ /\ G    (D   ![ P  < ,  &@#  !B 0  7P
M %T ! !;  L 60 / %@ % !7 !D 5P @ %8 )0!5 "H 4P P %( - !1 #D
M4  _ $\ 1 !. $L 30!2 $L 6@!* &, 20!O $< ? !& (P 10"= $4 L !$
M ,< 1 #H $0 ^@!% /\ D@0  ( '  !Q"@  9@H  %X*  !9"0  50<  %0$
M  !2  < 4  , $\ $ !. !4 30 ; $P ( !+ "8 2@ K $D , !( #4 1P Z
M $8 0 !% $8 0P!. $( 5@!! %\ 0 !K #X >  ] (@ / "9 #P JP \ ,$
M.P#@ #L ]  [ /\ B0H  '@,  !J#@  7PX  %<.  !1#@  30P  $L+  !*
M" ( 200) $@ #0!& !$ 10 6 $0 ' !# "$ 0@ F $$ *P _ #$ /@ V #T
M/  \ $, .P!* #H 4@ Y %P . !H #8 =0 U (4 - "6 #0 J  S +P ,P#8
M #, [P S /L @@T  '$/  !D$   61$  %$1  !+$0  1Q   $0.  !"#0
M00L% $$'"P _!0X /@,2 #P"&  [ AT .@,B #D#*  X RT -P,R #8$.0 U
M!#\ - 5' #,%4  Q!EH , 9F "\'<P N!X, +0>5 "P'IP K![H *P?2 "L'
MZP K!_< ?1   &P1  !?$P  5!0  $P4  !&%   0A,  #X2   \$   .@X!
M #H-!@ Z"@P . D0 #8(%  U"!D - D? #())  Q"2D , DO "\*-@ N"CT
M+0I% "P+3@ K"UD *0QE "@,<P G#(, )@V5 "4-IP D#;L (PW2 ",-ZP C
M#?< >!(  &@4  !;%@  41<  $@7  !"%@  /18  #D5   W$P  -1$  #,0
M P S#@@ ,@T- # -$0 O#18 +0T; "P-(0 K#2< *@TM "D.-  H#CL )PY$
M "4.3@ D#UD (Q!E "$0<P @$(0 'Q"6 !X0J0 =$+T '!#8 !T0[@ =$/D
M<Q0  &06  !7&   31D  $49   _&0  .A@  #47   R%@  ,!4  "X3   M
M$00 +! * "L0#@ I$!( *! 8 "80'@ E$"0 )! J ",1,0 B$3D (1%" " 2
M2P >$E8 '1-C !P3<0 :$X( &125 !@4IP 7%+L %Q/4 !<3[@ 8$_H <!8
M & 9  !4&@  2AL  $(<   \&P  -AL  #(:   O&0  +!@  "H6   H% $
M)A,' "43#  C$Q  (A,5 " 3&@ ?$R$ 'A0G !T4+@ <%38 &Q4_ !H620 9
M%E0 &!=A !87<  5&($ %!B3 !,8I@ 2&+H $A?2 !(7[  3%_H ;!D  %T;
M  !1'0  1QT  #\>   Y'0  -!T  "\<   K&P  *!H  "89   D&   (A<$
M " 7"@ >%PX '!<2 !H7%P 9&!X &1@D !@9+  7&30 %AH] !4:1P 4&U(
M$QM? !(<;@ 1''\ $!R2 ! <I0 /'+D #AS0  X;Z@ /&_@ :1L  %H=  !.
M'P  11\  #T@   V'P  ,1\  "T>   I'0  )1T  ",<   @&P  '1L! !L;
M!P 9' T %QP0 !8<%0 5'!L %!TB !,=*0 2'C$ $1XZ !$?10 0'U  #R!=
M  X@;  -('P #2"/  P@H@ +(+4 "R#*  L@Y0 ,'_0 91T  %<?  !,(0
M0B$  #HA   T(0  +R$  "H@   F'P  (Q\  " >   ='@  &2   !8@!  4
M( L $B$. !$A$P 1(AD $"(?  \B)@ .(R\ #B,W  TC00 ,)$T "R19  HD
M9P ))'@ ""2+  <DG@ ')+$ !B3'  8CXP '(_$ 8A\  %0A  !)(P  0",
M #@C   R(P  +",  "@B   D(0  (2$  !XA   :(0  %B,  !,D P 1)0@
M#R8-  XG$0 -)Q8 #"<=  LG(P *)RL "2@T  @H/@ '*$D !BA5  4I9  $
M*70  RF'  (IFP !**\  "C%  $HX0 !)_  7B(  %$D  !&)0  /24  #4E
M   O)0  *B0  "8D   B(P  'R,  !LD   8)0  %"8  !$H P /*0@ #"P,
M  HL$  (+!0 !RP:  8L(0 %+"@  RTP  (M.@ !+44  "U2   N8   +G$
M "V$   MF0  +:T  "S"   LX   +/  6B0  $TF  !#)P  .B<  #,G   M
M)P  *"8  "0F   A)@  '28  !DG   5*0  $2L   \L P -+@< "3 ,  8Q
M#@ #,1(  3(7   R'@  ,B4  #(M   R-@  ,T(  #-.   S70  ,VT  #.!
M   RE@  ,JL  #'!   QWP  ,?  5B<  $HI   _*@  -RH  # J   K*0
M)R@  ",H   >*0  &BH  !8L   2+@  #S    TQ @ *- < !34+  (V#@
M-Q   #@4   X&@  ."(  #@J   Y,P  .3X  #E*   Y60  .6D  #E]   X
MDP  .*@  #>_   WW@  -O  42L  $8L   \+   -"P  "XL   J*P  )2L
M " L   ;+0  %R\  !,Q   0,P  #34   DW @ %.@8  3L*   \#0  /0\
M #X2   _%P  0!X  $ E  ! +P  0#H  $!&  ! 5   0&4  #]X   _CP
M/J8  #Z]   ]W   /?  32X  $(O   Y+P  ,B\  "TN   H+@  (B\  !TP
M   8,@  $S4  ! W   ,.@  "3P   4^    000  $((  !#"P  1 T  $80
M  !'%   2!D  $@A  !(*@  2#4  $A!  !(3P  2&   $=S  !'B@  1J(
M $6Y  !%V0  1/  2#(  #XR   V,@  ,#$  "LQ   E,@  'S0  !DV   3
M.0  $#P   P_   (0@   T0   !&    2 (  $H%  !+"   3 L  $X.  !/
M$0  414  %(<  !2)0  4C   %(\  !12@  45H  %%M  !0A   3YT  $ZU
M  !-T@  3>X 0S8  #LV   T-0  +S0  "<U   A.   &CL  !0^   000
M#$0   ='   "2@   $T   !/    40   %,"  !4!0  50@  %<+  !9#@
M6Q$  %T7  !='P  72H  %TV  !<1   7%0  %MG  !;?@  6I<  %FO  !8
MRP  5^H /SD  #@Y   S.   *SD  ",\   </P  %4,  !!'   +2@  !4X
M  !1    5    %<   !:    7    %T   !?    8 0  &('  !D"P  9@X
M &@2  !K&0  :R,  &HN  !J/   :DT  &E?  !H=0  9X\  &:H  !EP@
M9., /3T  #<\   N/0  )4   !U$   620  $$T   I1   $50   %H   !=
M    8    &,   !F    :    &H   !K    ;0   &\"  !Q!@  = H  '8.
M  !Y$P  >QL  'LG  !Z-0  >44  'A9  !X;0  =X8  ':?  !UMP  =-(
M/$$  #)"   H10  ($H  !=.   05   "ED   )>    8P   &<   !K
M;P   '(   !U    =P   'D   ![    ?0   '\   ""    A ,  (<)  "*
M#@  CA,  (\>  ".*P  CCL  (U.  "+8P  BGP  (J5  "(K0  A\4 -D<
M "Q+   B3P  &54  !!;   *80   6<   !M    <@   '<   ![    ?P
M (,   "&    B    (H   "-    CP   )$   "4    EP   )H!  "=!P
MH0T  *44  "D(0  I#$  *-$  "B60  H'   )^+  "=H@  G;< ,%   "55
M   ;6P  $F(   MI   !<    '<   !]    @P   (@   "-    D0   )4
M  "8    F@   )P   "?    H0   *,   "F    J0   *P   "P    M <
M +@.  "Z&   NB<  +DY  "X3@  MV4  +9^  "UE@  LZL *5L  !YB   4
M:0  #'$   )Y    @0   (D   "/    E@   )L   "@    I    *@   "K
M    K    *\   "R    M    +8   "Y    O    ,    #$    R    ,T'
M  #2$   TAT  -$O  #01   SUL  ,US  #+C0  RJ$ _P   /\   #[
M^@   /P " #X  \ ]0 7 /0 ( #Q "H ZP S .8 .P#B $, W@!) -H 3P#6
M %0 TP!9 -  7@#. &, RP!H ,D ;@#& '4 PP!] ,$ A@"^ )( NP"> +D
MK@"V ,, M #H +, _P"O /\ I0#_ )X _P"; /\ _0   /<   #R    \
M .<  P#A  P W  2 -@ &P#6 "0 T@ M ,P -@#& #T P@!# +\ 20"\ $X
MN@!3 +@ 6 "V %T M0!B +, 9P"Q &X KP!V *P ?P"J (H J "7 *4 I@"C
M +D H0#9 *  ^0"> /\ F #_ )( _P"/ /\ \P   .P   #C    TP   ,@
M  #!  D O0 / +L %@"Y !\ MP G +, +P"O #< K  ] *H 0P"H $@ I@!-
M *0 4@"C %8 H0!; )\ 80"> &< G !O )H > "7 (, E0"0 ), G@"1 +
MD #( (X \ "- /\ B@#_ (4 _P"" /\ YP   -T   #&    N    *X   "H
M  0 I0 , *$ $@"A !D H  B )\ *0"; #  F  W )8 /0"3 $( D@!' )
M2P"/ %  C0!5 (P 6@"* &$ B !H (< < "% 'L @P"( ($ E@!_ *< ?0"\
M 'P XP!\ /T ? #_ '@ _P!V /\ U@   ,    "O    HP   )D   "3
MCP ) (T #@"+ !0 B@ < (H (P"( "H A0 P (, -@"" #L @ !  '\ 10!^
M $H ? !/ 'L 5 !Z %H > !A '8 :0!U ', <P"  '$ C@!O )\ ;@"R &T
MSP!L /0 ; #_ &L _P!I /\ P    *L   ";    CP   (<   "     ?  $
M 'H # !X !$ >  7 '@ '@!W "0 =0 J ', , !Q #4 <  Z &X /P!M $0
M; !) &L 3@!J %0 : !; &< 8P!E &T 9 !X &( AP!@ )< 7P"J %X P@!>
M .D 7@#_ %X _P!= /\ K    )D   "*    ?P   '<   !Q    ;0   &H
M" !I  X :  2 &< & !G !\ 9P E &4 *@!C "\ 8@ T &$ .0!@ #X 7P!#
M %X 2 != $X 6P!5 %H 70!8 &< 5P!R %4 @0!4 )$ 4P"C %( N !1 -P
M40#Y %( _P!2 /\ G0   (L   !\    <0   &D   !D    8    %X !0!<
M  L 6P / %L % !: !D 6@ ? %D )0!7 "H 5@ O %4 - !4 #@ 4P ] %(
M0P!0 $D 3P!0 $X 6 !- &( 2P!M $H >@!) (L 2 "= $< L0!' ,P 1@#P
M $< _P!' /\ D    'X   !P    9@   %X   !9    5@   %,  0!2  @
M4  - $\ $ !/ !4 3@ : $X ( !- "4 3  J $H +@!) #, 2  X $< /@!&
M $0 10!+ $0 4P!# %T 00!H $  =0 _ (4 /@"7 #T JP ] ,, /0#F #T
M^P ^ /\ AP   '4#  !H!@  70<  %4&  !0!@  3 0  $H!  !)  0 1P *
M $8 #@!% !$ 10 6 $0 &P!# "  0@ E $$ *@!  "\ /P T #X .@ ] $
M.P!' #H 3P Y %D . !D #< <0 V ($ -0"3 #0 I@ T +L - #= #0 ]0 U
M /\ ?@8  &T)  !@"P  5@P  $X,  !("P  1 H  $((  ! !0$ /P$' #X
M"P ]  X /  2 #L %P [ !P .@ A #D )0 W "H -@ P #4 -0 T #P ,P!#
M #( 3  Q %4 , !@ "\ ;0 N 'T +0"/ "P H@ L +8 + #0 "P [@ L /P
M=PH  &<,  !:#@  4 X  $D.  !##@  /@T  #L,   Y"P  . D# #<%"  V
M @T -0$0 #0 $P S !@ ,@ = #$ (@ P "< +P L "X ,@ M #@ + !  "L
M20 J %( *0!= "@ :P G 7H )@&, "4 GP E +( )0#* "4 Z  E /< <@T
M &(.  !6$   3!$  $01   ^$0  .1   #8/   S#@  ,0T! # +!0 P" H
M+P8- "X%$0 L!!0 *P,9 "H#'@ I R, * 0I "<$+P F!34 )04] "0%1@ C
M!E  (@9< "$':0 @!WD 'P>+ !X'G0 >![  '0;& !T&XP =!?, ;0X  %X1
M  !2$@  2!,  $ 3   Z$P  -1(  #$1   N$   + \  "H. P J#0< *0L+
M "@)#@ G"1$ )0@6 "0(&P C"2  (@DF "$)+  @"C, 'PH[ !X+1  ="T\
M' Q; !L,:0 :#'D & R+ !@,G@ 7#+  %@S% !8,X0 6"_  :1   %H2  !.
M%   114  #T5   W%0  ,10  "T3   J$@  *!$  "80 0 D$ 0 (PX( ",-
M#  B# \ ( P3 !\,&  >#1T '0TC !P-*@ ;#3( &@XZ !@.1  7#E  %@]<
M !4/:@ 3$'L $A"- !$0H  1$+, $ _) ! /Y  1#_( 91(  %<4  !+%@
M0A<  #H7   T%P  +Q8  "H5   G%   )!,  "(3   @$@, 'A$& !T0"0 <
M$ T &P\0 !D0%0 8$!L %Q A !80*  5$3  %!$Y !,10P 2$DX $1): ! 2
M:0 0$WD #A.,  X3G@ -$[$ #1+%  P2X0 -$O$ 8A0  %06  !)&   /QD
M #<9   Q&0  +!@  "@7   D%@  (18  !\5   <% ( &A,$ !D2!@ 7$@L
M%1(. !02$@ 3$Q@ $A,? !$3)@ 1%"T $!0V  \500 .%4P #A97  T690 ,
M%W4 "Q>'  H7F@ )%JT "!;!  @6W0 )%>X 7Q8  %$8  !&&@  /1H  #4;
M   O&@  *AH  "49   B&   'Q@  !P7   9%@$ %Q8# !46!  3%@D $18-
M ! 7$0 /%Q8 #A<<  X8(P -&"H #!DS  P9/  +&D< "AI3  D:80 '&W$
M!AN#  4;EP $&JH  QJ_  ,9V@ $&>P 7!@  $X:  !#'   .AP  #,<   L
M'   )QP  ",;   @&@  '1D  !H9   7& $ %1@" !(9!  0&P< #AL,  T<
M$  ,'!, "QP9  H<'P )'2< "!TO  <>.0 &'D, !!Y0  ,?7@ "'VX  1^
M   ?E0  'JD  !Z]   =V   '>P 6!H  $L<  !!'@  .!X  # >   J'@
M)1T  "$<   >'   &QL  !@;   6&P$ $QL" !$<!  .'@< #!\+  H@#@ (
M(!( !B$7  4A'0 $(20  B(L  $B-0  (D   "--   C6@  (VL  "-^   C
MDP  (J<  "*\   AUP  (>T 51T  $@?   ^(   -2   "X@   H(   (Q\
M " >   ='0  &AT  !8=   3'@  $1\"  X@!  -(@< "B0+  8E#0 $)1
M B84   F&@  )B$  "<I   G,@  )ST  "=)   H5P  *&<  "=[   GD
M)Z4  ":[   FU@  )>T 42   $4A   [(@  ,B(  "PB   F(0  (B$  !X@
M   ;'P  &"   !0@   1(@  #R,   TE P *)@8 !B@*  ,I#0  *P\  "P2
M   L%P  +!X  "PF   M+P  +3D  "U&   M5   +60  "UW   LC0  +*0
M "NZ   KU@  *NX 32(  $$D   X)   ,"0  "DD   D(P  (2(  !TB   9
M(@  %2,  !(D   /)@  #2@   HJ @ &+ 4  BX)   O"P  , X  #(0   S
M%0  ,QL  #,B   S*P  ,S8  #-"   S4   ,V   #-S   RB@  ,J$  #&X
M   PU@  ,.\ 224  #XF   T)P  +2<  "@F   C)0  'R0  !LE   6)@
M$B@  ! J   -+   "BX   8P 0 ",@0  #0'   U"@  -PP  #@.   Z$@
M.A<  #H?   Z)P  .C(  #H^   Z3   .EP  #IO   YA@  .)X  #BV   W
MU   -N\ 1"D  #HI   Q*0  *RD  "8H   B)P  '2@  !@I   3*P  $"X
M  TP   ),@  !34   $W    .0(  #L%   \"   /@L  #\-  !!$   0Q0
M $,;  !#(P  0RX  $,Y  !#1P  0E<  $)J  !!@0  0)H  #^R   ^SP
M/N\ /RP  #8L   O+   *BL  "4J   ?*P  &2T  !0O   0,@  #34   @X
M   $.@   #P    _    00   $,"  !%!0  1@@  $@+  !*#@  3!$  $T6
M  !-'@  32@  $TT  !,0@  3%$  $MD  !+>P  2I0  $FM  !(R@  1^P
M.S   #,O   M+P  *"T  "(O   ;,0  %30  ! W   -.@  "#T   )
M0P   $8   !(    2@   $P   !. 0  3P0  %$'  !3"P  50X  %@2  !9
M&0  6"(  %@N  !7/   5TL  %9>  !6<P  58T  %2G  !2P@  4N8 .#,
M #$R   L,0  )3(  !TU   6.   $3P   Q    '1    $<   !*    30
M %    !3    50   %<   !9    6@   %P#  !>!P  80L  &0.  !F$P
M9QP  &8G  !F-   940  &17  !D:P  8H4  &&?  !@N0  7MP -3<  # U
M   H-P  (#H  !@]   10@  #$8   9*    3P   %,   !6    60   %P
M  !?    80   &0   !E    9P   &D   !L 0  ;@8  '$+  !T#P  =Q4
M '<@  !V+0  =CT  '5/  !T8P  <WL  '*5  !PKP  ;\D -3H  "L[   B
M/P  &D,  !)(   ,30  !5(   !7    7    &    !D    :    &L   !N
M    <0   ',   !U    =P   'H   !\    ?P   (($  "&"@  B@\  (P7
M  "+)   BC,  (E%  "'6P  AG(  (6+  "#I0  @KP +T   "5$   <20
M$TX   U4   $6@   &$   !F    :P   &\   !T    >0   'T   "
M@P   (4   "'    B@   (P   "/    D@   )8   "9 @  G@D  *(0  "B
M&@  H2D  * [  "?4   G6<  )J!  ":F0  F:\ *4D  !].   55   #EL
M  5B    :0   '    !W    ?0   ((   "&    BP   (\   "3    E0
M )<   ":    G0   *    "C    I@   *H   "N    L@   +<*  "[$0
MNA\  +DP  "W10  M5P  +1T  "QC@  KZ0 (E0  !A;   08@  !VH   !S
M    >P   ((   ")    D    )4   ":    GP   *,   "F    J    *L
M  "N    L    +,   "V    N@   +T   #"    QP   ,P!  #3"P  U!4
M -,F  #1.@  T%$  ,UH  #+@0  RI8 _    /8   #R    \0   /, !0#T
M  P \@ 3 /  ' #M "4 Z  N .( -@#> #X V0!$ -0 2@#1 $\ S@!4 ,L
M60#) %X Q@!C ,0 :0#! '  O@!X +P @0"Y (T M@": +, JP"Q ,  KP#F
M *X _P"E /\ F@#_ )0 _P"/ /\ ]    .P   #H    YP   -\   #9  D
MT@ 0 ,\ %P#/ "  S  H ,8 , #  #< O  ^ +D 1 "W $D M0!. +, 4P"Q
M %< KP!= *T 8@"K &D J0!Q *< >@"E (4 H@"3 *  H@"= +8 FP#4 )D
M^0"6 /\ C0#_ (@ _P"$ /\ Z    -\   #9    R0   +\   "X  0 M0 -
M +, $@"Q !H L  B *T *@"I #$ I@ X *0 /0"B $, H !( )X 3 "< %$
MFP!6 )D 7 "7 &( E0!I ), <@"1 'T CP"+ (T F@"+ *P B0#% (@ [@"&
M /\ ?P#_ 'H _P!X /\ V0   ,T   "[    K@   *4   "?    G  ) )D
M#P"9 !4 F0 = )@ ) "4 "L D0 Q (X -P", #P BP!! (D 1@"( $L A@!0
M (4 50"# %L @@!B (  :P!^ '4 ? "" 'H D@!X *, =P"Y '8 X !U /\
M<@#_ &X _P!L /\ QP   +4   "E    F0   (\   ")    A0 $ (0 # ""
M !$ @@ 7 (( '@"  "4 ?@ K 'P ,0!Z #8 >0 [ '< 0 !V $0 =0!) ',
M3P!R %4 < !< &\ 9 !M &X ; !Z &H B@!H )L 9P"O &8 S !E /4 9 #_
M &$ _P!@ /\ M    *    "0    A0   'T   !W    <P   '  " !O  X
M;P 2 &\ & !O !\ ;0 E &L *@!I #  :  T &< .0!F #X 90!# &, 2 !B
M $X 80!5 %\ 7@!> &< 7 !S %L @@!9 ), 6 "F %< OP!7 .H 5P#_ %8
M_P!4 /\ H0   (X   !_    =0   &P   !H    9    &$ ! !@  L 7P /
M %\ $P!? !D 7P ? %T )0!< "H 6P O %D ,P!8 #@ 5P ] %8 0P!5 $D
M4P!0 %( 6 !1 &$ 4 !M $X >P!- (P 3 "? $L M0!* -P 2@#Z $H _P!*
M /\ D@   (    !R    9P   %\   !:    5P   %4  0!3  < 4@ , %(
M$ !2 !0 4@ : %$ 'P!/ "0 3@ I $T +@!, #, 2P X $H /0!) $, 2 !*
M $8 4@!% %P 1 !G $, =0!" (8 00"8 $  K@!  ,L /P#R $  _P!  /\
MA0   '0   !G    70   %4   !/    3    $H   !(  0 1P * $< #0!&
M !$ 1@ 5 $8 &@!% !\ 1  D $, *0!" "T 00 S #\ .  ^ #X /0!% #P
M3@ [ %< .@!B #D ;P X (  -P"3 #8 IP V ,  -@#H #8 _@ V /\ ?
M &L   !> @  5 ,  $T#  !' P  0P$  $$    _  $ /@ ' #T "P ]  X
M/  1 #P %@ \ !H .@ ? #D )  X "D -P N #8 ,P U #H - !! #, 20 R
M %, ,0!> #  :P O 'L +@". "T H@ M +@ +0#= "T ^  N /\ <P$  &0%
M  !7!P  30@  $8(  ! "   .P<  #@%   W P  -@ $ #4 "  T  P -  /
M #0 $@ S !8 ,@ ; #$ (  P "0 +P I "X +P M #8 +  ] "L 10 J $\
M*0!: "@ 9P G '< )@") "8 G0 E +, )0#/ "4 \  F /\ ;08  %X)  !2
M"P  2 P  $ ,   Z"P  -@L  #(*   P"   +@8" "X#!@ M  H +  - "P
M$  K !, *@ 7 "D '  H "  )P E "8 *P E #( )  Y ", 0@ B $L (@!7
M "$ 9  @ ', 'P"% !\ F0 > *X '@#' !X Z0 ? /H : D  %D,  !-#0
M0PX  #P.   V#@  ,0T  "T-   J#   * L  "<)!  F!@@ )@0+ "4##@ D
M 1  ) $4 "(!&  A 1T (0 B "  *  ? "X '@$V !T!/P < 4D &P%4 !H!
M80 : 7  &0&" !@ E@ 8 *H & #! !@ X0 8 /0 8PP  %4.  !)#P  0!
M #@0   R$   +0\  "D.   F#@  (PT  "(, P @"P8 ( D) !\'#  >!@X
M'@41 !P%%0 ;!1H &@4? !H%)0 9!2L & 4S !<&/  6!D8 %@92 !4'7P 4
M!VX $P>  !('E  2!J< $@6\ !($V0 2 ^\ 7PX  %$/  !&$   /!$  #41
M   O$0  *A$  "80   B$   ( \  !T. @ <#04 &@T' !H+"@ 9"@T & D0
M !<)$@ 6"1< %0D< !0)(@ 4"BD $PHQ !(*.@ 2"T4 $0M1 ! ,7P /#&X
M#@R   X,E  -"Z< #0NZ  T*T@ -"NH 7 \  $X1  !#$@  .A,  #(3   L
M$P  )Q(  ",1   ?$0  '!   !H0 @ 8#P0 %@X' !4."0 4#0L $PP- !(,
M$  2#!0 $0P: !$-(  0#2@ #PTP  X..P -#D8 #0Y1  P/7@ +#VT "@]_
M  D/DP )#Z8 " ZY  @.T  '#N@ 6!$  $L2  ! $P  -Q0  # 4   I%
M)10  "$3   =$@  &A(  !<1 @ 5$04 $Q ' !(0"0 1#PH $ X,  X.#@ .
M#Q( #1 8  T0'@ ,$"4 #! M  L1-@ *$4$ "1%-  @26@ '$FH !A)\  42
MD  $$J0  Q&X  ,1SP "$>@ 51(  $D4   ^%0  -18  "T6   G%@  (A4
M !X4   ;%   &!,  !42 P 3$@4 $A$' ! 1"0 /$0H #1$+  P2#@ +$A$
M"A(5  D3&P )$R( "!,J  <4,P %%#X !!5*  ,56  "%6<  15Z   5C@
M%:,  !2W   4SP  $^D 4A0  $86   [%P  ,A<  "L7   E%P  (18  !P6
M   9%0  %A0! !03!  2$P8 $1((  \2"  .$PD #!0*  H5#0 (%A  !A83
M  46&0 $%Q\  Q<G  (8,  !&#L  !E'   950  &60  !EW   9C   &*(
M !BW   7SP  %^H 3Q8  $,8   Y&0  ,!D  "D9   C&0  'Q@  !L7   8
M%@  %14" !,5!0 1% 8 $!0&  X5!P ,%@@ "A<*  <9#  $&@X  AL2  $;
M%@  &QT  !PD   <+0  '#@  !U$   =4@  '6(  !UU   =B@  '*   !RV
M   ;T   &NL 3!@  $ :   V&P  +1L  "8;   A&@  '1D  !D9   7&
M%!<# !(6!  0%P0 #A<$  P9!0 *&@< !QP)  ,="P  'PT  " 0   @%
M(1H  "$B   A*@  (34  ")!   B3P  (E\  ")R   AB   (9\  ""V   ?
MT0  '^T 2!H  #T<   S'0  *QT  "0=   @'   '!L  !@:   6&0$ $QD!
M !$9 0 .&@$ #!P"  H= P ''P4  R$(   B"@  ) P  "8.   F$@  )A@
M "<?   G)P  )S(  "<^   G2P  )UP  "=N   FA0  )IT  "6T   DT0
M(^X 1!T  #D?   P'P  *!\  ",>   >'0  &QP  !@;   4'   $1P   X=
M   -'P  "B$   8B 0 #) 0  "8&   H"   *@L  "L-   M$   +14  "T<
M   M)   +BX  "XZ   N2   +5@  "UJ   M@0  +)H  "NR   JT   *>\
M0"   #8A   M(0  )B$  "$@   ='P  &AX  !8>   2'P  #R$   TB   *
M)   !B8   (H    *P(  "T$   O!@  , D  #(,   T#@  -1(  #48   U
M(   -2H  #4V   U0P  -5,  #1F   T?   ,Y8  #*O   QS0  ,.\ /",
M #(D   J)   )",  " B   <(0  %R$  !,C   0)0  #2<   DI   %*P
M 2X    P    ,@   #0!   V!   . 8  #H)   \#0  /A   #X4   ^'
M/B8  #XQ   ^/P  /4X  #UA   \=P  .Y$  #JK   YR0  ..T -R<  "\G
M   H)@  (R4  !\D   9)0  %"8  ! H   -*P  "2X   4P    ,P   #4
M   X    .@   #P    ^ 0  0 ,  $('  !$"@  1@T  $D1  !)%P  2"$
M $@L  !'.@  1TD  $9;  !%<0  1(L  $.E  !"PP  0>@ -"H  "PJ   G
M*   (B<  !PH   6*@  $2T   TP   ),P   S8    Y    /    #X   !!
M    0P   $8   !(    2@   $P#  !.!@  4 H  %,.  !4$P  5!P  %,G
M  !3-   4T,  %)5  !1:@  4(,  $^>  !-N0  3.  ,"T  "LL   F*P
M'RP  !@N   2,@  #34   @Y   "/0   $    !#    1@   $D   !,
M3@   %$   !3    50   %<   !9 0  7 8  %\*  !B#@  8Q4  &,?  !B
M+   83P  &!.  !?8@  7GL  %R6  !;L   6<\ +S   "HO   B,   &C,
M !,W   ..P  "#\   %$    2    $P   !/    4@   %4   !8    6P
M %T   !@    8@   &0   !F    :0   &T%  !P"P  =!   '08  !S)0
M<C0  ')%  !P60  ;W$  &V+  !KI@  :L  +C,  "4U   =.   %#P   Y!
M   '1P   $P   !1    50   %D   !=    80   &4   !H    :P   &T
M  !O    <@   '0   !W    >@   'X   ""!   A@L  (H1  ")'   B"L
M (8]  "$4@  @V<  (&!  !_FP  ?K( *3H  " ]   60@  #T@   A.
M5    %H   !@    9    &D   !N    <@   '8   !Z    ?0   (    ""
M    A0   (@   "+    C@   )(   "6    FP,  * ,  "B$P  H"$  )\S
M  "=1P  FEX  )AW  "7CP  E:< (T,  !E(   13@  "54   !<    8P
M &H   !Q    =@   'L   "     A@   (H   ".    D0   ),   "6
MF0   )P   "@    HP   *<   "K    L    +8$  "\#0  NA<  +DH  "W
M/   M%(  +)J  "OA0  K9P '$X  !-4   +7    60   !L    =    'P
M  "#    B0   (\   "4    F@   )\   "B    I    *<   "J    K@
M +$   "T    N    +P   #!    QP   ,T   #4!0  V!   -4>  #3,0
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M__________________________________________\
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M_/W^_VUF=#$      P0A   !                     0
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MA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VO?
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MQ\S-"0S+TPHMQ]0*6;+8"X">S2N:F,%0JY:X9[>5M76\E+1^OI2SA;^0LH7
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MFW^YP)N(O;Z9B<"\E8K#NI&+QKB-C<BWBH_*MHB1S+6%D\VT@Y;/LX&9T+.
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M@*6/TH"EC]* I8_2@*6/TH"EC]* I8_2@*6/TH"EC]* I8_2@*6/TH"EC]*
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ME*^$PY"OA<2-KH7%BJZ&QHBMAL:'K8?&A:V(QX.MB<>!K8O'@*R+QX"LB\>
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M'DZ-^B];AO(_9X#K3G%[Y5MY=N!E@''=;(1NVG*(:]EWBVG7>HUGUGZ.9M6
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M#$FI]!1EF>8E>([<.8:(U$^0AL]@EX3,;9R#R76@?\=XHGW&>Z1ZQ7VF><2
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MJK!YPZ>MA,>?JH3+F*B#S9"GA-")I8;2A*2*TX"DD--_I9?2?Z:@T'^EILZ
MH*C+@*"HRX"@J,N H*C+@*"HRX"@J,N H*C+@*"HRX"@J,N H*C+@*"HR_^Q
M$P3_LAX5_[ K+O^L-TSZK#ME[;4T>.*_*8G8S""8OK\]KK"X6;BILVR^I;!Z
MPJ*NA,6;K(/(E*J$RHZIA,R(J(;.@Z>)SX"GC<]^IY//?*B:SGRIHLU\IZC+
M?*>HRWRGJ,M\IZC+?*>HRWRGJ,M\IZC+?*>HRWRGJ,M\IZC+?*>HR_^R$@3_
MLQT5_[$I+O^M-DS\L35B\;TJ<N;-'X#(S"&;L;Q%LJBW7KFCLV^^H+%[P9ZO
MA,.7KH3&D:R$QXRKA<F'JH?*@ZJ)RX"JC,Q]J9#,?*J5RWJJG,IYJZ3*>:ND
MRGFKI,IYJZ3*>:NDRGFKI,IYJZ3*>:NDRGFKI,IYJZ3*>:NDRO^S$03_M!L4
M_[,F+O^O,TS]N2M=Z\H?:=+?$7^YS"><I[U,L:"W8KF=M'&]F[)\OYJQA,&4
ML(3#CZ^%Q8JNAL:&K8?'@ZR)QX"LB\A^K([(?*R2R'NLE\AYK9['>:V>QWFM
MGL=YK9['>:V>QWFMGL=YK9['>:V>QWFMGL=YK9['>:V>Q_^U$ /_MAD4_[4D
M+?^T+$GRQ1]4UMT28L'?$X&LS2Z:G\!/JYJX9;>7M7*[EK1\O96R@[^1L87!
MC;&&PHFPA\.&KXC#@Z^)Q(&OB\1_KHW%?:Z0Q7NNE,5ZKYG$>J^9Q'JOF<1Z
MKYG$>J^9Q'JOF<1ZKYG$>J^9Q'JOF<1ZKYG$>J^9Q/^W#@/_N!83_[<@+?F_
M'T'<V1%$Q.L29K'?&(&@T#.5E\90HY/ 8ZV1NW&SD;A[N)"V@KN.M(6]B[.&
MOXBRA\"&LHG A+&*P8*QB\& L8W!?K&/PGRQDL)[L97!>[&5P7NQE<%[L97!
M>[&5P7NQE<%[L97!>[&5P7NQE<%[L97!>[&5P?2Z"P/]NQ(2_KL;+.70#S+(
MZ0]*M/(59Z+B(GV6UC>-C\Y/F(S(8:"*Q&ZFBL%XJH>_?:V$OH"P@;R"L7^[
MA+-]NX6T>[J'M7JYB;5YN8NV=[F-MG:XC[=TN).W=+B3MW2XD[=TN).W=+B3
MMW2XD[=TN).W=+B3MW2XD[=TN).W=+B3M]R^!@+XP X1[L@.(LO;"RZV^!%,
MI?4=8Y?H+'6-WSV!A]A0BX/38)*"SVR7?\USFWS+=YUYR7J@=\A]H77'?Z-S
MQH*D<L6$I7#%AJ5OQ(BF;L2*IVW#C:=KPY"H:\.0J&O#D*AKPY"H:\.0J&O#
MD*AKPY"H:\.0J&O#D*AKPY"H:\.0J-? !@';Q@@.R],*%;CH##*F_Q5*F/HF
M7(WP-VF%Z49T?^13>WS?8(%XW&B%=-IMB7#8<8MNUG6-;-5XCVK4>Y!ITWZ1
M9]. DF;2@Y-ETH649-&'E&/0BI5BT(Z68M".EF+0CI9BT(Z68M".EF+0CI9B
MT(Z68M".EF+0CI9BT(Z68M".EM'"!@'-RPD%NMH'&:C^#C&9_QU#CO\O487Z
M/UQ^]$UD>?!8:G/L7V]MZF-S:>=I=F?E;GEEY')[8^-V?6+B>7Y@X7Q_7^!^
M@%[?@8%=WX."7-Z&@UO=B81:W8V%6MV-A5K=C85:W8V%6MV-A5K=C85:W8V%
M6MV-A5K=C85:W8V%6MV-A<O$!@"[T08'J><&&IK_$RN._R0YA?\V1'[_1$UY
M_U%5<?M76VOW76!E]&)D8O)H9U_P;6I=[W%L6^UU;5KM>&]9['MP6.M^<5?J
M@7)6ZH1R5>F'<U3IBG13Z(YU4^B.=5/HCG53Z(YU4^B.=5/HCG53Z(YU4^B.
M=5/HCG53Z(YU4^B.=;S)!0"KVP$(FO\+%H__&2.%_RLM?O\Y-WC_1D!P_TY'
M:?]436+_6E)>_F%66OQF65C[:UM5^7!=5/AT7E+W>%]1]WM@4/9^84_U@6)/
M]81C3O2'9$WTBV5,\Y!F3/.09DSSD&9,\Y!F3/.09DSSD&9,\Y!F3/.09DSS
MD&9,\Y!F3/.09O^@& /_HBP0_Z [)?^<23S_EU=3^))D9^R0;'GBCW6)V8Y^
ME]&-AZ+,C(VJQXJ1L<2(E+;#A9:XPH.9N<*!F[G!?YZZP7VAN\%[I+O >J>[
MP'FJO,!XKKS =[2[O'BTN[QXM+N\>+2[O'BTN[QXM+N\>+2[O'BTN[QXM+N\
M>+2[O'BTN_^@& /_HBP0_Z [)?^<23S_EU=3^))D9^R0;'GBCW6)V8Y^E]&-
MAZ+,C(VJQXJ1L<2(E+;#A9:XPH.9N<*!F[G!?YZZP7VAN\%[I+O >J>[P'FJ
MO,!XKKS =[2[O'BTN[QXM+N\>+2[O'BTN[QXM+N\>+2[O'BTN[QXM+N\>+2[
MO'BTN_^@& /_HBP0_Z [)?^<23S_EU=3^))D9^R0;'GBCW6)V8Y^E]&-AZ+,
MC(VJQXJ1L<2(E+;#A9:XPH.9N<*!F[G!?YZZP7VAN\%[I+O >J>[P'FJO,!X
MKKS =[2[O'BTN[QXM+N\>+2[O'BTN[QXM+N\>+2[O'BTN[QXM+N\>+2[O'BT
MN_^@& /_HBP0_Z [)?^<23S_EU=3^))D9^R0;'GBCW6)V8Y^E]&-AZ+,C(VJ
MQXJ1L<2(E+;#A9:XPH.9N<*!F[G!?YZZP7VAN\%[I+O >J>[P'FJO,!XKKS
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ME)O3>IB?T7B<HM!WGZ3.=:*FS72FJ,URJ:G,<:VJS'"RJ\MPMJO+;[RKR'#
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M)"J4_S YBO\Z18'_1D]Z_5%8<OA87FOU7F-E\F5H8.]L:UWM<FY:ZWEP5^J
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MKRD1^KLI$^S(+!/>V#<0T^%!'LG?23"\VE%$K]-85J'-7V:4R&5TB,1L@'S
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M.B[_P#LN_],[+?_K/"W_ZSPM_^L\+?_K/"W_ZSPM_^L\+?_K/+BP  "HO
MFLD  (S9  "!]0, >?\0 6[_%@-E_Q\&7O\G"U?_, ]1_S<32_\^%T;_11E!
M_TP;/?]2'3G_6!\V_U\A-/]F(C'_;B0O_W<E+?^ )BO_C"@I_Y<I*/^B*B?_
MK2LF_[DL)O_)+2;_R2TF_\DM)O_)+2;_R2TF_\DM)O_)+:JW  ":Q0  B],
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M3D+F^T]#W?M11-3\4T7/_%1%S_Q41<_\5$7/_%1%S_Q41<_\5.&5  #+I@
MN[   *Z[ 0"BR ( F-4% )#X#P&)^" $@O@N"WGY-Q-P^3\;:/E&(F#Z32A:
M^E0M5/I<,4_[935+^VTX1_QW.T/\@ST__9 _//V?03K^KT,X_\9$-__J13;\
M_44[\O]$/NK_1#[F_T8^YO]&/N;_1C[F_T8^YO]&/N;_1M"?  "]K   KK4
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M'QO_\!\;__ ?&__P'QO_\!\;__ ?&__P'Z2U  "5P@  AL\  '?>  !K]
M8O\# %G_"P%1_Q$!2O\7 D3_'P,__R8$.O\M!3;_- 8R_SH'+O] ""O_1@@H
M_TP))?]2"2+_60H@_V(+'?]K#!K_=@T7_X0.%?^2#Q3_H! 3_ZT1$_^Z$1/_
MPQ(3_\,2$__#$A/_PQ(3_\,2$__#$I>^  "&S   =]L  &GG  !<_0  5/\
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M45X>_T]J)?]-=RO_2H,O_TB.,_]&F#;_1*$X_T.I.O]"L#S_0K@]_T'!/O]
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M7TZQ]F!1JO9@4Z7V8%6A]F!5H?9@5:'V8%6A]F!5H?9@5:'V8/]W" #KC
MTYL  ,:H @"[L0( LKL" *K'!@"BTPH G=8: 976+ :,U#H1@])&'7K03R=R
MSE@Q:LU@.&3+:#]>RG)%6,I\253)B$U/R9513,FE4TK)N51)RMQ31\CW54C
M_%A*N/M93++[6DZM^EI.K?I:3JWZ6DZM^EI.K?I:3JWZ6O]_  #<DP  RJ(
M +RL 0"QM0  J, # )_+!@"6V0L D> ; 8K?+ :"WSD.>=Y#%W'=32!JW%8H
M8]M?+UW:9S58V7$Z4]E[/D_9B$)+V99%2-FF1T;:NDA%V]M'1-CT24+3_TU$
MR?]/1<+_4$>[_U)'N_]21[O_4D>[_U)'N_]21[O_4N:*  #/FP  OZ<  +*P
M  "GNP  G,8# )/1!@"+Z@X A>@? G[H+09VZ#@.;NA!%F;G2AU?YU(C6>=;
M*57G9"U0YVTQ3.=X-4GGA#A&Z)$Z0^B@/$#ILCX_ZLL^/NCO/CWF_S\]X/]"
M/]?_1$#._T9 SO]&0,[_1D#._T9 SO]&0,[_1M:3  #$HP  M*P  *>V  ";
MP0  D,P" (;9!@" \A( >?(? G'R*P9J\C8,8_,_$EWS1QA7\T\=4O-7(4WT
M8"1)]&DH1O1S*D+U?BT_]8LO//:9,3KVJ3,X][XT-OCA-3;U^34U\_\T-^S_
M-CGE_S@YY?\X.>7_.#GE_S@YY?\X.>7_.,B>  "VJ0  J+(  )N]  "/R
M@]0  'GH!P!S_!(!:_T= F3])P1>_C$(6/X[#5/_0Q%-_TL52?]3&$7_6AI!
M_V,=/O]L'SO_=B$W_X(C-/^0)3+_GR<P_[ H+O_(*2W_ZBHL__\J+/__*B_Y
M_RHO^?\J+_G_*B_Y_RHO^?\J+_G_*KFF  "JK@  G+D  ([%  "!T0  ==X
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M"0W_TPD-_],)#?_3"9&\  "!R0  <M<  &3D  !4ZP  2_\  $3_   ]_P0
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M\E24//!2G3_N4:9![%"O0^I/ND3H3L=$YD_=1>%/[D7=3OM(U$__2<A1_TK
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M7UZ0^%YAC/E<8XKZ6V2'^UIEAOM998;[666&^UEEAOM998;[6?]F#0#_=P,
MXX<  -.3 0#*G@0 PJ<$ +NO! "UM@T KK<A J6V,@F=LS\5E+!*((RM4RN$
MJELT?:AC/':E:D-PHW)*:J%[3V6@AE1@GI%86YV?6UB=L%U6G<==5IWK7%>:
M^EM:E?I:7)'[65Z._%A?C?Q77XW\5U^-_%=?C?Q77XW\5_]J"@#_?   W(P
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M2TFM_TQ*J_],2JO_3$JK_TQ*J_],2JO_3.E_  #1D   PIX  +6G  "JKP
MH+@  );! @",RP< A-4- (#5'@%YU2X%<M0\#&S31Q1ETE ;7]%9(5K18B=5
MT&LL4=!U,$W/@31)SXXW1L^=.430KCM"T,8[0]#J.D#-_3X^R_] 0,/_0D&]
M_T-"N?]$0KG_1$*Y_T1"N?]$0KG_1-V(  #'F   N*,  *NK  "@M   E;X
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M'2KW_QTJ]_\=*O?_';.C  "DJP  E[8  (G!  ![RP  ;]8  &/?  !;]08
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M56YZ_%-O>?]1<'?_3W%V_TUQ=?],<77_3'%U_TQQ=?],<77_3/];#@#_:00
M]G<  -V"  #0BP, R9,% ,29!@"^GA  MI\D JZ=- BFFD$3GY9,'9B352>1
MD%XOBXUE-X6*;3V B'5#>X5^2':#B$QR@I-0;H"@4VM_KE5H?\)69W_C56B
M^E-I?O]1:GS_3VM[_TUL>?],;'G_3&QY_TQL>?],;'G_3/]># #_; $ YGH
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M3%F-_TM;BO]*6XK_2EN*_TI;BO]*6XK_2O]H  #E>0  T8<  ,62  "[G
ML:(  *FI  "AL0( F[,5 )6S* *.LC8)AK!"$G^N3!MXK%0C<JI<*FRH9#%G
MIVPV8J5U.UVD?T!9HXI#5:*71U&AITE/H;I*3J+924Z@]4E.G_])4)G_25*6
M_TA4DO]'5)+_1U22_T=4DO]'5)+_1_]N  #>?P  RHT  +Z8  "SH   JJ<
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M-SVX_S<]N/\W/;C_-]&&  # E0  LI\  *6G  ":KP  CK<  (._  !XQP,
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M":*G  "3L0  A;L  ';&  !IT   6]H  $[@  !#Y0  /OL! #K_#  V_Q,
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M1W]G^$5^:/]#?FC_07UG_S]\9_\^?&?_/7QG_SU\9_\]?&?_/?]2#@#_70,
M_6D  .%R  #6>@( SG\% ,J#" #%AA( O(<F ;6&-@:N@T,/IX!.&*%\6"";
M>6 GEG=I+9)T<#..<GDWBG"!/(9NBS^#;95#?VRA17QKKD=Z:[](>&O=2'AL
M]D9X;/]$=VS_0G=K_T!W:O\_=VK_/G=J_SYW:O\^=VK_/O]4# #_7P  \FP
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M0V=X_T%H=O\_:';_/VAV_S]H=O\_:';_/_];! #W:0  W78  ,V   ##B
MNXX  +23 0"MEPD IY@: *"8+ .9ECH*DI1%$HR23QJ&CU<B@(U?*'N+9RYV
MB6\S<H=W.&V%@3QIA(M 9H*70V*!I49@@;9'7H'-1UZ![T9?@?]$8'__0F%]
M_T%B>_\_8WK_/V-Z_S]C>O\_8WK_/_]>  #I;0  UGD  ,B$  "^C   MI,
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M.U"/_SM0C_\[4(__.^MM  #3?   PXD  +>3  "LF@  HI\  )FE  ".JP
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M(;Z/  "OF@  HJ$  ):I  "*L   ?;@  '&_  !FQ@  6\P" %#2!P!'V@P
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M Q7_LP04_],$%/[T!!/\_P,3^O\#$_G_ Q/Y_P,3^?\#$_G_ YVE  "/K@
M@+@  '+"  !DRP  5M,  $G:   ^WP  -.0  "[T   K_PH */\0 "7_%P B
M_Q\ '_\F !S_+0 9_S0 %_\\ !3_1 $2_TX!$/]9 0[_9P$,_W<!"_^* @K_
MGP()_[4""/_5 @?_] ('__\"!___ @?__P('__\"!___ I&M  ""N   <\(
M &3,  !6U0  2-T  #OB   PYP  )^X  "/_   @_P0 '/\, !G_$0 6_Q8
M$_\; !'_(0 ._R< #?\N  K_-@ '_SX !/](  #_5   _V(! /]S 0#_AP$
M_YT! /^R 0#_R@$ _^H! /_S 0#_\P$ __,! /_S 82W  !TP0  9<P  %;8
M  !'WP  .>4  "WJ   C[@  '/T  !C_   5_P  $?\$  __"P -_PX "?\1
M  ;_%0 #_QH  /\@  #_)@  _RX  /\W  #_00  _TT  /]<  #_;0  _X(
M /^6  #_J   _[H  /_#  #_PP  _\,  /_# /\D+P'_)2\!_R@O ?\G,0'_
M)#8"_R ^ O\:20/_%U8#_Q5D _\3<@3_$G\$_Q**!/\2E 3_$IT%_Q*D!?\2
MK ;_$K,&_Q*Z!O\2PP;_$\X'_Q/?!_\3ZP?_$_8'_Q/_!_\3_P;_$_\&_Q3_
M!_\4_PC_$_\(_Q7_"?\5_PG_%?\)_Q7_"?\E+@'_*2T!_RLL ?\K+@'_*3,"
M_R0[ O\?1@/_'5,#_QMA!/\9;@3_%WL$_Q>'!?\7D07_%YH&_Q>A!O\7J0?_
M%[ '_Q>W"/\7P C_&,H(_QC;"/\8Z C_&/0(_QC]"/\9_PC_&?\(_QG_"?\9
M_PK_&/\+_QK_"_\:_PO_&O\+_QK_"_\F+0'_+"D!_RXH ?\O*@'_+2\"_RDW
M O\G0P/_)% #_R)=!/\@:@7_'G<%_QZ#!O\>C0?_'I8'_QZ>"/\>I0G_'JP)
M_QZS"?\>O K_'L8*_Q[3"O\>Y0K_'O$*_Q_\"OX?_PK]'_\+_!__#/P>_PW\
M'_\.]R'_#O<A_P[W(?\.]R'_#O\J*@'_+R8!_S(D ?\S)0'_,BH!_S$T O\O
M/P/_+4P#_RI9!/\H9@7_)G(&_R5^!_\EB0C_)9()_R6:"O\EH0O_):@+_R2P
M#/\DN S_)<$,_R7.#?\EX0W\)>\-^2;Z#/8F_PWU)O\/]"7_$/0E_Q'R)O\2
M[2?_$NTG_Q+M)_\2[2?_$O\N)@'_-"(!_S<@ ?\Y(0'_."4!_SDO O\X.P+_
M-4<#_S-4!?\Q80;_+VT'_RYY"?\MA K_+8T,_RR6#?\LG0W_+*4._2RL#_PL
MM _[++T/^2S)$/8LW1#S+>P/[RWX#^TM_Q+K+/\4ZBS_%>DL_Q;E+?\6X"[_
M%N N_Q;@+O\6X"[_%O\R(P'_.!T!_SP; ?\^&P'_0"(!_T$K ?] -@+_/D(#
M_SQ/!?\Y7 ;_.&@(_39S"_LU?@SX-8@.]S21#_4TF1#S-* 1\C.H$O SL!+O
M,[D3[C/%$^LTUQ/G-.H2XS3W%.$T_Q?>,_\9W#/_&MLS_QK4-/\:SC7_&LXU
M_QK.-?\:SC7_&O\V'P'_/!D!_T$6 /]$%@#_1QX!_TDG ?](,@+_1CT#_T1)
M!?I"5@?V0&()\C]N#.\]>0_M/(,0ZCR,$N@[E!/G.YP4Y3ND%>,ZK17B.K86
MX#O"%M\[TA;:.^@7U#KV&M Z_QS-.O\>RSK_'LHZ_Q_$._\?P#S_'L \_Q[
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M-)-5]C.25?\RD5;_,8]6_S"-5O\NC%?_+8Q7_RV,5_\MC%?_+?])#@#_404
M_UH! .YB  #?9P, V&H& -5K"@#-;14 Q6XI ;YM.02W:T<+L6A2$:QF7!BH
M9&4=I&)M(J%@=2:>7GXIFUV&+9A<CR^56IDRDUFD-)!9L#:.6< VC%G;-XI9
M\S:)6O\TB%O_,X=;_S&&6_\PA5O_+X5;_R^%6_\OA5O_+_]+# #_5   ^UX
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M-G-H_S5S9_\S<V;_,G-F_S)S9O\R<V;_,O]1! #_7   XF<  -)P  #'=@
MP'H  +I] @"T?PP K8$= *>!+@*@?SP(FGU'#Y5Z41:0>%H<BW9B(8=T:2:#
M<G$K?W%Z+WQO@S)X;HTU=6V8.')LI3MP:[0\;FO)/&UKZ3MM;/XY;6S_-VYL
M_S5N:_\T;FK_,FYJ_S)N:O\R;FK_,O]3  #T7P  WFH  ,US  ##>@  NWX
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MC ( G(X4 )>/)@&1CC0%BXQ "X6*2A& B%,8>X9;'7:%8R)R@VHG;H)R*VJ
M>R]G?X8S8WZ1-F!]GCE=?*XZ6WS!.UM\XSI;?/HX7'O_-UU[_S5>>?\T7W?_
M,U]W_S-?=_\S7W?_,_Y<  #A:@  S74  ,!^  "VA@  KHL  *6.  ";D0
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M*]=R  ##@   MHP  *J4  "?F0  E)X  (FC  !^J   <*X  &JP#@!HL1T
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M#S#(TP\PQO00+L3_$RW"_Q4LP?\6*\#_%RO _Q<KP/\7*\#_%[B-  "JEP
MGIX  )&E  "$K   >+(  &NY  !@OP  5,,  $K( @! S0< .M(. #G2&P X
MTR@ -],U #;40  TU4L!,]55 3'68 (OUFP#+==Z!"O8BP4JV)T%*-FQ!B?:
MS08GU^\&)M3_"272_PLDT?\,(]#_#2/0_PTCT/\-(]#_#:Z6  "@G0  E*0
M (:L  !YM   ;+L  &#"  !4Q@  2,L  #[0   UU00 +=T* "SA$P KXA\
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M  #_\   __\  /__  #__P  __\  /__ (VK  !]M0  ;K\  &#(  !2T
M0]<  #?=   KX@  (N8  !GJ   5^0  $O\  !#_"  ._PX #/\1  G_%@ &
M_QP  _\B  #_*@  _S,  /\]  #_20  _U<  /]I  #_?@  _Y4  /^L  #_
MQP  _^@  /_Z  #_^@  __H  /_Z ("U  !POP  8<D  %+3  !#VP  ->$
M "GF   >Z@  %>X  !#X   ._P  "_\   C_   $_P8  /\*  #_#@  _Q$
M /\5  #_&P  _R,  /\K  #_-@  _T,  /]3  #_90  _WH  /^1  #_I@
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M&J]!]QRM0?\=JT'_':E!_QRI0?\<ID'_&Z5!_QNE0?\;I4'_&_\]$ #_0@D
M_T@% /]-" #_4 L ^5$/ .M0%0#A3R  V% Q ,]000+)3TX%Q$Y:"<!,9 V]
M2VT0NDIV$[=)?A6U2(<7LT>/&;%'EQNO1J <K4:J'JM%MA^I1<8?IT;@(*1&
M]""A1O\AGT?_()Y'_R">1_\?FT?_'II'_QZ:1_\>FD?_'O] #0#_1@0 _TP
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M*(-6_R>"5O\E@5;_)(%6_R2!5O\D@5;_)/]' P#_3P  YU@  -E@  #-9
MQF8! ,%F! "[9@X M&D@ *YI,0*H:#\%HV9*"I]E5 ^:8UT4EV%E&)-@;1R0
M7G4?CEU](HM<AB6(6Y HA5J:*H-9IBR 6;0M?UG'+GU9YBU\6OHL>UK_*GM;
M_RA[6_\G>UK_)GI:_R5Z6O\E>EK_)?])  #[4@  XUP  -)C  #':   P&L
M +IK @"U:PT KFT= *AN+@&C;3P%G6M("IEJ40^4:%H4D&9B&(UE:AR*8W(@
MAV)Z(X1A@R:!8(PI?E^7*WM>HRUY7K$O=UW$+W5>XB]U7ODM=5__*W5?_REU
M7_\H=5[_)G5>_R9U7O\F=5[_)O]+  #P50  WE\  ,UG  ##;   NV\  +5P
M  "O;PH J'$: *-R*P&=<CD$F'!%"9-N3PZ/;5@4BVM@&(=I9QR$:&\@@6=W
M(WUF@"9Z9(HI=V.4+'5CH2YR8J\O<&+!,&]BWS!N8_<N;V/_+&]C_RIO8_\H
M;V+_)V]B_R=O8O\G;V+_)_]-  #K6   V6,  ,EJ  "_<   MW,  +!T  "I
M= < HW87 )YW* &8=C<$DW5""(YS3 Z)<543A7!=&(%N91Q^;6P?>VQT(WAJ
M?29T:8<I<6B2+&YGGBYL9ZPP:F>^,6EGW#!I9_4N:6?_+&EG_RIJ9_\I:F;_
M*&IF_R=J9O\G:F;_)_]0  #G6P  TV8  ,5N  "[<P  LW<  *MY  "D> ,
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M(#^:R" _F>L?/YC_(#Z6_R$^E?\A/Y3_(3^4_R$_E/\A/Y3_(<UP  "\?0
ML(@  *2/  "9E   CI@  (.=  !WH   ::0  &"G" !=J!0 6ZDD %FI,0%6
MJ3P"4ZE%!%"H3@9-J%<)2JA?#$>G: Y$IW,10:9_%#ZFC18\IIT7.J:O&#FF
MQQ@YI>H8.*/_&C>A_QLWH/\<-Y__'#>?_QPWG_\<-Y__',1X  "UA0  J8\
M )V5  "2F@  AI\  'JC  !NJ   8JP  %6P  !0L@X 3K(; $VS* !+LS4
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M Q[+_P0>RO\%'<G_!AW)_P8=R?\&'<G_!JB4  "<F@  D*$  (*H  !TKP
M9[8  %N\  !.P   0\,  #G'   OS   )] $ !_6"@ ;VA  &]L: !K;)@ :
MW#$ &=T\ !C=2  8WE4 %]]B !;@<@ 5X(4 %.&: !/BL0 2X\\ $N#T !+>
M_P$1W?\!$=O_ A';_P(1V_\"$=O_ IZ:  "2H0  A*D  ':Q  !HN   6[\
M $[$  !"R   -\P  "W0   DU0  '-L  !7?!0 4Z0X $NH4 !'K'0 0ZR8
M#NPP  [M.@ -[D8 "^Y3  KO8@ )\'0 "/&)  ?RH  %\KH !/'D  +Q_0 "
M[_\  ^W_  /M_P #[?\  ^W_ )6A  "&J0  >+(  &FZ  !;P@  3<@  $#,
M   TT0  *M8  "';   9X   $N0   _P 0 -^0H "_H/  G[%0 '^QP !/PD
M  '\+   _#<  /Q"  #\4   _&$  /UU  #\C   _*0  /S!  #\ZP  _/\
M /W_  #]_P  _?\  /W_ (FI  !YL@  :KL  %S$  !.S   /]$  #+7   G
MW0  '>$  !7E   .Z   "O$   C]   %_P,  ?\)  #_#@  _Q(  /\7  #_
M'P  _R<  /\Q  #_/@  _TT  /]?  #_=0  _XT  /^F  #_P@  _^<  /_\
M  #__P  __\  /__ 'RS  !LO   7<8  $[/   _U@  ,=T  "7B   :Y@
M$>H   SN   %\@   /\   #_    _P   /\   #_!0  _PH  /\.  #_$@
M_Q@  /\A  #_*P  _SD  /]*  #_70  _W,  /^,  #_I   _[D  /_4  #_
MW@  _]X  /_> /\8+ #_&2D _QDH /\5*P#_$#  _PLX ?\#1 '_ %$!_P!>
M ?\ ; '_ '@!_P"" ?\ C '_ )0!_P"< /\ H@#_ *@ _P"O /\ M@#_ +X
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M ](D^07/)?\&S27_!\LE_PC*)?\(RB3_",HD_PC*)/\(RB3_"/\N% #_,1
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M-/\/L33_#[ T_Q"O-/\0KC3_#ZXT_P^N-/\/KC3_#_\U#@#_. < _SP" /]
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M%YA!_Q>80?\6ET'_%9=!_Q670?\5ET'_%?\[!@#_/P  ^48  .5+  #<3@
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M''96_QMV5O\;=E;_&_]%  #L3@  VE@  ,E>  "_8@  MV0  +%C  "K80@
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M(DYYPR)->.4B37?[(4YW_Q].=O\>3W7_'4]U_QU/=?\=3W7_'=]<  #(:
MN7(  *YZ  "E@   FH(  (Z"  " @P  >84" '2&$0!QB"  ;H@N 6J(.0)G
MAT,%8X=,"&"&4PM=A5L.6H1C$5>$:Q14@W4748* &DZ!C1Q+@9L>28&L'TB
MP2!'@.,?1W_Z'DA^_QY(??\=27S_'$E\_QQ)?/\<27S_'-9A  #";@  M'@
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M$#.<_Q(SFO\2,YG_$S.9_Q,SF?\3,YG_$[UW  "O@P  HXL  )B1  "-E0
M@9D  '.<  !GGP  6Z(  $^F  !'J0@ 1*H2 $.J'P!!JRL 0*LW #^L00 ]
MK$H!.ZQ3 CFL7 ,WK&<$-:QS!3*L@08PK)$'+JRC""VLN DLK-D(+*KU"BNH
M_PLJIO\,*J7_#2JE_PTJI?\-*J7_#;6   "HBP  G)$  )&6  "%G   >*
M &NE  !?J   4ZP  $BO   ]L@  -K4+ #2U%0 SMB$ ,K8L #&W-P PMT$
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M  O2_P$+TO\!"]+_ 9J8  ".GP  @*8  '*M  !DM   5[H  $F_   ]P@
M,L8  "C)   ?S0  %]$  !'6   ,VP4 "-X+  ;?$0 %WQH !. D  +A+@ !
MXCH  .-'  #D5@  Y&<  .5[  #FD@  YJH  .?(  #G\   Z/\  .C_  #H
M_P  Z/\  .C_ )&?  ""IP  =*\  &6W  !7O@  2<,  #S'   PRP  )<\
M !S4   4V0  #MT   GA   "Y0   .D&  #I#0  Z1$  .H8  #K(0  [2L
M .\W  #Q10  \E8  /-H  #S?@  ])<  /6P  #VT   ]_,  /?_  #W_P
M]_\  /?_ (6G  !VL   9K@  %C!  !*R   .\P  "[1   CU@  &=P  !'@
M   ,XP  !.<   #J    ]0   /0   #U!0  ]0L  /8/  #V%   ^!T  /HG
M  #\-   _T,  /]5  #_:0  _X$  /^:  #_L@  _\\  /_M  #_^0  __D
M /_Y 'BP  !HN@  6<,  $O+   [T0  +=@  "'=   6X@  #N8   CJ
M[0   /    #X    _P   /\   #_    _P   /\&  #_#   _Q   /\8  #_
M(@  _S   /]   #_4P  _VD  /^!  #_F0  _Z\  /_#  #_U0  _]4  /_5
M /\3* #_$R4 _Q$E /\-)P#_!BT _P U /\ 00#_ $\ _P!< /\ :0#_ '0
M_P!^ /\ B #_ )  _P"7 /\ G0#_ *0 _P"J /\ L #_ +< _P#  /\ S #_
M -\ _P#L /\ ^ #_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\6
M)0#_%B( _Q0A /\0(P#_"B@ _P P /\ /0#_ $L _P!8 /\ 9 #_ '  _P!Z
M /\ A #_ (P _P"3 /\ F@#_ *  _P"F /\ K0#_ +0 _P"\ /X R #] -D
M^P#I /H ]@#Y /\ ^ #_ /@ _P#X /\ ^ #_ /D _P#Y /\ ^0#_ /\:(@#_
M&AX _Q@= /\3'@#_#B( _PHL /\'.0#_ T8 _P!3 /\ 8 #_ &L _P!V /\
M?P#_ (@ _P"/ /\ E@#_ )T _P"C /X J0#\ +  ^@"Y /< Q #U -( \P#F
M /( ] #Q /\ \ #_ .\ _P#O /\ [P#_ /  _P#P /\ \ #_ /\>'0#_'AD
M_QP7 /\7& #_$QX _Q$H /\.- #_#$$ _PI. /\(6P#_!V8 _P9Q /\&>@#_
M!H, _@:+ /P&D@#Z!ID ^ :? /8&I@#T!JT \@:U / %P #M!<X ZP7D .D&
M\P#F"/\ Y0K_ .0+_P#D"_\!Y O_ >0+_P'D"_\!Y O_ ?\A& #_(1, _R 1
M /\;$@#_'!H _QHD /\6+P#_$SP _Q%) /\050#\#F$ ^0YK /8.=0#T#GX
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M!;8E_P6U)?\&M27_!K4E_P6U)?\%M27_!?\L#0#_+04 _RX! /\Q!0#_,0L
M_2\0 /$K& #G*24 WR@S -@H0@#1*D\ S2M: ,DK90''*VX!Q"QV L(L?@+
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MD3S_#9$\_PV1//\-D3S_#?\U  #_.0  ZD$  -U&  #01P  R48  ,9!!0#
M0!$ N4(A +-$,@"O14 !JT5+ J=%50.D1%X%H41F!Y]#;@B=0W8*FT)^"YE"
MA@V708\.E4&9#Y-!I!&10; 2D$' $HY!V1*+0?$2B4+_$HA"_Q&(0O\0AT+_
M$(="_P^'0O\/AT+_#_\X  #S/0  XT<  -),  #(3@  P$T  +M* @"V1PX
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M%/)#  #?3P  RU@  +U=  "S80  JV(  *)@  ";7   E5X0 )!@'P",82X
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M'%IBOQQ98M\<66+W&EIB_QE:8?\76V'_%EMA_Q5;8?\56V'_%>=-  #/60
MOV(  +-H  "I;0  GFT  )-K  "):0  @VL) ']M%0!\;B4 >&XR 75N/0)Q
M;D8$;FU/!VML5@EH;%X,96ME#V-J;1%@:78476F!%EMHC1A89YL:5F>J&U5G
MO1Q49]P<5&?V&E1F_QA59O\7567_%E9E_Q569?\55F7_%>)1  #*70  NV8
M *]L  "F<0  F7   (YO  "#;@  ?7 % 'AR$@!U<R$ <G,O 6]S.@)L<T0$
M:7),!F9R5 AC<5L+8'!C#5UP:Q!;;W036&Y_%55NBQ=3;9D946VH&D]MNQM.
M;=D:3FST&4]K_QA/:_\74&K_%E!J_Q50:O\54&K_%=U5  #%80  MVH  *QQ
M  "B=0  E'0  (ET  !\<P  =G4  '%W$ !O>!T ;'DK &EY-P%F>4 #8WE)
M!6!X40===U@)6W=@#%AV: Y5=7$14G5\$U!TB!9-=)<72W.F&$ESN1E(<]49
M27+S&$EQ_Q=*<?\62G#_%4MP_Q1+</\42W#_%-1:  # 9@  LV\  *AV  "=
M>0  CW@  (1X  !W>0  ;WP  &I]#0!G?AD 9'\F &* ,@%?@#T"7(!& UI_
M3@57?U4'5'Y="5)]90Q/?6\.3'QY$4I\AA-'>Y0517ND%D1[MQ9#>](60WKR
M%D-Y_Q5#>/\41'?_%$1V_Q-$=O\31';_$\U?  "[:P  KG0  *1\  "7?@
MBGT  ']^  !R?P  9H,  &&$" !>AA, 7(<A %J'+@!8AS@!58=" E.'2@-0
MAU(%3H9:!TN&8@E)A6P+1H5W#4.$@P]!A)(1/X2B$CV$M1,\A,\3/(+P$CR!
M_Q(]@/\2/7__$CU^_Q$]?O\1/7[_$<5F  "U<0  JGL  )^"  "2@@  A8(
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M!B2>_P<DGO\'))[_!Z]^  "CB   EXX  (V3  !^E0  <)@  &.;  !7GP
M3*(  $*F   XJ0  +ZP# "JN#@ IKA@ **\C ">O+0 FL#< );!! "2P2P C
ML58 (K%C "&Q<0 ?L8( 'K*4 1RRJ0$;LL$!&['G 1NO_@(:K?\"&JS_ QJK
M_P,:J_\#&JO_ ZB(  ";CP  D90  (2:  !VGP  :*(  %NE  !/J0  1*T
M #FP   OLP  )K8  !ZY!0 8NPX %[L6 !>\(  6O"H %;TU !2]0  3ODL
M$KY8 !*^9P 1OW@ $+^, !# H@ .P+H #L#A  ^]^P /O/\ $+K_ 1"Z_P$0
MNO\!$+K_ 9^/  "4E0  AYL  'FA  !KIP  7JP  %*Q  !%M   .K8  "^Y
M   EO   ';\  !7#   /Q@4 "\H-  G*%  (RAT !\HG  ?*,@ &RSX !<M+
M  3,6@ #S&H  LQ^  ',E   S*L  ,W(  #,[0  S/\  ,O_  '*_P !RO\
M <K_ )>6  "*G   ?*,  &ZJ  !@L   4K8  $6Y   YO   +K\  "/#   ;
MQ@  $\H   W-   (T0   =0)  #4#@  U14  -8>  #8)P  V3$  -L^  #<
M2P  W5L  -YN  #>A   WYL  -^T  #>V0  W_<  -__  #?_P  W_\  -__
M (V=  !_I0  <*P  &&S  !3N@  1;\  #C"   LQ@  (<D  !C-   0T0
M"]4   3:    W@   . !  #A"0  X@X  .03  #E&P  YR0  .DO  #K/
M[4L  .Y=  #N<0  [XD  /"B  #PO   \.,  ._Y  #P_P  \/\  /#_ (&E
M  !RK0  8[4  %2]  !&Q   -\@  "K,   ?T   %=4   [:   'W@   .(
M  #F    Z0   .H   #L    [@4  .\,  #Q$   \Q<  /4@  #X*P  ^SD
M /U*  #^7@  _W0  /^-  #_I@  _\   /_A  #_]0  __4  /_U '2N  !E
MMP  5L   $?(   XS0  *M(  !W8   3W0  #.(   /F    Z0   .P   #P
M    \P   /0   #V    ^    /H   #]!P  _PT  /\2  #_&P  _R@  /\W
M  #_2@  _UX  /]V  #_CP  _Z8  /^Z  #_T0  _]$  /_1 /\/) #_#B(
M_PLA /\#) #_ "D _P R /\ /@#_ $P _P!9 /\ 90#_ '  _P!Z /\ A #_
M (P _P"2 /\ F0#_ )\ _P"E /\ JP#_ +( _P"Z /\ Q0#_ -, _P#G /\
M] #_ /\ _@#_ /\ _P#^ /\ _@#_ /X _P#^ /\ _@#_ /\1(0#_$!X _PT=
M /\''P#_ ", _P M /\ .@#_ $@ _P!5 /\ 80#_ &P _P!V /\ ?P#_ (<
M_P". /\ E0#_ )L _P"A /\ IP#^ *X _0"V /P P #[ ,T ^0#B /@ \ #W
M /P ]@#_ /4 _P#U /\ ]0#_ /4 _P#U /\ ]0#_ /\5'0#_$QH _Q 9 /\+
M&0#_ !T _P I /\ -@#_ $, _P!0 /\ 7 #_ &< _P!Q /\ >@#^ (, _ "*
M /H D0#Y )< ^ "= /< HP#U *H ] "R /( NP#Q ,@ [P#< .X [ #M /H
MZP#_ .H _P#J /\ Z@#_ .H _P#J /\ Z@#_ /\8&0#_%A4 _Q,3 /\.$P#_
M"QH _P<D /\", #_ #X _P!+ /\ 5P#_ &( _ !L /@ =0#U 'X \@"% /$
MC #O ), [@"9 .P H #K *8 Z0"N .< MP#F ,, Y #4 .( Z0#A /< WP#_
M -T _P#= /\ W0#_ -T _P#= /\ W0#_ /\;$P#_&A  _Q8. /\2#@#_$A4
M_P\? /\,*P#_"3@ _P9% /L#40#W EP \@)F .X"< #J G@ YP*  .8#AP#D
M XX X@.5 .$#G #?!*, W02K -L$M #8!<  U@70 -,&YP#0"/@ S@K_ ,P+
M_P#+#/\ RPS_ ,L+_P#+"_\ RPO_ /\?$ #_'@L _QH' /\9"P#_&!$ _Q89
M /\2) #Z$#  \PX^ .X-2@#I#%8 Y0QA .(,:@#>#7, VPU[ -D-@P#6#8H
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M Z$F_P.A)O\#H2;_ _\I  #_*   ]BT  .<P  #?+P  V2L$ -8B"@#.(Q8
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M"O8V  #F0   T4@  ,--  "Y3@  L4T  *E)  "D108 GT83 )I((P"623(
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M$V90O!-E4-@39%#S$F10_Q!D4/\/9%#_#F5/_PUE3_\,94__#.Q!  #43
MPU0  +99  "L7   H%H  )=7  "15   BU4, (97&0"#6"< @%DT 'U9/P%Z
M64@#=UA0!'186 9R5U\';U=F"6U6;@MK5G<-:%6!#V95C1%D5)H28E2I$V!4
MNA1?5-,47E3R$UY4_Q%?5/\/7U3_#E]3_PU?4_\-7U/_#>=$  #/4   OU@
M +-=  "H7P  G%T  ));  "+6   A5H* (%;%@!]7"0 >ETQ '==/ %T748"
M<5U.!&]<505L7%T':EQD"6A;; ME6G4-8UI_#V%9BQ%>69@27%BG%%M8N!19
M6= 465CP$UE8_Q%:6/\06EC_#EI7_PU:5_\-6E?_#>-(  #+4P  NUL  +!A
M  "D8@  EV$  (Y?  "%7   ?UX' 'M?$P!X82$ =6(N ')B.0%O8D,";&%+
M VIA4P5G85H'96!B"6-@:@M@7W,-7EY]#UM>B1%979825UVE$U5=MA147<X4
M5%WN$U1=_Q%57/\055S_#E5;_PY66_\-5EO_#=Y,  #'5@  N%\  *UD  "@
M90  DV0  (EC  !_80  >6(# '5D$0!R91X ;V8K &QG-P%J9T "9V9) V5F
M401B95@&8&5@"%UD9PI;9' ,66-[#E9CAA!48I024F*C$U!BM!-/8LP33V+M
M$D]A_Q%/8?\04&#_#E!@_PY08/\-4&#_#=E/  ##6@  M&,  *EI  ";:
MCV<  (1G  !Y90  <V<  &]I#@!L:AL :6LH &=L- !D;#T!8FQ& E]K3@1=
M:U8%6FI=!UAJ90E6:6X+4VEX#5%HA ].:)(03&>A$DMGLA))9\D226?K$DEF
M_Q!*9O\/2F7_#DME_PU+9/\-2V3_#=%4  "^7@  L6<  *9M  "7;   BFL
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M"CAX_PHX>/\*.'C_"KYD  "P;P  I7@  )9Y  "'>0  >WD  '!Z  !D?
M6(   %"#  !+A0H 2(84 $>'( !%B"L 1(@U $.(/@!!B4<!0(E/ 3Z(6 (\
MB&$#.HAL!#>(> 4UB(<&,XB8!S*'J@<PB, ',(?D!S"%^P@P@_\(,(+_"#"!
M_P@P@?\(,('_"+=K  "J=@  H'\  )!^  ""?@  =G\  &J   !>@P  4X<
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M :.&  "7C   C9$  'V2  !ME0  8)@  %2<  !(H   /J0  #2G   JJP
M(:X  !FQ   2LP< #[40  ZU%P .M2$ #;4K  VU-@ ,MD$ "[9.  JV7  )
MMFP "+9_  >VE  &MJH !;;%  :VZ@ 'M?\ "+3_  BS_P )LO\ ";+_ )J-
M  "0DP  A)@  '2<  !EH   5Z0  $NH  ! K   -;   "JS   AM0  &+@
M !&[   ,O@( !L +  + $0 !P1D  ,$B  #"*P  PC8  ,-"  ##4   Q%\
M ,1Q  #$AP  Q)T  ,2U  #$V@  Q/8  ,/_  ##_P  P_\  ,/_ ).4  "'
MF@  >*   &JF  !<K   3[$  $&U   UMP  *;H  !^]   6P   $,,   K&
M   #R@   ,P%  #,#   S1$  ,X8  #.(0  T"H  -$U  #30P  U%(  -1C
M  #5>   U8\  -6G  #6P@  UND  -;]  #6_P  UO\  -;_ (J;  ![H@
M;*D  %ZP  !0M@  0KH  #2]   HP0  '<0  !3'   -RP  !LX   #2
MUP   -D   #:!0  W L  -T0  #?%0  X1T  .,G  #E,P  YT(  .A4  #H
M9P  Z7X  .F7  #JKP  ZLX  .OO  #K_@  Z_\  .O_ 'VC  !NJP  7[(
M %&Z  !"P   -,,  "?'   ;RP  $L\   O3   "V    -T   #A    Y
M .4   #G    Z0   .L'  #M#0  [Q$  /$9  #T)   ]S$  /E!  #Z50
M^FH  /N$  #[G0  _+8  /S2  #][0  _?0  /WT '&L  !AM0  4KT  $3$
M   TR0  )LT  !K2   0V   "-T   #A    Y0   .@   #L    [P   /$
M  #S    ]0   /<   #Y 0  ^P@  /X.  #_%0  _R$  /\O  #_00  _U8
M /]M  #_AP  _Z   /^V  #_R@  _]0  /_4 /\+( #_!QX _P = /\ ( #_
M "4 _P N /\ .P#_ $D _P!6 /\ 8@#_ &T _P!V /\ ?P#_ (< _P". /\
ME #_ )H _P"@ /\ I@#_ *T _P"U /\ O@#_ ,L _P#A /\ \ #^ /T _0#_
M /T _P#] /\ _0#_ /P _P#Y /\ ^0#_ /\-'0#_"QH _P09 /\ &@#_ !\
M_P J /\ -P#_ $4 _P!1 /\ 7@#_ &@ _P!R /\ >@#_ (( _P") /\ D #_
M )8 _P"< /X H@#\ *D ^P"P /D N0#X ,8 ]@#9 /4 ZP#T /D \P#_ /(
M_P#S /\ \P#_ /, _P#S /\ \P#_ /\0&0#_#A4 _P@4 /\ % #_ !D _P E
M /\ ,@#_ $  _P!, /\ 60#_ &, _@!M /P =0#Z 'T ^0"$ /< BP#V )$
M] "7 /, G@#R *0 \ "L .X M #M ,  ZP#/ .D Y@#H /4 Y@#_ .< _P#F
M /\ Y0#_ .4 _P#E /\ Y0#_ /\2% #_$!  _PP/ /\#$ #_ !4 _P @ /\
M+ #_ #H _P!' /H 4P#W %X ] !G /$ < #O '@ [0!_ .L A@#J (P Z "3
M .< F0#E *  XP"G .$ L #? +H W0#) -L X #8 /  UP#^ -4 _P#4 /\
MTP#_ -, _P#3 /\ TP#_ /\5$ #_$@P _PX) /\+# #_"1( _P,: /\ )@#]
M #, ] !  .\ 30#K %@ Z !A .4 :@#B '( X !Z -X @ #< (< V@". -@
ME0#4 )P T@"C -  K #. +8 S #$ ,H V0#( .T QP#[ ,4 _P#$ ?\ PP'_
M ,0!_P#$ ?\ Q '_ /\8"P#_%04 _Q   /\0!@#_#PT _PP4 /P''P#Q RL
MYP Y .( 1@#> 5$ V@); -4"9 #2 VP SP-T ,T$>P#+!(( R@2) ,@%D #&
M!9@ Q 6@ ,(&J0#!!K0 OP;! +T(U0"[">P N O] +8,_P"U#?\ M W_ +0-
M_P"T#?\ M W_ /\;!0#_&   _Q<  /\6  #[$P8 ^A . .X,%@#C"2( V@DP
M -,*/@#."TH R@Q5 ,<-7@#%#6< P@YO ,$.=@"_#GX O0^% +P/C0"Z$)4
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M O\F  #R*0  XS$  -(T  #(-   P#   +LI @"X(PX L28< *PH*P"H*C@
MI"M$ *$L3@"?+5< G2U? )LM9P&9+6X!F"YU 98N?0*4+H8"DRZ0 I$NF@./
M+J8#C2ZS XPNQ0.*+^$$AR_V!(4O_P2$+_\#A"__ X,O_P.#+_\#@R__ _LI
M  #K,0  V3@  ,D\  "_/   MCD  + R  "L+0L IR\7 *(Q)@">,S0 FC1
M )@U2@"5-5, DS5; 9$U8@&/-6D"C35Q HPU>0.*-8(#B#6+!(8UE@2$-:(%
M@C6O!8$UP 9_-MP&?3;T!GLV_P5[-O\%>C;_!'HV_P1Z-?\$>C7_!/4M  #D
M-P  T#\  ,)#  "W1   K4   *<Z  "C-@8 G3<3 )DY(@"5.B\ DCP[ (\\
M1@",/$\!BCQ7 8@\7@*&/&4"A#QM X(\=02 /'T$?SR'!7T\D@9[.YX'>3NL
M!W<[O AV/-4(=#SQ"',\_P=R//\&<CS_!7(\_P5R._\%<CO_!?$R  #>/0
MR40  +Q(  "P20  ID8  )]!  ";/0$ E3T0 )$_'0"-02L BD(X (=#0@"$
M0TL!@D-3 8!#6P)^0F(#?$)I!'I"<05X0GH&=D&$!W1!CPAR09L(<$&I"6]!
MN0IM0= *;$'N"6M"_PAJ0O\':D'_!FI!_P9J0?\%:D'_!>TW  #60@  Q$D
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M#%A/_0M83_\)64__"%E._P=93O\'64[_!]]#  #'30  N%0  *Q9  "=5P
MD54  (A4  "!4   >U($ '=3$0!T5!X <54K &]6-@!L5D !:E9( 6A64 )F
M5E<#9%9>!&)59@5@56\'755X"%M4A I95)$+5U2@#%53L U44\4-4U/F#%-3
M_ M34_\)5%+_"%12_PA44O\'5%+_!]I&  ##4   M5@  *A;  "96@  C5@
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M"$5?_P=%7_\'15__!\A2  "X7   JV0  )MD  ",8P  @&,  '9C  !J8@
M8V0  %]F!@!;9Q$ 66@= %=I*0!6:C, 5&H\ %)J10%0:DP!3FI4 DQJ7 -*
M:F4$2&EO!49I>@=$:8@(0FB8"4!HJ0H_:+T*/FC>"3YG]PD^9O\(/V7_!S]E
M_P<_9/\'/V3_!\-7  "S80  IVD  )9H  "'9P  >V<  '%G  !E:   7&H
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M [%J  "E=   E78  (5U  !X=0  ;74  &%W  !7>@  3'X  $.!   [A0
M-8@) #*)$0 QB1L ,(DE "^*+P NBC@ +8M! "R+2@ JBU0 *8M? "B+:P F
MBWH!)(N+ 2.+G@$BB[,!(8S. 2&*\0$@B/\"((;_ B"%_P(AA?\"(87_ JMR
M  "A?   CWL  (!Z  !S>@  9GP  %M_  !0@@  1H8  #R*   TC0  +)$
M ":3#  DE!, (Y0< "*5)@ AE2\ ()4X !^60@ >EDP '998 !R69  :EW0
M&9>& !B7F0 7EZX %9?) !:5[@ 6D_\!%I+_ 1:1_P$6D/\!%I#_ :5[  "9
M@P  B8$  'N   !L@@  7X0  %2(  !)BP  /Y   #64   MEP  )9H  !V>
M 0 6H P %*$2 !2A&P 3H24 $J$N !&B.  1HD, $*)/  ^B7  .HVL #:-]
M  VCD@ ,HZ< "J+   NBY@ ,H/X #9__  V>_P -G?\ #9W_ )Z$  "2B0
M@X@  '.(  !EBP  6(X  $R2  !!EP  -YL  "Z>   DH@  '*4  !6H   /
MJP0 "JX,  >M$@ &K1L !:TD  2N+@ "KCD  :Y%  "N4@  KF$  *YS  "N
MAP  KIT  *ZT  "NU0  K?0  *W_  "L_P  J_\  *O_ ):+  ",D   >Y
M &N2  !=E@  4)H  $2?   YHP  +Z<  "6K   <K@  %+$   ZT   )MP
M ;@)  "X#@  N10  +D<  "Z)0  NB\  +LZ  "\1P  O%8  +QG  "\>P
MO)$  +RI  "\Q   O.L  +O^  "[_P  N_\  +O_ )"2  "#F   <YL  &.?
M  !5HP  1Z@  #NM   PL0  );0  !NW   2N@  #+T   6_    PP   ,0"
M  #%"@  Q0X  ,84  #'&P  R"0  ,HN  #,.@  S4D  ,U9  #-;   SH,
M ,Z;  #-M0  SMH  ,[V  #-_P  S?\  ,W_ (:9  !WH   ::8  %JL  !,
ML@  /K8  #"Y   DO   &;\  !'"   *Q0   LD   #,    T    -$   #2
M 0  TP@  -4-  #7$0  VA@  -PA  #?+   X3H  .)*  #C70  Y'(  .2+
M  #EI0  Y<   .7F  #E^   Y?\  .7_ 'JA  !KJ0  7*\  $VV   _O
M,+\  "/#   7QP  #\H   ?.    T0   -8   #<    WP   .    #B
MY    .8#  #H"0  Z0X  .P5  #N'@  \2L  /0Z  #U30  ]F$  /=Y  #X
MDP  ^*T  /G&  #YY   ^?,  /GS &VJ  !>L@  3[H  $#!   QQ0  (LD
M !;.   -T@  !-@   #=    X0   .0   #H    ZP   .T   #O    \0
M /,   #V    ^ ,  /H+  #]$0  _QL  /\I  #_.P  _T\  /]F  #_?P
M_YD  /^O  #_PP  _]8  /_6 /\$' #_ !D _P 9 /\ ' #_ "( _P K /\
M. #_ $8 _P!3 /\ 7@#_ &D _P!R /\ >@#_ (( _P") /\ CP#_ )4 _P";
M /\ H0#_ *@ _P"O /\ N0#_ ,4 _P#9 /X [ #] /L ^P#_ /L _P#[ /\
M^@#_ /0 _P#P /\ \ #_ /\'& #_ 14 _P 4 /\ %@#_ !L _P F /\ - #_
M $( _P!. /\ 6@#_ &0 _P!M /\ =0#_ 'T _P"$ /\ B@#] )  _ "6 /H
MG0#Y *, ^ "K /< M #U +\ ] #. /, Y@#Q /8 \ #_ .\ _P#O /\ [@#_
M .X _P#J /\ Z@#_ /\+% #_!A$ _P 0 /\ $ #_ !8 _P B /\ +@#_ #P
M_P!) /\ 5 #^ %\ ^P!H /D < #W '@ ]0!_ /, A0#R (L \ "2 .\ F #M
M )\ [ "F .H K@#H +D YP#' .4 W@#C /  X@#^ .  _P#@ /\ X0#_ .$
M_P#A /\ X0#_ /\-$ #_"0T _P$, /\ # #_ !( _P < /\ * #\ #8 ^0!#
M /8 3@#R %D [P!B .P :P#J '( Z !Y .8 @ #D (8 X@", .$ DP#? )H
MW0"A -L J@#8 +0 U0#  -( TP#0 .H S@#Z ,T _P#- /\ S0#_ ,P _P#,
M /\ S #_ /\0# #_# < _P," /\ " #_  X _P 6 /8 (@#P "\ [  \ .D
M2 #E %, X0!< -X 90#; &P UP!S -0 >@#2 (  T "' ,X C@#, )4 R@"=
M ,@ I0#& *\ Q "[ ,( RP#  .4 O@#U +T _P"\ /\ O #_ +P _P"\ /\
MO #_ /\1!0#_#@  _PH  /\( 0#_! H ^  0 .D &@#C "@ W@ U -D 00#3
M $P SP!6 ,L 7P#) &8 Q@!N ,0 = #" 'L P0"" +\ B0"] )  O "8 +H
MH0"X *L M@"W +0 QP"R .  L0'R *\"_P"N _\ K03_ *T$_P"M!/\ K03_
M /\4  #_$   _P\  /(-  #J"@  Z0,) -T $@#4 !\ S0$M ,@".@#$ T4
MP -0 +T$60"[!6$ N05H +<&;P"U!G8 M =] +('A "Q"(P KPB5 *T)G@"K
M":@ J@JU *@*Q0"F"]\ I WT *(._P"@#O\ GP[_ )\._P"?#O\ GP[_ /\7
M  #_$P  [Q@  .09  #;%@  TA " ,\)"P#("!8 P0HD +P,,@"W#3X M Y)
M +$.4P"O$%L K1!C *L0:@"I$7$ J!%X *81@ "E$8@ HQ*1 *$2FP"@$Z8
MGA.S )P3PP";%-X EQ;T )46_P"4%_\ DQ?_ )(7_P"2%O\ DA;_ /\:  #T
M'0  Y2,  -4E  #*)   PAT  +X6! "[$!  M!,= *\5*P"K%C@ IQA# *49
M30"B&58 H!I= )X;90"=&VP FQQS )H<>P"8'(, EQV- )4=EP"3'J( DAZO
M ) >OP"/']@ C"#Q 8D@_P&((/\!AR#_ 8<@_P&&(/\!AB#_ ?H>  #K)@
MVBT  ,HP  "^+@  M2@  + B  "N&PP J!T7 *,?)@"?(3, G"(^ )DC2 "7
M)%$ E219 ),E8 "2)6< D"9N (XF=@"-)G\ BR:( 8HGDP&()YX!AB>K 80G
MNP&#*-$!@"CN 7XI_P%]*?\!?"C_ 7PH_P%\*/\!?"C_ ?4D  #C+@  SS4
M ,$X  "T-@  JS$  *4L  "B)@8 GB83 )DH(0"5*BX DBLY (\L1 "-+4P
MBRU4 (DN7 "'+F, ABYJ 80N<@&"+GH!@2^$ 7\OCP)]+YH">R^G GHOMP)X
M+\P"=C#J G4P_@)S,/\"<S#_ G,O_P)S+_\"<R__ O J  #<-0  QSL  +H_
M  "L/   HC@  )PS  "8+P  E2X0 ) P' ",,BD B3,U (8T/P"$-4D @C51
M ( U6 !^-5\!?35F 7LV;@%Y-78">#6  G8UBP-T-9<#<C:D W VM 1O-L@$
M;3;G!&PV_ -K-O\#:S;_ FHV_P)J-?\":C7_ NHP  #3.@  PD$  +-#  "E
M00  FSX  )4Z  "0-@  C#4- (@W& "$."4 @3HQ '\[/ !\.T4 >CQ- '@\
M50%W/%P!=3QC 7,\:@)Q/',"<#Q\ VX[AP-L.Y0$:CNA!&@[L05G/,4%93SE
M!60\^@1D//\#8SO_ V,[_P-C._\"8SO_ N4U  #-/P  O48  *Y'  "?10
ME4,  (Y   ")/   A#P* ( ]% !]/B( >C\N 'A . !U04( <T%* ')!40%P
M05D!;D%@ FQ!9P)J07 #:$%Y V=!A 1E09$%8T&?!6%!K@9@0<(&7D'B!EY!
M^05=0?\$74#_ UU _P-=0/\#74#_ ]\Y  #(0P  N4H  *E+  ";20  D$<
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M!$U-_P1.3/\#3DS_ \Y$  "\3@  KE0  )Q3  ".4@  @U$  'I0  !R30
M;$\  &A0"P!E414 8U(A &%3+ !?4S8 750_ %M41P!:5$X!6%16 59470)4
M5&8#4E-O U!3>P1.4X@%3%.7!DM3IP=)4[H'2%/5!TA2\P9(4O\%2%'_!$E1
M_P1)4/\#25#_ \I(  "Y4@  JE<  )A6  "*50  ?U0  '93  !L40  9U,
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M [Q5  "M7P  G&   (M?  !]7P  <E\  &A?  !=8   56(  $]D  !+9@H
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M 25ZF0$C>JP!(GK% 2)YZ0$B=_\!(G;_ 2)U_P(B=/\"(W3_ JQH  "=;@
MBFT  'ML  !O;   96P  %IN  !0<0  174  #UX   V?   +G\" "F!#0 G
M@A0 )H(> "6")P D@B\ (X,X "*#0@ A@TL ((16 !^$8@ >A'$ '(2" !N$
ME0 :A*D &(3! !B#Y@ 8@?T &8#_ 1E__P$9?O\!&7[_ :9P  "5<P  A'(
M '9Q  !K<0  7G,  %1V  !)>0  /WT  #>!   OA   )X@  ""+!0 ;C0X
M&HT5 !F-'@ 8CB< %XXP !:..0 5CD, %(]/ !./6P 2CVH $8][ !"/CP /
MCZ0 #H^[  V/X  .C?H #XO_ !"*_P 0B?\ $(G_ *%Z  ".>0  ?G<  ')W
M  !D>   6'L  $U^  !"@@  .88  "^*   GC@  ()$  !B5   2F 4 #IH.
M  V:%  ,FAT "YHF  N:,  *FCL "9I&  B:4P &FV$ !9IR  2:A@ "FIL
M )JQ  &9SP "F?   IC_  27_P %EO\ !9;_ )F!  "'?P  >GX  &M^  !=
M@0  4(4  $6)   [C0  ,9(  "B6   ?F0  &)T  !&@   ,HP( !J4*  &E
M$   I18  *8?  "F*   IC(  *<]  "G2@  IU@  *=H  "G?   IY$  *:H
M  "FPP  I>D  *7\  "E_P  I/\  *3_ )&'  ""A@  <H8  &.(  !5C
M29$  #V6   RF@  *)X  !^B   7I@  $*D   NL   $KP   +$&  "Q#
MLA$  +(7  "S'P  LR@  +0R  "U/P  M4T  +5=  "U<   M88  +6=  "U
MM@  M=P  +3W  "T_P  M/\  +3_ (N/  !ZC@  :I$  %N5  !-F@  0)\
M #6D   JJ   (*P  !:P   /M   ";<   &Y    O0   +X   "^!@  OPP
M , 0  #!%@  PAT  ,,G  #%,@  QD   ,91  #'8P  QW@  ,>1  #'J0
MQ\<  ,?L  #'_@  Q_\  ,?_ (.7  !QF@  89X  %*C  !%J0  .*X  "RS
M   @MP  %KH   Z]   &P    ,,   #'    R0   ,H   #,    S0,  ,X)
M  #0#@  TA,  -0;  #8)0  VS(  -U"  #=5   WFD  -Z!  #>G   W[4
M -_9  #?\P  W_\  -__ '>?  !HI@  6:T  $JS   [N   +;L  !^_   4
MP@  #,8   /)    S    -    #5    V0   -H   #<    W@   .    #B
M!0  Y L  .<0  #J&   [20  / R  #Q1   \E@  /-O  #TB@  ]*0  /2_
M  #TWP  ]/,  /3T &JH  !;KP  3+<  #V]   MP0  '\8  !/*   +S@
M -(   #7    W    .    #E    YP   .D   #K    [0   .\   #Q
M\P   /8'  #Y#@  _!8  /\B  #_,P  _T<  /]=  #_=@  _Y$  /^I  #_
MO@  _]@  /_; /\ & #_ !8 _P 5 /\ & #_ !X _P G /\ -@#_ $, _P!/
M /\ 6@#_ &0 _P!M /\ =0#_ 'T _P"$ /\ B@#_ )  _P"6 /\ G #_ *,
M_P"K /\ M #^ +\ _0#/ /L YP#Z /@ ^0#_ /D _P#Y /\ ]0#_ .X _P#I
M /\ YP#_ /\ % #_ !$ _P 1 /\ $@#_ !< _P C /\ ,0#_ #X _P!* /\
M5@#_ &  _P!H /\ < #_ '@ _0!^ /P A0#Z (L ^0"1 /@ F #W )X ]0"F
M /0 K@#R +D \0#' .\ X #N /( [ #_ .P _P#L /\ ZP#_ .4 _P#@ /\
MW@#_ /\#$ #_  X _P - /\ #0#_ !, _P > /\ *P#_ #@ _P!% /X 4 #[
M %H ^ !C /4 :P#S '( \0!Y .\ ?P#N (8 [ ", .H D@#I )D YP"@ .8
MJ0#D +, X0#  .  TP#> .L W #[ -L _P#: /\ V@#_ -D _P#4 /\ T@#_
M /\'#0#_  D _P & /\ "0#_  \ _P 8 /L )0#X #( ]0 _ /( 2@#M %0
MZ@!= .< 90#D &P X@!S .  >@#> (  W "& -H C0#7 )0 U "; -( I #/
M *T S0"Y ,L R0#) .0 R #V ,8 _P#% /\ Q@#_ ,< _P#' /\ QP#_ /\*
M!@#_ 0  _P   /\ ! #_  L ]  2 .\ 'P#J "P Y0 X .( 0P#= $X V0!7
M -0 7P#1 &< S@!M ,P = #* 'H R "  ,8 AP#% (X PP"6 ,$ G@"_ *@
MO0"S +H P@"Y -L MP#P +4 _P"V /\ M0#_ +4 _P"U /\ M0#_ /\,  #_
M!   _P   /X   #V  , Z  - .  %P#9 "0 T0 Q ,T / #* $< Q@!1 ,,
M60#  &  O@!G +P ;@"Z '0 N0![ +< @@"U (D LP"1 +( F@"P *0 K@"O
M *P O0"J -  J #K *< ^P"F /\ I@#_ *4 _P"E /\ I0#_ /\-  #_!P
M] D  .H)  #B!   V@ ' ,\ $0#( !P P@ I +X -0"[ $  MP!* +0 4P"R
M %L L !B *X : "L &\ JP!U *D ?0"H (0 I@"- *0 E@"C *  H0"K )\!
MN0"= \P G 3H )H&^0"9!_\ F C_ )<(_P"7"/\ EPC_ /\0  #W$   Z!0
M -P5  #.$0  Q@T  ,($"P"\ !0 MP$A +(#+@"N!3H JP9$ *@(30"F"%4
MI E< *(*8P"@"FH GPMQ )T+> "<"X  F@R) )D,DP"7#)X E0VJ )0-N "2
M#<P D [J (X0_ ",$/\ BQ#_ (L0_P"+$/\ BA#_ /L3  #M&@  W2   ,PA
M  "_'0  MQ<  +,1  "R"PT JPT9 *<.)@"C#S, GQ ^ )T11P":$5  F!)7
M )827@"5$V4 DQ-L )(3<P"0%'P CQ2% (T5CP"+%9H BA6G (@6M0"&%LD
MA!?G ((8^P" &?\ ?QG_ '\9_P!_&/\ ?QC_ /4:  #D(P  SRD  , J  "S
M)@  JB(  *4<  "D%0@ H!03 )L6(0"7&"T E!DX )$:0@"/&TL C1Q2 (L<
M60")'6  B!UG (8>;P"%'G< @Q^  ((?BP" 'Y< ?B"C 'T@L@![(,4 >2'D
M '<B^0!V(O\ =2+_ '0A_P!T(?\ ="'_ .\A  #;*P  QS$  +8Q  "I+@
MH"H  )LF  "8(0$ E1X0 ) @&P"-(2@ B2,S (<D/0"%)$8 @R5. ($F50!_
M)EP ?B9C 'PG:P![)W, >2=\ '@HAP!V*), ="B@ 7(HKP%Q*<$!;RG@ 6TI
M]P%L*?\!:RG_ 6LI_P%K*/\!:RC_ >@H  #0,@  P#@  *XW  "A-0  F#(
M )(M  ".*0  BR<, (<H%P"#*B, @"LO 'XL.0!\+$( >BU* '@N40!W+E@
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M E8Z_P%6.O\!5CG_ =0W  # 00  KT0  )U#  "00@  A4   'X^  !Y.P
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M TM%[0-+1/\"2T3_ DM#_P),0O\"3$+_ LH_  "Y2   IDH  )5)  "'2
M?4<  '5%  !N0@  :4,  &5$"0!B11, 7T8> %U'* !<2#( 6D@[ %E)0P!7
M24H 5DE2 %1)60%326$!44EK 4])=@)-28("2TF1 TI)H0-(2;,#1TG* T9)
M[ -&2/\"1DC_ D='_P)'1O\"1T;_ L9#  "V3   HDP  )%,  "$2P  >4H
M '!)  !I1@  9$<  %])!@!<2A  6DL; %A,)0!63"\ 54TX %--0 !234@
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M C=4_P(W4_\".%/_ KI/  "I5@  E54  (54  !X5   ;50  &14  !85
M4E8  $Y7  !*60D 1UH1 $9:&P!$6R4 0ULN $)<-@!!7#X /UQ& #Y=3P ]
M75< .UUA #I=; $X77D!-EV( 31=F0(S7:L",5W" C%<Y0(Q6_P",5K_ C%9
M_P(R6?\!,EC_ ;94  "D60  D%@  (!8  !S5P  :5<  &!8  !460  3EL
M $A=  !#7P0 0& . #YA%P ]82  .V(I #IB,@ Y8CH .&-" #=C2P V8U0
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M :9F  "190  ?V0  '%D  !F9   760  %)F  !(:0  /VP  #=O   P<P
M*78  ")Y"  ?>Q  'GL7 !Q['P ;>R@ &GLP !E\.0 8?$, %WQ. !9\6@ 5
M?&< %'UX !)]BP 1?9\ $'VU  ]]U0 0>_4 $7G_ !%X_P 2=_\ $G?_ )YK
M  "*:@  >FD  &UI  !B:0  5VH  $QM  !#<   .70  #%X   I>P  (G\
M !N"   4A0D $880 !&&%P 0AQ\ $(<H  Z',0 .ASL #8=&  R'4P +AV$
M"H=Q  F'A  'AY@ !H:N  6&R0 &A>P !X3_  B#_P )@O\ "8+_ )5Q  "#
M;P  =&X  &EN  !<;P  4'(  $9U   \>0  ,GT  "J!   BA0  &XD  !2,
M   /CP, "I(+  :2$0 $DA@  I(@  &2*0  DC,  ),^  "32P  DUD  )-I
M  "3>P  DI   )*F  "1OP  D>4  )#Z  "/_P  C_\  (__ (UW  !]=0
M<'0  &)U  !5>   27P  #^    TA   *XD  "*-   :D0  $Y0   Z7   )
MFP   9T(  "=#@  G1,  )X:  ">(@  GRL  )\U  "@0@  H%   *!?  "@
M<0  H(<  )^=  "?M0  GMH  )WV  "=_P  G/\  )S_ (9]  !X?   :7P
M %M_  !.@P  08@  #:,   LD0  (Y8  !J:   2G@  #:$   :D    IP
M *D#  "I"@  J@X  *L3  "L&0  K2(  *XK  "O-P  KT4  *]4  "O9@
MKWL  *Z4  "NJP  KLD  *[O  "M_P  K?\  *W_ (&$  !QA   88<  %.+
M  !&D   .98  "Z;   CH   &J0  !*H   ,K   !*\   "R    M@   +<
M  "W @  N @  +D-  "Z$@  NQ@  +TA  "^*P  P#@  ,!(  # 6@  P6X
M ,&&  #!H   P;H  ,'C  # ^0  P/\  ,#_ 'F-  !HD   690  $N:   ]
MH   ,:4  "6K   :KP  $;,   NX   "NP   +X   #!    Q    ,4   #&
M    QP   ,@%  #*"P  S \  ,X5  #0'P  TRL  -4Z  #53   UF   -AW
M  #8D@  V*P  -G)  #9[   V?L  -C_ '"9  !@G@  4:0  $.J   UL
M*+8  !RZ   1O@  "<$   #%    R    ,L   #/    T@   -,   #6
MV    -L   #=    WP<  .(-  #E$P  Z!T  .PJ  #M/   [5$  .YG  #O
M@0  [YP  /"W  #PTP  \.P  /#T &>F  !8K0  2;0  #JZ   JO@  ',(
M !#&   'R@   ,X   #2    U@   -P   #@    XP   .0   #F    Z
M .L   #M    [P   /("  #U"@  ^!$  /P<  #_+   _S\  /]5  #_;@
M_XH  /^D  #_N@  _]$  /_A /\ % #_ !( _P 2 /\ % #_ !D _P E /\
M,@#_ #\ _P!+ /\ 5@#_ &  _P!H /\ < #_ '@ _P!_ /\ A0#_ (L _P"1
M /\ F #_ )X _@"F /T K@#\ +D ^@#( /D X@#X /0 ]P#_ /8 _P#V /\
M[P#_ .< _P#B /\ W@#_ /\ $0#_  X _P . /\ #P#_ !0 _P @ /\ +0#_
M #H _P!& /\ 40#_ %L _P!C /X :P#\ ', ^@!Y /D @ #W (8 ]@", /4
MD@#S )D \@"@ /  J0#N +, [0#! .L U@#J .X Z0#^ .< _P#G /\ Y0#_
M -T _P#5 /\ T0#_ /\ #0#_  H _P ( /\ "0#_ !  _P ; /\ * #_ #4
M_P!  /H 2P#V %4 \P!> /$ 9@#N &T [ !T .L >@#I (  YP"& .8 C0#D
M ), X@"; .  HP#> *T W "Y -H R@#7 .8 U #X -( _P#2 /\ T@#_ ,X
M_P#) /\ Q@#_ /\ " #_  , _P   /\  P#_  T _  6 /< (@#S "X [P Z
M .P 10#H $\ Y !8 .$ 8 #> &< VP!M -D = #5 'H TP"  -$ AP#/ (X
MS0"5 ,L G@#) *< QP"S ,4 P@## -P P0#Q +\ _P"_ /\ O@#_ +X _P"]
M /\ NP#_ /\   #_    _P   /\   #V  @ [@ 1 .< &P#A "< W0 S -D
M/@#3 $D SP!2 ,L 60#( &$ Q@!G ,0 ;0#" ', P !Z +\ @ "] (@ NP"0
M +D F "X *( M0"M +, NP"Q ,X L #J *\ _ "M /\ K0#_ *X _P"N /\
MK@#_ /\"  #_    _0   /(   #H    W@ , -, %0#, "$ R  L ,0 . #!
M $( O0!+ +H 4P"X %H M@!A +0 9P"R &T L !T *\ >@"M (( K "* *H
MDP"H )T I@"H *0 M0"B ,8 H0#C )\ ]@"> /\ G@#_ )X _P"> /\ G@#_
M /\&  #[    [@4  .($  #5    RP & ,, #P"] !D N  E +0 ,0"Q #L
MK@!% *P 30"I %4 IP!; *4 8@"D &@ H@!N *$ =0"? 'P G@"% )P C@":
M )@ F "D )8 L "5 ,$ DP#< )( \@"1 /\ D #_ )  _P"/ /\ CP#_ /T*
M  #P#@  X1$  ,X0  #"#0  NP<  +< "@"Q !( K  > *@ *0"E #0 H@ ^
M )\ 1P"= $\ FP!6 )D!7 "7 6, E@)I )0"< "3 W@ D0.  ) $B@".!)4
MC 6A (H%K@")!KX APC8 (8)\ "$"O\ @PO_ (,+_P"#"_\ @PO_ /80  #F
M%P  TAP  , :  "S%@  K!(  *@-  "F!PT H@46 )T'(@"9"2X E@HX )0+
M00"2#$H D Q1 (X-6 ",#5X BPUE (D-; "(#G0 A@Y] (4.AP"##I, @0^?
M ( 0K0!^$+X ?1#; 'H1] !X$O\ =Q+_ '<2_P!W$O\ =Q+_ .\7  #;(0
MQB0  +0C  "H(   H!P  )L7  "9$00 F X0 ),0&P"/$2< C!(R (D3/ "'
M$T0 A11, (,44P"!%5H @!5@ 'X6: !]%F\ >Q9X 'D7@P!X%X\ =AB< '08
MJ@!S&;L <AG4 &\:\0!N&_\ ;1O_ &T:_P!M&O\ ;1K_ .<@  #0*0  O"L
M *LJ  ">*   EB0  ) @  "-'   C!<, (@8%@"$&B( @1LM 'X<-P!\'4
M>AU( 'D>3P!W'E4 =A]< '0?8P!S'VL <2!T ' @?P!N(8L ;"&8 &LAIP!I
M(K@ :"+/ &8B[@!E(_\ 9"/_ &0B_P!D(O\ 9"'_ . F  #(+P  M#$  *,P
M  "6+@  C2L  (<H  "$)   @B ( 'X@$@![(AX >",I '4D,P!S)3P <25#
M ' F2P!N)E( ;2=9 &LG8 !J)V@ :2AQ &<H>P!E*(@ 9"F5 &(II !@*;4
M7RG+ %XJ[ !<*O\ 7"G_ %PI_P!<*?\ 7"C_ -@L  ##-0  K34  )TT  "0
M,P  AC$  ( M  !\*P  >2@# '8G$ !R*1H <"HE &TK+P!K+#@ :BQ  &@M
M1P!G+4X 92Y5 &0N70!C+F4 82]N %\O> !>+X0 7"^2 %HOH0%9+[(!6##(
M 58PZ0%5,/X!52__ %4O_P!5+O\ 52[_ - Q  "].@  J#D  )<X  "*-P
M@#8  'HR  !U,   <BX  &XN#0!K+Q8 :3 A &8Q*P!D,C0 8S(] &$S1 !@
M,TL 7S12 %TT6@!<-&( 6C1K %DU=0!7-8( 5360 50UGP%2-; !437& 5 U
MYP%/-?T!3S7_ 4\T_P%/-/\!3S/_ <LV  "X/0  HSP  )(\  "%.P  >SH
M '0W  !O-0  ;#,  &@T"@!E-1, 8C8> & W* !>-S$ 73@Z %LX00!:.4@
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M 3]!_P% 0?\!0$#_ ;]!  "J10  ED4  (9%  !Y1   ;T0  &="  !@/P
M6T$  %="  !40PT 4405 $]%'P!.12@ 3$8Q $M&.0!*1T$ 24=( $A'4 !&
M1U@ 14=A $-(; !"2'@!0$B' 3Y(EP$\2*D!.TB^ 3I(WP$Z1_@!.D;_ 3I%
M_P$[1?\!.T3_ ;M%  "F2   DD<  ()'  !V1P  :T<  &-&  !;0P  5D4
M %)'  !.2 H 3$D2 $I)' !(2B4 1THN $9+-@!%2SX 0TM& $),30!!3%8
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M :]1  "840  A5$  '90  !J4   8%   %A1  !.4@  1U,  $%5   [6
M.%D* #5:$0 T6AH ,ULB #);*P Q6S, +UP[ "Y<0P M7$P +%Q6 "M=8  I
M76T *%U\ "9=C@ D7:$ (UVU ")=T@ B7/, (EO_ "-:_P C6?\ )%C_ *A5
M  "25   @%0  '%4  !F5   7%0  %15  !*5@  0U@  #Q;   V70  ,& %
M "UA#@ K814 *F(= "EB)0 H8BX )V,V "9C/@ E8T< (V-1 ")D7  A9&D
M'V1Y !YDB@ <9)X &V2S !EDS@ :8_$ &V'_ !M@_P <8/\ '%__ *%9  ",
M6   >U@  &U8  !B6   65@  %!9  !'6P  /EX  #=@   Q8P  *F8  "1I
M"0 A:A  (&H7 !]J(  >:R@ '6LP !QK.0 ;:T( &FQ, !EL6  7;&4 %FQT
M !1LA@ 3;)H $FRO !%LR@ 1:^\ $FG_ !-H_P 3:/\ $V?_ )E=  "%70
M=5P  &A<  !>7   55P  $M>  !"80  .60  #)G   K:@  )&T  !YP 0 7
M<PL %701 !1T&  3="$ $G4I !%U,@ 1=3L $'5&  ]U4@ .=5\ #75N  QU
M@0 +=94 "G6J  ATPP )=.< "G/]  MQ_P ,<?\ #'#_ )%B  !_80  <&$
M &1A  !:80  3V(  $5E   \:   ,VP  "MO   D<@  '78  !=Y   1? 0
M#7\,  M_$@ *?QD "7\B  A_*@ &?S0 !7\_  1_2P "?U@  7]G  !_>0
M?XX  '^C  !^NP  ?>   'WW  !\_P  >_\  'O_ (EG  !X9P  :V8  &%F
M  !49P  26D  #]M   U<0  +'4  "1Y   =?   %H   !"#   ,A@( !HD*
M  &)#P  B10  (H;  "*(P  BRP  (LW  "+0P  BU   (M?  "+<0  BX8
M (N<  "*LP  B=,  (CS  "(_P  A_\  (?_ ()M  !S;   :&P  %IM  !.
M;P  0G,  #AW   N>P  )8   !V$   5B   $(P   N/   $D@   )0&  "5
M#   E1   )85  "7'   F"0  )@N  "9.0  F4<  )E6  "9:   F7T  )F4
M  "8JP  E\@  );N  "6_P  E?\  )7_ 'MT  !O<P  87,  %-V  !&>@
M.W\  #"$   FB   '8T  !22   .E@  "9D   &<    H    *$   "B!@
MH@P  *00  "E%   I1P  *<D  "H+P  J#T  *E,  "I7@  J7(  *B)  "H
MH@  J+P  *?E  "F^P  IO\  *7_ '=[  !H>P  67X  $N"   ^AP  ,HT
M ">2   =EP  %)P   Z@   'I    *@   "K    K@   *\   "P    L00
M +,*  "T#@  M1,  +8;  "X)   NC$  +I   "Z4@  NV4  +M]  "ZEP
MNK$  +K2  "Z\P  N?\  +G_ &^#  !?A@  48L  $.0   VEP  *IT  !^B
M   5IP  #:P   6P    M    +<   "[    O@   +\   #     P0   ,,!
M  #$!P  Q0T  ,<1  #*&0  S20  ,XS  #/1   T%@  -!N  #1B   T*0
M -#!  #1Y@  T?@  -'_ &>/  !7E   29H  #NA   NIP  (:T  !:S   .
MN   !KP   #     PP   ,8   #+    S0   ,X   #0    T0   -0   #6
M    V@(  -P)  #?#P  XQ<  .8D  #G-@  Z$D  .E?  #J>   ZY0  .NO
M  #KS   [.@  .SV %^>  !0I   0JL  #2R   FN0  &;X   ["   $Q0
M ,H   #-    T0   -@   #;    WP   .    #B    Y    .8   #I
MZP   .X   #Q!0  ]0T  /D6  #\)0  _3D  /Y/  #_9P  _X(  /^=  #_
MM0  _\L  /_D /\ $0#_  \ _P / /\ $0#_ !8 _P B /\ +P#_ #L _P!'
M /\ 4@#_ %L _P!D /\ ; #_ ', _P!Z /\ @ #_ (8 _P", /X DP#] )D
M^P"A /H J0#X +0 ]P#" /8 V@#U /$ ] #_ /, _P#S /\ Z0#_ .  _P#8
M /\ TP#_ /\ #@#_  L _P * /\ "P#_ !$ _P = /\ *@#_ #8 _P!! /\
M3 #_ %8 _@!? /L 9@#Y &T ]P!T /4 >@#T (  \@"& /  C0#O )0 [0";
M .P I #J *X Z0"Z .< S0#E .D Y #[ ., _P#B /\ W@#_ -$ _P#, /\
MR #_ /\ "0#_  0 _P ! /\ ! #_  X _P 8 /\ ) #] #  ^P [ /< 1@#S
M %  [P!9 .P 8 #J &< YP!N .8 = #D 'H X@"  .  AP#> (X W "5 -H
MG@#6 *@ U "S -$ PP#/ -\ S@#T ,P _P#+ /\ RP#_ ,4 _P"_ /\ O #_
M /\  @#_    _P   /\   #]  L ]P 3 /$ '@#M "H Z@ U .< 0 #B $H
MW0!2 -D 6@#5 &$ T@!G -  ;0#. ', S !Z ,H @ #( (< Q@"/ ,0 F #"
M *$ P "M +X NP"\ -  N@#M +D _@"X /\ N #_ +< _P"S /\ L #_ /\
M  #_    _P   /D   #N  4 Y0 . -X & #8 ", T@ N ,\ .0#+ $, QP!,
M ,0 5 #! %L OP!A +P 9P"[ &T N0!S +< >@"U ($ M ") +( D@"P )L
MKP"G *P M "K ,8 J0#D *< ^ "F /\ I@#_ *4 _P"E /\ I #_ /\   #_
M    ]0   .H   #>    T  * ,@ $@#" !T O@ H +L ,P"Y #T M0!& +(
M30"P %4 K0!; *P 80"J &< J !M *< <P"E 'H I "" *( C "@ )8 GP"A
M )T K@"; +X F0#8 )< \0"6 /\ E@#_ )< _P"7 /\ EP#_ /\   #U
MYP$  -0   #)    P  $ +@ #@"S !8 KP A *L + "H #8 I@ _ *, 1P"A
M $\ GP!5 )T 6P"; &$ F@!G )@ ;@"7 '4 E0!] )0 A@"2 )$ D "< (X
MJ0", +@ BP#- (D ZP"( /T B #_ (@ _P"( /\ B #_ /D&  #I#   U X
M ,,,  "W"0  L (  *L "0"F !  H@ : )X )0"; #  F  Y )8 00"4 $D
MD@!0 )  5@". %P C0!B (L :0"* '  B !X (< @0"% (P A "8 (( I0"
M +0 ?@#( 'T!YP!\ OD >P/_ 'L$_P![!/\ >P3_ /$.  #>%0  Q14  +04
M  "I$0  H0X  )X*  "; PP EP 3 ), '@"0 2D C0(S (H#/ "(!$, A@5+
M (4&40"#!E< @@=> ( '9 !_"&P ?0AT 'P(?@!Z"8D > F6 '<*HP!U"K,
M<PO' '(,Y@!P#?L < W_ &\-_P!O#?\ ;PW_ .@6  #0'@  N1T  *D<  "=
M&@  E18  ) 3  "/#@, C@H. (D+%P"&#", @PTM ( --@!^#CX ? Y& 'L.
M30!Y#U, >!!: '8080!U$&@ <Q!Q '$1>P!P$8< ;A&4 &P1H@!K$K( :1+'
M &@3YP!F$_T 913_ &44_P!E$_\ 91/_ -\>  #&)   L"0  * C  "4(0
MBQ\  (8;  "#%P  @A(( '\1$@!\$AT >10H '84,0!T%3H <A9! '$62 !O
M%T\ ;A=6 &P770!K&&0 :1AM &@9=P!F&8, 9!F0 &,:GP!A&J\ 8!K$ %X;
MY !='/L 7!S_ %P;_P!<&_\ 7!O_ -4E  "]*@  J"D  )@I  ",*   @R4
M 'TB  !Y'P  >!L# '89#P!R&A@ ;QPC &T=+0!K'34 :1X] &@>1 !F'TL
M91]2 &,@60!B(&$ 82!I %\A<P!=(7\ 7"&- %HBG !9(JP 5R+  %8CX0!5
M(_D 5"/_ %0B_P!4(O\ 5"+_ ,TK  "V+@  HBX  )(N  "%+0  ?"L  '8H
M  !R)@  ;R,  &TA# !J(A4 9R,? &4D*0!C)#$ 8B4Y & F00!?)D@ 729/
M %PG5@!;)UT 62=F %@H< !6*'P 5"B* %,IF0!1*:H 4"F^ $\IW@!.*?<
M32G_ $TI_P!-*/\ 3BC_ ,@P  "P,@  G#(  (PR  " ,0  =C   ' M  !K
M*P  :"D  &8H"0!C*!$ 8"D< %XJ)0!<*RX 6RLV %DL/0!8+$0 5RU, %4M
M4P!4+5L 4RUC %$N;@!0+GH 3BZ( $POEP!++Z@ 22^[ $@OVP!(+_8 1R__
M $<N_P!'+?\ 2"W_ ,0T  "K-0  ES4  (<U  ![-0  <C0  &LR  !F+P
M8BX  %\M!0!<+A  6B\8 %@P(@!6,"L 53$S %,Q.@!2,D( 43)) % R4 !.
M,U@ 33-A $LS:P!*,W< 2#2% $<TE0!%-*8 0S2Y $(TU@!"-/0 0C3_ $(S
M_P!",O\ 0C+_ , X  "G.   DS@  (,X  !W.   ;3<  &8V  !A,P  73(
M %DR @!7,PT 5#05 %(U'P!1-2@ 3S8P $XV. !,-S\ 2S=& $HW3@!).%8
M1SA? $8X:0!$.'4 0SB# $$YDP! .:0 /CFX #TYTP \.?, /#C_ #TW_P ]
M-_\ /3;_ +L[  "B.P  CSL  '\[  !S.P  :CH  &(Y  !=-P  6#8  %0W
M  !1. L 3SD3 $TY' !+.B4 2CHM $@[-0!'.SP 1CQ$ $4\2P!$/%, 0CQ<
M $$]9P _/7, /CV! #P]D0 Z/:, .3VV #@]T0 W/?( -SS_ #@[_P X._\
M.#K_ +8]  ">/@  BSX  'P^  !O/@  9CT  %X]  !8.P  4SH  $\[  !,
M/ @ 23T1 $<^&0!&/R( 1#\J $,_,@!"0#H 04!! $! 20 ^05$ /4%: #Q!
M9  Z07  .$%_ #=!CP U0J$ -$*T #)"S@ R0?  ,D#_ #- _P S/_\ -#[_
M +%   ":0   AT   'A!  !L00  8D   %M   !4/P  3C\  $I   !&004
M1$(. $)#%@! 0Q\ /T0G #Y$+P \1#< .T4^ #I%1@ Y14X .$98 #9&8@ U
M1FX ,T9\ #%&C0 P1I\ +D:S "U&S  M1N\ +47_ "Y$_P N0_\ +D/_ *Q#
M  "60P  @T,  '1#  !H0P  7T,  %=#  !00P  2$,  $1%  !!1@$ /D<,
M #Q($P Z2!P .4DD #A)+  V230 -4H[ #1*0P S2DP ,DI5 #!+7P O2VL
M+4MZ "Q+BP J2YT *$NQ "=+R@ G2^T )TK_ "A)_P H2/\ *4?_ *=&  "1
M1@  ?T8  '!&  !E1@  6T8  %1&  !,1P  1$@  #]*   [2P  -TP) #5-
M$  S3A@ ,DX@ #%/*  P3S  +T\X "Y/0  L4$@ *U!2 "I07  H4&@ )U!W
M "50B  D4)L (E"O "%0R  @4.L (4__ ")._P B3?\ (TW_ *%)  ",20
M>DD  &Q*  !A2@  6$H  %!*  !)2P  0$P  #M.   U4   ,5($ "U3#0 L
M5!0 *E0< "E5)  H52P )U4S "95/  E5D4 )%9. ")660 A5F4 'U9T !Y6
MA0 <5I@ &U:L !E6Q0 95ND &E7_ !M4_P ;4_\ '%+_ )M-  "&30  =4T
M &A-  !=30  5$T  $U.  !%3P  /%$  #93   Q50  *U@  "9:"0 C6Q
M(EL7 "%<'P @7"< 'UPN !U<-P <74  &UU* !I=50 876$ %UUP !5=@0 4
M794 $UVJ !%=P@ 17>< $EO^ !-:_P 36O\ %%G_ )11  " 40  <%$  &11
M  !940  45$  $E2  !!4P  .%8  #)9   K6P  )5X  !]A P :8PP &&01
M !=D&0 69"$ %60I !1E,0 393H $F5$ !%E4  095T #V5K  YE?0 -99$
M#&6E  IDO  *9.  "V/Y  QB_P -8?\ #6'_ (U5  !Z50  :U4  %]5  !6
M50  3E4  $17   \60  -%P  "Q?   F8@  'V4  !EH   3:P4 $&T-  YN
M$@ -;AH #&XB  QN*P +;C0 "FX^  AN2@ ';E< !FYE  1N=@ ";HH  &V?
M  !MM@  ;-8  &SS  %K_P ":O\  VK_ (5:  !T6@  9EH  %Q9  !360
M2%H  #]=   V8   +F,  "9G   ?:@  &6T  !-Q   .= , "G<*  5W$  !
M=Q4  '<<  !W)   >"T  '@W  !X0P  >%   'A>  !X;P  >(0  'B9  !W
ML   =LT  '7P  !U_P  =/\  '3_ 'Y?  !N7P  8EX  %E>  !-7P  0F(
M #EE   P:   )VP  !]P   8=   $G<   U[   (?@   H (  "!#0  @1$
M ((7  "#'@  @R8  (0P  "$.P  A$@  (17  "$:   A'P  (23  "#J@
M@L4  ('K  "!_@  @/\  (#_ '=E  !I9   7V,  %)D  !'9P  /&L  #%O
M   H<P  ('<  !A\   1?P  #(,   :'    B@   (P#  ","0  C0X  (X1
M  "/%P  D!X  )$G  "2,@  DC\  )).  "27P  DG,  )*+  "1H@  D;P
M )#E  "/_   CO\  ([_ '%K  !F:@  6&L  $MM   _<0  -'8  "I[   @
M@   %X4  !")   +C0  !)$   "5    F    )D   ": P  FP@  )P-  ">
M$0  GQ8  * >  "B*   HC4  *-$  "C50  HVD  **   "BF@  H;,  *#8
M  "@]@  G_\  )__ &YQ  !?<@  474  $1Y   W?@  +(0  "&*   7CP
M$)0   J9   !G0   *    "D    IP   *@   "I    J@   *P&  "M"P
MKQ   + 5  "R'@  M"D  +0Y  "T2@  M5T  +5S  "UC@  M:@  +3&  "S
M[0  LO\  ++_ &9Z  !7?0  28(  #R'   OC@  (Y0  !B:   0GP  ":0
M  "I    K0   +    "T    MP   +@   "Y    NP   +P   "^ @  P @
M ,(.  #$%   QQX  ,@L  #)/0  RE   ,IF  #*?P  RIL  ,JX  #*W0
MRO4  ,K_ %Z&  !/BP  09$  #.8   GGP  &Z4  !&K   )L    +4   "Y
M    O0   ,$   #&    R    ,D   #+    S    ,X   #0    T@   -0%
M  #9#   W1(  .$>  #B+@  XT(  .17  #E;P  YHP  .:H  #EQ0  Y><
M .;V %:4  !(FP  .J(  "RI   ?L   $[8   N\    P0   ,4   #)
MS0   -(   #6    V@   -L   #>    X    .(   #D    YP   .D   #M
M    \ H  /01  #X'P  ^3(  /I(  #[7P  _'H  /V7  #]KP  _<<  /WD
M /\ #@#_  T _P , /\ #@#_ !, _P > /\ *@#_ #8 _P!" /\ 30#_ %<
M_P!? /\ 9P#_ &X _P!T /\ >@#_ ($ _0"' /P C0#Z )0 ^0"< /< I0#U
M *\ ] "\ /, SP#Q .P \ #^ .\ _P#O /\ XP#_ -< _P#. /\ R@#_ /\
M"@#_  8 _P $ /\ " #_ !  _P 9 /\ )0#_ #$ _P ] /\ 1P#^ %$ ^P!9
M /D 80#V &@ ] !N /, = #Q 'H [P"! .X AP#L (X Z@"6 .@ GP#F *D
MXP"U .( Q@#@ ., WP#X -T _P#= /\ U #_ ,D _P#" /\ O@#_ /\  P#_
M    _P   /\  0#_  T _P 4 /T ( #Z "L ]P V /, 00#O $L [ !4 .@
M6P#F &( XP!H .$ ;@#? '0 W !Z -H @0#8 (@ U "0 -( F #/ *( S0"N
M ,L O #) -, QP#P ,8 _P#$ /\ Q #_ +L _P"V /\ LP#_ /\   #_
M_P   /\   #W  @ \  0 .L &@#G "4 Y  P .$ .P#< $4 U0!- -$ 50#.
M %L RP!B ,D 9P#' &T Q0!S ,, >@#! ($ OP") +T D@"[ )P N0"G +<
MM0"U ,@ LP#F +( ^P"Q /\ L #_ *X _P"J /\ IP#_ /\   #_    _@
M /$   #E  ( W  - -, % #- !\ R@ J ,< - #$ #X P !' +P 3@"Z %4
MMP!; +4 80"S &< L@!M +  <P"N 'H K "" *H BP"H )4 IP"@ *4 K0"C
M +X H0#; *  ] "? /\ G@#_ )\ _P"= /\ FP#_ /\   #\    [@   .
M  #0    Q0 ( +X $ "Y !D M0 C +, +@"P #< K0!  *H 2 "H $\ I0!5
M *, 6P"B &  H !F )\ ; "= ', FP![ )H A "8 (X E@": )4 IP"3 +<
MD0#, )  [ "/ /\ C@#_ (X _P". /\ CP#_ /P   #O    VP   ,D   "]
M    M0 " *X # "I !, I0 = *( )P"@ #$ G0 Z )H 0@"8 $D E@!/ )0
M50"3 %L D0!@ )  9P". &T C0!U (L ?@") (D B "5 (8 H@"% +$ @P#$
M ($ Y "  /D ?P#_ (  _P"  /\ @ #_ /0"  #@"0  QP@  +<'  "L P
MI@   *  !P";  \ F  7 )4 (0"2 "H CP S (T / "+ $, B0!) (< 4 "&
M %4 A !; (, 80"! &@ @ !P 'X >0!\ (0 >P"0 'D G0!X *P =@"^ '4
MW0!S /0 <P#_ ', _P!S /\ <P#_ .D-  #/$   N1   *D0  ">#@  EPL
M ),&  "0  L C  1 (D &@"& "0 @P N ($ -@!_ #X ?0!$ 'P 2P!Z %$
M>0!7 '< 70!V &0 = !L ',!=0!Q 8  ;P*- &X"F@!L ZH :P.[ &D$U@!H
M!O$ : ?_ &<'_P!G!_\ 9P?_ -\4  ##%P  KA<  )X6  "3%0  BQ(  (80
M  "$# ( @P8- ( #% !\!1X >0<H '<(, !U"#@ <PE  '()1@!P"DP ;PI3
M &T+60!L"V$ :@MI &D,<@!G#'X 9@R+ &0-F0!B#:D 80V[ & -V !>#O,
M70[_ %T._P!=#O\ 70[_ -0<  "Y'0  I!X  )4=  ")'   @1H  'L7  !X
M$P  >! & '<-#P!S#A@ < XB &X/*P!L$#, :A [ &D00@!G$4D 9A%/ &01
M5@!C$ET 81)F & 2;P!>$GL 7!.( %L3EP!9$Z< 5Q2Z %84U0!5%?, 5!7_
M %05_P!4%?\ 5!3_ ,HB  "P(@  G2,  (TC  "!(@  >2$  ',>  !O&P
M;A<  &T3# !J%!0 9Q4> &46)P!C%B\ 81<W & 7/@!>&$4 71A+ %P94@!:
M&5H 61EB %<:; !6&G< 5!J% %(;E !1&Z0 3QNW $X;T !-'/$ 3!S_ $P<
M_P!-'/\ 31O_ ,,F  "J)P  EB<  (<H  ![)P  <B8  &PD  !H(0  9AX
M &0;" !B&Q$ 7QP: %T=(P!;'BL 6AXS %@?.@!7'T$ 5B!( %0@3P!3(%<
M42%? % A:0!.(70 32&" $LBD0!)(J( 2"*T $<BS0!&(^\ 12/_ $4B_P!&
M(O\ 1B'_ +PJ  "D*P  D2L  ((L  !V*P  ;2H  &8I  !B)@  7R0  %TB
M! !;(0X 6"(6 %8C'P!4)"@ 4R0P %(E-P!0)3X 3R9% $XF3 !,)E0 2R=<
M $DG9@!()W$ 1B=_ $4HCP!#**  02BR $ HRP _*.T /RC_ #\H_P! )_\
M0"?_ +<M  "?+@  C"\  'TO  !Q+P  :"X  &$M  !=*P  6B@  %<G  !4
M)PP 4B@3 % I' !.*24 32HL $LJ- !**SL 22M" $@L20!&+%$ 12Q: $0L
M9 !"+6\ 0"U] #\MC0 ]+9X /"VP #HMR  Z+>L .BW_ #HM_P Z+/\ .BS_
M +(P  ";,0  B#(  'DR  !M,@  9#(  %TQ  !8+P  52P  %$L  !/+0D
M3"T1 $HN&0!)+R( 1R\J $8P,0!%,#@ 0S _ $(Q1P!!,4\ 0#%7 #XQ80 ]
M,FT .S)[ #DRBP X,IP -C*O #4RQP T,ND -#+_ #4Q_P U,?\ -3#_ *TS
M  "6-   A#4  '4U  !I-0  8#4  %DT  !4,P  4#   $PQ  !),08 1S(/
M $4S%@!#,Q\ 0C0G $ T+@ _-38 /C4] #TU1  \-DP .C95 #DV7P W-FL
M-C9X #0WB0 R-YH ,3>M "\WQ0 O-^@ +S;^ # U_P P-?\ ,#3_ *DV  "2
M-@  @#<  '(X  !F.   73<  %8W  !0-@  2S0  $<U  !$-@, 03<- #\X
M%  ^.!P /#DD #LY+  Z.3, .3HZ #@Z0@ V.DH -3I3 #0[70 R.V@ ,#MV
M "\[AP M.YD +#NL "H[PP I.^8 *CK] "HZ_P K.?\ +#C_ *0X  "..0
M?#H  &XZ  !C.@  6CH  %,Z  !-.@  1C@  $(Z   _.P  /#P+ #H\$0 X
M/1D -STA #8^*0 T/C  ,SXW #(_/P Q/T< ,#]0 "X_6@ M0&8 *T!T "E
MA  H0)< )D"J "5 P0 D0.4 )#_\ "4^_P F/?\ )CW_ )\[  "*/   >#T
M &H]  !?/0  5CT  $\]  !)/0  0CT  #P^   Y/P  -D$( #1!#P R0A8
M,4(> "]#)0 N0RT +4,T "Q$/  K1$0 *D1- "A$6  G16, )45Q "-%@@ B
M194 ($6H !]%OP >1., 'T3[ !]#_P @0O\ (4'_ )H^  "%/P  =$   &=
M  !<0   4T   $Q   !&0   /D$  #A#   T10  ,$8# "U'#0 K2!( *D@:
M "E((@ H22D )TDQ "5).0 D24$ (TI* ")*50 @2F$ 'TIO !U*?P ;2I(
M&DJF !A*O0 72N  &$GZ !E(_P :1_\ &D?_ )5"  " 0@  <$,  &-#  !8
M0P  4$,  $E#  !"1   .T4  #5'   P20  *TL  "9-"0 D3A  (DX6 "%/
M'0 @3R4 'T\L !Y/-0 =3ST '%!' !I040 94%T %U!K !90?  44(\ $U"D
M !%0N@ 14-X $4_X !)._P 33?\ %$W_ (]%  ![1@  :T8  %]'  !51P
M34<  $9'   _1P  -TH  #%,   K3@  )E   "!3 P <50P &E81 !E6&  7
M5B  %E8G !56,  45CD $U=" !)730 15UD $%=H  ]7>0 .5XP #5>@  M7
MM@ +5M0 "U;T  Q5_P -5/\ #E/_ (A)  !V2@  9TH  %M*  !12@  2DH
M $-*   [3   ,TX  "Q1   F5   (58  !M9   57 < $5X- !!>$P 07AH
M#EXB  Y>*@ -7C, #%X]  M>2  *7E0 "%YB  =><P %7H8  UZ;  )>L0 "
M7<P  EWN  -<_P $6_\ !5O_ (%.  !P3@  8DX  %=.  !.3@  1TX  #Y/
M   V40  +E0  "=7   A6@  &UT  !5@   08P, #&8+  AG$  &9Q4 !6<<
M  1G)  "9RT  6<W  !G0@  9TX  &=<  !G;0  9X   &:5  !FK   9<<
M &7K  !D_   9/\  &/_ 'I2  !J4P  75(  %12  !+4@  0E,  #E5   P
M6   *%L  "%?   :8@  %&4  !!H   ,:P$ !FX)  !O#@  ;Q(  &\8  !P
M'P  <"<  '$P  !Q.P  <4@  '%6  !Q9@  <7D  '&/  !PIP  ;\$  &_G
M  !N_   ;?\  &W_ '-8  !E5P  6E<  %%6  !&5P  /%H  #)=   J80
M(F0  !IH   4;   #F\   IR   $=@   '@%  !X"P  >0X  'H3  ![&0
M?"   'TI  !],P  ?4   'U.  !]7@  ?7(  'V(  !\H0  ?+H  'OB  !Z
M^@  >?\  'C_ &U=  !@7   5UP  $M=  ! 7P  -6,  "MG   C:P  &F\
M !-S   .=P  "'L   )^    @@   (,!  "$!@  A0L  (8/  "($P  B1D
M (HA  "+*P  BS<  (Q&  "+5@  BVD  (N   "+F0  BK,  (G8  "(]P
MB/\  (?_ &AC  !>8@  46(  $1E   X:0  +FX  "1S   :>   $WT   V!
M   &A0   (D   "-    D    )(   "2    E 4  )4*  "7#@  F!(  )H8
M  ";(0  G"T  )T\  "=3   G%\  )QV  ";D0  FZL  )K)  ":\   F?\
M )C_ &5I  !7:0  26P  #UQ   P=@  )7P  !N!   2AP  #(P   21
ME0   )D   "=    H    *$   "B    I    *4!  "G!P  J0P  *H1  "M
M&   KR(  *\P  "O00  KU0  *]K  "NA0  KJ$  *Z^  "MY@  K/P  *S_
M %YQ  !/=   0GD  #5_   HA0  '8P  !.2   ,F    YT   "B    I@
M *H   "N    L    +$   "S    M    +8   "X    N@0  +P*  "^$
MP1<  ,,D  ##-0  Q$D  ,1>  #%=P  Q9,  ,6O  #%T0  P_(  ,/_ %9\
M  !'@@  .H@  "R/   @E@  %)T   VC   #J0   *X   "R    MP   +L
M  "_    P@   ,(   #%    Q@   ,@   #*    S0   ,\   #2"   U0X
M -L8  #=)P  WCH  -]0  #@:   X(0  .&A  #AO0  X>(  .#T $Z+  !
MD@  ,ID  "6A   8J   #J\   6U    N@   +\   #$    R    ,X   #1
M    U    -4   #8    V@   -T   #?    X@   .0   #G    ZP4  .\.
M  #T&0  ]2L  /9!  #W6   ^'(  /F0  #YJP  ^,0  /CA /\ "P#_  @
M_P ) /\ # #_ !( _P : /\ )@#_ #( _P ^ /\ 2 #_ %( _P!: /\ 8@#_
M &D _P!O /\ =0#^ 'L _ "! /L B #Y (\ ]P"7 /4 H #S *H \@"W .\
MR0#M .8 [ #[ .L _P#K /\ W0#_ ,X _P#& /\ P@#_ /\ ! #_    _P
M /\ !0#_  T _P 5 /\ (0#_ "P _P X /\ 0P#] $P ^0!4 /< 7 #T &,
M\@!I /  ;P#N '4 [ ![ .H @@#H (D YP"1 .0 F@#B *0 X "P -T P #:
M -P V #T -4 _P#3 /\ RP#_ ,$ _P"[ /\ MP#_ /\   #_    _P   /\
M  #_  H _0 1 /D &P#V "< ]  R /  / #L $8 Z !. .0 5@#A %P W@!C
M -P : #9 &X U0!T -( >P#0 (( S0"* ,L DP#( )T Q@"H ,0 MP#! ,P
MP #K +X _P"] /\ O0#_ +0 _P"N /\ JP#_ /\   #_    _P   /H   #R
M  4 Z@ . .4 %@#@ "$ W0 K -L -@#3 #\ S@!( ,H 3P#' %8 Q !< ,(
M80#  &< O@!M +P <P"Z 'H N "" +8 BP"T )8 L@"A +  KP"N ,$ K0#@
M *L ]P"J /\ J0#_ *8 _P"A /\ GP#_ /\   #_    ]P   .@   #<
MT  * ,H $0#% !L P@ E +\ +P"\ #@ N !! +4 2 "R $\ L !5 *X 6P"L
M &$ J@!F *@ ; "G ', I0![ *, A "A (X GP": )T IP"; +@ F@#0 )D
M[P"8 /\ EP#_ )8 _P"4 /\ D@#_ /\   #V    Y    -(   #%    NP %
M +4 #@"P !4 K  ? *H *0"H #( I0 Z *( 0@"@ $D G@!/ )P 50": %H
MF !@ )8 9@"5 &P DP!T )( ?0"0 (< C@"3 (P H0"+ +  B@#% (@ Y@"'
M /L A@#_ (< _P"' /\ A@#_ /@   #E    S0   +T   "S    J@   *,
M"@"? !$ FP 9 )D (P"7 "P E0 T )( / "0 $, C@!) (P 3P"* %0 B0!:
M (< 8 "& &8 A !N (, =P"! ($ ?P"- 'X FP!\ *H >P"\ 'H VP!X /4
M> #_ '@ _P!X /\ > #_ .T   #1 @  NP(  *P!  "B    FP   )8 !0"1
M  T C0 4 (L '0"( "8 A@ N (0 -@"" #T @ !# 'X 20!] $\ ? !5 'H
M6P!Y &$ =P!I '4 <0!T 'P <@"( '$ E@!O *4 ;@"V &T S@!L .X :P#_
M &L _P!K /\ :P#_ -\+  #"#   K@P  )X,  "3"P  C <  (@"  "%  D
M@0 0 '\ %P!\ "  >@ H '@ , !V #@ =  ^ ', 1 !Q $H < !0 &X 5@!M
M %T ; !D &H ;0!H '< 9P"$ &4 D@!D *$ 8P"R &$ R0!@ .D 8 #\ &
M_P!@ /\ 8 #_ - 0  "V$0  HA(  ),2  "($0  @ \  'P-  !Y"0$ > ,+
M '4 $0!S !H <  C &X!*P!L 3, :@(Y &D#0 !G T8 9@1, &4$4@!C!5D
M8@5A & %:@!?!G0 70:! %P'CP!:!Y\ 60>P %<'Q@!6">< 5@K[ %4*_P!5
M"O\ 5@K_ ,85  "M%P  F1@  (H8  !_%P  =A8  '$3  !N$   ;0T% &T)
M#0!J"10 9PH= &4*)@!C"RX 8@PU & ,/ !?#$( 7@U( %P-3P!;#58 60U>
M %@.: !6#G, 50Z  %,.CP!1#I\ 4 ZQ $X.R !-$.H 31#] $T0_P!-$/\
M31#_ +P;  "E'   DAT  (,>  !W'0  ;QP  &D:  !F%P  9!0  &00" !B
M#Q  7Q 8 %T0(0!;$2D 6A$Q %@2. !7$CX 5A)% %023 !3$U, 41-; % 3
M90!.%'  3!1] $L4C !)%)P 1Q6N $85Q0!%%>@ 11;^ $46_P!%%?\ 117_
M +4?  ">(0  BR(  'PB  !Q(@  :"$  &(?  !?'0  7!H  %L7 @!:%0T
M5Q84 %46'0!4%R4 4A@M %$8- !/&#L 3AE" $T92 !+&E  2AI8 $@:8@!'
M&FT 11MZ $,;B0!"&YH 0!NL #\;P@ ^'.4 /1S\ #X<_P ^&_\ /AO_ *\C
M  "8)   AB4  '<F  !L)@  8R4  %TD  !9(@  5A\  %0=  !3' L 41P2
M $X=&@!-'2( 2QXI $H>,0!)'S< 1Q\^ $8@10!%($T 0R!5 $(@7P! (6H
M/R%W #TAAP [(9@ .2&J #@BP  W(N, -R+[ #<B_P X(?\ ."'_ *HF  "4
M)P  @2D  ',I  !G*0  7RD  %@H  !4)@  42,  $\B  !,(@< 2B(0 $@B
M%P!'(Q\ 120F $0D+@!")#0 024[ $ E0P _)4H /293 #PF7  Z)F< .29U
M #<GA  U)Y8 -">H #(GO@ Q)^$ ,2?Y #(F_P R)O\ ,R7_ *4I  "/*@
M?2P  &\L  !D+0  6RP  %4K  !0*@  3"@  $HF  !')P0 1"<- $(H% !!
M*!P /RDC #XI*P ]*3( /"HY #LJ0  Y*D@ ."M0 #8K6@ U*V4 ,RMR #$K
M@@ P+)0 +BRG "PLO  K+-X +"SX "PK_P M*O\ +2K_ *$L  "++0  >2X
M &LO  !@+P  6"\  %$N  !,+@  2"P  $4K  !!*P  /RP+ #TL$0 [+1D
M.BXA #DN*  W+B\ -B\V #4O/@ T+T4 ,R]. #$P6  P,&, +C!P "PP@  J
M,)( *3"E "<PN@ F,-P )C#W "<O_P H+_\ *"[_ )PN  "',   =C$  &@R
M  !=,@  53(  $XQ  !(,0  1#   $ O   \,   .C$) #<Q$  V,A8 -3(>
M #,S)0 R,RP ,3,S # T.P O-$, +31, "PT5@ J-6$ *35N "<U?@ E-9
M(S6C "(UN0 A-=D (33V "(T_P C,_\ (S+_ )@Q  "#,P  <C0  &4T  !:
M-0  434  $LT  !%-   0#0  #HS   W-   -#4& #(V#@ P-Q, +S<; "XW
M(@ M."D *S@Q "HX.  I.4  *#E) "8Y4P E.5\ (SEL "$Z?  @.HX 'CJB
M !PZMP ;.=4 '#GU !TX_P =./\ 'C?_ ),T  !_-@  ;C<  &$W  !7-P
M3C<  $@W  !"-P  /#<  #4X   R.0  +SH" "P["P J/!$ *3P8 "@]'P F
M/28 )3TN "0]-0 C/CT (CY& " ^4  ?/EP '3]I !L_>0 :/XP &#^@ !8_
MM0 5/M( %C[S !<]_P 8//\ &#S_ (XW  !Z.   :CD  %XZ  !3.@  2SH
M $4Z   _.@  .3H  #(\   N/@  *4   "9!"  D0@X (D(4 "%"&P @0R,
M'T,J !Y#,@ <0SH &T1# !I$30 81%D %T1G !5$=P 31(H $D2> !%$LP 0
M1-  $$/R !%"_P 20O\ $T'_ (D[  !V/   9CT  %H]  !0/0  2#T  $(]
M   \/0  -CX  "]    J0@  )40  "%& P =2 P &TD1 !E)%P 821X %TDF
M !9)+@ 52C8 %$I  !-*2@ 12E8 $$ID  ]*=  .2H< #4J;  Q*L  *2LH
M"TGL  Q(_P -1_\ #4?_ (,^  !Q/P  8D   %9   !-0   14   #]    Y
M00  ,D(  "M%   F1P  (4D  !Q+   63@< $U . !)0$P 14!D $% A  ]0
M*0 .4#$ #5 [  U11@ +45$ "E%?  E1;P '4($ !5"6  -0JP "4,4  T_H
M  -/^P %3O\ !DW_ 'U"  !K0P  740  %)$  !*1   0T,  #Q$   U10
M+D<  "=*   A3   '$\  !=1   25 , #E<*  M8$  *6!4 "%@<  =8)  &
M6"P !5@V  -80  !6$P  %A:  !8:0  6'P  %B1  !7IP  5\   %;E  !6
M^0  5?\  %7_ '9'  !F1P  64@  $]'  !'1P  0$<  #A(   P2@  *4T
M ")0   <4P  %E4  !%8   -6P( "5X)  1?#@  7Q(  %\8  !@'P  8"<
M & P  !@.P  8$<  &!4  !@8P  8'8  &"+  !?H@  7[L  %_B  !>^0
M7?\  %W_ &]+  !A3   54P  $Q+  !$2P  .TP  #).   K40  (U0  !Q7
M   66P  $5X   U@   (8P   F8'  !G#   9P\  &@3  !I&0  :B$  &HI
M  !J-   :D   &I-  !J70  :F\  &J%  !JG0  :;8  &C=  !H]P  9_\
M &;_ &E1  !<4   4E   $I/   _4   -5,  "U6   D60  '5T  !9@   0
M9   #&<   9J    ;@   &\#  !P"   <0T  '(0  !T%   =1L  '8C  !W
M+   =S@  '9&  !V5@  =F@  '9^  !VEP  =;$  '33  !S]0  <_\  '+_
M &-6  !850  4%0  $15   Y6   +UL  "9?   =8P  %6<  !!L   *<
M!',   !V    >@   'P   !\ P  ?@@  '\,  "!$   @A0  (0;  "%)
MAB\  (8]  "&30  A5\  (5U  "%CP  A*D  (/)  ""\0  @?\  (#_ %];
M  !66@  25L  #U>   R80  )V8  !YK   5<   #G4   EY   !?@   ($
M  "%    B    (H   "+    C0$  (X&  "0"P  D0\  ),4  "5&P  ER8
M )<T  "71   EU8  )9L  "5A@  E:(  )3!  "3Z@  DO\  )+_ %UA  !/
M80  0F0  #9I   J;@  'W0  !5Y   .?P  !X0   ")    C@   )(   "6
M    F    )H   ";    G0   )\   "A P  HP@  *4-  "G$P  J1P  *HH
M  "J.0  JDL  *IA  "I>@  J)D  *BU  "GW0  I_@  *;_ %9H  !(;
M.G   "YV   B?0  %X0   Z*   'D    )8   ":    GP   *,   "G
MJ@   *L   "M    KP   +$   "S    M0   +@%  "Z#   O1(  , <  #
M+0  P$   +]5  "_;@  OHL  +ZH  "^R0  O>\  +S^ $YT  ! >0  ,G\
M "6'   9C@  $)4   ><    H@   *<   "L    L    +4   "Y    O
M +T   "_    P0   ,,   #&    R    ,H   #- @  T L  -42  #6(0
MUS0  -A)  #98   VGP  -J:  #;M0  V]D  -OR $:"   XB0  *Y   !V8
M   2H   "J<   "N    M    +D   "^    P@   ,@   #+    S@   ,\
M  #2    U    -8   #:    W0   -\   #B    Y@   .H*  #O$P  \"4
M /(Z  #S40  ]&L  /2)  #UI0  ];\  /7= /\ !@#_  , _P % /\ "P#_
M !  _P 7 /\ (@#_ "T _P Y /\ 1 #_ $T _P!5 /\ 70#_ &0 _P!J /\
M< #] '8 ^P!\ /D @P#W (H ]0"2 /, FP#P *8 [@"S .L Q #I .0 YP#Y
M .8 _P#E /\ TP#_ ,< _P"_ /\ NP#_ /\   #_    _P   /\  @#_  L
M_P 2 /\ '0#_ "@ _P S /\ /@#\ $< ^ !/ /0 5P#Q %T [@!C .P :0#J
M &\ Z !U .8 ? #D (, X@"+ -\ E0#< )\ V0"K -4 NP#2 -0 SP#R ,T
M_P#, /\ Q0#_ +H _P"T /\ L #_ /\   #_    _P   /\   #_  8 ^0 /
M /4 %P#S "( \0 M .T -P#G $  X@!) -\ 4 #; %< UP!= -0 8P#1 &@
MSP!N ,P =0#* 'P R "$ ,4 C0#" )@ P "D +T L@"[ ,8 N0#H +@ _0"W
M /\ M@#_ *T _P"G /\ HP#_ /\   #_    _P   /4   #K  $ Y  , -X
M$P#9 !P TP F -$ , #, #H R !" ,0 2@#  %  O0!6 +L 7 "Y &$ MP!G
M +4 ;0"S '0 L0!\ *\ A0"M )  J@"< *@ J@"F +L I0#: *, ]0"C /\
MH@#_ )X _P": /\ EP#_ /\   #^    [P   -\   #0    QP ' ,$ #P"\
M !< N0 @ +< *@"U #, L  [ *T 0P"K $D J !/ *8 50"D %H HP!@ *$
M9@"? &T G0!T )P ?0": (@ F "4 )8 H@"4 +( D@#) )$ ZP"1 /\ D #_
M )  _P", /\ B@#_ /P   #L    V0   ,<   "Z    L0 " *L # "G !(
MI  ; *$ ) "@ "P G@ U )L / "8 $, E@!) )0 3P"2 %0 D !: (\ 7P"-
M &8 BP!M (D =@"( (  A@", (0 F@"" *H @0"^ (  X "  /D ?P#_ '\
M_P!_ /\ ?@#_ /$   #8    P@   +,   "H    H    )D !P"5  X D@ 5
M )  '@". "8 C0 N (H -@"' #T A0!# (0 20"" $X @0!4 '\ 60!^ &
M? !G 'H ;P!Y 'H =P"& '4 E !T *, <@"U '( SP!Q /$ < #_ '  _P!P
M /\ <0#_ .$   #$    L    *(   "7    D0   (L  @"&  L @P 1 ($
M& !_ "$ ?0 I 'P , !Y #< >  ] '8 0P!T $D <P!. '( 5 !P %H ;P!B
M &T :@!K '0 :@"  &@ C@!G )T 90"O &4 Q@!D .@ 9 #] &, _P!C /\
M9 #_ ,\%  "V!P  HP@  )0(  ")!P  @@,  'X   ![  8 =P . '4 $P!R
M !L <0 C &\ *P!M #( ;  X &H /@!I $0 9P!) &8 3P!E %8 8P!= &(
M90!@ &\ 7P![ %T B0!< )D 6P"J %D OP!9 .$ 6 #X %@ _P!8 /\ 60#_
M ,(,  "J#0  EPX  (D.  !]#@  =@T  '$*  !O!@  ;0 * &L $ !I !8
M9P > &4 )@!C "T 80 S &  .0!? #\ 70!% %P 2P!; %( 6@!9 %@ 8@!7
M &P 50!X %, A@!2 )8 40"G %  NP!/ =L 3@+T $X#_P!.!/\ 3@/_ +@0
M  "A$@  CA,  '\3  !T$P  ;!(  &<0  !E#@  8PL# &,&# !A!!$ 7@,9
M %P$(0!;!2@ 608O %@&-0!6!SL 50=" %0'2 !3"$\ 40A6 % )7P!."6D
M30EV $L*A !)"I0 2 JF $<*N@!&"M@ 10OS $4,_P!%#/\ 10S_ + 4  "9
M%@  AQ@  '@9  !M&   91<  %\6  !<$P  6A$  %H.!@!:# T 5PP4 %4,
M' !3#20 4@TK % -,0!/#C@ 3@X^ $T.10!+#DT 2@Y5 $@/7@!'#V@ 10]U
M $,0A !!$)4 0!"F #X0NP ]$-P /1'V #T1_P ]$/\ /A#_ *D9  "2&P
M@1P  '(=  !G'0  7QP  %D;  !5&0  4Q8  %(3  !2$0H 4! 0 $X1& !,
M$2  2A(G $D2+@!($S0 1Q,[ $430@!$$TD 0Q12 $$46P _%&4 /A5R #P5
M@0 Z%9( .!6D #<5N0 U%=@ -1;U #86_P V%O\ -Q7_ *,<  "-'@  >R
M &TA  !B(0  6B$  %0?  !0'@  31L  $P9  !+%@8 218. $<7%0!%%QP
M1!@D $(8*@!!&#$ 0!DX #\9/P ]&48 /!I/ #H:6  Y&F, -QMO #4;?@ S
M&Y  ,ANB # ;MP O&], +QSS "\;_P P&_\ ,!O_ )T?  "((@  =R,  &DD
M  !>)   5B0  % C  !+(@  2"   $8=  !%' ( 0QP, $$<$@ _'1D /ATA
M #P>)P ['BX .A\U #D?/  W'T0 -A], #0@5@ S(&  ,2!M "\@?  M(8X
M+"&@ "HAM0 I(=  *2'R "DA_P J(/\ *R#_ )DB  "$)0  <R8  &4G  !;
M)P  4R<  $PF  !')0  1"0  $(A   _(0  /2$) #LA$  Y(A8 ."(> #8C
M)0 U(RL -"0R #,D.0 R)$$ ,"1* "\E4P M)5X *R5K "HE>@ H)8P )B6?
M "0ELP C)<X (R7P "0E_P E)/\ )23_ )0E  " )P  ;RD  &(J  !7*@
M3RH  $DI  !$*   0"<  #TF   Z)0  -R8& #4F#@ T)Q0 ,B<; #$H(@ P
M*"D +R@P "TI-P L*3\ *RE' "DI40 H*EP )BII "0J>  C*HH (2J= !\J
ML@ >*LP 'BKO !\I_P @*?\ (2C_ ) H  !\*@  ;"L  %\L  !4+   3"P
M $8L  !!*P  /"L  #@J   U*@  ,BL# # K#  N+!$ +2P8 "PL'P J+28
M*2TM "@M-  G+CP )BY% "0N3P C+EH (2]G !\O=@ =+X@ '"^; !HOL  8
M+\H &"[M !DN_P ;+?\ &RW_ (PK  !X+0  :"X  %LO  !1+P  22\  $,O
M   ^+@  .2X  #0N   P+@  +2\  "LP"@ I,1  )S$5 "8Q'  E,B, )#(J
M ",R,0 A,SD (#-" !\S3  =,U< &S-D !HT=  8-(8 %C2: !0SK@ 3,\@
M$S/L !0S_P 5,O\ %C'_ (<N  !T+P  93$  %@Q  !.,@  1C(  $ Q   [
M,0  -C$  #$Q   K,P  *#0  "4U!@ C-@T (382 " W&0 ?-R  'C<G !TX
M+@ ;.#8 &C@_ !DX20 7.54 %3EB !0Y<0 2.80 $3F8 ! YK0 ..,< #CCK
M ! X_P 0-_\ $3;_ (,Q  !P,@  830  %4T  !+-   1#0  #TT   X-
M,S0  "TU   H-P  )#D  " Z @ =.PL &SP0 !D]%0 8/1P %STC !8]*P 5
M/C, %#X\ !(^1@ 1/E( $#Y?  \^;P ./H$ ##Z5  L^J0 */L$ "CWD  L]
M^P ,//\ #3O_ 'TT  !K-@  73<  %$W  !(-P  03<  #LW   U-P  ,#<
M "HY   E.P  (#T  !P_   7008 %$,- !)#$@ 10Q@ $4,? !!$)P /1"\
M#D0Y  U$0P ,1$X "T1;  E$:@ '1'P !D20  1#I0 "0[T  T/@  -#]@ $
M0O\ !D'_ '@X  !G.0  63H  $XZ  !%.@  /CH  #@Z   S.@  +3L  "<]
M   A0   '$(  !=$   31@, #TD*  U*#P ,2A0 "TH;  E*(P (2BL !THT
M  5*/@ $2DD  DI6  !*90  2G<  $J+  !*H0  2;D  $G=  !)]0  2/\
M $C_ '(\  !B/0  53X  $H^  !"/0  /#T  #8]   O/@  *4   "-"   =
M10  %T<  !-*   /3 ( "T\)  =0#0 #41$  %$7  !1'@  428  %$O  !1
M.0  440  %)1  !28   47(  %&'  !1G0  4;4  %#8  !0]0  3_\  $__
M &Q   !=00  44$  $=!  ! 0   .4   #)!   J0P  )$8  !Y(   72P
M$DX   Y1   +4P$ !E8'  !7#   6!   %@3  !9&0  6B$  %HI  !:,P
M6C\  %I,  !:6@  6FP  %J!  !9F0  6;$  %C1  !8]   5_\  %?_ &5%
M  !810  344  $5$   ^1   -44  "U'   E2@  'DT  !A0   24P  #E8
M  I9   $7    %X$  !?"0  8 T  &$0  !B%0  8QL  &0C  !D+0  9#@
M &1%  !D5   9&8  &1[  !CDP  8ZT  &+,  !A\@  8?\  &#_ %]*  !3
M2@  2DD  $-(   Y20  +TP  "=/   ?4@  &%4  !)9   -70  "&    )C
M    9@   &@!  !I!0  :@H  &L-  !M$0  ;A8  ' =  !Q)@  <3$  ' ^
M  !P3@  <%\  '!S  !OC0  ;Z<  &[&  !M[P  ;/\  &S_ %I/  !03@
M2$T  #U.   S40  *50  "!8   87   $6    QD   &:    &L   !O
M<@   '0   !U    =P0  '@)  !Z#0  ?!   'T6  !_'@  @"@  ( U  "
M10  ?U8  ']K  !_A   ?J   'V^  !\Z0  >_\  'K_ %94  !.4P  0E0
M #=6   L6@  (E\  !AC   1:   "VT   -R    =@   'H   !]    @
M (,   "$    A@   (<"  ")!P  BPP  (T0  "0%@  DA\  )(L  "2.P
MDDT  )%B  "1>@  CY<  (^T  ".X0  C/L  (S_ %59  !(6@  .UT  "]A
M   D9@  &6P  !%R   *=P   GT   ""    A@   (L   ".    D0   ),
M  "5    EP   )D   ";    G00  )\*  "B#P  I!8  *8A  "F,0  ID,
M *57  "D<   HXX  *.K  "AT   H/4  )__ $YA  ! 9   ,VD  "=N   ;
M=0  $7P   N#    B0   (X   "3    F    )T   "A    I    *4   "G
M    J0   *L   "M    L    +(   "U"   N X  +P6  "\)0  O#<  +M,
M  "Z9   N8$  +>B  "WP   M^H  +?\ $9K   Y<   *W<  !]_   3A@
M"XX   &5    FP   *$   "F    JP   +    "S    MP   +<   "Z
MO    +\   #!    Q    ,<   #*    S04  -$.  #4&0  U"L  -1   #3
M6   TW0  -.2  #2L   TM,  -+R #YY   Q@   (X@  !>1   -F0   Z
M  "G    K@   +,   "X    O0   ,(   #&    R@   ,H   #-    SP
M -(   #5    V0   -T   #?    XP   .<%  #K#P  [!\  .TS  #N2P
M[V0  .^"  #PGP  \;D  /'8 /\   #_    _P $ /\ "0#_  X _P 5 /\
M'@#_ "D _P T /\ /P#_ $@ _P!0 /\ 6 #_ %X _P!E /T :P#[ '$ ^0!W
M /@ ?@#V (4 \P"- /$ EP#N *( ZP"O .@ P #F .  XP#X .( _P#; /\
MRP#_ ,$ _P"Y /\ M #_ /\   #_    _P   /\   #_  D _P 0 /\ &0#_
M ", _P N /T .0#Y $( ]0!* /( 4@#N %@ ZP!> .D 9 #F &H Y !P .(
M=@#? 'T W0"& -D CP#5 )H T0"G ,X M@#+ ,X R0#P ,< _P#% /\ NP#_
M +0 _P"M /\ J0#_ /\   #_    _P   /\   #[  ( ]@ - /$ $P#M !X
M[  H .D ,@#C #L W0!$ -@ 2P#3 %$ T !8 ,T 70#+ &, R0!H ,8 ;P#$
M '8 P@!^ +\ AP"\ )( N@"? +< K0"U ,$ L@#D +$ _0"O /\ K #_ *4
M_P"@ /\ G #_ /\   #_    ^P   .X   #D    W  ( -, $ #/ !@ RP B
M ,D *P#& #0 P0 ] +T 1 "Z $L MP!1 +4 5@"R %P L !A *X 9P"L &X
MJ@!V *@ ?P"F (H HP"6 *$ I0"? +8 G0#1 )P \P"; /\ G #_ )8 _P"3
M /\ D #_ /\   #V    YP   -,   #&    O0 # +@ #0"S !, L0 < *\
M)0"N "X J0 V *8 /0"C $0 H0!* )\ 3P"= %4 FP!: )H 8 "8 &8 E@!N
M )0 =P"2 ($ D ". (X G ", *T B@## (D Z "( /\ B0#_ (< _P"% /\
M@@#_ /,   #C    S    +P   "P    IP   *$ " ">  \ FP 6 )D 'P"8
M "< E@ O ), -P"1 #T C@!# (P 20"+ $X B0!4 (< 60"% &  A !G ((
M;P"  'H ?@"& 'P E !Z *0 >0"X '@ V !W /< > #_ '@ _P!W /\ =0#_
M .8   #+    MP   *@   ">    E@   (\ ! "+  P B  2 (< &0"% "$
MA  I (( , !_ #< ?0 ] 'P 0P!Z $@ >0!- '< 4P!V %D = !A '( :0!Q
M ', ;P!_ &T C0!L )T :@"O &D R !H .T :0#_ &D _P!I /\ :0#_ -(
M  "X    I0   )<   "-    A@   ($   !\  @ >0 . '< % !V !P =  C
M ', *P!Q #$ ;P W &X /0!L $, :P!( &H 3@!H %0 9P!; &4 8P!C &T
M8@!X &  AP!? )8 70"H %T O@!< .0 7 #[ %P _P!< /\ 7 #_ ,(   "J
M 0  F ,  (D$  !_ @  >    '0   !P  0 ;0 , &L $0!I !< :  > &8
M)0!E "P 8P R &( . !@ #T 7P!# %X 20!< $\ 6P!6 %H 7@!8 &@ 5P!S
M %4 @0!4 )$ 4@"C %$ MP!1 -8 40#U %$ _P!1 /\ 4@#_ +8'  "?"0
MC0L  'X,  !S"P  ; H  &@'  !E P  8P ' &$ #0!? !, 70 : %P (0!;
M "< 60 M %@ ,P!6 #D 50 _ %0 10!3 $L 40!2 %  6@!/ &0 30!O $P
M?0!* (T 20"? $@ L@!' ,P 1P#O $8 _P!' /\ 1P#_ *P,  "5#@  @Q
M '40  !K$   8P\  %X.  !;#   6@D" %D$"@!7  \ 50 5 %, ' !2 ",
M40 I $\ +P!. #4 30$[ $P!00!* D@ 20)/ $@"5P!& V$ 10-M $,#>@!"
M XL 0 .< #\#KP ^ \@ /03J #T%_  ]!O\ /@;_ *00  ".$@  ?!,  &X4
M  !D%   7!,  %82  !3$0  40X  % ,!0!0"0P 3P<1 $T'%P!+"!\ 20@E
M $@)*P!'"3$ 1@DX $0*/@!#"D4 0@I- $ +50 _"U\ /0MK #P+>0 Z#(H
M. R< #<,KP U#,< -0SI #4-_0 U#?\ -@S_ )T3  "'%0  =A<  &D8  !>
M&   5A@  % 7  !-%0  2A,  $D1  !)#@< 2 T. $8-$P!$#1H 0PXA $(.
M* ! #BX /PXU #X//  ]#T, .Q!+ #H05  X$%X -A!K #00>0 R$(H ,1"<
M "\0L  M$,D +1'L "T1_P N$?\ +Q#_ )<6  ""&0  <1L  &0<  !9'
M41P  $P;  !'&@  1!@  $,5  !"$P( 01(+ $ 1$  ^$A< /!(> #L3)0 Z
M$RL .!,R #<3.0 V%$  -!1( #,440 Q%%P ,!5H "X5=P L%8@ *A6: "@5
MK@ G%<< )A7J "<5_P H%?\ *17_ )$:  !]'   ;1X  & ?  !6'P  3A\
M $@>  !#'0  0!P  #X:   ]&   .Q<' #D6#@ X%Q0 -A<; #48(@ S&"@
M,A@O #$9-@ P&3T +AE& "T:3P K&ED *AIF "@:=  F&H8 )!J9 "(:K0 A
M&L4 (!KH "$:_@ B&O\ (QK_ (T=  !Y'P  :2$  %PB  !2(@  2B(  $0A
M   _(0  /"   #D>   X&P  -1P$ #0<#0 R'!( ,!T8 "\='P N'24 +1XL
M "L>,P J'CL *1]# "<?30 F'U< )!]D "(?<@ @'X0 'Q^7 !T?JP ;'\,
M&Q_G !L?_0 ='_\ 'A[_ (D@  !U(@  92,  %DD  !/)0  1R4  $$D   \
M(P  .",  #4B   S(   ," ! "XA"@ L(1  *R$5 "HB'  H(B, )R(I "8C
M,  E(S@ (R-! "(D2@ A)%4 'R1A !TD<  ;)(( &225 !<DJ@ 6),$ %23E
M !8D_  7(_\ &2/_ (4B  !Q)   8B8  %8G  !,)P  1"<  #XG   Y)@
M-28  #$E   N)   *R4  "DE!P G)@X )283 "0G&0 C)R  (B<G "$H+@ @
M*#8 'B@^ !TH2  ;*5, &2E? !@I;@ 6*8  %"F4 !(IJ  1*<  $2CD !$H
M^P 3*/\ %"?_ ( E  !N)P  7R@  %,I  !)*@  0BD  #LI   V*0  ,B@
M "XH   J*   )BD  "0J!  B*PP ("L1 !\L%@ =+!T '"PD !LM*P :+3,
M&"T\ !<M10 6+E  %"Y= !(N;  1+GX $"Z2  XNIP -+;T #2W?  TM^0 .
M+/\ $"S_ 'PH  !J*@  6RL  % L  !&+   /RP  #DL   T*P  +RL  "LK
M   F+   (BX  !\O   <, D &C$. !DQ$P 7,1H %C(A !4R*  4,C  $S(Y
M !(S0P 1,TX $#-;  XS:0 -,WH ##..  HSH@ (,KD "#+9  @R]  *,?\
M"S'_ '<K  !F+0  6"X  $TO  !#+P  /"X  #8N   Q+@  +2X  "DN   C
M,   'S(  !LS   7-04 %#8, !(W$0 1-Q8 $3<= ! X)  /."P #C@U  TX
M/P ,.$H "SA7  DX90 '.'8 !3B*  ,XGP !-[4  3?3  (W\0 #-O\ !3;_
M ',N  !B,   5#$  $DQ  !!,0  .3$  #0Q   O,   *S   "4R   @,P
M&S8  !<X   3.@( $#P)  T]#@ ,/1, "ST9  H](0 )/2D "#TQ  8^.P %
M/D8  SY2  $^80  /G(  #Z&   ]G   /;(  #W0   \\   //\  #S_ &TR
M  !=,P  4#0  $8T   ^-   -S0  #(S   M,P  )S0  "(V   =.   &#H
M !0]   0/P( #4$(  E##0 &1!$  T06  )$'0  1"0  $0M  !$-@  1$$
M $1.  !$7   1&T  $2!  !$F   0Z\  $/-  !"\   0O\  $+_ &@V  !8
M-P  3#@  $,X   [-P  -38  # V   I-P  (SD  !X[   8/0  $T   !!"
M   -10$ "$<'  -)#   20\  $H3  !+&0  2R   $LH  !+,@  2ST  $Q)
M  !,5P  2V@  $M]  !+E   2JP  $K*  !)[P  2?\  $G_ &(Z  !4.P
M23L  $ [   Y.@  ,SD  "PZ   E/   'S\  !E!   31   $$<   Q)   (
M3    D\%  !0"@  4 T  %$0  !2%0  5!L  %0C  !4+   5#<  %1$  !4
M4@  5&,  %1W  !4CP  4Z@  %+&  !2[0  4?\  %'_ %P_  !//P  13\
M #X^   W/0  +SX  "=    @0P  &48  !-)   /3   "T\   92    5
M %<"  !8!P  60L  %H.  !;$0  718  %X=  !?)@  7S$  %X]  !>3
M7ET  %YQ  !=B0  7:,  %S!  !;ZP  6O\  %K_ %9$  !+0P  0T(  #Q!
M   R0@  *44  "%(   :2P  $TX   Y2   *50   UD   !;    7@   &
M  !B @  8P8  &4*  !F#@  :!$  &H7  !K'P  :RD  &LV  !K10  :U8
M &IJ  !J@@  :9T  &B[  !GYP  9O\  &7_ %%(  !(2   048  #='   L
M2@  (TT  !M1   350  #ED   A=   !80   &0   !G    :@   &P   !N
M    <    '(%  !S"0  =0T  '<1  !Z&   >R$  'LN  !Z/0  >DX  'EB
M  !Y>0  >)8  '>S  !UX   =/P  '/_ $Y-  !'3   .TT  #!/   F4P
M'%@  !-<   -80  !F8   !J    ;P   '(   !V    >0   'P   !]
M?P   ($   "# @  A@<  (@,  "+$0  CA@  (XD  ".,P  C40  (Q8  "+
M;P  BHP  (FJ  "(SP  AO<  (7_ $U1  !!4P  -%4  "E:   >7P  %&4
M  UJ   %<    '8   ![    ?P   (,   "'    B@   (T   ".    D0
M ),   "5    F    )H%  "=#   H!$  *,:  "C*   HCH  *%.  "@90
MH($  )Z@  "=P0  F^X  )K_ $99   Y7   +6$  "%G   6;@  #G4   5[
M    @0   (<   "-    D@   )8   ":    G0   )\   "A    I    *8
M  "H    JP   *X   "Q P  M L  +@1  "Y'@  N2\  +A#  "W6@  M78
M +27  "TM0  L>(  +#\ #]D   Q:0  )6\  !AW   /?P  !H<   ".
ME    )H   "@    I0   *H   "N    L0   +(   "U    MP   +H   "\
M    OP   ,,   #&    R0   ,X*  #2$P  TB,  -$W  #03P  SFH  ,V*
M  #*JP  R\L  ,OO #=Q   I>   '8   !&)   (D0   )H   "A    IP
M *T   "S    N0   +X   #"    Q0   ,8   #)    S    ,X   #2
MU0   -H   #>    X0   .4   #J"P  ZQ<  .HK  #J0P  ZEX  .IZ  #K
MF0  Z[4  .O5 /\   #_    _P ! /\ !P#_  T _P 2 /\ &P#_ "4 _P O
M /\ .@#_ $, _P!+ /\ 4P#_ %H _0!@ /L 9@#Z &L ^ !R /8 > #T (
M\0") .\ D@#L )T Z0"J .8 O #C -P WP#W -T _P#, /\ O@#_ +4 _P"P
M /\ K0#_ /\   #_    _P   /\   #_  8 _P - /\ % #_ !\ _P I /L
M,P#W #T \P!% .\ 30#L %, Z !9 .4 7P#C &4 X !J -T <0#: '@ U@"
M -( B@#/ )4 S "B ,@ L@#% ,D P@#M ,  _P"[ /\ L #_ *@ _P"D /\
MH0#_ /\   #_    _0   /H   #X    \  ) .P $0#H !D YP C .4 +0#>
M #8 U@ ^ -$ 1@#- $P R@!2 ,@ 6 #% %T PP!C ,  :0"^ '  O !X +D
M@0"W (T M ": +$ J0"N +P K #A *H _ "H /\ H #_ )D _P"6 /\ E #_
M /\   #Y    \@   .<   #;    T0 $ ,H #0#' !0 Q  = ,( )@"_ "\
MNP W +< /P"T $4 L0!+ *X 40"L %8 J@!< *@ 80"F &@ HP!P *$ >0"?
M (0 G0"1 )H H "8 +$ E@#, )4 \0"4 /\ D0#_ (L _P"( /\ A@#_ /<
M  #L    W@   ,D   "\    M    *\ "@"K !  J0 7 *@ ( "G "@ H@ P
M )\ . "< #X F@!$ )@ 2@"6 $\ E !5 ), 6@"1 &$ CP!H (T <0"+ 'L
MB0"( (< EP"% *@ @P"^ ($ Y "  /\ @ #_ 'P _P![ /\ >0#_ .D   #7
M    P0   +$   "F    G0   )< !0"4  T D@ 2 )  &@"/ "( C@ J (L
M,0") #@ AP ^ (4 0P"# $@ @0!. '\ 5 !^ %H ? !A 'H :0!X ', =@!_
M '4 C@!S )\ <0"S '  T !O /8 ;P#_ &\ _P!M /\ ; #_ -H   "_
MK    )X   "3    C    (4   ""  D ?P / 'X %0!] !P ?  D 'H *P!W
M #$ =0 W '0 /0!R $( <0!( &\ 30!N %, ; !: &L 8@!I &P 9P!X &8
MA@!D )< 8@"J &$ P@!@ .L 80#_ &$ _P!A /\ 8 #_ ,4   "M    FP
M (T   "#    ?    '<   !R  4 <  , &X $0!L !< ;  > &L )0!I "P
M9P Q &8 -P!D #T 8P!" &( 2 !@ $X 7P!5 %T 70!< &8 6@!R %D @ !7
M )  5@"C %4 N0!4 -X 5 #[ %0 _P!5 /\ 50#_ +8   "?    C0   '\
M  !U    ;@   &D   !F  $ 8P ) &$ #@!@ !, 7P 9 %X ( != "8 6P L
M %H ,@!8 #< 5P ] %8 0P!5 $D 4P!0 %( 6 !1 &$ 3P!L $X >@!, (H
M2P"< $H L0!) ,X 20#S $D _P!) /\ 2@#_ *H!  "4!0  @@<  '0(  !J
M"   8P8  %X$  !;    60 % %< # !6 !  5  5 %, &P!2 "( 40 H %
M+0!. #, 30 X $P /@!+ $4 2@!, $@ 5 !' %T 1@!H $0 =0!# (4 00"8
M $  JP!  ,4 /P#J #\ _P!  /\ 0 #_ * (  "*"P  >0T  &P-  !A#0
M6@T  %4+  !2"0  4 8  $\"" !.  T 3  2 $L %P!* !X 20 C $< *0!&
M "\ 10 T $0 .@!" $$ 00!( $  4  ^ %H /0!D #P <@ Z (( .0"4 #@
MIP W +X -@#C #8 ^0 V /\ -P#_ )@-  "##@  <A   &41  !;$0  4Q
M $X0  !*#@  2 T  $<* P!'!PH 100. $0"$P!" AH 00(@ $ #)0 ^ RL
M/00Q #P$-P [!#X .@5% #D%3@ W!5< -@5B #0&<  R!H  ,0:2 # &I0 O
M!;L +@7= "X&]0 M!_\ +@?_ )$0  !]$0  ;!,  %\4  !5%   3A0  $@3
M  !$$@  01   $ .  ! #08 0 H, #X)$  \"18 .PH< #D*(@ X"B@ -PLN
M #8+-0 U"SL ,PM# #(,3  P#%8 +PQA "T,;P K#'\ *@R2 "@,I0 G#+L
M)0S= "4-]0 F#?\ )PW_ (L2  !W%   9Q8  %L7  !1&   21<  $,7   _
M%0  /!0  #H2   Y$0$ .0\( #@.#0 W#A( -0X8 #0.'P R#B4 ,0\L # /
M,@ O$#H +1!" "P02P J$%4 *!!A "80;P D$(  (Q"3 "$0IP ?$+T 'A#@
M !X1]P ?$/\ (!#_ (84  !S%P  8QD  %<:  !-&P  11H  $ :   [&0
M.!@  #46   T%   ,Q($ #(2"P Q$A  +Q(5 "T2'  L$R( *Q,I "H3,  H
M$S< )Q0_ "842  D%%, (A1? " 5;0 ?%7X '161 !L5I0 9%;L &!7> !@5
M^  9%/\ &A3_ ((7  !O&@  7QP  %,=  !*'0  0AT  #P=   W'   -!L
M #$:   O&0  +A8  "P7"  K%@X *1<3 "@7&0 G&"  )1@F "08+0 C&#0
M(AD] " 91@ >&5$ '1E= !L::P 9&GP %QJ/ !4:HP 4&;H $AG; !,9]@ 4
M&?\ %1C_ 'T:  !K'0  7!\  % @  !'(   /R   #D?   T'P  ,1X  "T=
M   K'   *1L  "<;!0 E&PP )!P1 "(<%@ A'!T (!TC !\=*@ >'3( '!XZ
M !L>1  9'DX %QY; !8>:0 4'WH $AZ- !$>H@ 0'K@ #A[8  \>]0 0'?\
M$1W_ 'H=  !G'P  62$  $TB  !$(@  /"(  #8B   R(0  +B$  "H@   G
M(   )!\  "(@ @ @( H 'B$/ !TA%  <(1H &R(A !DB)P 8(B\ %R(X !4C
M00 4(TP $B-8 !$C9P 0(W@ #B.+  TCGP ,([0 "R/0  LB\  ,(O\ #2'_
M '8?  !D(@  5B,  $LD  !!)   .B0  #0D   O(P  *R,  "@C   D(P
M(",  !TD   ;)0< &28- !<F$0 6)A< %2<> !0G)0 3)RP $B<U !$H/P 0
M*$H #BA6  TH9  ,*'0 "BB'  DHFP ')[$ !2?,  8G[  ')OX "";_ '$B
M  !@)   4R8  $@G   _)P  -R8  #$F   M)@  *24  "4E   B)0  '2<
M !DH   6*@0 %"L+ !(L$  1+!0 $"P; ! L(@ .+"D #BTR  TM.P ++48
M"BU2  @M8  &+7  !"V#  (MF   +*X  "S)   LZP !*_P  BO_ &TE  !=
M)P  3R@  $4I   \*0  -2D  "\H   K*   )R<  ",G   ?*   &RH  !<L
M   3+@( $# (  XQ#0 -,1( ##$7  LQ'@ *,28 "#(N  <R-P %,D(  S).
M  $R7   ,FP  #)_   RE0  ,:P  #''   PZ@  ,/P  ##_ &@I  !8*@
M3"L  $$L   Y+   ,BL  "TK   I*@  )2H  " K   <+   %RX  !,P   0
M,@( #C0'  HW#  '-Q  !3<4  ,W&P "-R(  #<J   X,P  .#X  #A*   X
M6   .&@  #A\   WD@  -ZD  #;%   VZ@  -OT  #7_ &,L  !4+@  2"\
M #XO   V+@  ,"X  "LM   G+0  (BT  !TO   8,0  %#,  ! U   .-P$
M"CH'  8["P "/ X  #T2   ^%P  /AX  #XF   ^+P  /CH  #Y&   ^5
M/F0  #YW   ^CP  /:<  #W#   \Z0  //T  #O_ %XP  !0,0  1#(  #LR
M   T,0  +C   "DO   D,   'C(  !DT   4-@  $#D   T[   */0  !4 %
M  !!"@  0@T  $,0  !$%   11H  $8B  !&*P  1C4  $9!  !&3P  1E\
M $9S  !%B@  1:0  $3   !#Z   0_X  $+_ %@T  !+-0  034  #DU   R
M-   +3,  "8T   @-0  &C@  !0Z   0/0  #4    E"   $10   $<#  !(
M!P  2@L  $L.  !,$0  3A4  $\<  !/)0  3R\  $\\  !/2@  3UH  $YM
M  !.A0  3:   $R\  !+YP  2_X  $K_ %,Y  !'.0  /CD  #<X   Q-P
M*3<  "$Y   ;/   %3\  !!"   ,10  !T@   )*    30   $\   !1!
M4@<  %0+  !5#@  5Q$  %D7  !:'P  62D  %DV  !91   650  %AG  !8
M?P  5YH  %:W  !5XP  5/T  %3_ $X]  !#/0  /#P  #4[   L/   )#X
M !Q!   51   $$@   M+   %3@   %$   !4    5P   %D   !;    70(
M %X&  !@"P  8@X  &02  !G&   9R(  &8N  !F/   9DT  &5@  !E=P
M9),  &.Q  !AW0  8/P  %__ $E"  !!00  .C\  #!    F0P  'D8  !5*
M   03@  "E(   -6    6@   %T   !@    8P   &4   !G    :0   &L!
M  !M!0  ;PH  '(.  !U$@  =QL  '8F  !V-0  =48  '19  !T;P  <XL
M '*I  !PS0  ;_<  &[_ $9&  ! 10  -48  "I(   @3   %U$  !!6   )
M6@   5\   !C    :    &L   !O    <@   '4   !W    >0   'L   !]
M    @ ,  (,(  "&#0  B1,  (H=  "**P  B3P  (A/  "&9@  A8$  (2@
M  ""P@  @?   '__ $9+   Z3   +D\  "-3   86   $%X   ED    :0
M &\   !T    >    'P   "!    A    (<   "(    BP   (X   "0
MDP   )8   "9!P  G0T  *$4  "@(0  H#$  )Y$  "=6P  G'8  )F6  "9
MM0  EN4  )7^ #]2   R50  )EH  !M@   19P  "6T   !T    >P   ($
M  "&    BP   )    "4    EP   )D   "<    GP   *$   "D    IP
M *H   "M    L08  +4-  "X%@  MR8  +8Y  "U4   M&H  +*)  "PJ@
MKL\  *WU #=<   K80  'F@  !-P   +>    (    "'    C@   )4   ":
M    GP   *0   "H    K    *T   "P    LP   +4   "X    NP   +\
M  ##    QP   ,L%  #1#@  T1L  - N  #/10  S5\  ,M^  #)G@  R+X
M ,7I "]I   C<   %GD   V!   !BP   ),   ";    H@   *@   "N
MM    +@   "]    P    ,(   #%    R    ,L   #.    T0   -8   #;
M    WP   .0   #H!@  ZQ$  .HC  #J.@  Z50  .=R  #EDP  X[,  ./4
M /\   #_    _P   /\ ! #_  L _P 0 /\ %P#_ "$ _P K /\ -0#_ #X
M_P!' /\ 3@#_ %4 _ !; /H 80#X &8 ]@!M /0 <P#R 'L [P"$ .T C@#J
M )D Y@"G ., N0#? -4 VP#W -8 _P#  /\ L@#_ *H _P"E /\ H@#_ /\
M  #_    _@   /P   #\  , _@ + /\ $0#_ !H _0 D /D +@#T #@ \ !
M .P 2 #I $X Y@!4 .( 6@#? %\ W !E -@ :P#4 '( T ![ ,T A0#* )$
MQP"> ,, K@#  ,4 O0#K +L _P"P /\ I #_ )P _P"8 /\ E0#_ /\   #Z
M    ]    /$   #R    Z@ % .< #@#B !4 X0 > .$ * #8 #$ T  Y ,L
M0 #( $< Q0!- ,( 4P"_ %@ O0!> +L 9 "Y &L M@!S +0 ? "Q (@ K@"5
M *L I "H +@ I@#< *, ^P"? /\ E0#_ (\ _P"+ /\ B0#_ /D   #O
MYP   -\   #/    R    ,$ "@"_ !$ O  8 +L (0"Y "H M  R +$ .@"N
M $  JP!& *@ 3 "F %$ HP!6 *$ 7 "? &, G0!J )L <P"9 'X E@", )0
MFP"2 *T D #' (X \ "- /\ A@#_ (  _P!] /\ ? #_ .T   #@    T0
M +\   "S    J@   *8 !0"B  T H0 3 *  &P"? ", FP K )@ ,@"5 #D
MDP _ )$ 1 "/ $H C@!/ (P 50"* %L B !C (8 :P"$ '8 @@"" (  D@!^
M *, ? "Z 'H X0!Y /\ =P#_ '( _P!P /\ ;P#_ -T   #+    M@   *<
M  "=    E    (X  0"+  H B0 0 (@ %0"' !T AP E (0 + "" #( ?P X
M 'T /0![ $, >0!( '@ 3@!V %0 =0!; ', 8P!Q &X ;P!Z &T B0!L )H
M:@"N &D S !H /8 9P#_ &4 _P!D /\ 8P#_ ,H   "T    H0   ),   ")
M    @@   'L   !X  4 =@ , '4 $0!T !@ <P ? '( )0!P "P ;@ R &P
M-P!J #P :0!" &@ 2 !F $X 90!5 &, 70!B &8 8 !R %X @ != )( 6P"E
M %H O@!9 .D 60#_ %D _P!8 /\ 6 #_ +D   "B    D    (,   !Y
M<0   &T   !I  $ 9@ ) &4 #@!D !, 8P 9 &, ( !A "8 8  L %X ,0!<
M #< 6P \ %H 0@!8 $@ 5P!/ %8 5P!4 &  4P!L %$ >0!0 (H 3P"> $X
MM !- -H 30#[ $T _P!- /\ 30#_ *H   "4    @@   '4   !K    9
M &    !=    6@ % %@ # !7 !  5@ 5 %8 &P!5 "$ 4P G %( + !1 #$
M3P W $X /0!- $, 3 !* $H 4@!) %L 2 !F $8 <P!% (0 1 "7 $, K !"
M ,D 0@#Q $( _P!# /\ 0P#_ )X   ")    > ,  &H$  !A!   6@,  %4!
M  !2    4  " $X "0!-  T 3  1 $L %P!* !P 20 B $@ )P!' "T 10 R
M $0 . !# #X 0@!% $$ 30 _ %8 /@!A #T ;@ [ 'X .@"1 #D I@ X +\
M. #H #@ _P Y /\ .0#_ )4#  " !P  ;PD  &(*  !8"P  40H  $P(  !)
M!@  1P,  $8 !@!$  L 0P / $( $P!! !@ 00 > #\ (P ^ "D /0 N #L
M-  Z #H .0!! #@ 20 W %( -@!= #0 :@ S 'H ,@", #$ H0 P +@ +P#>
M "\ ^0 O /\ , #_ (P)  !X#   : T  %P.  !2#@  2PX  $4-  !!#
M/PH  #X( @ ]! @ / $- #L $  Z !4 .0 : #@ (  V "4 -0 K #0 ,  S
M #< ,@ ^ #$ 1@ O %  +@!: "T 9P K '< *@") "D G0 H +, )P#1 "<
M\@ G /\ )P#_ (8,  !R#@  8Q   %81  !-$0  11$  $ 0   \#P  .0X
M #<-   V"P0 -@@* #4&#@ T!1( ,@07 #$%'  P!2( +P4H "X&+@ M!C0
M*P8\ "H&1  I!TX )P=9 "8'90 D!W4 (P>' "('FP @!K  ( ;+ !\%[0 ?
M!OX 'P?_ ( .  !M$0  7A(  %(3  !($P  01,  #L3   W$@  -!$  #(0
M   P#P$ , T& # +"P O"A  +0H4 "P+&0 J"Q\ *0LE "@,*P G##( )@PZ
M "0,0P C#$T (0U8 " -90 >#74 ' V( !H-G  9#;$ & S* !<,ZP 7#?P
M& S_ 'L1  !I$P  6A4  $X6  !%%@  /18  #@5   S%0  ,!0  "T3   K
M$@  *A # "H/"  I#@T * X1 "8.%@ E#QT ) \C ",/*0 A$#$ (! Y !X0
M0@ =$$P &Q!8 !D09@ 7$'8 %1") !00G@ 2$+, $1#. !$0[@ 2$/X $A#_
M '<3  !E%0  5Q<  $L8  !"&0  .AD  #08   P%P  +!<  "D6   G%0
M)A0! "42!  C$@L (A(/ "$2%  @$AH 'A,@ !T3)P <$RX &A,V !D40  7
M%$H %A16 !049  2%'0 $12' ! 4G  .%+$ #13*  T4ZP .$_X #A/_ ',5
M  !A&   4QH  $@;   _&P  -QL  #(:   M&@  *1D  "88   D&   (A<
M " 6 0 >%@@ '18- !L7$@ :%Q< &1<= !@8)  6&"L %1@T !08/0 2&4@
M$1E4 ! 98@ .&7( #1F$  P9F  *&:T "1C&  D8YP )&/H "A?_ &\8  !>
M&@  4!P  $4=   \'0  -1T  "\=   J'   )AL  ",;   A&@  'AH  !P:
M   :&P4 &!L, !8<$  5'!4 %!P; !,<(@ 2'2D $1TQ ! =.P .'44 #1Y1
M  P>7@ *'FT "1Z   <>E  %':H  QW"  ,=Y@ $'/@ !1S_ &L:  !;'0
M31X  $(?   Z'P  ,A\  "T?   H'@  )!X  "$=   >'0  '!T  !@>   5
M'P( $R ) !(A#@ 0(1( $"$8  XA'P .(B8 #2(N  PB-P *(D$ "2)-  <B
M6@ %(FD  R)\  $BD0  (J@  "'    AY0  (/@  "#_ &<=  !7'P  2B$
M $ A   W(@  ,"$  "HA   F(   (B   !\?   <'P  &2   !8A   2(P(
M$"0'  XF#  ,)A  "R85  HF'  ))B( ""8J  8G,P $)ST  R=)  $G5@
M)V8  "=Y   GCP  )J8  ":_   EY   )?D  "3_ &,@  !4(@  1R,  #TD
M   T)   +B,  "@C   D(@  (2(  !XA   :(@  %R,  !,D   0)@( #B@'
M  LJ"P (*PX !BL3  0K&  "*Q\  2PG   L,   +#H  "Q%   L4P  +&,
M "QV   LC   *Z0  "N^   JY   *OH  "G_ %\C  !0)0  1"8  #HF   R
M)@  *R8  "8E   C)   'R0  !LD   7)0  %"<  !$I   .*P( "RT&  <O
M"P $, X  # 1   Q%0  ,1P  #$C   R+   ,C8  #)"   R3P  ,E\  #)R
M   QB0  ,:(  #"\   PY   +_L  "__ %HG  !,*   0"D  #<I   O*0
M*2@  "4G   A)@  '"<  !@H   4*@  $2P   XN   +, $ !S(%  ,T"0
M-0P  #8/   W$@  .!@  #@@   X*   .#(  #D]   Y2P  .5L  #AN   X
MA0  -Y\  #>Z   VY   -?P  #7_ %4J  !(+   /2P  #0L   M*P  *"H
M "0I   >*@  &2L  !0M   1+P  #3$   HT   '-@   C@$   Z!P  .PH
M #T-   ^$   0!0  $ ;  ! )   0"X  $ Y  ! 1P  0%8  $!I  ! @
M/YL  #ZW   ]XP  //P  #S_ % O  !#+P  .2\  #(O   L+0  )RP  " M
M   :+P  %3$  !$S   --@  "3@   4[    /0   $ !  !!!   0P<  $4+
M  !&#@  2!$  $H6  !*'@  2B@  $HT  !)0@  25$  $ED  !(>P  2)<
M $>T  !&X   1?P  $3_ $HS   _,P  -C,  # Q   J,   (S$  !PS   6
M-0  $3@   T[   (/@   T$   !#    1@   $@   !*    3 0  $X'  !/
M"P  40X  %02  !5&0  52(  %0N  !4/   5$L  %->  !3=   4I   %&N
M  !0UP  3_L  $[_ $4W   \-P  -38  "\T   F-0  'C<  !<Z   1/0
M#$$   =$    2    $H   !-    4    %,   !5    5P   %@"  !;!@
M70L  %\.  !B$P  8AL  &(G  !B-   844  &!7  !@;0  7XD  %VG  !<
MS   6O@  %G_ $$\   Z.P  -#D  "HZ   A/   &$   !%#   ,1P  !DL
M  !/    4P   %8   !9    7    %\   !A    8P   &4   !G 0  :@4
M &T*  !P#@  <Q4  '(@  !R+0  <3T  '!/  !O90  ;H   &V?  !KP0
M:?$  &C_ #]    Y/@  +C\  "1"   :1@  $DH   Q/   $5    %@   !=
M    80   &4   !H    :P   &X   !Q    <P   '4   !X    >P   'X#
M  "!"@  A0\  (<7  "&)   A30  (1&  ""70  @78  '^6  !^M@  ?.<
M 'K_ #]$   S10  *$@  !U,   34@  #%<   -=    8P   &@   !M
M<0   '8   !Z    ?@   ($   "#    A@   (D   "+    C@   )(   "5
M 0  F0D  )X0  ">&@  G2D  )P\  ":4@  F&P  ):+  "4J@  DM0  )#Z
M #A+   L3@  (%,  !59   -8    V<   !N    =    'H   "     A
M (H   ".    D@   )4   "7    F@   )T   "@    HP   *<   "K
MKP   +0)  "X$   MQX  +4P  "S1@  L6   *]^  "LH   J\$  *GN #%5
M   D6P  &&$   YI   %<0   'D   "!    B    (\   "4    F@   )\
M  "D    J    *D   "L    KP   +,   "U    N0   +T   #!    Q@
M ,L   #1"@  TQ0  -$E  #0.P  S50  ,IQ  #(D@  Q;,  ,/> "EB   <
M:0  $7$   =[    A    (T   "5    G0   *,   "I    KP   +0   "Y
M    O    +X   #"    Q0   ,@   #,    T    -0   #:    WP   .0
M  #J    [@P  .T:  #L+P  ZDD  .AE  #FA@  Y*4  .+& /\   #_
M_P   /P  0#\  @ _@ . /\ % #_ !T _P F /\ , #_ #H _P!" /\ 20#^
M %  ^P!6 /D 7 #V &( ] !H /( ;P#P '8 [0!_ .H B0#G )4 Y "C .
MM0#; -  U0#V ,H _P"V /\ J #_ )\ _P": /\ E@#_ /\   #[    ]@
M /,   #S    ]@ ) /H #@#] !8 ^P @ /< *@#R #, [0 [ .D 0P#F $D
MX@!/ -X 50#; %L U@!@ -( 9P#/ &X S !V ,D @ #& (P P@": +\ J@"[
M ,$ N #I +8 _P"G /\ F@#_ )( _P"- /\ B@#_ /H   #Q    Z@   .<
M  #G    Y  ! .  "P#; !$ V@ : -L (P#1 "P R@ T ,8 .P#" $( OP!(
M +P 3@"Z %, N !9 +8 7P"S &8 L0!N *X =P"L (, J0"1 *8 H0"C +4
MH #8 )X ^P"5 /\ BP#_ (4 _P"  /\ ?@#_ .\   #C    V@   -,   #&
M    OP   +D !@"W  X M  4 +0 '0"S "4 K@ M *L - "G #L I !! *$
M1@"? $P G0!1 )L 5P"9 %X EP!E )4 ;@"3 'D D "' (X EP", *D B0#$
M (@ [P"% /\ ? #_ '8 _P!S /\ <@#_ .    #0    Q@   +8   "I
MH0   )T  0"9  H F  0 )@ %@"7 !X E  F )$ +0"/ #0 C  Z (H /P"(
M $4 AP!* (4 4 "# %8 @0!> (  9@!^ '$ ? !] 'D C0!W *  =0"V ',
MWP!R /\ ;@#_ &D _P!G /\ 90#_ ,P   "^    JP   )T   "3    B@
M (4   ""  4 @  - '\ $0!_ !@ @  @ 'T )@!Z "T =P S '4 . !T #X
M<@!# '  20!O $\ ;0!6 &P 7@!J &@ : !U &< A !E )8 9 "K &( R0!A
M /8 8 #_ %P _P!; /\ 6@#_ +T   "I    EP   (D   !^    >    ',
M  !O  $ ;0 ) &P #@!K !, :P 9 &H ( !H "8 9@ L &4 ,@!C #< 8@ \
M &  0@!? $@ 70!/ %P 5P!: &$ 60!M %< >P!6 (X 50"B %, NP!2 .D
M4@#_ %  _P!/ /\ 3P#_ *T   "8    A@   '@   !N    9P   &,   !@
M    70 % %P "P!; !  6P 5 %L &P!: "$ 6  F %8 + !4 #$ 4P V %(
M/ !1 $( 3P!) $X 40!- %L 2P!F $H = !) (4 2 "9 $< L0!& -@ 1@#\
M $4 _P!% /\ 10#_ )\   ")    >    &P   !B    6P   %8   !3
M40 " $\ " !/  T 3@ 1 $X %@!- !P 3  A $H )@!) "P 2  Q $< -P!%
M #T 1 !$ $, 3 !" %4 0 !@ #\ ;@ ^ 'X /0"2 #P J0 [ ,< .P#S #L
M_P [ /\ / #_ ),   !^    ;@   &$   !8    40   $P   !)    1P
M $4 !0!$  L 0P . $, $@!# !< 0@ = $  (@ _ "< /@ L #T ,@ [ #@
M.@ _ #D 1P X %  -P!; #4 :  T '@ ,P", #( H@ Q +P ,0#G #$ _P R
M /\ ,P#_ (D   !V P  9@4  %D'  !0!P  208  $,%  !  P  /@$  #P
M P [  @ .@ - #H $  Y !0 .0 9 #< '@ V ", -0 H #0 +@ S #0 ,@ [
M #  0P O $P +@!7 "T 9  L ', *P"' "H G  I +4 *0#< "D ^P I /\
M*@#_ ($$  !N"   7PH  %,+  !*"P  0@L  #T*   Y"0  -@@  #4%   T
M @8 ,P * #( #@ Q !$ ,0 5 #  &@ O !\ +@ D "P *@ K #  *@ W "D
M/P H $D )P!4 "8 8  D &\ (P"" "( EP A *X (0#, "$ \P A /\ (@#_
M 'L)  !H#   6@T  $X.  !%#@  /0X  #@-   S#0  , P  "X+   M"0,
M+08( "P$#  K @\ *@$2 "D!%P H 1P )P A "8 )P E "T )  T ",!/0 B
M 48 (0%1 !\!70 > 6P ' %_ !L E  : *H &@#% !H ZP 9 /\ &@#_ '4,
M  !D#@  50\  $H0  ! $   .1   #,0   O#P  + X  "D.   G#0$ )PP%
M "<*"@ F" T )0<0 "0&%  B!AD (08? " ')  ?!RL '@<R !T'.@ <"$0
M&@A/ !D(7  7"&L %@A] !4'D0 4!Z< $P:_ !(%Y  2!?H $@7_ '$.  !?
M$   41$  $82   ]$@  -A(  # 2   K$0  *!$  "40   C$   (@X$ "$-
M!P A# L ( L. !\+$@ ="Q< ' P< !L,(@ :#"D &0PQ !@,.0 6#4, %0U/
M !,-7  2#6L $ U^  \-D@ .#:< #0R^  T,X  -#/4 #0S_ &T0  !<$0
M3A,  $,4   Z%   ,A0  "T4   H$P  )1,  "(2   @$0  'A$# !P0!0 <
M#P@ &P\, !H.$  9#Q0 %P\: !8/(0 5$"@ %! P !(0.0 1$$0 $!!0  X0
M70 -$&L #!!\  L0D  )$*4 "!"\  <0WP '$/0 !P__ &D1  !8%   2Q4
M $ 6   W%@  ,!8  "H6   F%0  (A4  !\4   =$P  &A," !D2!  7$@8
M%A(* !42#@ 4$A( $A(8 !$3'@ 1$R4 $!,N  X3-P -%$  #!1+  L46  )
M%&< !Q1X  84C0 $%*,  Q.[  (3W0 !$O0  A+_ &43  !5%@  2!<  #T8
M   T&   +1@  "@8   C%P  (!<  !T6   :%0  &!4" !85!  4%04 $A8(
M !$6#0 0%Q  #A<5  X7&P -%R( #!<I  L8,@ )&#P !QA'  485  $&&,
M AAU  $8BP  %Z$  !>Y   7W0  %O4  !;_ &$6  !2&   11H  #L:   R
M&@  *QH  "4:   A&0  'A@  !L8   8%P  %A<" !07 P 2& 4 $!D'  X;
M"P ,&P\ "QL3  H;&  ('!\ !QPF  4<+P $'#@  AQ$   =40  '6   !UR
M   <B   '*   !NY   ;W@  &O8  !K_ %X8  !/&@  0AP  #@<   O'0
M*1P  ",<   ?&P  '!H  !D9   7&0$ %!D" !(: P 0&P0 #AT'  P>"P )
M'PX !B 1  4@%@ #(!P  2$C   A*P  (34  "%    A3@  (5T  "%O   A
MA@  ()X  ""X   ?W@  'O@  ![_ %H;  !+'0  /QX  #4?   M'P  )QX
M "(=   >'0  &QP  !@;   5&P  $AP  ! = @ .'P0 #"$&  DB"@ %(PT
M B00   E$P  )1D  "8@   F*   )C(  "8]   F2@  )EH  "9L   F@P
M)9P  "6W   DWP  (_D  "/_ %4>  !'(   /"$  #(A   K(0  )2   " ?
M   ='@  &AT  !8>   3'@  $"    XA   ,(P( ""4%  4G"0  * L  "H.
M   K$0  +!8  "P=   L)0  +"X  "PZ   L1P  +%8  "QI   L@   *YH
M "JU   IWP  *?L  "C_ %$B  !$(P  ."0  "\D   H(P  (R(  !\A   <
M(   %R   !,A   0(P  #B0   LF   (*   !"H$   L!P  +@D  # ,   Q
M#P  ,Q,  #,9   S(0  ,RH  #,U   S0P  ,U(  #-E   R>P  ,I<  #&S
M   PW@  +_L  "[_ $PE   _)@  -2<  "TF   G)0  (B0  !XC   9(P
M%"0  !$F   .*   "RH   <L   #+P   #$"   S!   -0<  #<*   Y#0
M.A   #L5   ['0  .R8  #LQ   [/@  .TX  #M@   Z=P  .9(  #BP   W
MVP  -OP  #7_ $<I   [*@  ,BH  "LI   E)P  (28  !LG   5*   $2H
M  XL   *+P  !C$   $T    -@   #@    [ 0  /00  #\'  !!"@  0PX
M $41  !%&   12$  $4L  !$.0  1$@  $1;  !#<0  0HT  $&K  ! T@
M/_H  #[_ $(M   X+@  +RT  "DK   D*@  '2H  !<L   1+@  #3$   DT
M   $-P   #H    \    /P   $$   !$    1@   $@#  !*!P  3 L  $X.
M  !0$P  4!P  % G  !/-   3T,  $]5  !.:@  388  $RD  !*R@  2?@
M $C_ #XR   U,0  +B\  "DN   @+@  &3$  !(S   .-P  "3H   (]
M0    $0   !'    20   $P   !/    40   %,   !5 0  6 8  %H+  !=
M#@  7Q4  %X@  !>+   73P  %Q.  !;8P  6GX  %B=  !7P   5?(  %3_
M #HV   S-   +3(  "0S   ;-@  $SD   X]   (00   $4   !)    3
M %    !3    5@   %D   !;    70   &    !B    90   &@%  !K"P
M;Q   &\8  !N)0  ;30  &U&  !K6P  :G4  &B4  !FM@  9.D  &+_ #@Y
M   R-P  *#D  !X[   5/P  #D0   =)    30   %(   !6    6@   %X
M  !B    90   &@   !K    ;0   '    !S    =@   'D   !]!   @0L
M (41  "$'0  @BP  ( ^  !^5   ?FL  'N*  !ZJ@  =]8  '7] #@]   L
M/@  (D$  !=&   /2P  !U$   !7    7    &(   !F    :P   &\   !T
M    >    'L   !^    @    (,   "&    B@   (T   "1    E@,  )L,
M  "=$P  FR$  )HS  "720  E&(  )-_  "0H   CL4  (SS #%$   E2
M&DT  !!3   (6@   &$   !H    ;@   '0   !Y    ?P   (0   ")
MC0   )$   "3    E@   )D   "=    H    *0   "H    K    +(#  "W
M#0  MQ<  +4H  "R/@  L%8  *QS  "JE   J;0  *7E "I/   >5   $EL
M  IB    :@   ',   ![    @@   (D   ".    E    )H   "?    I
M *8   "I    K0   +    "S    MP   +L   #     Q0   ,L   #1!
MU0X  -,=  #0,@  S4L  ,IF  #&AP  PJD  ,'+ ");   68@  #&L   %T
M    ?0   (<   "0    EP   )X   "D    JP   +$   "V    N@   +P
M  #     Q    ,@   #+    SP   -0   #:    X    .8   #K    \08
M / 3  #N)P  [#\  .I;  #G>@  Y)L  ."[ /\   #[    ]@   /,   #T
M  4 ]@ , /H $0#_ !D _P B /\ + #_ #4 _P ] /\ 10#\ $P ^@!2 /<
M6 #U %X \P!D /$ :@#N '( [ !Z .D A0#E )$ X0"@ -T L@#8 ,X T@#V
M ,$ _P"M /\ G@#_ )8 _P"0 /\ C #_ /H   #R    [    .D   #I
M[  % /( # #X !( ]P ; /4 )0#P "X ZP W .8 /@#B $4 W0!+ -@ 4 #3
M %8 T !< ,T 8@#* &H R !R ,4 ? #" (@ O@"6 +H J "W +\ M #H *X
M_P"= /\ D #_ (@ _P"# /\ @ #_ /    #E    W@   -H   #;    W
M -@ !P#1  X T0 5 -( '@#+ "< Q0 O ,  -P"] #T N@!$ +< 20"U $\
ML@!5 +  6P"N &$ K !I *D <P"G '\ I "- *$ G@"> +( FP#5 )D _ ",
M /\ @@#_ 'L _P!V /\ = #_ .(   #3    R@   ,<   "\    M@   +
M 0"O  L K  1 *T & "M "  J  H *0 +P"@ #8 G0 \ )L 0@"9 $< EP!-
M )4 4P"3 %D D0!A (\ :@", '4 B@"# (@ E "& *< @P#" (( \ !\ /\
M<P#_ &T _P!J /\ : #_ ,\   #!    N0   *T   "@    F    )0   "1
M  8 D  - )  $@"/ !D C@ A (L * "( "\ A@ U (0 .@"" $  @ !% 'X
M2P!\ %( >@!9 '@ 8@!V &P = !Y '( B0!Q )T ;P"T &T WP!L /\ 90#_
M &  _P!> /\ 7 #_ +X   "Q    H    )(   ")    @@   'P   !Z  $
M>  ) '< #@!X !0 =P : '0 (0!R "< <  M &X ,P!L #@ :P ^ &D 1 !H
M $H 9@!1 &0 6@!C &0 80!P %\ ?P!> ), 70"I %P R !; /< 5P#_ %0
M_P!2 /\ 40#_ +    "?    C0   '\   !T    ;@   &H   !F    90 $
M &, "P!C !  8P 5 &, &P!A "$ 7P G %T + !< #( 6@ W %D /0!7 $,
M5@!+ %4 4P!3 %P 4@!H %  =P!/ (D 3@"? $T N@!, .D 2P#_ $D _P!'
M /\ 1P#_ *(   "-    ?    &X   !E    7@   %D   !7    50 ! %0
M!P!3  T 4P 1 %0 %@!2 !L 40 A $\ )@!. "L 3  Q $L -P!* #T 20!$
M $< 3 !& %8 1 !A $, < !" ($ 00"7 $  KP _ -< /P#_ #X _P ] /\
M/@#_ )0   !_    ;P   &,   !9    40   $T   !*    2    $< ! !'
M  H 1@ . $8 $0!' !8 10 < $0 (0!" "8 00 K $  ,0 ^ #< /0 ^ #P
M1P Z %  .0!; #@ :0 W 'H -@"/ #4 IP U ,8 - #U #0 _P T /\ -0#_
M (@   !T    90   %@   !/    2    $,    _    /0   #P  @ \  <
M.P , #L #P [ !( .@ 7 #D '  W "$ -@ F #4 +  T #( ,P Y #$ 00 P
M $L +P!6 "X 8P M ', + "( "P H  K +L *P#J "L _P K /\ + #_ '\
M  !L    70$  %$"  !( P  0 ,  #L"   W    -    #,    R  4 ,@ )
M #( #0 Q !  ,0 3 #  &  O !T +0 B "P *  K "X *@ U "D /0 H $8
M)P!1 "8 7@ E &X ) "" ", F0 C +, (@#> "( _P C /\ ) #_ '<   !E
M!   5@8  $L'  !""   .@@  #4'   P!@  +04  "P#   K  , *@ ' "D
M"P I  X *0 1 "@ %0 G !D )@ > "4 )  D "H (P Q "( .0 A $, ( !.
M !\ 6@ > &D '0!\ !P DP ; *P &P#- !L ]@ ; /\ ' #_ ' %  !?"
M40H  $8+   ]"P  -0L  # +   K"@  * D  "4(   D!P( (P0& ",""0 B
M 0P (@ / "$ $@ @ !8 'P ; !X (  = "8 '  N !L -@ : #\ &0!* !@
M5P 7 &8 %@!X !4 CP 5 *8 % ## !0 [@ 4 /\ %0#_ &L(  !;"P  30P
M $(-   Y#0  ,0T  "P-   G#0  (PP  "$,   ?"P$ '@H% !T("  =!@L
M' 4- !P$$  ;!!0 &008 !D$'@ 8!", %P0K !8$,P 5!#P % 1' !,#5  2
M V, $0-U ! "B@ 0 :( #P"\  \ Y0 / /X $ #_ &<+  !7#0  20X  #X/
M   U#P  +@\  "@/   D#@  ( X  !T.   ;#0$ &0T$ !@,!P 8"PD %PD,
M !<)#@ 6"1( %0D6 !0)&P 3"2$ $@DH !(),  1"3H $ E%  \)4@ ."6$
M#0ES  P(B  +")\ "@>W  H&VP *!?8 "@3_ &,-  !3#@  1A   #L1   R
M$0  *Q$  "40   A$   '1   !H/   8#P$ %@X$ !4.!P 4#0D $PT+ !,,
M#0 2#!  $0P4 ! ,&0 0#!\ #PPG  X-+P -#3D # U%  L-40 )#6  " UQ
M  8-A@ %#9T ! RT  ,,T@ "#/$  @O_ %\.  !0$   0Q$  #@2   O$@
M*!(  ",2   >$0  &Q$  !@1   5$ ( %! % !(0!P 1#PD $ \* ! .#  .
M#@X #@\2  T/%P ,$!T #! D  H0+  )$#8 "!!!  803@ %$%T  Q!O  $0
MA   $)P   ^T   .U   #O,   [_ %P0  !-$@  0!,  #84   M%   )A0
M "$3   <$P  &1(  !82   4$0, $A$& !$1"  0$ H #A +  T1"P ,$0T
M"Q(1  H2%0 )$AH "!(A  83*0 %$S,  Q,^  (32P  $UH  !-L   3@@
M$IL  !*T   1UP  $?4  !'_ %@2  !)%   /14  #,6   K%@  )!4  !\5
M   :%   %Q0  !03 0 3$@0 $1(' ! 2"0 .$@D #1()  L3"@ )% T !Q4/
M  86$P $%A@  Q8?  (6)P  %S   !<[   72   %U@  !=J   6@   %ID
M !6T   5V0  %/<  !/_ %44  !&%@  .A<  # 8   H&   (A<  !T6   9
M%@  %A4  !,4 P 2$P8 $!,'  \3!P -% < "Q4(  D6"0 && P  QH.  $:
M$0  &A8  !L<   ;)   &RT  !LX   ;1@  '%4  !MG   ;?0  &Y<  !JS
M   9VP  &/D  !?_ %$6  !#&   -QD  "X:   F&@  (!D  !L8   8%P
M%18! !,5!0 1%00 #Q4$  T6!  +%P4 "1D&  8:"  "' H  !X-   @$
M(!,  " 9   @(0  (2H  "$U   A0@  (5(  "!D   @>@  'Y4  !^Q   >
MVP  '?H  !S_ $T9   _&P  -!P  "L<   D'   'AL  !H:   7&   %!<"
M !(7 @ 0& $ #1D!  L: @ (' , !1T$  (?!@  (0@  ",+   E#@  )A$
M "86   F'@  )R<  "<R   G/P  )DX  "9@   F=P  )9(  "2O   CV@
M(OL  "'_ $@=   \'@  ,1\  "@>   B'@  '1P  !D;   6&@  $AH  ! ;
M   -'   "QT   @?   $(0   2,"   E!   )P8  "D)   L#   +@\  "X3
M   N&@  +B,  "XN   N.P  +DH  "U<   M<@  +(X  "NL   JU   *?L
M "C_ $0@   X(0  +B$  "8A   @(   '!X  !@=   4'0  $!X   X?   +
M(0  !R,   ,E    )P   "D    L 0  +@,  # &   S"@  -0T  #81   V
M%P  -A\  #8I   V-@  -D4  #57   U;0  -(D  #*H   QSP  ,/H  "__
M #\D   T)   *R0  "0C   ?(0  &R   !8@   1(0  #B,   HE   &*
M BH    M    +P   #(    T    -P   #D#   [!@  /@H  $ .  !!$@
M01H  $ E  ! ,0  0$   #]2   ^9P  /8(  #RB   ZQP  .?@  #C_ #HH
M   P*   *2<  ",E   ?(P  &"0  !(E   .*   "BH   4M    ,    #,
M   V    .    #L    ^    0    $(   !% @  1P8  $H*  !-#@  314
M $P?  !,*P  2SH  $I,  !)80  2'P  $>;  !%OP  0_,  $+_ #8L   M
M*P  )RD  ",G   ;*   %"H   XM   *,   !#,    W    .@   #T   !
M    0P   $8   !(    2P   $T   !0    4P$  %8&  !9"P  6Q   %L9
M  !:)0  630  %A&  !76@  570  %23  !2M0  4.H  $__ #,P   L+@
M)RP  !XM   6+P  $#(   HV   #.@   #\   !"    1@   $D   !,
M3P   %(   !5    6    %H   !=    8    &,   !G!@  :PP  &P2  !K
M'@  :RP  &D]  !G4@  9FH  &2)  !AJP  7]P  %W_ #$S   L,0  (C(
M !DU   1.0  "CT   )"    1P   $P   !0    5    %@   !;    7P
M &(   !E    :    &L   !N    <0   '4   !Y    ?08  ((-  ""%@
M@"0  'XU  !\20  >V$  'A_  !VGP  <\8  '#W #$V   F.   '#L  !)
M   +10   DL   !1    5@   %L   !@    90   &D   !N    <@   '8
M  !Y    ?    'X   ""    A0   (D   ".    DP   )@&  "<#@  FQH
M )@K  "60   DED  )%S  "-E0  B[4  (CH "L^   @00  %4<   U-   "
M5    %L   !A    :    &X   !S    >0   'X   "#    B    (P   "/
M    D@   )4   "9    G0   *$   "E    J@   +    "W!P  N!$  +4A
M  "R-0  KTT  *II  "HB   IJ@  *+1 "-(   83@  #E0   1<    9
M &T   !U    ?    (,   ")    CP   )4   ";    H    *,   "F
MJ0   *T   "Q    M0   +D   "^    Q    ,H   #2    V@H  -86  #2
M*0  SD$  ,I<  #%?   PIT  ,&] !Q5   17   !V4   !N    =P   '\
M  "(    D    )@   "?    I0   *T   "S    N    +H   "^    P@
M ,8   #*    S@   -,   #:    X    .<   #M    \P   /0.  #R'@
M[S8  .Q1  #H;@  Y)   -^Q                       ! P0%!@@)"@L-
M#@\1$A,4%A<8&AL<'1\@(2(D)28H*2HK+2XO,#(S-#8W.#D[/#T^0$%"1$5&
M1TE*2TU.3U!24U155UA96UQ=7F!A8F-E9F=I:FML;F]P<7-T=7=X>7I\?7Z
M@8*#A8:'B(J+C(Z/D)&3E)66F)F:G)V>GZ&BHZ2FIZBJJZRMK["QL[2UMKBY
MNKN]OK_!PL/$QL?(R<O,S<_0T=+4U=;7V=K;W=[?X.+CY.;GZ.GK[.WN\/'R
M]/7V]_GZ^_S^________________________________________________
M______\                      0,$!08("0H+#0X/$1(3%!87&!H;'!T?
M("$B)"4F*"DJ*RTN+S R,S0V-S@Y.SP]/D!!0D1%1D=)2DM-3D]04E-455=8
M65M<75Y@86)C969G:6IK;&YO<'%S='5W>'EZ?'U^@(&"@X6&AXB*BXR.CY"1
MDY25EIB9FIR=GI^AHJ.DIJ>HJJNLK:^PL;.TM;:XN;J[O;Z_P<+#Q,;'R,G+
MS,W/T-'2U-76U]G:V]W>W^#BX^3FY^CIZ^SM[O#Q\O3U]O?Y^OO\_O______
M________________________________________________
M          $#! 4&" D*"PT.#Q$2$Q06%Q@:&QP='R A(B0E)B@I*BLM+B\P
M,C,T-C<X.3L\/3Y 04)$149'24I+34Y/4%)35%576%E;7%U>8&%B8V5F9VEJ
M:VQN;W!Q<W1U=WAY>GQ]?H"!@H.%AH>(BHN,CH^0D9.4E9:8F9J<G9Z?H:*C
MI*:GJ*JKK*VOL+&SM+6VN+FZN[V^O\'"P\3&Q\C)R\S-S]#1TM35UM?9VMO=
MWM_@XN/DYN?HZ>OL[>[P\?+T]?;W^?K[_/[_________________________
M_____________________________P ! @,$!08'" D*"PP-#@\0$1(3%!46
M%Q@9&AL<'1X?("$B(R0E)B<H*2HK+"TN+S Q,C,T-38W.#DZ.SP]/C] 04)#
M1$5&1TA)2DM,34Y/4%%24U155E=865I;7%U>7V!A8F-D969G:&EJ:VQM;F]P
M<7)S='5V=WAY>GM\?7Y_@(&"@X2%AH>(B8J+C(V.CY"1DI.4E9:7F)F:FYR=
MGI^@H:*CI*6FIZBIJJNLK:ZOL+&RL[2UMK>XN;J[O+V^O\#!PL/$Q<;'R,G*
MR\S-SL_0T=+3U-76U]C9VMO<W=[?X.'BX^3EYN?HZ>KK[.WN[_#Q\O/T]?;W
M^/GZ^_S]_O]M9G0Q      ,$(0   0                    $
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MH#X:_ZA')O^N433_KUM%_ZUE5_BI;VCMHWAYXYM_A]N2A934BXR>SX61ILN
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M_ZUE5_BI;VCMHWAYXYM_A]N2A934BXR>SX61ILN E:S'?)FQQ7F>M<)VH[G
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MQVZLG\=NK)_';JR?QVZLG\?_GAX$_YTI"?^I,@[_MCH4^L)#'_#.2B[GW4]
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M;+2RO6RTLKW_FAL#_YDF"/^G+0K_M38/^<$_%^[.1B/DW$PRW>=/2<_H5E[
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M5%;_HU16_Z-45O^C5%;_HU16_Z-45O^C5%;_HU16_Z-45O^C5%;_HU39N@4
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MVH?38-J'TV#:A]-@VH?38-J'TV#:A]-@VH?_@QP#_X G!_][,PW_AC@1_XY
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M9DC_F'%6^Y-\8O2-AFWNAXYWZ("5@.1ZG(?@=:*,W7*HD=IOKY78;;>9U6O
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M8E#VRF)0]LIB4/;*8E#VRF)0]LIB4/;*8E#VRF+_HPL UK@& ,;$!P"[U D
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M?53#X7U4P^%]5,/A?53#X7U4P^%]5,/A?53#X7W_AQ,!_YP2 ?^N$0#:P@H
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M:EVD[VI=I.]J7:3O:EVD[VK_>1$!_XP. /^>#0#<K@@ TKL) ,S("0#'U@X
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M)CK_KR8Y_[HG./_*)SC_W"@X_]PH./_<*#C_W"@X_]PH./_<*#C_W"BUKP
MI[H  )K&  "-U   @>8! 'K_$ %P_Q@"9_\A!5__*0=8_S$*4O\Y#4W_00])
M_T@11?]/$T+_511 _UP5/?]B%CO_:1<Y_W 8-_]Y&37_@ADS_XP:,O^7&S#_
MH1LO_ZH<+_^U'"[_OQPN_[\<+O^_'"[_OQPN_[\<+O^_'"[_OQRIM0  FL(
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M7VZ,]U]NC/=?;HSW7VZ,]U__;!,!_WT/ ?^-$ #_FQ  ]*@/ .6U#0#5OQ
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M1T7AS$=%X.A'1=_V1D7>_T1%WO]$1=[_1$7>_T1%WO]$1=[_1$7>_T39EP
MQZ8  +BP  "LN0$ HL4" )C1!@"/ZPT B>X? H#N*P9X[30,<.T]$VCM1AEB
M[4X>7>U7(UGM8"=5[6@J4NUQ+4_M>2],[8,R2NZ--$?NF#5%[J4W0^^S.$+P
MQ#A!\-\Y0>_O.$#M_3A [/\X0.S_.$#L_SA [/\X0.S_.$#L_SC+H   NJL
M *VT  "AP   ELP! (O9!0"$^!$!?/@? G3X*09L^#(*9/@[#U[Y0Q-8^4L7
M4_E3&E#Y6QU-^F0?2OIL(4CZ="-&^GXE1/N()D'[DRA ^YXI/ORK*CW\N2L[
M_<LK._WB*SK\]"LZ_/<K.OSW*SK\]RLZ_/<K.OSW*SK\]RN]J   KK   *&\
M  "5R   B=0  '[H!0!W_Q(!;_\< F?_)@5@_R\(6?\W"U3_/PY/_T<12_].
M$T?_5A5$_UT60O]D&$#_;!D]_W4:._]^&SG_B1PW_Y0=-O^@'C7_K!\S_[D?
M,__('S+_XB R_^<@,O_G(#+_YR R_^<@,O_G(#+_YR"PK0  HK<  )7$  "'
MT   >]T  '+]"0!J_Q$!8?\9 EK_(@-4_RH%3O\R!TG_.@E%_T$+0?](##[_
M3@X[_U4/./];$#;_8A$T_VD1,O]R$B__>Q,M_X84*_^2%2K_GA4I_ZD6*/^S
M%B?_PA8G_\<6)__'%B?_QQ8G_\<6)__'%B?_QQ:DM   EL   (?,  !ZV@
M;>L  &3_!0!<_PX!5/\4 4W_' )(_R0$0O\L!3[_,P8Z_SD'-O] "#/_10@P
M_TL)+O]1"BO_5PHI_UT+)_]D"R3_; PB_W8-(/^ #1[_C X=_Y<.'/^A#AO_
MK \;_ZX/&_^N#QO_K@\;_ZX/&_^N#QO_K@^7O   B,D  'G6  !KXP  7_8
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M O]M& +_=QT"_WXD _^$+ 7^AS4)]8@^$.V'2!CE@U0BWGY?+M1X:3C.<W-
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M47Y]_U%^??]1?GW_47Y]_U'_8Q0!_W(/ ?^!$ #_C1$ _)@2 .RA$P#?JA8
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M64^NQEE/KN184:[V5%.N_U!4K/]-5*S_352L_TU4K/]-5*S_352L_TW_?0
MWX\  ,Z=  ##J ( N; " +"Z @"HQ 4 H<P/ )O,(P*2RC,*B<@_%8'&21]Y
MQ%(H<L):,&O!83=FOV@\8;YP05R]>$58O(%)5+R+3%&[ED].NZ-13+NS4DJ[
MQE)*N^113+OV3DVZ_TM.N?])3KG_24ZY_TE.N?])3KG_24ZY_TGOA0  U)4
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M+CWH_"X]Y_\M/>?_+3WG_RT]Y_\M/>?_+3WG_RW%GP  M:D  *BQ  "<O
MD,<  (32 0!ZWP8 =/03 &WT( )F]"H$7_0T"%KU/0M4]44/3_5,$DSU511)
M]ET71O9E&$3V;AI!]G<</_>!'3WWC1\[]YD@.?BF(3CXM2(W^<@B-OGC(C;X
M\R(V]_PB-O?\(C;W_"(V]_PB-O?\(C;W_"*WI@  J:X  )RY  "0Q   @\\
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M"A3_LPH4_[,*%/^S"A3_LPJ3NP  A,<  '73  !GX0  6.@  $[[  !(_P
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M.-A<BSS36I0_T%B<0LY7HT3+5:Q&R56U1\=4P$G%5-!)PE/F2<!6]46^6?]
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M08]Q_T&/<?]!CW'_08]Q_T'_6Q0!_V@/ /]U#P#_@!$ _XD3 /*0%P#EEAP
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M65^-PUI>C>!88H_U4F20_TUFD/](9H__1V:/_T=FC_]'9H__1V:/_T?_; @
M_GP  -Z*  #0E@( R)\$ ,"G! "YK@, LK(4 *JQ* .AKS<,F:Q#%Y&H32&)
MI54J@J-<,GR@8SEWGFH^<IQQ1&V:>4AHF8%,9)>+4&"6E5-=EJ)56I6P5UF5
MP5=8E=Y66Y;S4%V7_TQ?E_]'8);_1F"6_T9@EO]&8);_1F"6_T;_< , ZX$
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M0TJU_T%+M?\^2[3_/4NT_SU+M/\]2[3_/4NT_SWB@P  S9(  ,&?  "TIP
MJJ\  *"X  "6P , C,H' (;-% "!S28">LPU"'/+00]LRDH79LE3'6'(6R-<
MQV(H6,9J+%3&<C!0Q7PS3<6&-DK$DCE'Q)\[1<2N/$3%P3Q#Q=\\1,3S.T3#
M_SE%PO\W1<'_-T7!_S=%P?\W1<'_-T7!_S?5BP  Q9H  +>D  "KK   H+0
M ):^  "+QP0 @= ( 'C9#@!UV2 !;]@O!&G8/ ECUD807M90%5G56!I5U& ?
M4=1H(D[4<29+TWLI2-.%*T73DBY"U)\O0=2O,#_5PC$_U>$P/]/R,#_2_2\_
MT?\N/]#_+C_0_RX_T/\N/]#_+C_0_R[*E   NZ$  *VI  "BL0  EKL  (O$
M  " S0, ==@( &_D$0!JY" !9.0M U[D. =9Y$$+5>1+#U'D5!)-Y%T62N1E
M&$?D;AM%Y'<=0N2"'T#DCB$^Y9LC/.6J)#OFO"0ZYM,D.>7N)#GC^B,YXO\D
M.>+_)#GB_R0YXO\D.>+_)#GB_R2_G@  KZ8  *.N  "7N   BL(  '[,  !S
MU@( :>4) &3O% !?\" !6? K U3P-05/\#X'2_%&"D?Q3@Q$\5<.0O%?$#_R
M9Q(]\G 4.O)[%3CSAQ8V\Y08-?2B&3/TL1DR]<4:,?7B&C'T\1DQ\?X9,?'_
M&3'Q_QDQ\?\9,?'_&3'Q_QFRI   I:L  )BV  "+P   ?LH  ''5  !EW@
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M_Q#_-BT"_SLL O] + /_0R\#_T,U!/]"/@;_0$H(_SY7"_\\90W_.G,/_SB
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M4&YWQ%!M=^!/<'GU2')[_T-T?/\^=7W_.W5]_SMU??\[=7W_.W5]_SO_80H
M_V\" .A\  #9A@$ SXX$ ,B5!@##F@8 NYP6 +.<*@.JF3D+HI5%%)N13AV4
MCE<FCHM?+8F(9C.$AFTX@(1T/7N">T%W@(1%='^-2'!]ETMM?*-.:GRP3VA\
MP5!G?-U0:G[S26V _T-N@?\_;X'_/&^!_SQO@?\\;X'_/&^!_SS_9 @ _W(
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M1UJ2_4)<D_\^79/_.UV3_SM=D_\[79/_.UV3_SO_;@  X'X  ,Z+  #$E0
MNIT  +&C  "IJ0  H:X+ )NO'0&4KBX$C*P[#(6J1A5^J$X<>*96(W*D72IM
MHF0O::%K-&2?<SA@GGL\7)V%/UF<CT)5FYQ%4YNJ1U&;ND=0F]%'49ON1%.;
M_$!5F_\\5IO_.E:;_SI6F_\Z5IO_.E:;_SKQ=   V8,  ,B0  "^F@  LZ$
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M+4&\_RU!O/\M0;S_+4&\_RW.B@  OY@  +&@  "FJ   F[   )"X  "%OP
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M"B#\_ JBIP  E;$  (>[  !YQ@  ;,\  %_9  !2WP  2.@  $/_"  __Q
M._\9 #?_(0 T_RD!,/\P 2W_-P(J_SX")_]$ B7_2P,B_U,#(/]< QW_9@0;
M_W($&?^ !1?_CP46_Y\&%?^O!A3_P 84_]8&$__I!A/_Z083_^D&$__I!A/_
MZ0:7KP  B+H  'K%  !LSP  7MH  %#@  !$Y@  //4  #?_!  S_PT +_\3
M "O_&@ H_R$ )?\G 2'_+0$>_S(!&_\X 1G_/P$6_T8"%/]- A'_5@(0_V "
M#O]L @S_>P,+_XL#"O^: PK_J ,)_[4#"/_" PC_P@,(_\(#"/_" PC_P@.*
MN   >\,  &S.  !>VP  3^(  $+G   V[   ,?\  "S_   G_P< (_\. "#_
M$@ <_Q@ &/\= !7_(0 2_R8 $/\L 0[_,0$-_S<!"O\^ 0C_1@$%_T\! ?]9
M 0#_9@$ _W0! /^" @#_D ( _YP" /^F @#_I@( _Z8" /^F @#_I@+_+B\"
M_S,L O\W+0+_.# "_S<V _\T/P3_,4L&_R]8!_\L9@C_*G0)_RF!"O\HC0O_
M*)<+_RB?"_\HI@S_)ZT,_R>T#/\GNPS_)\0,_R?.#/\HW@O_*.D+_RCS"_\H
M^PO_*/\*_RG_"O\I_PK_*?\*_RC_"O\H_PK_*/\*_RC_"O\H_PK_,"T"_S8J
M O\Y*@+_.RX"_SHT _\X/ 3_-DD&_S-6!_\Q8PG_+W$*_RU^"_\MB@S_+)0,
M_RR<#?\LI W_+*L-_RRQ#?\LN0W_*\$-_RS+#?\LV@W_+.<-_RSQ#?\L^@W_
M+/\,_BW_#/TM_PS]+?\,_2S_"_TL_PO]+/\+_2S_"_TL_PO_,BL!_SDH O\]
M* +_/RH"_SXP _\].@3_/$8&_SE3"/\W8 G_-6T+_S-Z#/\RA@W_,9 ._S&9
M#O\QH0__,:@/_S"N#_\PM0__,+T0_S#'$/\PU!#_,.00_S'O$/XQ^0_[,?\/
M^3'_#_@Q_P[W,?\.]S'_#O8Q_P[V,?\.]C'_#O8Q_P[_-2@!_SPE ?] ) +_
M0R<"_T,L _]$-P3_0D,&_T!/"/\]7 K_.VD,_SEV#?\X@@__-XP0_S>5$?\V
MG1'_-J02_S:K$O\VLA/_-;H3_S7#$_\USQ/\->$3^3;M$_8V]Q/S-O\3\3;_
M$O V_Q+P-_\1[S?_$>\W_Q#O-_\0[S?_$.\W_Q#_.24!_T A ?]%( '_1R("
M_TDI O]*- 3_23\%_T9+"/]$6 K_0F4-_T!Q#_\^?1'_/8<2_SV1%/X\F17]
M/* 5_#NG%OH[KA?Y.[87^#N_%_8[RACT.]P8\#OJ&.T[]ACJ._\7Z#S_%^<\
M_Q;F/?\5Y3W_%.4]_Q3E/?\4Y3W_%.4]_Q3_/2(!_T0> ?])' '_31X!_U F
M O]1, /_4#L%_TY&"/]+4PO_2& ._T9L$?M%>!/X1((5]D.,%_1"E!CS09P9
M\4&C&^] JAON0+(<[3^['>L_QA[I/]4>Y3_H'^) ]![?0/X=W4'_&]M"_QK9
M0O\8V$+_%]A"_Q?80O\7V$+_%]A"_Q?_0!\!_T@: ?].& '_4AL!_U8C O]8
M+ /_5S<$_U5"!_]230OY4%H.]4UG$O%,<A;N2GT8ZTB&&^E'CQWG1I<?Y46>
M(.-$IB+A1*XCX$.W)-Y#PB7<0] FUT/E)M-$\R301?XBS4;_(,Q'_Q[*1_\<
MR4C_&\E(_QO)2/\;R4C_&\E(_QO_1!L!_TP6 ?]2% '_6!@!_UT? ?]?* +_
M7C(#_5T]!O9:20KP5U4/ZE5B$^92;1CB4'<<WTZ!']Q,BB+92Y(DU4J:)M-)
MH2C12:DISTBR*LU(O"O+2,DLR$C?+,5([RO"2OPHP$O_);],_R*^3?\@O4W_
M'[U-_QZ]3?\>O4W_'KU-_Q[_1Q@!_T\3 ?]6$0#_7A4 _V(< ?]E) '^92T"
M]&0X!>UA0PGF7U$.X%Q=%-I8:!K45G(>T%1[(LQ2A";*4(PHQT^4*L5.FRS#
M3J,NP4VL+[],MC"]3,(QNTS3,KA,Z3&V3O@MM%#_*K-1_R>S4O\DLE+_(K)2
M_R*R4O\BLE+_(K)2_R+_2A4!_U,1 /];#P#_8A( _V@7 /]J'P'V:R@![&LR
M ^1I/@?<9DP-TV)8%,U?8QO(7&T@Q%IV),%8?BB^5H8KNU6.+KE3EC"V4IXR
MM%*F,[)1L#6P4;PVKE#+-ZQ0XS>J4O0SJ53_+JA6_RNH5_\HJ%?_):A7_R6H
M5_\EJ%?_):A7_R7_31, _U8. /]?#0#_9Q  _VP3 /MP&0#O<2(!Y'$L MMP
M.@71;$@,R6A4%,-E7QN^8F@ANE]Q)K9=>2JS6X$ML%J),*Y8D3.K5YDUJ5:A
M-Z=6JSBE5;8ZHU7%.Z%5W3N?5O WGUC^,I]:_RZ>6_\KGES_*)Y<_RB>7/\H
MGES_*)Y<_RC_4!$ _UD, /]C# #_:PT _W 0 /5T$P#H=AH W7<E =%V-@3(
M<D0,P6Y0%+MK6QNV9V0AL65M)ZUB=2NJ8'POIU^$,J1=C#2B7)0WGUN=.9U:
MICN:6;$]F%F_/I=9TSZ56NP[E5W[-99>_S&67_\MEF#_*I9@_RJ68/\JEF#_
M*I9@_RK_4@\ _UP* /]F"0#_;@H ]G0, .]X#@#A>Q( U'P@ ,I[,P3!=T$+
MNG1-$[1P6!NN;&$AJ6II)Z9G<2NB97@OGV2 ,YQBB#:989 XEE^9.Y1>HCV1
M7JT_CUV[0(U=S4&,7N@_C6'Y.(UB_S..9/\PCF3_+(YE_RR.9?\LCF7_+(YE
M_RS_50X _U\& /]I!@#T<@8 XG@& -M\"0#9?PP S8$= ,1_, .[?#\*M'A+
M$JUU51JH<5XAHVYF)I]L;BN;:G4OF&A],Y5GA#:298PYCV25/(QCGSZ)8JI
MAV&W0H5AR4*$8N1!A63W.X9F_S6'9_\QAVC_+H=I_RV':?\MAVG_+8=I_RW_
M5PP _V$$ /YL P#D=0$ VWL% -. " #0@PH QX4: +Z$+0.V@3P)KWU($JAY
M4AFB=EL@G7-C)IEP:RN5;G(OD6UY,XYK@3:+:8DZB&B2/(5GG#^"9J=!@&:T
M0WYFQ41\9N%#?FCU/']J_S> :_\S@6S_+X%L_R^!;/\O@6S_+X%L_R__60L
M_V,! /1O  #?>   U'\$ ,Z#!@#*AP@ PH@8 +F'*P*QA3H(JH%&$:-^4!B=
M>ED?F'=A)9-U:"J/<V\OBW%W,XAO?C:%;H8Z@FR//7]KF4!\:J5">6JQ1'=J
MPD1V:MU$>&SS/GEN_SAZ;_\T>W#_,'QP_S!\</\P?'#_,'QP_S#_6P@ _V8
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M0&A[_3IJ>_\V:WS_,FM\_S)K?/\R:WS_,FM\_S+_80  ZF\  -EZ  #,A
MPXL  +N1 0"TE0$ K)<. *67(0&>EC$%EY,^#)"02!2*CE$;A(M9(7^)8"=[
MAV<K=X5N,'.$=31O@GTW:X&'.VB D3YE?YQ!8GZI0V!^N41??L]$8'_L0&*
M_#ID@/\V98'_,V:!_S)F@?\R9H'_,F:!_S+_9   Y7(  --^  #'AP  OH\
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M,%*6_S!2EO\P4I;_,%*6_S#F<@  T(   ,*,  "XE@  K9P  *.A  "9I@
MCJT  (BN$0"#KB(!?:TQ!'>L/0IRJD<0;*E/%F>H5QMCIUX?7Z9E)%ND;2=8
MI'4K5*-_+E&BB3%.H98T2Z&D-DFAM#9(H<@W2*#G-4F@^3)*G_\P2Y__+DN?
M_RU+G_\M2Y__+4N?_RW=>0  R88  +R2  "QF@  IJ   )RF  "1K   AK(
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M'#;$_QR^D0  L)L  *2C  "8J@  C+(  ("Y  !TP   :,<  %W-!0!3TPH
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M!![YF@4<^:L%&_K !1KZW@4:^?(%&O?]!1GV_P49]O\%&?;_!1GV_P6>I@
MD:\  (.Y  !UP@  9\L  %K3  !-V@  0M\  #CE   U^P< ,?\/ "[_%@ K
M_Q\ *?\F "7_+0 C_S0 (/\[ 1[_0P$;_TL!&?]3 1;_70(4_VH"$O]X A'_
MB (0_YH"$/^K P[_O@,._]4##O_M P[_\ ,.__ ##O_P P[_\ .3K@  A+@
M ';"  !GS   6M4  $S<   _X0  ->8  "WT   J_P( )O\+ "/_$0 @_Q<
M'?\= !G_(P 6_RD %/\O !+_-0 0_ST #O]% 0S_3@$*_U@!!_]E 07_= $#
M_X4! O^6 0'_I@$ _[4! /_& 0#_R@$ _\H! /_* 0#_R@&&MP  =\$  &C,
M  !:UP  2]X  #[D   RZ0  )^T  "/_   ?_P  &_\% !?_#  4_Q  $?\4
M  __&  -_QT "_\B  C_*  %_RX  O\U  #_/0  _T<  /]2  #_7@  _VT
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M,Y-5RC.15>4SD5?W+9%9_RF16O\ED5O_(Y%;_R&16_\AD5O_(9%;_R'_3PL
M_U<" /]A @#J: $ WFT$ -AP" #5< L RW(; ,)Q+@*Z;ST&M&Q)#:YI5!.I
M9UT9I&1E':%B;2&=870EFE]\*)A>@RN578LMDEN4,)!;GC*-6J@TBUFU-8I9
MQC:(6>$VB%ST,(A=_RN)7O\HB5__)8E?_R.)7_\CB5__(XE?_R/_40D _UH
M /5D  #@;   UW$# -!T!@#-=0D Q'87 +QV*@&T=#H%KG%&#*=N41*B:UH8
MGFEB'9IG:2&697$EDV1X*)!B@"N-88@NBV"1,8A?FC.&7J4U@UZR-X)>PC>
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M-G1I_3!U:O\L=FO_*7=K_R=W:_\G=VO_)W=K_R?_5P  ]F,  -]M  #1=0
MR'L  ,%_ @"[@ , M($0 *R"(P&E@3($GGX_"9A[2A"2>5,6C79;&XET8B"%
M<FDD@7%P)WYO=RM[;G\N>&V(,75LDC1S:YXW<&JJ.6YJN3IM:LXZ;6OK-V]M
M_#%P;O\M<6[_*G%O_RAQ;_\H<6__*'%O_RC_60  ZV4  -MP  #->   Q'X
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M*V%\_REA?/\I87S_*6%\_RGU8@  WF\  ,QZ  # @P  MXD  *^.  "FD0
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M)$>:_R34=P  PH0  +:/  "KE@  H9P  ):@  "+I0  ?ZH  '2N!0!OKQ0
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M$C7#JQ,SP\ 3,\/@$S/!]1,RP/\4,K__%#&^_Q0QOO\4,;[_%#&^_Q2XD
MJYD  )^@  "3IP  AZX  'NT  !NNP  8\   %C% 0!-R@4 1,\, $/0%P!"
MT"4 0- R #_1/0$]T4<!.]%0 CG260,VTF,$--)N!3+2>@<PTH@(+M*8"2W3
MJ0DLT[X*+-/?"2O1\PHJS_X+*<[_#"G-_PTIS?\-*<W_#2G-_PVNF   HI\
M ):F  ")K@  ?+8  &^]  !CPP  5\@  $S-  !"T@, .=D) #7?$  TWQL
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M 0C_N@$'_]0!!__K 0;_]@$&__8!!O_V 0;_]@&/K   @+8  '*_  !CR0
M5M$  $C8   [W0  ,.(  ";F   ?\   '/\  !G_"0 6_PX %/\3 !'_&0 /
M_QX #?\D  O_*P )_S( !O\[  /_1   _T\  /]<  #_:P  _WT  /^0  #_
MHP  _[0  /_&  #_U@  _]8  /_6  #_U@""M0  <[\  &3)  !6TP  1]L
M #K@   NY0  (^D  !KM   5_0  $O\  !#_ @ ._PD "_\-  C_$  $_Q,
M ?\8  #_'@  _R0  /\K  #_,P  _ST  /])  #_5@  _V8  /]X  #_B@
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M';!#V1ZM0^T=JT7\&JE%_QBH1O\6J$;_%:='_Q.G1_\3IT?_$Z='_Q/_1 X
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M*8-8_B2#6?\@A%K_'H1:_QR$6O\<A%K_'(1:_QS_3@$ _U<  .5?  #89@
MSFH  ,=L P##:P4 O&P2 +1M)0"M;#4#IVI"!Z%G30R<9581F&->%91B91B1
M8&P;CE]T'HQ>>R&)78,DAER,)H1;E2B!6J J?UJL+'U:NRU\6L\N>UOL*WQ<
M_"9\7?\B?5[_'WU>_QU]7O\=?5[_'7U>_QW_4   ]5D  .%C  #2:@  R6X
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M(FQJ_R!L:O\@;&K_(&QJ_R#_5P  Y&(  -)L  #&<P  O7@  +5[  "M?
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M(%=\_R#E9   SW   ,%Z  "V@P  K8D  *.,  "9C@  C8\  (:0#@"!D1T
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M($.7J"%"E[HB09?3(D&6[R!"E?X>0I7_'4.4_QQ#E/\<0Y3_'$.4_QS,=0
MO($  +&,  "FD@  FY<  )&;  "%GP  >:,  &JG  !EIPX 8Z@< &"H*P%=
MJ#8"6:= !%:G2093IE$)4*99#$VE8 Y*I6D11Z1R%$2D?19"HXD8/Z.7&CVC
MIQL\H[D<.Z/2&SNB[QL[H/X:.Y__&3R?_Q@\G_\8/)__&#R?_QC$?   MHD
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M!"7+[@0DR?P&(\C_!R/'_P<CQ_\'(\?_!R/'_P>IE@  GIT  )*C  "%JP
M>+(  &NX  !?O@  4L(  $?&   ]R@  -,\$ "O4"0 FV0\ )=D9 "7:)0 D
MVC  (]L[ "/;10 BW%  (=U; "#=:  >WG8 '=Z' 1S?F0$:WZP!&=_$ 1C>
MYP$8W/@!&-O_ A?:_P(7VO\"%]K_ A?:_P*@G   E*,  (>K  !YLP  ;+H
M %_!  !2Q@  1LH  #O.   QTP  *=D  "'>!0 >Z X '>@5 !OI'@ 9Z2<
M&.HP !;J.0 5ZT, %.Q. !+L6@ 1[6< $.YW !#NB@ .[YX #O"S  WPS0 ,
M[^P #.W\  SK_P ,Z_\ #.O_  SK_P"7HP  B:L  'NT  !MO   7\0  %+*
M  !%S@  .=,  "_8   EW0  '>$  !CL @ 6]PL %/<1 !'X%P 0^!X #ODE
M  WY+0 +^C4 "?L_  ?[2@ $_%<  _UF  +^=P  _8L  /V?  #\M0  _-$
M /SM  #\_   _/T  /S]  #\_0"+JP  ?;0  &Z]  !@Q@  4LT  $32   W
MV   +-T  "+A   9Y0  $^H  !#Z   ._P8 #?\,  K_$  '_Q0 !/\:  '_
M(   _R<  /\P  #_.@  _T4  /]3  #_8@  _W4  /^*  #_GP  _[,  /_'
M  #_Y0  _^4  /_E  #_Y0!_M   <+T  &''  !3T   0]8  #;=   JX@
M'^8  !;J   0[0  #/H   G_   &_P   O\$  #_"0  _PT  /\0  #_%
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M!M4KYP;0*_4'S2S_!\LL_P?)+/\'R"S_!\<L_P;'+/\&QRS_!L<L_P;_-1(
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M%YE%_Q681O\3F$;_$9A&_Q"71O\0ET;_$)=&_Q#_0@4 _T<  /=/  #E4P
MW54! -=5!@#54@L RU,9 ,-4*P"\5#L!ME)(!+%14@>M4%P*J4YD#:9-; ^D
M3'01H4M[$Y]*@A6=2HH7FTF3&)E)G!J72*8;E4BR')1(P1V22-@=D$GO&X]*
M_AB/2_\6CDO_%(Y,_Q*.3/\2CDS_$HY,_Q+_10  _TL  .E3  #>6   TUL
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M&7=9_Q=W6?\6=UG_%G=9_Q;_3   Z58  -E?  #+90  P6@  +II  "T:
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M&6)H_QGL5P  V6(  ,=K  "\<@  LW<  *IY  "A>0  EW<! )!X$0"+>"$
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M(5%WIB)0=[<C3W?.(T]W["%0=_T>47?_&U)W_QE2=_\94G?_&5)W_QG>8@
MR&X  +MW  "P?P  IX0  )V'  "2AP  A(<  'V'"0!XB!8 =(@F '"(,@)L
MAST$:(9&!F6%3@EAA54,7H1<#UN#8Q)9@FL55H%T%U. ?AI0@(D<3G^6'DQ_
MI2!*?[8A27_,(4E^ZQ]*?OP<2W[_&DM^_QE,?O\83'[_&$Q^_QC59P  PW,
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M$S>=Z!(VF_H2-IK_$C:9_Q$WF?\1-YG_$3>9_Q&^>P  L8<  *6/  ";E
MD)@  (2<  !WH   :Z0  %^G  !2J@  3:L. $NK&@!*JR< 2*LS $:K/0%$
MJT8!0JM. D"K5@,^JU\%.ZMH!CFJ<P@WJH )-*J/"S*JGPPQJK ,,*K'##"I
MYPPOI_H-+Z;_#2^E_PTOI?\-+Z7_#2^E_PVVA   JHX  )Z4  "4F0  AYX
M 'NC  !OJ   8ZP  %>O  !+L@  0;4& #ZV$0 ]MAX .[8I #JW-  YMSX
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M !#2_P$0T?\!$-'_ 1#1_P&<F@  D:$  (.H  !UL   :+<  %N]  !.P0
M0L4  #?(   MS   )-   !S5   5V@4 $.(+ !#C$0 .Y!H #N0C  WE+0 ,
MY3< "^9"  KF3P )YUT ".=M  ;F@  %YI4 !.:K  +FQ  !YN8  .?Y  #G
M_P  YO\  .;_  #F_P"3H0  A:D  '>Q  !IN0  6\   $[&  !!R@  -<X
M "K2   AU@  &=L  !+?   -XP  "_$(  GS#@ '\Q, !/(:  +R(@  \BH
M /(T  #R/P  \DP  /)<  #R;0  \H(  /*8  #SK0  \\8  /3E  #T]@
M]/L  /3[  #T^P"'J0  >;(  &JZ  !<P@  3LD  $#.   STP  *-@  ![=
M   5X0  #^0   KH   %\P   _T!  #\"   ^PT  /L1  #[%@  _!X  /PF
M  #\,   _3P  /Y)  #^6@  _FT  /^"  #_F   _ZP  /_   #_V   _^0
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M ,T _P#? /\ [ #_ /@ _P#_ /T _P#] /\ _0#_ /T _P#] /\ _0#_ /T
M_P#_'R, _Q\A /\>(0#_&2, _Q,I /\.,@#_#$  _PE- ?\'6@'_!&<!_P-S
M ?\#?0'_ X<!_P./ /\"E@#_ IP _P*B /\"J #_ J\ _P&V /\!O@#_ <D
M_P'; /\ Z@#\ /8 ^ #_ /<"_P#W _\ ]@3_ /8$_P#V!?\ ]@7_ /8%_P#_
M(A\ _R(< /\A' #_'A\ _Q@D /\5+P#_$CP _Q!) /\.5@'_#&(!_PMN ?\+
M>0'_"X(!_PN+ ?\+D@'_"ID!_PJ? /\*I0#_"JL _PJR /\*NP#]"L8 ^PK4
M /<*YP#S"O0 \ K_ .\+_P#N#/\ [0S_ >T,_P'M#/\![0S_ >T,_P'_)1L
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M!K@L_P:V+/\%M2S_!;0L_P6T+/\%M"S_!;0L_P7_- P _S8% /\Y P#_/ @
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M#HA&_PV(1O\-B$;_#8A&_PW_0   \D<  .-/  #44P  RU4  ,14  # 4 0
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M$6Q8_Q'Q2P  WU8  ,Q>  # 9   MV<  *YH  "G9@  GV(& )AC% "29"0
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M&EUBIAQ;8K8=6F+,'5IBZAQ;8_P87&/_%EQC_Q1=8_\376/_$UUC_Q/F50
MSU\  ,%H  "V;@  K'(  *1T  ":<P  CF\  (=O#0"";QL ?7 I 'EO-0%U
M;C\#<FU(!6YL4 =K;%<*:6M>#&9J90YD:6P186EU$U]H?Q9<:(H86F>6&EAG
MI!Q69[0=56?*'55GZ!M69_L85V?_%E=H_Q189_\36&?_$UAG_Q/A6   RV,
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M&$1ZY!A%>?@61GG_%$9X_Q)'>/\11WC_$4=X_Q'-90  O7   +%Y  "G@
MG(0  )*&  "&A@  =X8  &N&  !FAPT 8X<9 &"()P!>B#,!6X@\ EB'10-6
MATT$4X94!E"&6PA.A6,*2X1L#$F$=@]&@X$11(./$T*#G11 @JX5/X/"%3Z"
MXA4_@?<3/X'_$D" _Q% @/\00(#_$$" _Q#&:P  MW8  *Q_  "BA0  EXD
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M!RF@_P@IG_\(*9__""F?_PBQ@@  I8L  )J1  "0E@  @YH  ':?  !JH@
M7J8  %*I  !&JP  /*T  #6O#  SL!4 ,K A #&P*P OL#4 +K$^ "VQ2  L
ML5$ *[%; "FQ9P$GL70!)K&# 22QE (CL:8"(K*[ B&RVP(AK_,#(*[_ R"M
M_P0?K/\$'ZS_!!^L_P2JBP  G9$  ).7  "'G   >J(  &VG  !@JP  5:\
M $FQ   ^M   ,[<  "JZ P DO T (KT5 "&](  AO2H (+TS !^^/0 >OD<
M';Y2 !R_7@ :OVP &;]\ !B_C@ 7P*$ %L"V !3 TP 5OO$ %;S_ 16[_P$4
MNO\"%+K_ A2Z_P*AD@  EI@  (J>  !]I   ;ZH  &*O  !6M   2K<  #ZZ
M   SO0  *L   "'$   9QP4 $\L+ !',$@ 1S!L $,PE  _-+P .S3H #LU&
M  W-4@ -SF  #,YP  O.@P *SI< "<ZL  C.Q@ (SN@ ",W[  G+_P )R_\
M"<O_  G+_P"8F   C9X  '^E  !QK   9+,  %>Y  !*O0  /L   #+#   H
MQ@  '\H  !?-   1T0  #-8%  C9#  &V1( !=H;  3:)  #VRX  =LY  #<
M10  W5(  -YB  #><P  WH@  -^=  #?LP  W\X  .#N  #?^@  W_\  -__
M  #?_P"/GP  @:8  '.N  !EM0  6+T  $K"   ]Q0  ,<D  ";,   =T
M%-0   [9   )W0   ^$   #C!P  XPT  .02  #E&0  YB(  .<K  #I-@
MZT,  .Q2  #L8@  [78  .Z,  #NH0  [[<  ._1  #OZP  \/8  /#V  #P
M]@"$IP  =:\  &>W  !9OP  2\8  #S*   OS@  )-(  !K8   2W   #.
M  7C    YP   .L   #K    [04  .X+  #P$   \14  /,>  #T)P  ]S,
M /E   #Z40  ^V,  /QW  #]C0  _:,  /ZV  #^R0  _]\  /_?  #_WP!W
ML   :+D  %K!  !,R@  /,\  "[4   BV@  %]X  !#B   )Y@   .D   #L
M    \    /8   #V    ]P   /@   #Z!P  ^PT  /T1  #_&0  _R,  /\O
M  #_/@  _T\  /]B  #_=P  _XT  /^?  #_K@  _[H  /^Z  #_N@#_%B,
M_Q4A /\2(0#_#B0 _P8J /\ ,P#_ $$ _P!. /\ 7 #_ &@ _P!T /\ ?@#_
M (< _P"/ /\ E@#_ )P _P"B /\ J #_ *X _P"U /\ O0#_ ,< _P#6 /\
MYP#^ /, _@#^ /T _P#\ /\ ^P#_ /L _P#[ /\ ^P#_ /L _P#_&B  _QD>
M /\6'@#_$"  _PHE /\$, #_ #T _P!+ /\ 6 #_ &0 _P!P /\ >@#_ (,
M_P"+ /\ D@#_ )@ _P"> /\ I #_ *H _P"Q /T N0#[ ,, ^@#0 /@ XP#W
M /$ ]@#\ /0 _P#T /\ \P#_ /, _P#S /\ \P#_ /, _P#_'1P _QP9 /\9
M&0#_%!L _PXA /\,+ #_"3D _P5& /\"4P#_ %\ _P!K /\ =0#_ 'X _P"&
M /\ C@#_ )0 _@"; /P H0#Z *< ^ "N /4 M0#S +\ \0#+ /  WP#N .X
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M /0/:@#Q#W0 [PY\ .T.A #K#HL Z0Z2 .<.F0#F#J  Y ZG .(.KP#@#K@
MW@[% -P.V@#6$.P TA'Z ,\2_P#-$O\!S!+_ <L3_P'*$_\!RA+_ <H2_P'_
M)P\ _R<, /\E"0#_)@T _R43 /\C' #_("@ ^QPU /4:0@#O&$\ ZA=: .86
M90#C%FX X!9W -X6?P#<%H< V1:. -86E0#4%IP TA>C - 7JP#.&+4 S!C!
M ,L8T@#'&N@!PQOX < ;_P&^'/\!O1S_ KP<_P*\&_\"O!O_ KP;_P+_*PP
M_RL% /\K P#_+0D _RP. /\I%0#W)B  [B,M .<A.@#A'T@ VQ]4 -4@7P#1
M(&@ SB!Q ,PA>0#*(8$!R"&( <8ACP'$(98!PR&> <$BI@&_(J\!O2*[ KPC
MR@*Y(^,"M23T K,D_P.Q)/\#KR3_ Z\D_P.N)/\#KB3_ ZXD_P/_+P8 _R\
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M"X\Z]PJ-.O\)C#O_"(P[_P>,._\'C#O_!XP[_P?_.   \3X  .-%  #420
MRTH  ,5'  #!000 NC\1 +-!(0"M0C$ J$,^ *1#20&@0E,"G4%; YM!8@28
M0&H%ED!Q!I0_> >2/W\(D#^("H\^D0N-/IL,BSZF#8D^LPV(/L0.AC_@#H0_
M] V#0/\+@T#_"H) _PF"0?\(@D'_"()!_PC_/   ZT,  -Q*  #,3P  PU
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M#FQ/_PQL3_\+;$__"VQ/_PON10  W%   ,E7  "]7   M%X  *Q>  "D6P
MG%8$ )56$@"05R$ BU@O (=7.P&#5D0"?U9- WQ55 5Z5%L&=U1B"'53: ES
M4W +<5)X#6]2@@]M48T1:U&9$FE1IA1G4;859E'+%652Z11E4OL19E/_#V93
M_PUF4_\,9E/_#&93_PSJ20  U5,  ,5:  "Z7P  L&(  *AB  "?7P  EEH
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M#5=>_PW>4P  R%T  +MD  "P:@  IFT  )UN  "3;0  A6<  'YG"0!X9Q4
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M$$ENFQ%';:L21FZ^$T5NW!)&;?011FW_#T=M_PY';/\-1VS_#4=L_PW,7P
MO&D  +!Q  "E=P  G'L  )%\  "&>P  =7@  &MW  !E=PP 87@7 %]X) !=
M>3  6GDZ 5AY0@)6>$H"4WA1!%%W6 5/=V '3'9H"$IV<@I(=7T,176*#D-U
MF0]"=:D00'6\$$!UV1! =/,/0'3_#D%S_PU!<_\,07/_#$%S_PS&9   MVX
M *MV  "B?   EW\  (R!  "!@0  <H   &5_  !=?P@ 67\3 %> ( !5@"L
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M!BR2T08LD>\&*X__!BN._P8KC?\'*XW_!RN-_P>S>   IX(  )R(  "1C
MAY   'J3  !ME0  89<  %69  !)FP  /YP! #F=#@ WG1< -IXB #2>+  S
MGC4 ,IX^ #&>1P PGU  +I]: "V?9 $KGW$!*9Y_ B>>D (FGJ$"))ZU B.>
MS@(CG>X#(YO^ R*:_P0BF?\$(IG_!"*9_P2L@0  H(@  )6.  "+D@  ?Y8
M '*:  !EG0  6:   $ZC  !"I   -Z8  "ZH!0 IJ0\ **D8 ">J(@ FJBP
M):HU "2J/P CJD@ (JM3 "&K7@ @JVH 'JMY !VKBP ;JYT &JNQ !FKR@ 9
MJNP!&:C] 1BG_P(8IO\"&*;_ ABF_P*EB0  F8\  (^4  "#F0  =9X  &BB
M  !<I@  4*D  $2L   YK@  +[   ":S   >M08 &;</ !BW%P 7MR$ %K<J
M !6W-  4N#X $[A) !*X5  2N6( $;EQ !"Y@P /N9< #KFL  VYQ  -N.<
M#K;[  ZU_P .M/\ #K3_  ZT_P"<D   DI4  (:;  !YH   :Z8  %ZK  !2
MKP  1K(  #JU   OMP  );H  !V]   5P   $,,&  O&#@ *Q14 "<4>  C%
M*  'Q3( !L8]  7&20 %QE<  \9F  +&=P !QHL  ,:@  #%M@  QM(  ,7O
M  #%_   Q?\  ,7_  #%_P"5E@  B9P  'NC  !MJ0  8*\  %.T  !&N
M.KL  "Z^   DP0  &\0  !/'   .R@  ",X!  '0"@  T!   - 6  #1'@
MTB<  -,Q  #4/   U4D  -98  #6:0  UGP  -:2  #6IP  UK\  -;@  #6
M\P  UOX  -;_  #6_P",G0  ?J0  &^K  !AL@  5+D  $:]   YP0  +<0
M "+'   9RP  $<X   S2   %U0   -L   #< P  W0H  -X/  #?%   X1P
M .(D  #D+@  YCH  .=)  #H60  Z&L  .F!  #IF   Z:T  .G%  #IX@
MZ?(  .GU  #I]0" I0  <:T  &.U  !5O   1\(  #G&   LR@  (,X  !;2
M   /U@  "-L   #?    XP   .4   #G    Z $  .H'  #K#0  [1$  .\8
M  #Q(0  \RL  /8X  #W2   ^%H  /EM  #ZA   ^IL  /JO  #ZP@  ^MH
M /K?  #ZWP!TK@  9;8  %:^  !(Q@  .<L  "O0   ?U   %-H   W?   %
MXP   .8   #I    [0   .\   #Q    \P   /4   #V @  ^ D  /H.  #]
M$P  _QP  /\H  #_-@  _T<  /]:  #_;@  _X4  /^:  #_JP  _[D  /^\
M  #_O #_$2  _Q > /\,'@#_!"$ _P G /\ , #_ #X _P!, /\ 60#_ &4
M_P!P /\ >@#_ (, _P"+ /\ D@#_ )@ _P"> /\ I #_ *H _P"P /\ N #_
M ,( _P#. /\ X@#^ /  _0#[ /L _P#[ /\ ^P#_ /H _P#Z /\ ^@#_ /H
M_P#_%!P _Q(: /\.&@#_"!P _P A /\ +0#_ #H _P!( /\ 50#_ &$ _P!L
M /\ =@#_ '\ _P"' /\ C@#_ )0 _P": /X H #] *8 _ "L /L M #Y +T
M^ #) /< W #U .P \P#X /, _P#R /\ \0#_ /  _P#P /\ \ #_ /  _P#_
M%Q@ _Q46 /\1%0#_#!< _P4= /\ * #_ #8 _P!# /\ 4 #_ %P _P!G /\
M<0#_ 'H _ "" /H B0#X )  ]P"6 /4 G #T *( \P"H /$ L #P +@ [@##
M .P TP#J .< Z0#U .< _P#F /\ Y0#_ .4 _P#E /\ Y0#_ .4 _P#_&A,
M_Q@1 /\4$ #_#Q$ _PT9 /\*) #_!3  _P$^ /\ 2P#_ %< _@!B /H ; #U
M '4 \@!] /  A #N (L [ "1 .L EP#I )X YP"D .8 K #D +0 X@"_ .
MS0#> ., W #R -H _0#8 /\ U@#_ -4!_P#5 ?\ U0+_ -4"_P#_'A  _QP-
M /\7"P#_%0X _Q05 /\1'P#_#BH _PLX /T(10#X!E$ ] 1< .X$9@#J!&\
MY@-W .0$?P#B!(8 X 2, -X$DP#=!9H VP6@ -@%J #5!;$ T@6[ - &R0#.
M!^  S CQ ,D*_P#'"_\ Q@S_ ,4,_P#%#/\ Q0S_ ,4,_P#_(0P _R & /\<
M P#_'0H _QL0 /\8& #_%", ]A$P .\./@#J#DH Y0U6 .$-8 #=#6D V0UQ
M -4->0#3#8$ T0V( ,\-CP#-#I8 RPZ= ,H.I0#(#JX Q@^Y ,00R #"$-\
MOA'R +L2_P"Y$_\ MQ/_ ;83_P&V$_\!MA/_ ;83_P'_)08 _R,  /\C  #_
M) , _R$* /T=$0#Q&AL Z!8G .$4-0#:$T, TQ1/ ,X560#+%6, R!9K ,46
M<P##%WL P1>" , 8B0"^&)  O!B8 +L9H "Y&:D MQFT +4:P@"T&M8 L!OM
M :T<_ &K'?\!J1W_ :D=_P&H'?\!J!W_ :@=_P'_*   _R<  /XJ  #O*@
MYR<! .<B"0#D'1  V1L= ,\=+0#)'CP Q"!) +\@4P"\(5T N2%E +<B;0"U
M(G0 LR)\ +$B@P&P(HH!KB*2 :PCFP&K(Z0!J2.O :<CO &F),X!HR3H J E
M^0*>)?\"G27_ IPE_P*;)?\"FR7_ ILE_P+_+   _RT  .TR  #B-   VC,
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M!GP[_P5\._\%?#O_!7P[_P7T-P  Y4   -)'  #%2@  O$L  +5)  "O0P
MJ3X+ *(_%P"=0"8 F$$T )1!/P"104D!CD%1 8M 60*)0& #AT!G X4_;02#
M/W4%@3]]!G\^AP=]/I$(>SZ<"7H^J0EX/K@*=S_-"G4_Z@IT0/P(=$#_!W1
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M"&!._PCC1P  S5   +Y7  "S6P  JET  *%=  "86@  C5,  (92# " 4Q@
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M"U19F@U26:H.45F\#E!9V Y06?(-45G_"U%9_PI16?\)45G_"%%9_PC440
MPEH  +1A  "J9@  H&@  )=I  ",9P  ?6   '5? P!O7Q  :U\< &A@* !F
M8#, 8V \ 6%@1 %?7TP"7%]3 UM?6@197V$%5UYI!E5><PA37GX)45V*"T]=
MF0Q-7:@-3%ZZ#DM>U Y+7O$,3%[_"TQ=_PI,7?\)3%W_"$Q=_PC/5   OEX
M +%E  "G:@  G6T  )1M  ");   >&4  &]D  !I9 X 9609 &)D)0!@93
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M"CMPS0HZ;^P).V[^"#MN_P@[;?\'.VW_!SMM_P>_8@  L6L  *9S  "=>0
MDGL  (=\  ![?   ;7H  &!X  !6=P$ 4'<. $YX& !,>"0 2WDN $EY-P!(
M>4  1GE( 41Y3P%">5<"07E@ C]X:0,\>'0$.GB"!3AXD08W>*$'-7BS!S1X
MRP<T=^L'-';]!S1U_P<U=?\&-73_!C5T_P:Y:   K7$  *)Y  "8?@  C8
M (*!  !V@@  :8$  %N!  !1@0  2( * $6!$P!#@1X 0H(I $&",@! @CL
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M 1N4_P$;D_\"&Y/_ AN3_P*G?P  G(8  )&+  "'CP  >I(  &V5  !AF
M59L  $F=   ]G@  ,Y\  "JA   AHPH 'Z,1 !ZC&@ =I"0 '*0M !ND-@ :
MI#\ &:1* !BD50 6I6$ %:5P !2E@0 3I90 $J6H !&EOP 0I.( $:+X !&A
M_P 1H/\!$:#_ 1&@_P&@A@  E8P  (R1  !_E0  <9H  &2>  !8H0  3*0
M $"F   UIP  *JD  "*L   9K@  $K ) !"Q$  0L1@ #K$B  ZQ*P -L34
M#;%   RQ2P +L5@ "K%G  BQ>  'L8L !;&@  2PM0 $L-  !+#O  6O_@ &
MKO\ !J[_  :N_P"8C@  CY,  (*8  !UG0  9Z(  %JG  !.JP  0:T  #6O
M   KL0  (;0  !BV   1N0  #;P#  >^#  #O1(  ;T9  "^(@  OBL  +XV
M  "^00  OTX  +]<  "_;0  OX   +Z5  "^J@  OL(  +WD  "]]@  O?\
M +W_  "]_P"2E   A9H  'B@  !JI@  7*L  $^P  !"LP  -;8  "JX   @
MNP  %[X  !#!   +Q   !,<   #)!P  R0T  ,D2  #*&0  RR(  ,LK  #-
M-0  SD$  ,Y0  #/8   SW(  ,^'  #/G0  S[,  ,_.  #/ZP  SO@  ,[^
M  #._@"(FP  >J(  &RH  !>KP  4+4  $*Y   UO   *;\  !["   5Q@
M#LD   C,    T    -,   #5    U@8  -@,  #9$0  VQ8  -P?  #>*
MX#0  .)!  #B40  XV,  .-W  #DC@  Y*0  .2Z  #EU   Y>H  .7S  #E
M\P!\HP  ;JH  &"R  !1N0  0[X  #7"   HQ@  ',D  !/-   ,T0  !-4
M  #:    W@   .$   #B    Y    .4#  #G"0  Z0X  .L2  #M&@  [R0
M /(Q  #T00  ]%,  /5F  #U?   ]I,  /:I  #WO   ]\X  /??  #WWP!P
MK   8;0  %.[  !%PP  -L<  "?,   ;T   $=4   K;    WP   .(   #E
M    Z0   .P   #M    \    /$   #S    ]00  /<*  #Z$   _!8  /\A
M  #_+@  _T   /]3  #_:   _X   /^6  #_J   _[8  /^_  #_OP#_#1P
M_PH; /\"&P#_ !X _P D /\ +@#_ #P _P!* /\ 5@#_ &, _P!M /\ =P#_
M '\ _P"' /\ C@#_ )0 _P": /\ H #_ *8 _P"L /\ M #_ +T _P#) /X
MW0#] .T _ #Z /L _P#Z /\ ^0#_ /H _P#Z /\ ^@#_ /H _P#_$!D _PT7
M /\&%@#_ !@ _P > /\ *@#_ #< _P!% /\ 4@#_ %X _P!I /\ <@#_ 'L
M_P"" /\ B0#_ )  _@"6 /T G #\ *$ ^P"H /D KP#X +@ ]@## /0 T@#S
M .< \@#V /  _P#O /\ \ #_ .\ _P#O /\ [@#_ .X _P#_$A0 _P\2 /\+
M$@#_ !( _P : /\ )0#_ #, _P!  /\ 30#_ %D _P!D /T ;0#[ '8 ^0!]
M /< A #U (L ] "1 /, EP#Q )T \ "C .X J@#L +, Z@"] .@ RP#G .$
MY0#Q ., _0#C /\ X@#_ .$ _P#A /\ X #_ .  _P#_%!  _Q$. /\-#0#_
M!P\ _P(5 /\ ( #_ "T _P Z /\ 1P#Y %, ]0!> /( : #P '  [0!X .L
M?P#I (4 Z ", .8 D@#E )@ XP"? .$ I@#? *X W "X -H Q0#6 -D U #L
M -( ^0#1 /\ SP#_ ,X _P#. /\ S@#_ ,X _P#_%PP _Q0( /\/!0#_#@L
M_PP1 /\'&@#_ 28 _  T /0 00#M $T Z0!8 .8 8@#C &H X !R -X >0#;
M (  V0"& -8 C0#3 ), T0": ,\ H0#- *H RP"S ,D OP#& -  Q0#H ,,
M]@#! /\ P +_ +\#_P"_ _\ OP/_ +\#_P#_&P8 _Q<  /\4  #_$P4 _Q$-
M /\.% #Y"A\ \ 8L .8#.0#@ T8 W -1 -8$6P#2!&0 SP5L ,P%<P#*!7H
MR 6! ,8%AP#%!HX PP:6 ,$&G0"_!J8 O0:P +L'O "Y",T N KE +4+]P"S
M#?\ L0W_ + -_P"P#O\ KP[_ *\._P#_'@  _QL  /\;  #Z&@  ]18% /81
M#0#K#A4 X@LB -@+,0#0##X RPU* ,<-50#$#EX P0YF +\.;0"]#G0 NP][
M +D/@@"W$(H MA"1 +00F@"R$*, L!&M *\1N@"M$<H JA+E *<4]P"E%?\
MHQ7_ *(5_P"B%?\ HA7_ *(5_P#_(@  _R   / C  #F)   X"$  -P9!0#;
M$ P T!$9 ,@3*0#"%3< O19$ +D73@"U%U< LQA@ + 89P"N&&X K!EU *L9
M? "I&80 J!J, *8:E "D&IX HQNH *$;M "?',4 GAS? )H=\P&8'O\!EQ[_
M 98?_P&5'_\!E1__ 94?_P'_)@  ]"<  .8M  #:+P  SRT  ,HG  #''P@
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M VTZ_P/J.0  U4(  ,1(  "Y2P  KTL  *=)  "?1   F#X! )$\$ ",/1T
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M!EY'F@=<1ZD(6TB["%I(U A:2/$'6DG_!EI)_P5:2/\%6DC_!%I(_P3;1
MQDT  +A3  "M5P  HUD  )I8  "15   ADX  'U+" !W2Q( <TP? '!,*P!M
M3#4 :TP^ &A,1@!F3$T!9$Q3 6),6@)A3&("7TQJ UY,<P1<2WX%6DN*!EA+
MF =73*<(5DRY"55,T0E43.\(5$W_!E5,_P953/\%54S_!55,_P752   PE$
M +57  "J6P  H%P  )=<  "-60  @5,  '=/! !Q3Q  ;E < &I0* !H4#(
M95 [ &-00P!A4$H!7U!1 5U06 )<4%\"6E!G UA0<0174'L%55"(!E-0E@=2
M4*4(4%"W"5!0S@E/4.T(4%#_!U!0_P904/\%4%#_!5!0_P702P  OU0  +):
M  "G7@  G6   )1@  ")70  ?%<  ')4  !L4PX :%09 &54) !B5"\ 8%0X
M %Y40 !<5$@!6E1/ 5E45@%75%T"551E U14;@125'D%4%2&!DY4E =-5*0(
M2U2U"$M4S E*5.L(2U3^!TM4_P9+5/\%2U3_!4M4_P7,3@  NU<  *Y>  "D
M8@  FF0  )%D  "&8@  =UL  &U8  !F6 P 8E@6 %]8(@!=62P 6UDV %E9
M/@!7648 5EE- 5195 %265L"45EC T]9; --67<$2UB$!4E8D@=(6*('1UFS
M"$99R@A%6>H(1EG]!D98_P9&6/\%1UC_!4=8_P7'4@  N%L  *MA  "A9@
MF&@  (YI  "#9P  <F   &A>  !A70D 7%T3 %I='@!772D 5EXS %1>.P!2
M7D, 45Y* 4]>4@%.7ED"3%YA DI>:@-(7G4$1EZ"!41=D 9#7J '05ZQ!T!>
MR = 7N@'0%W\!D%=_P5!7?\%05S_!4%<_P7#5@  M%\  *AF  ">:@  E6T
M (IM  !_;   ;V<  &1D  !;8@4 5F(0 %1B&P!28R4 4&,O $YD. !-9$
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M RYP_P,N;_\#+F__ RYO_P.S9@  IV\  )UV  "3>@  B'P  'Y]  !R?0
M9'P  %=[  !,>@  0GD# #QY#@ Z>A< .7HA #AZ*@ W>S, -GL[ #1[1  S
M>TP ,GM5 #![7P O>VH!+7MW 2M[AP$J>Y@"*'NJ B=[OP(F>^$")GKW B9X
M_P(F>/\")W?_ B=W_P*N;   HW8  )E\  ".?P  A((  'B#  !LA   7X0
M %&$  !'A   /(0  #.$"0 PA!$ +X0: "V$)  LA2T *X4U "J%/@ IA4<
M*(90 ">&6@ FAF8 )(9S ".&@P AAI4 ((:G 1Z&O $>AMX 'H3U 1Z"_P$>
M@O\!'H'_ 1Z!_P&H=   GGT  )."  ")A0  ?H@  '&*  !EBP  6(P  $R-
M  ! C@  -HX  "R/   ED P (Y 3 "*0'  AD"4 ()$N !^1-@ >D4  '9%)
M !R15  :D6  &9%N !B1?@ 6DI  %9*D !21N0 3D=@ $X_T !2._P 4C?\
M%(S_ 12,_P&C?0  F(,  (Z(  "$C   =X\  &F1  !=DP  4)4  $67   Y
MF   +ID  "6:   =FP( %IT, !6=$P 4G1L $YTD !*=+0 1GC< $9Y! !">
M3  /GE@ #IYG  V>=P ,GHH "YV>  J=L@ )G<P "9SL  J;_@ +FO\ "YG_
M  N9_P"<A   D8H  (B.  ![D@  ;98  &"9  !4G   2)\  #R@   PH0
M)J,  !VE   5IP  $*D%  NK#0 (JA, !ZH;  :J)  %JBX !*HX  *J1  !
MJE   *I>  "J;@  JH$  *J5  "IJ@  J<$  *CD  "H]@  I_\  *?_  "G
M_P"5BP  C)   '^5  !QF@  8YX  %:B  !*I@  /:@  #&J   FJP  ':T
M !2P   .L@  ";4!  *V"@  M@\  +85  "W'0  MR4  +<O  "X.0  N$8
M +A4  "X9   N'8  +B+  "WH   M[8  +?3  "V[P  MOP  +;_  "V_P"/
MD@  @I<  '2=  !FH@  6*<  $NL   ^KP  ,;$  ":S   <M@  $[@   V[
M   &O@   ,$   #"!   P@L  ,,0  #$%0  Q!P  ,4D  #&+@  R#H  ,E'
M  #)5P  R6D  ,E]  #)E   R*H  ,C#  #(Y   R/0  ,C]  #(_0"%F0
M=Y\  &BF  !:JP  3;$  #^U   QN   );H  !J]   1P   "\,   /'
MR@   ,T   #.    SP,  - )  #1#@  TQ(  -49  #7(@  VBT  -TY  #>
M20  WEH  -]N  #?A0  WYP  -^R  #>RP  WN8  -_T  #?] !YH0  :Z@
M %RO  !.M0  0+L  #&^   DP0  &<4  !#(   )S    ,\   #3    V0
M -P   #=    WP   .$   #B!0  Y L  .80  #H%@  ZB   .TK  #P.@
M\4L  /%>  #R<P  \XL  /.B  #SM@  \\D  //A  #SX0!MJ@  7K$  %"Y
M  !!OP  ,L0  "3(   7S   #M    ;5    V@   -X   #B    Y@   .D
M  #J    [    .X   #P    \@   /0&  #V#   ^1(  /P<  #_*0  _SH
M /]-  #_8@  _W@  /^0  #_HP  _[,  /_!  #_P0#_!QD _P$7 /\ %P#_
M !H _P A /\ *P#_ #D _P!' /\ 5 #_ %\ _P!J /\ <P#_ 'L _P"# /\
MB@#_ )  _P"6 /\ FP#_ *$ _P"H /\ KP#_ +@ _P#$ /X U0#\ .H ^P#X
M /H _P#Y /\ ^ #_ /@ _P#V /\ \P#_ /$ _P#_"Q4 _P43 /\ $P#_ !0
M_P : /\ )P#_ #0 _P!" /\ 3P#_ %L _P!E /\ ;@#_ '8 _P!^ /\ A0#^
M (L _0"1 /L EP#Z )T ^ "C /< JP#V +, ] "^ /, S #Q ., [P#S .X
M_P#M /\ [ #_ .L _P#L /\ [ #_ .L _P#_#1$ _PD0 /\ #P#_ !  _P 6
M /\ (@#_ "\ _P ] /\ 2@#_ %4 _0!@ /H :0#X '$ ]@!Y /0 ?P#S (8
M\0", .\ D@#N )@ [ "? .L I@#I *X YP"X .4 Q0#C -H X0#M -\ ^P#>
M /\ W0#_ -T _P#= /\ W0#_ -T _P#_#PT _PP+ /\#"0#_  P _P 2 /\
M'0#_ "D ^P W /@ 1 #U %  \@!: .X 8P#L &L Z0!S .< >@#E (  XP"&
M .$ C #? ), W0"9 -L H0#9 *D U0"R -( O@#0 ,X S@#F ,P ]@#* /\
MR@#_ ,D _P#( /\ R #_ ,@ _P#_$0@ _PT" /\'  #_!0@ _P . /\ %@#W
M "( [P P .L /0#H $D Y !4 .  70#= &4 V0!M -4 <P#2 'H T "  ,X
MAP#, (T R@"4 ,@ FP#& *0 Q "M ,( N #  ,< O0#? +P \0"[ /X N0#_
M +@ _P"X /\ N #_ +@ _P#_%   _P\  /\-  #_#   _P<) /@!$ #H !H
MXP H -T -@#8 $( T@!- ,X 5P#* %\ QP!F ,4 ;0## '0 P0!Z +\ @0"]
M (@ NP"/ +D EP"W )\ M0"H +, LP"Q ,( KP#8 *X"[0"L _L JP7_ *H&
M_P"I!O\ J0;_ *D&_P#_%@  _Q(  /<2  #L$0  Y@X  .4&" #= Q( U ,@
M ,T$+0#(!#H PP5& +\%4 "\!E@ N09@ +<'9P"U!VX LP=U +$(>P"O"((
MK@F* *P)D@"J"9L J JE *8*L "E"[\ HPS4 *$-[0"?#OX G0[_ )P/_P";
M#_\ FP__ )L/_P#_&@  ]QD  .H>  #?'@  U1H  - 3 @#.# L QPL6 , -
M)0"Z#C( M@X_ +(/20"O$%( K!!: *H080"H$6@ IA%O *01=@"B$7T H1&%
M )\2C@"=$I< G!*B )H3K0"8$[P EQ30 )05[ "2%OT D!?_ (\7_P".%_\
MCA?_ (X7_P#Z'0  [B,  -\H  #0*@  QR<  ,$A  "]&04 N1(0 +(5'@"M
M%BP J!<X *080P"A&4P GQE4 )P:7 ":&F( F1II )<;< "5&W< E!M_ )(<
MB "0')( CQR= (T=J0"+';< BA[* (@?YP"&(/H A"#_ 8,@_P&#(/\!@B#_
M 8(@_P'U)   Y2P  -,Q  #&,P  O#$  +8M  "P)0  K!T, *8>& "A("8
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M FTSG0)L,ZL":C2\ FDTU0-H-?$"9S7_ F<U_P)F-?\"9C7_ F8T_P+B-@
MS#\  +U$  "R1P  J$<  *!$  "8/P  D#D  (@T#0"#-1< ?S8D 'PW+P!Y
M-SD =SA" '0X20!R.%  <3A7 &\X7@!M.&4!;#AM 6HX=0%H.( "9SB, F4X
MF0-D.:@#8CFY V$ZT -@.NX#8#K_ U\Z_P)?.O\"7SK_ E\Z_P+=.P  QT,
M +E)  "N2P  I$P  )M*  "210  B3\  ($Z"0![.A0 =SL@ '0\*P!R/#4
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M!$]'QP1.1^<$3D?[!$Y'_P-.1_\#3T?_ T]'_P/,1@  NTX  *]4  "D5P
MFE@  )%7  "&5   >TX  '!*  !I2 T 94@6 &))(0!?22L 74DT %M)/ !9
M24, 5TE* %9)4@!52ED!5$IA 5)*:@%12G4"3TJ! TY*CP-,2Y\$2TNP!$I+
MQ01)2^8$24OZ!$E+_P-*2_\#2DO_ TI+_P/(20  N%$  *Q7  "A6P  F%P
M (Y<  "#60  =E,  &M.  !D30H 7TP3 %Q-'@!:32@ 6$TQ %9-.@!434$
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M SI8_P,[5_\#.U?_ SM7_P.\5   KEP  *-C  "99P  D&D  (5I  !Y9P
M:V(  &!@  !570  3EL, $M;% !)7!\ 1UPH $9=,0!%73D 0UU! $)=2 !!
M7E  0%Y8 #Y>80$\7FP!.UYX CE>AP(W7I<"-EZI S5>O0,T7]T#-%[U S5=
M_P(U7?\"-5S_ C5<_P*X60  JF$  *!G  "6;   C&X  (%N  !V;   9VD
M %QF  !19   2&() $1B$0!"8AL 06,D #]C+0 ^8S4 /60] #QD10 [9$T
M.615 #AD7P V9&D!-61V 3-DA0$Q994",&6G B]ENP(N9=H"+F3T BYC_P(O
M8_\"+V+_ B]B_P*S7@  IV8  )QM  "3<0  B',  'US  !R<@  9'   %AN
M  !-;   0FH# #QI#@ Z:A8 .6H@ #AJ*  V:S$ -6LY #1K00 S;$D ,FQ2
M #%L7  O;&8 +FQS "QL@@$J;),!*6RE 2ALN0$G;=8!)VOR 2=J_P$G:O\!
M*&G_ BAI_P*N9   HVP  )ES  ".=@  A'@  'EY  !M>   8'<  %-V  !(
M=0  /G,  #1R"@ Q<Q$ ,',: "]S(P N<RL +70T "QT/  K=$0 *71- "AU
M5P G=6, )75O "1U?P B=9  (76B "!UMP ?==( 'W3Q !]S_P$?<O\!(''_
M 2!Q_P&I:P  GG,  )1Y  "*?   @'X  '1_  !G?P  6G\  $U^  !#?@
M.'T  "]] @ H?0T )GT4 "1]'  C?B4 (GXM "%^-@ A?C\ 'W]( !Y_4@ =
M?UX '']K !I_>@ 9?XP %W^? !9_LP 5?\X %7[O !9\_P 6>_\ %GO_ !=[
M_P"D<@  FGH  (]_  "%@@  >X0  &V&  !@AP  5(<  $B(   \B   ,H@
M "B(   @B 4 &HD. !F)%0 8B1T %XHF !:*+@ 5BC< %(I! !.*3  2BU@
M$8ME !"+=0 /BX< #HJ;  V*KP ,BL@ #(GJ  V'_  .A_\ #H;_  Z&_P"?
M>P  E($  (J%  " B   <XL  &6-  !9CP  3)   $&2   TD@  *I(  "&3
M   9E   $I8&  Z7#@ -EQ4 #)<=  R7)@ +ER\ "I<Y  F71  (EU  !I=>
M  67;@ #EH   9:4  "5J   E;X  )3@  "4]   D_\  9+_  &2_P"8@@
MCH@  (6,  !WCP  :I(  %V5  !0F   1)H  #B;   LG   (IT  !F>   2
MH   #:("  >C"P !HQ   *,7  "C'P  HR<  *,Q  "D/   I$@  *16  "D
M90  HW<  *.+  "CH   HK8  *'2  "A\   H/L  *#_  "@_P"1B@  B8X
M 'N2  !MEP  8)L  %.>  !&H0  .:,  "VD   CI@  &:@  !&J   ,K
M!:X   "O!P  KPT  *\1  "P&   L"   +$H  "Q,@  LCX  +),  "R6P
MLFP  +*!  "QEP  L:P  +#&  "PZ   K_<  *__  "O_P",D   ?Y4  '&:
M  !CGP  5:0  $>H   ZJ@  +:P  "*N   8L   $+,   JU   "N    +L
M  "[    O <  +P-  "]$0  OA8  +\>  # )P  P3(  ,)   ##3P  PV
M ,-T  ##BP  PZ$  ,.X  #"UP  PN\  ,+Z  #!_@"!EP  <YT  &6C  !7
MJ   2:T  #NQ   MLP  (;8  !:Y   .NP  ![X   #!    Q0   ,<   #(
M    R0   ,H%  #+"P  S0\  ,X4  #0'   TR8  -8R  #800  V%,  -EF
M  #9?   V90  -FK  #9PP  V>$  -GP  #9] !VGP  9Z8  %FL  !+L@
M/+<  "ZZ   AO0  %<    W$   %QP   ,H   #.    T@   -4   #6
MV0   -L   #=    WP<  .$,  #C$0  YAD  .DD  #L,@  [4,  .Y6  #O
M:P  [X0  .^<  #OL@  [\8  ._=  #OY !JJ   6Z\  $RV   ^O   +\
M "#$   4R   #,P   +0    U    -D   #>    X@   .4   #F    Z
M .D   #L    [@   / "  #R"0  ]0\  /@7  #\(P  _S,  /]&  #_6@
M_W$  /^)  #_GP  _[$  /_   #_Q@#_ !4 _P 4 /\ % #_ !< _P = /\
M* #_ #< _P!$ /\ 40#_ %P _P!F /\ ;P#_ '< _P!^ /\ A0#_ (L _P"1
M /\ EP#_ )T _P"D /\ JP#_ +0 _@"_ /T S@#[ .8 ^0#V /@ _P#W /\
M]P#_ /< _P#P /\ [ #_ .D _P#_ Q( _P 0 /\ $ #_ !$ _P 7 /\ ) #_
M #( _P _ /\ 3 #_ %< _P!A /\ :@#_ '( _P!Y /T @ #\ (8 ^@", /D
MD@#X )@ ]@"? /4 I@#T *X \@"Y /  Q@#N -X [0#P .L _@#J /\ Z0#_
M .D _P#G /\ XP#_ .  _P#_!PX _P - /\ "P#_  P _P 3 /\ 'P#_ "P
M_P Z /\ 1@#^ %( ^P!< /@ 90#U &P \P!T /$ >@#O ($ [@"' .P C0#J
M ), Z0": .< H0#F *D XP"S .$ OP#? -  W0#I -H ^0#9 /\ UP#_ -4
M_P#5 /\ U0#_ -0 _P#_"0H _P$% /\  P#_  D _P 0 /\ &0#[ "8 ]P T
M /0 0 #R $P [@!6 .H 7P#G &< Y !N .( = #@ 'L W@"! -P AP#: (T
MU@"4 -0 FP#1 *, SP"M ,P N #* ,< R #@ ,8 \P#% /\ PP#_ ,, _P##
M /\ PP#_ ,, _P#_"P$ _P,  /\   #_  , _P + /, $@#N !\ Z@ M .8
M.@#B $4 W@!/ -D 6 #4 &  T0!H ,X ;@#, '0 R@![ ,@ @0#& (< Q ".
M ,( E@#  )X O@"G +L L@"Y ,  MP#4 +4 [ "S /L LP#_ +( _P"R /\
ML0#_ +$ _P#_#0  _P8  /\#  #W    ]  # .< #0#@ !@ V@ E -, ,@#.
M #X R@!) ,8 4@## %H P !A +X : "\ &X N@!T +@ >P"V ($ M "( +(
MD "P )D K@"B *P K0"J +H J #+ *8 Y@"E /< I #_ *, _P"B /\ H@#_
M *( _P#_$   ^PP  .\.  #F#0  WPD  -H !@#0 !$ R0 = ,0 *@"_ #<
MNP!" +< 2P"T %0 L@!; *\ 8@"M &@ JP!N *D =0"H 'L I@"# *0 BP"B
M )0 H "> )X!J "< K4 FP/& )D%X@"8!O0 E@C_ )4)_P"4"?\ E G_ )0)
M_P#\$0  \14  .,9  #6&0  S!4  ,<0  #$!PH O0,4 +<$(0"R!BX K@@Z
M *H)1 "G"4T I I5 *(*7 "@"F( G@MI )P+;P";"W8 F0Q^ )<,A@"6#)
ME R: )(-I@"1#;, CPW% (T.X@"+$/8 B1#_ (@1_P"'$?\ AQ'_ (<1_P#V
M&0  YR   -8D  #()0  OR(  +D<  "T% $ L0T. *H.&0"E#R< H1 S )T1
M/@":$4< F!)/ )425@"3$EP D1)C ) 3:0".$W  C!-X (L3@0")%(L AQ26
M (85H@"$%;  @Q;! ($7W0!_&/0 ?1G_ 'P9_P!\&?\ >QG_ 'L9_P#O(0
MW2D  ,HM  "^+P  M2P  *XG  "H(   HQ<( )X6$P"9%R$ E!DM )$:. ".
M&D$ BQM) (D;4 "'&U< A1Q> (0<9 ""'&L @!QS '\=? !]'88 ?!Z1 'H>
MG@!X'ZL =Q^\ '8@U !T(?  <B'_ '$B_P!Q(?\ <2'_ '$A_P#H*   TC
M ,(U  "W-P  K34  *4Q  ">*P  F"," )(>$ "-(!L B2$G (8B,@"#(SP
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M 5LTQ@%:-.8!637[ 5DU_P%9-/\!633_ 5DT_P'2.   P$   +-%  "H2
MGD@  )5&  "+0   @CL  'DU! !S,Q  ;S0: &PT)0!I-2\ 9S4W &4V/P!C
M-D8 8C9- & V5 !?-EL 73=C %PW:P!;-W8!63>" 5@XCP%6.)X!53BO E0Y
MPP)3.>0"4SKY 5,Y_P%2.?\!4SG_ 5,Y_P'-/   O$0  *])  "D3   FDP
M )%+  "'1@  ?4   ',[  !L. T :#D7 &4Y(@!C.BL 8#HT %XZ/ !=.D,
M6SI* %H[4 !8.U@ 5SM@ %8[: !5/',!4SQ_ 5(\C0%0/9P!3SVL DX^P0)-
M/N$"33[X DT^_P%-/O\!33W_ 4T]_P')0   N$@  *Q-  "A4   EU$  (Y/
M  "$2P  >44  &Y   !F/0L 8CT4 %\]'@!</B@ 6CXQ %@^. !7/D  53]&
M %0_30!3/U4 4D!= %! 9@!/0' !3D!\ 4Q!B@%+09H"2D&K DE"O@)(0MX"
M2$+V DA"_P)(0O\!2$'_ 4A!_P'%1   M4L  *E0  ">5   E50  (M3  "
M4   =4H  &I&  !A0@@ 7$$1 %E"&P!70B4 54(N %-"-0!10CT 3T)# $]#
M2P!.0U( 341: $M$8P!*1&X!245Z 4=%B %&19@"14:I D1&O0)#1MP"0T;U
M D-&_P)#1O\!0T7_ 4-%_P'!1P  LD\  *94  "<5P  DE@  (A8  !^50
M<4\  &9*  !<1@4 5T8/ %1&& !11B( 3T8K $Y&,P!,1SH 2T=! $I'20!)
M2%  2$A8 $=(80!%26P 1$EX 4))A@%!298!0$JG C]*NP(^2]@"/DKS CY*
M_P(^2?\!/TG_ 3])_P&]2@  KU(  *-8  "96P  D%T  (9<  ![60  ;5,
M &)/  !73 $ 44H- $Y*%0!,2Q\ 2DLH $E+, !'2S@ 1DP_ $5,1@!$3$X
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M 2Y6_P&R5P  I5\  )ME  "1:0  AVH  'QJ  !Q:   8V4  %AB  !-7P
M0UT" #Q;#0 Z7!0 .%P= #=<)@ U72X -%TV #-=/@ R748 ,5Y. #!>5P O
M7F( +5YN "Q??0 J7XX *5^@ "A?LP$G7\P )U_M 2=>_P$G7?\!*%W_ 2A<
M_P&M7   HF0  )AJ  ".;@  @V\  'EO  !N;@  8&L  %1I  !)9P  /V4
M #5C"0 R8Q$ ,&,9 "]D(0 N9"D +60Q "QD.0 K94( *F5* "AE5  G95\
M)F9K "1F>@ C9HL (F:= "!FL0 ?9LD 'V;K "!E_@ @9/\ (&/_ 2%C_P&I
M8@  GFH  )5P  "*<P  @'4  '5U  !I=   7'(  $]Q  !$;P  .FX  #!M
M P I; T )VP4 "9L'  E;20 )&TL "-M-  B;3T (6Y& "!N4  >;EL '6YG
M !QN=@ :;H< &6^: !AOK@ 6;\8 %F[I !=M_  8;/\ &&O_ !AK_P"D:0
MFG$  )!V  "&>0  ?'L  '%[  !D>P  5WH  $IY   _>   -7@  "MW   B
M=@< '78/ !QW%@ ;=QX &G<F !EW+@ 8=S< %WA  !5X2@ 4>%8 $WAC !)X
M<@ 1>(, $'B7  ]XJP .>,, #G?F  YV^@ /=?\ $'7_ !!T_P"?<0  E7@
M (M\  ""?P  =X$  &J"  !=@@  4((  $2"   X@@  +H(  "2"   <@@
M%(() !&#$  0@Q8 $(,>  Z#)P .@S  #8,Y  V#1  ,@U  "X-=  F#;  (
M@WX !H.1  6"I0 #@KL !(';  2!\@ %@/\ !G__  9__P":>0  D'X  (:#
M  !]A0  ;X<  &*)  !5B@  28L  #V,   QC   )HP  !V-   5C@  #X\#
M  J0#  &D!$ !(\8  ./(  !CRD  (\R  "0/0  D$D  (]6  "/90  CW8
M (^*  ".GP  CK0  (W/  ",[@  C/L  (O_  "+_P"4@   BX4  (*)  !T
MC   9H\  %F1  !,DP  0)4  #26   HE@  'I<  !68   /F@  "IL   *<
M"0  G X  )P3  "<&@  G"(  )TK  "=-0  G4   )U.  "=7   G6X  )R!
M  "<EP  G*P  )O&  ":Z   F?D  )G_  "8_P".B   AHP  'B0  !JE
M7)<  $^:  !"G0  -IX  "F?   ?H0  %:(   ZD   (I@   *@   "I!
MJ0H  *D.  "I$P  JAH  *HB  "K*P  K#8  *Q$  "L4P  K&,  *QW  "K
MC@  JZ0  *N\  "JW@  J?0  *G]  "I_P")C@  >Y,  &V7  !?G   4:
M $2D   VI@  *J@  !ZI   4JP  #:X   :P    L@   +4   "U    M0,
M +8)  "W#@  N!(  +@9  "Z(0  NRL  +PX  "]1P  O5@  +UK  "]@0
MO9D  +VP  "]S   O.H  +SW  "[_@!^E0  <)L  &*@  !3I0  1JH  #BM
M   JKP  'K$  !.T   ,MP   [D   "\    OP   ,(   #"    PP   ,0
M  #&!@  QPP  ,@0  #*%@  S"   ,\K  #0.@  T4L  -%>  #2<P  THL
M -*D  #3NP  T]@  -/M  #3]@!SG0  9*,  %:I  !'KP  .;,  "JV   =
MN0  $KP   J_    PP   ,8   #)    S0   ,\   #0    T@   -0   #6
M    V0(  -L(  #>#@  X1,  .0=  #H*@  Z#P  .E/  #I9   ZGP  .N5
M  #KK   Z\(  .S5  #LY0!FI@  6*P  $FS   [N0  *[P  !W    1Q
M"<@   #,    SP   -,   #9    W0   .    #A    XP   .4   #G
MZ@   .P   #N!   \0L  /42  #X'   ^RL  /T^  #^4P  _FH  /^#  #_
MFP  _ZX  /^^  #_R@#_ !( _P 0 /\ $0#_ !, _P 9 /\ )@#_ #0 _P!!
M /\ 30#_ %@ _P!B /\ :P#_ ', _P!Z /\ @0#_ (< _P"- /\ DP#_ )D
M_P"@ /\ IP#^ *\ _ "Z /H R0#Y .$ ^ #S /< _P#V /\ ]0#_ /$ _P#I
M /\ Y #_ .$ _P#_  \ _P - /\ #0#_  X _P 4 /\ (0#_ "X _P \ /\
M2 #_ %, _P!= /\ 9@#^ &T _ !U /L >P#Y (( ^ "( /< C@#V )0 ] ";
M /, H@#Q *H [P"T .T P0#K -4 Z@#L .@ _ #G /\ Y0#_ .8 _P#@ /\
MV0#_ -0 _P#_  L _P ( /\ !@#_  D _P 0 /\ ' #_ "D _P V /\ 0@#[
M $X ]P!7 /0 8 #R &@ [P!O .T =@#L 'P Z@"" .@ B #G (X Y0"5 .,
MG #A *0 WP"N -T N0#: ,H UP#D -0 ]@#1 /\ T #_ -  _P#/ /\ RP#_
M ,< _P#_  , _P   /\   #_  0 _P - /H %@#V ", \P P /  / #M $<
MZ0!1 .4 6@#B &( WP!I -T ;P#: '8 V !\ -0 @@#2 (@ T "/ ,T E@#+
M )X R0"H ,< LP#% ,$ P@#8 ,  [P"_ /X O@#_ +T _P"\ /\ O #_ +P
M_P#_ @  _P   /\   #_    ]  ' .T $0#H !P XP I -\ -0#; $$ U@!+
M -$ 5 #- %P R@!C ,@ :0#& &\ PP!U ,$ >P"_ (( O@"( +P D "Z )@
MN "B +4 K "S +D L0#+ *\ YP"N /@ K #_ *L _P"L /\ K #_ *L _P#_
M!   _P   /8   #N    YP   -\ # #6 !4 SP B ,H +@#' #H PP!$ ,
M30"\ %4 N0!< +< 8P"U &D LP!O +$ =0"O 'L K0"" *L B@"I )( IP"<
M *4 I@"C +, H0## )\ W@"> /( G0#_ )P _P"< /\ FP#_ )L _P#_!P
M]@D  .D+  #?"@  U00  ,X !0#& !  P  : +L )P"W #( LP ] +  1@"M
M $\ J@!6 *@ 7 "F &, I !H *( ;P"A '4 GP!\ )T A "; (T F0"7 )<
MH@"5 *X DP"] )$ TP"0 .T CP#\ (X _P"- ?\ C0'_ (T!_P#Y#@  ZA(
M -P5  #-%0  Q!$  +X,  "Z @H M  2 *X '@"J "H I@ U *( /P"@ $@
MG0%0 )L"5@"9 EP EP-C )4#:0"3 V\ D01V ) $?P".!8@ C 62 (H&G@"(
M!JH A@>Z (4(SP"$"NL @@O\ ($,_P" #/\ @ S_ ( ,_P#Q%0  X!T  ,T@
M  #!(0  N!T  +$7  "L$   J D- *('%@"="2, F0HN )4+. "3#$$ D Q)
M (X-4 ",#5< B@U= (@-8P"'#6H A0YQ (,.>@""#H0 @ Z/ 'X/FP!\#Z@
M>Q"X 'H0S@!X$>P =A+_ '42_P!T$_\ =!/_ '03_P#H'@  TR8  ,,J  "X
M*@  KB@  *<C  "@'   FQ,# )8/$ "0$!L C!$G (D2,@"&$SL A!-# ((4
M2P" %%$ ?A17 'P47@![%64 >15L '<5= !V%GX =!:* '(7E@!Q%Z0 ;QBT
M &X8R0!M&>@ :QK\ &H;_P!J&_\ :AO_ &H;_P#@)@  RBT  +PQ  "P,P
MIS$  )\L  "7)@  D!\  (H7# "%&!8 @1DB 'X:+ ![&S8 >1L^ '<<10!U
M'$P <QQ3 '$=60!P'6  ;AUG &T>< !K'GH :AZ% &@?D@!G'Z  92"P &0A
MQ0!C(>0 8B+Z &$B_P!A(O\ 82+_ &$B_P#7+   PS0  +8X  "J.0  H3@
M )@U  "0+P  B"@  ( A" ![(!( =R$= '0B)P!Q(C$ ;R,Y &TC00!K(T@
M:2-. &@D50!F)%L 921C &,E:P!B)74 826! %\FC@!>)IT 72>M %LHP0!;
M*.  6BGW %DI_P!9*?\ 62G_ %DH_P#/,@  OCD  +$]  "F/P  G#\  ),\
M  "*-@  @3   'DJ P!R)@\ ;B<9 &LH(P!I*"P 9BDU &4I/ !C*4, 82I*
M & J40!>*E< 72I? %PK: !:*W( 62Q] %@LBP!6+9H 52VJ %0NO0!3+MP
M4B_U %(O_P!2+O\ 4B[_ %(N_P#*-@  NCT  *U"  "B1   F$0  (]!  "%
M/   >S<  '(Q  !K+ P 9RT5 &0M'P!A+B@ 7RXQ %TN.0!<+T  6B]& %@O
M30!7+U0 5C!< %4P9 !3,6X 4C%Z %$QB !0,I< 3C*H $TSNP!---@ 3#3S
M $PT_P!,-/\ 3#/_ $PS_P#&.@  MD(  *E&  ">20  E4D  (M'  "!0@
M=ST  &TW  !D,@D 8#(2 %TR' !:,B4 6#,M %8S-0!5,SP 4S1# %(T2@!1
M-%$ 4#19 $\U80!--6P 3#9W $LVA0!*-Y4 2#>F $<XN %'.-,!1CCQ 48X
M_P%&./\ 1CC_ $8W_P#!/@  LD4  *9*  "<30  DDT  (A+  !^1P  <T(
M &D]  !?-P8 6C80 %<W& !4-R( 4C<J % W,@!/.#D 33A  $PX1P!+.$X
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M 3A#_P"W20  J5   )Y5  "46   BUD  (!8  !V5@  :%   %U,  !32
M2D4) $9$$0!$1!D 0D0B $%%*0 _13$ /D4X #U%/P \1D< .T9/ #I'6  Y
M1V( .$AN #9(?  U2(T -$F> #-)L0 R2<D ,4GK #))_@ R2/\ ,DC_ #-(
M_P"T3   IU0  )Q9  "27   B%T  'Y=  !S6@  954  %M2  !03@  1DH%
M $!)#@ ^218 /4D> #M*)@ Z2BX .4HU #A+/0 W2T0 -DM- #1,5@ S3&
M,DQL #%->@ P38L +DV< "U.KP L3L< +$[I "Q-_0 M3?\ +4S_ "U,_P"P
M4   I%@  )E=  "/80  AF(  'MA  !P7P  8EL  %A8  !.50  0U$! #M/
M#  X3Q, -D\; #5/(P T4"L ,U R #)0.@ Q4$( ,%%* "Y14P M4ET +%)I
M "M2>  I4H@ *%.: "=3K0 F4\4 )E/G "93_  G4O\ )U'_ "=1_P"L50
MH%P  )9B  "-9@  @V<  'AF  !M90  8&$  %5>  !*6P  /U@  #56"  Q
M51  ,%87 "Y6'P M5B< +%8O "M7-@ J5SX *5=' "A74  F6%H )5AG "18
M=0 C688 (5F8 "!9JP ?6<( 'UGE !]8^@ @6/\ (%?_ "%7_P"H6@  G6(
M )-G  "*:P  ?VP  '5L  !J:P  76@  %%E  !&8P  .V   #%> P J70T
M*%T3 "9=&P E7B, )%XJ "->,@ B7CH (5Y# "!?3  ?7U< 'E]C !Q@<0 ;
M8(( &6"5 !A@J0 78,  %F#B !=?^0 87O\ &5[_ !E=_P"D8   F6@  )!N
M  "&<   ?'(  ')R  !F<0  6&X  $QL  !!:P  -FD  "UG   C9@@ 'V8/
M !UF%0 <9AT &V8E !IF+0 99S4 &&<^ !=G2  69U, %6A? !-H;@ 2:'\
M$6B2 !!HI@ /:+T #FC@ !!G]P 09O\ $67_ !%E_P"?9P  EF\  (QS  ""
M=@  >'@  &UX  !@=P  4W8  $9T   [<P  ,7(  "=Q   ><0  %G * !-P
M$  3<!< $G ? !%Q)P 0<2\ $'$X  YQ0@ .<4X #7%;  QQ:0 +<7H "G&-
M  AQH0 &<;8 !G#2  =P[P (;_\ "6[_  EN_P";;P  D74  (=Y  !^?
M='X  &9^  !9?@  37X  $!]   U?0  *GP  "%\   8?   $7P$  Q\#  *
M?!$ "7P9  A\(0 '?"D !GPR  1\/0 #?$@  7Q5  !\8P  ?'0  'R'  ![
MG   >[$  'K+  !YZP  >?H  'G_  !X_P"6=P  C'P  (.   !Y@P  ;(0
M %Z%  !1A@  18<  #F'   MAP  (X<  !J'   2AP  #8@!  :)"@ !B0\
M (D4  "(&P  B",  (DL  ")-@  B4(  (A.  "(70  B&T  (B!  "'E0
MAZL  (;$  "%Y@  A/@  (3_  "$_P"0?@  AX,  'Z'  !QB0  8XL  %:-
M  !)CP  /)$  #"1   DD0  &I(  !*3   -E   !I4   "6!@  E@P  )40
M  "6%0  EAT  )8D  "6+@  ECD  )9&  "650  EF4  )9X  "5C@  E:0
M )2\  "3WP  D_4  )+_  "2_P"+A@  @XH  '6-  !GD   690  $R7   _
MF0  ,IH  ":;   ;G   $IT   R?   $H    *(   "C 0  HP<  *,,  "C
M$   I!4  *0<  "E)0  IB\  *8\  "F2P  IEL  *9N  "EA   I9L  *2S
M  "CT   H^\  *+\  "B_P"&C0  >)$  &J5  !<F0  3IT  $&@   SH@
M)J,  !NE   1IP  "JD   &K    K0   *\   "P    L    + %  "Q"P
ML@\  +,4  "T&P  M20  +<P  "W/P  MU   +=B  "W>   MY   +:I  "V
MP@  MN0  +;U  "U_@![DP  ;9@  %^=  !0H@  0J8  #2I   FJP  &JT
M !"O   )L@   +0   "W    N@   +P   "]    O@   +X   #  @  P0@
M ,(-  #$$@  QAD  ,DD  #*,@  RT,  ,M5  #,:@  S(,  ,R<  #+M0
MS,X  ,SI  #,]@!PFP  8:$  %*F  !$JP  -K   ">R   :M0  $+@   >[
M    O@   ,$   #$    R    ,L   #+    S0   ,X   #0    T@   -4#
M  #8"@  VQ   -X8  #B)   XS4  .1(  #E7   YG,  .:-  #FI0  YKP
M .;3  #GYP!CI   5:H  $:P   XM0  *+D  !J\   /P   !<0   #'
MRP   ,\   #4    V    -P   #=    WP   .$   #C    Y0   .@   #J
M    [08  /$.  #U%@  ^"4  /DX  #Y30  ^F,  /M\  #\E0  _*H  /R[
M  #]RP#_  \ _P . /\ #@#_ !  _P 6 /\ (P#_ #  _P ] /\ 20#_ %0
M_P!> /\ 9@#_ &X _P!V /\ ? #_ (( _P") /\ CP#_ )4 _@"; /T HP#[
M *L ^@"U /D PP#W -L ]@#P /0 _P#S /\ \@#_ .P _P#B /\ W #_ -8
M_P#_  P _P ) /\ " #_  H _P 2 /\ '@#_ "L _P X /\ 1 #_ $\ _P!9
M /X 80#\ &D ^@!P /@ =P#W 'T ]@"# /0 B0#R (\ \0"6 .\ G0#M *4
M[ "O .H O #H ,T Y@#H .0 ^@#C /\ X@#_ .  _P#5 /\ S@#_ ,L _P#_
M  8 _P ! /\   #_  0 _P . /\ &0#_ "4 _0 R /L /@#W $D \P!3 /
M7 #N &, [ !J .H <0#H '< Y@!] .0 @P#B (D X "0 -X EP#< )\ V0"I
M -8 M #3 ,0 T #> ,X \P#, /\ RP#_ ,H _P#( /\ P@#_ +X _P#_
M_P   /\   #_    ^P + /8 $P#Q "  [0 L .H . #G $, XP!- .  5@#<
M %T V0!D -4 :P#2 '$ T !V ,X ? #, (, R@") ,@ D0#& )D Q "C ,$
MK0"_ +L O0#/ +L ZP"Y /P MP#_ +< _P"V /\ M #_ +$ _P#_    _P
M /\   #V    [@ % .< #P#A !D VP E -4 ,0#2 #P S@!& ,H 3P#' %<
MQ !> ,$ 9 "_ &H O0!P +L =@"Y 'P N "# +8 B@"S ), L0"< *\ IP"M
M +, JP#% *D X0"G /4 I@#_ *4 _P"D /\ I #_ *0 _P#_    _    /$
M  #H    X    -0 "P#, !, QP ? ,( *@"_ #4 O  _ +@ 2 "U %  LP!7
M +  7@"N &0 K !I *L ;P"I '4 IP!\ *4 A "C (P H0"6 )\ H0"= *T
MF@"\ )@ T@"7 .X E0#^ )0 _P"5 /\ E0#_ )4 _P#\ 0  \ 4  .,'  #5
M!0  S    ,4 ! "^  X N  7 +, (P"O "X JP X *D 00"F $H HP!1 *$
M5P"? %T G0!C )L :0": &\ F !V )8 ?0"4 (8 D@"0 )  FP". *< C "V
M (H R0"( .< AP#Y (< _P"& /\ A@#_ (8 _P#T#   Y!   -$2  #%$0
MO0X  +8(  "Q  @ JP 1 *8 &P"A "8 G@ Q )H .@"8 $, E0!* ), 40"1
M %< CP!= (X 8P", &D B@!P (@ =P"& (  A "+ (( E@"  *, ?@"Q 'T
MQ ![ N$ >@/U 'H%_P!Y!?\ > ;_ '@&_P#J$P  UAH  ,8=  "Z'   L1D
M *H3  "D#0  GP4, )D % "5 !\ D0(I (T#,P"+!#P B 5$ (8&2P"$!E$
M@@=7 ($'70!_!V, ?0AJ 'L(<@!Z"'P > F& '8)D@!T"J  <PJO '$+P0!P
M#-\ ;PWV &X._P!M#O\ ;0[_ &T._P#A'   RR,  +PF  "Q)@  J"0  * >
M  "9&   DQ " (X+#@"("Q< A PB ($-+ !^#34 ? X] 'H.10!X#DL =PY1
M '4/6 !S#UX <1!E ' 0;@!N$'< ;!"" &L0CP!I$9T :!&M &82P !E$M\
M9!/V &,4_P!C%/\ 8A3_ &(4_P#6)   PRH  +4N  "J+P  H"T  )@H  "0
M(@  B1L  ((3" !]$1( >1(< '83)P!S%#  <10X &\5/P!M%48 ;!5, &H6
M4P!H%ED 9Q9A &46:0!D%W( 8A=^ &$8BP!?&)D 7AFI %P9O !<&M@ 6AOS
M %H<_P!9'/\ 61S_ %D<_P#-*@  O3$  *\U  "D-@  FS0  )(Q  ")*P
M@24  'D= P!S& X ;QD8 &P:(@!I&RL 9QLS &4<.P!D'$$ 8AU( & =3@!?
M'54 71U< %P>9 !;'FX 61]Y %@?AP!6()8 52"F %0AN !3(=( 4B+Q %(C
M_P!2(_\ 4B+_ %(B_P#(+P  N#8  *LZ  "@/   ECL  (TX  "#,@  >BT
M '(F  !J( P 9B 3 &,A'0!A(28 7R(O %TB-@!;(CT 6B-$ %@C2@!7(U$
M52-8 %0D80!3)&H 425V % E@P!/)I, 3B>C $PGM0!,*,X 2RCN $LI_P!+
M*/\ 2RC_ $LH_P##-   LSL  *<_  "<00  DD   (D^  !_.0  =3,  &PM
M  !C)P@ 7B81 %PF&0!9)R( 5R<K %4H,@!4*#D 4BA  %$H1@!0*4T 3BE5
M $TI70!,*F< 2RIS $DK@ !(*Y  1RRA $8MLP!%+<L 12[L $0N_P!$+O\
M12W_ $4M_P"^.   L#\  *1#  "910  CT4  (5#  ![/@  <3D  &<T  !>
M+@0 6"L. %4K%@!2+!\ 4"PG $\L+P!-+38 3"T\ $HM0P!)+4H 2"Y2 $<N
M6@!&+V0 12]P $,P?@!",(T 03&> $ RL0 _,L@ /S/J #\S_@ _,O\ /S+_
M #\R_P"[/   K4,  *%'  "620  C$D  (-(  !X1   ;3X  &,Y  !:-
M4C , $\P$P!,,!P 2C D $DQ*P!',3( 1C$Y $0Q0 !#,D< 0C)/ $$S6 !
M,V( /S1M #XT>P ]-8L /#:< #LVKP Z-\8 .3?H #DW_  Z-_\ .C;_ #HV
M_P"W0   JD8  )Y+  "430  BDX  (!,  !U2   :D,  & ^  !6.0  334)
M $DT$0!'-1D 134A $,U* !!-2\ 0#4V #\V/0 ^-D4 /3=- #PW50 [.&
M.CAK #DY>0 X.8D -SJ; #4ZK0 U.\0 -#OF #0[^P U._\ -3K_ #4Z_P"T
M0P  ITH  )Q.  "240  B%(  'Y0  !S30  9T@  %Q$  !2/P  2#H& $0Y
M#P!!.18 /SD> #XY)@ \.2T .SHT #HZ.P Y.T( .#M* #<\4P V/%T -3UI
M #0]=P S/H< ,3Z9 # _JP O/\( +S_D "\_^@ P/_\ ,#[_ # ^_P"Q1P
MI$T  )E2  "/50  AE8  'Q5  !Q4@  9$P  %E)  !/10  14 # #\^#0 \
M/A, .CX; #D^(P W/BH -C\Q #4_.  T/T  ,T!( #) 40 Q05L ,$%G "Y"
M=0 M0H4 +$.7 "M#J@ J0\  *43B "I#^0 J0_\ *T+_ "M"_P"N2@  H5$
M )=6  "-60  @UH  'E:  !N5P  85(  %=.  !-2P  0T<  #I#"@ V0Q$
M-$,8 #-#(  R1"< ,40O #!$-@ O13T +45& "Q%3P K1ED *D9D "E'<@ H
M1X, )D>5 "5(J  D2+X (TC@ "1(]P E1_\ )4?_ "9'_P"J3P  GU4  )1:
M  "+7@  @5\  '=>  !K7   7U@  %55  !+40  0$T  #5*!P P20X +DD5
M "U)'0 L220 *THK "I*,P H2CL )TM# "9+3  E2U8 )$QB "-,<  A3(
M($V3 !]-I@ >3;L '4[= !Y-]@ >3/\ 'TS_ "!+_P"G4P  G%H  ))?  "(
M8P  ?F0  '1C  !I80  7%X  %);  !'6   /%4  #)2 @ J4 P )T\2 "90
M&0 E4"  )% H "-0+P B43< (5%  "!120 >4E, '5)? !Q2;0 :4WT &5.0
M !A3I  64[D %5/9 !93]  74O\ &%'_ !E1_P"C60  F&   (]E  "%:
M>VD  '%I  !F9P  660  $UA  !"7P  .%P  "Y:   E6 @ (%<. !Y7%  =
M5QP '%@C !M8*P :6#, &5@\ !A810 665  %5E; !19:0 36GH $EJ- !%:
MH0 06K< #EK5 !!9\P 06?\ $5C_ !%8_P"?7P  E68  (QK  "";0  >&X
M &YO  !B;0  56H  $AH   ^9@  ,V4  "EC   @80$ && + !5@$  48!<
M$V > !)@)@ 28"X $6$W !!A0  /84L #F%8  UA9@ ,8G8 "V*)  IAG0 )
M8;( "&'+  AAZP )8/T "E__  M?_P";9@  DFT  (AQ  !^<P  =74  &IT
M  !<<P  3W(  $-P   X;P  +6X  "1L   ;:P  $VL$  YJ#  -:A( #&H9
M  MJ(0 *:BD "6HR  AJ/  ':T< !6M3  1K80 ":W$  &J$  !JF   :JT
M &G&  !IYP  :?@  &C_  !H_P"7;0  C7,  (1W  ![>@  <'L  &-[  !6
M>@  27H  #UY   Q>   )W<  !UV   5=@  #W8"  EV"@ $=@\  '85  !V
M'   =B0  '4L  !U-@  =4$  '5.  !U7   =6P  '5^  !TDP  =*@  '/
M  !SXP  <O<  '+_  !Q_P"2=0  B7H  (!^  !V@   :8$  %N"  !.@@
M08(  #6#   I@@  'X$  !:!   0@@  "H(   *#!P  @@T  ((1  ""%P
M@AX  ((F  ""+P  @CL  ()'  ""50  @64  (%X  "!C0  @*(  '^Z  !_
MW0  ?O0  'W_  !]_P"-?   A($  'N$  !NA@  8(@  %**  !%BP  .8P
M "R,   AC   %XP  !"-   )C@   H\   "0 P  CPD  (\.  "/$@  D!@
M ) ?  "0*   D#(  ) _  "030  D%T  (]P  "/A0  CIP  (ZS  "-T
MC/   (O^  "+_P"(A   @(@  '*+  !DC0  5I   $B3   [E0  +I8  "*6
M   7EP  #Y@   B9    FP   )T   "=    G0,  )T)  "=#0  GA$  )X7
M  "?'P  GRD  * U  "@0P  H%0  *!F  "?>P  GI,  )ZK  "=Q@  G>D
M )SY  "<_P"#BP  =8X  &>2  !9E@  2YD  #V<   PG@  (Y\  !>@   .
MH@  !Z0   "F    J    *H   "J    J@   *L!  "K!P  K P  *T0  "N
M%@  KQX  +$I  "Q.   L4@  +%:  "Q;P  L8@  +&@  "PN@  K]T  *_R
M  "O_0!XD0  :I8  %R:  !-GP  /Z,  #&F   CIP  %ZD   ZK   %K@
M +    "R    M0   +<   "W    N    +D   "Z    O ,  +T)  "^#@
MP!0  ,,>  #%*P  Q3P  ,9.  #&8@  QGH  ,:4  #&K0  QL@  ,7E  #%
M\P!LF0  7IX  $^D  !!J   ,JP  "2O   6L0  #;0   .W    N@   +T
M  #     Q    ,8   #&    R    ,D   #+    S    ,X   #0!@  TPT
M -@3  #<'@  WBT  -]   #@5   X6L  .&%  #AGP  X;<  .'/  #AY@!@
MH0  4J<  $.M   TL@  );4  !>Y   -O    ;\   ##    QP   ,H   #/
M    TP   -8   #7    V@   -P   #?    X0   .,   #F    Z0$  .P+
M  #P$@  \Q\  /0Q  #V1@  ]UP  /AT  #XCP  ^:8  /FX  #XR0#_  T
M_P + /\ "P#_  X _P 3 /\ 'P#_ "P _P Y /\ 10#_ %  _P!9 /\ 8@#_
M &H _P!Q /\ =P#_ 'X _P"$ /X B@#] )  _ "7 /H G@#Y *< ]P"Q /8
MO@#U -( \P#L /$ _@#P /\ \ #_ .8 _P#< /\ T@#_ ,T _P#_  < _P $
M /\  @#_  8 _P 0 /\ &P#_ "< _P S /\ /P#_ $H _@!4 /L 70#Y &0
M]P!K /4 <@#S '@ \@!^ /  A #O (H [0"1 .P F0#J *$ Z "K .8 M@#D
M ,< X@#C .  ]P#> /\ W0#_ -D _P#, /\ Q0#_ ,$ _P#_    _P   /\
M  #_  $ _P - /\ %@#\ "( ^0 N /8 .0#S $4 [P!. .P 5P#I %X Y@!E
M .0 ; #B '( X !W -\ ?@#= (0 VP"+ -@ D@#5 )L T@"D ,\ KP#- +X
MRP#5 ,D [P#' /\ Q0#_ ,0 _P"^ /\ N #_ +4 _P#_    _P   /\   #^
M    ]P ) /$ $0#K !P YP H .0 ,P#A #X W0!( -@ 40#3 %@ T !? ,X
M90#, &L R@!Q ,@ =P#& 'T Q "$ ,( C #  )0 O@"> +L J "Y +8 MP#(
M +4 Y@"S /H L0#_ +  _P"P /\ K #_ *D _P#_    _P   /H   #Q
MZ  # .  #0#8 !8 T0 B ,T +0#* #< Q@!! ,( 2@"_ %( O0!9 +H 7P"X
M &4 MP!J +4 < "S '8 L0!] *\ A0"M (T JP"7 *D H0"G *X I0"^ *(
MV "@ /( GP#_ )X _P"> /\ G@#_ )P _P#_    ]P   .L   #A    U@
M ,L "0#% !$ OP ; +L )@"W #$ M  Z +$ 0P"N $L JP!2 *D 6 "G %X
MI@!D *0 :0"B '  H !V )X ?@"< (8 F@"0 )@ FP"6 *< E "V )( R@"0
M .D CP#\ (X _P"- /\ C #_ (T _P#X    Z0(  -L#  #, 0  Q    +T
M @"V  T L  5 *L ( "G "H I  T *$ / "> $0 G !+ )H 4@"8 %@ E@!=
M )4 8P"3 &D D0!P (\ =P"- (  BP"* (D E0"' *$ A0"O (, P0"! .
M@ #U '\ _P!_ /\ ?P#_ '\ _P#N"@  W X  ,H0  "^#@  M0L  *\#  "I
M  < HP 0 )X & "9 ", E@ L ), -0"0 #X C@!% (P 2P"* %$ B !7 (8
M70"% &, @P!J ($ <0!_ 'H ?0"$ 'L CP!Y )P =P"J '4 NP!T -0 <@#P
M '( _P!R /\ <0#_ '$ _P#C$0  S1<  +\9  "S&0  JA4  *,0  "="@
MEP$* )$ $@"- !L B0 E (4 +P"# #< @  ^ 'X 10!] $L >P!1 'D 5P!X
M %T =@!D '0!:P!R 70 < )_ &X"BP!L Y@ :P.F &D$MP!H!<X 9P?L &8(
M_0!F"?\ 90G_ &4)_P#6&@  Q"   +8C  "K(P  H2   )D;  "2%   C X!
M (8'#0" !!0 ? 8> 'D'* !V"#  = @X '()/P!P"44 ;PI, &T*4@!L"E@
M:@M? &@+9P!G"W  90QZ &,,AP!B#)4 8 VD %\-M@!>#<X 7 [M %P/_P!;
M$/\ 6Q#_ %L0_P#-(0  O"@  *\K  "D*P  FBD  )(D  ")'P  @A@  'L1
M!0!U#0\ <0T7 &X.(0!K#BH :0\R &<0.0!E$$  9!!& &,030!A$%, 7Q%:
M %X18@!<$6L 6Q%V %D2@P!8$I( 5A.B %43M !4$\L 4Q3L %(5_P!2%O\
M4A7_ %(5_P#&*   MBX  *DR  "?,@  E3$  (PM  "#)P  >B$  '(:  !K
M$PL 9Q,3 &04' !A%"4 7Q4M %T5- !<%3L 6Q9" %D62 !8%D\ 5A=6 %47
M7@!3%V< 4AAR % 8?P!/&8X 3AJ? $P:L !+&\< 2QOI $H<_0!*'/\ 2AS_
M $H<_P#!+0  L30  *4W  ":.   D#<  (<T  !]+P  ="D  &PC  !D' <
M7AD0 %L:& !9&R$ 5QLI %4;, !4'#< 4AP] %$<1 !/'4L 3AU2 $T=6@!+
M'F, 2AYN $D?? !''XL 1B"< $4AK@!$(<0 0R+F $,B_ !#(O\ 0R+_ $,B
M_P"\,@  K3@  *$\  "7/@  C3T  (,Z  !Y-0  ;S   &8J  !>) ( 5R -
M %0@% !1(!T 3R$E $XA+ !,(3, 2R(Z $DB0 !((D< 1R). $8C5P!$(V
M0R1K $(D>0!!)8@ /R:9 #XFJP ])\$ /2?C #TH^@ ]*/\ /2?_ #TG_P"X
M-@  JCT  )Y   "40@  BD(  ( _  !V.P  ;#8  &(P  !9*@  424+ $TE
M$0!+)1D 224A $<F* !%)B\ 1"8V $,F/0!")T0 02=+ #\H5  ^*%T /2EI
M #PI=@ [*H8 .2N7 #@KJ0 W++\ -RS@ #<L^  W+/\ -RS_ #@L_P"U.@
MIT   )Q$  "11@  AT8  'U$  !S0   :#L  %\V  !5,0  3"L' $<I#P!%
M*A8 0RH> $$J)0 _*BP /BLS #TK.0 \*T$ .RQ( #HL40 Y+5L ."YF #8N
M<P U+X, -"^5 #,PIP R,+T ,3'> #$Q]P R,?\ ,C#_ #,P_P"Q/@  I$0
M )E(  "/2@  A4H  'M)  !P10  94   %L[  !2-@  2#$$ $(N#0 _+A,
M/2X; #LN(@ Y+RD ."\O #<O-@ V,#X -3!& #0Q3P S,5D ,C)D #$R<0 P
M,X$ +S23 "XTI@ L-;L +#7; "PU]0 M-?\ +33_ "XT_P"N00  HD@  )=,
M  "-3@  @TX  'E-  !N2@  8D4  %A   !./   13<  #TS"P Y,Q$ -S,8
M #8S'P T,R8 ,S,M #(T-  Q-#P ,#5$ "\U3  N-E8 +39B "PW;P K-W\
M*CB1 "@XI  G.;D )CG8 "<Y]  H.?\ *#C_ "DX_P"K10  GTL  )1/  "+
M4@  @5,  '=2  !L3P  7TD  %9&  !,0@  0CT  #@X"  T. \ ,C@5 #$X
M'0 O."0 +C@K "TY,@ L.3D *SI! "HZ2@ I.U0 *#M? "<\;0 E/'T )#V/
M ",]H@ B/;< (3[4 "$^\P B/?\ (SW_ ",\_P"H20  G4\  ))3  ")5@
M?U<  '56  !J4P  74\  %-,  !*2   0$0  #9 !0 O/0T +3T3 "L]&@ J
M/B$ *3XH "@^+P G/C< )C\_ "0_2  C0%( (D!= "%!:@ @07H 'D&- !U"
MH  <0K4 &T+1 !M"\0 <0O\ '4'_ !Y!_P"E30  FE,  )!8  "&6P  ?5P
M ');  !G6   6U0  %%2  !(3@  /4H  #-'   J0PL )D,0 "5#%@ D0QX
M(T0E ")$+  A1#0 ($4\ !Y%10 =14\ '$9: !M&:  91G@ &$>* !='G@ 6
M1[, %$C. !5'[P 61_\ %T;_ !=&_P"B4@  EU@  (U=  "$8   >F$  '!@
M  !E7@  65H  $]8  !$5   .5$  "].   F2P8 ($H. !Y*$P =2AH '$HA
M !M+*  :2S  &4LX !=+0@ 63$P %4Q7 !1,90 3374 $DV( !%-G  03;$
M#D[,  ]-[@ 03?\ $4S_ !%,_P">5P  E%T  (MB  "!90  =V8  &UF  !C
M9   5F$  $I>   _6P  -5@  "M6   B5 $ &E(* !92$  54A8 %%(= !-2
M)  24BP $5(T !%2/@ 04T@ #U-4  Y38@ -5'( #%2$  M4F  )5*T "%3%
M  E4YP *4_L "U+_  M2_P";70  D60  (AH  !^:P  =&P  &ML  !?:@
M4F<  $5D   Z8@  ,&   "9>   =70  %5L% !!:#  .6A$ #EH8  U;(  ,
M6R< "ULP  I;.@ )6T4 !UM1  9;7@ $6VT  UN   %;E   6Z@  %O   !:
MX@  6O8  5K_  )9_P"79   CFL  (1N  ![<   <G(  &=Q  !9<   3&X
M $!L   U:P  *FD  "%G   89@  $68!  QE"@ '90\ !&44  -D&P "9",
M &0L  !D-0  9$   &1,  !D6@  9&D  &1[  !DCP  8Z0  &.[  !BW0
M8O0  &+_  !A_P"3;   B7$  (!U  !X=P  ;7@  &!W  !2=@  1G4  #ET
M   N=   (W(  !IQ   2<0  #7$   9Q"   < T  ' 2  !P%P  ;Q\  &\F
M  !O,   ;SL  &]'  !O5   ;V0  &]U  !NB@  ;:   &VV  !LU@  :_(
M &O_  !K_P".<P  A7@  'U[  !S?0  97X  %A^  !+?@  /GX  #)^   F
M?0  ''P  !-\   -?   !GT   !]!0  ? L  'P/  !\$P  ?!D  'PA  !\
M*0  ?#0  'M   ![3@  >UX  'MO  !ZA   >IH  'FQ  !XS@  =^\  ';^
M  !V_P")>@  @7\  'B"  !K@P  784  $^&  !"AP  -8@  "F'   =AP
M%(<   V(   &B0   (H   "*    B08  (D,  ")#P  B1,  (D:  "*(@
MBBP  (HX  "*1@  B58  (EH  ")?   B)0  (>K  "&Q@  A>H  (7[  "$
M_P"%@@  ?88  &^(  !ABP  4XT  $6/   XD0  *Y$  !^2   4D@  #9,
M  24    E@   )<   "8    EP   )<%  "7"P  F X  )@3  "9&@  F2(
M )HN  ":/0  F4T  )E>  "9<P  F(L  )BC  "7O   EN(  );W  "5_P"
MB0  <HP  &2/  !6DP  2)8  #J9   LF@  'YL  !2<   ,G@   Y\   "A
M    HP   *4   "E    I0   *4   "F @  IP@  *<-  "H$0  J1D  *LC
M  "K,0  JT$  *Q3  "L9P  JX   *J:  "JLP  JM   *GO  "I^P!UCP
M9Y0  %F8  !*G   /)\  "VB   @HP  $Z4   NG   !J0   *L   "N
ML0   +(   "R    LP   +0   "U    M@   +@$  "Y"P  NQ   +T8  "_
M)   OS4  ,!'  # 6P  P'(  ,"-  #!I@  P,$  +_C  "^\P!JEP  6YP
M $VA   ^I0  +ZD  "&K   3K0  "[    "S    M0   +@   "\    OP
M ,$   #!    PP   ,0   #&    QP   ,D   #+    S@@  -$/  #5&
MV"<  -DY  #:30  VV0  -M^  #<F0  W+   -S)  #<XP!=GP  3Z4  $"J
M   RKP  (K(  !2U   *N    +L   "_    PP   ,8   #+    S@   -$
M  #1    U    -8   #9    VP   -X   #@    Y    .<&  #K#@  [QD
M / J  #R/P  \U4  /1M  #TB   ]*$  /2V  #TQP#_  D _P & /\ !P#_
M  P _P 1 /\ ' #_ "@ _P T /\ 00#_ $P _P!5 /\ 70#_ &4 _P!L /\
M<@#^ '@ _ !^ /L A #Z (L ^0"2 /< F0#V *( ] "L /, N0#Q ,L \ #H
M .X ^P#M /\ [ #_ .$ _P#2 /\ R0#_ ,0 _P#_  $ _P   /\   #_  0
M_P . /\ %P#_ ", _P O /\ .P#] $8 ^@!0 /< 6 #T %\ \@!F /  ; #O
M '( [0!X .P ?@#J (4 Z0", .< DP#E )P XP"F .$ L0#? ,$ W0#= -L
M] #9 /\ U@#_ ,\ _P#$ /\ O0#_ +D _P#_    _P   /\   #_    _P +
M /P $P#W !X ]  J /( -0#N $  Z0!* .8 4@#C %D X !@ -X 9@#< &P
MV@!R -< > #4 'X T@"% -  C0#. )4 S "? ,D J@#' +@ Q0#- ,, ZP#
M /X OP#_ +X _P"V /\ L #_ *T _P#_    _P   /\   #Y    \@ & .L
M#P#F !D X0 D -X +P#: #D TP!# ,\ 3 #, %, R0!: ,< 8 #% &8 PP!K
M ,$ <0"_ '< O0!^ +L A@"Y (X MP"8 +4 HP"S +  L0#" *X X "L /<
MJP#_ *H _P"H /\ HP#_ *  _P#_    _P   /4   #K    X0   -8 # #/
M !, R@ > ,8 *0#" #, OP ] +L 10"X $T M@!4 +, 6@"Q %\ L !E *X
M:@"L '  JP!W *D ?P"G (< I0"1 *, G "@ *D G@"X )P S@": .X F0#_
M )< _P"6 /\ E@#_ ), _P#]    \0   .4   #9    S0   ,0 !@"]  \
MMP 8 +, (@"P "P K0 V *D /@"G $8 I !- *( 4P"@ %D GP!> )T 9 ";
M &H F@!P )@ =P"6 (  E "* )$ E0"/ *( C0"P (L PP") ., B #Y (8
M_P"& /\ A@#_ (8 _P#S    XP   -$   #%    O0   +8   "N  L J  2
M *0 ' "@ "8 G  O )H -P"7 #\ E0!& )( 3 "1 %( CP!8 (T 70"+ &,
MB@!J (@ <0"& 'D A "# (( CP!_ )L ?@"I 'P NP!Z -4 > #R '@ _P!W
M /\ =P#_ '< _P#G!P  T0P  ,,-  "X#   K@@  *@   "B  4 FP . )8
M%0"2 !\ C@ H (L ,0"( #D A@!  (0 1@"" $P @ !2 '\ 5P!] %T >P!C
M 'H :P!X ', =@!] '0 B !Q )4 < "D &X M !L ,H :P#J &H _ !J /\
M:@#_ &H _P#:$   QA0  +@6  "M%0  I!(  )P.  "6!P  D  ) (H $ "%
M !@ @0 A 'X *@![ #( >0 Y '< 0 !U $8 <P!, '( 40!P %< ;@!> &T
M90!K &X :0!W &< @P!E )$ 8P"? &( KP!@ ,0 7P#D %\!^ !> O\ 7@+_
M %X"_P#.&   O1T  + @  "E'P  FQP  ),7  "+$0  A P  'X$"P!Y !(
M=0 ; '( (P!O "L ;0$S &L!.@!I D  9P-& &8#3 !D!%( 8P19 &$$8 !?
M!6D 7@5S %P&?P!:!HT 60>< %<(K0!6",$ 50GA %0+]@!4"_\ 5 O_ %0+
M_P#&'P  MB4  *DH  ">*   E"4  (LA  "#&P  >Q0  '0. P!N"0T :0@4
M &8)'0!D"B4 8@HM & +- !>"SH 70M  %L,1P!:#$T 6 Q4 %<-7 !5#60
M5 UO %(->P!0#HH 3PZ: $X.K !,#\( 3!#C $L0^0!+$/\ 2Q'_ $L0_P"_
M)@  L"L  *0O  "9+P  CRT  (8I  !])   =!X  &P7  !E$0< 7PX0 %P/
M%P!:$!\ 6! G %80+@!4$#4 4Q [ %(10@!0$4@ 3Q%0 $X15P!,$F  2Q)K
M $D2> !($X< 1A.7 $44J0!$%+X 0Q7? $,6^ !#%O\ 0Q;_ $,6_P"Z*P
MJS$  * T  "5-0  BS0  ($Q  !X*P  ;R8  &8@  !>&0$ 5Q0- %04$P!1
M%!L 3Q4C $X5*@!,%3$ 2Q8W $D6/@!(%D0 1Q=, $475 !$%UT 0QAG $$8
M= ! &8, /QJ4 #T:I@ \&[L .QO; #L<]@ \'/\ /!S_ #P<_P"U,   J#8
M )PY  "1.P  ASH  'XW  !S,@  :BT  &$G  !9(0  41L) $P9$ !*&A<
M2!H? $8:)@!%&RT 0QLS $(;.@!!'$$ 0!Q( #X<4  ]'5D /!YD #L><0 Y
M'X  .!^2 #<@I  V(+@ -2'6 #4A]  U(O\ -2'_ #8A_P"R-   I#H  )D^
M  "//P  A3\  'L\  !P.   9S(  %TM  !4*   3"(% $8?#@!#'Q0 01\;
M #\?(@ ^("D /2 P #L@-@ Z(3T .2%% #@B30 W(E< -B-B #0C;@ S)'X
M,B2/ #$EH@ O);8 +R;2 "\F\@ O)O\ ,";_ # F_P"O.   HCX  )9"  ",
M0P  @D,  'A!  !N/0  8S@  %HS  !1+@  2"@! $ D#  ](Q$ .R08 #DD
M'P X)"8 -B0L #4E,P T)3H ,R9" #(F2@ Q)U0 ,"=? "\H;  N*'L +"F-
M "LJH  J*K0 *2K/ "DK\  J*_\ *BK_ "LJ_P"L/   GT(  )1&  "*1P
M@$<  '9%  !L0@  83T  %<X  !.,P  1"X  #PI"0 W*!  -2@5 #,H'  R
M*", ,"@I "\I,  O*C< +BH_ "TK2  L*U( *RQ= "HL:@ H+7D )RV+ "8N
MG@ E+K, )"_- "0O[@ E+_\ )2__ "8N_P"I/P  G44  )))  "(2P  ?DP
M '1*  !J1P  7D(  %0]  !+.0  030  #@O!@ R+0T ,"T3 "XM&0 M+2
M*RTG "HN+@ I+C4 *2\] "@O1@ G,$\ )3!; "0Q:  C,7< (C*) "$RG0 ?
M,[$ 'C/+ !XS[0 ?,_\ (#/_ "$R_P"F0P  FDD  )!-  "&3P  ?%   '-/
M  !H3   7$8  %)#  !)/P  /SL  #8V @ N,@P *S(1 "DR%P H,AX )C(D
M "4S*P D,S( (S0Z "(T0P A-4T (#58 !\V90 >-G4 '#>' !LWFP :-Z\
M&3C( !DXZP :./\ &S?_ !LW_P"C1P  F$T  (Y1  "$4P  >U0  '%3  !F
M4   6DP  %!)  !'10  /4$  #,]   J.0D )3<. ",W%  B.!L (3@B " X
M*  ?.#  'CDX !TY00 <.DL &CI6 !D[8P 8.W( %CN% !4\F0 4/*T $SW&
M !,]Z0 4//T %3S_ !8[_P"@2P  E5$  (M5  ""6   >5D  &Y8  !D5@
M6%$  $Y/  !%2P  .D<  #!#   G0 4 (#X- !T^$0 </A< &SX> !H^)0 9
M/BT &#\U !8_/@ 5/T@ %$!3 !- 8  207  $4&" !!!EP /0:P #D+$  Y"
MYP /0?P $$'_ !! _P"=4   DU8  (E:  " 70  =EX  &Q=  !B6P  5E<
M $Q5  !!40  -DX  "Q+   C2   &T4) !=$#P 51!0 %$4; !-%(@ 212D
M$44Q !%%.P 01D4 #T90  Y'7@ -1VT #$=_  M'DP )1Z< "$>^  A'X  )
M1_8 "D;_  M&_P":50  D%L  (=@  !]8@  <V,  &IB  !@80  4UX  $=:
M   \5P  ,E4  "A2   ?4   %TX$ !%,#  /3!$ #DP7  Y,'@ -324 #$TN
M  M--P *34( "4U-  =.6@ &3FD !$Y[  ).CP !3J0  $VZ  !-VP !3?(
M 4W_  ),_P"66P  C6(  (1F  !Z:   <6D  &AI  !<9P  3V0  $)A   W
M7P  +5P  "-:   :6   $E<!  U6"0 )50X !U43  95&@ $52(  U4J  )5
M-   53X  %5*  !65P  5F4  %5W  !5BP  5:   %6V  !4U   5/$  %/]
M  !3_P"38@  BF@  (!L  !W;@  ;V\  &-N  !6;   26H  #UH   R9@
M)V4  !UC   58@  #F$   E@"  #8 T  %\1  !?%P  7QX  %\F  !?+P
M7SH  %]%  !?4P  7V$  %YR  !>AP  79P  %VR  !<SP  7.\  %O]  !;
M_P"0:@  AF\  'UR  !U=   :G4  %UT  !/<P  0G(  #9P   K;P  (&X
M !=M   0;   "FP   )K!@  :PL  &H/  !J%   :AH  &HA  !I*@  :30
M &E   !I3@  :5P  &EM  !H@@  :)@  &>N  !FR@  9>T  &7\  !D_P"+
M<0  @G8  'IY  !P>P  8GL  %5[  !(>@  .WH  "]Z   C>0  &7@  !%W
M   *=P   W<   !W @  =P@  '8-  !V$   =A4  '8;  !V(P  =BX  '4Z
M  !U1P  =58  '5H  !T?   =)(  '.J  !RQ   <>D  '#[  !P_P"&>0
M?WT  '9_  !H@0  6H(  $R"   _@P  ,H0  "6#   :@P  $8,   J#   "
M@P   (0   "%    A ,  (,(  "##0  @Q   (,5  "$'   A"8  (0R  "$
M/P  @T\  (-@  ""=0  @HP  (&D  " O0  ?^,  '[Y  !^_P""@   >H0
M &R&  !>B   4(H  $*+   UC0  )XT  !N-   1C@  "HX   "/    D0
M )(   "2    D@   )(!  "2!P  D@P  )(0  "3%0  DQT  )0H  "4-@
ME$4  )-7  "3:P  DX(  )*<  "1M@  D-@  (_S  "/_P!^AP  <(H  &&-
M  !3D   19,  #>5   IE@  ')<  !&8   )F0   )L   "<    G@   *
M  "@    H    *    "A    H00  *()  "C#@  I!0  *4=  "F*@  ICH
M *9,  "E8   I7@  *62  "DK   I,D  */K  "B^@!SC@  9)$  %:5  !'
MF0  .9P  "J>   =H   $:$   BC    I0   *<   "I    K    *X   "N
M    K@   *\   "P    L0   +(   "S!@  M0T  +<3  "Y'@  N2X  +I
M  "Z5   NVH  +J%  "YH0  N;L  +K>  "Y\@!GE0  6)D  $J>   [H@
M+*8  !VH   1J@  !ZP   "O    L0   +0   "X    NP   +P   "\
MO@   +\   #     P@   ,0   #&    R ,  ,L+  #/$@  T2   -$R  #2
M1@  TUT  -1V  #4D@  U:L  -7$  #4X@!;G0  3*(  #VG   OK   'Z\
M !&Q   'M0   +@   "[    O@   ,(   #'    R@   ,P   #,    S@
M -    #2    U0   -@   #;    WP   .(   #F"P  ZQ,  .PD  #M.
M[DX  .]G  #P@@  \)P  /"R  #QQ0#_  , _P ! /\ ! #_  D _P / /\
M& #_ "0 _P P /\ / #_ $< _P!1 /\ 60#_ &  _0!G /P ;0#Z ', ^0!Y
M /@ ?P#V (4 ]0", /, E #R )T \ "G .X LP#L ,0 ZP#A .H ^ #I /\
MYP#_ -D _P#+ /\ P@#_ +T _P#_    _P   /\   #_    _P , /\ % #_
M "  _P K /X -P#Z $( ]@!+ /( 4P#P %L [@!A .P 9P#J &T Z !S .<
M>0#E '\ XP"& .$ C@#? )8 W0"@ -L K #8 +L U #1 -, \ #0 /\ S@#_
M ,@ _P"] /\ M@#_ +( _P#_    _P   /\   #_    _0 ( /< $ #S !H
M[P F .T ,0#H #L XP!% .  30#< %4 V0!; -8 80#3 &< T0!L ,\ <@#-
M '@ RP!_ ,D AP#' )  Q0": ,, I0#  +( O@#% +P Y0"Z /L N #_ +<
M_P"P /\ J0#_ *4 _P#_    _P   /X   #U    [  # .4 #0#? !4 V@ @
M -0 *@#0 #4 RP ^ ,@ 1P#% $X P@!5 ,  6P"^ &$ O !F +H ; "X '(
MM@!X +4 @ "S (@ L0"2 *X G@"L *H J0"[ *@ U0"F /, I #_ *, _P"A
M /\ FP#_ )@ _P#_    ^P   /    #E    V    ,X "0#' !$ P@ : +X
M) "[ "X MP X +0 0 "Q $@ K@!. *P 5 "J %H J0!? *< 90"E &L I !Q
M *( > "@ ($ G@"+ )P E@"9 *, EP"R )8 QP"3 .@ D@#^ )$ _P"0 /\
MC0#_ (L _P#Y    ZP   -T   #/    Q@   +P ! "U  T L  5 *P '@"H
M "@ I0 Q *( .0"? $$ G0!( )L 3@"9 %, EP!9 )8 7@"4 &0 D@!J )
M<0". 'H C "# (H CP"( )P A@"J (0 O "" -P @0#V (  _P!_ /\ ?P#_
M 'X _P#L    V@   ,D   "^    M@   *X   "G  D H0 0 )P & "8 "(
ME0 J )( ,@"0 #H C0!! (L 1P") $T AP!2 (8 6 "$ %T @@!D ($ :P!_
M ', ?0!] 'L B !X )4 =@"C '4 M !S ,P <0#M '  _P!P /\ < #_ '
M_P#?!0  R@H  +P+  "Q"0  J 0  *$   ";  , E  , (\ $P"* !L AP D
M (0 + "! #, ?P Z 'T 00![ $< >0!, '< 4@!V %< = != '( 9 !P &T
M;P!V &P @@!J (\ :0"= &< K@!E ,, 9 #D &, ^@!C /\ 8@#_ &, _P#0
M#@  OQ(  +(3  "G$@  G1   )4+  "/ P  B0 ' (( #@!^ !4 >@ > '8
M)0!T "T <0 T &\ .@!N $  ; !& &H 3 !I %( 9P!8 &8 7P!D &< 8@!Q
M &  ? !> (D 7 "8 %L J0!9 +P 6 #< %@ ] !8 /\ 5P#_ %< _P#&%@
MMAH  *H=  "?'   E1D  (T4  "%#P  ?@D  '<!"@!R !  ;@ 7 &H 'P!H
M "< 90 N &0 - !B #L 8 !  %\ 1@!= $P 7 !3 %H 6@!8 &( 5P!L %4
M=P!3 (4 4@"4 % !I0!/ ;@ 3@+2 $T$\ !-!?\ 307_ $T%_P"_'0  L"(
M *,E  "9)0  CR(  (4=  !]&   =1(  &X- @!G!@P 8P,1 %\"&0!= R$
M6P0H %D$+P!7!34 5@4[ %0&00!3!D< 409. % '50!.!UX 30AG $L(<P!)
M"8$ 2 F2 $<*HP!%"K8 1 O0 $0,[P!##?\ 0PW_ $0-_P"Y)   JBD  )XL
M  "4+   BBH  ( F  !W(0  ;AL  &84  !?#P4 60L- %4*$P!3"QL 40LB
M $\,*0!-#"\ 3 PV $L-/ !)#4( 2 U) $8-40!%#EH 1 YD $(.< ! #G\
M/P^0 #X0H@ \$+8 .Q#1 #L1\0 [$?\ .Q'_ #P1_P"T*0  IB\  )HR  "0
M,@  AC$  'PM  !R*   :2,  &$=  !9%@  41$( $P/$ !*$!8 2! = $80
M) !%$"L 0Q$Q $(1-P!!$3X 0!%% #X230 ]$E8 /!)A #H3;0 Y$WP -Q2-
M #84GP U%;, -!7- #,6[@ T%O\ -!;_ #06_P"O+@  HC0  )<W  ",.
M@C8  '@T  !N+@  92H  %PD  !4'@  3!@$ $84#0!"%!( 0!09 #\4(  ]
M%2< /!4M #L5-  Y%CH .!9" #<62@ V%U, -1=> #,8:@ R&7D ,!F* "\:
MG0 N&K$ +1O* "T;[  M'/\ +AO_ "X;_P"L,@  GS@  )0[  "*/   @#P
M '8Y  !K-   8B\  %DJ  !0)0  1Q\  $ :"@ \&1  .AD6 #@9'0 V&B,
M-1HI #0:,  S&C< ,AL^ #$;1P O'%  +AU; "T=9P L'G8 *AZ( "D?FP H
M'ZX )R#' "8@Z@ G(/X *"#_ "@@_P"I-@  G3P  )(_  "'00  ?4   '0^
M  !I.@  7S4  %8P  !-*P  1"4  #L@!P V'@X ,QX3 #(>&0 P'B  +QXF
M "X?+0 M'S0 +" [ "L@1  J(4X *2%8 "<B90 F(G0 )2.% ",CF0 B)*T
M(23% "$EZ  B)?T (B3_ ",D_P"F.@  FC\  (]#  "%10  >T0  ')#  !G
M/P  73H  %,V  !*,0  02P  #@F P Q(PP +B(1 "PB%@ J(AT *2(C "@C
M*@ G(S$ )B0Y "4E00 D)4L (R96 "(F8P A)W( 'R># !XHEP =**L &RG#
M !LIY@ <*?L '2G_ !XH_P"C/@  F$,  (U'  "#20  >DD  '!'  !F1
M6C\  %$[  !'-P  /C(  #4M   L* D *"</ "<G%  E)QH )"<A ",H)P B
M*"X (2DV " I/P ?*DD 'BI4 !TK8  ;*V\ &BR! !DLE0 7+:D %BW! !8M
MY  7+?H &"W_ !DM_P"A00  E4<  (M+  ""30  >$T  &Y,  !D20  6$0
M $]   !&/0  /3@  #,T   J+P8 )"P- "$L$@ @+!@ 'RT> !XM)0 =+2P
M'"XT !LN/  :+T8 &"]1 !<P7@ 6,&T %3%_ !,QDP 2,:@ $3*_ !$RX@ 2
M,OD $S'_ !,Q_P">10  DTL  (E/  " 40  =E(  &U0  !B3@  5DD  $U&
M  !$0P  .S\  #$Z   G-@, 'S(+ !PR$  ;,A4 &3(; !@R(@ 7,RD %C,Q
M !4T.@ 4-$0 $S1/ !(U7  1-6L $#9]  \VD0 .-J8 #3>\  TWW0 --O8
M#C;_  \V_P";20  D4\  (=3  !^5@  =58  &I5  !@4P  54\  $Q,  !"
M20  .$4  "Y!   D/0  '#H( !8X#@ 5.!( %#@8 !,Y'P 2.28 $3DN ! Y
M-P /.D$ #CI,  T[60 -.V@ "SMZ  H[C0 )/*( !SRX  <\U0 (//  "3O_
M  H[_P"83@  CE0  (58  !\6P  <EL  &A:  !>6   4U4  $E2   ^3@
M-$L  "I'   A1   &$(# !) "P 0/Q  #C\5  X_'  -0", #$ K  M -  *
M0#X "4%*  =!5@ &064 !$%V  -!B@ !09\  $&T  !!T  !0>X  4'\  )
M_P"55   C%D  (->  !Y8   <&   &9@  !=7@  45L  $57   Z5   +U$
M "5/   <3   %$H   Y("  +1PX "$<2  ='&0 &1R  !4@H  -(,0 "2#L
M $A'  !(4P  2&(  $AS  !(A@  2)L  $BQ  !'S   1^T  $?[  !'_P"2
M6@  B6   (!C  !W90  ;F8  &5F  !99   3&   $!=   U6P  *ED  "!7
M   750  $%,   M2!P %40T  5 1  !0%@  4!T  % E  !0+@  4#@  %!#
M  !04   4%X  %!O  !0@P  3Y@  $^N  !.R0  3NL  $W[  !-_P"/80
MAF8  'UI  !T;   ;&T  &%K  !3:0  1F<  #ID   O8P  )&$  !I?   2
M7@  #%P   9<!@  6PL  %H/  !:$P  6AD  %DA  !9*0  63,  %D_  !9
M3   65H  %EK  !8?@  6)0  %>K  !7Q0  5ND  %7[  !5_P",:   @FT
M 'IP  !R<@  9W(  %IQ  !,<   /VX  #-M   H:P  '6H  !1H   -9P
M!V<   !F P  9@D  &4-  !E$0  9!4  &0<  !D)   9"X  &0Z  !C1P
M8U4  &-F  !C>@  8I   &&G  !@P0  7^8  %_Z  !>_P"';P  ?W0  'AW
M  !N>   8'@  %)W  !%=P  .'8  "MV   @=   %G,   YS   '<@   '(
M  !R    <04  '$*  !Q#@  <!$  ' 7  !P'@  <"<  ' S  !O0   ;U
M &]@  !N=   ;HL  &VB  !LO   :^(  &KX  !I_P"#=P  ?'L  '-]  !E
M?@  5W\  $E_   \?P  +X   ")_   7?@  #WX   =^    ?P   '\   !_
M    ?@   'X%  !^"@  ?@T  'X1  !^%P  ?B   'XK  !].0  ?4@  'U9
M  !\;0  ?(0  'N<  !ZM@  >=H  'CU  !W_P" ?P  =X(  &F#  !;A0
M388  #^(   RB0  )(D  !B)   /B0  !XH   "+    C    (T   "-
MC    (P   ", P  C @  (T-  "-$0  C1<  (XB  ".+P  CC\  (U0  "-
M9   C'L  (R5  "+K@  BLT  (GO  ")_P![A0  ;8@  %Z*  !0C0  0H\
M #21   FD@  &9,   Z4   &E0   )8   "8    F@   )L   ";    FP
M )L   ";    G    )T%  "="P  GA   )\7  "@)   H#0  *!&  "@60
MGW   )^*  ">I0  GL(  )WH  "<^0!PC   88\  %.2  !$E@  -ID  ">;
M   9G   #YT   6?    H0   *,   "E    J    *D   "I    J0   *H
M  "K    K    *T   "N 0  L D  +(/  "S&   M"<  +0Y  "U30  M&0
M +1^  "SF@  L[0  +/5  "S\ !DDP  59<  $>;   XGP  *:(  !JD   .
MI@  !*@   "K    K0   +    "T    M@   +@   "X    N0   +H   "\
M    O0   +\   #     PP   ,4'  #)#P  RAH  ,LL  #,0   S58  ,YO
M  #-BP  S*@  ,S"  #,X@!8FP  2:   #JE   LJ0  '*L   ^N   $L0
M +0   "W    N@   +X   ##    Q@   ,@   #(    R@   ,L   #-
MSP   -(   #5    V0   -T   #A!0  Y@\  .<>  #H,@  Z4@  .I@  #K
M>P  ZY<  .RN  #LP@#_    _P   /\   #_  8 _P - /\ %0#_ "$ _P L
M /\ . #_ $, _P!, /X 5 #[ %L ^@!B /@ : #V &X ]0!T /0 >@#R (
M\0"' .\ CP#M )< ZP"A .D K0#G +T Y0#8 .0 \P#B /\ X #_ -  _P#$
M /\ O #_ +8 _P#_    _P   /\   #_    _P ) /\ $0#_ !P _0 G /D
M,@#U #T \0!& .T 3P#K %8 Z !< .8 8@#D &@ XP!N .$ <P#? 'D W0"
M -H B #8 )$ U "; -( I@#/ +0 S #) ,D Z0#( /\ QP#_ ,$ _P"W /\
MKP#_ *L _P#_    _P   /\   #_    ^  % /( #@#N !< Z@ B .8 + #A
M #< W0!  -@ 20#3 %  T !6 ,X 7 #, &( R@!G ,@ ;0#& ', Q !Y ,(
M@0#  (H O@"4 +P GP"Y *P M@"^ +0 W0"S /< L0#_ +  _P"H /\ H@#_
M )X _P#_    _P   /D   #O    Y@   -\ "P#6 !( T  < ,P )@#( #
MQ  Z ,  0@"] $H NP!0 +@ 5@"V %L M0!A +, 9@"Q &P L !R *X >@"L
M (( J0", *< F "E *4 HP"T *  RP"? .X G0#_ )P _P"9 /\ E #_ )$
M_P#_    ]@   .H   #=    SP   ,< !@#   \ NP 7 +< ( "S "H L  S
M *T .P"J $, IP!) *4 3P"C %4 H@!: *  7P"> &4 G0!K )L <@"9 'L
MEP"% )0 D "2 )T D "L (X OP", .( BP#Z (D _P") /\ A@#_ (, _P#T
M    Y    -0   #(    OP   +4  0"N  L J0 2 *4 &P"A ", G@ L )L
M- "8 #P E@!# )0 20"2 $X D !3 (X 60"- %X BP!D (D :P"' ', A0!]
M (, B "! )4 ?P"D 'T M0![ ,\ >0#Q '@ _P!W /\ =P#_ '4 _P#E
MT0   ,,   "X    KP   *@   "@  8 F@ . )4 %0"1 !X C@ F (L +0"(
M #4 A@ \ (0 0@"" $< @ !- '\ 4@!] %@ >P!> 'D 90!X &T =@!V ',
M@0!Q (X ;P"= &T K@!L ,0 :@#G &D _0!H /\ : #_ &D _P#5 P  PP<
M +8(  "K!@  H@   )L   "4    C0 * (@ $ "# !@ ?P @ 'P )P!Z "X
M=P U '4 .P!T $$ <@!' '  3 !O %( ;0!8 &L 7P!I &8 9P!P &4 >P!C
M (@ 8@"7 &  IP!> +L 70#< %P ]@!< /\ 6P#_ %L _P#)#0  N1   *P1
M  "A$   EPT  (\(  "(    @@ % 'L #0!W !( <P : &\ (0!L "@ :@ O
M &@ -0!G #L 90!! &, 1@!B $P 8 !2 %\ 60!= &$ 6P!J %D =0!7 ((
M50"1 %0 H@!3 +4 40#/ %  [P!0 /\ 4 #_ %  _P"_%   L!@  *0:  "9
M&0  CQ8  (<1  !_#0  =P8  '$ " !K  X 9P 4 &0 &P!A "( 7@ I %T
M+P!; #4 60 [ %@ 00!6 $8 50!- %, 5 !2 %P 4 !E $X < !, 'T 2P"-
M $D G@!( +  1P#' $8 Z0!& /L 1@#_ $4 _P"X&P  JB   )XB  "3(@
MB1\  ( :  !W%0  ;Q   &@+  !A! H 70 0 %D %@!6 !T 5  C %( *@!0
M #  3P U $X .P!, $$ 2P!( $D 3P!' 5< 1@%A $0"; !# GD 00.) $ #
MF@ ^!*T /03$ #P%Y0 \!_@ / ?_ #P'_P"R(@  I2<  )DI  ".*0  A"<
M 'LC  !Q'@  :1@  &$2  !:#0, 4P@, $\%$0!,!1< 2@8> $@&) !'!BH
M10<P $0'-@!#"#T 00A# $ (2P ^"5, /0E= #L*:  Z"G8 . N' #<+F0 U
M"ZP - S" #,,Y  S#?D ,PW_ #0-_P"M)P  H"P  )4O  "++P  @"X  '<J
M  !M)0  9"   %P:  !4%   3 \& $8,#0!##!( 00P8 #\,'P ^#"4 / TK
M #L-,@ Z#3@ . T_ #<.1P V#E  - Y: #,.9@ Q#W0 , ^% "X0F  M$*L
M+!## "L1Y0 L$?H +!'_ "T1_P"J+   G3$  )(T  "'-0  ?30  '0Q  !J
M*P  8"<  %@A  !/&P  1Q8  $ 1"0 [$ \ .1 4 #<0&P V$"$ -! G #,1
M+0 R$30 ,1$[ # 10P N$DT +1)7 "P28P J$W$ *1." "<4E0 F%*D )17
M "05XP E%OH )A;_ "85_P"F,0  FC8  (\Y  "%.@  >SD  '$V  !G,0
M72T  %0H  !,(@  0QT  #L7!0 U% T ,A,1 #$4%P O%!T +A0D "P4*@ K
M%3$ *A4X "D60  H%DH )Q=4 "878  D&&\ (QB  "$9DP @&:< 'QF^ !X:
MX  ?&O@ (!K_ " :_P"C-   F#H  (T]  "#/@  >3T  &\[  !E-P  6S(
M %(M  !)*   0",  #@> 0 P&0H +!@/ "H8%  I&!H )Q@@ "89)P E&2T
M)!HU ",:/@ B&T< (1M2 " <7@ ?'6P '1U^ !P=D0 :'J4 &1Z\ !@?W0 9
M'_8 &A__ !L>_P"A.   E3T  (M!  "!0@  =T(  &U   !C/   63<  $\S
M  !&+@  /2D  #4D   M( < )QT- "4=$@ C'1< (1T= "$=)  @'BL 'QXR
M !X?.P ='T4 '"!/ !HA7  9(6H &")[ !8BCP 5(J, %".Z !,CV@ 4(_4
M%2/_ !8C_P">/   DT$  (E$  !_1@  =48  &Q$  !B00  5SP  $TX  !$
M-   /#   #,K   J)@, (R(+ " A$  >(14 '"(; !LB(0 :(B@ &B,P !DC
M.  8)$( %B5- !4E60 4)F@ $R9Y !(FC0 1)Z( $">X  XGU@ 0*/0 $2?_
M !$G_P"<0   D44  (=(  !]2@  =$H  &I)  !@1@  54$  $P^  !#.@
M.C8  #$R   H+0  ("D) !LG#@ 9)Q( &"<8 !8G'P 5*"4 %"@M !,H-@ 2
M*4  $BE+ !$J5P 0*F8 #BMW  XKBP -+)\ #"RU  LLSP ,+.\ #2S_  TK
M_P"91   CTD  (5,  !\3@  <T\  &E.  !>2P  4T<  $I$  !"0   .3T
M "\X   E-   '3 % !8M#  4+!  $RT5 !(M'  1+2, $"TJ  \N,P .+CT
M#2](  TO50 ,,&, "C!T  DPB  (,9P !C&Q  8QRP &,>L !S#\  @P_P"7
M2   C4T  (-1  !Z4P  <50  &=2  !=4   4DP  $E*  ! 1@  -4(  "L^
M   B.@  &C<! !(T"0 /,PX #C,3  TS&0 -,R  ##0H  LT,0 *-3L "#5&
M  <U4@ %-F  !#9Q  (VA   -ID  #:O   VR   -N@  #;Y  $U_P"430
MBE(  (%6  !X6   ;UD  &58  !;50  45(  $=/   \3   ,4@  "=$   >
M00  %C\  ! \!P +.@T "3H1  @[%P &.QX !3LF  0[+@ ".S@  3Q#   \
M3P  /%X  #QN   \@0  /)<  #RL   [Q0  .^<  #OX   [_P"14@  B%@
M ']<  !V70  ;5X  &-=  !:7   3E@  $)4   W40  +4X  "-+   :20
M$D8   U$!@ '0PP  T,0  !#%0  0QL  $,C  !#*P  0S4  $-   !#30
M0UL  $-K  !#?@  0Y0  $*J  !"PP  0>8  $'Y  !!_P".6   AEX  'UA
M  !S8P  :V0  &)C  !780  25T  #U:   R6   )U4  !Y3   540  #D\
M  E-!0 "30L  $P.  !,$P  2Q@  $L?  !+*   2S(  $L]  !+20  2U<
M $MG  !*>P  2I   $FG  !)P   2.0  $CX  !'_P"+7P  @V0  'IG  !Q
M:0  :6H  %YI  !09@  0V0  #=A   L7P  (5T  !A;   060  "E@   -7
M P  5PD  %8-  !5$   514  %0;  !4(P  5"T  %0Y  !410  5%,  %1D
M  !3=P  4XT  %*D  !1O0  4.(  %#X  !/_P"(9P  ?VL  '=N  !O<
M97   %=N  !*;   /6L  #!I   E:   &F8  !%D   +8P  !&(   !B 0
M808  & +  !@#@  7Q(  %\7  !?'@  7B@  %XS  !>0   7D\  %Y?  !=
M<@  78@  %R@  !;N0  6M\  %GW  !8_P"$;@  ?'(  '5U  !K=@  774
M $]T  !"<P  -7,  "AR   =<   $V\   QN   $;@   &X   !N    ; (
M &P'  !K"P  :PX  &L2  !J&0  :B(  &HM  !J.@  :4D  &E:  !I;
M:(,  &>;  !FM0  9=@  &3U  !D_P" =0  >GD  '![  !B>P  5'P  $9\
M   Y?   +'P  !][   4>@  #7H   1Z    >@   'H   !Z    >0   'D!
M  !X!@  > L  '@.  !X$P  >!H  '@E  !X,@  =T$  '=2  !W90  =GP
M '65  !TKP  <\X  '+Q  !Q_P!^?0  =8   &>!  !8@@  2H,  #R$   N
MA0  (84  !6%   -A0   X4   "&    AP   (@   "(    AP   (<   "'
M    AP0  (<)  "'#@  B!,  (@<  "(*0  B#@  (=*  "'70  AG,  (:-
M  "%IP  A,4  (/L  ""_@!XA   :H8  %R(  !-B@  /XP  #&.   CCP
M%H\   V0   "D0   )(   "3    E0   )8   "6    E@   )8   "6
MEP   )<   "7!P  F T  )D3  ":'P  FBT  )H_  ":4@  FF@  )F#  "9
MGP  F+H  )?B  "6^ !MB@  7XT  %"0  !!DP  ,Y8  "27   6F   #9D
M  &;    G0   )\   "A    I    *4   "D    I0   *4   "F    IP
M *@   "I    J@0  *P,  "N$P  KB$  *XS  "N1P  KET  *YV  "NDP
MKJX  *W-  "L[P!AD0  4Y4  $28   UG   )I\  !>A   -HP   *4   "G
M    J@   *P   "P    L@   +0   "S    M    +4   "W    N    +D
M  "[    O0   +\!  ##"P  Q14  ,4E  #&.0  QT\  ,=H  #&A0  QJ(
M ,:\  #&W@!5F0  1YT  #BB   II@  &:@   VK    K0   +$   "T
MMP   +H   "_    P0   ,0   ##    Q0   ,8   #(    R@   ,T   #/
M    T@   -8   #;    X P  .$8  #C*P  Y$$  .5:  #F=   YI$  .6L
M  #EQ #_    _P   /\   #_  $ _P * /\ $@#_ !T _P H /\ - #_ #X
M_0!( /H 4 #W %< ]0!= /0 8P#R &D \ !O .\ = #M 'L ZP"! .D B0#H
M )( Y@"< .0 J #B +< WP#- -P [@#9 /\ V0#_ ,H _P"^ /\ M0#_ +
M_P#_    _P   /\   #_    _P & /\ #P#\ !@ ^  C /0 +@#P #@ ZP!"
M .@ 2@#E %$ X@!8 .  70#> &, W !H -D ;@#6 '0 U ![ -$ @@#/ (L
MS0"5 ,H H0#( *\ Q0#! ,( XP#  /L P #_ +L _P"P /\ J #_ *0 _P#_
M    _P   /\   #[    \P ! .T # #H !, XP > .  * #: #( TP \ ,\
M1 #, $L R0!1 ,8 5P#$ %T P@!B ,$ 9P"_ &T O0!T +L >P"Y (0 MP".
M +0 F0"R *< KP"W *T T "K /( J@#_ *D _P"A /\ FP#_ )< _P#_
M_P   /0   #I    X    -4 " #. !  R0 8 ,4 (@#! "L O  U +D /0"V
M $4 LP!+ +$ 40"O %8 K@!; *P 80"J &8 J0!M *8 = "D 'P H@"& *
MD@"> )\ G "N )D PP"7 .< E@#_ )4 _P"2 /\ C0#_ (H _P#\    \
M .,   #4    R    +\  P"Y  T LP 3 *\ ' "L "4 J0 N *4 -@"C #X
MH !$ )X 2@"= %  FP!5 )D 6@"7 %\ E@!F )0 ; "2 '4 D !^ (X B@"+
M )< B0"F (< N "% -8 A #V (( _P"! /\ ?@#_ 'P _P#M    W0   ,P
M  #!    N    *X   "G  D H@ 0 )X %P": !\ EP G )0 +P"1 #< CP ]
M (T 0P"+ $D B0!. (@ 4P"& %D A !? (( 90"  &T ?@!W 'P @@!Z (\
M> "> '4 KP!S ,< <@#L '$ _P!P /\ < #_ &X _P#=    R0   +P   "Q
M    J0   *$   "9  , DP , (X $@"* !D AP A (0 *0"! #  ?P W 'T
M/0![ $( >0!( '@ 30!V %( = !8 '( 7P!Q &< ;P!P &P >P!J (@ : "7
M &8 J !E +P 8P#A &( ^@!A /\ 80#_ &$ _P#- 0  O 4  *\%  "E @
MG    )0   "-    A@ ( ($ #@!\ !0 >  ; '4 (P!R "D <  P &X -@!M
M #P :P!! &D 1P!H $P 9@!2 &0 60!C &  80!I %\ = != ($ 6P"0 %D
MH0!7 +0 5@#0 %4 \@!5 /\ 5 #_ %4 _P#!#   L@X  *8/  ";#@  D@L
M (D%  ""    >P " '4 "P!P !  ;  6 &@ '0!F ", 8P J &$ , !@ #8
M7@ [ %T 00!; $8 6@!, %@ 4P!6 %L 5 !D %( ;@!1 'L 3P"* $T FP!,
M *X 2P#& $H Z@!) /X 20#_ $D _P"Y$@  JA8  )X7  "4%@  BA,  ($0
M  !Y"P  <0,  &L !@!E  T 80 1 %T & !: !X 6  D %8 *@!4 #  4P V
M %$ .P!0 $$ 3@!' $T 3@!+ %8 20!? $< :0!& '8 1 "% $, EP!! *D
M0 "_ #\ X@ _ /@ /@#_ #\ _P"R&0  I!X  )@?  ".'P  A!P  'H8  !R
M$@  :@X  &((  !< 0@ 5P . %, $P!0 !D 3@ ? $P )0!* "L 2  P $<
M-@!& #P 1 !" $, 20!! %$ /P!: #X 90 \ '( .@"! #D DP X *4 -@"Z
M #8 VP U /0 -0#_ #4 _P"L(   GR0  )0F  "))@  ?R0  '4@  !L&P
M9!4  %P0  !4# $ 3@8* $H"#P!' !0 1  : $( ( !  "4 /P K #X!,0 \
M 3< .P(^ #D"10 X TT -@-6 #4$80 S!&X ,05^ # %D  O!:, +0:X "P&
MU  L!_  + C_ "P(_P"H)0  FRH  ) L  "&+0  >RL  '(G  !H(@  7QT
M %<7  !/$@  2 X$ $$*"P ^!Q  .P85 #D'&P X!R$ -@@F #4(+  S"#(
M,@DY #$)00 O"4D +@I3 "P*7@ K"VP *0M\ "@,CP F#*( )0RW "0,TP C
M#?  ) W_ "4-_P"D*@  F"\  (TR  "#,@  >3$  &\N  !E*0  7"0  %,?
M  !+&0  0Q,  #P0!@ U#0P ,PP1 #$,%@ O#!P +@TB "T-*  K#2X *@TU
M "D-/0 G#D8 )@Y0 "0.7  C#VH (@][ " 0C@ ?$*( '1"W !P0U  =$?(
M'1'_ !X1_P"A+P  E3,  (HV  " -P  =C8  &TS  !C+P  62H  % E  !(
M(   /QH  #@5   P$0@ +! . "H0$@ H$!@ )Q > "40)  D$"H (Q$R "(1
M.@ A$4, (!). !X26@ =$V@ &Q-X !H3BP 8%*  %Q2U !84T0 6%?$ %Q7_
M !@4_P">,P  DS<  (@Z  !^.P  =#L  &LX  !A-   5R\  $XK  !%)@
M/2$  #0<   M%P4 )A,, ",3$  B$Q4 (!,: !\3(0 >%"< '10O !P5-P ;
M%4$ &A9+ !D65P 7%V4 %A=V !08B0 3&)X $ABS !$9S@ 1&>\ $AG_ !,9
M_P"<-@  D3L  (8^  !\/P  <S\  &D]  !?.0  534  $PP  !#+   .B<
M #(B   J'@$ (AD) !X7#@ <%Q( &A<7 !D8'@ 9&"0 &!DL !<9-  6&CX
M%1I) !,;50 2&V, $1QT ! <AP /'9P #AVQ  T=RP -'>P #AW_  \=_P"9
M.@  CS\  (1"  ![1   <4,  &A"  !>/@  4SH  $HV  !!,@  .2T  #$I
M   H)0  (" & !H=#  7'!  %1P5 !0=&P 4'2( $QTI !(>,@ 1'SP $!]&
M ! @4P .(&$ #2%Q  PAA0 +(ID "B*N  DBQP )(N< "B+[  LA_P"7/@
MC$,  (-&  !Y2   <$@  &=&  !<1   4C\  $D[  ! .   .#0  "\P   G
M+   'B<# !8C"@ 2(0X $2$3 ! B&0 0(B  #R(G  XC+P -)#D #"1$  LE
M4  *)5X "29O  <F@@ &)I8 !":L  ,FQ  $)N4 !";W  8F_P"50@  BD<
M (%*  !X3   ;TP  &5+  !;2   4$0  $=!   _/@  -SL  "TV   D,0
M&RT  !,J!P /* T #2<1  TH%@ ,*!T "R@E  HI+0 )*3< !RI"  8J3@ $
M*UP  RML  $K?P  *Y0  "NI   KP0  *^,  "OV   J_P"21@  B$L  ']/
M  !V40  ;5$  &-0  !:30  3TH  $='   ^1   ,T   "D\   @.   %S0
M !$Q!0 ,+PP "2X0  <N%0 &+QL !2\C  ,O*P ",#4  # _   P3   ,5D
M #%I   Q?   ,9$  #&G   POP  ,.$  ##U   O_P"02P  AE   'U4  !U
M5@  :U8  &)5  !84P  3E   $5-   Z20  +T4  "5"   </@  %#L   XY
M!0 )-PL !#8/  $V$P  -AD  #8@   V*0  -C(  #<]   W20  -U<  #=G
M   W>0  -X\  #:E   VO0  -N   #7U   U_P"-4   A%8  'Q:  !R6P
M:5L  &!;  !760  3%8  $!2   U3@  *DL  "!(   71@  $$,   M!!  $
M0 H  #\.   ^$0  /A8  #X=   ^)@  /B\  #XZ   ^1@  /E0  #YD   ^
M=@  /8P  #VC   \NP  /-X  #OU   [_P"*5P  @EP  'E?  !P80  :&$
M %]A  !47@  1UL  #I7   O50  )5(  !M0   230  #$L   9* P  20D
M $@-  !'$   1Q0  $8:  !&(@  1BP  $8W  !&0P  1E$  $9@  !%<P
M18D  $2@  !$N   0]P  $+U  !"_P"(70  ?V(  '=E  !N9P  9V@  %MF
M  !.8P  06$  #1>   I7   'UH  !57   .5@  !U0   !3 0  4@8  %$+
M  !1#@  4!$  $\6  !/'@  3R<  $\R  !//P  3TT  $Y=  !.;P  3H4
M $V=  !,M0  2]@  $KU  !*_P"%90  ?&D  '1L  !M;@  8FT  %1K  !'
M:0  .F<  "UE   B9   &&(  !!@   )7P   %X   !>    70,  %P(  !;
M#   6@\  %H3  !9&0  62(  %DM  !9.@  64@  %A8  !8:P  5X$  %>9
M  !6L@  5=(  %3T  !3_P"!;   >7   '-S  !H<P  6G(  $QQ   _<
M,F\  "5N   :;   $6L   EJ    :@   &D   !I    :    &<#  !F"
M9@P  &8/  !E%   91P  &4G  !D-   9$,  &13  !D90  8WL  &*4  !A
MK0  8,T  %_Q  !>_P!]=   =W<  &YY  !?>0  47D  $-Y   V>   *7@
M !QW   1=@  "G4   !U    =0   '8   !U    =    '0   !S @  <P<
M ',,  !R$   <A4  '(@  !R+   <CL  '%,  !Q7P  <70  '".  !OJ
M;L8  &SM  !K_P![>P  <GX  &1^  !5?P  1X   #F!   K@@  'H$  !*!
M   *@0   ($   ""    @P   (,   "#    @@   ((   ""    @@   ((%
M  """@  @@\  ((7  ""(P  @C(  ()#  "!5@  @6P  ("&  !_H0  ?KT
M 'WF  !\_ !V@@  :(,  %F%  !+AP  /(D  "Z*   @BP  $XL   J+
MC    (T   "/    D0   )(   "1    D0   )$   "1    D0   )(   "2
M @  DPD  )0/  "4&0  E"<  )0X  "43   DV(  )-\  "3F   DK,  )'8
M  "0]@!JB   7(H  $V-   _D   ,)(  "&4   4E0  "I8   "7    F0
M )L   "=    GP   *    "@    H    *    "A    H@   *,   "D
MI0   *8'  "H$   J!P  *@M  "I0   J58  *EO  "IBP  J*@  *?'  "F
M[ !?CP  4)(  $&6   SF0  (YP  !2=   *GP   *$   "C    I@   *@
M  "L    K@   *\   "O    L    +    "R    LP   +0   "V    MP
M +H   "]!P  OQ   +\?  # ,P  P$D  ,!B  # ?@  P)L  ,"W  "_V !3
MEP  1)L  #6?   FHP  %J4   NG    J@   *T   "P    LP   +8   "[
M    O0   ,    "_    P0   ,(   #$    Q@   ,@   #*    S    ,\
M  #3    V@<  -L3  #=)0  WCL  -]3  #@;@  WXP  -VI  #=P@#_
M_P   /\   #_    _P ' /\ $ #_ !D _P D /\ +P#\ #H ^0!# /4 2P#S
M %( \0!9 .\ 7@#M &0 ZP!I .D ;P#G '4 Y@!\ .0 A #B (T X "7 -T
MH@#: +$ U0#% -( Z #0 /\ SP#_ ,0 _P"X /\ KP#_ *D _P#_    _P
M /\   #_    _P " /L #0#W !4 \P ? .\ *0#J #0 Y@ ] .( 10#> $P
MVP!3 -@ 6 #4 %X T@!C -  :0#. &X S !U ,H ?0#( (4 Q@"0 ,( FP#
M *D O@"Z +L V0"Y /< N #_ +0 _P"I /\ H@#_ )T _P#_    _P   /\
M  #V    [@   .< "@#A !$ W  : -< (P#0 "X RP W ,< /P#$ $8 P0!-
M +\ 4@"] %@ NP!= +D 8@"X &@ M@!N +0 =0"Q 'X KP"( *T DP"J *$
MJ "Q *8 R "D .T H@#_ *( _P"; /\ E0#_ )$ _P#_    _    .X   #C
M    V    ,T !0#&  X P0 5 +T '@"Y "< M0 P +( . "O $  K !& *H
M3 "H %$ IP!6 *4 6P"C &$ H0!G )\ ;@"> '8 FP"  )D C "7 )D E "H
M )( O "0 -\ C@#[ (X _P"+ /\ A@#_ (, _P#X    Z0   -P   #,
MP0   +@   "R  H K  1 *@ & "E "$ H@ I )X ,@"< #D F0 _ )< 10"5
M $H E !0 )( 50"0 %H CP!@ (T 9P"+ &\ B0!X (8 A "$ )$ @@"@ (
ML@!] ,P ? #Q 'L _P!Z /\ =P#_ '4 _P#F    TP   ,8   "[    L0
M *<   "A  4 FP - )< $P"3 !L D  C (P *P"* #( B  X (8 /@"$ $0
M@@!) ($ 3@!_ %, ?0!9 'L 8 !Y &@ =P!Q '4 ? !S (D < "8 &\ J0!M
M +\ :P#F &H _P!I /\ :0#_ &< _P#3    PP   +4   "K    HP   )L
M  "2    C  * (< $ "# !8 ?P = 'T ) !Z "L >  R '8 . !T #T <@!"
M '$ 2 !O $T ;0!3 &P 60!J &$ : !J &8 = !D ($ 80"1 %\ H@!> +8
M7 #5 %L ]P!; /\ 6@#_ %H _P#%    M@(  *D"  "?    E@   (X   "'
M    @  % 'H # !U !$ <0 8 &X '@!K "4 :0 K &< ,0!F #< 9  \ &,
M00!A $< 7P!- %X 4P!< %L 6@!D %@ ;@!6 'L 5 "* %( FP!1 *X 4 #(
M $\ [@!. /\ 3@#_ $T _P"["@  K T  * -  "5#   C @  (,"  !\
M=0   &X " !I  X 90 3 &( &0!? !\ 70 E %L *P!9 #$ 6  V %8 .P!5
M $$ 4P!' %$ 3@!0 %4 3@!> $P : !* '4 2 "$ $< E0!% *@ 1 "_ $,
MY !" /P 0@#_ $( _P"R$0  I10  )D5  ".$P  A!$  'L-  !S"   ;
M &4  P!?  L 6P / %< % !4 !H 40 ? $\ )0!. "L 3  P $L -@!) #P
M2 !" $8 2 !% %  0P!9 $$ 8P _ &\ /@!^ #P D  [ *, .@"X #D V0 X
M /4 . #_ #@ _P"L%P  GQL  ),=  ")'   ?QD  '45  !L$   9 P  %T&
M  !6  8 40 , $T $ !* !4 1P : $4 ( !$ "8 0@ K $$ ,0 _ #8 /@ ]
M #P 1  [ $L .0!4 #< 7P V &L - !Z #( C  Q )X , "S "\ S@ O .\
M+@#_ "X _P"G'@  FB(  (\D  "$)   >B$  '$=  !G&   7Q,  %<.  !0
M"@  20,( $4 #0!! !$ /@ 6 #P &P Z "$ .0 F #< +  V #( -  X #,
M/P Q $< , !0 "X 6P M &< *P!V "H B  H )P )P"P "8 R0 E .H )0'[
M "4!_P"B(P  EB@  (LJ  "!*@  =R@  &TE  !D(   6QL  %(5  !+$
M0PP" #T'"0 Y PX -@$2 #,!%P Q 1P , $B "\")P M BT + ,T "H#.P I
M!$, * 1- "8%6  E!64 (P9T "(&A@ @!IH 'P>N !X'Q@ =!^< '0CX !T)
M_P"?*   DRT  (@O  !^+P  ="X  &HK  !A)@  6"$  $\<  !'%P  /Q(
M #@.!  Q"PH +@@. "L'$@ I!Q< * @= "<((P E""D ) DP ",)-P A"D
M( I* !\+50 ="V( &PQR !H,A0 8#)D %PRM !8,Q@ 5#>8 %0WY !8-_P"<
M+0  D#$  (8T  !\-   <C,  &@Q  !?+   52<  $PC  !$'0  /!@  #03
M   M$ 8 )@T+ "0,#P B#!, (0P9 !\,'P >#24 '0TL !L--  :#CT &0Y'
M !<.4P 6#F$ % ]Q !,0A  2$)@ $1"N ! 0Q@ 0$.@ $!#[ !$0_P"9,0
MCC4  (0X  !Z.0  <#@  &<V  !=,@  4RT  $HH  !")   .1\  #$:   J
M%0$ (Q$' !T0#0 ;#Q  &0\5 !@0&P 7$"$ %A I !40,0 4$3H $Q%% !(2
M40 1$E\ $!)O  X3@@ .$Y8 #1.K  L3P@ +%., #!3Z  T3_P"7-0  C#D
M ((\  !X/0  ;ST  &4Z  !;-P  4C(  $DN  ! *@  -R4  "\A   H'
M(!@# !D4"@ 5$@X %!(2 !,3&  2$Q\ $10F !$4+@ 0%#@ #Q5"  X63P -
M%EP #!=L  L7?P )&), "!BH  88OP '&.  !QCU  D8_P"5.   BCT  (!
M  !W00  ;4$  &0_  !:/   4#@  $<S   ^,   -BL  "XG   G(P  'Q\
M !<:"  2%PT $!<1  \7%@ .&!P #A@C  T9+  ,&C4 "QI   H;3  )&UH
M!QQI  4<?  $'9$  AVF  $=O  "'-T  ASR  ,<_P"3/   B$$  ']$  !U
M10  ;$4  &-$  !900  3ST  $8Y   ^-@  -3(  "XN   E*@  '24  !0A
M!  /'0L #1T0  P=%  +'1H "AXB  @>*@ ''S, !B ^  0@2@ #(5<  2%G
M   A>0  (8X  "&D   AN@  (=L  "'R   @_@"00   AD4  'U(  !T2@
M:TH  &))  !81@  3D(  $4_   ]/   -3D  "LT   B+P  &2L  !(H!  -
M) H "2,.  8C$@ %(QD !"0@  (D*  !)3$  "4\   E2   )E4  "9E   F
M=P  )HP  ":B   FN0  )MD  "7R   E_@".10  A$D  'M-  !S3P  :D\
M &!.  !72P  34@  $1%   \0@  ,3T  "<Y   >-0  %3(   \N P *+ H
M!2L.  $J$0  *A8  "H>   J)@  *R\  "LY   K10  +%,  "QB   L=0
M+(H  "N@   KMP  *]8  "KR   J_P",20  @DX  'I2  !Q5   :%0  %]3
M  !640  3$X  $-+   W1P  +4,  ",_   :/   $C@   PV P &,PD  #(-
M   R$   ,10  #$;   Q(P  ,2P  #(W   R0P  ,E   #)@   R<@  ,H<
M #&>   QM0  ,-0  ##R   O_P")3P  @%0  'A7  !O60  9ED  %Y9  !5
M5P  25,  #Y/   R3   *$@  !Y%   50@  #D    @] @ !/ @  #L,   Z
M#P  .1(  #D8   Y(   .2D  #DT   Y0   .4X  #E=   Y;P  .(4  #B<
M   WLP  -](  #;R   U_P"'50  ?UH  '9=  !M7P  95\  %U?  !27
M1%@  #A5   M4@  (D\  !A,   02@  "D@   -& 0  108  $0*  !##0
M0A   $$5  !!'0  028  $$Q  !!/0  04H  $%:  !!;   0($  #^9   _
ML0  /M   #WR   \_P"$7   ?&   '-C  !L90  9&8  %ED  !+80  /EX
M #);   F60  '%8  !)4   ,4@  !%$   !/    3@,  $T(  !,#   2PX
M $L2  !*&0  2B(  $HL  !*.0  2D<  $I6  !):   27X  $B6  !'KP
M1LT  $7Q  !$_P"!8P  >6<  ')J  !K;   8&L  %)I  !$9@  -V0  "IB
M   ?8   %5X   U=   &6P   %H   !9    6    %<$  !6"   5@P  %40
M  !4%   5!T  %0G  !4-   5$(  %-2  !39   4GD  %*2  !1JP  4,H
M $_O  !._P!^:@  =VX  '!Q  !F<0  6'   $IO   \;0  +VP  ")J   7
M:0  #F<   9F    90   &4   !E    8P   &(   !B!   80@  &$-  !@
M$   8!<  & A  !?+@  7SP  %]-  !>7@  7G0  %V-  !<IP  6\4  %KM
M  !9_P![<@  =78  &MW  !==@  3W8  $%U   S=0  )G0  !ES   0<@
M!W$   !Q    <0   '$   !Q    ;P   &\   !N    ;@(  &X(  !M#
M;1$  &T:  !M)@  ;#4  &Q&  !K6   :VT  &J&  !IH0  :+X  &?H  !F
M_@!Y>@  <'P  &%\  !3?0  1'T  #9^   H?@  &WT  !!]   '?0   'T
M  !]    ?@   '\   !^    ?0   'T   !\    ?    'P   !\!@  ? P
M 'P2  !\'0  ?"P  'P\  !\3P  >V4  'M^  !ZF@  >;8  'C?  !W^@!S
M@   98$  %:#  !(A   .88  "N'   =AP  $8<   >(    B    (D   "*
M    C    (T   "-    C    (P   ",    C    (P   "-    C00  (X,
M  ".$P  CR$  (XR  ".1@  CEL  (UT  "-D   C*T  (O.  "*\P!HA@
M6H@  $N+   \C0  +8\  !Z0   1D0  !Y(   "3    E0   )<   "9
MFP   )P   ";    FP   )P   "<    G0   )X   ">    GP   *$#  "B
M#   HA8  *,F  "C.@  HT\  *-H  "BA@  HJ(  *+   "AZ !<C0  39
M #^3   PE@  (9D  !*:   'FP   )T   "@    H@   *0   "H    J@
M *L   "J    JP   *P   "M    K@   *\   "Q    L@   +0   "W 0
MN0T  +D:  "Z+0  ND,  +I;  "Z=P  NY0  +NQ  "YT@!0E0  09@  #*<
M   CH   $Z(   BD    IP   *H   "L    KP   +(   "W    N0   +L
M  "Z    O    +T   "_    P    ,(   #$    Q@   ,D   #-    T@$
M -0/  #5'P  US4  -A-  #8:0  UX8  ->C  #6O0#_    _P   /\   #_
M    _P # /\ #0#_ !4 _P @ /P *P#X #4 ]  _ /  1P#N $X ZP!4 .D
M6@#G %\ Y0!D ., :@#A '  WP!V -T ?@#; (< V "1 -, G0#/ *L S0"]
M ,L X #) /L QP#_ +T _P"Q /\ J0#_ *, _P#_    _P   /\   #_
M_    /8 "P#Q !$ [0 ; .D )0#D #  WP Y -H 00#5 $@ T0!. ,\ 5 #-
M %D RP!> ,D 8P#' &D Q0!O ,, =P#  '\ O@"* +L E0"X *, M@"T +0
MS0"R /( L #_ *P _P"C /\ G #_ )< _P#_    _P   /H   #Q    Z
M .  !@#9  X T@ 6 ,X 'P#( "D Q  R ,  .@"] $$ N@!( +@ 30"V %,
MM !8 +( 70"P &( K@!I *P ;P"J '@ J "" *8 C@"D )L H0"K )\ P "=
M .8 FP#_ )H _P"4 /\ C@#_ (H _P#_    ]@   .@   #<    S@   ,8
M 0"_  L N@ 1 +8 &@"R "( K@ K *H - "H #L I0!! *, 1P"A $P GP!1
M )X 5@"< %P F@!B )D : "7 '  E0!Z )( A@"0 ), C0"B (L M0") -,
MAP#W (8 _P"$ /\ ?P#_ 'P _P#R    XP   -(   #%    N@   +$   "K
M  < I0 . *$ % "> !P F@ E )< +0"4 #0 D@ Z )  0 ". $4 C0!* (L
M4 ") %4 B !; (8 80"$ &D @@!R '\ ?0!] (L >P": '@ JP!V ,0 = #K
M ', _P!S /\ < #_ &X _P#?    S    +\   "T    JP   *$   ":  (
ME  + )  $ ", !< B  > (4 )@"# "T @0 S '\ .0!] #\ >P!$ 'D 20!X
M $X =@!4 '0 6@!S &( < !K &X =0!L (, :@"2 &@ HP!F +@ 9 #> &,
M^P!B /\ 8@#_ &  _P#,    O    *\   "E    G0   )0   ",    A@ '
M ($ #0!\ !( >  9 '4 'P!S "8 <0 M &\ ,@!M #@ :P ] &H 0@!H $@
M9P!. &4 5 !C %L 80!D %\ ;@!= 'L 6P"* %D FP!7 *\ 5@#+ %4 \@!4
M /\ 5 #_ %0 _P"^    L    *0   "9    D    (@   "!    >0 " ',
M"@!O  \ :P 4 &< &@!E "  8P F &$ + !? #( 7@ W %P / !; $( 60!'
M %< 3@!6 %4 5 !> %( : !0 '0 3@"# $P E0!* *@ 20#  $@ Z !' /\
M1P#_ $< _P"T"0  I@L  )L,  "0"@  A@4  'X   !V    ;P   &@ !0!C
M  P 7P 0 %L %0!8 !H 5@ A %0 )@!3 "P 40 Q %  -@!. #P 30!" $L
M2 !) %  2 !8 $8 8@!$ &X 0@!] $  C@ _ *( /0"X #T W0 \ /@ / #_
M #P _P"L$   GQ(  )02  ")$0  ?P\  '8,  !N!0  9@   &   0!9  @
M50 - %$ $0!. !8 2P ; $D (0!( "8 1@ K $4 ,0!# #8 0@ \ $  0P ^
M $L /0!3 #L 70 Y &D -P!X #8 B0 T )P ,P"Q #( S@ R /$ ,0#_ #$
M_P"F%@  FAD  (X:  "$&@  >A8  ' 2  !H#@  7PH  %@#  !1  0 3  *
M $@ #@!$ !( 00 6 #\ &P ] "$ /  F #H +  Y #$ -P W #8 /@ T $8
M,P!/ #$ 60 O &4 +@!S "P A0 K )@ *@"M "D Q@ H .H * #^ "@ _P"A
M'   E2   (HA  !_(0  =1\  &P:  !C%@  6A$  %(-  !+!P  1  & $
M"P \  \ .  2 #8 %P T !P ,P A #$ )P P "P +@ S "T .@ K $( *@!+
M "@ 50 F &$ )0!P "0 @0 B )4 (0"I "  P0 @ .0 'P#Y !\ _P"=(@
MD28  (8H  !\)P  <B4  &DB  !?'0  5Q@  $X3  !&#@  /PL  #@%!P T
M  P ,0 0 "X $P L !@ *@ = "D (@ G "@ )@ N "0 -@ C #X (@!' "
M4@ ? %X '0!M !P ?@ : )( &0"G !@ O0 7 -\ %P'U !<"_P":)P  CBL
M (0M  !Y+0  <"L  &8H  !=)   5!\  $L:  !#%   .Q   #0- @ M"0D
M*04- "8#$  D 1, (@(9 "$"'@ @ B0 '@,J !T#,@ ;!#H &@5$ !D%3P 7
M!EP %@9J !0'?  3!Y  $@>E !$'NP 0!]L $ CR ! )_P"7*P  C"\  ($Q
M  !W,@  ;C$  &0N  !;*@  424  $D@  ! &P  .!8  #$2   I#@0 (PP)
M !\)#0 =!Q  &P<5 !D(&@ 8""  %PDG !8)+@ 5"C< $PI! !(+30 1"UH
M$ MI  X,>P .#)  #0RE  P-NP +#=D "PWQ  P-_P"5+P  BC,  '\V  !V
M-@  ;#4  &,S  !9+P  4"L  $<F   ^(0  -AT  "X8   G$P  (! % !D.
M"@ 5# X % P1 !,,%@ 2#!P $0TC ! -*P /#30 #@X_  T.2@ ,#U@ "P]G
M  H0>0 ($(T !Q"B  80N  %$-0 !1#O  80_P"2,P  B#<  'XZ  !T.P
M:SH  &$X  !8-0  3C   $4L   ])P  -2,  "T?   F&@  'A8! !<3!@ 1
M$ L #@X.  X/$P -$!D #1 @  P0*  +$3( "A$\  @22  '$E4 !A-E  03
M=@ #$XL  12@   3M@  $]$  !/N   3^P"0-@  ACL  'P^  !S/P  :C\
M & ]  !7.0  338  $0Q   \+@  -"H  "PF   E(@  'AX  !8: @ 0%0D
M#!,.  H3$@ )%!< "!0?  <5)@ &%2\ !!8Z  ,61@ !%U,  !=B   8=
M&(D  !B?   8M0  %]   !?M   7^P"..@  A#\  'M"  !R0P  :$,  %]"
M  !6/P  3#L  $,W   [-   ,S   "PL   D*0  &R0  !,? @ -&PD "1D-
M  89$0 $&18  AD=  $:)   &BT  !LX   ;1   '%$  !Q@   =<@  '8<
M !R=   <LP  ',X  !OM   ;_ ",/@  @D,  'E&  !P2   :$@  %Y&  !5
M1   2T   $,]   [.@  ,S<  "HR   @+0  %RD  ! E @ +(@D !2 -  $?
M$   'Q0  !\;   @(@  ("L  "$V   A00  (4\  "%>   B<   (H4  "&;
M   AL@  (<T  "#M   ?_ "*0P  @$@  'A+  !O3   9DT  %U+  !420
M2D8  $)#   Z0   +SL  "4W   <,P  $R\   TL @ '*0@  2<,   F#@
M)1(  "89   F(0  )BD  "8S   G/P  )TT  "=<   G;0  )X(  ">9   F
ML   )<P  "7N   D_0"(2   ?TP  '90  !N40  95(  %Q1  !33P  2DP
M $%)   U1   *T   "$\   7.0  $#8   HR 0 #, <  "\+   N#@  +1$
M "T6   M'@  +2<  "TQ   M/0  +4H  "U9   M:P  +8   "R7   LKP
M*\L  "KN   J_@"%30  ?5(  '55  !L5P  8U<  %M6  !350  1U$  #M-
M   P20  )48  !Q#   3/P  #3T   8Z    . 4  #<)   V#0  -0\  #04
M   T&P  -"0  #0N   T.@  -$<  #17   T:   -'T  #.5   RK0  ,<H
M #'N   P_P"#4P  >U@  '-;  !J70  8ET  %M=  !/6@  0E8  #92   J
M3P  ($P  !9)   .1P  "$0   !"    00,  #\'   ^"P  /0X  #T1   \
M&   /"$  #PK   \-P  /$0  #Q3   \90  .WH  #J2   ZJP  .<@  #CM
M   W_P"!6@  >5X  '%A  !I8P  8F0  %=B  !)7@  /%L  "]8   D50
M&5,  !!1   *3P   4T   !,    2@   $D$  !("   1PP  $8/  !&%
M11P  $4G  !%,P  14   $50  !$80  1'8  $./  !"J   0<8  $#L   _
M_P!^80  =F4  &]H  !H:@  76D  $]F  !"9   -&$  "A?   =70  $EL
M  M9   "6    %8   !6    5    %,   !2!   40D  % -  !0$   3Q@
M $\B  !/+@  3SP  $]+  !.70  3G(  $V+  !,I0  2\(  $GJ  !(_P![
M:0  =&P  &YO  !D;P  56T  $=L   Y:@  +&D  "!G   490  #60   -B
M    8@   &$   !@    7P   %X   !=    7 0  %P)  !;#0  6Q(  %L<
M  !:*   6C8  %I&  !96   66T  %B%  !7H   5KT  %7H  !3_@!Y<
M<W0  &EU  !;=   3',  #YS   P<@  (W$  !9O   -;@  !&T   !M
M;0   &T   !L    :P   &H   !I    :0   &D#  !H"0  : X  &@5  !G
M(0  9R\  &<_  !F4@  9F8  &5_  !DF@  8[<  &+A  !A_ !W>   ;7H
M %]Z  !0>@  0GH  #-[   E>P  &'H   YY   $>0   'D   !Y    >@
M 'H   !Z    >    '@   !W    =P   '<   !W 0  =P@  '<.  !W&
M=R8  '8V  !V20  =5\  '5W  !TDP  <Z\  '+3  !Q]P!Q?@  8W\  %2
M  !%@@  -H,  "B$   :A   #H,   2$    A    (4   "&    B    (D
M  "(    AP   (<   "'    AP   (<   "(    B    (@'  ")$   B1P
M (DL  "(/P  B%4  (AM  "'B0  AJ<  (7'  "$[P!FA   5X8  $B(   Y
MB@  *HP  !N-   /C0  !(X   "0    D0   ),   "5    EP   )@   "6
M    EP   )<   "7    F    )@   "9    F@   )L   "=!P  G1$  )TA
M  "=,P  G4D  )QB  "<?P  G)P  )RY  ";X@!:BP  2XX  #R1   MDP
M'I4  !"6   $F    )H   "<    G@   *$   "D    I@   *<   "F
MIP   *<   "H    J0   *H   "L    K0   *\   "Q    LPD  +,5  "T
M)P  M#T  +55  "U<   M(X  +2L  "TS !-D@  /Y8  "^:   @G0  $9\
M  6A    HP   *8   "I    K    *\   "S    M0   +<   "V    MP
M +@   "Z    NP   +T   "_    P0   ,0   #'    RP   ,T,  #.&@
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M_____________________________________________________P
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M]/7V]_CY^OO\_?[_;69T,0     # 2$   $                    !
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M________^X Q        "6',____________________________TEH"
M     %W,____________________________J#4          %S3________
M____________________?0T          %36________________________
M___N?44          $34___________________________\JF0O @  !"(W
M25C.____________________________Z:1K02@_8W^5I[K:____________
M___________________5LJRRS.3Z________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___ENY=W8LC_________________________________VYYG-@H  HS_____
M___________________________(?S\%     %[/____________________
M_________]F!.0       #RJ_____________________________YY,
M     ".0____________________________W&\:         !!]^?______
M____________________KT@           !O[O______________________
M____A!,           !DYO_________________________L40
M  !7WO________________________^X%0            !(UO__________
M______________]T%              XS_________________________FB
M6A,            CQ?_________________________?FUPL           -
MNO__________________________[[%]53DB$0<! A$BLO______________
M________________W[^EF9B:H*R]VO______________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________X[Z=@'S[____________________
M____________\K>$5S . !VL_______________________________2BDP5
M      !R\____________________________]9_-@        !+R?______
M____________________^I$^           OJ_______________________
M____P%H            :E?__________________________C20
M   (A/_________________________G7@              =___________
M______________^T)0              :O________________________]]
M                6_3_______________________TK
M3.O______________________Z4                 /.'_____________
M_________S ,                +=G_____________________F8IA)P
M            )]?______________________^V^B54G            )=S_
M_________________________LJ==EU*/#(M+# Y1][_________________
M______________WFW=;2T-/9Y/__________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___OU+O6_________________________________^>XCVI++Q5O________
M_______________________DH6<T!P     \R?______________________
M_____]:".P         2E___________________________[84Q
M    ;___________________________ID(             4.'_________
M_______________L:0              -\G_______________________^S
M+P              (K;_______________________]Y
M$*?_______________________(T                 )G_____________
M_________ZD                  (S______________________T8
M             '______________________WP                   '3_
M____________________EP                   &K_________________
M____S@                   &/______________________RDB 0
M         &'______________________[FC@%<W%P           &C_____
M______________________K3KI2&?'5Q<')W@93_____________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________V[J=@FEIT_______________________________R)-E/1D
M   =GO___________________________]N.3!,         ;O__________
M________________VWPL            1=?_________________________
MBRH             (K3________________________"1
M Y?_______________________]] 0               '______________
M_________^<V                 &K______________________YT
M             %C______________________T8                  $?X
M____________________Z0                   #7I________________
M____E@                   "7;____________________O
M         !C.____________________ZP                    _"____
M_________________P                    JY____________________
M_R<                   JU_____________________W
M      VY_____________________^"<C'!50C,F&Q0/#0X2&B:_________
M____________________^>38TL[,R\S/UN#\________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________Z].\X___________
M_____________________]*IA65(+!(!A?__________________________
M__&K<3P/        3^#_________________________U7\U
M'[+________________________C=1T              (G_____________
M__________^0(P               &?______________________]5#
M             $CV_____________________XH                  "[=
M_____________________S@                  !?(________________
M____O@                    2V____________________G
M          "E____________________N@                    "3____
M________________W                     ""____________________
M_P                    !T_____________________Q,
M      !H_____________________T(                   !@________
M_____________WH                   !=_____________________]$
M                  !A______________________\D
M  !F_______________________)K)F)?79Q;&EG9F=K<'J,____________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________XL6JD7EA
M=______________________________=IG=0+ P     ,<3_____________
M____________X)).$P           (_________________________2<!T
M             &#______________________^YO#P               #?B
M_____________________Y8<                 !3 ________________
M_____T                    "C____________________K@
M          ")____________________G@                    !R____
M________________O                     !?____________________
MV@                    !-____________________^@
M       [_____________________PX                    J^?______
M_____________S,                    ;Z?___________________UX
M                   /V____________________X\
M   &T/___________________]                      RO__________
M__________\K                    R/____________________^
M                R______________________W%@$%!0,!       !!@T8
MR________________________.OAV,_,S<_0TM37W.+J________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________________':QO______________________________
M\<:CA&A-,A@ %:O__________________________[E\1A@          ''_
M_______________________7?"\              #OC________________
M_____]]D"0                RU_____________________W0#
M          "-____________________Q14                   !J____
M________________F0                    !+____________________
MM@                     P_?__________________UP
M       9Y___________________]@                     %T_______
M_____________PX                     P?___________________R\
M                    K____________________U(
M    GO___________________WD                     CO__________
M_________Z4                     @/___________________]@
M                =/____________________\V
M;?____________________]\                    :?______________
M_______7#0                  :/______________________<
M            8?_______________________U \1DY465UA9&AL<'9^B?__
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________[]6[HXMS6I7_________________
M__________B_CF1!(04      %+\_______________________WG588
M         !?!_____________________^5L%@                "-____
M_________________V,                   !>____________________
MG0                     U_/__________________H0
M       1V?__________________R@                      N_______
M____________[@                      H?___________________PP
M                    BO___________________RT
M    =O___________________TT                     9/__________
M_________V\                     4O___________________Y0
M                0/___________________[P
M,/___________________^H.                    (O______________
M______]$                    %?____________________^!
M            "_7____________________("P                   NS_
M____________________7@                   .7_________________
M____R1P                  -K______________________YT!
M      <.%\7________________________5N;S!Q\[5V^'F[?3[________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______XW\______________________________[,:EB&U4.R$' #+>____
M____________________UY)9*0            "@____________________
M__^)-@                !G_____________________V8
M       R]O__________________E0                     #R/______
M____________IP                      H/__________________UP
M                    ?/___________________P
M    7O___________________R4                     0___________
M_________T@                     +/___________________VH
M                &/___________________XL
M!?/__________________Z\                      .'_____________
M_____]4                      ,____________________\D
M             +[___________________]4                     *[_
M__________________^+                     )__________________
M___+#@                   )+_____________________5P
M         (;_____________________J@H                  'G_____
M_________________VT                  &;_____________________
M__=5                 $7_________________________:B,K-3]*56!J
M=7Z'D9S_____________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________^C/MIV#:4ZY_________________________^RR@UPZ'0(
M      ![_______________________%;2D               ! ________
M_____________X,;                   'R___________________D@
M                    F/__________________I
M    :O__________________W0                      0?__________
M_________PX                     '?___________________SD
M                 .C__________________V
M ,[__________________X4                      +?_____________
M_____Z@                      */__________________\L
M             )#__________________^\6                     'W_
M__________________\^                     &S_________________
M__]I                     %K___________________^9
M         $G____________________2%@                   #G_____
M________________6                    "G_____________________
MH@                   !G_____________________]58
M      3______________________[LO                  #X________
M______________^K*0                #/________________________
MR4<     !Q,@+CY2:(3M________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________________________]-7)________
M____________________^M*PDG==0B@,  !*________________________
MQ7U%%P             1V/___________________\10
M    G___________________H@P                     :/__________
M________E                       -O__________________V@
M                !^S__________________Q4
M ,3__________________T@                      *+_____________
M_____W4                      (/__________________YT
M             &G__________________\,                      %+_
M_________________^</                     #[_________________
M__\S                     "O___________________]8
M         !C___________________^!                      7_____
M______________^L                      #____________________>
M(@                    #R____________________7
M      #?____________________GP                    #,________
M____________Z$H                   "W_____________________Z 6
M                  "<______________________]Z @
M  !W________________________>@L               5,____________
M_____________Z)7:'2 C9RKO-#G________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_^WC___________________________2HWI8.BDC'!8.!@  G___________
M__________^L4@X                 :?__________________Y$,
M                -/__________________>0
M ./_________________S0                       ++_____________
M_____Q,                      (7__________________T\
M             %W__________________X,                      #K_
M_________________[(                      !S_________________
M_]L#                      +___________________\J
M          #[__________________]/                      #G____
M______________]T                      #4__________________^;
M                      # ___________________$!P
M      "M___________________P,P                    ":________
M____________9P                    "&____________________HP
M                  !R____________________XT0
M  !<_____________________Y$&                  !!____________
M_________^M?                   =_______________________*2P
M                ________________________RU<   P8)#$_3F!TBZ?'
M___________________________7Y_+_____________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________________KU,W'PKZZM[.PK:FH
MI?___________________]U^4S\P(QD1"0(          -O_____________
M____=@                       *?_________________N@
M             '7__________________P<                      $;_
M_________________TX                      !K_________________
M_XP                       #]_________________\$
M          #;__________________$9                      "^____
M______________]$                      "D__________________]K
M                      "-__________________^1
M      !Y__________________^W                      !F________
M___________>(0                    !3____________________2@
M                   _____________________=P
M   K____________________K H                    6____________
M________YT4                     _____________________XH
M                _____________________]9-
M_?____________________^G+@                  U?______________
M________F"H           88+45@X/_______________________ZAC=(&/
MG*N[S>+Z____________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________GR[>IG96.B82 ?'AT<&QH99#_
M________________O&I(+1D*                 #'_________________
M_P                        /__________________T(
M          #<_________________XX                       "R____
M_____________\X                       "-__________________\I
M                      !K__________________]:
M      !.__________________^&                       T________
M__________^N                       >___________________4%P
M                   *___________________Z/0
M    ____________________90                      ____________
M________C@                      ____________________O!D
M                [___________________\4X
MV/___________________XL                     O_______________
M_____\Q#                    H?____________________^1&0
M            >O_____________________R= H                17___
M____________________Z'03'RPX15-B<H6;M-+U____________________
M_______7Z/3_________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________________________________________________OW
M\_'N[.OK[/'__________________]FRF8=Y;61=5E%+1D$\.#(M*"/$____
M_____________TLE"P                    "2_________________X@
M                      !F_________________]<
M       ]__________________\S                       8________
M__________]L                        __________________^=
M                    ___________________)#
M    ]O_________________Q-0                      W___________
M________6P                      R___________________@@
M                M___________________J08
MH___________________TR\                     C?______________
M_____UX                     =____________________Y,'
M            7O___________________\U#                    0/__
M__________________^'$                   '/__________________
M___87@                   /______________________OTX       X<
M+#Y2:H:ER/_______________________\)\C)JGML76Z/W_____________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________________________________^[AU\_)P[ZZMK&M
MJ:>FIJ>N_________________[Z&;5M,0#<O*"(<%A +!      4________
M_________]<%                        __________________\T
M                    ]O________________]V
M    TO________________^P                        LO__________
M_______A)                       EO__________________40
M                ?/__________________>0
M9O__________________H                       4?______________
M____QR,                     //__________________[DL
M            )____________________W0                     $/__
M_________________Z,6                     /__________________
M_]A,                     /____________________^(#P
M         /_____________________+4P                   /______
M________________I3@           D=-$YKC/______________________
M_YDY0U%?;GV.H+7+Y?_____________________________K^?__________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________________________KS+FLH9F1BX:!?'AT<&MH
M9F9H\?________________]A13(C& X&                GO__________
M______]^                        =?_________________#
M                4O_________________[-P
M,O__________________:@                      %O______________
M____E@                       /__________________OQL
M             /__________________YD(                      /__
M_________________VD                      /__________________
M_Y "                     /___________________[DL
M         /3__________________^A<                     -G_____
M______________^1&                    +S____________________*
M4P                   )W_____________________F"X
M$"E&9L3_____________________[G\=#!HH-T97:7Z5K\SN____________
M_____________^>@JKG(V.G\____________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________________________________________________________?7P
MZ^;BW]O8U-+1T-+7X/_________________.GHI\<6EA6U913$A#/CHV,B\N
M,?_________________2)1$#                     /______________
M____0@                       /__________________?0
M             /__________________L L                      /;_
M________________W3D                      -S_________________
M_V(                      ,7__________________XD
M         *___________________Z\B                     )G_____
M_____________]9(                     (+___________________]R
M                     &G___________________^A*
M     $[____________________37                    #/_________
M____________EBX              !4R4G?_____________________X'(3
M   !#Q\O0EAPBZC([/_______________________\IO;GZ.GK##V.______
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________________________^>#2R,"ZM;"L
MJ*6BGYV;FYR@I___________________@F162T,\-C K)R(=&!,."00  -3_
M________________D@                       *W_________________
MS!X                      (O_________________^U(
M         &W__________________X                       %'_____
M_____________ZD;                     #K__________________]!"
M                     "/___________________5H
M      S___________________^/%                     #_________
M__________^X/@                    #____________________E;0,
M                  #_____________________GS<              ! O
M4'3_____________________W7(4      87*D%:=92VVO______________
M_________[Q81%1D=8::K\CC_______________________________2S>'Q
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________\^_K[_?______________________[KFHG9:/BH:"?WMX
M=G1R<W5X?Y#_________________ZT\Z,"@A&Q40"P<"         "/_____
M_____________VD                       #__________________YL*
M                      #__________________\@Y
M      #___________________!C                      #_________
M__________^*#@                    #___________________^P-
M                  #____________________56P
M  #_____________________A1H                   /L____________
M________L4D              !@Y78'_____________________Y7L>
M   ,(3A2;X^SV?_______________________[M8*3E)6FR E[#-[?______
M______________________^SGK3%U^O_____________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________________________________Z
M[^?AW-G6U-+0T-#1T]G@Z_?__________________[B*?G=Q;&AD85Y;65A7
M5UE>97'__________________[\Q'Q80"@4               #_________
M_________^U6                      #H__________________^"!
M                  #,__________________^K+P
M  "S___________________25P                    ";____________
M_______W?!                    "%____________________HC<
M            !2N4____________________RV$"            #"Q0=I[1
M____________________]8TP       -(SM7=IF^Y?__________________
M_____\-C&"H[3%]TC:?&Y_____________________________^H?Y:HN]#G
M_____________________________________?______________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________________________________________=SL6_
MO+FVM+.QLK*UN<#)U>/___________________^7;&1>65513TQ*2$=&2$M0
M66:A__________________^G)@X' @                !6____________
M_______.4                      Z___________________T>0L
M               A____________________GS(                    .
M____________________Q%@                (,5J$________________
M____Z7\?           &)TMQFL+I_____________________Z=)      (7
M+TIHBJ[5_/_______________________]-U'B8X2EYUCZO+[___________
M__________________^N<H68K,+;]O______________________________
M____W^______________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________O[*JIJ.A
MH)^?H:.FK+3 S=WL____________________BEI33TM(1D1#0D%"0T=.66E]
M____________________GBX&                    ________________
M____PU8                  !5!____________________YWL:
M      DT8(NT_____________________Y\_          0E2G&9PNO_____
M_________________\9F#P   !,J1&*#I\WU________________________
M_^N.-2L^46B!G;S>______________________________^^=G^4J<'<^?__
M________________________________TMCS________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______V\O#O[^_Q\_C]____________________________^+"?FI>6EI:8
MFY^DK+;"T>'N_____________________HY02D=%1$1$149'2U%::(.I____
M_________________Z9! 0          !S9CC[KA____________________
M_\9E"@      !"=,<YS$[/_______________________^6(+P  $RI$8H*F
MS/3___________________________^K4#9*87N6M-;Z________________
M_______________2AWR8L<OI____________________________________
MU,[M________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___MY>/CY.;H[?'Y______________________________VQE)*2E9F=HZFR
MO-#M__________________________^=4T=)35%68'.*K];\____________
M______________^R5@ :-5!MBZ[2]______________________________-
M;SY?>YFWU_G________________________________NGX.FPN'_________
M____________________________X\[K____________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________
M
M
M              #_____________________________________________
M____________________________________________________________
M____________________________________________________________
M_____P   /_A:G%H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O #P_>'!A
M8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED
M(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B('@Z>&UP
M=&L](D%D;V)E(%A-4"!#;W)E(#8N,"UC,# R(#<Y+C$V-#,V,"P@,C R,"\P
M,B\Q,RTP,3HP-SHR,B @(" @(" @(CX*(" @/')D9CI21$8@>&UL;G,Z<F1F
M/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C
M(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @
M(" @(" @>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q
M+C$O(@H@(" @(" @(" @("!X;6QN<SIX;7 ](FAT=' Z+R]N<RYA9&]B92YC
M;VTO>&%P+S$N,"\B"B @(" @(" @(" @('AM;&YS.GAM<$=);6<](FAT=' Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]G+VEM9R\B"B @(" @(" @(" @('AM
M;&YS.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(@H@
M(" @(" @(" @("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(*(" @(" @(" @(" @>&UL;G,Z
M<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O
M=7)C945V96YT(R(*(" @(" @(" @(" @>&UL;G,Z:6QL=7-T<F%T;W(](FAT
M=' Z+R]N<RYA9&]B92YC;VTO:6QL=7-T<F%T;W(O,2XP+R(*(" @(" @(" @
M(" @>&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(CX*
M(" @(" @(" @/&1C.F9O<FUA=#YI;6%G92]J<&5G/"]D8SIF;W)M870^"B @
M(" @(" @(#QD8SIT:71L93X*(" @(" @(" @(" @/')D9CI!;'0^"B @(" @
M(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<](G@M9&5F875L="(^4')I;G0\
M+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \+V1C
M.G1I=&QE/@H@(" @(" @(" \>&UP.DUE=&%D871A1&%T93XR,#(P+3 T+3(Y
M5#$T.C(Q.C0S*S R.C P/"]X;7 Z365T861A=&%$871E/@H@(" @(" @(" \
M>&UP.DUO9&EF>41A=&4^,C R,"TP-"TR.50Q,CHR,3HT,UH\+WAM<#I-;V1I
M9GE$871E/@H@(" @(" @(" \>&UP.D-R96%T941A=&4^,C R,"TP-"TR.50Q
M-#HR,3HT,RLP,CHP,#PO>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX;7 Z
M0W)E871O<E1O;VP^061O8F4@26QL=7-T<F%T;W(@,C0N,2 H36%C:6YT;W-H
M*3PO>&UP.D-R96%T;W)4;V]L/@H@(" @(" @(" \>&UP.E1H=6UB;F%I;',^
M"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @
M/'AM<$=);6<Z=VED=&@^,C4V/"]X;7!'26UG.G=I9'1H/@H@(" @(" @(" @
M(" @(" @(" \>&UP1TEM9SIH96EG:'0^,3@T/"]X;7!'26UG.FAE:6=H=#X*
M(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z9F]R;6%T/DI014<\+WAM<$=)
M;6<Z9F]R;6%T/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SII;6%G93XO
M.6HO-$%!45-K6DI29T%"06=%05-!0DE!040O-U%!<U5':'9D1SEZ84<Y=TE$
M375-04$T46ML3D$K,$%!04%!04)!05-!04%!045!)B-X03M!44))04%!04%1
M04(O*S1!1&M&:V(R2FQ!1U1!04%!04%F+V)!25%!0F=114)!545"9U5&0F=K
M1T)164I#=V='0F=G3$1!;TM#=V]+)B-X03M$0D%-1$%W341!=U%$031014$X
M3T1"351&0E%417AW8D=X<V-(>#AF2'@X9DAX.&9(=T5(0G=C3D1!,%E%0D%9
M1VA54D92;V9(>#AF)B-X03M(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF
M2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&8O.$%!15%G075!14%!
M=T52)B-X03M!04E205%-4D%F+T5!84E!04%!2$%114)!445!04%!04%!04%!
M05%&07=)1T%104A#06M+0W=%04%G241!445"05%%04%!04%!04%!)B-X03M!
M44%#07=11D)G8TE#46],14%!0T%1341!9U%#0F=C1$)!24=!;DU"06=-4D)!
M049)4DEX459%1T4R16EC645537!':$)X5WA1:5!")B-X03M5=$AH37A::3A#
M4GEG=D5L47I25&MQ2WE9,U!#3E51;FLV3WI.:&156DA41#!U24E*;TU*0VAG
M6FA*4D92<5,P5G1.5DM"<GDT+U!%)B-X03LQ3U0P6EA71FQA5S%X9%AL.5=:
M,FAP86UT<V)7-799,U(Q9&YD-&58<#=F2#$K9C-/16A984AI26U+:31Y3FIO
M*T-K-5-6;'!E66U:)B-X03MQ8FY*,F5N-4MJ<$M7;7 V:7!Q<75S<F$V=F]2
M04%)0T%1241"455%0E%914-!341B445!06A%1$)#15--545&55).:$EG6GAG
M6D5Y)B-X03MO8DAW1DU(4C133D-&5DII8W9%>DI$4D1G:&%357E7:5DW3$-"
M,U!33F5*16=X9%5K=V=*0VAG6DIJ6D9':61K9$95,SAQ3WIW>6=P)B-X03LP
M*U!Z:$I3:W1-5%4U4%)L9%E75G!B6$8Q95@Q4FQ:;61O85=P<F)',75B,E(Q
M9&YD-&58<#=F2#$K9C-/16A984AI26U+:31Y3FIO)B-X03LK1&Q*5U=L-6E:
M;7!U8VY:-F9K<4]K<&%A;G%+;7%Q-GET<G$K=B]A04%W1$%104-%44U2040X
M03E5-'$W1EA9<3=&6%EQ-T9867$P)B-X03LW<$=J3S="555&;5IJ44%$8VMK
M-'$K6B]Z52\U>4\Q5SAV6G1&.&MY1S)S:UEX4V%Q;T14>G18:BLT-CA%4%IV
M=$AT>'IC-F)S.$%C)B-X03M5*V9C-G9583 S=W<K85(V4B]Z:B]W1&UT-7)5
M87!R5GET;3 O=T%99E9*<%I,;&=X<5-506M:5#=/46-T;G)S54YO-RLU<FIO
M.&LY)B-X03LU2#5R.5,O2G8X-5!)56)A=&]D-C X34E,>79P33AG9%9(6&Y#
M=VI,:GA!1%E)-G9$;#)K4&UK-F),:C-I9FLY12]*;C@O.$$O160Q)B-X03M&
M-64X,#A)3F%K4$=Y=FQ!4T\U8B]F8F].:VPX2V).,&]$4W5*<3E$=T1I:GEC
M;E1A=FHY375B,C=.835Z<U9D:7)S5F1I<G-69&ER)B-X03MS5F1I<G-69&ER
M<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<GE,+VY*
M9GIH4&]N:V%04S=347@S5W5Y;3-D)B-X03MH<V9Q,&$X<'=$+VQC:U$K>$]:
M+UHR3&EN6B]H8U!7-4]'1D1Q.#@O-7AC.&HR5W V>&9E6C<V35-R<$)33%0P
M65956$5G3$Y*=C-J)B-X03M51&HW=%AQ0FU8,FQM35%):G$T,UHK245M4C90
M<41.2S=6,DMV;$0O04IY5#AL5S-L=GID6C8Y<%-F5F].6D1Z3W-F=SA,=4)L
M36IR)B-X03M4-U!)3W)F-C%C,W9:*UEZ9UEN<#EZ<4YD:31:0U$V=F]8.')V
M3F-N;7)Y2'!'=%1%1S=M:3E/.$EO2WIW<UEP1V]/;DIK-54X1&UP)B-X03LQ
M3TQG>4=,<W-'5&IG0WER2T<Q,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+
M=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+)B-X03MU>%8R2W9N5"]N
M3'5/5W9L85=T65(Y95=L3VI(-G5E=BM54#%:="MY>CE8=R]3-GIT1694.%52
M+WII6G(Q<6)(6$Y"9#%7-E=63#9&)B-X03M$.7 P6E)&25(O<49%+S1,0C)P
M03)*9D)06C!X4D0V1'I5=7ED:7(U<2\U>7HQ>7IM,5!1=$5I64YD5V-C.7IC
M9T=V151L1FI5,#9()B-X03LY,%0X<5IU97DT14%Y-S-6.6]Z1W=:.2]Z:DQ&
M2VXU6%%S-FM,3&583'A%.3%$0F%J+UI+8WA/,%0K.2M$:S9,*S=$,69-1GDS
M67$W)B-X03M&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T98
M67$W1EA9<3=&6%EQ-T9867$W1E=++VUN<D]P84PK6'5U87!P:S,Q)B-X03ME
M+W1R9FQ"34%R1E=,<7111T)(435F<&]#5U%!.&UR4$EX9U-/-6=0;7EX4#5U
M+VMP6C9P<#9I6%AB5E)C<D-L2VTV:%5X,TU!2&)M)B-X03M+;%(S*TA-<D9,
M=TUX0BML>#AK9D=X5T]B-6XX=F599&$X<S8U0G$R;'I.839H6G5E2DDR.$=2
M,5!65T=Z035U8VU/330P951Q651L)B-X03M#5FIM*VMF3$@O3U9(;$\V=$58
M>D1:6$=M,W=!16IW3#8Y=7@W<W4T:U@O5DMM;FEC,"M4<S)94'!.:#)M4%AW
M23E7>6HU="\U>7 X)B-X03MU,CEM.&9L97AM=G(Y<6E/93=8,&)D4$)U25EY
M4"]Q+T0X.$],<WE24'%.0F-M=FE"-F1Y*V5H+VE4>G(U<4%,4'%'=6%V3T)Y
M4%9N)B-X03MB-6)+:7%0:W%J=WIB96Y(2'5I2%=E<DI,>DPW:#AM*U=R8GEZ
M-5<P>E%B8SAK<TE&:F%18F,U1#A5:C W8S5'6G9P>FUS,E1J:UID)B-X03LW
M=CA!2$1H:4(S2GIL8DXR2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R
M2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%9+)B-X03MV3FUI3')V;&I6
M9$=*04]O5VLQ=6I'=$9E4D-Q='0T3E$U6FEN=WE"-VEX;DAI:5(S=FQ$.&UV
M>E-U+WDY.'=81VUA<W(O;T\V;#E0)B-X03M564M693-N43A05U9F1F%C6$$V
M:C-!>F5A=E1$3$=X.51P.4QN.$M62&LY8R]-2#AI+TQ(;C)%95IV2V0W0EHS
M,39V<F5Q;G@R9#!7)B-X03M0,C(T5DM0+T%$36]/+U9A-S5G64YB3$8V6FI9
M9DU/8FTP:V-N<6IZ94LV="M16#5Q-F))>6Y25W4T=U1X;71*27!L86AP54M'
M16<V)B-X03LY,4=B2T]U>$AQ-BM7:7E$<&%-,$PO;DA0.#!.5&Y68FEW:C!U
M06UJ6$8S36Q"5"]!0TEJ2DHO=W52;G(X565T<V]A2$EE97HR8E)F)B-X03M,
M;C5C9FMH;VIA<G$Q,F)V5W)L9E1-+T948U,W,4UD<D18-$4O;4IB+U=B;TTQ
M,#AM5%5Y;T1B.&,S4&A$2&=J6C5V5W)+-D8S6G=8)B-X03M1:F5)6$5A4VE+
M54%32GI53GAC06M":%=H,WI!26\P-6=6<T-U>%8R2W5X5C)+=7A6,DMU>%8R
M2W5X5C)+=7A6,DMU>%8R2W5X5C)+)B-X03MU>%8R2W5X5C)+=7A6,DMU>%8R
M2W5X5CAT+SA!3U0S:U!49$DQ<3$X>E=,<D5D8F0Q=DQ4645Z>'%#6FM(9S10
M>"\U5R]W0S%M-S=/)B-X03MZ;55E13E(538O0T%E2618;5AL4#AW4$]F;$=4
M,61#,4=7,&AK2DQ7-7!*8GE%8D5M2G=Y12LY2S5M-6-%36XQ0GA-96%C3U)E
M;E=0)B-X03LO3U=(;D-/3E9V9$ES3&QL1D=E37EW;'1U<'$P9RME655U>DED
M0UA,2&%-=6]11W,O=T1/55 U:6%H0V)F5&],4%1'9EE3=U)T3$Y5)B-X03LW
M555Y<S9F.$IK;V1M-'AU8DQ'5W9M9&=+6DXK5E U3F5:3F8Q<4AZ<"M93'IY
M8U=783!S<GAM965:;$Y585I8<55I6#EL1'5F04PQ)B-X03MP,4]R:D-00FIB
M=%!P<%-02$XY1UIQ2%I/>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X)B-X03M6,DMU>%8R2W5X5C)+=FQ'>%9F
M>E4O33-6.6(X>C-9='9+=FPY2&YU135(9VQN0S5%8TMS;R]B;U=D:'5D-F(P
M>F5Y+V-9:$=).55V)B-X03MV9%-"-#)1;5@P>&5Y*U=F3U@U5B]M0W,S;%!4
M9$TK=6%D6E%&+U-L=$)(87AX9VA&.4]T0VI(;#A.041M=7E9<W5,,6LW;GIC
M,TAL)B-X03MX-5!33G@W;FTO-6AF.#1U,TUB4U@O:VUB,6]J5FTP:35C0C$Y
M;UIM,EEE,&Q0.$%73UIM1'1)8W O3GAC,F<V=RM4169Y>C@R848K)B-X03M8
M1W5Y5R]N1'EP2BML63-"6%5(52]7<F144VY'0V%I53=H,$E0>GI),4=+5V%.
M=VQS,#1-9WA'<'@S-S,P,S57+TUF>50U<%)F,$IQ)B-X03LP1GA-=W%B4FTY
M3S1',CE96D],-V5)1DTP=5A4>F@Y461R:GI2;GE,2DUP8DA9<3=&6%EQ-T98
M67$W1EA9<3=&6%EQ-T9867$W1EA9)B-X03MQ-T9867$W1EA9<3=&6%EQ-T98
M67$W1EA9<3=&6%EQ.%DO-7E.+TY#-CAT-EA(-6$P<FQ(<65R=W,X.3!.=E-T
M4U-H0V8U8VA"1F5W)B-X03MR,W!M>#!';45Z>$AK2$,Q=6-W1D1M530O2FHX
M<')B>70U4'5)9%EH5V95.65J539T8GE$:VEX1E=#,GA",E!&6&)N-&LK04=6
M-G96)B-X03M'8SEU56544%1A8U%J4C5N;7IN>34U5#AU95=R3C=04710:7-,
M95)U8VEX03%D=6Q76FE78C)Q8WAS;5=5>F-J8F9#15EI9TM48DLR)B-X03MB
M-6,O4%!82E!Z0B]-6%1F2B]L>49,<5A4;F4Q*W-R*S-C4T5'87)D;S11;34O
M,6IM-S!54$-X;6-U<G%T6$QX2FE%96ER*UI0+T]/)B-X03LK;&55=DIC,VU/
M>#%M-&$V,#)/1G)Q2UI%2U-Y=DES6DU43'=-63505E%E4CDX1VXQ-7E4-%-/
M835T14E2-&=E4U5E5618+S5Y2C O)B-X03MY.5HV,V]B6#)Q-DID0GAB;W=8
M54YO;DU26#!M.5-D04=1,#1G93)76EEA8WE-6E5*9DIH:FQN15%2=5!N*S%0
M=$LO-7EW.'=7>G1$)B-X03MR=FPK0V0P<6IM,FMK=&Y6;#)02DI"4'8T:F)+
M<&1M4E P;'-J,F=2.5%:9' O.$%Z;%@U0VU10SES3E)T2D\Y16EL468W25-+
M,R]#)B-X03LU:GDW37E$:U$S4C$X1'IS2C=A+S@U1R]L3$UP36UQ>3)X04)#
M>3)T>5-A.78S8V-N5$MZ,F9L2%0W5WHX-VDW+W96;B]W0V-H+WEG)B-X03M6
M1UEA-EA)0DE28E,X<6%D:%=%1#=Z9R])6G4W-U%V-7I&,R]!2'!B8R\X04]4
M9C58>$0Y,TQE,T<Q85(R-4@P9G9'5$IJ<S=,-4E/)B-X03MU>#DV5#,S+T%$
M;&HU3VI*1FIP1V]81D\X=F]W9S<Y=4QY.7-S:C):4'%1,6YT0TAC56MU4"MC
M=&)M6#1,1'ET.%$S3%-86F8T86(O)B-X03M!07!#=$XK.6-S2%I9-GDK>&@O
M2T8X;V]J4U K8W1R2C555%=03#!K359F,VLY<&-,2V%64%-+4DEV.$%I94-F
M6EHV4U=084DV:#=4)B-X03LU5#@U*U<O3FUM1%5D0W9&=6]!47-Q-W)*135&
M945I3E)L4#8K,5)M='DT6EEZ56<U*U!*1UES1D]S<EIU>%8R2W5X5C)+=7A6
M,DMU)B-X03MX5C)+=7A6,DMU>%8R2W5X5C)+=7A6-7@K9% U55)E971%5U=Z
M-'AE64Y01$=W;%DX5FM5-W1!-3A'+UI062MX3UIM:C%8:%,S*VMU)B-X03M.
M<610-&MF35!+9$XX,"\X-4HK5G1'5%1Z;W,Q>EHV96YP<$I.86TU9%DP-D0Q
M26TK2E9(9F9B33973%143C-U9DYX235.4D%66$HV)B-X03M&*U0O04]E.%AN
M4SEB43E9=%DY4#$T2WIW0T5T-DTT459C27)L;5(Q1R]%<V1Q;759;7(P6&AJ
M:4<X6$DP,G(X43!D<$HS*V0S;C%V)B-X03M*,VME-&YT6#1A='%"*W V8U%A
M36IU<#5Z1'8K-U1C2"MB:FQE:G=E2E!F:T=Z535U0T8Y5TEF.#1Z9FPT;6TV
M1R]M*R]J<G%/<D%P)B-X03M9.'AV2&%H=#)(=DUW<B]Q9V5*>2]T2%!C=4%C
M9S V2$1594DX>6IV*V-O=&)7>2],>4Q4;&-I6%9B>4M-;T13<U5)37I%*W=D
M57E0)B-X03M:<TQY6#-"3W9L5T]U.6LO:SDW8GE:*U1M;EA6,%%).4XP:UAK
M-FXT874X6FY:3RLU9"M).&-P>3-K>D5$<5<W2#9-679O2&U8+T]-)B-X03M0
M;&DP,5=X.'@V-7$Y;D9E<&54>#(P9C%I3EI&3$M';&TR8T5B;59->D\P8VAI
M67A"<'AD1$=X2U(V;$IF>5<X:F54+T%$0C4S.#1A)B-X03M:<F5N>#-S1FY)
M,S%/2FDV1D%T=S9%<5EY;F)I370Q;6%C25)-5%1$5%EO>6Y-1618<3%Z+W=!
M-#9F;$I-454P:5,S<%=V<%A6>G98)B-X03MX-7E0,#ES=T)R.&\V+UDU4C!7
M3'559BMH8E!Y<"\U66)J+W!+;"]R:W8U47DY-E!Y5TQU954V8BM8;FQ'>"\U
M>4AB>69C5U%U.4-K)B-X03MJ3%<Q=$LX:&]F<5%U4E9G,TDP6E<V;DTR5V5:
M,"]'1#9V,G5*2$1%6BM'=&MY.'HK5F1%+TQJ.#9D0G5O8DM&+TLK=D51=&$S
M15EL)B-X03MI:4QS25IU4%!L+V1L,&M"-C<P>4]03$Q.:$EV,5):>F=-5U5%
M9E1*3B]/9'!B*U=V*V-J=DLQ-W!+<D,R<W!&2&4R.%E!52MQ>C)R)B-X03M.
M>$%!;U5#;C5R6$LX2DTY4$E(<"]A,EI"=S4T:V17+RMC<'9*,FEP;TYL-6UT
M<F5/,S%-6&=T<FU33E%P;5-:2&5S;%!T37)2-T4K)B-X03M*>#=.>7DT:D4X
M<5)R.%DT94QQ.&,O2TQZ>F1E5"]/,6IF0U%J5#=L,71T5&ER.$Q14TU!5TDX
M67EE82],,T]B1%994FMG4C$V3T1P)B-X03MC<&A-9'AF8T=C,#<U,DMU>%8R
M2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=FYF.$$U>4@X
M;E1E6&1A,#<X>"],)B-X03MQ0S)U63=L4#!G63%!55A!4$M+9&=0-39&6#A4
M5'54;3(P1UAJ:6-C;EAA>DAW:UI).#)(9FUD-3!J+TY$>FHU5# O5'DP9'10
M1F)7)B-X03LW46LQ.4LW=DI1<R\O03!55CEQ-6LV9D0T34I%+V=";S%'45I:
M>$$U9G)F5VQN85<Q;F%15V1R1TER83)J5T=#261&4D9#<6]R-$%:)B-X03MO
M4U-46F1W0E0U=R\U>71M=F@U:3AU:31G9#E':6=D,4EQ165:<&8S<6,K;DPP
M,%0W.#(O6F=(1$QV9%HR9V0T,WE12&YF.$%.5'I$)B-X03LK87$R=FLS>61P
M13%V6E1S:'5K2D):=VA"45-&4&=J:%%J:V%N<U!$2C1D3DA"-C5N9&IL,45S
M,V]G2#!&-4$X;U=V;$1Y;G K9S(W)B-X03M#43)Y5G5*9TME<$\U-5-V.&EX
M,CEQ1$Y4;GEN2DUY9&II>&E%4D501"]Y-C%V4R]+=C4O96-B5%=,:4Q4-V$O
M;'9"0DI/5FEI1'9C)B-X03MR4$5P6G%+;TUB2&IV-&5/8E!544TX15-.-G!W
M8TUH1$Y)2'$Y+VDX>BM7<'$K;'$Q;$I18VIW=4EM*TAX,F)P;7$X3UAC6%DX
M43<P)B-X03M&<4@U9V52=$]G864X,2MW:6I55E K:WA->"\Q559I>D@R07E5
M8T5Z>4)9>7E22$UH-% U1S%G961F.$%N2E=8>DAP84TK;#)Q5$]*)B-X03M#
M<%@Y>$A:;7I2>41U3V)U0T%D.3@R;6%(:#9B:%!0.71U=7A3.%10>$1K2&]8
M-3DO;#$U;3@S,D=J6$AL,%)Y6"MK>GE396DW<D=7)B-X03M%;U0T;%IQ3%97
M:D=X3UEM:'IX>&LX6$EU5G%S37!G8U!-250X=2]Y:#AY<C5R2&YJ>B]Q0S9H
M<C9G+U9,5D-'4T5K1E%Z14)5*T5%)B-X03LX55%C4C%Y5V964C1/1$=+:7AW
M-F581GAZ3GE5+W=$;DMM5E4O3&UZ43E:3E5H5F9O9VYB*T=06F<O94@S23$U
M+V0O1CAN-7984W8P)B-X03M".')8<VPO-5HP:2MK2F%3-G-R960R3S5*:VE6
M:50Q.&,U6$M+:U(U=E-X3F=&33AG>61I<G-69&ER<U9D:7)S5F1I<G-69&ER
M<U9D)B-X03MI<G-69&ER<U9D:7)S5E,S>DQO1FHU:#!#+S!3*U=T<F9W=$,U
M-FQ39G-U4&1';W<Y>&LX8WI#46M/:D=C4DE%2'$K241B-G U13@O)B-X03M2
M2F92:U@R9U@X57)O2V=30T-26D9+,7 X36EG165)3V1,67DT.7559S9#:FIY
M8CE#*S9.3#%/>3%45')B56)'55179#-'<S%V2W92)B-X03MK8U9">FU:4DU4
M4C5V44%G:7=V=3=/,'9)5$)D=U(S14153%)3;W)O861+<7=)=T%K8VMK3&),
M5'10<UEZ1EI7,%9R1U15<$-I>'%4)B-X03LT,%5$17E*-6]!<$5917-"."MF
M:VPU23@V-F=.4S%*3&DQ,45Q16QU-THQ:F525D9&-6@P;%$P07!8:E=M6E=$
M5U1X:6AY8V9.<&]:)B-X03M.>GI95R\X07II8C513'-5,6Y51E-P-'%W:$I!
M-T%K24LO9&U4+TMK*S1.2#AN=S=Y:6)(+VY&4'E&0S-+-S%$56)Q:#)14$1'
M;%!!)B-X03LP:DQF8S)2;#)N:S9!2FHR9D%D-S S>6XU23AR954W2G)044Q#
M3WIJ:TE->FER>7E%9$,X:FQN86Y95F]/,EEE6$Y,26)K6$QX-#1W)B-X03M&
M4D-E6E5Z9&ER-3DO=T-C=#E10S9D-6,P.$U+>7I83G=Y8E9!:E9%56YV=C9H
M>F$Y;'@S:UA89&]Y,D%E22M9=DIS,FHK5U!,5W5T)B-X03M)6&DX=U$S16Y!
M:6YP=F)Z1D-O.%%56D=R-VY.;FIY.%5P4B]M=4)K>&--67DO;E!S:CAR8F=8
M2#5B*U=*079';6U7<V1/=CDQ0W-D)B-X03MF<#0Q>FYT4TMY4SDU9#-G+W4T
M*S1-;WEH=&1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER
M<U9D:7)X8B]!2GE+)B-X03LO2V\V+W!:.# V5$5$<2MM4D@V-T5O;UHW5D%7
M2CDS:3-).%8R-T%:<V1"<65%.$HU1G=D6G K36-1-6@U6BM44#4T6&9K=&AO
M*W-#)B-X03M3-SAT>4U3:7)V2F%U>'%Z4F<Y56)Q>65/-#-R6$\Q96I'5&-F
M531M;#%F0G1,-E@Q6F]8;4129&4P-E!59$=V67(V>6LK>DY#,5%$)B-X03LO
M2W<V<7<W<7="1V%/94]55%)&1C(X6D-1<TIH:T=3465D9E!0;#=Y8F\W87!R
M52]P>&LX24E%2$MA85-L945A,494-&YO3RM7-&--)B-X03MS:'%,6&QY>&=,
M3#4Q.'HO05!/53-N2SEM6DY!=&)F4TQ7=G=/-FDU;E!Z3"]U>#AU2# U=#AF
M6G-".5<W<DUN845J.4EP:%8Q*V1F)B-X03LU<5A5;G%395DW<%=084PP-%8S
M+T%-;4Y56#A->5)O.%$O:$119%AK-S!-;C5T+VUA<DUW.'IA:%9T>E=::5!O
M0C)(,%EF>75,*V%%)B-X03MF;7-N96HW2#@Y4'I8<VU":CAW>E-!8D9:,&AN
M0D).9CDR23)2;&]S4B]H6D176D(Q6F9O4"]/5E!N5S!:13%I=W1.56A"*TYK
M1%<P)B-X03MX2"MS<&50+T%*2C5J>C=-9V5226)O9&]32$U7.6@X;&9N-RM8
M+VUF:D,Y,2MH.5%.4#A!4F(X<D=R2"]!27)M<C9B93%31SES,2MB)B-X03M1
M-4EE63AN3WAA=44K=$8T2"]Z:U(U=W,O368U9U!(651,4%EA5$%T;DA.1S-*
M2&M$1C5756I9+T4O1&(K6$YP;TU2:&HS-6PQ,G5Y)B-X03M#539(4FM0-7IA
M4TQ,.&YF>39#9V9U<F1E8F5$,T9U:W)$+V=G8W$P:W)Z5&)D5D=S569X,&4S
M+T%*351.3"M6=FQT;4%"1F]Q8F5#)B-X03M->6HO04EJ;70Q62]E>3DW;C9F
M*S=J-VUA6FI.>G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER
M<U9D:7)S5F%:5EI3)B-X03MR04932T5(8T5(1E@U.38O6G@R5W4V;%IX+S-D
M=&1447 R*T=/4FQ(-G,V=4)U24QZ95%626IZ4EAL8GIJ-6LX<F%I3"]1<C93
M>FXR)B-X03M%:7%A>'E+1%AJ2D=A<30K67E/5$9'67%15&IY>6=B0F95,S53
M9FYT<%AN37!P3W!O;6YE62M0=WA!;C!B:6TU34I9:VAU-5%M=F=4)B-X03MV
M5%-A<E)(2'5.-'4T,"MR1U19-U-E2B]M8G%7<2]M3BMC5&%*6GE6:&EU=C!6
M<'EN9$532G5-,#(S549G>FLO>3 X33)7;FE-3TAI)B-X03M09&)G6GEC=5AH
M2'5F4U!K>CAQ4$I8;%14;W)A>C V1S1U,5=K*V\S16%36$5J52M).&U"-&<O
M>7)T;6YZ87%C>EI,=$U70TU"44-B)B-X03MA<#5+.&]A<D-99%(P5WEU:TDT
M,6MG:DQ!9C5,535,.4)Y=4]A8V523$]73THU:&AD<"]Z:FXK5T9R<GDV<6QL
M3$I#;TI84S5P5$IA)B-X03M".7%.>&%R=%1F-%=C<C=::VY8-51'<BM,44Y(
M:D)U;5HV;#5(.&]A;'!J-EIE85!A4%EU=D@P5FA23U!U:%%+54DW1F-X-#5P
M9S)#)B-X03MB8C59-&M54G,K2'9/3V=J>2\U<3%B4D9K37%A9F13=U)Y;EES
M:4U1:D=N8W)3=61*:6YX>$5U.34O3D1G:U%G3DTP>2LQ5%5,9E0W)B-X03M#
M1G)I.75N16-%2R]A6C(V059Y8W!#27,X;4U9;5)O8S!->7-R1E="1$$P24]X
M0D=&1#9'+U R-F=U9GEI.&IZ>$U#:WDR-W T,$YN)B-X03LO0W4K87)1:7-S
M+W@Q9'!R5&5/2B](2C9V*U-8+VMQ=DQN+TU-9CA!:S0K64=S+W9:3UIP=C=U
M4'5:=FU-,T]X5C)+=7A6,DMU>%8R)B-X03M+=7A6,DMU>%8R2W5X5C)+=7A6
M,DMU>%8R2W5X5C)+=GHU,38W5S@Q>E5B=&%C8FDV;6Q&3VQ(:TQB9F9N5G=&
M4D%E8GE'-44K8C9F)B-X03LO278X;W1&=%!):EAU=C)%5C5E*UEO9S@P539"
M=E1T1RM+2TU6*WE7,FM*1D17;F1C,'5T,55J3V]N85 S=3,P;6Y!:'5.-5!*
M=GIL)B-X03LO2T,X.&AA;$AR1VI022MG6$5O*W)406XQ8E=B-U-X=30S-U92
M+W8S-C4K:S%1>6EJ.51H86Y42$=E2U!,-VMN+TDW530W2#@R9DPY)B-X03MZ
M8TAK2EHU3&9K5'9Z=6]:249.5"]L>41,3EI'.%5G=S!K=C-O=#ES6GIB=EA9
M<3=&5G-S<U5-5'EY<T5I:E5V23='9U961E-39EE9)B-X03MG2RM!+TXR="]P
M,WI4<3)S56]T+V1Z6$-+97E/-4M$-D9O339R1D1H:4(S0C5Z3%!I:U,Y22\U
M>&DX='EA;"M92C%::W)B84QB=DM8)B-X03M)<5!7;D)H:E@U.%=D:"]Q-6@Y
M;S5+>#$S=59O25A/*S5)+WHV.'1W-D8K6G5Q4E<V0T\Q=G5&+T-G04%(<FES
M;$%/,W%H-EIB;W-N)B-X03M&:4AL<S$V>4A$:U!M:79/5W5,<5 U2RM2-$=*
M33%N9%@Y<S4W56A+;%(O>4QL5$DT;U9M;C4P>GEZ=D1&.4DO:VPO-4MR>34O
M=T%W)B-X03MX+S5/4&UN,6XY-THR;6TO=30K-6TK67IC-T9867$W1EA9<3=&
M6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&5TXO;5)R>39")B-X03LU
M1#$S5F525C=E,&M70F@O=C9596Q&+WE59&-U,#A/3$E"-71E869$06PX869L
M=C568GI6-3,P;E)#0UE,:6-.9# R<&)X07E48CEJ)B-X03MW56=E*V1$<4UV
M0D%Y9$9P.&9(34(Y,TEI4F]Q26]61D%65E5504$R04%'8W<Y0VPO;5!19% X
M04U':%AU:39G;D]Z=F]M:6Q(8U8S)B-X03M6,2]Y:UE";#EX:SAC>D-1:T]J
M1V-22558=VYQ5FAQ9FQ4>EA06GE(:G%/:EAL031Q05I)2DMQ-BMX-&AH;E1X
M:TIX=F]1."])2$A/)B-X03MU;TPW>#!85F)B5CE(<V16='8X065E+V=J=5ET
M-B]$2V=C02]+=6-V3TII4T0P96AJ2WA94FU24S=&6&U0+T]1=FY.9DQV-698
M3G!#)B-X03LO2%5.8G)9,C1";W=J659N9C5#4#1F;7=Z3C!'2&IY6#!'-VDV
M=DQW45!E6'I,*U=N-60V<C4V.'A*<&QN5T<P:7!*<4XX4E9967$P)B-X03MR
M,G$W9$98=CAG5&TU,4=C66\R6%4V9D%C:W$V4',O>6XU4C!$>7!O.%=L84QB
M0S-T;W@X8F1:2E@W>5-V,5IJ+UE+1&)/9'DU6E1.)B-X03MY9#=$1TE#9RMA
M+RMC<E=5+VU*<#1"0DLV5$-'2&=F<DYW9C0U=65Z4#=S*R]W1%4V<G1$-G@W
M=C%V24I.479:3$-$5#-M6G)/,FML)B-X03MM9VA0,E9K;D-,27<O=T)947 Y
M,EHO0TQV<31816%R;RLQ9GE3+SA!2E9E6% K65DO=T1*>#@U>E=F,W-N9C9B
M*S=J-VUB-6I.>G-6)B-X03MD:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER
M<U9D:7)S5F1I<G-69E S+T%$;&(U=E=+=S!Z>6YB=BLY=4<K=EAW2%52<%9)
M5E K)B-X03MS+TIV.6E-,G9:;4QC>BM$<G4P36Q!4C<P<2\U>$XX=DQ,<3)T
M95E:1D)&<D-L;&)K:79X5$XV:VA(9U%S86HO04=75V1P-4YH1F@R)B-X03MD
M1&Y*.4Q:<&YA3WA6.&DO.#5/-E-T;"M:<EA3:6<Q3WEG=5=)+VU4;&)N-F%1
M:DXO=T)N4W9&6&-85&$K3EI,-W<Y:B]W0V-A=DUN)B-X03LV5B],94MW:V-'
M-#!A95,Q669T96MX.5=*:B]W6E5F-G5A-W1$2'<U3#<S3S!5*TQ(-VYQ*UE,
M;'%6,V0R,6YA>EAD,4MS1G1B;S!S)B-X03LX>FUI;VE#<DUX4%E!65%#5%%1
M5%0T<B]!1%(X.%@O-6DK95!6<V\U2'1!>3)7:5=92'AL0S%&4$5F='EU86XV
M0C)Z;SE.:$=+1R]X)B-X03MD2'%-<'EZ,BM$-G$O2WHX=C=0>5(U5'0Y35)6
M8E5*44IT5'561SAK-T1C5B]L5#=++V8Q2GI2-FY/8VLW-F1(8C1-27AX<&PK
M63=C)B-X03LK3&9Z.3%T3E<O3E!71VI02TMY84]Y5#)-0T):0B]Y3C5:,&5H
M:'<T:#5U:C%S-WE(>65E-6Q/22LS9GE3+SA!2E9E6% K65DO=T1*)B-X03MX
M.#5V5V8S<VYO9$XO9'@Y>DXX>&TU,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X
M5C)+=7A6,DMU>%8R2W5X5D0V:G%&;G Q:&-A:&5Y)B-X03MI1S!T23-M=4I7
M-DMI07-X4#!$1$=*2F])2D%&;#A)*V4O3FPQ-7,X,F%J<C%X5F9R8W!-15(O
M,UA#;G=X2B]S54%R-S<U,"M(14E1)B-X03M%43@Y;7EC8VE8,4PO=T$T,C9.
M*VIV>71S-7E!2DY4=4HW='9';E P5G(O<UE18S!N844W>6YY9'9O;S%J2&TY
M4GI#8W0R2W9L:B]N)B-X03M,0FQ0;FY3:W(X43!T0U(W1S1M<"MR3C,R6CE"
M.3=Q93!4-F@W;78K8U9F34)S+T]7;V%+-VM287!A8S0Q.%IR6G53+SAK,VMW
M.7!W)B-X03MU06PS1DA:.#9K4C-V<6I.1S=D.'5F.$%/45 U>6I82C502VYL
M*V-N4C=D-F%J9$ED<FU61"]D<64X84U/=C=2.6=+-W91-E1H.6-U)B-X03MB
M<61:<6(Y36585E,O=T-C65!)>39R-6QN.'HS8V9+>C!7:5=G66).9'E$63=I
M:#E*3B]9;%1H-U)Z8TUE161F=5)O359N:5!2.55:)B-X03MO,V)P3C5Y.'DR
M=FQJ>79Q5W4S3D-L:D,P:4EF,C5$.$UA9C=.>49Y>D1J335#239S36MX1TI*
M-E!G;39U<#=U-FUU<FAZ2E!C3S!S)B-X03MS:#9S-VMS>%!Z2GIQ44M&4$]%
M,F)E=&%&+WIJ1C4W,5A38EA5;79,0WI&,T5S,&1V33AX;%9(2$IE9D-.;$)O
M96=*>D%N,FI#2G%I)B-X03M83VAO2D574T$K;&9Y+SA!3&1Z-5HX;396;U9Z
M2VLY>%E1*VY,3$A89WI&:7@T.'%';GA:<',K451M6D1Q-U1&1&AI0C--9WEP
M<V1I)B-X03MR<U9D:7)S5F1I<G-667HU;"]-6'DS;T8V;6UZ=%!F87A+=D]0
M4V1/:&4W=6EH+V%-8UE0168V>$9E,EA9.5!+679K3SAT8SAS66UU)B-X03MQ
M>GDS*UI(;')89%)/:W Y6C W5VQ5>69O<E5R95,P=5-G1F53<$E+3B]S4V9U
M=S5.4$M)=FU/.&)O:&UJ23$Q.#)5-5$R=7A6,DMU)B-X03MX5C)+=7A6,DMU
M>%8T6"]Z;%(U=79D4#!$5'9,;'%'4U!6,F57.&U',5ER8W%6:4@K<S=":CAV
M9DYN,F)I0FM:2&\T1W9Y15)%4C%F)B-X03M,*V)P,#<W>2],<E1','9Y1C5E
M<TA1>'EW869B0V5.:%%R2S!3=$E#2T0Y<VY/63%%=4Q*22MB,&5'3E%!.&U2
M6E,R3WA6.&1F.#5))B-X03MA:DIE9FUR<4540F=L:D)B,C!8245F1#91;$Y!
M44YU57):,%!:.&%X1'ID2G)P6&LY>5,O:W1C,V1V.$%M;#5C:W166G!$9&E.
M=V=*)B-X03M0<'EQ,&-H3D]W4GE4;&UR04]+5CEZ1%-F,V=E>68X04]39C5P
M87!P2$AY9'!183-E*W1X3G%&.$-68C!86FQ%35I&4'1C1'I0:'0T)B-X03LU
M<G5Z.4U*97,Y2$\Q=6]-9E-/<C5N5E=:9W%G<WI':7%.>5-E=WIC=7!F8U U
M42M59CA!0W8U9C98<'-S9G!8,&MF,7)51DE)8C9X)B-X03M0.&)+=U!D0E)0
M.$%9-7I7<7DX95%N;SE"<#AF0D%";5=9-V,K8W8K8W(O3F0T='IP6&Q7249,
M5F]V,&QC=C)K674X55,O-T1G>%!Z)B-X03M(:&TS-TUX0VI0-$]S-U%Y2&%,
M>&9Y0C5D9GI(-7HP9E)G:E-2,V0Q1W1W1D93249B;$TS*WAJ5FIM>'HU3T-"
M3&<T26-5=T@S<4%!)B-X03M!04M!9$)N3'91=7A6,DMU>%8R2W5X5C)+=7A6
M,DMV;E-*8C)8>34U93%M,&QV-61C.#%A-65T<EHP>34K<#-K,W!#9%5T;&PU
M4FA5)B-X03MI15,X55DP.$)M,S(T<$$Q=WAI2W9C3W9024AE-5-.,70S<3!K
M=6]8+W=#5D]U95IR>35N3C5O3W%,4#5C83EM32MP5TUS16M58C(Y)B-X03MX
M35%J9D=X<#9:.%(Q,G=50FQ%4B]%3BLT<$I*>&U88V1U.3E#-7%84&1I<G-6
M9&ER<U9D:7)S5F1I<6YC5W1T8TE%=4EK;5%(:T9K)B-X03M534LY2S!.9DA#
M0U)Y5E)J,')3-#-74T]Z9U(Q3E9D63!"0DAC141$>&YV4E%25U)3-T9867%O
M6$9H63-,0C=I,FEM64-G85)&66=E)B-X03M&4T1H16E/4TMB=#='>71I>'0W
M94]%=#EO>&]Q5G T,$%X36EE86%D8U=6;F,X9G)-16,S0W9$,456-E8V,'%$
M-%EI4DA*85=W-F)P)B-X03LP16=K9W1967!",&1),59H6&)Q0FA-:65Q2U)'
M4E,W1E9'-'-R3S4T+U=9235U1F5(<4ER,'(Q<%5(=W=I4DA*861B,DYL8D9J
M8C(X)B-X03MC2F(W4FI257)4>&]":5I%.#%P5W=+-T989T@U1V5F+T%$:#5G
M+TY$6#E0,695-6)U>%,R=5IO<E8K4'!X=DAD4DEN04%F1%)823)Z)B-X03MA
M-C-"0T=)141F.$%9-B]46G!3>5-"3S(O=T(V62]M4&$O;FI**V%&;3-L;5,U
M6'DO=T0V4#E8351Q3%)12T=B-GET440X6$PW6%55)B-X03MP:TY/8TAH2&DK
M<C=795E:9D5(1#E,,C=.835R<U935'IX9C-E;BM3=DU&+UIY1TLW<SE.=DHW
M85552E-32T(S4G%';S)95GEZ1$5')B-X03MC464X3F574D5#4C-03"\K8UHO
M3U!M9GI(638K3F,Q1V)54'%K='0Y6&%C:&U4,49K-6=.4W1$=T<R6C-A3TM-
M0T]%531U:7EY;41X)B-X03M',W1E83%Z;FUU<B]!2F,V+W!N;49T8CAP1WAU
M8F53-6956#!45E!64TM+.61#:VQX85-W,4M.2T12;%EC9C1::TY217@T6C,S
M5T\W)B-X03MZ8V5726<S1W9C9C!+1VYF;&IR;7-A*S)R*V%K<TQ#>&MU23<V
M9E$Y3$UR<&0S8TYF4VQV2EIE26)H6#=+3%)V,G-L3%5X:D=O5U1Y)B-X03MS
M.5!C9UE35&-Q2&M0,'90=$,O3T0X-E!Z1#%U8E0O2TU6:G!C8TMM5U)M5E@Y
M3TES1D134U1E<'E.5"MX2#E'6E4Y3&AX4G5D;'A9)B-X03MA;DQL3E)O2G U
M;'9F*V-M4$IU;5-A,V8V<G K<S9F8E5E-E-#1TDK;6=.0WIQ24Q6*T\K+T4W
M93)1>&I46D1W9T5(.&5:6E1/94%S)B-X03MK2#AF0C9,*U58-6UW*V9V3'-L
M-CA#,G5P,F-G:'8W6D-3;DEJ:W-I13<X6#,R3S1)4'I/2G%T4#15<39&>710
M;CA33G-)."LO;F8U)B-X03MK=5!.,RM#=GDW<S!V9%9747=4,W)Q2$AR2B]E
M3$5R1E5#>%503C,R-CEH535'1%)X14]026%$4FPQ575,9V=,2T,Q93DO-7EF
M.'-A)B-X03MC*W58,3-:871:5S9M83=S-&]O2&%/3E0X6$I9-&](24$S4$)J
M46(K3U1I3DY-.$E"0EEY3V]I3$Y&;$AL-S@S8GIZ;BM7,G1A<#5F)B-X03MJ
M:G103FUK,C=03EEY07EO1U93-&5-8F-L:U9'0T$Y1S).4G5A36UL1U!)0DPV
M4S-9.5(T:T-9+U5%4"M16#5T878U,FDQ3W<Q,31M)B-X03LQ4W@T5%%V16YP
M;5-">59A<6HT9F=9068W25ED9'!2:F]X-49J<$Y18V=..'<Y2C@P-CEB95@O
M3&UP83%C54U7;C(X:R]%;6Y*;%@T)B-X03M%*V)T4E(X.'<X8T]/46HS=59/
M6$-#934U6BM82#5W83(S-69A>C4P.#=3>$=W=#=G46%B2&)X:4]35G=V>%)O
M2S!B:WI!3#15875W)B-X03MZ3S%';&HT9VA$;C%C5$1Q0UE'8S!I,$QZ>"MF
M+W=#67)Z86@U5BMP-D9O,&)M3T]75DDR56MB.&5C,&,W=7<W;%5!>3)E2%0T
M='!8)B-X03M)=&-C=6),=D=O:'1F>F@O3D1Y1#5H='1-+TUM>FEV3D]U=#$Q
M0S-21F9G0T%Z>$Y%1FIF:E@T:TMH=FPS9GEM3$Q'.%HS6#AZ:WAY)B-X03MR
M24YU.3<O83-.=F17,$XQ8E-,3&)Z;W-S37%M<7-J:FMR02M"0GI6155A3'-1
M5E1!<C5W=%!Z;R].>GIZ-6]N,%!Y6&)796YI3#%*)B-X03M!>G%R=6M#3T4U
M>E-3.&LV<V\K0D\K8F<V5$9I:GA4<W5T1W!Y5&U9=T%48GI!4"MC;G9,1VQZ
M87IC87IP*W-7=&]P;'593&%'1FU7)B-X03M.0E9N2VTR=&U)038X5W)L95 X
M04Q43E52*U!E>6PK66=,<T@X9D)M=C5-+VUU4% K:UA46%9U;'!R1VY-:3-K
M55)0<$US=&94:VI$)B-X03M%<T%E1$%Q4V%5-C<U:F%V4RM%9'528CE.<5!%
M2&U'3F9M8BME1W,R6&UD9DIN:V%Y4R\Q-6Y%33%W-#E12DTR+W!2<%963$M0
M=$UX)B-X03LT<C1B1VPR;C!9365/6G%,6&XQ4D5U0T%U4UAA9S,O3U4R:3)$
M-GA095=E;W=W2UI:.4]I:71N:T-,=3-W<$9%>E5(6DA*.$UN2#AR)B-X03M)
M,5)(>EE(.'A(9EDK5$YV>68X07IE<R]0*VYZ>'I1<EIA-5I!1S=T54I+3VIB
M0U=+=2]'=7A"*WHT-S5J8793;D5E*TIB.4YQ0FM()B-X03MM."LQ=C@Q+WI5
M,3<X,$QR>5(U56QS.4TY0S9N=%E:,VI746QB8TU8;&QA55-J;VA.1E0R,WI,
M:'!C56-1;D]Y-#@Y4FML:TU),$5A)B-X03LR<F8X-4LK6%!.1FA:,S92*UID
M3W5:558U-V$Q:DU(0FU!8FY*1D9!,$I59#,R*UEY4$1P<'A*2'!,3&EZ>&M!
M9E5%."].=C@X+SA!)B-X03M#,F]P-6(X=5=Q-FPU:VLT:5%-1V5/1G!0<TIW
M46AP2D=Q0T9".$]V5$MT3&]U36-5=&]S.5)Q=4$X360U2D)B,V8X07IL871U
M=6]T)B-X03M$87EO1CE8.4AY3%IH>7989U95<3%A9'5D9G!Y,&I3,U@V,D%/
M;W$Y;4LO.#1W>5139FUN<E5K-F5N3RMM,TQ3>"]Y=6)U,TQ$9G=/)B-X03M8
M.6\O,U$Y+S9#,&%);GA49F-F=EIN*UEV-7@K8F1!+TYU=SAT5T@Q8V%3>C)A
M5'AV2'EE5#9Y=S5N;E=Q,$1B57I(,"MK:%!%6DAN)B-X03MU-4=B57EJ:T52
M>3)::BMC9C5R4F513D=T,V=T,74Y6#%";E=X9VM*16%I341N2DIX25EQ=DE#
M9W!7=EA-9E-A8GA4-4)U,4]O.$UE)B-X03MB07AF+W=$3U4X,FMJ5S1X87)(
M26]M5%-X1F(K=G=)<4(V8DM7<E0Y:W9Y*VY-<F@P=#A,4F5O<3EV8WDV1'I$
M-7$Q+SAK9DUL.35O)B-X03LP<#E),5ID3C%+2C1(:FMH3'%L<3-'55)3+T=N
M2W1+2'=R,'I(3T]-8S!213),2#-T=DA+5T5M46\P5T8O=T1/23,K.%AM9B]!
M27E7)B-X03MF+T5:<WEE,4]C9FDP9&YF4U=4+T%*-V9N0G%0:W=73VLV0C94
M-C-E9WEY=$EH:SE'14AI<$-603533E5#=&1G9'5M56%,4VI*6FPY)B-X03M)
M8F16<51J;T1M6&]F:S)8>D9.-5<P>6)Z1T585S591F4K4TYE058R,T-L97I+
M<$%B+TMR;4IM165).% P=51J=FA(1GI4;DLR8C5G)B-X03LO=T-C5% X06Q+
M9&(O=T-91F8X06LX=6)R=%0V4C<S5F1N8WDK9W90:7$S:V)Z17)!1E1P;#1#
M1'5#1&)V;7%W+UA(,V@R5U0V5#=N)B-X03MH4#A!>FI.9G9P,VQ4>GIQ0T5"
M-T]'2S15:U9&66]B:'AT.4=B4'1'3GIG4'@P8T111V]Y2VHO>FEF<"\Q<GI*
M-6<Q959F56QT-V%+)B-X03M(,5=O4T=U<$=C;F9E<#E$1#)N2V]X1$AS.%A+
M4F941$MR2U9907%246<W9V<U<&YA4&QJ.&EM;#!(.#AT5#!+33A)6$XO65-2
M.5(O)B-X03MO,&AD96YH-D]B>E<K<D%*931U<#!N<'I%93E3,#52*U=(+T]1
M;C%C;C!D275R9WA#<$E8-FYF,$UD5#123U9R+W%96F9V=%!F6#E))B-X03M5
M9G5S+VMF,'91+RMC;V9-:VQT-5<P+WEZ845T9#8U8T%Y4G%A<UEB8V<X4W98
M-'!74VYY3UEN6G5/-4=2+VAC:EA4<4EI3V-M1B]N)B-X03LS<%0K5E!Y-SAJ
M9559:E-*0F-46%E5+T,Y>D5S6F1T<58K3S5K<&U2;W!C95-C+W@K3FUJ5T1G
M:$=$,V8X<CE.=#E.+TQR>35A44-I)B-X03M$5#=E5G9E4V1"3$EF<&1Y8S%M
M<&QE4U(X,UE963%!1'E92"]!3354869B>B]L-6)88G%06',W*TPP<$MB:%I%
M9%A7=F=D:69L;50R)B-X03MB26I*6&LT*W9J94\K-' Y+W=!-"MA;$YF9FQ2
M;WAM2EHW8C$W64U45W%X5$]%+S1&2TPY1U8V-DY:4S)A4U8T=SE&>D1C;#AS
M+SA!)B-X03M/3"\O04I.2%=F.$%T;5A0+U588C5U*S!F-V]E+W=$45A5-DPK
M.5!U4#-V<&Y81E8Y1C%"5T%:5W1P9WEN8T5'33=(3DY$-F<W53AN)B-X03MZ
M;"]Z:69.2$)Q4&UE95$P:FET64AC.69H5FY*>F-D<&EX2#-U<C=/+VE1;B]/
M37-4878K6FUR83-E+W9B<$Q3930Y4G1Y2C=M6E%Z)B-X03LO37%Z:C9C4&%*
M-&-9:4\Y1V@Y5U%Y4#1T.5,U<$AB4&QF.$%,-'(U9"\U>55U.4YT+S-.;E!E
M-FAA96UV5#!N5U-72DYU=V15>F5:)B-X03LO6'!G971",4],,#9G:C,O04LP
M5#5'+SEA:S%(+VU/,50O:S-,:V,S*TMJ,T)L:2]X9R]&.4XS3397.79,8U-6
M-%%O,&HP-C!55DY-)B-X03LP=T9M;F%0;"]W1#5X,&=8>DPK85=R95ET54AR
M,W--33$W2'DS<%!C4VAE67(O2W)-0FTV,34T35%I3U1Q=$8V.&AK6#%*;6MD
M<2M9)B-X03M0*V-B9B]*=F599BM91S@O-FI933-884@Y>D@S:C=I-G)2+S,P
M=FHY-D0O3V(O,6]'>"\T>F%:+WA*36YO+S=G+T9'<"]V>#A'9&8X)B-X03LU
M3RM23F$Q<E1.3C$W4V]8=6IP26Q3.70T>'EC47EC5T5Q<4YY14MN;%1T=C!"
M>D8W3WIX:51%.5<O6%E424%J;S,K6"]W1'IK-35E)B-X03MV-$QE=S@R;S)M
M86M!16LQ0E8U5W-J1&)K=U@T-&DS:%%R-V=9-2MZ<$1E1S181')O;F%7>&5K
M*V9R<3%U+WEZ.'DS3G)-;'AB5&%.)B-X03MF4$9.17=D2%4R<VQ#<DM30U!L
M;49G0D=325 X-&9E-5=9+W4U931V;3<X;69Z3C O=T%G*U9V36PW4$)*9%@Q
M,TQB4C9F8G%P.4YP)B-X03M&4UDQ;&LV2V]R.'HR2%=M-#%E;D]755(P9%IP
M8S1X=TI097HW.&YF>35V+T%$4'$V+VUH-7AN4SEU-W54-GAP9'-R2S9!;V5+
M>5!X)B-X03M*0RML>#1P2"MZ5&9C6FDV=E5#03A+1S-E-4=M=VU2.%-F4&\Y
M-GI6=7=D:7(U9R\U>$TO-5-N5R]W1&U"6"]K.'5B<G14-E(W,U9D)B-X03MN
M8WDK9R]06"]+16599CA!=&U8;B]53RMA<D0Y8V9E2%I:4'!0=65'9C@T=E=#
M-FHU8S@V865X05<X4T,S2DEQ04I9<# V9E1M>C=3)B-X03ML56](.&1(03=0
M1GAK14(O>FI"<41A3C4V,7IY-7%"*W)89'I#53E">5%48U=C:$1*5"M92S=N
M-D1K=3!9.%5"269I,D=G4$1->%!0)B-X03LY5#9:=DQU,G,W4V$W=7!&:'1R
M9$=L;FQC,%95459::69!05IP9T-4461O5%0U9R\U>#9T8FYZ0BMB=7)E6FER
M96A!=#%D>5-S2R]V)B-X03MB,E%Q:6LO>DUR=69O3V)R6&M1>$-0=2MX,65J
M2$9L375N-C)59CA!3U9N;$UZ-E9P;FUQ,U@Y-UEV.$%5<GAH,3E+56QO;5!S
M:VQ2)B-X03LX,GEJ<WI,4DU/.70W47@S15,W;4XO;"]Q3CDK85@U=#9(<5=O
M2WAT9DQE;C(X:R])9SAP<EI2.&1A9%I,=51N=G9X2'1L,F5)=UEI)B-X03M"
M+T5F>#EJ6&AL-#)113AO:&Q(+T%$;&YO,7AC95@Y0S%E3E,P3FAC5%%4169S
M+U=L47%4-U9G<%@U6E0R6$]P160W6C)H0S1G.7HP)B-X03MJ.&]T9'1T82],
M9E%,<4)G>E$R8U9P8TM#0U9L=&Q%3&AG3VQ3;DMN9U)M2'%O1T]1:GIC<E1Z
M-&]!*U1"4#A!;DMR5S=3,SAL5T=K)B-X03M&>#EC=C<Q6E5I-RMJ06IC,B\T
M2C!'6EA::T-::SE!2$@Q.'=)5C-S=2])<E$U.4@O2S=224QH4VLY=VHS8G$R
M,4)C4TY);3-B.3)Y)B-X03LU:C8R9D9L3&1P66-/34)N=5ER:U!L;B]!2GAF
M+W=$2F\V>B]!3G-Y-2\V:3=F3C,R:B]D1#,O;TQQ9$8O96XS2#<S,#%R4"]!
M0G@W)B-X03LW+VU(;"\T9V,P,%!Q1'14>69/9B]/2F%*2G%V;5)(54UJ5S%U
M<DMW<4-#-V=G9S5T*S%/569E-GIS-VY,-$E$+VY(-EDK5F9Z9#%0)B-X03MY
M-7%:.4=E84LT,#E1>$%";F=L5C%(9V53>'1X.&$W6E!81&IW:5$Y-TA2*VI+
M66PY4WE34GA2=DQ+-%-.05=D,DE#<6]&4U-4,$%Z)B-X03M29T\R9DQ0-51+
M9DY8+T]15CDU9W0P36QH0F-8,2]Z3S1%8VY/2T-P4&5S<6MF3$XU<792<'A(
M<G-(539F,35Z3'!U:69),R]!2S%*)B-X03MQ4#A!>DAA<"]W06TU8VIM+W=!
M5DAU1$Q&+VI"*TPV8VUH:FUH:VAL2$M/5E-J<G5+<7=O4E5:<&=A9&\K579Y
M4#%24$EV-718*V=A)B-X03LR=W1X8VE85$=L8S!66C!L1%%T6"M6*U!%9'9I
M0GIE87E0:31H2U!V9%)P6F5(;$U3*W--,%1T,WI"+WIJ8B\U3C=Z1"]W07=.
M-2\Q)B-X03M'=UIU=3!0-VU0=D@S1C%7:B]V<&9(-S!(*V,S+W)13FHO>&TP
M>B]I4UI04B]W0G=F:6I5+W="*U!G*V]:9%8P=4<K:7-*<GE#3RMN)B-X03M(
M2T,P95)&;6126&1)>6541%DY0FUK15-29&)/,7--02].6#AP4$DK=C9&<65P
M>E=S5VYA<F(R.'1Y3E5H06I.66QA46U93#A-:6XY)B-X03MO<T]63RM:5VTQ
M531Y075X,T]0;C X2F=K."LY-6(K4W5Q-FQC9FLW*UEU;E1Y33EJ639F8U!:
M<7AQ16%E,&Y-<7(T1#DR<' T;C-Z)B-X03M/,6M133!$,4HO4TA$,#!I8TUX
M,T$O8V\O=T1/4'9K+U103B]K,WIL;V5O3"LW;F5Z345W1E=H;59:=E1L6#-5
M+V5+:G9H,3)5-#5X)B-X03MK4$YD2&I%-%-"5R]L3#4S,50X<V9/9#4U23@Q
M5FDP=6%F,'DW13A)2C)O16Y5;B]!2%9+=$LK,4<W1W)Q<TEZ444T8S$P*U4T
M<#A%)B-X03MU5#9J0D)!24Y196AZ4T\Q9&ER>E X<5!Y56@O3#=63E%V,3%D
M=%-.-T5)16I-06<T2T@U-VXQ2D]2,DAH;6)Q=%HT;T%Q<6-85#9B)B-X03MW
M>60W=#9"<E=M<'%U:E@K;4\U:5,K=#5B6G!!2VQ236A1<T%F1&QM2D-80U%E
M-7E:0WA40W9Y:B]+669L-6(V;D8K;% P;V12949I)B-X03LS;V96=V=H1&EL
M4%5L<EAN;51Q=%8T=&)65%)P.5 T64EU,'(O36HX:'10.'DV=5!-5V@S-V%&
M-6E$3$DX.%E0<'E32E1J265"5F\U)B-X03M.=G1Q9F]R=FLY4')406--:'A2
M65IT2TIN:4)Q5$<W,SAL4'II,39"9$XX>65D,6PP8VME=$9'6G!#-G%A:FMH
M5T50-"]%>'DT87I$)B-X03M(94U.,G57;7E3,FQ,6C9R-4,X9S9"-4HP4F1+
M,&A'4$IV575R<5-H;&UK-F-N24%'=S)51%EF9FU$;GIY>5-S=5AI>$-!;TDW
M>EHU)B-X03MC<R]-=FQV561#=7IX9S%#1F]J24)Y2TUD,&M!,G%58T)H.'-J
M:7E'16A)9$4U24-54T0Q678X06Q,*U5T;BM8=&QF>'!F2%5R>E5()B-X03M2
M<&)O=VE#:V-925)!=D]8;U=9:SAS=3%7<4]5:F%Q8710<'AJ2&5Z2%<Y1C S
M5SE*=71*,4]%6$9J95)M2V5*=3108TAS=T\V:V1$)B-X03MV;5!#6FEB2$U.
M,&]I46]V1DDO>4,X*V578BME5'E&-79.:EDS1&-N=')N;6A(54M(-$Q*2$E6
M2#=80F,R6#4W2$UF=DDR6$-':VY!)B-X03LK:59"1C9$+T%--#<S=#5R,&5U
M+VU$<G(V+V12;%-,4F5::F)H=7%V2DI2:6XK47%J27HQ-$5E2$=/1DUD2&-U
M2UHT;G1I<7%Q1E5!)B-X03M+0E%!8D%!6G)83V)X5C5H*U=F-4AW95)V3D]O
M83=(<D18-'9)2DQA3S)A05)E;6MK>5,Q6GA)+TUJ,'=0<VI-,U5A>GA9:4Y6
M5&DT)B-X03MD3'=337(U=E-R<3-7-71:<F1I47-Y3D=X2%5"9U)T.2M964Y'
M,TM,>G8X04M4.&U9+WDY=3E4=4)Q>#%--F=K8V%R.5A%06I%6EDW)B-X03LO
M=DIE4E!,,GI,,5=R.%5!5E9/3' Y3C16-S-A;"M:+S5'-E(U>796,7%X=3(P
M:GI#9U=T-4=V2DI42#EG>4M#<D)L;T%(53$K93)()B-X03M483 T>'=K6$9C
M*VQ%>F9+5$9,=CAM9GIQ,64Q+U)7=&5E56LP9"]G;597;6MD,'(P9%-S6% U
M32M8:E8T66TT=S-A:G!S<VA2;G,Y)B-X03M/+TQR.'1V3"]K5%-7<V1,1%,S
M135$,W0Y3%0Q6FU58E9P<W%R53A62%0U-S5H86I54WEM>3572$1(1TM$2&1$
M+TI/3%-V>E-U=E!F)B-X03LV6&%B-GA,8WIR<#,Q8TQX8396;$E-,W%.54QZ
M4#=!>39E<S1S6&@P,5(P,5I$3S-P=5E4;%!.=GI2+TDW>3DU-FQ';W)-,FUA
M-'%H)B-X03M$97AQ2%-65D9&13!D5C55-D)G46%E27!M6G!T6DQ&='II-#)F
M4WAY8CAI=RM$.&XO=T$Y8F4Q1VY1965W;6Y+06EF=G)N,4910V=#)B-X03MN
M:'E5061G.4UY1'$X0DXX1R]W85)P.&]&8V5Z3"]Y<"]*3%10258S4'%J86A,
M<5=S6%5*=#5::6]I:5=.;5=29W-D6$I*84UF15<K)B-X03MG6FHV;E=(2TMQ
M9S(T3DM-6G4W2T@X-69K6D(U;"]-1S$X,W1R3%=O9V$R95-X1G5*3UIT;4(K
M1U@Q1C0X9V\O64]3=S8S9W@X1DQK)B-X03LP=D9-4W9K=2].6#AK8F9Z<G%5
M1W571W!Y859R='1'<U-3,$QX3TDR3$HY:W$X8D%T.7!4.4=$5&%Z=WAW:UA&
M8RML1U$R1%)9=&0O)B-X03MK="MC=70R<396-6<X.$I,;S4R;%)$3DLW2T18
M-#%+=RMP+W,S>3AA>D1%,T='-U5D3FQK2VQ06C90;VXU6&%&;V9K0R]W1$HK
M;4\X)B-X03M55W!7,7A$9#-Z9U!+.'1Z15EM;5EF0TYH4VEJ86<K;DU/97!L
M3$E*;F\U36-%67=-4C%14#52+VQ-;C5E5S)P4D161'%B-FDX5&PO)B-X03M1
M*W)H0D-'04A(,4IA,35N9754,5=Q.%5J87%9-F94*T=#3'12+TYF.&QT2C@O
M=&$S6#%S-EAQ='%$2#EC5TE40U-%;79",#5X,31N)B-X03MD5'DR<6-/;3%H
M>&)665)Q3DU-;FM75652+TQU<&589DQ6<&\R;V%O9%EK<W=9-')X;W928C!H
M+V1O5C5Y,31$879,<&Q'8DE*>4UG)B-X03M+8F-51$=)0DYP.6Q462\O,E$]
M/3PO>&UP1TEM9SII;6%G93X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]X;7 Z5&AU;6)N86EL
M<SX*(" @(" @(" @/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#HU,3(Y9#8S
M.2UB9#4U+30Y8C(M.&8U9BUB.#,W-#1E83-F-S8\+WAM<$U-.DEN<W1A;F-E
M240^"B @(" @(" @(#QX;7!-33I$;V-U;65N=$E$/GAM<"YD:60Z-3$R.60V
M,SDM8F0U-2TT.6(R+3AF-68M8C@S-S0T96$S9C<V/"]X;7!-33I$;V-U;65N
M=$E$/@H@(" @(" @(" \>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/G5U:60Z
M-40R,#@Y,C0Y,T)&1$(Q,3DQ-$$X-3DP1#,Q-3 X0S@\+WAM<$U-.D]R:6=I
M;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.E)E;F1I=&EO;D-L87-S
M/G!R;V]F.G!D9CPO>&UP34TZ4F5N9&ET:6]N0VQA<W,^"B @(" @(" @(#QX
M;7!-33I$97)I=F5D1G)O;2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(#QS=%)E9CII;G-T86YC94E$/GAM<"YI:60Z.&%E-&%A8F4M
M-S0Y-2TT,C4Y+6%D93@M-6%B8C Q,SDP-3$Y/"]S=%)E9CII;G-T86YC94E$
M/@H@(" @(" @(" @(" \<W12968Z9&]C=6UE;G1)1#YX;7 N9&ED.CAA931A
M86)E+3<T.34M-#(U.2UA9&4X+35A8F(P,3,Y,#4Q.3PO<W12968Z9&]C=6UE
M;G1)1#X*(" @(" @(" @(" @/'-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#YU
M=6ED.C5$,C X.3(T.3-"1D1",3$Y,31!.#4Y,$0S,34P.$,X/"]S=%)E9CIO
M<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(" @(#QS=%)E9CIR96YD:71I
M;VY#;&%S<SYP<F]O9CIP9&8\+W-T4F5F.G)E;F1I=&EO;D-L87-S/@H@(" @
M(" @(" \+WAM<$U-.D1E<FEV961&<F]M/@H@(" @(" @(" \>&UP34TZ2&ES
M=&]R>3X*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z,#<T.3)E
M8S0M96(W-BTT939B+6(Y9#DM,S<T930T-F0U-F8T/"]S=$5V=#II;G-T86YC
M94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(P+3 T+3(Y
M5#$R.C0S.C,Q*S R.C P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R871O<B R-"XQ
M("A-86-I;G1O<V@I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @
M(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#ID.3$X,&5F,RTY.6-C
M+30P83 M8C9C-"UD,#DR86(R86$Y,#(\+W-T179T.FEN<W1A;F-E240^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C M,#0M,CE4,3,Z-3DZ
M,S$K,#(Z,# \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IS;V9T=V%R94%G96YT/D%D;V)E($EL;'5S=')A=&]R(#(T+C$@*$UA8VEN
M=&]S:"D\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S
M951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C
M=&EO;CYC;VYV97)T960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.G!A<F%M971E<G,^9G)O;2!A<'!L:6-A=&EO;B]P;W-T<V-R
M:7!T('1O(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YI;&QU<W1R871O<CPO<W1%
M=G0Z<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @
M(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA
M8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM
M<"YI:60Z.&%E-&%A8F4M-S0Y-2TT,C4Y+6%D93@M-6%B8C Q,SDP-3$Y/"]S
M=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE
M;CXR,#(P+3 T+3(Y5#$T.C(Q.C R*S R.C P/"]S=$5V=#IW:&5N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU
M<W1R871O<B R-"XQ("A-86-I;G1O<V@I/"]S=$5V=#IS;V9T=V%R94%G96YT
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC
M:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#HU
M,3(Y9#8S.2UB9#4U+30Y8C(M.&8U9BUB.#,W-#1E83-F-S8\+W-T179T.FEN
M<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C M
M,#0M,CE4,30Z,C$Z-#,K,#(Z,# \+W-T179T.G=H96X^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E($EL;'5S=')A=&]R
M(#(T+C$@*$UA8VEN=&]S:"D\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^
M"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI3
M97$^"B @(" @(" @(#PO>&UP34TZ2&ES=&]R>3X*(" @(" @(" @/&EL;'5S
M=')A=&]R.E-T87)T=7!0<F]F:6QE/E!R:6YT/"]I;&QU<W1R871O<CI3=&%R
M='5P4')O9FEL93X*(" @(" @(" @/'!D9CI0<F]D=6-E<CY!9&]B92!01$8@
M;&EB<F%R>2 Q-2XP,#PO<&1F.E!R;V1U8V5R/@H@(" @(" \+W)D9CI$97-C
M<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z>&UP;65T83X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_^  $$I&248  0(!
M $@ 2   _^T +%!H;W1O<VAO<" S+C  .$))30/M       0 $@    !  $
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MLG)*M7&QLU#HKP.HX^9VHHFND8Q'#=>=IS&2I[)TU5*)%$7$DBL0_4HEZE,
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ME*_[334643223.JJJ<J:2293'444.8"D33(4!,<YS"   !U$<\5*2A)6L@(
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M==2L>@/;+Y0&V['E5T!4.57>#OK:CINGKL=^FQWG9G:J>U49UTH>D&Q<D_\
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M6WENJ%HJS.Y0#6UU!W8X"5A&UKJSU5=!E9*VO)M&R4[ .UVRA$GC456ZATS
M4XB40#Y%KO\ 8KV[*8LLV),?@R51Y*6'FW51Y"0"IA\-J46GDA22IISE6 02
MD C?VI,&;#2TN6RZTAYL.-E:%)#B#N M!4!S()! 4G<'8]:^9;[U9KNY<6;3
M=K9<WK//<M=V:M\^+-<M=S90A;UNN*(SKJH4]I#B2IET)<2% D=17*_PY-_-
M>,'.'C5NN4<^I5ZK;)C8RWO!.4A65(N[1[0KL^,!Q*FI[GU6S.UP*82@8R8!
MW%^O!T[Q0:</:M: 95@<1'>7.7:EN1D[?-2HJDRXJ.G4<\AAM&XWV"CT/@>6
M:<9 C%\YME[=/+':DA+A]C3H+3I^XVM1^YY>(ZLXAL#=U+T4U&PV,WWUPN>.
M2)-I9V)+UZLKK-]LS Y=U)[^YVUI!(!("O ^!J%E,4Y2F*8#%, &*8H@)3%$
M.H&*(=0$! ?8.9)R"#L>A%6C#KU'A69X@@D$$$'8@]""/$$>1%?[G\I7\K%1
MZ0#X7L_0-@6'G/HZLKR&L;XZ+(;[@H9L*RFO[XZ4(@OL$6;=/S$ZC>5S%4D%
M^ABLYHRBBIP(]2*G?%V;O%M;LCQN-P^Z@2TM99;D<EH==5L)D1()$/F)V,F(
M-PRCH78H2E"2IA97"?B!TND6^X.9U8VBJUR#O*2D;]TZ>A=V'Z[=/59^"YN2
M=E@"Y3@,XF(%]L-OT2S6Y-Q\EL31CX+.F.<B;]8VDJ6BP!YQ7*JZV1 *6$;@
MO0PE*05,J*LN>6X5%NK-*8I2F*4IBE*8I2MR_@#^&)+<;Z2YY<;SKRT3N?;%
M<2C]<U*7:^5*:WUA*>KOU9*4:K!YL;;[Z":!U$#E*XCXU(B)^Q5R[0)GY[1S
MBRA:HW].B^GTE+V"V:45S9#:MVYT]O= 0VH=%QH>ZPE8)0\^I3B>9#3+BIT:
M :8/8W!.7WULHO4MO9EM0]9EA6QYE#R<=Z$CQ0@!)V*EI%)O'=Q*Q-1+TWI1
MA,]$K#L5N*I&0W6(YSQLBR:+WC"8\9U!Y9%HL7,M*5@EN1)45IYDMM+5I,RK
M.I*5736?STCS?K36' Q#4+5^BE9.1NQZS6"QX*%(^4IE ?M-B6B4;?#*KZLT
MG(:#9.!* ]228$-\$X@-D79>:<O99Q$JS5YM1M>+VM]_GVW0)4Q"H4=M73;F
M4T[*=1OYL%0ZI&T?>)#($6O A9TJ DW*2A&WGW;1#RU#X@I+23^?V\#4\^SQ
MP1W)=<UY8ZPM5NT\QZY7(O\ *2PF\7YAW'[9&<Z%/>.PIDUYO?;8QMQU2*P/
MYHPJ M7JTQ2E,4I3%*4Q2E,4I3%*4Q2E,4I3%*4Q2E,4I3%*4Q2E,4I3%*4Q
M2E,4I3%*4Q2E,4I3%*4Q2E,4I3%*4Q2E,4I3%*4Q2E,4I3%*4Q2E,4I3%*4Q
M2E,4I3%*4Q2E,4I3%*4Q2E,4I3%*4Q2E,4I3%*5__]>?_BE;^*8I2F*4IBE*
M8I2F*4IBE*8I2F*4IBE*8I2F*4IBE*8I2F*4IBE*WM>,WPMB]T>&!3IZA5I
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M]%GM(M7[I,@1"UAV>O3,GQEUM(3'COOO)<O]C2  EM5IN,GF;0!LF(^QUWW
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MS2X+'M3;APZV._ZM3I=PRNZ]_-#DD\SR8DAY2XB5*/4A;'(\V.G(VZAL !
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M<.7"QS'.<YA,<PB(B(B(YIJ888BL(C1D(;C-H"4(2 E*4I&R4I2-@E*0
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M.64)2E"0A  0!L .@ '@ /94>R23N>I-3Y2E*$I2E(2E("4I2 $I2!L$I V
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MWO7C],A7]WZ@V/JB54660:H7RGSE;2DC(  J*0[V39-V,TV I@,"S159(Q1
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MV\!WPO+F=PX3X[N*>_<^:)WM)V?M.'(F90#=IF\.XN$C6VWDF-W% C(I>H
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M1JEWJ*',HH*91,(B "'4]ZUQUIR115D&79/-W\GKI-<2.JCL$K?*4@%2MD@
M#<[ ;UR>'AF(6\;0;5;F?SD9E)\O$A )/0;D]3M76UVU?U8OQ)O6IVH-VW._
M+<,RR&6VD<SB@E#3]Q6VVA)=5RI2 E/,=@-ZY"L(]A%-$F$8Q9QS%#O\ADP;
M(LVB/FJ'65\INW(FBGYBRACFZ%#J8PB/M$<ZSD29,QXR);BW9"MMU+45*.P
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M[.M24"[Q6DMR6=SMSRXK82U(;&^ZEQD,O)2"0U(6=JC-GW#; D-.7+ UEB6
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M>E#;&+#\8N.FJB./)<7S>$I=CI$6434=QVM*/*Q#E%1,A@(NS(_V8T4.4X"
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MT]X<5X2K\Y)5NQ[.V3JO74#,PTB[B9=F[1L@;(?>YT@Q6;NVZSB#UT[2.)#
M(HG.'Q".5P=G!@T3-N*&WKN4=J5:[3:KA->:=0EQM22QZ"CG0L%) =FMJ&X^
M:"34@.(&].V?3=\1W%-R94EAE*DDI4"%]\=B-B"4LJ!V\B:@?P'8?%R[B'LJ
MI\*/<;=C6.9/D$Z',CM2HCS2[=^1UGTAA]#C3B&YN0-*3N#LM*:QD:U\5;Q%
MM3 W)3^8&Z%D&@H"V9W>R%VE'H$;F$R*"4=L]K<&)&I>O0403\HQ0 HE$H
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MQIQI1VJK<M91NQHRZO=L'IT:U![9[)7'$*I7D-=V5R]<LCUHRAS@_;AV.4A
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M.8G-W>6Y8M[ZY2#V/WDZQ,0XG;#KFAHEK5;DF@& #HDM)&2LTJF(F\MQ)*%
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M;*,>RJG4B9CN9=\W5=+',4#**K&,(=1',UFI6:SM2-0KWGURYO3+Q=),L@_
M#[JG$MCJ=DMH*6T@$@)2 .@JPK'K.SC]BAV./MW42,VT"//D2$E7RJ(*B?,F
MJ#<^RV9GF;Y;FD\K]*RC(;M?'$+.Y83<9KTEF*G8J"6XC#B6D $A*$ #H*PQ
M^D5;X<[5\064ULV>'5KG'G7U1H+1J0X&9C9;+'I[$M4FD';U!XH6T,8Y?V]
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M4Q2E,4I3%*4Q2E,4I3%*5Z-L'6&M=LP"]5VGKZD[)K#D#E<5V^U6#M\(L"@
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M[\%SM_LDM'E-*$;)LE0_MZI4(2T@_&D1D$CX@I/RU\5'%'E@4"Y;K<4>8'?
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M1WAZ\;E+?!I1DONW9+UY4-*UN53,XCSS+=NBXG[E-M$UFZKFNTB/=I*K)D,
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MP!4'!S(,HZM;ED%1 IR+&$"HV=4P&*;I[IB(&4?$I>XT>SM:;9E:K</4/E"
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M HDK=GC<^!9Z>)VV 92=4PJJ4IBE*_PQBD*8QC 4I0$QC&$ *4H!U$QA'H
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MI)E$QC&$"E* B(],\VFG'G$LLI4MY:@E*4@DJ).P  ZDD] !U)KQ4I*$E:R
MD#<D]  /,_%7FVVXZXAII"W77%I;;;;25N..+(2A"$)!4M:U$  #<FIF/BD\
MQWO-[F7L_;35ZLOKN#>#KG3C,Z@F19ZSJ#QZWAWZ2?4WDK6^1<.YQP3N/Y3B
M3.F!A(0G35MPBZ'L:!:&VG#7FTIR:0CTVYJVZJG24H4X@GS$9"6XB#L.9#"5
M$!2E;UDZIYDO.,SE7="B;<@]S''D&6R0D_$7"5.D>161X 5I%X9-(6=%M'\:
MQ5UE",@FL_DAR]X)V6[DEV99<EL+5TYT6F.VU";5L.9N,%$ J-=>&29KKNI
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M E( 2!L /*LSZUK<6IQQ2EK6I2UK6HJ6M:CNI2E'<J4HG<D]2:_3/&O[7C7
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MYV89:4M1]B4)*C^D*^C9[7*O=WM=EA(+DV[W&#:XB -RN5/DM1(Z -QN5.O
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MTE%W"ZA$4$$2&56665,!$DDDB 8ZBBAS !2@ B(CT#/!QQ#2"ZZ0EM()))V
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M^&CG\O+/6L9%13)U)2<B^72:LH^/8H*.GKUXY6,1%LU:-DC***'$"D(41$0
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M6UO\FZ.\Y%*"NKAF\=1SQK(,'"S1\Q<H/&;MNH9)PU=-E2K-W""I! Z:R*Q
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MGGRCUYS2N%1X]SU<U$^HZJVQY]E6X>8FD]ATV29*5R5E#-&TY&3D(U-(1[E
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M2VH\=124K#;[[;BD*2M*"D@GL_#-(<VSA@3K7'0S:E'8/OJ+;:MNAY  IQP
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MR*2H,J203H?U;Z,%Q2@8]N;;^]]Y;'G2)]'"E.3IFLJTLH9/M.8(=]!;#FR
M10>XG26#X@[@,'4!K-R[M9]8KC)4,*QW'[7;R>@DF5/? WZ>^H=A-=1T/Y7^
M3;QJ1-JX7L3CMCW8GSI+^W7N^[81^\E+ROD]\JO_ "?M+=4ITAP8E@^$X[!*
MMVTW=5XR6XH2%;@&6Q.Q^$=T]%?E7Y-J^DS?HS_ "1CUFT5=>2]??"!C-Y)I
M?Z*_%-4$U"I%<-)35SM!PU\TQ3'(7RE3 7H50G41SBL#M5^)"-)2[,@8I)C_
M  D*ART;C<;[*;GI(5MN 3S)&^Y0KPKZ;_#-I^XV4M/W-MSR(=:/Z(4P01[?
M _&*XY#[1_7F/(0Y*LVF\]@$!R.[8;XQS)YDE1;=C9.TMMWE!"2>=(WW*3X5
MU:<J/1FMY4")DK5Q7VU";T:LD5G8ZZN<:VUW?U4D^_M95^;&3D:797XE #?6
MM6!*/M*0#& H'EWI!VK6G^1S6K1J_9G\>=<4$^FQ5JFPP3\)YKNT2F$>7O:9
M9\"=AN4]5Y5PR7VWLJE8K+1/2D;]RXD,N_(A7,6UG\\6OBW.V\G-,.TBPF^R
MH]KU/Q2;A#KRT-#(;/(<R"PH4K;=Z?"]&CWFW, DCWI$XCH3L-R,U-SI=OUU
M:IZC7ZL3M,N=6DG$/8ZM9XIY"3\'*-3=J[&4BI!%N\9N4^H#VG( B40$.H"
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M4 H$",MPMT^TS'+?<V7(\YI6RVW$E*DGXP=CX=1Y$$$="*L@L-_LF46B#?\
M'+M;[Y9;FR)$"Z6N4S-@RVB2DJ9D,+6VHH6DI4-^9"@4D @@>G9]RO3KZ],4
MI3%*4Q2E>]ZRUAL+<U[K>LM54^=OM_MS\(VN56ML59"6E'0)*N%O*13^"DV9
MM$%%W"ZAB(-FZ9U53D3(8P<>RO+,:P7'I669A-CV['(3?._(?6$-MIW"1N3X
MJ4HA"$)!6M:DH0E2E 'W[9:[C>I[=KM3+DBX/*Y4-H&ZE'Q\/8 "23L  22
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MM+;%-R!;2B@2Y#H@1%$'HME'=OR76_[N-Q5'RV&RC)K&N&/(9[*).2368*5
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MT\W[^\6R\>J5+L!VX$_>'9LZY7;3G7*-IS+?4<*RQ1C.-*4>1J>E"E0Y#:?
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MM.Y]I-6C6K@\X;;3#:ALZ5V26EM*0J1=9=XNDQY82 IQV3.N3[G,X1N4IY4
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MA%#9ED69:OU$98$#E;[ N+=_ZO. BX[DW)ZA7HV1F2)&35375CR)*%\LYA"
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M(]HMA$C#>*F^2EI*8%\8BW)@GX2764L/'?S_ "W'D#X@ /EL6T#O+=VTSAM
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MKNU&D+$=(ZGU6HRVF4^&P;VVV )KUUXM3%JU-G^C@):DAI_8>2G&T]X3\:G
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M&G9B_2L1/KW</X(BH!\1GT2W?W#8_?35['9\?2YVW[+<I^^8]=*^O?P/J/\
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MX\YRDMQV$$I[V0\1RM-@[J/4D)"E#[F.8[=LKO#-CLK1=FO* \#RH3N.9Q9
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MD4U['6-W#(*]_8@20,V*83="]1'K$O!-<M>="GW;+A=^O-BY'"7(2BKN4N*
MYE+@R4+92Z1MNLLA9&W7PKM&]89A.:(3,N\*)-W2.5X <Y2/ !YLI64CV!?+
M\51HP[6#6;1UZ3:<3S+*\.[EYPR\?=6YZ S*=2DN.OX[>&9%O:F+3R[K5'#A
M&W7PKX/K[P9O#'UE--;!6>)-'>2+-RD[;EO-BV+M&,*NB8ADS'@]FW*WPBQ"
MF( ]AVYB"/QA[1Z]AY+QS\6&5P%VV[9G<$17$E*O1&84!>Q\=G8,6,Z#U\0L
M'XZ^#;]&-,+8^)$6T,%Q)W'>K>?3O^=><<2?NC:N<W_C"XE,DANP+EJM>F8[
MS:FG#9+?CV,R2A8(4!-QNSVF:@D*/5+@/QU]6Y,^(7PMX4U]XWV[N*E0$S7H
MTJ$9J*G.6%BV2X(T;$3C(:*U[ *J/XA%<H$1;K/BL(Q$.GF.$DRF.7A^E'#3
MKMKS<D.878Y\F#)=W<N,E*V8(*E$K=<F/ (<(ZJ6EHO/J^"VM1 /U<GU#PK"
M8Y3=YC#;S:=DQVR%O'8>JE+*.J0>@!5R('FH $CBVFV@.L>LL]ES$\1O,Z'<
M)!7)RR[MOV_'&RZX529DJ_ST)8EK02I;B&"_)7\%M2B <,WBB>*UM+Q%;JSB
M6[)_KCCM2I)5Y0-5A(%<N9&3*1PT)>]@N6O:TEK>X8N#IMT$^]G#MU3H-C*'
M4<NG6@CA(X/,1X8["Y,<<;NFIL]H)F7#DY4H;W2KT2&E7K-Q@M(4M1V<DK2E
MQT)2EIEJ"^J6J]UU&FI92E4;'6%;M,;[DJZCO72.BG"#L -TM@E*=R5+7=GP
MS<+>,</EF>EN/,9#J!>8Z6;]E!8+;<>,2VZ;'86G=W8MI0^V%.+5L]+<2E;@
M2E+;374UDR:ZEJ5-,4I3%*50@\+CQ3.,^Q.$FE4]^<F-)ZRW'KZ 3U;>H3;.
MVJ/1+'+NJ*1*(@K<BUN,_$2$VUM-4(P=KODDS(FD5'2/<)T3YFLXN>$35;&-
M?+\K3G%+]=L'N4DSXCMNMTN6PVF62X[&*HS+B&E1Y!>;0THA082RO8)6FK"M
M+-5,9N.$0A?[G!BWF.WW#J9$AII:BUZJ7 '%I*@MOD45 ;<Y4-]TFJ#.)KAB
MU(Q_6C,E8)IOF>28A?YZLGLDW%<5O=\MT1J]J5+FVE;MH@RH\)VV70OM(84H
M+$=+2]@E8KHE](IYRZ]Y&[6TSI#1^R:CLS6&J:T_NMCM.O;-#6VGS&QKLH5F
MWCVT_ NI")E%ZA5(I/J=NN<J*TPX1/T53.4MA?9C\/V2Z88??<_S^U3;5EMX
ME(BL1YC#L:2U"BCF4M3+R4.-B3(<5T6@%28S;B?44DGHCB,SJW9'=H5CL<EF
M5:XC1<6MI:7&U/.]  M!*5%MM(\"=BXI)Z@@3@[/K1._Z>XOF&:9KCEVQO)<
MIN+%FMULO]MF6J[1,>LR2ZY(<@3FH\J,W=KI*5T<0"M$1M8]50)S<Y:14;*L
M3IBE*]TUUL2\:DO-6V7K6SRU,OE)F6=@JUG@W M9.(E6)^]%P@<0.DJD<HBF
MLBJ4Z#A$YTE2'3.<AOA9/C&/YGC\S%,JB,SL=GL*9D,.IYFW&UC8@CH01T*5
M)(6A02M"DJ2"/=MUQG6B<U<[8ZMF>PL+0M)V4E0\"/YH@[@@D$$$@_'R#'[)
ME=DNF-Y';8MXL=YAO0+G;)K?>1I<5].RVUC<*2H'92%I*5MK 4DI4 1N+\/K
MT@CCKOBN0-#Y9S,-QZW:U:MF#ZV3)A8:7O;M,B21IAA9E#*-]>O78E.JX9S)
MD(]#V>2^6$X(IY_^)/LVM3M.[I)R+1IA_)L!6M2T1VO7ND1))/=K8&QF)3T2
MAV,%/+_7D= 3SJG+I[Q!XY?HS<#+5HMU\  +BND9T_5!?@R3XE+FR!\%P[["
ME+7O@)U!P:X3KYI5#F9_A;KKC[%JA@/YC8VE%2A$?MJ0ER_LM A+;T,+D+^&
MPG;G5VU[BXH\,>;4)!67:^J-2;VC?4P"LWQ K*0DO<L514]6@MAU-ZUF_<=1
M<!,9%N_]6.<.HE$<AEA&L6NF@D^1:L.O-ZQZ5S^_Q#SH1WFVW,["D)4UW@'0
M*6SS@= 0*[;O.)X7F[#<F[1(<]KE]1T;%7+[$O-D*Y=_(+VJ*>(ZI:PZ,39U
MNQ;*<KP>3WW\>5C67F(WI(3R]Y.Q^ZLNPO2TH.P6XQW@'@=JX[47P7?#"UU,
M-YVO<2:6]?M5T7**=VM.S-FQ7FH"(I^9 [(NUK@UTNH_"(HW,0_L[@'H'3L[
M(>.SBSR>"JWW/,Y[<=:2DF+'@P7-CX[/08L=T'V$+!'D17'8&BVE]N>#\>T,
M*<!W]]6\\GI^RO.N)/R$;5V#?.,7B6R&&Y!N&JUX98=;6VM5EMF-XW*Y5C97
M+.QVRVJ:A6W@I+@4/(BOMG(KG7PPX1U4S7;>W=?452N123:#U16%X^4OBK1D
MV(C&Q%<UG6O.F&C/L!-%)0[=K'-@,7S5D4P$P<"TQX>M==?+N'L,LMRN"93Q
M4[<'PMN(%*42MQZ<_LTI6_,I0"W'E['D0M70_;R/.\+PB)R7>9'8+:-DL((4
M[L!ZJ4,H]8#P )"4#INH#J.&:?:(:Q:T70.XIB=_O:;C*4Y-RFYMR(UC2Z\X
M5R9=PR2X\D1UW<J6M*7'9#A!Y4+5T.'3Q3_%NV5XB%F9U. CY76?&NH21G]3
MUNL^25E[1,)>>BWNVQUF"BC%Y.D:+&(T8(J+,HHAS@DHLJ=1PI?_ ,(7!CBO
M#-:5WFY.,W;5.:UR2)P00W':.Q,6$%@+2R5 %QY02[((25I;0E#28-:J:N7/
M464F)'2N+C3*MVV2?66KKLZ\1T*MCLE()2V"=BHDJ-UG##PI8YP_6UZZSY$7
M)-1KM'#%UR)#*TQ+9#7R+<LN/(?2E]J"74 NOK2AZ44I*DH2E+:>GW)M5T]4
MMZ8I2F*4IBE*[Y_1W=UZ?T7S;V-9MU;1H&I*S.<8;Q5HNR[)ML%2:X[L;C:&
MFIUM"A/6-]'1*4@ZB:^\62346*90K<P%ZFZ -=G::8'FVH.@=KM6!VBY7JZQ
M\LBR'&(,9V4^EA,"YM*=[EA"W"A+CS25*"2$E8)V&Y'??#K>[/8LWDRKW*CQ
M(KEK=0E;SB6D%9?CJ">99"=RE"B 3UV.U09[0+#<NS?1?'K;AN,W[*[E"U*L
MMTE6W'+5-O-P:M[>,YA!<F&#;V9$I4=N5/90I24$)+@WV&Y&MKD9XA/!1+C[
MO,\?S$XPV.0^H?V22/KU5WUJFQV:=?*4Z939P]?@(JVN9*9F9)R<J+9L@0RB
MRQRE .HY3'IAPT\0B]2<?$G",LBQO=N"5O2+1<&&&D"2T5.O/.1TH::0G=2U
MJ(2E()/A4N,CU#P08]/+=YM;CGH;VR&Y3"UJ/=JV2A"7"I2E'HD ;DG:JIM/
M= M;U9[A(D:1ZE6Z/^2W'2_<+I@N4VZVP6$W>&IZ7/G2K4W'APXS8*W'%J"4
M(22:F?9JOJLRM'],4I3%*52>XA\_.#3#BCQGC9GF)QAK<S%:"U!$3->M6]M8
M5BR0<Q$T"OQLK$3E>GK1'S$1)QS]JHBL@X134(<@^SIT$<LFM7#CQ R-8LKE
M0<(RR5!>R.Y.-/1[3/?8=;<F/+;<:>986TXVM"DJ2M"E @^/LLJP_/\ !6\3
MMC;UYM;3R+?'2I"Y3"%I4EI 4E2%K"DJ!!!! /2LZ.K.A&MC^J6I$F'I'J5<
M8<K.\MEPY]KP?);G;IL27?I\B++A3X-LD1)<:0PZE:%MK4D@UEM](NWOI;>W
M*W34GI/:NOMNPM;T PBIJPZTMT#>*XQEW6P;T_)$*6"M/Y.(-*HL54EE6Y5A
M51363$Y2]Y>MN?9B:>9WI[H[?(N>V>Y66=*R1;C3,Z,]$?6VF'$1W@9?0ASN
MRL*2E92$J*5!)/*=HL\1M^LM^RR$[9)<>8PU;PE2V7$.H"BZZ>7G05)YMMB1
MON 1OXBK-NSWP?,<'TMS"-F>+W_$YEQSQ^5#@9):9UDN#\1NP6-@RTP+DQ&E
MB*M]"D)<* E:D* )Y3MGSRRBH]U/BN[KPH_&1OO %R.J-D1<QM#C!-RJLBK6
M&#E'WVZPE7ZQE92?UT:0608NF$HLH*S^%<+-VSAQU<(+-ESN!=0&XQ.!W'>(
M]K\F.+/,6C5J.R$!]:3Z-/;0-FV9O("M*VP.5F4A*UH1[TXAUM+0:[OTGUEG
MZ?J]R;DA<K%UKWY 1WC"C\TMG?8$*/539(23ZR5)45<T+N*3A!L6O#?Y*<=E
M1,9U+AQ4QTW)]M?N3DL5A 1%@Y (Z''VGXJ$\C$QM#CC;?O:T.(2V&]L>C>8
M?#'G%2UV.K-JZNVY$V2,5;6'6,\>-"T>H+HAZ['6W5=M1;V K(0$Q#BX8'9K
M]AO+.H0.[*%M0=$==.'^^ID9?9[O99D5T*9GLA?H_.#ZJX]PCE3//X$<CP=1
MN.9*2=JFW8LQPO.81;M4N+,9=3LMA?+S['Q#C#@"]O+J@I.W0D53-FVD>L.B
MEY0_D^+Y-B<NW24NV_)8*9/N9WZ%^\R;5E%J6Y +P("AW;X>1N.9*2=JX\VK
MP4/"[N4TI/R_$FILWRKD[HR%5NFUJ)"@JH9,QBIUJD7VO5U%L I!VHD:E1*
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MN4#IK(J%^R,4P"&?C(CQY;*HTI"'8ZQLI*TA25#V%)!!'Q$5YH<6TL.-J*7
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04Q2E,4I3%*4Q2E,4I7__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
